<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37774908</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>147</Volume><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Evaluation of OMOP CDM, i2b2 and ICGC ARGO for supporting data harmonization in a breast cancer use case of a multicentric European AI project.</ArticleTitle><Pagination><StartPage>104505</StartPage><MedlinePgn>104505</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2023.104505</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(23)00226-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Observational research in cancer poses great challenges regarding adequate data sharing and consolidation based on a homogeneous data semantic base. Common Data Models (CDMs) can help consolidate health data repositories from different institutions minimizing loss of meaning by organizing data into a standard structure. This study aims to evaluate the performance of the Observational Medical Outcomes Partnership (OMOP) CDM, Informatics for Integrating Biology &amp; the Bedside (i2b2) and International Cancer Genome Consortium, Accelerating Research in Genomic Oncology (ICGC ARGO) for representing non-imaging data in a breast cancer use case of EuCanImage.</AbstractText><AbstractText Label="METHODS">We used ontologies to represent metamodels of OMOP, i2b2, and ICGC ARGO and variables used in a cancer use case of a European AI project. We selected four evaluation criteria for the CDMs adapted from previous research: content coverage, simplicity, integration, implementability.</AbstractText><AbstractText Label="RESULTS">i2b2 and OMOP exhibited higher element completeness (100% each) than ICGC ARGO (58.1%), while the three achieved 100% domain completeness. ICGC ARGO normalizes only one of our variables with a standard terminology, while i2b2 and OMOP use standardized vocabularies for all of them. In terms of simplicity, ICGC ARGO and i2b2 proved to be simpler both in terms of ontological model (276 and 175 elements, respectively) and in the queries (7 and 20 lines of code, respectively), while OMOP required a much more complex ontological model (615 elements) and queries similar to those of i2b2 (20 lines). Regarding implementability, OMOP had the highest number of mentions in articles in PubMed (130) and Google Scholar (1,810), ICGC ARGO had the highest number of updates to the CDM since 2020 (4), and i2b2 is the model with more tools specifically developed for the CDM (26).</AbstractText><AbstractText Label="CONCLUSION">ICGC ARGO proved to be rigid and very limited in the representation of oncologic concepts, while i2b2 and OMOP showed a very good performance. i2b2's lack of a common dictionary hinders its scalability, requiring sites that will share data to explicitly define a conceptual framework, and suggesting that OMOP and its Oncology extension could be the more suitable choice. Future research employing these CDMs with actual datasets is needed.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Frid</LastName><ForeName>Santiago</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Informatics Service, Hospital Cl&#xed;nic de Barcelona, Villarroel 170, 08036 Barcelona, Spain. Electronic address: https://twitter.com/santifrik.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bracons Cuc&#xf3;</LastName><ForeName>Guillem</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; de Recerca Cl&#xed;nic Barcelona - Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer, Rossell&#xf3; 149-153, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gil Rojas</LastName><ForeName>Jessyca</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinical Informatics Service, Hospital Cl&#xed;nic de Barcelona, Villarroel 170, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Rueda</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Informatics Service, Hospital Cl&#xed;nic de Barcelona, Villarroel 170, 08036 Barcelona, Spain; Radiology Service, Hospital Cl&#xed;nic de Barcelona, Villarroel 170, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastor Duran</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Clinical Informatics Service, Hospital Cl&#xed;nic de Barcelona, Villarroel 170, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-S&#xe1;ez</LastName><ForeName>Olga</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Oncology Service, Hospital Cl&#xed;nic de Barcelona, Villarroel 170, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lozano-Rub&#xed;</LastName><ForeName>Raimundo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Oncology Service, Hospital Cl&#xed;nic de Barcelona, Villarroel 170, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="Y">Breast Neoplasms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="N">Information Dissemination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="N">Genomics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Health information interoperability</Keyword><Keyword MajorTopicYN="N">Health research</Keyword><Keyword MajorTopicYN="N">I2b2</Keyword><Keyword MajorTopicYN="N">ICGC ARGO</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">Secondary use of health data</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>30</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37774908</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2023.104505</ArticleId><ArticleId IdType="pii">S1532-0464(23)00226-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37794003</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2052-4463</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Scientific data</Title><ISOAbbreviation>Sci Data</ISOAbbreviation></Journal><ArticleTitle>Scalable Infrastructure Supporting Reproducible Nationwide Healthcare Data Analysis toward FAIR Stewardship.</ArticleTitle><Pagination><StartPage>674</StartPage><MedlinePgn>674</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">674</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41597-023-02580-7</ELocationID><Abstract><AbstractText>Transparent and FAIR disclosure of meta-information about healthcare data and infrastructure is essential but has not been well publicized. In this paper, we provide a transparent disclosure of the process of standardizing a common data model and developing a national data infrastructure using national claims data. We established an Observational Medical Outcome Partnership (OMOP) common data model database for national claims data of the Health Insurance Review and Assessment Service of South Korea. To introduce a data openness policy, we built a distributed data analysis environment and released metadata based on the FAIR principle. A total of 10,098,730,241 claims and 56,579,726 patients' data were converted as OMOP common data model. We also built an analytics environment for distributed research and made the metadata publicly available. Disclosure of this infrastructure to researchers will help to eliminate information inequality and contribute to the generation of high-quality medical evidence.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Kim</LastName><ForeName>Ji-Woo</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Big Data Department, Health Insurance Review and Assessment Service, Wonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kim</LastName><ForeName>Chungsoo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1802-1777</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kyoung-Hoon</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Review and Assessment Research Department, Health Insurance Review and Assessment Service, Wonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yujin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Review and Assessment Research Department, Health Insurance Review and Assessment Service, Wonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Dong Han</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Big Data Department, Health Insurance Review and Assessment Service, Wonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yun</LastName><ForeName>Jeongwon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Big Data Department, Health Insurance Review and Assessment Service, Wonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baek</LastName><ForeName>Hyeran</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Big Data Department, Health Insurance Review and Assessment Service, Wonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0003-4989-3287</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea. veritas@ajou.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea. veritas@ajou.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-5052-6399</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea. chandryou@yuhs.ac.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institution for Innovation in Digital Healthcare, Yonsei University, Seoul, Republic of Korea. chandryou@yuhs.ac.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Data</MedlineTA><NlmUniqueID>101640192</NlmUniqueID><ISSNLinking>2052-4463</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CoiStatement>RWP reports grants from the Ministry of Trade, Industry &amp; Energy (MOTIE, Korea) and the Ministry of Health &amp; Welfare (Korea). SCY reports being CTO of PHI Digital Healthcare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>5</Day><Hour>1</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37794003</ArticleId><ArticleId IdType="pmc">PMC10550904</ArticleId><ArticleId IdType="doi">10.1038/s41597-023-02580-7</ArticleId><ArticleId IdType="pii">10.1038/s41597-023-02580-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schneeweiss S. Learning from Big Health Care Data. New England Journal of Medicine. 2014;370:2161&#x2013;2163. doi: 10.1056/NEJMp1401111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1401111</ArticleId><ArticleId IdType="pubmed">24897079</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC, Krumholz HM. The Evolution of Evidence-Based Medicine: When the Magic of the Randomized Clinical Trial Meets Real-World Data. Circulation. 2022;145:107&#x2013;109. doi: 10.1161/CIRCULATIONAHA.121.057931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.057931</ArticleId><ArticleId IdType="pubmed">35007161</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo-Ciganic W-H, et al. Developing and validating a machine-learning algorithm to predict opioid overdose in Medicaid beneficiaries in two US states: a prognostic modelling study. The Lancet Digital Health. 2022;4:e455&#x2013;e465. doi: 10.1016/S2589-7500(22)00062-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(22)00062-0</ArticleId><ArticleId IdType="pmc">PMC9236281</ArticleId><ArticleId IdType="pubmed">35623798</ArticleId></ArticleIdList></Reference><Reference><Citation>Nosrati E. Harnessing administrative data to study health inequality. The Lancet Public Health. 2022;7:e726&#x2013;e727. doi: 10.1016/S2468-2667(22)00172-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(22)00172-4</ArticleId><ArticleId IdType="pubmed">35907411</ArticleId></ArticleIdList></Reference><Reference><Citation>Portuondo JI, Harris AHS, Massarweh NN. Using Administrative Codes to Measure Health Care Quality. JAMA. 2022;328:825&#x2013;826. doi: 10.1001/jama.2022.12823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.12823</ArticleId><ArticleId IdType="pubmed">35904795</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarrazin MSV, Rosenthal GE. Finding Pure and Simple Truths With Administrative Data. JAMA. 2012;307:1433&#x2013;1435. doi: 10.1001/jama.2012.404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.404</ArticleId><ArticleId IdType="pubmed">22474208</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J-A, Yoon S, Kim L-Y, Kim D-S. Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data. J Korean Med Sci. 2017;32:718&#x2013;728. doi: 10.3346/jkms.2017.32.5.718.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2017.32.5.718</ArticleId><ArticleId IdType="pmc">PMC5383602</ArticleId><ArticleId IdType="pubmed">28378543</ArticleId></ArticleIdList></Reference><Reference><Citation>Suissa S, Garbe E. Primer: administrative health databases in observational studies of drug effects&#x2014;advantages and disadvantages. Nature Clinical Practice Rheumatology. 2007;3:725&#x2013;732. doi: 10.1038/ncprheum0652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncprheum0652</ArticleId><ArticleId IdType="pubmed">18037932</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbusch PJM, Oostenbrink JB, Zuurbier JJ, Schaepkens FJM. The risk of upcoding in casemix systems: A comparative study. Health Policy. 2007;81:289&#x2013;299. doi: 10.1016/j.healthpol.2006.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthpol.2006.06.002</ArticleId><ArticleId IdType="pubmed">16908086</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC, Lee S, Choi B, Park RW. Establishment of an International Evidence Sharing Network Through Common Data Model for Cardiovascular Research. Korean Circ J. 2022;52:853&#x2013;864. doi: 10.4070/kcj.2022.0294.</Citation><ArticleIdList><ArticleId IdType="doi">10.4070/kcj.2022.0294</ArticleId><ArticleId IdType="pmc">PMC9742390</ArticleId><ArticleId IdType="pubmed">36478647</ArticleId></ArticleIdList></Reference><Reference><Citation>Rho Y, et al. COVID-19 International Collaborative Research by the Health Insurance Review and Assessment Service Using Its Nationwide Real-world Data: Database, Outcomes, and Implications. J Prev Med Public Health. 2021;54:8&#x2013;16. doi: 10.3961/jpmph.20.616.</Citation><ArticleIdList><ArticleId IdType="doi">10.3961/jpmph.20.616</ArticleId><ArticleId IdType="pmc">PMC7939755</ArticleId><ArticleId IdType="pubmed">33618494</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, et al. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nature Communications. 2020;11:5009. doi: 10.1038/s41467-020-18849-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18849-z</ArticleId><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC, et al. Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. JAMA. 2020;324:1640&#x2013;1650. doi: 10.1001/jama.2020.16167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.16167</ArticleId><ArticleId IdType="pmc">PMC7592033</ArticleId><ArticleId IdType="pubmed">33107944</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson MD, et al. The FAIR Guiding Principles for scientific data management and stewardship. Scientific Data. 2016;3:160018. doi: 10.1038/sdata.2016.18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2016.18</ArticleId><ArticleId IdType="pmc">PMC4792175</ArticleId><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams RD, et al. Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network. BMC Medical Research Methodology. 2022;22:35. doi: 10.1186/s12874-022-01505-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-022-01505-z</ArticleId><ArticleId IdType="pmc">PMC8801189</ArticleId><ArticleId IdType="pubmed">35094685</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkel D. Docker: lightweight Linux containers for consistent development and deployment. Linux J. 2014;2014:Article 2. doi: 10.5555/2600239.2600241.</Citation><ArticleIdList><ArticleId IdType="doi">10.5555/2600239.2600241</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacketer C, Defalco FJ, Ryan PB, Rijnbeek PR. Increasing trust in real-world evidence through evaluation of observational data quality. Journal of the American Medical Informatics Association. 2021;28:2251&#x2013;2257. doi: 10.1093/jamia/ocab132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocab132</ArticleId><ArticleId IdType="pmc">PMC8449628</ArticleId><ArticleId IdType="pubmed">34313749</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford, H. &amp; Noorden, R. V. in Nature (Nature, 2020).</Citation></Reference><Reference><Citation>Ioannidis JPA. Why Most Published Research Findings Are False. PLOS Medicine. 2005;2:e124. doi: 10.1371/journal.pmed.0020124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0020124</ArticleId><ArticleId IdType="pmc">PMC1182327</ArticleId><ArticleId IdType="pubmed">16060722</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanelli D. How Many Scientists Fabricate and Falsify Research? A Systematic Review and Meta-Analysis of Survey Data. PLOS ONE. 2009;4:e5738. doi: 10.1371/journal.pone.0005738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005738</ArticleId><ArticleId IdType="pmc">PMC2685008</ArticleId><ArticleId IdType="pubmed">19478950</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyakawa T. No raw data, no science: another possible source of the reproducibility crisis. Molecular Brain. 2020;13:24. doi: 10.1186/s13041-020-0552-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-020-0552-2</ArticleId><ArticleId IdType="pmc">PMC7033918</ArticleId><ArticleId IdType="pubmed">32079532</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel MA, et al. The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment. Journal of the American Medical Informatics Association. 2021;28:427&#x2013;443. doi: 10.1093/jamia/ocaa196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa196</ArticleId><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>Puttmann D, et al. Assessing the FAIRness of databases on the EHDEN portal: A case study on two Dutch ICU databases. International Journal of Medical Informatics. 2023;176:105104. doi: 10.1016/j.ijmedinf.2023.105104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2023.105104</ArticleId><ArticleId IdType="pubmed">37267810</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlett P, Kjaer J, Broich K, Cooke E. Real-World Evidence in EU Medicines Regulation: Enabling Use and Establishing Value. Clinical pharmacology and therapeutics. 2022;111:21&#x2013;23. doi: 10.1002/cpt.2479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.2479</ArticleId><ArticleId IdType="pmc">PMC9299492</ArticleId><ArticleId IdType="pubmed">34797920</ArticleId></ArticleIdList></Reference><Reference><Citation>Seong Y, et al. Incorporation of Korean Electronic Data Interchange Vocabulary into Observational Medical Outcomes Partnership Vocabulary. Healthc Inform Res. 2021;27:29&#x2013;38. doi: 10.4258/hir.2021.27.1.29.</Citation><ArticleIdList><ArticleId IdType="doi">10.4258/hir.2021.27.1.29</ArticleId><ArticleId IdType="pmc">PMC7921574</ArticleId><ArticleId IdType="pubmed">33611874</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko SH, et al. Past and Current Status of Adult Type 2 Diabetes Mellitus Management in Korea: A National Health Insurance Service Database Analysis. Diabetes Metab J. 2018;42:93&#x2013;100. doi: 10.4093/dmj.2018.42.2.93.</Citation><ArticleIdList><ArticleId IdType="doi">10.4093/dmj.2018.42.2.93</ArticleId><ArticleId IdType="pmc">PMC5911525</ArticleId><ArticleId IdType="pubmed">29676539</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37804398</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1179-1942</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Drug safety</Title><ISOAbbreviation>Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study.</ArticleTitle><Pagination><StartPage>1335</StartPage><EndPage>1352</EndPage><MedlinePgn>1335-1352</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40264-023-01353-w</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Individual case reports are the main asset in pharmacovigilance signal management. Signal validation is the first stage after signal detection and aims to determine if there is sufficient evidence to justify further assessment. Throughout signal management, a prioritization of signals is continually made. Routinely collected health data can provide relevant contextual information but are primarily used at a later stage in pharmacoepidemiological studies to assess communicated signals.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to examine the feasibility and utility of analysing routine health data from a multinational distributed network to support signal validation and prioritization and to reflect on key user requirements for these analyses to become an integral part of this process.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Statistical signal detection was performed in VigiBase, the WHO global database of individual case safety reports, targeting generic manufacturer drugs and 16 prespecified adverse events. During a 5-day study-a-thon, signal validation and prioritization were performed using information from VigiBase, regulatory documents and the scientific literature alongside descriptive analyses of routine health data from 10 partners of the European Health Data and Evidence Network (EHDEN). Databases included in the study were from the UK, Spain, Norway, the Netherlands and Serbia, capturing records from primary care and/or hospitals.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ninety-five statistical signals were subjected to signal validation, of which eight were considered for descriptive analyses in the routine health data. Design, execution and interpretation of results from these analyses took up to a few hours for each signal (of which 15-60 minutes were for execution) and informed decisions for five out of eight signals. The impact of insights from the routine health data varied and included possible alternative explanations, potential public health and clinical impact and feasibility of follow-up pharmacoepidemiological studies. Three signals were selected for signal assessment, two of these decisions were supported by insights from the routine health&#xa0;data. Standardization of analytical code, availability of adverse event phenotypes including bridges between different source vocabularies, and governance around the access and use of routine health data were identified as important aspects for future development.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Analyses of routine health data from a distributed network to support signal validation and prioritization are feasible in the given time limits and can inform decision making. The cost-benefit of integrating these analyses at this stage of signal management requires further research.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gauffin</LastName><ForeName>Oskar</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-1593-356X</Identifier><AffiliationInfo><Affiliation>Uppsala Monitoring Centre, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brand</LastName><ForeName>Judith S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0002-3720-1274</Identifier><AffiliationInfo><Affiliation>Uppsala Monitoring Centre, Uppsala, Sweden. judith.brand@who-umc.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vidlin</LastName><ForeName>Sara Hedfors</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0003-1619-3751</Identifier><AffiliationInfo><Affiliation>Uppsala Monitoring Centre, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sartori</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-3634-0317</Identifier><AffiliationInfo><Affiliation>Uppsala Monitoring Centre, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asikainen</LastName><ForeName>Suvi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>BCB Medical Ltd, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catal&#xe0;</LastName><ForeName>Mart&#xed;</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chalabi</LastName><ForeName>Etir</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Heliant Ltd, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dedman</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Clinical Practice Research Datalink (CPRD), The Medicines and Healthcare Products Regulatory Agency, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danilovic</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CHC Zvezdara, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a Morales</LastName><ForeName>Maria Teresa</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria Hospital 12 de Octubre, CIBER de Epidemiolog&#xed;a y Salud P&#xfa;blica, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hiltunen</LastName><ForeName>Saara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>BCB Medical Ltd, Espoo, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xf6;dicke</LastName><ForeName>Annika M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazarevic</LastName><ForeName>Milan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinic for cardiac and transplant surgery, University Clinical Center Nis, Nis, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>Miguel A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Hospital del Mar Medical Research Institute, Parc de Salut Mar, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miladinovic</LastName><ForeName>Jelena</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinic for infectious diseases, University Clinical Center Nis, University Clinical Center Nis, Nis, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Uppsala Monitoring Centre, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pistillo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram&#xed;rez-Anguita</LastName><ForeName>Juan Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Hospital del Mar Medical Research Institute, Parc de Salut Mar, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes</LastName><ForeName>Carlen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudolph</LastName><ForeName>Annette</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Uppsala Monitoring Centre, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandberg</LastName><ForeName>Lovisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Uppsala Monitoring Centre, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savage</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Uppsala Monitoring Centre, Uppsala, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Practice, University of Otago, Christchurch, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Epidemiology Department, Johnson &amp; Johnson, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spasic</LastName><ForeName>Dimitrije</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Clinic for cardiac and transplant surgery, University Clinical Center Nis, Nis, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trinh</LastName><ForeName>Nhung T H</ForeName><Initials>NTH</Initials><AffiliationInfo><Affiliation>PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veljkovic</LastName><ForeName>Nevena</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Heliant Ltd, Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vinca Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vujovic</LastName><ForeName>Ankica</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinic for Infectious and Tropical Diseases, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Wilde</LastName><ForeName>Marcel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zekarias</LastName><ForeName>Alem</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Uppsala Monitoring Centre, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Epidemiology Department, Johnson &amp; Johnson, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nor&#xe9;n</LastName><ForeName>G Niklas</ForeName><Initials>GN</Initials><Identifier Source="ORCID">0000-0002-4595-230X</Identifier><AffiliationInfo><Affiliation>Uppsala Monitoring Centre, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>No 806968</GrantID><Agency>Innovative Medicines Initiative (IMI)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Saf</MedlineTA><NlmUniqueID>9002928</NlmUniqueID><ISSNLinking>0114-5916</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060735" MajorTopicYN="Y">Pharmacovigilance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="N">Adverse Drug Reaction Reporting Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="Y">Drug-Related Side Effects and Adverse Reactions</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Suvi Asikainen and Saara Hiltunen are employed by BCB Medical Oy; Martijn Schuemie and Patrick Ryan are employed by Johnson &amp; Johnson. All other authors have no conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>7</Day><Hour>16</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>7</Day><Hour>11</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37804398</ArticleId><ArticleId IdType="pmc">PMC10684396</ArticleId><ArticleId IdType="doi">10.1007/s40264-023-01353-w</ArticleId><ArticleId IdType="pii">10.1007/s40264-023-01353-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pacurariu AC, Coloma PM, van Haren A, Genov G, Sturkenboom MCJM, Straus SMJM. A description of signals during the first 18 months of the EMA pharmacovigilance risk assessment committee. Drug Saf. 2014;37:1059&#x2013;1066. doi: 10.1007/s40264-014-0240-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0240-1</ArticleId><ArticleId IdType="pubmed">25398646</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartori D, Aronson JK, Nor&#xe9;n GN, Onakpoya IJ. Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: a scoping review of the global literature. Drug Saf. 2023;46:109&#x2013;120. doi: 10.1007/s40264-022-01258-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-022-01258-0</ArticleId><ArticleId IdType="pmc">PMC9883307</ArticleId><ArticleId IdType="pubmed">36469249</ArticleId></ArticleIdList></Reference><Reference><Citation>McNaughton R, Huet G, Shakir S. An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decision-making. BMJ Open. 2014;4:e004221. doi: 10.1136/bmjopen-2013-004221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2013-004221</ArticleId><ArticleId IdType="pmc">PMC3902466</ArticleId><ArticleId IdType="pubmed">24435895</ArticleId></ArticleIdList></Reference><Reference><Citation>Onakpoya IJ, Heneghan CJ, Aronson JK. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med. 2016;14:10. doi: 10.1186/s12916-016-0553-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-016-0553-2</ArticleId><ArticleId IdType="pmc">PMC4740994</ArticleId><ArticleId IdType="pubmed">26843061</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency (EMA) and Heads of Medicines Agencies. Guideline on good pharmacovigilance practices (GVP) Module IX&#x2014;Signal management (Rev 1). https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-gvp-module-ix-signal-management-rev-1_en.pdf Accessed 18 Aug 2023.</Citation></Reference><Reference><Citation>Waller P, Heeley E, Moseley J. Impact analysis of signals detected from spontaneous adverse drug reaction reporting data. Drug Saf. 2005;28:843&#x2013;850. doi: 10.2165/00002018-200528100-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00002018-200528100-00002</ArticleId><ArticleId IdType="pubmed">16180935</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards IR. Causality assessment in pharmacovigilance: still a challenge. Drug Saf. 2017;40:365&#x2013;372. doi: 10.1007/s40264-017-0509-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-017-0509-2</ArticleId><ArticleId IdType="pubmed">28247280</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenbroucke JP. In defense of case reports and case series. Ann Intern Med. 2001;134:330. doi: 10.7326/0003-4819-134-4-200102200-00017.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-134-4-200102200-00017</ArticleId><ArticleId IdType="pubmed">11182844</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal Pan GJ, Lindquist M, Gelperin K. Postmarketing spontaneous pharmacovigilance reporting systems. Pharmacoepidemiology. 6. New York: Wiley; 2020. pp. 169&#x2013;201.</Citation></Reference><Reference><Citation>Pal SN, Duncombe C, Falzon D, Olsson S. WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems. Drug Saf. 2013;36:75&#x2013;81. doi: 10.1007/s40264-012-0014-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-012-0014-6</ArticleId><ArticleId IdType="pmc">PMC3568200</ArticleId><ArticleId IdType="pubmed">23329541</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieu TA, Kulldorff M, Davis RL, Lewis EM, Weintraub E, Yih K, et al. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care. 2007;45:S89&#x2013;95. doi: 10.1097/MLR.0b013e3180616c0a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e3180616c0a</ArticleId><ArticleId IdType="pubmed">17909389</ArticleId></ArticleIdList></Reference><Reference><Citation>Coloma PM, Trifir&#xf2; G, Schuemie MJ, Gini R, Herings R, Hippisley-Cox J, et al. Electronic healthcare databases for active drug safety surveillance: is there enough leverage? Pharmacoepidemiol Drug Saf. 2012;21:611&#x2013;621. doi: 10.1002/pds.3197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3197</ArticleId><ArticleId IdType="pubmed">22315152</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacurariu AC, Straus SM, Trifir&#xf2; G, Schuemie MJ, Gini R, Herings R, et al. Useful interplay between spontaneous ADR reports and electronic healthcare records in signal detection. Drug Saf. 2015;38:1201&#x2013;1210. doi: 10.1007/s40264-015-0341-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-015-0341-5</ArticleId><ArticleId IdType="pmc">PMC4659852</ArticleId><ArticleId IdType="pubmed">26370104</ArticleId></ArticleIdList></Reference><Reference><Citation>Trifir&#xf2; G, Pariente A, Coloma PM, Kors JA, Polimeni G, Miremont-Salam&#xe9; G, et al. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? Pharmacoepidemiol Drug Saf. 2009;18:1176&#x2013;1184. doi: 10.1002/pds.1836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.1836</ArticleId><ArticleId IdType="pubmed">19757412</ArticleId></ArticleIdList></Reference><Reference><Citation>Cederholm S, Hill G, Asiimwe A, Bate A, Bhayat F, Persson Brobert G, et al. Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network. Drug Saf. 2015;38:87&#x2013;100. doi: 10.1007/s40264-014-0251-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0251-y</ArticleId><ArticleId IdType="pmc">PMC4302222</ArticleId><ArticleId IdType="pubmed">25539877</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Madigan D, Stang PE, Marc Overhage J, Racoosin JA, Hartzema AG. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership. Stat Med. 2012;31:4401&#x2013;4415. doi: 10.1002/sim.5620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5620</ArticleId><ArticleId IdType="pubmed">23015364</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Stang PE, Overhage JM, Suchard MA, Hartzema AG, DuMouchel W, et al. A comparison of the empirical performance of methods for a risk identification system. Drug Saf. 2013;36:143&#x2013;158. doi: 10.1007/s40264-013-0108-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0108-9</ArticleId><ArticleId IdType="pubmed">24166231</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SV, Maro JC, Baro E, Izem R, Dashevsky I, Rogers JR, et al. Data mining for adverse drug events with a propensity score-matched tree-based scan statistic. Epidemiology. 2018;29:895&#x2013;903. doi: 10.1097/EDE.0000000000000907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000000907</ArticleId><ArticleId IdType="pmc">PMC6167151</ArticleId><ArticleId IdType="pubmed">30074538</ArticleId></ArticleIdList></Reference><Reference><Citation>Coste A, Wong A, Bokern M, Bate A, Douglas IJ. Methods for drug safety signal detection using routinely collected observational electronic health care data: a systematic review. Pharmacoepidemiol Drug Saf. 2022;pds.5548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10092128</ArticleId><ArticleId IdType="pubmed">36218170</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen M, Ball R, Midthun K, Lieu TA. The food and drug administration&#x2019;s post-licensure rapid immunization safety monitoring program: strengthening the federal vaccine safety enterprise: MINI-SENTINEL, PRISM, AND VACCINE SAFETY. Pharmacoepidemiol Drug Saf. 2012;21:291&#x2013;297. doi: 10.1002/pds.2323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.2323</ArticleId><ArticleId IdType="pubmed">22262619</ArticleId></ArticleIdList></Reference><Reference><Citation>Suissa S, Henry D, Caetano P, Dormuth CR, Ernst P, Hemmelgarn B, et al. CNODES: the Canadian network for observational drug effect studies. Open Med. 2012;6:e134&#x2013;e140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3654509</ArticleId><ArticleId IdType="pubmed">23687528</ArticleId></ArticleIdList></Reference><Reference><Citation>AsPEN collaborators, Andersen M, Bergman U, Choi N-K, Gerhard T, Huang C, et al. The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia. Pharmacoepidemiol Drug Saf. 2013;22:700&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">23653370</ArticleId></ArticleIdList></Reference><Reference><Citation>Donegan K, Owen R, Bird H, Burch B, Smith A, Tregunno P. Exploring the potential routine use of electronic healthcare record data to strengthen early signal assessment in UK medicines regulation: proof-of-concept study. Drug Saf. 2018;41:899&#x2013;910. doi: 10.1007/s40264-018-0675-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-018-0675-x</ArticleId><ArticleId IdType="pubmed">29725942</ArticleId></ArticleIdList></Reference><Reference><Citation>Star K, Watson S, Sandberg L, Johansson J, Edwards IR. Longitudinal medical records as a complement to routine drug safety signal analysis. Pharmacoepidemiol Drug Saf. 2015;24:486&#x2013;494. doi: 10.1002/pds.3739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3739</ArticleId><ArticleId IdType="pmc">PMC5024044</ArticleId><ArticleId IdType="pubmed">25623045</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandler RE. Nintedanib and ischemic colitis: Signal assessment with the integrated use of two types of real-world evidence, spontaneous reports of suspected adverse drug reactions, and observational data from large health-care database. Pharmacoepidemiol Drug Saf. 2020;29:951&#x2013;957. doi: 10.1002/pds.5022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.5022</ArticleId><ArticleId IdType="pmc">PMC7496543</ArticleId><ArticleId IdType="pubmed">32399991</ArticleId></ArticleIdList></Reference><Reference><Citation>The European Health Data and Evidence Network (EHDEN). https://www.ehden.eu/ Accessed 18 Aug 2023.</Citation></Reference><Reference><Citation>Hughes N, Rijnbeek PR, van Bochove K, Duarte-Salles T, Steinbeisser C, Vizcaya D, et al. Evaluating a novel approach to stimulate open science collaborations: a case series of &#x201c;study-a-thon&#x201d; events within the OHDSI and European IMI communities. JAMIA Open. 2022;5:ooac100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9670330</ArticleId><ArticleId IdType="pubmed">36406796</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindquist M. VigiBase, the WHO Global ICSR Database System: Basic Facts. Drug Inf J. 2008;42:409&#x2013;419. doi: 10.1177/009286150804200501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/009286150804200501</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Ostropolets A, Makadia R, Shoaibi A, Rao G, Sena AG, et al. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study. BMJ. 2021;373:n1435. doi: 10.1136/bmj.n1435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1435</ArticleId><ArticleId IdType="pmc">PMC8193077</ArticleId><ArticleId IdType="pubmed">35727911</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, Li X, Kostka K, Stewart HM, Reich C, Seager S, et al. Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf. 2022;31:495&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9088543</ArticleId><ArticleId IdType="pubmed">35191114</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics (OHDSI). ATLAS. https://github.com/OHDSI/Atlas Accessed 18 Aug 2023.</Citation></Reference><Reference><Citation>Uppsala Monitoring Centre. The WHO Programme for International Drug Monitoring https://who-umc.org/about-the-who-programme-for-international-drug-monitoring/# Accessed 18 Aug 2023.</Citation></Reference><Reference><Citation>Lagerlund O, Strese S, Fladvad M, Lindquist M. WHODrug: A Global, Validated and Updated Dictionary for Medicinal Information. Ther Innov Regul Sci [Internet]. 2020 [cited 2020 Feb 23]; Available from: 10.1007/s43441-020-00130-6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7458889</ArticleId><ArticleId IdType="pubmed">32078733</ArticleId></ArticleIdList></Reference><Reference><Citation>Nor&#xe9;n GN, Orre R, Bate A, Edwards IR. Duplicate detection in adverse drug reaction surveillance. Data Min Knowl Discov. 2007;14:305&#x2013;328. doi: 10.1007/s10618-006-0052-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10618-006-0052-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics (OHDSI). RxNorm Extension - an OHDSI resource to represent international drugs. https://www.ohdsi.org/web/wiki/doku.php?id=documentation:international_drugs#rxnorm_extension_-_an_ohdsi_resource_to_represent_international_drugs Accessed 18 Aug 2023.</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics (OHDSI). Phenotype definitions of selected adverse events. https://data.ohdsi.org/Covid19VaccineAesiDiagnostics/ Accessed 18 Aug 2023.</Citation></Reference><Reference><Citation>Caster O, Juhlin K, Watson S, Nor&#xe9;n GN. Improved statistical signal detection in pharmacovigilance by combining multiple strength-of-evidence aspects in vigiRank: retrospective evaluation against emerging safety signals. Drug Saf. 2014;37:617&#x2013;628. doi: 10.1007/s40264-014-0204-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0204-5</ArticleId><ArticleId IdType="pmc">PMC4134478</ArticleId><ArticleId IdType="pubmed">25052742</ArticleId></ArticleIdList></Reference><Reference><Citation>Nor&#xe9;n GN, Hopstadius J, Bate A. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Stat Methods Med Res. 2013;22:57&#x2013;69. doi: 10.1177/0962280211403604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280211403604</ArticleId><ArticleId IdType="pmc">PMC6331976</ArticleId><ArticleId IdType="pubmed">21705438</ArticleId></ArticleIdList></Reference><Reference><Citation>Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.fda.gov/media/76860/download Accessed 18 Aug 2023.</Citation></Reference><Reference><Citation>Food and Drug Administration. Purple Book: Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations. https://purplebooksearch.fda.gov/downloads Accessed 18 Aug 2023.</Citation></Reference><Reference><Citation>European Medicines Agency. List of European Public Assessment Reports. https://www.ema.europa.eu/sites/default/files/Medicines_output_european_public_assessment_reports.xlsx Accessed 18 Aug 2023.</Citation></Reference><Reference><Citation>Juhlin K, Star K, Nor&#xe9;n GN. A method for data-driven exploration to pinpoint key features in medical data and facilitate expert review. Pharmacoepidemiol Drug Saf. 2017;26:1256&#x2013;1265. doi: 10.1002/pds.4285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4285</ArticleId><ArticleId IdType="pmc">PMC5656922</ArticleId><ArticleId IdType="pubmed">28815800</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci. 2016;113:7329&#x2013;7336. doi: 10.1073/pnas.1510502113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1510502113</ArticleId><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Markus AF, Verhamme KMC, Kors JA, Rijnbeek PR. TreatmentPatterns: an R package to facilitate the standardized development and analysis of treatment patterns across disease domains. Comput Methods Programs Biomed. 2022;225:107081. doi: 10.1016/j.cmpb.2022.107081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2022.107081</ArticleId><ArticleId IdType="pubmed">36084453</ArticleId></ArticleIdList></Reference><Reference><Citation>Tillotts Pharma UK. Octasa 1g Suppositories - Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/12469/smpc Accessed 18 Au 2023.</Citation></Reference><Reference><Citation>Allergan Pharmaceuticals. Asacol Structured Product Label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019651s028lbl.pdf Accessed 18 Aug 2023.</Citation></Reference><Reference><Citation>Gatto NM, Wang SV, Murk W, Mattox P, Brookhart MA, Bate A, et al. Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting. Pharmacoepidemiol Drug Saf. 2022;31:1140&#x2013;1152. doi: 10.1002/pds.5529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.5529</ArticleId><ArticleId IdType="pmc">PMC9826437</ArticleId><ArticleId IdType="pubmed">35984046</ArticleId></ArticleIdList></Reference><Reference><Citation>Nor&#xe9;n GN, Hopstadius J, Bate A, Star K, Edwards IR. Temporal pattern discovery in longitudinal electronic patient records. Data Min Knowl Discov. 2010;20:361&#x2013;387. doi: 10.1007/s10618-009-0152-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10618-009-0152-3</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37811595</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1744-828X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Personalized medicine</Title><ISOAbbreviation>Per Med</ISOAbbreviation></Journal><ArticleTitle>Cloud-based digital healthcare development for precision medical hospital information system.</ArticleTitle><Pagination><StartPage>435</StartPage><EndPage>444</EndPage><MedlinePgn>435-444</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2217/pme-2023-0074</ELocationID><Abstract><AbstractText><b>Aim:</b> This study aims to develop a cloud-based digital healthcare system for precision medical hospital information systems (P-HIS). <b>Methods:</b> In 2020, international standardization of P-HIS clinical terms and codes was performed. In 2021, South Korea's first tertiary hospital cloud was established and implemented successfully. <b>Results:</b> P-HIS was applied at Korea's first tertiary general hospital. Common data model-compatible precision medicine/medical service solutions were developed for medical support. Ultrahigh-quality medical data for precision medicine were acquired and built using big data. Joint global commercialization and dissemination/spreading were achieved using the P-HIS consortium and global common data model-based observational medical outcome partnership network. <b>Conclusion:</b> To provide personalized precision medical services in the future, establishing and using big medical data is essential.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>SeJun</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6332-107X</Identifier><AffiliationInfo><Affiliation>Human Behavior &amp; Genetic Institute, Associate Research Center, Korea University, Seoul, 02841, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joo</LastName><ForeName>Hyung Joon</ForeName><Initials>HJ</Initials><Identifier Source="ORCID">0000-0003-1846-8464</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University of College of Medicine, Seoul, 02841, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sohn</LastName><ForeName>Jang Wook</ForeName><Initials>JW</Initials><Identifier Source="ORCID">0000-0003-4792-0456</Identifier><AffiliationInfo><Affiliation>Division of Infectious Disease, Department of Internal Medicine, Korea University College of Medicine, Seoul, 02841, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sangsoo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Global Sport Studies, Korea University Sejong Campus, Sejong, 30019, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Jin Su</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0002-8263-0852</Identifier><AffiliationInfo><Affiliation>Human Behavior &amp; Genetic Institute, Associate Research Center, Korea University, Seoul, 02841, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seong</LastName><ForeName>Jiwon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Korea University Medicine Center, Seoul, Biomedical Research Institute, Seoul, 02841, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Huniverse, Seoul, 02566, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Kwang Jin</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Huniverse, Seoul, 02566, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sang Heon</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0003-0701-0028</Identifier><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Korea University Medical Center, Seoul, 02841, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>IITP-2023-2020-0-01819</GrantID><Agency>Ministry of Science and ICT, South Korea</Agency><Country/></Grant><Grant><GrantID>HR22C1302</GrantID><Agency>The Korea Health Industry Development Institute</Agency><Country/></Grant><Grant><GrantID>S1906-21-1001</GrantID><Agency>The Ministry of Science and ICT and the Ministry of Health and Welfare</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Per Med</MedlineTA><NlmUniqueID>101238549</NlmUniqueID><ISSNLinking>1741-0541</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067917" MajorTopicYN="Y">Cloud Computing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006751" MajorTopicYN="Y">Hospital Information Systems</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CDM</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">P-HIS</Keyword><Keyword MajorTopicYN="N">digital health care</Keyword><Keyword MajorTopicYN="N">precision medical</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>9</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37811595</ArticleId><ArticleId IdType="doi">10.2217/pme-2023-0074</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37829182</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2754-0413</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>1</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>BMJ medicine</Title><ISOAbbreviation>BMJ Med</ISOAbbreviation></Journal><ArticleTitle>Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM.</ArticleTitle><Pagination><StartPage>e000651</StartPage><MedlinePgn>e000651</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e000651</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjmed-2023-000651</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To assess the uptake of second line antihyperglycaemic drugs among patients with type 2 diabetes mellitus who are receiving metformin.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">Federated pharmacoepidemiological evaluation in LEGEND-T2DM.</AbstractText><AbstractText Label="SETTING" NlmCategory="UNASSIGNED">10 US and seven non-US electronic health record and administrative claims databases in the Observational Health Data Sciences and Informatics network in eight countries from 2011 to the end of 2021.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="UNASSIGNED">4.8 million patients (&#x2265;18 years) across US and non-US based databases with type 2 diabetes mellitus who had received metformin monotherapy and had initiated second line treatments.</AbstractText><AbstractText Label="EXPOSURE" NlmCategory="UNASSIGNED">The exposure used to evaluate each database was calendar year trends, with the years in the study that were specific to each cohort.</AbstractText><AbstractText Label="MAIN OUTCOMES MEASURES" NlmCategory="UNASSIGNED">The outcome was the incidence of second line antihyperglycaemic drug use (ie, glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors, and sulfonylureas) among individuals who were already receiving treatment with metformin. The relative drug class level uptake across cardiovascular risk groups was also evaluated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">4.6 million patients were identified in US databases, 61&#x2009;382 from Spain, 32&#x2009;442 from Germany, 25&#x2009;173 from the UK, 13&#x2009;270 from France, 5580 from Scotland, 4614 from Hong Kong, and 2322 from Australia. During 2011-21, the combined proportional initiation of the cardioprotective antihyperglycaemic drugs (glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors) increased across all data sources, with the combined initiation of these drugs as second line drugs in 2021 ranging from 35.2% to 68.2% in the US databases, 15.4% in France, 34.7% in Spain, 50.1% in Germany, and 54.8% in Scotland. From 2016 to 2021, in some US and non-US databases, uptake of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors increased more significantly among populations with no cardiovascular disease compared with patients with established cardiovascular disease. No data source provided evidence of a greater increase in the uptake of these two drug classes in populations with cardiovascular disease compared with no cardiovascular disease.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Despite the increase in overall uptake of cardioprotective antihyperglycaemic drugs as second line treatments for type 2 diabetes mellitus, their uptake was lower in patients with cardiovascular disease than in people with no cardiovascular disease over the past decade. A strategy is needed to ensure that medication use is concordant with guideline recommendations to improve outcomes of patients with type 2 diabetes mellitus.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khera</LastName><ForeName>Rohan</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9467-6199</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Health Informatics, Department of Biostatistics, Yale University School of Public Health, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhingra</LastName><ForeName>Lovedeep Singh</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aminorroaya</LastName><ForeName>Arya</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3197-2657</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jin J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arshad</LastName><ForeName>Faaizah</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blacketer</LastName><ForeName>Clair</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowring</LastName><ForeName>Mary G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bu</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorr</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University School of Medicine, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8274-0357</Identifier><AffiliationInfo><Affiliation>Real-World Epidemiology Research Group, Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Veterans Affairs Informatics and Computing Infrastructure, United States Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Utah School of Medicine, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>French</LastName><ForeName>Tina E</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>Tennessee Valley Healthcare System, Veterans Affairs Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanchrow</LastName><ForeName>Elizabeth E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Tennessee Valley Healthcare System, Veterans Affairs Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horban</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Wallis Cy</ForeName><Initials>WC</Initials><Identifier Source="ORCID">0000-0003-2320-0470</Identifier><AffiliationInfo><Affiliation>Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Medicines Optimisation Research and Education, University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Data Transformation, Analytics, and Artificial Intelligence, Real World Solutions, IQVIA Inc, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yuntian</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Man</LastName><ForeName>Kenneth Kc</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Medicines Optimisation Research and Education, University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Tennessee Valley Healthcare System, Veterans Affairs Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathioudakis</LastName><ForeName>Nestoras</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, Diabetes, and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLemore</LastName><ForeName>Michael F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Tennessee Valley Healthcare System, Veterans Affairs Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minty</LastName><ForeName>Evan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, O'Brien Institute for Public Health, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Daniel R</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0002-0063-8069</Identifier><AffiliationInfo><Affiliation>Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagy</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Health Science Informatics, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishimura</LastName><ForeName>Akihiko</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pistillo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Real-World Epidemiology Research Group, Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posada</LastName><ForeName>Jose D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Systems Engineering and Computing, School of Engineering, Universidad del Norte, Barranquilla, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pratt</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes</LastName><ForeName>Carlen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Real-World Epidemiology Research Group, Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Joseph S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0002-9218-3320</Identifier><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of General Medicine and National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Policy and Management, Yale University School of Public Health, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seager</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Data Transformation, Analytics, and Artificial Intelligence, Real World Solutions, IQVIA Inc, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Excellence Research Center, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Technology and Digital Solutions, Stanford Health Care, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simon</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Tennessee Valley Healthcare System, Veterans Affairs Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Eric Yf</ForeName><Initials>EY</Initials><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family Medicine and Primary Care, School of Clinical Medicine, University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jianxiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Computational Medicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Can</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Data Transformation, Analytics, and Artificial Intelligence, Real World Solutions, IQVIA Inc, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea (aka South Korea).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Innovation in Digital Healthcare, Yonsei University, Seoul, Republic of Korea (aka South Korea).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Epidemiology, Office of the Chief Medical Officer, Johnson &amp; Johnson, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krumholz</LastName><ForeName>Harlan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Policy and Management, Yale University School of Public Health, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veterans Affairs Informatics and Computing Infrastructure, United States Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomathematics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 GM136577</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG006139</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F30 HL168842</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>K23 HL153775</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Med</MedlineTA><NlmUniqueID>9918487584306676</NlmUniqueID><ISSNLinking>2754-0413</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiology</Keyword><Keyword MajorTopicYN="N">Diabetes mellitus</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Pharmacology, clinical</Keyword><Keyword MajorTopicYN="N">Quality of health care</Keyword></KeywordList><CoiStatement>Competing interests: This study is undertaken within Observational Health Data Sciences and Informatics, an open collaboration. RK received support from the National Heart, Lung, and Blood Institute of the National Institutes of Health (under award K23HL153775) and the Doris Duke Charitable Foundation (under award, 2022060). He is an Associate Editor of JAMA. He also receives research support, through Yale, from Bristol-Myers Squibb. He is a coinventor of US Provisional Patent Applications 63/177,117 and 63/346,610, unrelated to current work. He is also a founder of Evidence2Health, a precision health platform to improve evidence-based cardiovascular care. TD-S acknowledges receiving financial support from the Instituto de Salud Carlos III (ISCIII; Miguel Servet 2021: CP21/00023). KKCM reports grants from C W Maplethorpe Fellowship, grants from National Institute of Health Research, UK, grants from European Commission Framwork Horizon 2020, grants from Hong Kong Research Grant Council, grants from Innovation and Technology Commission of the Hong Kong Special Administration Region Government, and personal fees from IQVIA outside of the submitted work. DRM was supported by a Wellcome Trust Clinical Research Fellowship (214588/Z/18/Z). MJS is an employee and shareholder of Johnson &amp; Johnson. HK received expenses and/or personal fees from UnitedHealth, Element Science, Aetna, Reality Labs, Tesseract/4Catalyst, F-Prime, the Siegfried and Jensen Law Firm, Arnold and Porter Law Firm, and Martin/Baughman Law Firm. He is a co-founder of Refactor Health and HugoHealth, and is associated with contracts, through Yale New Haven Hospital, from the Centers for Medicare and Medicaid Services and through Yale University from Johnson &amp; Johnson. MAS receives contracts and grants from the National Institutes of Health, the US Department of Veterans Affairs, the US Food and Drug Administration and Janssen Research and Development, the latter two of which are outside the scope of this work. Other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>13</Day><Hour>3</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37829182</ArticleId><ArticleId IdType="pmc">PMC10565313</ArticleId><ArticleId IdType="doi">10.1136/bmjmed-2023-000651</ArticleId><ArticleId IdType="pii">bmjmed-2023-000651</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zinman B, Wanner C, Lachin JM, et al. . Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 2015;373:2117&#x2013;28. 10.1056/NEJMoa1504720</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1504720</ArticleId><ArticleId IdType="pubmed">26378978</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiviott SD, Raz I, Sabatine MS, et al. . Dapagliflozin and cardiovascular outcomes in type 2 diabetes. reply. N Engl J Med 2019;380:1881&#x2013;2. 10.1056/NEJMc1902837</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1902837</ArticleId><ArticleId IdType="pubmed">31067395</ArticleId></ArticleIdList></Reference><Reference><Citation>Neal B, Perkovic V, Matthews DR, et al. . Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med 2017;377:2099. 10.1056/NEJMc1712572</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1712572</ArticleId><ArticleId IdType="pubmed">29166232</ArticleId></ArticleIdList></Reference><Reference><Citation>Marso SP, Bain SC, Consoli A, et al. . Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 2016;375:1834&#x2013;44. 10.1056/NEJMoa1607141</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1607141</ArticleId><ArticleId IdType="pubmed">27633186</ArticleId></ArticleIdList></Reference><Reference><Citation>Marso SP, Daniels GH, Brown-Frandsen K, et al. . Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2016;375:311&#x2013;22. 10.1056/NEJMoa1603827</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1603827</ArticleId><ArticleId IdType="pmc">PMC4985288</ArticleId><ArticleId IdType="pubmed">27295427</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee A, Draznin B, Aroda VR, et al. . 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2022. Diabetes Care 2022;45:S125&#x2013;43. 10.2337/dc22-S009</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc22-S009</ArticleId><ArticleId IdType="pubmed">34964831</ArticleId></ArticleIdList></Reference><Reference><Citation>Nargesi AA, Jeyashanmugaraja GP, Desai N, et al. . Contemporary national patterns of eligibility and use of novel cardioprotective antihyperglycemic agents in type 2 diabetes mellitus. J Am Heart Assoc 2021;10:e021084. 10.1161/JAHA.121.021084</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.021084</ArticleId><ArticleId IdType="pmc">PMC8403287</ArticleId><ArticleId IdType="pubmed">33998258</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangha V, Lipska K, Lin Z, et al. . Patterns of prescribing sodium-glucose cotransporter-2 inhibitors for medicare beneficiaries in the United States. Circ: Cardiovascular Quality and Outcomes 2021;14. 10.1161/CIRCOUTCOMES.121.008381</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.121.008381</ArticleId><ArticleId IdType="pmc">PMC9022137</ArticleId><ArticleId IdType="pubmed">34779654</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy RG, Dykhoff HJ, Sangaralingham L, et al. . Adoption of new glucose-lowering medications in the U.S.-The case of SGLT2 inhibitors: nationwide cohort study. Diabetes Technol Ther 2019;21:702&#x2013;12. 10.1089/dia.2019.0213</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dia.2019.0213</ArticleId><ArticleId IdType="pmc">PMC7207017</ArticleId><ArticleId IdType="pubmed">31418588</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy RG, Van Houten HK, Deng Y, et al. . Comparison of diabetes medications used by adults with commercial insurance vs medicare advantage, 2016 to 2019. JAMA Netw Open 2021;4:e2035792. 10.1001/jamanetworkopen.2020.35792</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.35792</ArticleId><ArticleId IdType="pmc">PMC7851726</ArticleId><ArticleId IdType="pubmed">33523188</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy RG, Van Houten HK, Karaca-Mandic P, et al. . Second-line therapy for type 2 diabetes management: the treatment/benefit paradox of cardiovascular and kidney comorbidities. Diabetes Care 2021;44:2302&#x2013;11. 10.2337/dc20-2977</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-2977</ArticleId><ArticleId IdType="pmc">PMC8929191</ArticleId><ArticleId IdType="pubmed">34348996</ArticleId></ArticleIdList></Reference><Reference><Citation>Nargesi AA, Clark C, Aminorroaya A, et al. . Persistence on novel cardioprotective antihyperglycemic therapies in the United States. Am J Cardiol 2023;196:89&#x2013;98. 10.1016/j.amjcard.2023.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC11007258</ArticleId><ArticleId IdType="pubmed">37012183</ArticleId></ArticleIdList></Reference><Reference><Citation>Schernthaner G, Shehadeh N, Ametov AS, et al. . Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2I and GLP-1 RA) in high-risk patients with type 2 diabetes. Cardiovasc Diabetol 2020;19:185. 10.1186/s12933-020-01154-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-020-01154-w</ArticleId><ArticleId IdType="pmc">PMC7585305</ArticleId><ArticleId IdType="pubmed">33097060</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P, Dhruva SS, Shah ND, et al. . Trends in within-class changes in US average wholesale prices for brand-name medications for common conditions from 2015 to 2020. JAMA Netw Open 2021;4:e2035064. 10.1001/jamanetworkopen.2020.35064</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.35064</ArticleId><ArticleId IdType="pmc">PMC7823226</ArticleId><ArticleId IdType="pubmed">33481031</ArticleId></ArticleIdList></Reference><Reference><Citation>Tummalapalli SL, Montealegre JL, Warnock N, et al. . Coverage, formulary restrictions, and affordability of sodium-glucose cotransporter 2 inhibitors by US insurance plan types. JAMA Health Forum 2021;2:e214205. 10.1001/jamahealthforum.2021.4205</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2021.4205</ArticleId><ArticleId IdType="pmc">PMC8796944</ArticleId><ArticleId IdType="pubmed">35977296</ArticleId></ArticleIdList></Reference><Reference><Citation>Faridi KF, Dayoub EJ, Ross JS, et al. . Medicare coverage and out-of-pocket costs of quadruple drug therapy for heart failure. J Am Coll Cardiol 2022;79:2516&#x2013;25. 10.1016/j.jacc.2022.04.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.04.031</ArticleId><ArticleId IdType="pubmed">35738713</ArticleId></ArticleIdList></Reference><Reference><Citation>Green JB, Bethel MA, Armstrong PW, et al. . Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. N Engl J Med 2015;373:232&#x2013;42. 10.1056/NEJMoa1501352</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1501352</ArticleId><ArticleId IdType="pubmed">26052984</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenstock J, Perkovic V, Johansen OE, et al. . Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial. JAMA 2019;321:69&#x2013;79. 10.1001/jama.2018.18269</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.18269</ArticleId><ArticleId IdType="pmc">PMC6583576</ArticleId><ArticleId IdType="pubmed">30418475</ArticleId></ArticleIdList></Reference><Reference><Citation>Wexler DJ. Sulfonylureas and cardiovascular safety: the final verdict JAMA 2019;322:1147&#x2013;9. 10.1001/jama.2019.14533</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.14533</ArticleId><ArticleId IdType="pubmed">31536110</ArticleId></ArticleIdList></Reference><Reference><Citation>White WB, Cannon CP, Heller SR, et al. . Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med 2013;369:1327&#x2013;35. 10.1056/NEJMoa1305889</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1305889</ArticleId><ArticleId IdType="pubmed">23992602</ArticleId></ArticleIdList></Reference><Reference><Citation>
Observational Health Data Sciences, Informatics . Chapter 4 the common data model. 2021. Available: https://ohdsi.github.io/TheBookOfOhdsi/CommonDataModel.html#fn20 [Accessed 13 Oct 2022].</Citation></Reference><Reference><Citation>Khera R, Schuemie MJ, Lu Y, et al. . Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies. BMJ Open 2022;12:e057977. 10.1136/bmjopen-2021-057977</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-057977</ArticleId><ArticleId IdType="pmc">PMC9185490</ArticleId><ArticleId IdType="pubmed">35680274</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. . Observational health data sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, et al. . Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet 2019;394:1816&#x2013;26. 10.1016/S0140-6736(19)32317-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32317-7</ArticleId><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane JCE, Weaver J, Kostka K, et al. . Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study. Rheumatology (Oxford) 2021;60:3222&#x2013;34. 10.1093/rheumatology/keaa771</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa771</ArticleId><ArticleId IdType="pmc">PMC7798671</ArticleId><ArticleId IdType="pubmed">33367863</ArticleId></ArticleIdList></Reference><Reference><Citation>Khera R, Lu Y, Chen R, et al. . Comparative cardiovascular effectiveness and safety of individual angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a multinational participant-level assessment from LEGEND-HTN. J Am Coll Cardiol 2021;77:1474. 10.1016/S0735-1097(21)02832-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(21)02832-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Recalde M, Rodr&#xed;guez C, Burn E, et al. . Data resource profile: the information system for research in primary care (SIDIAP). Int J Epidemiol 2022;51:e324&#x2013;36. 10.1093/ije/dyac068</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyac068</ArticleId><ArticleId IdType="pmc">PMC9749711</ArticleId><ArticleId IdType="pubmed">35415748</ArticleId></ArticleIdList></Reference><Reference><Citation>Elm E von, Altman DG, Egger M, et al. . Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335:806&#x2013;8. 10.1136/bmj.39335.541782.AD</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39335.541782.AD</ArticleId><ArticleId IdType="pmc">PMC2034723</ArticleId><ArticleId IdType="pubmed">17947786</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner RM, Kwok CS, Chen-Turner C, et al. . Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis. Br J Clin Pharmacol 2014;78:258&#x2013;73. 10.1111/bcp.12306</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcp.12306</ArticleId><ArticleId IdType="pmc">PMC4137819</ArticleId><ArticleId IdType="pubmed">24325197</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham DJ, Ouellet-Hellstrom R, MaCurdy TE, et al. . Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone. JAMA 2010;304:411&#x2013;8. 10.1001/jama.2010.920</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.920</ArticleId><ArticleId IdType="pubmed">20584880</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Rosenthal N. Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non-SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: a real-world meta-analysis of 4 observational databases (OBSERVE-4D) Diabetes Obes Metab 2019;21:444&#x2013;5. 10.1111/dom.13509</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.13509</ArticleId><ArticleId IdType="pubmed">30136414</ArticleId></ArticleIdList></Reference><Reference><Citation>
Observational Health Data Sciences, Informatics . Chapter 11 characterization. 2021. Available: https://ohdsi.github.io/TheBookOfOhdsi/Characterization.html [Accessed 13 Oct 2022].</Citation></Reference><Reference><Citation>
Public Health Scotland . World standard population by sex. 2018. Available: https://www.opendata.nhs.scot/dataset/standard-populations [Accessed 24 May 2023].</Citation></Reference><Reference><Citation>
LEGEND T2DM class cohort explorer, Available: https://data.ohdsi.org/LegendT2dmClassCohortExplorer/ [Accessed 14 Jul 2022].</Citation></Reference><Reference><Citation>Limonte CP, Hall YN, Trikudanathan S, et al. . Prevalence of SGLT2i and GLP1RA use among US adults with type 2 diabetes. J Diabetes Complications 2022;36:108204. 10.1016/j.jdiacomp.2022.108204</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2022.108204</ArticleId><ArticleId IdType="pubmed">35537891</ArticleId></ArticleIdList></Reference><Reference><Citation>Knudsen JS, Baggesen LM, Lajer M, et al. . Changes in SGLT2i and GLP-1Ra real-world initiator profiles following cardiovascular outcome trials: a danish nationwide population-based study. PLoS One 2020;15:e0229621. 10.1371/journal.pone.0229621</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0229621</ArticleId><ArticleId IdType="pmc">PMC7055862</ArticleId><ArticleId IdType="pubmed">32130249</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahtta D, Ramsey DJ, Lee MT, et al. . Utilization rates of SGLT2 inhibitors and GLP-1 receptor agonists and their facility-level variation among patients with atherosclerotic cardiovascular disease and type 2 diabetes: insights from the department of veterans affairs. Diabetes Care 2022;45:372&#x2013;80. 10.2337/dc21-1815</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-1815</ArticleId><ArticleId IdType="pmc">PMC8914426</ArticleId><ArticleId IdType="pubmed">35015080</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies MJ, D&#x2019;Alessio DA, Fradkin J, et al. . Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care 2018;41:2669&#x2013;701. 10.2337/dci18-0033</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dci18-0033</ArticleId><ArticleId IdType="pmc">PMC6245208</ArticleId><ArticleId IdType="pubmed">30291106</ArticleId></ArticleIdList></Reference><Reference><Citation>Khera R, Valero-Elizondo J, Das SR, et al. . Cost-related medication nonadherence in adults with atherosclerotic cardiovascular disease in the United States, 2013 to 2017. Circulation 2019;140:2067&#x2013;75. 10.1161/CIRCULATIONAHA.119.041974</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.041974</ArticleId><ArticleId IdType="pubmed">31760784</ArticleId></ArticleIdList></Reference><Reference><Citation>Taha MB, Valero-Elizondo J, Yahya T, et al. . Cost-related medication nonadherence in adults with diabetes in the United States: the national health interview survey 2013-2018. Diabetes Care 2022;45:594&#x2013;603. 10.2337/dc21-1757</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-1757</ArticleId><ArticleId IdType="pubmed">35015860</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevreul K, Berg Brigham K, Durand-Zaleski I, et al. . France: health system review. Health Syst Transit 2015;17:1&#x2013;218,</Citation><ArticleIdList><ArticleId IdType="pubmed">26766545</ArticleId></ArticleIdList></Reference><Reference><Citation>
Protecting patients: france&#x2019;s transparency committee steps in, Available: https://english.prescrire.org/en/81/168/58485/0/2020/ArchiveNewsDetails.aspx?page=3 [Accessed 17 Sep 2022].</Citation></Reference><Reference><Citation>Scheen AJ. About the safety profile of SGLT2 inhibitors. Rev Med Liege 2022;77:218&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">35389005</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippatos TD, Panagiotopoulou TV, Elisaf MS. Adverse effects of GLP-1 receptor agonists. Rev Diabet Stud 2014;11:202&#x2013;30. 10.1900/RDS.2014.11.202</Citation><ArticleIdList><ArticleId IdType="doi">10.1900/RDS.2014.11.202</ArticleId><ArticleId IdType="pmc">PMC5397288</ArticleId><ArticleId IdType="pubmed">26177483</ArticleId></ArticleIdList></Reference><Reference><Citation>Honigberg MC, Chang L-S, McGuire DK, et al. . Use of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and cardiovascular disease: a review. JAMA Cardiol 2020;5:1182&#x2013;90. 10.1001/jamacardio.2020.1966</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1966</ArticleId><ArticleId IdType="pmc">PMC7744318</ArticleId><ArticleId IdType="pubmed">32584928</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilding J, Fernando K, Milne N, et al. . SGLT2 inhibitors in type 2 diabetes management: key evidence and implications for clinical practice. Diabetes Ther 2018;9:1757&#x2013;73. 10.1007/s13300-018-0471-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13300-018-0471-8</ArticleId><ArticleId IdType="pmc">PMC6167302</ArticleId><ArticleId IdType="pubmed">30039249</ArticleId></ArticleIdList></Reference><Reference><Citation>Adhikari R, Jha K, Dardari Z, et al. . National trends in use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists by cardiologists and other specialties. JAHA 2022;11. 10.1161/JAHA.121.023811</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.023811</ArticleId><ArticleId IdType="pmc">PMC9238581</ArticleId><ArticleId IdType="pubmed">35475341</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Pratt N, et al. . Large-scale evidence generation and evaluation across a network of databases (LEGEND): assessing validity using hypertension as a case study. J Am Med Inform Assoc 2020;27:1268&#x2013;77. 10.1093/jamia/ocaa124</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa124</ArticleId><ArticleId IdType="pmc">PMC7481033</ArticleId><ArticleId IdType="pubmed">32827027</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37853326</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2288</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>BMC medical research methodology</Title><ISOAbbreviation>BMC Med Res Methodol</ISOAbbreviation></Journal><ArticleTitle>Mapping Hungarian procedure codes to SNOMED CT.</ArticleTitle><Pagination><StartPage>240</StartPage><MedlinePgn>240</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">240</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12874-023-02036-x</ELocationID><Abstract><AbstractText Label="BACKGROUND">Data harmonisation is essential in real-world data (RWD) research projects based on hospital information systems databases, as coding systems differ between countries. The Hungarian hospital information systems and the national claims database use internationally known diagnosis codes, but data on medical procedures are recorded using national codes. There is no simple or standard solution for mapping the national codes to a standard coding system. Our aim was to map the Hungarian procedure codes (OENO) to SNOMED CT as part of the European Health Data Evidence Network (EHDEN) project.</AbstractText><AbstractText Label="METHODS">We recruited 25 professionals from different specialties to manually map the procedure codes used between 2011 and 2021. A mapping protocol and training material were developed, results were regularly revised, and the challenges of mapping were recorded. Approximately 7% of the codes were mapped by more people in different specialties for validation purposes.</AbstractText><AbstractText Label="RESULTS">We mapped 4661 OENO codes to standard vocabularies, mostly SNOMED CT. We categorized the challenges into three main areas: semantic, matching, and methodological. Semantic refers to the occasionally unclear meaning of the OENO codes, matching to the different granularity and purpose of the OENO and SNOMED CT vocabularies. Lastly, methodological challenges were used to describe issues related to the design of the above-mentioned two vocabularies.</AbstractText><AbstractText Label="CONCLUSIONS">The challenges and solutions presented here may help other researchers to design their process to map their national codes to standard vocabularies in order to achieve greater consistency in mapping results. Moreover, we believe that our work will allow for better use of RWD collected in Hungary in international research collaborations.</AbstractText><CopyrightInformation>&#xa9; 2023. BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>M&#xe9;sz&#xe1;ros</LastName><ForeName>&#xc1;gota</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Department of Public Health, Semmelweis University, Budapest, Hungary. meszaros.agota@semmelweis.hu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kov&#xe1;cs</LastName><ForeName>S&#xe1;ndor</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, Center for Health Technology Assessment and Pharmacoeconomic Research, University of P&#xe9;cs, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xe9;ja</LastName><ForeName>Tibor</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, Center for Health Technology Assessment and Pharmacoeconomic Research, University of P&#xe9;cs, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bagyura</LastName><ForeName>Zsolt</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Heart and Vascular Centre, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zempl&#xe9;nyi</LastName><ForeName>Antal</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, Center for Health Technology Assessment and Pharmacoeconomic Research, University of P&#xe9;cs, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Res Methodol</MedlineTA><NlmUniqueID>100968545</NlmUniqueID><ISSNLinking>1471-2288</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039061" MajorTopicYN="Y">Systematized Nomenclature of Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006814" MajorTopicYN="N" Type="Geographic">Hungary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016347" MajorTopicYN="Y">Medical Records Systems, Computerized</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011996" MajorTopicYN="N">Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data harmonization</Keyword><Keyword MajorTopicYN="N">Electronic medical record</Keyword><Keyword MajorTopicYN="N">Federated data network</Keyword><Keyword MajorTopicYN="N">Health data</Keyword><Keyword MajorTopicYN="N">Real-world data</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>19</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>18</Day><Hour>23</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37853326</ArticleId><ArticleId IdType="pmc">PMC10585817</ArticleId><ArticleId IdType="doi">10.1186/s12874-023-02036-x</ArticleId><ArticleId IdType="pii">10.1186/s12874-023-02036-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Agency EM. &#x201c;A vision for use of real-world evidence in EU medicines regulation,&#x201d; 2022. https://www.ema.europa.eu/en/news/vision-use-real-world-evidence-eu-medicines-regulation (accessed Dec. 18, 2022).</Citation></Reference><Reference><Citation>Food US, Administration D, &#x201c;, Real-World Evidence. &#x201d; 2022. https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence (accessed Dec. 18, 2022).</Citation></Reference><Reference><Citation>Oortwijn W, Sampietro-Colom L, Trowman R. &#x201c;How to Deal with the Inevitable: Generating Real-World Data and Using Real-World Evidence for HTA Purposes &#x2013; From Theory to Action,&#x201d; Int J Technol Assess Health Care, vol.&#xa0;35, no. 4, pp.&#xa0;346&#x2013;350, Jun. 2019, 10.1017/S0266462319000400</Citation><ArticleIdList><ArticleId IdType="pubmed">31198129</ArticleId></ArticleIdList></Reference><Reference><Citation>Tachkov K, et al. Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries. Front Public Health. Jul. 2022;10. 10.3389/fpubh.2022.921226</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9330148</ArticleId><ArticleId IdType="pubmed">35910914</ArticleId></ArticleIdList></Reference><Reference><Citation>Agency EM, &#x201c;Data Analysis and Real World Interrogation Network (DARWIN EU)., &#x201d; 2021. https://www.ema.europa.eu/en/about-us/how-we-work/big-data/data-analysis-real-world-interrogation-network-darwin-eu (accessed Dec. 18, 2022).</Citation></Reference><Reference><Citation>Observational Health Data Sciences and, Informatics &#x201c;OMOP, Common Data Model. &#x201d; 2022. https://www.ohdsi.org/data-standardization/the-common-data-model/ (accessed Jul. 15, 2022).</Citation></Reference><Reference><Citation>Rieke N, et al. The future of digital health with federated learning. NPJ Digit Med. Sep. 2020;3(1):119. 10.1038/s41746-020-00323-1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7490367</ArticleId><ArticleId IdType="pubmed">33015372</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO., &#x201c;WHO Family of International Classifications (FIC),&#x201d; 2022. https://www.who.int/standards/classifications (accessed Dec. 18, 2022).</Citation></Reference><Reference><Citation>Ministry of National Resources., 9/2012 (II. 28.) NEFMI Decree. Accessed: Dec. 18, 2022. [Online]. Available: https://njt.hu/jogszabaly/2012-9-20-2V</Citation></Reference><Reference><Citation>Ministry of National Resources., 10/2012 (II. 28.) NEFMI Decree. Accessed: Dec. 18, 2022. [Online]. Available: https://njt.hu/jogszabaly/2012-10-20-2V</Citation></Reference><Reference><Citation>WHO., &#x201c;International Classification of Procedures in Medicine.&#x201d; Accessed: Jan. 19, 2023. [Online]. Available: https://apps.who.int/iris/bitstream/handle/10665/40527/9241541253_eng.pdf;sequence=2</Citation></Reference><Reference><Citation>Endrei D, &#xc1;goston I, Boncz I. Eg&#xe9;szs&#xe9;g&#xfc;gyben haszn&#xe1;latos adatb&#xe1;zisok &#xe9;s k&#xf3;drendszerek [Databases and code systems used in healthcare]. 2015. Accessed: Jan. 19, 2023. [Online]. Available: https://www.etk.pte.hu/protected/OktatasiAnyagok/%21Palyazati/eukodrendszerek/EubenHasznalatosKodrendszerek_20160118jo.pdf</Citation></Reference><Reference><Citation>Boncz I, Nagy J, Sebesty&#xe9;n A, K&#x151;r&#xf6;si L. &#x201c;Financing of health care services in Hungary,&#x201d; The European Journal of Health Economics, formerly: HEPAC, vol.&#xa0;5, no. 3, pp.&#xa0;252&#x2013;258, Sep. 2004, 10.1007/s10198-004-0228-3</Citation><ArticleIdList><ArticleId IdType="pubmed">15714346</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaal P, Stefka N, Nagy J. &#x201c;Cost accounting methodologies in price setting of acute inpatient services in Hungary,&#x201d; Health Care Manag Sci, vol.&#xa0;9, no. 3, pp.&#xa0;243&#x2013;250, Aug. 2006, 10.1007/s10729-006-9091-3</Citation><ArticleIdList><ArticleId IdType="pubmed">17016930</ArticleId></ArticleIdList></Reference><Reference><Citation>International SNOMED, SNOMED-CT. &#x201c;.&#x201d; https://www.snomed.org/ (accessed Dec. 18, 2022).</Citation></Reference><Reference><Citation>LOINC &#x201c;LOINC. &#x201d; https://loinc.org/ (Accessed Dec 18, 2022).</Citation></Reference><Reference><Citation>National Libraray of Medicine., &#x201c;RxNorm.&#x201d; https://www.nlm.nih.gov/research/umls/rxnorm/index.html (accessed Dec. 18, 2022).</Citation></Reference><Reference><Citation>HemOnc.org., HemOnc.org - A free Hematology/Oncology reference. https://hemonc.org/wiki/Main_Page (accessed Dec. 18, 2022).</Citation></Reference><Reference><Citation>Service NCT, &#x201c;SNOMED CT-AU, -. Mapping Guidelines v2.0&#x201d;, Accessed: Dec. 18, 2022. [Online]. Available: https://www.healthterminologies.gov.au/library/NEHTA_1790_2014_SNOMEDCTAU_MappingGuidelines_v2.0.pdf?_filename=NEHTA_1790_2014_SNOMEDCTAU_MappingGuidelines_v2.0.pdf</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics., &#x201c;Mapping of Concepts.&#x201d; https://www.ohdsi.org/web/wiki/doku.php?id=documentation:vocabulary:mapping (accessed Dec. 18, 2022).</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics., The Book of OHDSI. Accessed: Dec. 18, 2022. [Online]. Available: https://ohdsi.github.io/TheBookOfOhdsi/</Citation></Reference><Reference><Citation>OHDSI., &#x201c;Standardized Data: The OMOP Common Data Model.&#x201d; https://www.ohdsi.org/data-standardization/ (accessed Jan. 19, 2023).</Citation></Reference><Reference><Citation>International SNOMED, &#x201c;SNOMED CT Editorial Guide. &#x201d; https://confluence.ihtsdotools.org/display/DOCEG (accessed Jan. 19, 2023).</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics., &#x201c;Chapter 5 Standardized Vocabularies&#x201d;, Accessed: Dec. 18, 2022. [Online]. Available: https://ohdsi.github.io/TheBookOfOhdsi/StandardizedVocabularies.html#conceptAncest</Citation></Reference><Reference><Citation>Observational Health Data Sciences and, Informatics. 10.3 Concept Sets. https://ohdsi.github.io/TheBookOfOhdsi/Cohorts.html#conceptSets (accessed Dec. 18, 2022).</Citation></Reference><Reference><Citation>Maier C, et al. Towards implementation of OMOP in a German University Hospital Consortium. Appl Clin Inform. Jan. 2018;09(01):054&#x2013;61. 10.1055/s-0037-1617452</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefan S, Johannes S, Peter P, Matvey P, Philipp D. Aligning an administrative Procedure Coding System with SNOMED CT, Creative Commons License Attribution 4.0 International (CC BY 4.0).</Citation></Reference><Reference><Citation>Hwang EJ et al. &#x201c;Mapping Korean EDI Medical Procedure Code to SNOMED CT.,&#x201d; Stud Health Technol Inform, vol.&#xa0;264, pp.&#xa0;178&#x2013;182, Aug. 2019, 10.3233/SHTI190207</Citation><ArticleIdList><ArticleId IdType="pubmed">31437909</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang H, Park H-A. &#x201c;Mapping Korean National Health Insurance Reimbursement Claim Codes for Therapeutic and Surgical Procedures to SNOMED-CT to Facilitate Data Reuse.,&#x201d; Stud Health Technol Inform, vol.&#xa0;290, pp.&#xa0;101&#x2013;105, Jun. 2022, 10.3233/SHTI220040</Citation><ArticleIdList><ArticleId IdType="pubmed">35672979</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopanitsa G. Mapping russian Laboratory terms to LOINC. &#x201d; Stud Health Technol Inform. 2015;210:379&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">25991170</ArticleId></ArticleIdList></Reference><Reference><Citation>Brammen D, et al. Mapping equivalence of German Emergency Department Medical Record Concepts with SNOMED CT after implementation with HL7 CDA. &#x201d; Stud Health Technol Inform. 2017;243:175&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28883195</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37860059</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2379-6146</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Learning health systems</Title><ISOAbbreviation>Learn Health Syst</ISOAbbreviation></Journal><ArticleTitle>A computable biomedical knowledge object for calculating in-hospital mortality for patients admitted with acute myocardial infarction.</ArticleTitle><Pagination><StartPage>e10388</StartPage><MedlinePgn>e10388</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e10388</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/lrh2.10388</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Quality indicators play an essential role in a learning health system. They help healthcare providers to monitor the quality and safety of care delivered and to identify areas for improvement. Clinical quality indicators, therefore, need to be based on real world data. Generating reliable and actionable data routinely is challenging. Healthcare data are often stored in different formats and use different terminologies and coding systems, making it difficult to generate and compare indicator reports from different sources.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The Observational Health Sciences and Informatics community maintains the Observational Medical Outcomes Partnership Common Data Model (OMOP). This is an open data standard providing a computable and interoperable format for real world data. We implemented a Computable Biomedical Knowledge Object (CBK) in the Piano Platform based on OMOP. The CBK calculates an inpatient quality indicator and was illustrated using synthetic electronic health record (EHR) data in the open OMOP standard.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The CBK reported the in-hospital mortality of patients admitted for acute myocardial infarction (AMI) for the synthetic EHR dataset and includes interactive visualizations and the results of calculations. Value sets composed of OMOP concept codes for AMI and comorbidities used in the indicator calculation were also created.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Computable biomedical knowledge (CBK) objects that operate on OMOP data can be reused across datasets that conform to OMOP. With OMOP being a widely used interoperability standard, quality indicators embedded in CBKs can accelerate the generation of evidence for targeted quality and safety management, improving care to benefit larger populations.</AbstractText><CopyrightInformation>&#xa9; 2023 Evidentli Pty Ltd. Learning Health Systems published by Wiley Periodicals LLC on behalf of University of Michigan.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sadsad</LastName><ForeName>Rosemarie</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2488-953X</Identifier><AffiliationInfo><Affiliation>Evidentli Sydney New South Wales Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruber</LastName><ForeName>Gema</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Evidentli Sydney New South Wales Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Johnson</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0001-9030-3624</Identifier><AffiliationInfo><Affiliation>Evidentli Sydney New South Wales Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicklin</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Evidentli Sydney New South Wales Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsafnat</LastName><ForeName>Guy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Evidentli Sydney New South Wales Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Health Informatics, Australian Institute of Health Innovation Macquarie University Sydney New South Wales Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Learn Health Syst</MedlineTA><NlmUniqueID>101708071</NlmUniqueID><ISSNLinking>2379-6146</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">healthcare quality and safety</Keyword><Keyword MajorTopicYN="N">learning health systems</Keyword><Keyword MajorTopicYN="N">quality indicators</Keyword></KeywordList><CoiStatement>Rosemarie Sadsad, Gema Ruber, Steven Nicklin, and Guy Tsafnat are employed by Evidentli Pty Ltd and as such hold securities tied to the success of the company. Guy Tsafnat is also a director and major shareholder. None of the authors are associated with the ACSQHC, nor with any company or product related to myocardial disease.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>20</Day><Hour>4</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37860059</ArticleId><ArticleId IdType="pmc">PMC10582239</ArticleId><ArticleId IdType="doi">10.1002/lrh2.10388</ArticleId><ArticleId IdType="pii">LRH210388</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Agency for Healthcare Research and Quality (AHRQ)
. AHRQ Quality Indicators. 2022. Viewed March 2023. https://qualityindicators.ahrq.gov/
</Citation></Reference><Reference><Citation>
Australian Commission on Safety and Quality in Health Care (ACSQHC)
. National core, hospital based outcome indicator Toolkit, version 3.1, 2021. Sydney: ACSQHC; 2017. Viewed March 2023. https://www.safetyandquality.gov.au/publications&#x2010;and&#x2010;resources/resource&#x2010;library/national&#x2010;core&#x2010;hospital&#x2010;based&#x2010;outcome&#x2010;indicator&#x2010;specification
</Citation></Reference><Reference><Citation>
NHS England
. Summary Hospital&#x2010;level Mortality Indicator (SHMI) Indicator specification, version 1.46. 2023. Viewed March 2023. https://digital.nhs.uk/data-and-information/publications/statistical/shmi/2023-03
</Citation></Reference><Reference><Citation>Committee on Core Metrics for Better Health at Lower Cost; Institute of Medicine (IOM) . In: Blumenthal D, Malphrus E, McGinnis J, eds. Vital Signs: Core Metrics for Health and Health Care Progress. Washington, DC: National Academies Press (US); 2015. doi:10.17226/19402</Citation><ArticleIdList><ArticleId IdType="doi">10.17226/19402</ArticleId><ArticleId IdType="pubmed">26378329</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Level Seven International Fast Healthcare Interoperability Resources HL7&#xae; FHIR&#xae;. 2012. Viewed March 2023. https://www.hl7.org/fhir/overview.html
</Citation></Reference><Reference><Citation>
Observational Health Data Sciences and Informatics (OHDSI)
. 2014. Viewed March 2023. https://ohdsi.org
</Citation></Reference><Reference><Citation>Haendel MA, Chute CG, Bennett TD, et al. The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment. J Am Med Inform Assoc. 2021;28(3):427&#x2010;443. doi:10.1093/jamia/ocaa196</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa196</ArticleId><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>
21st Century Cures Act
. H.R. 34, 114th Congress (Cures Act). 2016. Viewed March 2023. https://www.gpo.gov/fdsys/pkg/BILLS-114hr34enr/pdf/BILLS-114hr34enr.pdf
</Citation></Reference><Reference><Citation>
NHS England
. Digital Transformation. 2021. Viewed March 2023. https://www.england.nhs.uk/digitaltechnology/connecteddigitalsystems/interoperability/
</Citation></Reference><Reference><Citation>
European Health Data and Evidence Network (EHDEN)
. European Health Data and Evidence Network. 2018. Viewed March 2023. https://www.ehden.eu/
</Citation></Reference><Reference><Citation>Hong K, Bandaranayake D, Tsafnat G. Hong K, Bandaranayake D, Tsafnat G. Evidence Hub: A place to exchange medical knowledge and form communities. Learn Health Sys. 2023;e10387. doi:10.1002/lrh2.10387</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lrh2.10387</ArticleId><ArticleId IdType="pmc">PMC10582213</ArticleId><ArticleId IdType="pubmed">37860058</ArticleId></ArticleIdList></Reference><Reference><Citation>
Evidentli
. Piano (v23.2.0.1) [computer software]. 2023. https://www.evidentli.com/. Accessed March 2023.</Citation></Reference><Reference><Citation>Institute of Medicine (IOM) . In: McGinnis JM, Stuckhardt L, Saunders R, Smith M, eds. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Washington, DC: National Academies Press (US); 2013. doi:10.17226/13444</Citation><ArticleIdList><ArticleId IdType="doi">10.17226/13444</ArticleId><ArticleId IdType="pubmed">24901184</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37869827</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>309</Volume><PubDate><Year>2023</Year><Month>Oct</Month><Day>20</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Application of OMOP Common Data Model for Data Integration: The Bulgarian Diabetes Register.</ArticleTitle><Pagination><StartPage>141</StartPage><EndPage>142</EndPage><MedlinePgn>141-142</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI230761</ELocationID><Abstract><AbstractText>This paper considers mapping of the Bulgarian Diabetes Register(BDR) onto OMOP Common Data Model (CDM). Research results are referenced and plans for analysis of drug shortages from federated data sources are outlined.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krastev</LastName><ForeName>Evgeniy</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Mathematics and Informatics, Sofia University St. Kliment Ohridski, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tcharaktchiev</LastName><ForeName>Dimitar</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Medical University, Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abanos</LastName><ForeName>Simeon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Mathematics and Informatics, Sofia University St. Kliment Ohridski, Bulgaria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002031" MajorTopicYN="N" Type="Geographic">Bulgaria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">data integration</Keyword><Keyword MajorTopicYN="N">diabetes register</Keyword><Keyword MajorTopicYN="N">observational data</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>5</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37869827</ArticleId><ArticleId IdType="doi">10.3233/SHTI230761</ArticleId><ArticleId IdType="pii">SHTI230761</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37942786</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2291-9694</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2023</Year><Month>Nov</Month><Day>07</Day></PubDate></JournalIssue><Title>JMIR medical informatics</Title><ISOAbbreviation>JMIR Med Inform</ISOAbbreviation></Journal><ArticleTitle>Assessing the Use of German Claims Data Vocabularies for Research in the Observational Medical Outcomes Partnership Common Data Model: Development and Evaluation Study.</ArticleTitle><Pagination><StartPage>e47959</StartPage><MedlinePgn>e47959</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e47959</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/47959</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">National classifications and terminologies already routinely used for documentation within patient care settings enable the unambiguous representation of clinical information. However, the diversity of different vocabularies across health care institutions and countries is a barrier to achieving semantic interoperability and exchanging data across sites. The Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) enables the standardization of structure and medical terminology. It allows the mapping of national vocabularies into so-called standard concepts, representing normative expressions for international analyses and research. Within our project "Hybrid Quality Indicators Using Machine Learning Methods" (Hybrid-QI), we aim to harmonize source codes used in German claims data vocabularies that are currently unavailable in the OMOP CDM.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This study aims to increase the coverage of German vocabularies in the OMOP CDM. We aim to completely transform the source codes used in German claims data into the OMOP CDM without data loss and make German claims data usable for OMOP CDM-based research.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">To prepare the missing German vocabularies for the OMOP CDM, we defined a vocabulary preparation approach consisting of the identification of all codes of the corresponding vocabularies, their assembly into machine-readable tables, and the translation of German designations into English. Furthermore, we used 2 proposed approaches for OMOP-compliant vocabulary preparation: the mapping to standard concepts using the Observational Health Data Sciences and Informatics (OHDSI) tool Usagi and the preparation of new 2-billion concepts (ie, concept_id &gt;2 billion). Finally, we evaluated the prepared vocabularies regarding completeness and correctness using synthetic German claims data and calculated the coverage of German claims data vocabularies in the OMOP CDM.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Our vocabulary preparation approach was able to map 3 missing German vocabularies to standard concepts and prepare 8 vocabularies as new 2-billion concepts. The completeness evaluation showed that the prepared vocabularies cover 44.3% (3288/7417) of the source codes contained in German claims data. The correctness evaluation revealed that the specified validity periods in the OMOP CDM are compliant for the majority (705,531/706,032, 99.9%) of source codes and associated dates in German claims data. The calculation of the vocabulary coverage showed a noticeable decrease of missing vocabularies from 55% (11/20) to 10% (2/20) due to our preparation approach.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">By preparing 10 vocabularies, we showed that our approach is applicable to any type of vocabulary used in a source data set. The prepared vocabularies are currently limited to German vocabularies, which can only be used in national OMOP CDM research projects, because the mapping of new 2-billion concepts to standard concepts is missing. To participate in international OHDSI network studies with German claims data, future work is required to map the prepared 2-billion concepts to standard concepts.</AbstractText><CopyrightInformation>&#xa9; Elisa Henke, Mich&#xe9;le Zoch, Michael Kallfelz, Thomas Ruhnke, Liz Annika Leutner, Melissa Spoden, Christian G&#xfc;nster, Martin Sedlmayr, Franziska Bathelt. Originally published in JMIR Medical Informatics (https://medinform.jmir.org).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Henke</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-5002-2676</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoch</LastName><ForeName>Mich&#xe9;le</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5577-7760</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kallfelz</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0005-6786-3569</Identifier><AffiliationInfo><Affiliation>Odysseus Data Services GmbH, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruhnke</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-5955-4142</Identifier><AffiliationInfo><Affiliation>Wissenschaftliches Institut der AOK (AOK Research Institute), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leutner</LastName><ForeName>Liz Annika</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0009-0002-9566-7096</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spoden</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6730-4469</Identifier><AffiliationInfo><Affiliation>Wissenschaftliches Institut der AOK (AOK Research Institute), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;nster</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3085-6259</Identifier><AffiliationInfo><Affiliation>Wissenschaftliches Institut der AOK (AOK Research Institute), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9888-8460</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bathelt</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-4139-5489</Identifier><AffiliationInfo><Affiliation>Thiem-Research GmbH, Cottbus, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Med Inform</MedlineTA><NlmUniqueID>101645109</NlmUniqueID><ISSNLinking>2291-9694</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">Observational Health Data Sciences and Informatics</Keyword><Keyword MajorTopicYN="N">Observational Medical Outcomes Partnership</Keyword><Keyword MajorTopicYN="N">claims data</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">interoperability</Keyword><Keyword MajorTopicYN="N">vocabularies</Keyword></KeywordList><CoiStatement><b>Conflicts of Interest:</b> None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>9</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>9</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37942786</ArticleId><ArticleId IdType="pmc">PMC10653283</ArticleId><ArticleId IdType="doi">10.2196/47959</ArticleId><ArticleId IdType="pii">v11i1e47959</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Office of the Commissioner  Real-world evidence. US Food and Drug Administration. 2023. May 2,  [04-05-2023]. https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence URL. Accessed.</Citation></Reference><Reference><Citation>Code C03. Athena &#x2013; OHDSI vocabularies repository.  [23-03-2023]. https://athena.ohdsi.org/search-terms/terms?query=C03 URL. Accessed.</Citation></Reference><Reference><Citation>Reinecke I, Zoch M, Reich C, Sedlmayr M, Bathelt F. The usage of OHDSI OMOP - a scoping review. Stud Health Technol Inform. 2021 Sep 21;283:95&#x2013;103. doi: 10.3233/SHTI210546. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI210546</ArticleId><ArticleId IdType="pubmed">34545824</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016 Dec;64:333&#x2013;341. doi: 10.1016/j.jbi.2016.10.016. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.10.016</ArticleId><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Athena &#x2013; OHDSI vocabularies repository.  [25-11-2022]. https://athena.ohdsi.org/ URL. Accessed.</Citation></Reference><Reference><Citation>Bardenheuer K, van Speybroeck M, Hague C, Nikai E, Price M. Haematology Outcomes Network in Europe (HONEUR)-a collaborative, interdisciplinary platform to harness the potential of real-world data in hematology. Eur J Haematol. 2022 Aug;109(2):138&#x2013;145. doi: 10.1111/ejh.13780. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejh.13780</ArticleId><ArticleId IdType="pubmed">35460296</ArticleId></ArticleIdList></Reference><Reference><Citation>Biedermann P, Ong R, Davydov A, Orlova A, Solovyev P, Sun H, et al. Standardizing registry data to the OMOP Common Data Model: experience from three pulmonary hypertension databases. BMC Med Res Methodol. 2021 Nov 2;21(1):238. doi: 10.1186/s12874-021-01434-3. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-021-01434-3</ArticleId><ArticleId IdType="pmc">PMC8565035</ArticleId><ArticleId IdType="pubmed">34727871</ArticleId></ArticleIdList></Reference><Reference><Citation>Haberson A, Rinner C, Sch&#xf6;berl A, Gall W. Feasibility of mapping Austrian health claims data to the OMOP Common Data Model. J Med Syst. 2019 Sep 7;43(10):314. doi: 10.1007/s10916-019-1436-9. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10916-019-1436-9</ArticleId><ArticleId IdType="pmc">PMC6732152</ArticleId><ArticleId IdType="pubmed">31494719</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamer A, Abou-Arab O, Bourgeois A, Parrot A, Popoff B, Beuscart J-B, et al. Transforming anesthesia data into the Observational Medical Outcomes Partnership Common Data Model: development and usability study. J Med Internet Res. 2021 Oct 29;23(10):e29259. doi: 10.2196/29259. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/29259</ArticleId><ArticleId IdType="pmc">PMC8590192</ArticleId><ArticleId IdType="pubmed">34714250</ArticleId></ArticleIdList></Reference><Reference><Citation>Spoden M, Dr&#xf6;ge P, Roessler M, Datzmann T, Lang C, Sedlmayr M, et al. Hybride qualit&#xe4;tsindikatoren mittels machine learning-methoden (Hybrid-QI). 21 Deutscher Kongress f&#xfc;r Versorgungsforschung (DKVF 2022); Oct 5-7, 2022; Potsdam, Germany. Presented at. doi.</Citation><ArticleIdList><ArticleId IdType="doi">10.3205/22dkvf107</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y, Henke E, Reinecke I, Zoch M, Sedlmayr M, Bathelt F. An ETL-process design for data harmonization to participate in international research with German real-world data based on FHIR and OMOP CDM. Int J Med Inform. 2023 Jan;169:104925. doi: 10.1016/j.ijmedinf.2022.104925. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2022.104925</ArticleId><ArticleId IdType="pubmed">36395615</ArticleId></ArticleIdList></Reference><Reference><Citation>Henke E, Zoch M, Reinecke I, Spoden M, Ruhnke T, G&#xfc;nster C, et al. German claims data for real-world research: content coverage evaluation in OMOP CDM. Stud Health Technol Inform. 2023 May 18;302:3&#x2013;7. doi: 10.3233/SHTI230053. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI230053</ArticleId><ArticleId IdType="pubmed">37203598</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathappan SMK, Jeon YS, Dang TK, Lim SC, Shao YM, Tai ES, et al. Transformation of electronic health records and questionnaire data to OMOP CDM: a feasibility study using SG_T2DM dataset. Appl Clin Inform. 2021 Aug;12(4):757&#x2013;767. doi: 10.1055/s-0041-1732301. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1732301</ArticleId><ArticleId IdType="pmc">PMC8357458</ArticleId><ArticleId IdType="pubmed">34380168</ArticleId></ArticleIdList></Reference><Reference><Citation>OMOP CDM v5.3 - concept. OMOP Common Data Model.  [23-03-2023]. https://ohdsi.github.io/CommonDataModel/cdm53.html#CONCEPT URL. Accessed.</Citation></Reference><Reference><Citation>OMOP CDM frequently asked questions. OMOP Common Data Model.  [13-03-2023]. https://ohdsi.github.io/CommonDataModel/faq.html URL. Accessed.</Citation></Reference><Reference><Citation>Schuemie M, Li W, Rijnbeek P, Borgdorff J, Voss E. Usagi. GitHub. Apr 9, 2021.  [03-03-2023]. https://github.com/OHDSI/Usagi URL. Accessed.</Citation></Reference><Reference><Citation>Usagi. OHDSI Usagi.  [26-10-2023]. http://ohdsi.github.io/Usagi/ URL. Accessed.</Citation></Reference><Reference><Citation>Pentaho data integration. Hitachi Vantara. Nov 17, 2022.  [03-03-2023]. https://help.hitachivantara.com/Documentation/Pentaho/9.4/Products/Pentaho_Data_Integration URL. Accessed.</Citation></Reference><Reference><Citation>Henke E. OMOP-CDM-German-vocabularies. GitHub. Mar 28, 2023.  [24-03-2023]. https://github.com/elisahenke/OMOP-CDM-German-vocabularies URL. Accessed.</Citation></Reference><Reference><Citation>Henke E. OMOP-vocabulary-evaluation. GitHub. Mar 24, 2023.  [24-03-2023]. https://github.com/elisahenke/OMOP-vocabulary-evaluation URL. Accessed.</Citation></Reference><Reference><Citation>Ditscheid B, Storch J, Krause M, Meyer I, Freytag A. Leistungs- und abrechnungsdatum in GKV-routinedaten: umgang mit zeitlichen abweichungen. Date of service provision and date of payment in claims data: dealing with time differences. Artice in German. Gesundheitswesen. 2020 Mar;82(S 01):S20&#x2013;S28. doi: 10.1055/a-1030-4223. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1030-4223</ArticleId><ArticleId IdType="pubmed">31822022</ArticleId></ArticleIdList></Reference><Reference><Citation>Papez V, Moinat M, Payralbe S, Asselbergs FW, Lumbers RT, Hemingway H, et al. Transforming and evaluating electronic health record disease phenotyping algorithms using the OMOP Common Data Model: a case study in heart failure. JAMIA Open. 2021 Feb 4;4(3):ooab001. doi: 10.1093/jamiaopen/ooab001. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamiaopen/ooab001</ArticleId><ArticleId IdType="pmc">PMC8423424</ArticleId><ArticleId IdType="pubmed">34514354</ArticleId></ArticleIdList></Reference><Reference><Citation>Papez V, Moinat M, Voss EA, Bazakou S, van Winzum A, Peviani A, et al. Transforming and evaluating the UK Biobank to the OMOP Common Data Model for COVID-19 research and beyond. J Am Med Inform Assoc. 2022 Dec 13;30(1):103&#x2013;111. doi: 10.1093/jamia/ocac203. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocac203</ArticleId><ArticleId IdType="pmc">PMC9619789</ArticleId><ArticleId IdType="pubmed">36227072</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida JR, Silva JF, Matos S, Oliveira JL. A two-stage workflow to extract and harmonize drug mentions from clinical notes into observational databases. J Biomed Inform. 2021 Aug;120:103849. doi: 10.1016/j.jbi.2021.103849. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2021.103849</ArticleId><ArticleId IdType="pubmed">34214696</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacketer C, Voss EA, DeFalco F, Hughes N, Schuemie MJ, Moinat M, et al. Using the Data Quality Dashboard to improve the EHDEN network. Applied Sciences. 2021 Dec 15;11(24):11920. doi: 10.3390/app112411920. doi.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app112411920</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima DM, Rodrigues JF Jr, Traina AJM, Pires FA, Gutierrez MA. Transforming two decades of ePR data to OMOP CDM for clinical research. Stud Health Technol Inform. 2019 Aug 21;264:233&#x2013;237. doi: 10.3233/SHTI190218. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI190218</ArticleId><ArticleId IdType="pubmed">31437920</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JW, Kim S, Ryu B, Song W, Lee HY, Yoo S. Transforming electronic health record polysomnographic data into the Observational Medical Outcome Partnership&#x2019;s Common Data Model: a pilot feasibility study. Sci Rep. 2021 Mar 29;11(1):7013. doi: 10.1038/s41598-021-86564-w. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-86564-w</ArticleId><ArticleId IdType="pmc">PMC8007756</ArticleId><ArticleId IdType="pubmed">33782494</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer P, St&#xf6;hr MR, Gall H, Michel-Backofen A, Majeed RW. Data integration into OMOP CDM for heterogeneous clinical data collections via HL7 FHIR bundles and XSLT. Stud Health Technol Inform. 2020 Jun 16;270:138&#x2013;142. doi: 10.3233/SHTI200138. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI200138</ArticleId><ArticleId IdType="pubmed">32570362</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinner C, Gezgin D, Wendl C, Gall W. A clinical data warehouse based on OMOP and i2b2 for Austrian health claims data. Stud Health Technol Inform. 2018;248:94&#x2013;99. doi: 10.3233/978-1-61499-858-7-94. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/978-1-61499-858-7-94</ArticleId><ArticleId IdType="pubmed">29726424</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamer A, Depas N, Doutreligne M, Parrot A, Verloop D, Defebvre MM, et al. Transforming French electronic health records into the Observational Medical Outcome Partnership&#x2019;s Common Data Model: a feasibility study. Appl Clin Inform. 2020 Jan;11(1):13&#x2013;22. doi: 10.1055/s-0039-3402754. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-3402754</ArticleId><ArticleId IdType="pmc">PMC6949163</ArticleId><ArticleId IdType="pubmed">31914471</ArticleId></ArticleIdList></Reference><Reference><Citation>Paris N, Lamer A, Parrot A. Transformation and evaluation of the MIMIC database in the OMOP Common Data Model: development and usability study. JMIR Med Inform. 2021 Dec 14;9(12):e30970. doi: 10.2196/30970. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/30970</ArticleId><ArticleId IdType="pmc">PMC8715361</ArticleId><ArticleId IdType="pubmed">34904958</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37952118</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>22</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>European Health Data &amp; Evidence Network-learnings from building out a standardized international health data network.</ArticleTitle><Pagination><StartPage>209</StartPage><EndPage>219</EndPage><MedlinePgn>209-219</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocad214</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Health data standardized to a common data model (CDM) simplifies and facilitates research. This study examines the factors that make standardizing observational health data to the Observational Medical Outcomes Partnership (OMOP) CDM successful.</AbstractText><AbstractText Label="MATERIALS AND METHODS">Twenty-five data partners (DPs) from 11 countries received funding from the European Health Data Evidence Network (EHDEN) to standardize their data. Three surveys, DataQualityDashboard results, and statistics from the conversion process were analyzed qualitatively and quantitatively. Our measures of success were the total number of days to transform source data into the OMOP CDM and participation in network research.</AbstractText><AbstractText Label="RESULTS">The health data converted to CDM represented more than 133 million patients. 100%, 88%, and 84% of DPs took Surveys 1, 2, and 3. The median duration of the 6 key extract, transform, and load (ETL) processes ranged from 4 to 115&#xa0;days. Of the 25 DPs, 21 DPs were considered applicable for analysis of which 52% standardized their data on time, and 48% participated in an international collaborative study.</AbstractText><AbstractText Label="DISCUSSION">This study shows that the consistent workflow used by EHDEN proves appropriate to support the successful standardization of observational data across Europe. Over the 25 successful transformations, we confirmed that getting the right people for the ETL is critical and vocabulary mapping requires specific expertise and support of tools. Additionally, we learned that teams that proactively prepared for data governance issues were able to avoid considerable delays improving their ability to finish on time.</AbstractText><AbstractText Label="CONCLUSION">This study provides guidance for future DPs to standardize to the OMOP CDM and participate in distributed networks. We demonstrate that the Observational Health Data Sciences and Informatics community must continue to evaluate and provide guidance and support for what ultimately develops the backbone of how community members generate evidence.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Voss</LastName><ForeName>Erica A</ForeName><Initials>EA</Initials><Identifier Source="ORCID">0000-0002-0651-0613</Identifier><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Pharmaceutical Research and Development LLC, Raritan, NJ 08869, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blacketer</LastName><ForeName>Clair</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2570-2124</Identifier><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Pharmaceutical Research and Development LLC, Raritan, NJ 08869, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Sandijk</LastName><ForeName>Sebastiaan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Odysseus Data Services, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moinat</LastName><ForeName>Maxim</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kallfelz</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Odysseus Data Services, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Speybroeck</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Janssen Pharmaceutical Research and Development LLC, Raritan, NJ 08869, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Pharmaceutical Research and Development LLC, Raritan, NJ 08869, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, CA 90095, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008511" MajorTopicYN="Y">Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OMOP common data model</Keyword><Keyword MajorTopicYN="N">data standardization</Keyword><Keyword MajorTopicYN="N">observational data</Keyword></KeywordList><CoiStatement>E.A.V., C.B., M.v.S., and M.J.S. are employees of Janssen Research and Development LLC and shareholders of Johnson &amp; Johnson (J&amp;J) stock. P.R.R. on this project has received funding from the Innovative Medicines Initiative (IMI) 2 Joint Undertaking (JU) under grant agreement number 806968. The JU receives support from the European Union&#x2019;s Horizon 2020 research and innovation program and EFPIA. The funding source had no role in writing the manuscript or the decision to submit it for publication. P.R.R. works for a department that receives/received unconditional research grants from UCB, Chiesi, Amgen, Johnson and Johnson, European Medicines Agency. Odysseus Data Services, where M.K. and S.v.S. are employed, is a beneficiary of the mentioned IMI 2 JU project. D.P.-A.&#x2019;s research group has received funding from the European Medicines Agency and Innovative Medicines Initiative. D.P.-A.&#x2019;s department has received grant(s) from Amgen, Chiesi-Taylor, Lilly, Janssen, Novartis, and UCB Biopharma. His research group has received consultancy fees from AstraZeneca and UCB Biopharma. Amgen, Astellas, Janssen, Synapse Management Partners, and UCB Biopharma have funded or supported training programs organized by D.P.-A.&#x2019;s department.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>12</Day><Hour>5</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37952118</ArticleId><ArticleId IdType="pmc">PMC10746315</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocad214</ArticleId><ArticleId IdType="pii">7407971</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Reisinger SJ, Ryan PB, O&#x2019;Hara DJ, et al. Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J Am Med Inform Assoc. 2010;17(6):652-662. 10.1136/jamia.2009.002477</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.002477</ArticleId><ArticleId IdType="pmc">PMC3000752</ArticleId><ArticleId IdType="pubmed">20962127</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong T, Pradhananga R, Holve E, Kahn MG.. A framework for classification of electronic health data extraction-transformation-loading challenges in data network participation. EGEMS (Washington, DC). 2017;5(1):10. 10.5334/egems.222</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/egems.222</ArticleId><ArticleId IdType="pmc">PMC5994935</ArticleId><ArticleId IdType="pubmed">29930958</ArticleId></ArticleIdList></Reference><Reference><Citation>
Common Data Model (CDM). OMOP Common Data Model (CDM). Accessed May 14, 2023. https://github.com/OHDSI/CommonDataModel</Citation></Reference><Reference><Citation>
Observational Health Data Sciences and Informatics. The Book of OHDSI. The Book of OHDSI. Accessed August 29, 2019. https://ohdsi.github.io/TheBookOfOhdsi/</Citation></Reference><Reference><Citation>
<i>OHDSI/WhiteRabbit [program].</i> Version V0.10.1. GitHub. Accessed May 14, 2023. https://github.com/OHDSI/WhiteRabbit</Citation></Reference><Reference><Citation>
<i>OHDSI/Usagi [program].</i> Version V1.3.0. GitHub. Accessed May 14, 2023. https://github.com/OHDSI/Usagi</Citation></Reference><Reference><Citation>
<i>OHDSI/Automated Characterization of Health Information at Large-scale Longitudinal Evidence Systems (ACHILLES) [program].</i> Version V1.6.3. GitHub. Accessed May 14, 2023. https://github.com/OHDSI/Achilles</Citation></Reference><Reference><Citation>
<i>OHDSI/DataQualityDashboard (DQD) [program]</i>. GitHub. Accessed May 14, 2023. https://github.com/OHDSI/DataQualityDashboard</Citation></Reference><Reference><Citation>
OHDSI Forums. OHDSI Forums [Web Forum]. Accessed May 14, 2023. https://forums.ohdsi.org/</Citation></Reference><Reference><Citation>
European Health Data &amp; Evidence Network (EHDEN). European Health Data &amp; Evidence Network (EHDEN) [Web Page]. Accessed May 14, 2023. https://www.ehden.eu/</Citation></Reference><Reference><Citation>European Health Data &amp; Evidence Network (EHDEN). 04/2020&#x2014;COVID19 Rapid Collaboration Call. 04/2020&#x2014;COVID19 Rapid Collaboration Call. Accessed November 6, 2022. https://www.ehden.eu/open-calls/04-2020-covid19-data-partner-call/</Citation></Reference><Reference><Citation>OHDSI White Rabbit. OHDSI White Rabbit. Accessed November 6, 2022. http://ohdsi.github.io/WhiteRabbit/index.html</Citation></Reference><Reference><Citation>OHDSI Usagi. OHDSI Usagi. Accessed August 27, 2023. https://www.ohdsi.org/web/wiki/doku.php?id=documentation:software:usagi</Citation></Reference><Reference><Citation>
Adverse Events of Special Interest within COVID-19 Subjects Code Repository. Adverse Events of Special Interest within COVID-19 Subjects Code Repository [GitHub Repository] 2021. Accessed November 6, 2022. https://github.com/ohdsi-studies/Covid19SubjectsAesiIncidenceRate</Citation></Reference><Reference><Citation>
Voss EA, Sa Ostropolets A, Nyberg F, et al.  Adverse Events of Special Interest within COVID-19 Subjects&#x2014;Research Protocol. Adverse Events of Special Interest within COVID-19 Subjects&#x2014;Research Protocol. Accessed November 6, 2022. https://ohdsi-studies.github.io/Covid19SubjectsAesiIncidenceRate/Protocol.html</Citation></Reference><Reference><Citation>
Voss EA, Shoaibi A, Yin Hui Lai L,. 
et al. 
Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study. <i>EClinicalMedicine</i>. 2023;58:101932. 10.1016/j.eclinm.2023.101932</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101932</ArticleId><ArticleId IdType="pmc">PMC10072853</ArticleId><ArticleId IdType="pubmed">37034358</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacketer C, Voss EA, DeFalco F, et al. Using the data quality dashboard to improve the EHDEN network. Appl Sci. 2021;11(24):11920.</Citation></Reference><Reference><Citation>Oja M, Tamm S, Mooses K, et al. Transforming Estonian health data to the Observational Medical Outcomes Partnership (OMOP) Common Data Model: lessons learned, medRxiv 2023:2023.02.16.23285697. 10.1101/2023.02.16.23285697, preprint: not peer reviewed.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.02.16.23285697</ArticleId><ArticleId IdType="pmc">PMC10697784</ArticleId><ArticleId IdType="pubmed">38058679</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Zong N, Wen A, et al. Developing an ETL tool for converting the PCORnet CDM into the OMOP CDM to facilitate the COVID-19 data integration. J Biomed Inform. 2022;127:104002. 10.1016/j.jbi.2022.104002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2022.104002</ArticleId><ArticleId IdType="pmc">PMC8791245</ArticleId><ArticleId IdType="pubmed">35077901</ArticleId></ArticleIdList></Reference><Reference><Citation>Puttmann D, De Keizer N, Cornet R, Van Der Zwan E, Bakhshi-Raiez F.. FAIRifying a quality registry using OMOP CDM: challenges and solutions. Stud Health Technol Inform. 2022;294:367-371. 10.3233/shti220476</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/shti220476</ArticleId><ArticleId IdType="pubmed">35612098</ArticleId></ArticleIdList></Reference><Reference><Citation>Carus J, N&#xfc;rnberg S, &#xdc;ckert F, Schl&#xfc;ter C, Bartels S.. Mapping cancer registry data to the episode domain of the Observational Medical Outcomes Partnership Model (OMOP). Appl Sci. 2022;12(8):4010.</Citation></Reference><Reference><Citation>Papez V, Moinat M, Voss EA, et al. Transforming and evaluating the UK Biobank to the OMOP Common Data Model for COVID-19 research and beyond. J Am Med Inform Assoc. 2022;30(1):103-111. 10.1093/jamia/ocac203</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocac203</ArticleId><ArticleId IdType="pmc">PMC9619789</ArticleId><ArticleId IdType="pubmed">36227072</ArticleId></ArticleIdList></Reference><Reference><Citation>Biedermann P, Ong R, Davydov A, et al. Standardizing registry data to the OMOP Common Data Model: experience from three pulmonary hypertension databases. BMC Med Res Methodol. 2021;21(1):238. 10.1186/s12874-021-01434-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-021-01434-3</ArticleId><ArticleId IdType="pmc">PMC8565035</ArticleId><ArticleId IdType="pubmed">34727871</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamer A, Depas N, Doutreligne M, et al. Transforming French electronic health records into the observational medical outcome partnership&#x2019;s common data model: a feasibility study. Appl Clin Inform. 2020;11(1):13-22. 10.1055/s-0039-3402754</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-3402754</ArticleId><ArticleId IdType="pmc">PMC6949163</ArticleId><ArticleId IdType="pubmed">31914471</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Joss MAH, Embree K, Murphy SN.. Data model harmonization for the All Of Us Research Program: transforming i2b2 data into the OMOP Common Data Model. PLoS One. 2019;14(2):e0212463. 10.1371/journal.pone.0212463</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0212463</ArticleId><ArticleId IdType="pmc">PMC6380544</ArticleId><ArticleId IdType="pubmed">30779778</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC, Lee S, Cho SY, et al. Conversion of National Health Insurance Service-National Sample Cohort (NHIS-NSC) Database into Observational Medical Outcomes Partnership-Common Data Model (OMOP-CDM). Stud Health Technol Inform. 2017;245:467-470.</Citation><ArticleIdList><ArticleId IdType="pubmed">29295138</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon D, Ahn EK, Park MY, et al. Conversion and data quality assessment of electronic health record data at a Korean Tertiary Teaching Hospital to a common data model for distributed network research. Healthc Inform Res. 2016;22(1):54-58. 10.4258/hir.2016.22.1.54</Citation><ArticleIdList><ArticleId IdType="doi">10.4258/hir.2016.22.1.54</ArticleId><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, Resnic FS, Robbins SL, et al. Creating a common data model for comparative effectiveness with the observational medical outcomes partnership. Appl Clin Inform. 2015;6(3):536-547. 10.4338/aci-2014-12-cr-0121</Citation><ArticleIdList><ArticleId IdType="doi">10.4338/aci-2014-12-cr-0121</ArticleId><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A, Ryan P, Fife D, Reich C.. Fidelity assessment of a clinical practice research datalink conversion to the OMOP Common Data Model. Drug Saf. 2014;37(11):945-959. 10.1007/s40264-014-0214-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0214-3</ArticleId><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Makadia R, Ryan PB.. Transforming the Premier Perspective Hospital Database into the Observational Medical Outcomes Partnership (OMOP) common data model. EGEMS (Washington, DC). 2014;2(1):1110. 10.13063/2327-9214.1110</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1110</ArticleId><ArticleId IdType="pmc">PMC4371500</ArticleId><ArticleId IdType="pubmed">25848597</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Murugesan S, Bhullar H, et al. An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance. Drug Saf. 2013;36(2):119-134. 10.1007/s40264-012-0009-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-012-0009-3</ArticleId><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE.. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54-60. 10.1136/amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>
Perseus. Perseus [Git Repository]. Accessed January 28, 2023. https://github.com/OHDSI/Perseus</Citation></Reference><Reference><Citation>Susana [Web Page]. Accessed May 14, 2022. https://interhop.frama.io/omop/susana/</Citation></Reference><Reference><Citation>de Ridder MAJ, de Wilde M, de Ben C, et al. Data resource profile: the Integrated Primary Care Information (IPCI) database, The Netherlands. Int J Epidemiol. 2022;51(6):e314-e323. 10.1093/ije/dyac026</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyac026</ArticleId><ArticleId IdType="pmc">PMC9749682</ArticleId><ArticleId IdType="pubmed">35182144</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37955965</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1438-8871</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><PubDate><Year>2023</Year><Month>Nov</Month><Day>13</Day></PubDate></JournalIssue><Title>Journal of medical Internet research</Title><ISOAbbreviation>J Med Internet Res</ISOAbbreviation></Journal><ArticleTitle>Development and Validation of a Prognostic Classification Model Predicting Postoperative Adverse Outcomes in Older Surgical Patients Using a Machine Learning Algorithm: Retrospective Observational Network Study.</ArticleTitle><Pagination><StartPage>e42259</StartPage><MedlinePgn>e42259</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e42259</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/42259</ELocationID><Abstract><AbstractText Label="BACKGROUND">Older adults are at an increased risk of postoperative morbidity. Numerous risk stratification tools exist, but effort and manpower are required.</AbstractText><AbstractText Label="OBJECTIVE">This study aimed to develop a predictive model of postoperative adverse outcomes in older patients following general surgery with an open-source, patient-level prediction from the Observational Health Data Sciences and Informatics for internal and external validation.</AbstractText><AbstractText Label="METHODS">We used the Observational Medical Outcomes Partnership common data model and machine learning algorithms. The primary outcome was a composite of 90-day postoperative all-cause mortality and emergency department visits. Secondary outcomes were postoperative delirium, prolonged postoperative stay (&#x2265;75th percentile), and prolonged hospital stay (&#x2265;21 days). An 80% versus 20% split of the data from the Seoul National University Bundang Hospital (SNUBH) and Seoul National University Hospital (SNUH) common data model was used for model training and testing versus external validation. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC) with a 95% CI.</AbstractText><AbstractText Label="RESULTS">Data from 27,197 (SNUBH) and 32,857 (SNUH) patients were analyzed. Compared to the random forest, Adaboost, and decision tree models, the least absolute shrinkage and selection operator logistic regression model showed good internal discriminative accuracy (internal AUC 0.723, 95% CI 0.701-0.744) and transportability (external AUC 0.703, 95% CI 0.692-0.714) for the primary outcome. The model also possessed good internal and external AUCs for postoperative delirium (internal AUC 0.754, 95% CI 0.713-0.794; external AUC 0.750, 95% CI 0.727-0.772), prolonged postoperative stay (internal AUC 0.813, 95% CI 0.800-0.825; external AUC 0.747, 95% CI 0.741-0.753), and prolonged hospital stay (internal AUC 0.770, 95% CI 0.749-0.792; external AUC 0.707, 95% CI 0.696-0.718). Compared with age or the Charlson comorbidity index, the model showed better prediction performance.</AbstractText><AbstractText Label="CONCLUSIONS">The derived model shall assist clinicians and patients in understanding the individualized risks and benefits of surgery.</AbstractText><CopyrightInformation>&#xa9;Jung-Yeon Choi, Sooyoung Yoo, Wongeun Song, Seok Kim, Hyunyoung Baek, Jun Suh Lee, Yoo-Seok Yoon, Seonghae Yoon, Hae-Young Lee, Kwang-il Kim. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 13.11.2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Choi</LastName><ForeName>Jung-Yeon</ForeName><Initials>JY</Initials><Identifier Source="ORCID">0000-0001-5139-5346</Identifier><AffiliationInfo><Affiliation>Departmentof Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yoo</LastName><ForeName>Sooyoung</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8620-4925</Identifier><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Song</LastName><ForeName>Wongeun</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-4314-3995</Identifier><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Science and Technology, Graduate School of Convergence Science and Technology, Seoul National University, Seongnam-si, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seok</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4996-8613</Identifier><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baek</LastName><ForeName>Hyunyoung</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-0810-9396</Identifier><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jun Suh</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0001-9487-9826</Identifier><AffiliationInfo><Affiliation>Department of Surgery, G Sam Hospital, Gunpo, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Yoo-Seok</ForeName><Initials>YS</Initials><Identifier Source="ORCID">0000-0001-7621-8557</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Seonghae</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9438-0045</Identifier><AffiliationInfo><Affiliation>Department of Clinical Pharmacology and Therapeutic, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hae-Young</ForeName><Initials>HY</Initials><Identifier Source="ORCID">0000-0002-9521-4102</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kwang-Il</ForeName><Initials>KI</Initials><Identifier Source="ORCID">0000-0002-6658-047X</Identifier><AffiliationInfo><Affiliation>Departmentof Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Med Internet Res</MedlineTA><NlmUniqueID>100959882</NlmUniqueID><ISSNLinking>1438-8871</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071257" MajorTopicYN="Y">Emergence Delirium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CDM</Keyword><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">Observational Health Data Sciences and Informatics</Keyword><Keyword MajorTopicYN="N">adverse event</Keyword><Keyword MajorTopicYN="N">adverse outcome</Keyword><Keyword MajorTopicYN="N">ageing</Keyword><Keyword MajorTopicYN="N">algorithm</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">elder</Keyword><Keyword MajorTopicYN="N">elderly</Keyword><Keyword MajorTopicYN="N">geriatric</Keyword><Keyword MajorTopicYN="N">model</Keyword><Keyword MajorTopicYN="N">older adult</Keyword><Keyword MajorTopicYN="N">patient-level prediction</Keyword><Keyword MajorTopicYN="N">postoperative</Keyword><Keyword MajorTopicYN="N">postoperative outcome</Keyword><Keyword MajorTopicYN="N">predict</Keyword><Keyword MajorTopicYN="N">surgery</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>13</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>13</Day><Hour>11</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37955965</ArticleId><ArticleId IdType="pmc">PMC10682929</ArticleId><ArticleId IdType="doi">10.2196/42259</ArticleId><ArticleId IdType="pii">v25i1e42259</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>2017 Statistics on the Aged. Statistics Korea. 2017. Sep 26,  [2023-10-06].  
 https://kostat.go.kr/board.es?mid=a20111030000&amp;bid=&#x200b;11759&amp;act=view&amp;list_no=363974&amp;tag=&amp;nPage=1&amp;ref_bid=
</Citation></Reference><Reference><Citation>Etzioni DA, Liu JH, O'Connell JB, Maggard MA, Ko CY. Elderly patients in surgical workloads: a population-based analysis. Am Surg. 2003 Nov;69(11):961&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">14627256</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall MJ, DeFrances CJ, Williams SN, Golosinskiy A, Schwartzman A. National hospital discharge survey: 2007 summary. Centers for Disease Control and Prevention. 2010. Oct 26,  [2023-10-23].  
 https://www.cdc.gov/nchs/data/nhsr/nhsr029.pdf
.</Citation><ArticleIdList><ArticleId IdType="pubmed">21086860</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen T, Eliasen K, Henriksen E. A prospective study of mortality associated with anaesthesia and surgery: risk indicators of mortality in hospital. Acta Anaesthesiol Scand. 1990 Apr;34(3):176&#x2013;182. doi: 10.1111/j.1399-6576.1990.tb03066.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.1990.tb03066.x</ArticleId><ArticleId IdType="pubmed">2343717</ArticleId></ArticleIdList></Reference><Reference><Citation>Etzioni D, Liu J, Maggard M, Ko C. The aging population and its impact on the surgery workforce. Ann Surg. 2003 Aug;238(2):170&#x2013;177. doi: 10.1097/01.SLA.0000081085.98792.3d.00000658-200308000-00003</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.SLA.0000081085.98792.3d</ArticleId><ArticleId IdType="pmc">PMC1422682</ArticleId><ArticleId IdType="pubmed">12894008</ArticleId></ArticleIdList></Reference><Reference><Citation>van Diepen S, Bakal JA, McAlister FA, Ezekowitz JA. Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing noncardiac surgery: an analysis of 38 047 patients. Circulation. 2011 Jul 19;124(3):289&#x2013;296. doi: 10.1161/CIRCULATIONAHA.110.011130.CIRCULATIONAHA.110.011130</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.110.011130</ArticleId><ArticleId IdType="pubmed">21709059</ArticleId></ArticleIdList></Reference><Reference><Citation>Eamer G, Al-Amoodi MJ, Holroyd-Leduc J, Rolfson DB, Warkentin LM, Khadaroo RG. Review of risk assessment tools to predict morbidity and mortality in elderly surgical patients. Am J Surg. 2018 Sep;216(3):585&#x2013;594. doi: 10.1016/j.amjsurg.2018.04.006. 
 
S0002-9610(17)31369-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2018.04.006</ArticleId><ArticleId IdType="pubmed">29776643</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR, van der Lei J, Pratt N, Nor&#xe9;n GN, Li Y, Stang PE, Madigan D, Ryan PB. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54&#x2013;60. doi: 10.1136/amiajnl-2011-000376. 
 
amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Walstra BR, Janevski BK, J&#xf6;rning PJ. Primary arteriovenous fistula between common iliac vessels: ultrasound, computer tomographic, and angiographic findings--a case report. Angiology. 1989 Mar;40(3):222&#x2013;226. doi: 10.1177/000331978904000310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000331978904000310</ArticleId><ArticleId IdType="pubmed">2644879</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo W, Phung D, Tran T, Gupta S, Rana S, Karmakar C, Shilton A, Yearwood J, Dimitrova N, Ho TB, Venkatesh S, Berk M. Guidelines for developing and reporting machine learning predictive models in biomedical research: a multidisciplinary view. J Med Internet Res. 2016 Dec 16;18(12):e323. doi: 10.2196/jmir.5870. 
 
v18i12e323</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.5870</ArticleId><ArticleId IdType="pmc">PMC5238707</ArticleId><ArticleId IdType="pubmed">27986644</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xf8;rgensen C C, Kehlet H, Lundbeck Foundation Centre for Fast-track HipKnee Replacement Collaborative group Time course and reasons for 90-day mortality in fast-track hip and knee arthroplasty. Acta Anaesthesiol Scand. 2017 Apr;61(4):436&#x2013;444. doi: 10.1111/aas.12860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12860</ArticleId><ArticleId IdType="pubmed">28150297</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-P&#xe9;rez A, Pay&#xe1;-Llorente C, Santarrufina-Mart&#xed;nez S, Sebasti&#xe1;n-Tom&#xe1;s JC, Mart&#xed;nez-L&#xf3;pez E, de'Angelis N. Predictors for prolonged length of stay after laparoscopic appendectomy for complicated acute appendicitis in adults. Surg Endosc. 2021 Jul;35(7):3628&#x2013;3635. doi: 10.1007/s00464-020-07841-9.10.1007/s00464-020-07841-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-020-07841-9</ArticleId><ArticleId IdType="pubmed">32767147</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal N, Simmons KD, Epstein AJ, Morris JB, Kelz RR. Using patient outcomes to evaluate general surgery residency program performance. JAMA Surg. 2016 Feb;151(2):111&#x2013;119. doi: 10.1001/jamasurg.2015.3637.2466606</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2015.3637</ArticleId><ArticleId IdType="pubmed">26510131</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins TC, Daley J, Henderson WH, Khuri SF. Risk factors for prolonged length of stay after major elective surgery. Ann Surg. 1999 Aug;230(2):251&#x2013;259. doi: 10.1097/00000658-199908000-00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-199908000-00016</ArticleId><ArticleId IdType="pmc">PMC1420868</ArticleId><ArticleId IdType="pubmed">10450740</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB, Rijnbeek PR. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc. 2018 Aug 01;25(8):969&#x2013;975. doi: 10.1093/jamia/ocy032. 
 
4989437</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy032</ArticleId><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>PatientLevelPrediction. GitHub.  [2023-10-23].  
 https://github.com/OHDSI/PatientLevelPrediction
.</Citation></Reference><Reference><Citation>Eagle K, Berger P, Calkins H, Chaitman B, Ewy G, Fleischmann K, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery) J Am Coll Cardiol. 2002 Feb 06;39(3):542&#x2013;553. doi: 10.1016/s0735-1097(01)01788-0. 
 
S0735109701017880</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0735-1097(01)01788-0</ArticleId><ArticleId IdType="pubmed">11823097</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc Ser B. 2018 Dec 05;58(1):267&#x2013;288. doi: 10.1111/j.2517-6161.1996.tb02080.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2517-6161.1996.tb02080.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Corti M, Guralnik JM, Salive ME, Sorkin JD. Serum albumin level and physical disability as predictors of mortality in older persons. JAMA. 1994 Oct 05;272(13):1036&#x2013;1042.</Citation><ArticleIdList><ArticleId IdType="pubmed">8089886</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudsk K, Tolley E, DeWitt R, Janu P, Blackwell A, Yeary S, King B. Preoperative albumin and surgical site identify surgical risk for major postoperative complications. JPEN J Parenter Enteral Nutr. 2003;27(1):1&#x2013;9. doi: 10.1177/014860710302700101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/014860710302700101</ArticleId><ArticleId IdType="pubmed">12549591</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg. 1999 Jan;134(1):36&#x2013;42. doi: 10.1001/archsurg.134.1.36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.134.1.36</ArticleId><ArticleId IdType="pubmed">9927128</ArticleId></ArticleIdList></Reference><Reference><Citation>van Stijn MFM, Korkic-Halilovic I, Bakker MSM, van der Ploeg T, van Leeuwen PAM, Houdijk APJ. Preoperative nutrition status and postoperative outcome in elderly general surgery patients: a systematic review. JPEN J Parenter Enteral Nutr. 2013 Jan;37(1):37&#x2013;43. doi: 10.1177/0148607112445900.0148607112445900</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0148607112445900</ArticleId><ArticleId IdType="pubmed">22549764</ArticleId></ArticleIdList></Reference><Reference><Citation>American Geriatrics Society Expert Panel on Postoperative Delirium in Older Adults  Postoperative delirium in older adults: best practice statement from the American Geriatrics Society. J Am Coll Surg. 2015 Feb;220(2):136&#x2013;48.e1. doi: 10.1016/j.jamcollsurg.2014.10.019. 
 
S1072-7515(14)01793-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2014.10.019</ArticleId><ArticleId IdType="pubmed">25535170</ArticleId></ArticleIdList></Reference><Reference><Citation>Abate SM, Checkole YA, Mantedafro B, Basu B, Aynalem AE. Global prevalence and predictors of postoperative delirium among non-cardiac surgical patients: a systematic review and meta-analysis. Int J Surg Open. 2021 May;32:100334. doi: 10.1016/j.ijso.2021.100334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijso.2021.100334</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Z, Hu J, Ma D. Postoperative delirium: perioperative assessment, risk reduction, and management. Br J Anaesth. 2020 Oct;125(4):492&#x2013;504. doi: 10.1016/j.bja.2020.06.063. 
 
S0007-0912(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.06.063</ArticleId><ArticleId IdType="pubmed">32798069</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalid S, Yang C, Blacketer C, Duarte-Salles T, Fern&#xe1;ndez-Bertol&#xed;n S, Kim C, Park RW, Park J, Schuemie MJ, Sena AG, Suchard MA, You SC, Rijnbeek PR, Reps JM. A standardized analytics pipeline for reliable and rapid development and validation of prediction models using observational health data. Comput Methods Programs Biomed. 2021 Nov;211:106394. doi: 10.1016/j.cmpb.2021.106394. 
 
S0169-2607(21)00468-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2021.106394</ArticleId><ArticleId IdType="pmc">PMC8420135</ArticleId><ArticleId IdType="pubmed">34560604</ArticleId></ArticleIdList></Reference><Reference><Citation>Prognostic Classification Model Predicting Postoperative Adverse Outcomes in Older Surgical Patients. GitHub.  [2023-10-23].  
 https://github.com/HIRC-SNUBH/Geriatrics_PLP
.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10682929</ArticleId><ArticleId IdType="pubmed">37955965</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37957229</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>13</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Effect of statin use on head and neck cancer prognosis in a multicenter study using a Common Data Model.</ArticleTitle><Pagination><StartPage>19770</StartPage><MedlinePgn>19770</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">19770</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-45654-7</ELocationID><Abstract><AbstractText>Few studies have found an association between statin use and head and neck cancer (HNC) outcomes. We examined the effect of statin use on HNC recurrence using the converted Observational Medical Outcome Partnership (OMOP) Common Data Model (CDM) in seven hospitals between 1986 and 2022. Among the 9,473,551 eligible patients, we identified 4669 patients with HNC, of whom 398 were included in the target cohort, and 4271 were included in the control cohort after propensity score matching. A Cox proportional regression model was used. Of the 4669 patients included, 398 (8.52%) previously received statin prescriptions. Statin use was associated with a reduced rate of 3- and 5-year HNC recurrence compared to propensity score-matched controls (risk ratio [RR], 0.79; 95% confidence interval [CI], 0.61-1.03; and RR 0.89; 95% CI 0.70-1.12, respectively). Nevertheless, the association between statin use and HNC recurrence was not statistically significant. A meta-analysis of recurrence based on subgroups, including age subgroups, showed similar trends. The results of this propensity-matched cohort study may not provide a statistically significant association between statin use and a lower risk of HNC recurrence. Further retrospective studies using nationwide claims data and prospective studies are warranted.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Seol</LastName><ForeName>Soobeen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, 164 World cup-ro Yeongtong-gu, Suwon-si, Gyeonggi-do, 16499, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Choi</LastName><ForeName>Jung Ran</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Ajou University School of Medicine, Ajou University Hospital, 164 World cup-ro Yeongtong-gu, Suwon-si, Gyeonggi-do, 16499, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Byungjin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, 164 World cup-ro Yeongtong-gu, Suwon-si, Gyeonggi-do, 16499, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sungryeal</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology-Head and Neck Surgery, Inha University College of Medicine, Incheon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Ja Young</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Ki Nam</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University, Bucheon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jae Hong</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University Cheonan Hospital, Cheonan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Min Woo</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Kangdong Sacred Heart Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eun</LastName><ForeName>Young-Gyu</ForeName><Initials>YG</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Kyung Hee University, Kyung Hee University Medical Center, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jung Je</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, College of Medicine, Gyeongsang National University and Hospital, Jinju, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Sciences, Gyeongsang National University, Jinju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Byung-Joo</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Pusan National University and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Yoo Seob</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Ajou University School of Medicine, Ajou University Hospital, 164 World cup-ro Yeongtong-gu, Suwon-si, Gyeonggi-do, 16499, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Chul-Ho</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Ajou University School of Medicine, Ajou University Hospital, 164 World cup-ro Yeongtong-gu, Suwon-si, Gyeonggi-do, 16499, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, 164 World cup-ro Yeongtong-gu, Suwon-si, Gyeonggi-do, 16499, Republic of Korea. veritas@ajou.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, 164 World cup-ro Yeongtong-gu, Suwon-si, Gyeonggi-do, 16499, Republic of Korea. veritas@ajou.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Jeon Yeob</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, 164 World cup-ro Yeongtong-gu, Suwon-si, Gyeonggi-do, 16499, Republic of Korea. jyjangmd@ajou.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otolaryngology, Ajou University School of Medicine, Ajou University Hospital, 164 World cup-ro Yeongtong-gu, Suwon-si, Gyeonggi-do, 16499, Republic of Korea. jyjangmd@ajou.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="Y">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006258" MajorTopicYN="Y">Head and Neck Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>14</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>13</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37957229</ArticleId><ArticleId IdType="pmc">PMC10643676</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-45654-7</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-45654-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rettig EM, D&#x2019;Souza G. Epidemiology of head and neck cancer. Surg. Oncol. Clin. 2015;24:379&#x2013;396. doi: 10.1016/j.soc.2015.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.soc.2015.03.001</ArticleId><ArticleId IdType="pubmed">25979389</ArticleId></ArticleIdList></Reference><Reference><Citation>Getz KR, et al. Statin use and head and neck squamous cell carcinoma outcomes. Int. J. Cancer. 2021;148:2440&#x2013;2448. doi: 10.1002/ijc.33441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.33441</ArticleId><ArticleId IdType="pmc">PMC8203748</ArticleId><ArticleId IdType="pubmed">33320960</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourguillon RO, Stokes WA, Dorth J, Schmitt NC. Repurposing statin drugs to decrease toxicity and improve survival outcomes in head and neck cancer. OTO Open. 2021;5:2473974X211065715. doi: 10.1177/2473974X211065715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2473974X211065715</ArticleId><ArticleId IdType="pmc">PMC8669126</ArticleId><ArticleId IdType="pubmed">34917872</ArticleId></ArticleIdList></Reference><Reference><Citation>Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet. 2008;371:1695&#x2013;1709. doi: 10.1016/S0140-6736(08)60728-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)60728-X</ArticleId><ArticleId IdType="pmc">PMC7720415</ArticleId><ArticleId IdType="pubmed">18486742</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigneswaran N, Williams MD. Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral Maxillofac. Surg. Clin. 2014;26:123&#x2013;141. doi: 10.1016/j.coms.2014.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coms.2014.01.001</ArticleId><ArticleId IdType="pmc">PMC4040236</ArticleId><ArticleId IdType="pubmed">24794262</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang J, et al. Comprehensive treatment of squamous cell cancer of head and neck: Chinese expert consensus 2013. Future Oncol. 2014;10:1635&#x2013;1648. doi: 10.2217/fon.14.44.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fon.14.44</ArticleId><ArticleId IdType="pubmed">24635574</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleire L, et al. Drug repurposing in cancer. Pharmacol. Res. 2017;124:74&#x2013;91. doi: 10.1016/j.phrs.2017.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2017.07.013</ArticleId><ArticleId IdType="pubmed">28712971</ArticleId></ArticleIdList></Reference><Reference><Citation>Gormley M, et al. Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study. PLoS Genet. 2021;17:e1009525. doi: 10.1371/journal.pgen.1009525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1009525</ArticleId><ArticleId IdType="pmc">PMC8096036</ArticleId><ArticleId IdType="pubmed">33886544</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation. 2000;101:207&#x2013;213. doi: 10.1161/01.CIR.101.2.207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.101.2.207</ArticleId><ArticleId IdType="pubmed">10637210</ArticleId></ArticleIdList></Reference><Reference><Citation>Demierre M-F, Higgins PD, Gruber SB, Hawk E, Lippman SM. Statins and cancer prevention. Nat. Rev. Cancer. 2005;5:930&#x2013;942. doi: 10.1038/nrc1751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc1751</ArticleId><ArticleId IdType="pubmed">16341084</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell. 2011;144:646&#x2013;674. doi: 10.1016/j.cell.2011.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.02.013</ArticleId><ArticleId IdType="pubmed">21376230</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown AJ. Cholesterol, statins and cancer. Clin. Exp. Pharmacol. Physiol. 2007;34:135&#x2013;141. doi: 10.1111/j.1440-1681.2007.04565.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1681.2007.04565.x</ArticleId><ArticleId IdType="pubmed">17250629</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong WW, Dimitroulakos J, Minden M, Penn L. HMG-CoA reductase inhibitors and the malignant cell: The statin family of drugs as triggers of tumor-specific apoptosis. Leukemia. 2002;16:508&#x2013;519. doi: 10.1038/sj.leu.2402476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.leu.2402476</ArticleId><ArticleId IdType="pubmed">11960327</ArticleId></ArticleIdList></Reference><Reference><Citation>Denoyelle C, et al. Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: An in vitro study. Carcinogenesis. 2001;22:1139&#x2013;1148. doi: 10.1093/carcin/22.8.1139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/22.8.1139</ArticleId><ArticleId IdType="pubmed">11470741</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusama T, et al. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. Cancer Res. 2001;61:4885&#x2013;4891.</Citation><ArticleIdList><ArticleId IdType="pubmed">11406567</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridman WH, Pag&#xe8;s F, Saut&#xe8;s-Fridman C, Galon J. The immune contexture in human tumours: Impact on clinical outcome. Nat. Rev. Cancer. 2012;12:298&#x2013;306. doi: 10.1038/nrc3245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc3245</ArticleId><ArticleId IdType="pubmed">22419253</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffy SA, et al. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer Interdiscip. Int. J. Am. Cancer Soc. 2008;113:750&#x2013;757.</Citation><ArticleIdList><ArticleId IdType="pubmed">18536030</ArticleId></ArticleIdList></Reference><Reference><Citation>Spector ME, et al. Prognostic value of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma. JAMA Otolaryngol. Head Neck Surg. 2019;145:1012&#x2013;1019. doi: 10.1001/jamaoto.2019.2427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2019.2427</ArticleId><ArticleId IdType="pmc">PMC6735419</ArticleId><ArticleId IdType="pubmed">31486841</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N, et al. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma. Head Neck. 2016;38:1074&#x2013;1084. doi: 10.1002/hed.24406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.24406</ArticleId><ArticleId IdType="pmc">PMC4900934</ArticleId><ArticleId IdType="pubmed">26879675</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaie-Majd A, et al. Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler. Thromb. Vasc. Biol. 2002;22:1194&#x2013;1199. doi: 10.1161/01.ATV.0000022694.16328.CC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000022694.16328.CC</ArticleId><ArticleId IdType="pubmed">12117737</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyngdoh T, Vollenweider P, Waeber G, Marques-Vidal P. Association of statins with inflammatory cytokines: A population-based Colaus study. Atherosclerosis. 2011;219:253&#x2013;258. doi: 10.1016/j.atherosclerosis.2011.07.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2011.07.117</ArticleId><ArticleId IdType="pubmed">21855068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascer E, et al. Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients. Atherosclerosis. 2004;177:161&#x2013;166. doi: 10.1016/j.atherosclerosis.2004.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2004.07.003</ArticleId><ArticleId IdType="pubmed">15488879</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T, Khan A, Liu Y, El-Serag HB, Thrift AP. The association between statin use after diagnosis and mortality risk in patients with esophageal cancer: A retrospective cohort study of United States veterans. Off. J. Am. Coll. Gastroenterol. ACG. 2018;113:1310. doi: 10.1038/s41395-018-0169-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41395-018-0169-6</ArticleId><ArticleId IdType="pubmed">29946180</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong S, Zhang X, Chen L, Ma T, Tang J, Zhao J. Statin use and mortality in cancer patients: Systematic review and meta-analysis of observational studies. Cancer Treat. Rev. 2015;41:554&#x2013;567. doi: 10.1016/j.ctrv.2015.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctrv.2015.04.005</ArticleId><ArticleId IdType="pubmed">25890842</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei Z, et al. Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals. Int. J. Cancer. 2017;140:1068&#x2013;1081. doi: 10.1002/ijc.30526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.30526</ArticleId><ArticleId IdType="pubmed">27859151</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascitelli L, Goldstein MR. Statin immunomodulation and thyroid cancer. Clin. Endocrinol. 2015;82:620. doi: 10.1111/cen.12600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.12600</ArticleId><ArticleId IdType="pubmed">25174914</ArticleId></ArticleIdList></Reference><Reference><Citation>Beales I, Vardi I, Dearman L, Broughton T. Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: A case control study. Dis. Esophagus. 2013;26:838&#x2013;846. doi: 10.1111/j.1442-2050.2012.01412.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-2050.2012.01412.x</ArticleId><ArticleId IdType="pubmed">22989236</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T, Duan Z, Naik AD, Kramer JR, El-Serag HB. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett&#x2019;s esophagus: A nested case-control study. Gastroenterology. 2015;149:1392&#x2013;1398. doi: 10.1053/j.gastro.2015.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2015.07.009</ArticleId><ArticleId IdType="pubmed">26208896</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, et al. Statin use associated with improved overall and cancer specific survival in patients with head and neck cancer. Oral Oncol. 2019;90:54&#x2013;66. doi: 10.1016/j.oraloncology.2019.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.oraloncology.2019.01.019</ArticleId><ArticleId IdType="pmc">PMC6659746</ArticleId><ArticleId IdType="pubmed">30846177</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen SF, Nordestgaard BG, Bojesen SE. Statin use and reduced cancer-related mortality. N. Engl. J. Med. 2012;367:1792&#x2013;1802. doi: 10.1056/NEJMoa1201735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1201735</ArticleId><ArticleId IdType="pubmed">23134381</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao LT, Hung SH, Kao PF, Liu JC, Lin HC. Inverse association between statin use and head and neck cancer: Population-based case-control study in Han population. Head Neck. 2019;41:1193&#x2013;1198. doi: 10.1002/hed.25501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.25501</ArticleId><ArticleId IdType="pubmed">30809863</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebo NL, Griffiths R, Hall S, Dimitroulakos J, Johnson-Obaseki S. Effect of statin use on oncologic outcomes in head and neck squamous cell carcinoma. Head Neck. 2018;40:1697&#x2013;1706. doi: 10.1002/hed.25152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.25152</ArticleId><ArticleId IdType="pubmed">29934959</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J. Am. Med. Inform. Assoc. 2012;19:54&#x2013;60. doi: 10.1136/amiajnl-2011-000376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, van der Lei J, Pratt N, Nor&#xe9;n GN, Li Y, Stang PE, Madigan D, Ryan PB, et al. Observational health data sciences and informatics (OHDSI): Opportunities for observational researchers. Stud. Health Technol. Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi N, Peng Y, Wolfien M, Zoch M, Sedlmayr M. OMOP CDM can facilitate data-driven studies for cancer prediction: A systematic review. Int. J. Mol. Sci. 2022;23:11834. doi: 10.3390/ijms231911834.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231911834</ArticleId><ArticleId IdType="pmc">PMC9569469</ArticleId><ArticleId IdType="pubmed">36233137</ArticleId></ArticleIdList></Reference><Reference><Citation>Millar J. The need for a global language-SNOMED CT introduction. Stud. Health Technol. Inform. 2016;225:683&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pubmed">27332304</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong S, et al. Statin use and mortality in cancer patients: Systematic review and meta-analysis of observational studies. Cancer Treat. Rev. 2015;41:554&#x2013;567. doi: 10.1016/j.ctrv.2015.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctrv.2015.04.005</ArticleId><ArticleId IdType="pubmed">25890842</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei Z, et al. Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals. Int. J. Cancer. 2017;140:1068&#x2013;1081. doi: 10.1002/ijc.30526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.30526</ArticleId><ArticleId IdType="pubmed">27859151</ArticleId></ArticleIdList></Reference><Reference><Citation>Byon CH, et al. Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4. Lab. Investig. 2009;89:1221&#x2013;1228. doi: 10.1038/labinvest.2009.97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2009.97</ArticleId><ArticleId IdType="pmc">PMC2905319</ArticleId><ArticleId IdType="pubmed">19752858</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KK, Oza AM, Siu LL. The statins as anticancer agents. Clin. Cancer Res. 2003;9:10&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">12538446</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K, et al. Immune regulatory effects of simvastatin on regulatory T cell-mediated tumour immune tolerance. Clin. Exp. Immunol. 2010;161:298&#x2013;305. doi: 10.1111/j.1365-2249.2010.04170.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2010.04170.x</ArticleId><ArticleId IdType="pmc">PMC2909412</ArticleId><ArticleId IdType="pubmed">20491794</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo W-W, et al. Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: A distributed network analysis of 10 real-world databases. Cardiovasc. Diabetol. 2022;21:1&#x2013;14. doi: 10.1186/s12933-022-01524-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01524-6</ArticleId><ArticleId IdType="pmc">PMC9128291</ArticleId><ArticleId IdType="pubmed">35606846</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, et al. Second primary malignancy risk in thyroid cancer and matched patients with and without radioiodine therapy analysis from the observational health data sciences and informatics. Eur. J. Nucl. Med. Mol. Imaging. 2022;49:3547&#x2013;3556. doi: 10.1007/s00259-022-05779-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-022-05779-9</ArticleId><ArticleId IdType="pubmed">35362796</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundararajan V, et al. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J. Clin. Epidemiol. 2004;57:1288&#x2013;1294. doi: 10.1016/j.jclinepi.2004.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2004.03.012</ArticleId><ArticleId IdType="pubmed">15617955</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chronic Dis. 1987;40:373&#x2013;383. doi: 10.1016/0021-9681(87)90171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannay A, et al. The best use of the Charlson comorbidity index with electronic health care database to predict mortality. Med. Care. 2016;54:188&#x2013;194. doi: 10.1097/MLR.0000000000000471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0000000000000471</ArticleId><ArticleId IdType="pubmed">26683778</ArticleId></ArticleIdList></Reference><Reference><Citation>Extermann M. Measuring comorbidity in older cancer patients. Eur. J. Cancer. 2000;36:453&#x2013;471. doi: 10.1016/S0959-8049(99)00319-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0959-8049(99)00319-6</ArticleId><ArticleId IdType="pubmed">10717521</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary H, et al. Readmission following primary surgery for larynx and oropharynx cancer in the elderly. Laryngoscope. 2017;127:631&#x2013;641. doi: 10.1002/lary.26311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.26311</ArticleId><ArticleId IdType="pubmed">27659029</ArticleId></ArticleIdList></Reference><Reference><Citation>Stordeur S, et al. Comorbidity in head and neck cancer: Is it associated with therapeutic delay, post-treatment mortality and survival in a population-based study? Oral Oncol. 2020;102:104561. doi: 10.1016/j.oraloncology.2019.104561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.oraloncology.2019.104561</ArticleId><ArticleId IdType="pubmed">31918175</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue X, Xie X, Gunter M, et al. Testing the proportional hazards assumption in case-cohort analysis. BMC Med. Res. Methodol. 2013;13:88. doi: 10.1186/1471-2288-13-88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-13-88</ArticleId><ArticleId IdType="pmc">PMC3710085</ArticleId><ArticleId IdType="pubmed">23834739</ArticleId></ArticleIdList></Reference><Reference><Citation>Mnguni AT, Schietekat D, Ebrahim N, et al. The clinical and epidemiological characteristics of a series of patients living with HIV admitted for COVID-19 in a district hospital. BMC Infect. Dis. 2023;23:123. doi: 10.1186/s12879-023-08004-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08004-6</ArticleId><ArticleId IdType="pmc">PMC9972337</ArticleId><ArticleId IdType="pubmed">36855103</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleinbaum, D. G., Klein, M., Kleinbaum, D. G. &amp; Klein, M. Kaplan&#x2013;Meier survival curves and the log-rank test. Surv. Anal. Self-learn. Text 55&#x2013;96 (2012).</Citation></Reference><Reference><Citation>Schuemie, M., Suchard, M. &amp; Ryan, P. CohortMethod: New-user cohort method with large scale propensity and outcome models. 2022. Available from: https://ohdsi.github.io/CohortMethod, https://github.com/OHDSI/CohortMethod.</Citation></Reference><Reference><Citation>Schuemie, M., Ryan, P., Shaddox, T. &amp; Suchard, M. SelfControlledCaseSeries: Self-controlled case series. R package version 4.1.0. 2023. Available from:&#xa0;https://github.com/OHDSI/SelfControlledCaseSeries.</Citation></Reference><Reference><Citation>Gilbert, J., Schuemie, M. &amp; Ryan, P. SelfControlledCohort: Population-level estimation method that estimates incidence rate comparison of exposed/unexposed time within an exposed cohort. R package version 1.6.0. 2022. Available from: https://github.com/OHDSI/SelfControlledCohort.</Citation></Reference><Reference><Citation>Schuemie, M. &amp; Suchard, M. EvidenceSynthesis: Synthesizing causal evidence in a distributed research network. 2023. Available from: https://ohdsi.github.io/EvidenceSynthesis/, https://github.com/OHDSI/EvidenceSynthesis.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38025162</PMID><DateRevised><Year>2024</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-9145</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Ophthalmology science</Title><ISOAbbreviation>Ophthalmol Sci</ISOAbbreviation></Journal><ArticleTitle>Advancing Toward a Common Data Model in Ophthalmology: Gap Analysis of General Eye Examination Concepts to Standard Observational Medical Outcomes Partnership (OMOP) Concepts.</ArticleTitle><Pagination><StartPage>100391</StartPage><MedlinePgn>100391</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100391</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.xops.2023.100391</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Evaluate the degree of concept coverage of the general eye examination in one widely used electronic health record (EHR) system using the Observational Health Data Sciences and Informatics Observational Medical Outcomes Partnership (OMOP) common data model (CDM).</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">Study of data elements.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="UNASSIGNED">Not applicable.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Data elements (field names and predefined entry values) from the general eye examination in the Epic foundation system were mapped to OMOP concepts and analyzed. Each mapping was given a Health Level 7 equivalence designation-<i>equal</i> when the OMOP concept had the same meaning as the source EHR concept, <i>wider</i> when it was missing information, <i>narrower</i> when it was overly specific, and <i>unmatched</i> when there was no match. Initial mappings were reviewed by 2 graders. Intergrader agreement for equivalence designation was calculated using Cohen's kappa. Agreement on the mapped OMOP concept was calculated as a percentage of total mappable concepts. Discrepancies were discussed and a final consensus created. Quantitative analysis was performed on <i>wider</i> and <i>unmatched</i> concepts.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="UNASSIGNED">Gaps in OMOP concept coverage of EHR elements and intergrader agreement of mapped OMOP concepts.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 698 data elements (210 fields, 488 values) from the EHR were analyzed. The intergrader kappa on the equivalence designation was 0.88 (standard error 0.03, <i>P</i>&#xa0;&lt;&#xa0;0.001). There was a 96% agreement on the mapped OMOP concept. In the final consensus mapping, 25% (1% fields, 31% values) of the EHR to OMOP concept mappings were considered <i>equal</i>, 50% (27% fields, 60% values) <i>wider</i>, 4% (8% fields, 2% values) <i>narrower</i>, and 21% (52% fields, 8% values) <i>unmatched</i>. Of the <i>wider</i> mapped elements, 46% were missing the laterality specification, 24% had other missing attributes, and 30% had both issues. <i>Wider</i> and <i>unmatched</i> EHR elements could be found in all areas of the general eye examination.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Most data elements in the general eye examination could not be represented precisely using the OMOP CDM. Our work suggests multiple ways to improve the incorporation of important ophthalmology concepts in OMOP, including adding laterality to existing concepts. There exists a strong need to improve the coverage of ophthalmic concepts in source vocabularies so that the OMOP CDM can better accommodate vision research.</AbstractText><AbstractText Label="FINANCIAL DISCLOSURES" NlmCategory="UNASSIGNED">Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.</AbstractText><CopyrightInformation>&#xa9; 2023 by the American Academy of Ophthalmology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Cindy X</ForeName><Initials>CX</Initials><AffiliationInfo><Affiliation>Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halfpenny</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boland</LastName><ForeName>Michael V</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehmann</LastName><ForeName>Harold P</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Division of Health Sciences Informatics, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Informatics and Data Science, Division of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hribar</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Office of Data Science and Health Informatics, National Eye Institute, National Institute of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, Casey Eye Institute, Portland, Oregon.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics and Clinical Epidemiology, Oregon Health &amp; Science University, Portland, Oregon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goetz</LastName><ForeName>Kerry E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Office of Data Science and Health Informatics, National Eye Institute, National Institute of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baxter</LastName><ForeName>Sally L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP5 OD029610</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 EY022589</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 EY033440</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T35 EY033704</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 EY034146</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ophthalmol Sci</MedlineTA><NlmUniqueID>9918230896206676</NlmUniqueID><ISSNLinking>2666-9145</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data model</Keyword><Keyword MajorTopicYN="N">Data standards</Keyword><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">Terminologies</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38025162</ArticleId><ArticleId IdType="pmc">PMC10630664</ArticleId><ArticleId IdType="doi">10.1016/j.xops.2023.100391</ArticleId><ArticleId IdType="pii">S2666-9145(23)00123-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Boland M.V., Chiang M.F., Lim M.C., et al. Adoption of electronic health records and preparations for demonstrating meaningful use: an American Academy of Ophthalmology survey. Ophthalmology. 2013;120:1702&#x2013;1710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12312035</ArticleId><ArticleId IdType="pubmed">23806425</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim M.C., Boland M.V., McCannel C.A., et al. Adoption of electronic health records and perceptions of financial and clinical outcomes among ophthalmologists in the United States. JAMA Ophthalmol. 2018;136:164&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5838599</ArticleId><ArticleId IdType="pubmed">29285542</ArticleId></ArticleIdList></Reference><Reference><Citation>He J., Baxter S.L., Xu J., et al. The practical implementation of artificial intelligence technologies in medicine. Nat Med. 2019;25:30&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6995276</ArticleId><ArticleId IdType="pubmed">30617336</ArticleId></ArticleIdList></Reference><Reference><Citation>Halfpenny W., Baxter S.L. Towards effective data sharing in ophthalmology: data standardization and data privacy. Curr Opin Ophthalmol. 2022;33:418&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9357189</ArticleId><ArticleId IdType="pubmed">35819893</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.Y., Pershing S., Lee A.Y. Big data requirements for artificial intelligence. Curr Opin Ophthalmol. 2020;31:318&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8164167</ArticleId><ArticleId IdType="pubmed">32657996</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter S.L., Lee A.Y. Gaps in standards for integrating artificial intelligence technologies into ophthalmic practice. Curr Opin Ophthalmol. 2021;32:431&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8373825</ArticleId><ArticleId IdType="pubmed">34231531</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland M.V., Schuman J.S., Mattox C.G. American Glaucoma Society position statement: electronic data standards for clinical practice. J Glaucoma. 2013;22:174&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">21946554</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehan J., Hirschfeld S., Foster E., et al. Improving the value of clinical research through the use of common data elements. Clin Trials. 2016;13:671&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5133155</ArticleId><ArticleId IdType="pubmed">27311638</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent S., Burn E., Dawoud D., et al. Common problems, common data model solutions: evidence generation for health technology assessment. Pharmacoeconomics. 2021;39:275&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7746423</ArticleId><ArticleId IdType="pubmed">33336320</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisinger S.J., Ryan P.B., O'Hara D.J., et al. Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J&#xa0;Am Med Inform Assoc. 2010;17:652&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000752</ArticleId><ArticleId IdType="pubmed">20962127</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeks J., Pardee R. Learning to share health care data: a brief timeline of influential common data models and distributed health data networks in U.S. Health Care Research. EGEMS (Wash DC) 2019;7:4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6437693</ArticleId><ArticleId IdType="pubmed">30937326</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G., Duke J.D., Shah N.H., et al. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences, Informatics  The book of OHDSI. 2021. https://ohdsi.github.io/TheBookOfOhdsi/</Citation></Reference><Reference><Citation>Hoskins H.D., Jr., Hildebrand P.L., Lum F. The American Academy of Ophthalmology adopts SNOMED CT as its official clinical terminology. Ophthalmology. 2008;115:225&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">18243903</ArticleId></ArticleIdList></Reference><Reference><Citation>GitHub - OHDSI/Athena: web application for distributing and browsing the standardized vocabularies for all instances of an OMOP CDM. GitHub. https://github.com/OHDSI/Athena</Citation></Reference><Reference><Citation>Usagi. http://ohdsi.github.io/Usagi/</Citation></Reference><Reference><Citation>Codesystem-concept-map-equivalence - FHIR v4.3.0. https://www.hl7.org/fhir/codesystem-concept-map-equivalence.html</Citation></Reference><Reference><Citation>Cohen J. A&#xa0;coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37&#x2013;46.</Citation></Reference><Reference><Citation>GitHub - will-0/epic-omop-map-22: repository containing code for analysis of code mappings from EPIC kaleidoscope content coverage analysis. GitHub. https://github.com/will-0/epic-omop-map-22</Citation></Reference><Reference><Citation>Park K., Cho M., Song M., et al. Exploring the potential of OMOP common data model for process mining in healthcare. PLoS One. 2023;18:e0279641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9810199</ArticleId><ArticleId IdType="pubmed">36595527</ArticleId></ArticleIdList></Reference><Reference><Citation>Junior E.P.P., Normando P., Flores-Ortiz R., et al. Integrating real-world data from Brazil and Pakistan into the OMOP common data model and standardized health analytics framework to characterize COVID-19 in the Global South. J&#xa0;Am Med Inform Assoc. 2023;30:643&#x2013;655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9619798</ArticleId><ArticleId IdType="pubmed">36264262</ArticleId></ArticleIdList></Reference><Reference><Citation>Papez V., Moinat M., Voss E.A., et al. Transforming and evaluating the UK biobank to the OMOP common data model for COVID-19 research and beyond. J Am Med Inform Assoc. 2022;30:103&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9619789</ArticleId><ArticleId IdType="pubmed">36227072</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann J.G., Joss M.A.H., Embree K., Murphy S.N. Data model harmonization for the All of Us research program: transforming i2b2 data into the OMOP common data model. PLoS One. 2019;14:e0212463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6380544</ArticleId><ArticleId IdType="pubmed">30779778</ArticleId></ArticleIdList></Reference><Reference><Citation>Upcoming workgroup calls. https://www.ohdsi.org/upcoming-working-group-calls/</Citation></Reference><Reference><Citation>Biedermann P., Ong R., Davydov A., et al. Standardizing registry data to the OMOP common data model: experience from three pulmonary hypertension databases. BMC Med Res Methodol. 2021;21:238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8565035</ArticleId><ArticleId IdType="pubmed">34727871</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho S., Sin M., Tsapepas D., et al. Content coverage evaluation of the OMOP vocabulary on the transplant domain focusing on concepts relevant for kidney transplant outcomes analysis. Appl Clin Inform. 2020;11:650&#x2013;658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7557323</ArticleId><ArticleId IdType="pubmed">33027834</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M., Del Fiol G., Tenenbaum J., et al. Evaluating common data models for use with a longitudinal community registry. J&#xa0;Biomed Inform. 2016;64:333&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A., Ryan P., Fife D., Reich C. Fidelity assessment of a clinical practice research datalink conversion to the OMOP&#xa0;common data model. Drug Saf. 2014;37:945&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X., Murugesan S., Bhullar H., et al. An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance. Drug Saf. 2013;36:119&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference><Reference><Citation>Representing laterality&#xa0;+ general questions about post-coordination. https://forums.ohdsi.org/t/representing-laterality-general-questions-about-post-coordination/16872/7</Citation></Reference><Reference><Citation>Belenkaya R., Gurley M.J., Golozar A., et al. Extending the OMOP common data model and standardized vocabularies to support observational cancer research. JCO Clin Cancer Inform. 2021;5:12&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8140810</ArticleId><ArticleId IdType="pubmed">33411620</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein J.D., Rahman M., Andrews C., et al. Evaluation of an algorithm for identifying ocular conditions in electronic health record data. JAMA Ophthalmol. 2019;137:491&#x2013;497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6512255</ArticleId><ArticleId IdType="pubmed">30789656</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38027579</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2405-8440</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Heliyon</Title><ISOAbbreviation>Heliyon</ISOAbbreviation></Journal><ArticleTitle>Development and validation of the SickKids Enterprise-wide Data in Azure Repository (SEDAR).</ArticleTitle><Pagination><StartPage>e21586</StartPage><MedlinePgn>e21586</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e21586</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.heliyon.2023.e21586</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">To describe the processes developed by The Hospital for Sick Children (SickKids) to enable utilization of electronic health record (EHR) data by creating sequentially transformed schemas for use across multiple user types.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We used Microsoft Azure as the cloud service provider and named this effort the SickKids Enterprise-wide Data in Azure Repository (SEDAR). Epic Clarity data from on-premises was copied to a virtual network in Microsoft Azure. Three sequential schemas were developed. The Filtered Schema added a filter to retain only SickKids and valid patients. The Curated Schema created a data structure that was easier to navigate and query. Each table contained a logical unit such as patients, hospital encounters or laboratory tests. Data validation of randomly sampled observations in the Curated Schema was performed. The SK-OMOP Schema was designed to facilitate research and machine learning. Two individuals mapped medical elements to standard Observational Medical Outcomes Partnership (OMOP) concepts.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A copy of Clarity data was transferred to Microsoft Azure and updated each night using log shipping. The Filtered Schema and Curated Schema were implemented as stored procedures and executed each night with incremental updates or full loads. Data validation required up to 16 iterations for each Curated Schema table. OMOP concept mapping achieved at least 80&#xa0;% coverage for each SK-OMOP table.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">We described our experience in creating three sequential schemas to address different EHR data access requirements. Future work should consider replicating this approach at other institutions to determine whether approaches are generalizable.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Lin Lawrence</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calligan</LastName><ForeName>Maryann</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vettese</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>Sadie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gagnidze</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Information Management Technology, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Oscar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Information Management Technology, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inoue</LastName><ForeName>Jiro</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemmon</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Johnson</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Information Management Technology, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roshdi</LastName><ForeName>Medhat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Information Management Technology, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadovy</LastName><ForeName>Bohdan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Information Management Technology, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Information Management Technology, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sung</LastName><ForeName>Lillian</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heliyon</MedlineTA><NlmUniqueID>101672560</NlmUniqueID><ISSNLinking>2405-8440</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Electronic health records</Keyword><Keyword MajorTopicYN="N">Microsoft Azure</Keyword><Keyword MajorTopicYN="N">OMOP-CDM</Keyword><Keyword MajorTopicYN="N">Schema</Keyword><Keyword MajorTopicYN="N">Validation</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>17</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38027579</ArticleId><ArticleId IdType="pmc">PMC10661187</ArticleId><ArticleId IdType="doi">10.1016/j.heliyon.2023.e21586</ArticleId><ArticleId IdType="pii">S2405-8440(23)08794-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Duke Institute for Health Innovation  . 2018. Sepsis Watch: the Implementation of a Duke-specific Early Warning System for Sepsis - Duke Institute for Health Innovation. Impact Report.https://dihi.org/project/sepsiswatch/ [cited 2020 December 3]; Available from:</Citation></Reference><Reference><Citation>Escobar G.J., et al. Automated identification of adults at risk for in-hospital clinical deterioration. N. Engl. J. Med. 2020;383(20):1951&#x2013;1960.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787261</ArticleId><ArticleId IdType="pubmed">33176085</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong J.C., et al. System for high-intensity evaluation during radiation therapy (SHIELD-RT): a prospective randomized study of machine learning-directed clinical evaluations during radiation and chemoradiation. J. Clin. Oncol. 2020;38(31):3652&#x2013;3661.</Citation><ArticleIdList><ArticleId IdType="pubmed">32886536</ArticleId></ArticleIdList></Reference><Reference><Citation>Manz C.R., et al. Effect of integrating machine learning mortality estimates with behavioral nudges to clinicians on serious illness conversations among patients with cancer: a stepped-wedge cluster randomized clinical trial. JAMA Oncol. 2020;6(12)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7563672</ArticleId><ArticleId IdType="pubmed">33057696</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X., et al. An automated data cleaning method for Electronic Health Records by incorporating clinical knowledge. BMC Med. Inf. Decis. Making. 2021;21(1):267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8449435</ArticleId><ArticleId IdType="pubmed">34535146</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert P., et al. Identifying common enablers and barriers in European health information systems. Health Pol. 2021;125(12):1517&#x2013;1526.</Citation><ArticleIdList><ArticleId IdType="pubmed">34666917</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G., et al. Observational health data sciences and Informatics (OHDSI): opportunities for observational researchers. Stud. Health Technol. Inf. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI . OHDSI; 2019. The Book of OHDSI: Observational Health Data Sciences and Informatics.</Citation></Reference><Reference><Citation>Hripcsak G., et al. Preserving temporal relations in clinical data while maintaining privacy. J. Am. Med. Inf. Assoc. 2016;23(6):1040&#x2013;1045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070517</ArticleId><ArticleId IdType="pubmed">27013522</ArticleId></ArticleIdList></Reference><Reference><Citation>Ficheur G., et al. Elderly surgical patients: automated computation of healthcare quality indicators by data reuse of EHR. Stud. Health Technol. Inf. 2016;221:92&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">27071884</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopanitsa G. Integration of hospital information and clinical decision support systems to enable the reuse of electronic health record data. Methods Inf. Med. 2017;56(3):238&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">28361157</ArticleId></ArticleIdList></Reference><Reference><Citation>Koscielniak N., et al. The SHOnet learning health system: infrastructure for continuous learning in pediatric rehabilitation. Learn Health Syst. 2022;6(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9284925</ArticleId><ArticleId IdType="pubmed">35860324</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima D.M., et al. Transforming two decades of ePR data to OMOP CDM for clinical research. Stud. Health Technol. Inf. 2019;264:233&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pubmed">31437920</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyle J., et al. Veterans health administration experience with data quality surveillance of continuity of care documents: interoperability challenges for eHealth exchange participants. AMIA Annu Symp Proc. 2015;2015:870&#x2013;879.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765662</ArticleId><ArticleId IdType="pubmed">26958223</ArticleId></ArticleIdList></Reference><Reference><Citation>McWilliams C., et al. Curation of an intensive care research dataset from routinely collected patient data in an NHS trust. F1000Res. 2019;8:1460.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6733376</ArticleId><ArticleId IdType="pubmed">31543959</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezoulas V.C., et al. Medical data quality assessment: on the development of an automated framework for medical data curation. Comput. Biol. Med. 2019;107:270&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pubmed">30878889</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman N., et al. Processing of electronic medical records for health services research in an academic medical center: methods and validation. JMIR Med Inform. 2018;6(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6320424</ArticleId><ArticleId IdType="pubmed">30578188</ArticleId></ArticleIdList></Reference><Reference><Citation>Vishnyakova D., et al. Clinical data models at university hospitals of geneva. Stud. Health Technol. Inf. 2016;221:97&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">27071885</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S., et al. 2020. A New Paradigm for Accelerating Clinical Data Science at Stanford Medicine. arXiv preprint arXiv:2003.10534.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38028730</PMID><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2574-2531</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>JAMIA open</Title><ISOAbbreviation>JAMIA Open</ISOAbbreviation></Journal><ArticleTitle>Evaluating the impact of alternative phenotype definitions on incidence rates across a global data network.</ArticleTitle><Pagination><StartPage>ooad096</StartPage><MedlinePgn>ooad096</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ooad096</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamiaopen/ooad096</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">Developing accurate phenotype definitions is critical in obtaining reliable and reproducible background rates in safety research. This study aims to illustrate the differences in background incidence rates by comparing definitions for a given outcome.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">We used 16 data sources to systematically generate and evaluate outcomes for 13 adverse events and their overall background rates. We examined the effect of different modifications (inpatient setting, standardization of code set, and code set changes) to the computable phenotype on background incidence rates.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Rate ratios (RRs) of the incidence rates from each computable phenotype definition varied across outcomes, with inpatient restriction showing the highest variation from 1 to 11.93. Standardization of code set RRs ranges from 1 to 1.64, and code set changes range from 1 to 2.52.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">The modification that has the highest impact is requiring inpatient place of service, leading to at least a 2-fold higher incidence rate in the base definition. Standardization showed almost no change when using source code variations. The strength of the effect in the inpatient restriction is highly dependent on the outcome. Changing definitions from broad to narrow showed the most variability by age/gender/database across phenotypes and less than a 2-fold increase in rate compared to the base definition.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Characterization of outcomes across a network of databases yields insights into sensitivity and specificity trade-offs when definitions are altered. Outcomes should be thoroughly evaluated prior to use for background rates for their plausibility for use across a global network.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Makadia</LastName><ForeName>Rupa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY 10027, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Epidemiology, Janssen Pharmaceutical Research and Development, LLC, Titusville, NJ 08560, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoaibi</LastName><ForeName>Azza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY 10027, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Epidemiology, Janssen Pharmaceutical Research and Development, LLC, Titusville, NJ 08560, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Gowtham A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY 10027, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Epidemiology, Janssen Pharmaceutical Research and Development, LLC, Titusville, NJ 08560, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0847-6682</Identifier><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY 10027, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10027, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY 10027, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, 3000 CA, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voss</LastName><ForeName>Erica A</ForeName><Initials>EA</Initials><Identifier Source="ORCID">0000-0002-0651-0613</Identifier><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY 10027, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Epidemiology, Janssen Pharmaceutical Research and Development, LLC, Titusville, NJ 08560, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8274-0357</Identifier><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY 10027, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, 08007, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram&#xed;rez-Anguita</LastName><ForeName>Juan Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM), Barcelona, 08003, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>Miguel A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Management Control Department, Parc de Salut Mar (PSMAR), Barcelona, 08007, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maljkovi&#x107;</LastName><ForeName>Filip</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Research and Development, Heliant d.o.o, Belgrade, 11000, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denaxas</LastName><ForeName>Spiros</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9612-7791</Identifier><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, NW1 2DA, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>British Heart Foundation Data Science Centre, HDR, London, NW1 2DA, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0892-5668</Identifier><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 40530, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papez</LastName><ForeName>Vaclav</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-2123-7993</Identifier><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, NW1 2DA, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Anthony G</ForeName><Initials>AG</Initials><Identifier Source="ORCID">0000-0001-8630-5347</Identifier><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY 10027, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Epidemiology, Janssen Pharmaceutical Research and Development, LLC, Titusville, NJ 08560, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, 3000 CA, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY 10027, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Pharmacy, Prince Sattam Bin Abdulaziz University, Riyadh, 11942, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Lana Y H</ForeName><Initials>LYH</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY 10027, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Informatics, Imaging and Data Sciences, University of Manchester, Manchester, M13 9PL, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haynes</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Global Epidemiology, Janssen Pharmaceutical Research and Development, LLC, Titusville, NJ 08560, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0001-9818-479X</Identifier><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY 10027, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA 90025, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY 10027, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10027, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY 10027, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Epidemiology, Janssen Pharmaceutical Research and Development, LLC, Titusville, NJ 08560, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10027, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_20030</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20051</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20059</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMIA Open</MedlineTA><NlmUniqueID>101730643</NlmUniqueID><ISSNLinking>2574-2531</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">algorithms</Keyword><Keyword MajorTopicYN="N">electronic health record</Keyword><Keyword MajorTopicYN="N">incidence study</Keyword><Keyword MajorTopicYN="N">phenotype</Keyword></KeywordList><CoiStatement>R.M., A.S., G.R., E.A.V., A.G.S., K.H., and P.B.R. are employees of Janssen Pharmaceutical Company of Johnson &amp; Johnson and shareholder of Johnson &amp; Johnson. A.O. has received funding from the US National Institutes of Health and the US Food and Drug Administration. G.H. received support through a grant to Columbia University (NIH R01 LM006910). M.A.S. receives grants from the US Department of Veterans Affairs within the scope of this work, and grants and contracts from the US National Institutes of Health, US Food &amp; Drug Administration, and Janssen Research &amp; Development outside the scope of this work. P.R.R. has received funding from the Innovative Medicines Initiative (IMI) 2 Joint Undertaking (JU) under grant agreement No 806968. M.A.M., F.N., J.M.R.-A., F.M., T.D.-S., S.D., V.P., L.Y.H.L., and T.M.A. have no conflicts of interest to declare that are directly relevant to the contents of this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>17</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38028730</ArticleId><ArticleId IdType="pmc">PMC10662662</ArticleId><ArticleId IdType="doi">10.1093/jamiaopen/ooad096</ArticleId><ArticleId IdType="pii">ooad096</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Black S, Eskola J, Siegrist CA, et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet. 2009;374(9707):2115-2122. 10.1016/s0140-6736(09)61877-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(09)61877-8</ArticleId><ArticleId IdType="pmc">PMC2861912</ArticleId><ArticleId IdType="pubmed">19880172</ArticleId></ArticleIdList></Reference><Reference><Citation>Richesson RL, Smerek MM, Blake Cameron C.. A framework to support the sharing and reuse of computable phenotype definitions across health care delivery and clinical research applications. EGEMS (Wash DC). 2016;4(3):1232. 10.13063/2327-9214.1232</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1232</ArticleId><ArticleId IdType="pmc">PMC4975566</ArticleId><ArticleId IdType="pubmed">27563686</ArticleId></ArticleIdList></Reference><Reference><Citation>Center for Biologics Evaluation and Research Office of Biostatistics and Epidemiology. CBER Surveillance Program Background Rates of Adverse Events of Special Interest for COVID-19 Vaccine Safety Monitoring Protocol. 2021. Accessed May 5, 2021. https://www.bestinitiative.org/wp-content/uploads/2021/02/C19-Vaccine-Safety-AESI-Background-Rate-Protocol-FINAL-2020.pdf</Citation></Reference><Reference><Citation>ACCESS: Background rates of Adverse Events of Special Interest for monitoring COVID-19 vaccines. 2020. Accessed April 11, 2021. http://www.encepp.eu/encepp/viewResource.htm?id=37274 </Citation></Reference><Reference><Citation>Petousis-Harris H. Assessing the safety of COVID-19 vaccines: a primer. Drug Saf. 2020;43(12):1205-1210. 10.1007/s40264-020-01002-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-020-01002-6</ArticleId><ArticleId IdType="pmc">PMC7526515</ArticleId><ArticleId IdType="pubmed">32997318</ArticleId></ArticleIdList></Reference><Reference><Citation>
Li X, Ostropolets A, Makadia R, et al.  Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study. <i>BMJ</i>2021;373:n1435. 10.1136/bmj.n1435</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1435</ArticleId><ArticleId IdType="pmc">PMC8193077</ArticleId><ArticleId IdType="pubmed">35727911</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostropolets A, Li X, Makadia R, et al. Factors influencing background incidence rate calculation: systematic empirical evaluation across an international network of observational databases. Front Pharmacol. 2022;13:814198. 10.3389/fphar.2022.814198</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.814198</ArticleId><ArticleId IdType="pmc">PMC9087898</ArticleId><ArticleId IdType="pubmed">35559254</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubernot D, Jazwa A, Niu M, et al. U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines. Vaccine. 2021;39(28):3666-3677. 10.1016/j.vaccine.2021.05.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.05.016</ArticleId><ArticleId IdType="pmc">PMC8118666</ArticleId><ArticleId IdType="pubmed">34088506</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Levine ME, Shang N, Ryan PB.. Effect of vocabulary mapping for conditions on phenotype cohorts. J Am Med Inform Assoc. 2018;25(12):1618-1625. 10.1093/jamia/ocy124</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy124</ArticleId><ArticleId IdType="pmc">PMC6289550</ArticleId><ArticleId IdType="pubmed">30395248</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22(3):553-564. 10.1093/jamia/ocu023</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocu023</ArticleId><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE.. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54-60. 10.1136/amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>
R Core Team. <i>R: A Language and Environment for Statistical Computing</i>. Vienna, Austria; 2021. https://www.R-project.org/ </Citation></Reference><Reference><Citation>
Rao G, Schuemie M, Ryan P, Weaver J. CohortDiagnostics. 2020. Accessed May 4, 2020. https://ohdsi.github.io/CohortDiagnostics/ </Citation></Reference><Reference><Citation>Kimura S, Sato T, Ikeda S, Noda M, Nakayama T.. Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. J Epidemiol. 2010;20(5):413-419. 10.2188/jea.je20090066</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.je20090066</ArticleId><ArticleId IdType="pmc">PMC3900837</ArticleId><ArticleId IdType="pubmed">20699602</ArticleId></ArticleIdList></Reference><Reference><Citation>de Ridder MAJ, de Wilde M, de Ben C, et al. Data resource profile: the integrated primary care information (IPCI) database, The Netherlands. Int J Epidemiol. 2022;51(6):e314-e323. 10.1093/ije/dyac026</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyac026</ArticleId><ArticleId IdType="pmc">PMC9749682</ArticleId><ArticleId IdType="pubmed">35182144</ArticleId></ArticleIdList></Reference><Reference><Citation>Papez V, Moinat M, Voss EA, et al. Transforming and evaluating the UK biobank to the OMOP common data model for COVID-19 research and beyond. J Am Med Inform Assoc. 2022;30(1):103-111. 10.1093/jamia/ocac203</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocac203</ArticleId><ArticleId IdType="pmc">PMC9619789</ArticleId><ArticleId IdType="pubmed">36227072</ArticleId></ArticleIdList></Reference><Reference><Citation>
ATLAS. ATLAS: Software Application to Support the Design and Execution of Observational Analyses. 2020. Accessed May 5, 2020. https://github.com/OHDSI/Atlas</Citation></Reference><Reference><Citation>
Winston Chang JC, Allaire JJ, Sievert C, et al.  shiny: Web Application Framework for R. R package version 1.7.1. 2021. Accessed June 12, 2020. https://CRAN.R-project.org/package=shiny </Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38046363</PMID><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2352-9148</ISSN><JournalIssue CitedMedium="Print"><Volume>43</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Informatics in medicine unlocked</Title><ISOAbbreviation>Inform Med Unlocked</ISOAbbreviation></Journal><ArticleTitle>Conversion of CPRD AURUM Data into the OMOP Common Data Model.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">101407</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.imu.2023.101407</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Efforts to standardize clinical data using Common Data Models (CDMS) has grown in recent years. Use of CDMs allows for quicker understanding of data structure and reuse of existing tools. One CDM is the Observational Medical Outcomes Partnership (OMOP) CDM. Clinical Practice Research Datalink (CPRD) is a data collection program collecting general practitioner data in the UK.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">Our objective was to convert a static copy of CPRD AURUM data into the OMOP CDM and run existing tools on the converted data.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Two methods were used to convert each CPRD file into the OMOP CDM. The first was direct mapping used when converting CPRD files that had comparable tables in the OMOP CDM. The original names were changed to the OMOP equivalent and source values converted to standardized OMOP concepts. CPRD files: Patient (to OMOP Person), Staff (to Provider), Drug Issue (to Drug Exposure) and Practice (to Care Site) were directly mapped. The second method was indirect where for the CPRD Observation file the domain of each data row was used to assign data to proper OMOP tables or columns done by converting all source values to standard concepts.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The OMOP CDM conversion populated 12 tables and 20,240,453,339 rows, with the largest table being the Measurement table (5,202,579,174 data row). Mapping source values to OMOP standard concepts, we found 60.2% (46,413 of 77,149) of source concepts were also standard concepts. The Drug Exposure table had the fewest source values already in the standard form as only 4.7% (1,433 of 30,194) of the source concepts were standard concepts. On a data retention level, only 2.00% of all data rows were excluded as they did not have a clear fit in the developed CDM and were not able to stand alone without additional information which was not present.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">CPRD AURUM was successfully converted into the OMOP CDM with minimal data loss. Existing OHDSI tools were used with the converted data to show efficacy of the converted data. The existence of a standardized version of CPRD AURUM data vastly increases its reusability in future research due to increased understanding and tools available.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>Craig S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Lister Hill National Center for Biomedical Communication, National Library of Medicine, NIH Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Z99 LM999999</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Inform Med Unlocked</MedlineTA><NlmUniqueID>101718051</NlmUniqueID><ISSNLinking>2352-9148</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical Informatics</Keyword><Keyword MajorTopicYN="N">Common Data Model</Keyword><Keyword MajorTopicYN="N">Data Science</Keyword><Keyword MajorTopicYN="N">Real World Data</Keyword></KeywordList><CoiStatement>Declaration of interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>4</Day><Hour>4</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38046363</ArticleId><ArticleId IdType="mid">NIHMS1945870</ArticleId><ArticleId IdType="pmc">PMC10688258</ArticleId><ArticleId IdType="doi">10.1016/j.imu.2023.101407</ArticleId><ArticleId IdType="pii">101407</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zoch M, Gierschner C, Peng Y, Gruhl M, Leutner LizA, Sedlmayr M, et al.
Adaption of the OMOP CDM for Rare Diseases. In: Mantas J, Stoicu-Tivadar L, Chronaki C, Hasman A, Weber P, Gallos P, et al., editors. Studies in Health Technology and Informatics [Internet]. IOS Press; 2021.  [cited
2022 Dec 13]. Available from: https://ebooks.iospress.nl/doi/10.3233/SHTI210136</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI210136</ArticleId><ArticleId IdType="pubmed">34042721</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi N, Zoch M, Kelbert P, Noll R, Schaaf J, Wolfien M, et al. Methods Used in the Development of Common Data Models for Health Data: Scoping Review. JMIR Med Inform. 2023. Aug 3;11:e45116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10436118</ArticleId><ArticleId IdType="pubmed">37535410</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi N, Peng Y, Wolfien M, Zoch M, Sedlmayr M. OMOP CDM Can Facilitate Data-Driven Studies for Cancer Prediction: A Systematic Review. IJMS. 2022. Oct 5;23(19):11834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9569469</ArticleId><ArticleId IdType="pubmed">36233137</ArticleId></ArticleIdList></Reference><Reference><Citation>Belenkaya R, Gurley MJ, Golozar A, Dymshyts D, Miller RT, Williams AE, et al. Extending the OMOP Common Data Model and Standardized Vocabularies to Support Observational Cancer Research. JCO Clinical Cancer Informatics. 2021. Dec;(5):12&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8140810</ArticleId><ArticleId IdType="pubmed">33411620</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimitriadis VK, Gavriilidis GI, Natsiavas P. Pharmacovigilance and Clinical Environment: Utilizing OMOP-CDM and OHDSI Software Stack to Integrate EHR Data. In: Mantas J, Stoicu-Tivadar L, Chronaki C, Hasman A, Weber P, Gallos P, et al., editors. Studies in Health Technology and Informatics [Internet]. IOS Press; 2021.  [cited
2022 Dec 13]. Available from: https://ebooks.iospress.nl/doi/10.3233/SHTI210232</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI210232</ArticleId><ArticleId IdType="pubmed">34042637</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, Resnic FS, Robbins SL, Denton J, Nookala L, Meeker D, et al. Creating a Common Data Model for Comparative Effectiveness with the Observational Medical Outcomes Partnership. Appl Clin Inform. 2015;06(03):536&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Zhou X, Suehs BT, Hartzema AG, Kahn MG, Moride Y, et al. A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance. Drug Saf. 2015. Aug;38(8):749&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">26055920</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Joss MAH, Embree K, Murphy SN. Data model harmonization for the All Of Us Research Program: Transforming i2b2 data into the OMOP common data model. Lovis C, editor. PLoS ONE. 2019. Feb 19;14(2):e0212463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6380544</ArticleId><ArticleId IdType="pubmed">30779778</ArticleId></ArticleIdList></Reference><Reference><Citation>Papez V, Moinat M, Voss EA, Bazakou S, Van Winzum A, Peviani A, et al. Transforming and evaluating the UK Biobank to the OMOP Common Data Model for COVID-19 research and beyond. Journal of the American Medical Informatics Association. 2022. Oct 13;ocac203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9619789</ArticleId><ArticleId IdType="pubmed">36227072</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams N Building the observational medical outcomes partnership&#x2019;s T-MSIS Analytic File common data model. Informatics in Medicine Unlocked. 2023;39:101259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10249773</ArticleId><ArticleId IdType="pubmed">37305615</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf A, Dedman D, Campbell J, Booth H, Lunn D, Chapman J, et al. Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum. International Journal of Epidemiology. 2019. Dec 1;48(6):1740&#x2013;1740g.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6929522</ArticleId><ArticleId IdType="pubmed">30859197</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, et al. Data Resource Profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015. Jun;44(3):827&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4521131</ArticleId><ArticleId IdType="pubmed">26050254</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee G CPRD Aurum Data Specification. :14.</Citation></Reference><Reference><Citation>CPRD GOLD - Janssen CDM Documentation [Internet]. [cited
2022 Dec 6]. Available from: https://ohdsi.github.io/ETL-LambdaBuilder/docs/CPRD</Citation></Reference><Reference><Citation>Matcho A, Ryan P, Fife D, Reich C. Fidelity Assessment of a Clinical Practice Research Datalink Conversion to the OMOP Common Data Model. Drug Saf. 2014. Nov;37(11):945&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>OMOP CDM v5.4 [Internet]. [cited
2023 Sep 15]. Available from: https://ohdsi.github.io/CommonDataModel/cdm54.html</Citation></Reference><Reference><Citation>Approved studies using CPRD Data | CPRD [Internet]. [cited
2023 Sep 15]. Available from: https://cprd.com/approved-studies-using-cprd-data</Citation></Reference><Reference><Citation>Home &#xb7; OHDSI/Vocabulary-v5.0 Wiki [Internet]. [cited
2023 Feb 22]. Available from: https://github.com/OHDSI/Vocabulary-v5.0/wiki</Citation></Reference><Reference><Citation>index.knit [Internet]. [cited
2022 Dec 6]. Available from: https://ohdsi.github.io/CommonDataModel/</Citation></Reference><Reference><Citation>Athena [Internet]. [cited
2022 Jan 5]. Available from: https://athena.ohdsi.org/search-terms/start</Citation></Reference><Reference><Citation>OHDSI. OMOP CDM Specification [Internet]. [cited
2020 Dec 21]. Available from: https://ohdsi.github.io/CommonDataModel/cdm60.html#clinical_data_tables</Citation></Reference><Reference><Citation>General Structure, Download and Use &#xb7; OHDSI/Vocabulary-v5.0 Wiki &#xb7; GitHub [Internet]. [cited
2023 Nov 3]. Available from: https://github.com/OHDSI/Vocabulary-v5.0/wiki/General-Structure,-Download-and-Use</Citation></Reference><Reference><Citation>CRI/OHDSI/ETL/CPRD at master &#xb7; lhncbc/CRI &#xb7; GitHub [Internet]. [cited
2022 Dec 6]. Available from: https://github.com/lhncbc/CRI/tree/master/OHDSI/ETL/CPRD</Citation></Reference><Reference><Citation>CRI/achilles2.R at master &#xb7; lhncbc/CRI &#xb7; GitHub [Internet]. [cited
2022 Dec 6]. Available from: https://github.com/lhncbc/CRI/blob/master/AoU/achilles2/achilles2.R</Citation></Reference><Reference><Citation>CDE/scyros at master &#xb7; lhncbc/CDE &#xb7; GitHub [Internet]. [cited
2022 Dec 6]. Available from: https://github.com/lhncbc/CDE/tree/master/scyros</Citation></Reference><Reference><Citation>ATLAS: Home [Internet]. [cited
2021 Nov 5]. Available from: https://atlas-demo.ohdsi.org/#/home</Citation></Reference><Reference><Citation>OHDSI/Achilles: Automated Characterization of Health Information at Large-scale Longitudinal Evidence Systems (ACHILLES) - descriptive statistics about a OMOP CDM database [Internet]. [cited
2021 Nov 5]. Available from: https://github.com/OHDSI/Achilles</Citation></Reference><Reference><Citation>ATLAS: Cohort Definitions [Internet]. [cited
2023 Mar 16]. Available from: https://atlasdemo.ohdsi.org/#/cohortdefinitions</Citation></Reference><Reference><Citation>CDE/S2-comparison.csv at master &#xb7; lhncbc/CDE &#xb7; GitHub [Internet]. [cited
2022 Dec 14]. Available from: https://github.com/lhncbc/CDE/blob/master/scyros/S2-comparison.csv</Citation></Reference><Reference><Citation>Yoon D, Ahn EK, Park MY, Cho SY, Ryan P, Schuemie MJ, et al. Conversion and Data Quality Assessment of Electronic Health Record Data at a Korean Tertiary Teaching Hospital to a Common Data Model for Distributed Network Research. Healthc Inform Res. 2016;22(1):54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38058679</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2574-2531</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>JAMIA open</Title><ISOAbbreviation>JAMIA Open</ISOAbbreviation></Journal><ArticleTitle>Transforming Estonian health data to the Observational Medical Outcomes Partnership (OMOP) Common Data Model: lessons learned.</ArticleTitle><Pagination><StartPage>ooad100</StartPage><MedlinePgn>ooad100</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ooad100</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamiaopen/ooad100</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To describe the reusable transformation process of electronic health records (EHR), claims, and prescriptions data into Observational Medical Outcome Partnership (OMOP) Common Data Model (CDM), together with challenges faced and solutions implemented.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">We used Estonian national health databases that store almost all residents' claims, prescriptions, and EHR records. To develop and demonstrate the transformation process of Estonian health data to OMOP CDM, we used a 10% random sample of the Estonian population (<i>n</i>&#x2009;=&#x2009;150&#xa0;824 patients) from 2012 to 2019 (MAITT dataset). For the sample, complete information from all 3 databases was converted to OMOP CDM version 5.3. The validation was performed using open-source tools.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In total, we transformed over 100 million entries to standard concepts using standard OMOP vocabularies with the average mapping rate 95%. For conditions, observations, drugs, and measurements, the mapping rate was over 90%. In most cases, SNOMED Clinical Terms were used as the target vocabulary.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">During the transformation process, we encountered several challenges, which are described in detail with concrete examples and solutions.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">For a representative 10% random sample, we successfully transferred complete records from 3 national health databases to OMOP CDM and created a reusable transformation process. Our work helps future researchers to transform linked databases into OMOP CDM more efficiently, ultimately leading to better real-world evidence.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oja</LastName><ForeName>Marek</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3650-8194</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamm</LastName><ForeName>Sirli</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mooses</LastName><ForeName>Kerli</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pajusalu</LastName><ForeName>Maarja</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talvik</LastName><ForeName>Harry-Anton</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>STACC, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ott</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laht</LastName><ForeName>Marianna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malk</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf5;o</LastName><ForeName>Marcus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holm</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haug</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x160;uvalov</LastName><ForeName>Hendrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe4;rg</LastName><ForeName>Dage</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>STACC, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vilo</LastName><ForeName>Jaak</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5604-4107</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>STACC, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laur</LastName><ForeName>Sven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolde</LastName><ForeName>Raivo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reisberg</LastName><ForeName>Sulev</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6835-9632</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>STACC, 51009 Tartu, Estonia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMIA Open</MedlineTA><NlmUniqueID>101730643</NlmUniqueID><ISSNLinking>2574-2531</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EHR</Keyword><Keyword MajorTopicYN="N">ETL</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">electronic health record</Keyword><Keyword MajorTopicYN="N">mapping</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>7</Day><Hour>4</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38058679</ArticleId><ArticleId IdType="pmc">PMC10697784</ArticleId><ArticleId IdType="doi">10.1093/jamiaopen/ooad100</ArticleId><ArticleId IdType="pii">ooad100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Hubbard T, Paradis R.. 
Real World Evidence: A New Era for Health Care Innovation. NEHI&#x2014;Network for Excellence in Health Innovation; 2015. Accessed January 14, 2023. https://www.nehi-us.org/writable/publication_files/file/rwe_issue_brief_final.pdf</Citation></Reference><Reference><Citation>Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence&#x2014;what is it and what can it tell us? N Engl J Med. 2016;375(23):2293-2297. 10.1056/NEJMsb1609216</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsb1609216</ArticleId><ArticleId IdType="pubmed">27959688</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Food and Drug Administration, <i>Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices. Guidance for Industry and Food and Drug Administration Staff</i>. 2017. Accessed January 14, 2023. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-real-world-evidence-support-regulatory-decision-making-medical-devices </Citation></Reference><Reference><Citation>Schneeweiss S, Avorn J.. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58(4):323-337. 10.1016/j.jclinepi.2004.10.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2004.10.012</ArticleId><ArticleId IdType="pubmed">15862718</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22(3):553-564. 10.1093/jamia/ocu023</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocu023</ArticleId><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent S, Burn E, Dawoud D, et al. Common problems, common data model solutions: evidence generation for health technology assessment. PharmacoEconomics. 2021;39(3):275-285. 10.1007/s40273-020-00981-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-020-00981-9</ArticleId><ArticleId IdType="pmc">PMC7746423</ArticleId><ArticleId IdType="pubmed">33336320</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacketer C, Defalco FJ, Ryan PB, et al. Increasing trust in real-world evidence through evaluation of observational data quality. J Am Med Inform Assoc. 2021;28(10):2251-2257. 10.1093/jamia/ocab132</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocab132</ArticleId><ArticleId IdType="pmc">PMC8449628</ArticleId><ArticleId IdType="pubmed">34313749</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinecke I, Zoch M, Reich C, et al. The usage of OHDSI OMOP&#x2014;a scoping review. In: R&#xf6;hrig R, Bei&#xdf;barth T, K&#xf6;nig J, et al. , eds. Studies in Health Technology and Informatics. IOS Press; 2021:95-103. 10.3233/SHTI210546</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI210546</ArticleId><ArticleId IdType="pubmed">34545824</ArticleId></ArticleIdList></Reference><Reference><Citation>
OHDSI. <i>OHDSI Community Dashboard. Publication Analysis</i>. Accessed November 22, 2022. https://dash.ohdsi.org/publication_dashboard/</Citation></Reference><Reference><Citation>
OHDSI. <i>Our Journey. Where the OHDSI Community Has Been and Where We Are Going</i>. 2022.</Citation></Reference><Reference><Citation>Papez V, Moinat M, Voss EA, et al. Transforming and evaluating the UK biobank to the OMOP common data model for COVID-19 research and beyond. J Am Med Inform Assoc. 2022;30(1):103-111. ocac203. 10.1093/jamia/ocac203</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocac203</ArticleId><ArticleId IdType="pmc">PMC9619789</ArticleId><ArticleId IdType="pubmed">36227072</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamer A, Depas N, Doutreligne M, et al. Transforming French electronic health records into the Observational Medical Outcome Partnership&#x2019;s Common Data Model: a feasibility study. Appl Clin Inform. 2020;11(1):13-22. 10.1055/s-0039-3402754</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-3402754</ArticleId><ArticleId IdType="pmc">PMC6949163</ArticleId><ArticleId IdType="pubmed">31914471</ArticleId></ArticleIdList></Reference><Reference><Citation>Papez V, Moinat M, Payralbe S, et al. Transforming and evaluating electronic health record disease phenotyping algorithms using the OMOP common data model: a case study in heart failure. JAMIA Open. 2021;4(3):ooab001. 10.1093/jamiaopen/ooab001</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamiaopen/ooab001</ArticleId><ArticleId IdType="pmc">PMC8423424</ArticleId><ArticleId IdType="pubmed">34514354</ArticleId></ArticleIdList></Reference><Reference><Citation>Delanerolle G, Williams R, Stipancic A, et al. Methodological issues in using a common data model of COVID-19 vaccine uptake and important adverse events of interest: feasibility study of data and connectivity COVID-19 vaccines pharmacovigilance in the United Kingdom. JMIR Form Res. 2022;6(8):e37821. 10.2196/37821</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/37821</ArticleId><ArticleId IdType="pmc">PMC9400842</ArticleId><ArticleId IdType="pubmed">35786634</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier C, Lang L, Storf H, et al. Towards implementation of OMOP in a German University Hospital Consortium. Appl Clin Inform. 2018;9(1):54-61. 10.1055/s-0037-1617452</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1617452</ArticleId><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J-W, Kim S, Ryu B, et al. Transforming electronic health record polysomnographic data into the Observational Medical Outcome Partnership&#x2019;s Common Data Model: a pilot feasibility study. Sci Rep. 2021;11(1):7013. 10.1038/s41598-021-86564-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-86564-w</ArticleId><ArticleId IdType="pmc">PMC8007756</ArticleId><ArticleId IdType="pubmed">33782494</ArticleId></ArticleIdList></Reference><Reference><Citation>Paris N, Lamer A, Parrot A.. Transformation and evaluation of the MIMIC database in the OMOP common data model: development and usability study. JMIR Med Inform. 2021;9(12):e30970. 10.2196/30970</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/30970</ArticleId><ArticleId IdType="pmc">PMC8715361</ArticleId><ArticleId IdType="pubmed">34904958</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji H, Kim S, Yi S, et al. Converting clinical document architecture documents to the common data model for incorporating health information exchange data in observational health studies: CDA to CDM. J Biomed Inform. 2020;107:103459. 10.1016/j.jbi.2020.103459</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2020.103459</ArticleId><ArticleId IdType="pubmed">32470694</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathappan SMK, Jeon YS, Dang TK, et al. Transformation of electronic health records and questionnaire data to OMOP CDM: a feasibility study using SG_T2DM dataset. Appl Clin Inform. 2021;12(4):757-767. 10.1055/s-0041-1732301</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1732301</ArticleId><ArticleId IdType="pmc">PMC8357458</ArticleId><ArticleId IdType="pubmed">34380168</ArticleId></ArticleIdList></Reference><Reference><Citation>Haberson A, Rinner C, Sch&#xf6;berl A, et al. Feasibility of mapping Austrian health claims data to the OMOP common data model. J Med Syst. 2019;43(10):314. 10.1007/s10916-019-1436-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10916-019-1436-9</ArticleId><ArticleId IdType="pmc">PMC6732152</ArticleId><ArticleId IdType="pubmed">31494719</ArticleId></ArticleIdList></Reference><Reference><Citation>Biedermann P, Ong R, Davydov A, et al. Standardizing registry data to the OMOP common data model: experience from three pulmonary hypertension databases. BMC Med Res Methodol. 2021;21(1):238. 10.1186/s12874-021-01434-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-021-01434-3</ArticleId><ArticleId IdType="pmc">PMC8565035</ArticleId><ArticleId IdType="pubmed">34727871</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Jiang G, Brandt E, et al. Integrating real-world data to assess cardiac ablation device outcomes in a multicenter study using the OMOP common data model for regulatory decisions: implementation and evaluation. JAMIA Open. 2023;6(1):ooac108. 10.1093/jamiaopen/ooac108</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamiaopen/ooac108</ArticleId><ArticleId IdType="pmc">PMC9831049</ArticleId><ArticleId IdType="pubmed">36632328</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Fukuoka Y, Goldberg K, et al. Applying machine learning to predict future adherence to physical activity programs. BMC Med Inform Decis Mak. 2019;19(1):169. 10.1186/s12911-019-0890-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-019-0890-0</ArticleId><ArticleId IdType="pmc">PMC6704548</ArticleId><ArticleId IdType="pubmed">31438926</ArticleId></ArticleIdList></Reference><Reference><Citation>
EHDEN. <i>2022&#x2014;European Health Data Evidence Network</i>. Accessed January 14, 2023. https://www.ehden.eu/</Citation></Reference><Reference><Citation>
EHDEN DPC. <i>A Federated Network of Data Partners</i>. Accessed January 14, 2023. https://www.ehden.eu/datapartners/</Citation></Reference><Reference><Citation>Estonian Health Insurance Fund. Estonian Health Insurance Fund Annual Report of Financial Year 2020. Estonian Health Insurance Fund; 2021.</Citation></Reference><Reference><Citation>K&#xf5;nd K, Lillev&#xe4;li A.. E-prescription success in Estonia: the journey from paper to paharmacogenomics. Eurohealth. 2019;25(2):18-20.</Citation></Reference><Reference><Citation>
National Library of Medicine. <i>RxNorm</i>. Accessed January 14, 2023. https://www.nlm.nih.gov/research/umls/rxnorm/index.html</Citation></Reference><Reference><Citation>
OHDSI. <i>ATHENA OHDSI Vocabularies Repository</i>. Accessed January 14, 2023. http://athena.ohdsi.org</Citation></Reference><Reference><Citation>
Schuemie M.
<i>Usagi</i>. Accessed January 14, 2023. https://github.com/OHDSI/Usagi</Citation></Reference><Reference><Citation>
<i>Automated Characterization of Health Information at Large-Scale Longitudinal Evidence Systems (ACHILLES)</i>. Accessed January 14, 2023. https://github.com/OHDSI/Achilles </Citation></Reference><Reference><Citation>
CdmInspection. <i>R Package to Support Quality Control Inspection of An OMOP-CDM Instance</i>. Accessed January 14, 2023. https://github.com/EHDEN/CdmInspection </Citation></Reference><Reference><Citation>
<i>Dashboard of Estonian MAITT Dataset</i>. Accessed January 14, 2023. http://omop-apps.cloud.ut.ee/ShinyApps/MAITTOverview/#/MAITT/dashboard </Citation></Reference><Reference><Citation>Omar MI, Roobol MJ, Ribal MJ, et al. ; PIONEER Consortium. Introducing PIONEER: a project to harness big data in prostate cancer research. Nat Rev Urol. 2020;17(6):351-362. 10.1038/s41585-020-0324-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41585-020-0324-x</ArticleId><ArticleId IdType="pubmed">32461687</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Williams RD, Swerdel JN, et al. Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis. Semin Arthritis Rheum. 2022;56:152050. 10.1016/j.semarthrit.2022.152050</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2022.152050</ArticleId><ArticleId IdType="pubmed">35728447</ArticleId></ArticleIdList></Reference><Reference><Citation>Candore G, Hedenmalm K, Slattery J, et al. Can we rely on results from IQVIA medical research data UK converted to the Observational Medical Outcome Partnership Common Data Model?: a validation study based on prescribing codeine in children. Clin Pharmacol Ther. 2020;107(4):915-925. 10.1002/cpt.1785</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.1785</ArticleId><ArticleId IdType="pmc">PMC7158210</ArticleId><ArticleId IdType="pubmed">31956997</ArticleId></ArticleIdList></Reference><Reference><Citation>Uusk&#xfc;la A, Oja M, Tisler A, et al. Prevaccination prevalence of type-specific human papillomavirus infection by grade of cervical cytology in Estonia. JAMA Network Open. 2023;6(2):e2254075. 10.1001/jamanetworkopen.2022.54075</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.54075</ArticleId><ArticleId IdType="pubmed">36745455</ArticleId></ArticleIdList></Reference><Reference><Citation>
Solvak M, Vilo J, Reisberg S, et al. <i>RITA MAITT&#x2014;Programmi RITA tegevuse 1 projekti &#x201e;Masin&#xf5;ppe ja AI toega teenused &#x201c;l&#xf5;pparuanne&#x201d; [Final Report of the Project &#x201c;Machine Learning and AI Supported Services&#x201d; of RITA Programme Task 1].</i>2022. Accessed January 14, 2023. https://www.etis.ee/Portal/Publications/Display/f077ca2a-db43-41e9-8076-51e3e2fb7ac3 </Citation></Reference><Reference><Citation>K&#xfc;nnapuu K, Ioannou S, Ligi K, et al. Trajectories: a framework for detecting temporal clinical event sequences from health data standardized to the Observational Medical Outcomes Partnership (OMOP) Common Data Model. JAMIA Open. 2022;5(1):ooac021. 10.1093/jamiaopen/ooac021</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamiaopen/ooac021</ArticleId><ArticleId IdType="pmc">PMC9097714</ArticleId><ArticleId IdType="pubmed">35571357</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer K, Moris L, Lardas M, et al. ; PIONEER Consortium. Updating and integrating core outcome sets for localised, locally advanced, metastatic, and nonmetastatic castration-resistant prostate cancer: an update from the PIONEER consortium. Eur Urol. 2022;81(5):503-514. 10.1016/j.eururo.2022.01.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2022.01.042</ArticleId><ArticleId IdType="pubmed">35184906</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandaglia G, Pellegrino F, Golozar A, et al. ; PIONEER Consortium. Clinical characterization of patients diagnosed with prostate cancer and undergoing conservative management: a PIONEER analysis based on big data. Eur Urol. 2023. 10.1016/j.eururo.2023.06.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2023.06.012</ArticleId><ArticleId IdType="pubmed">37414703</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38061012</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2473-4276</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>JCO clinical cancer informatics</Title><ISOAbbreviation>JCO Clin Cancer Inform</ISOAbbreviation></Journal><ArticleTitle>MI-Common Data Model: Extending Observational Medical Outcomes Partnership-Common Data Model (OMOP-CDM) for Registering Medical Imaging Metadata and Subsequent Curation Processes.</ArticleTitle><Pagination><StartPage>e2300101</StartPage><MedlinePgn>e2300101</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2300101</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1200/CCI.23.00101</ELocationID><Abstract><AbstractText Label="PURPOSE">The explosion of big data and artificial intelligence has rapidly increased the need for integrated, homogenized, and harmonized health data. Many common data models (CDMs) and standard vocabularies have appeared in an attempt to offer harmonized access to the available information, with Observational Medical Outcomes Partnership (OMOP)-CDM being one of the most prominent ones, allowing the standardization and harmonization of health care information. However, despite its flexibility, still capturing imaging metadata along with the corresponding clinical data continues to pose a challenge. This challenge arises from the absence of a comprehensive standard representation for image-related information and subsequent image curation processes and their interlinkage with the respective clinical information. Successful resolution of this challenge holds the potential to enable imaging and clinical data to become harmonized, quality-checked, annotated, and ready to be used in conjunction, in the development of artificial intelligence models and other data-dependent use cases.</AbstractText><AbstractText Label="METHODS">To address this challenge, we introduce medical imaging (MI)-CDM-an extension of the OMOP-CDM specifically designed for registering medical imaging data and curation-related processes. Our modeling choices were the result of iterative numerous discussions among clinical and AI experts to enable the integration of imaging and clinical data in the context of the ProCAncer-I project, for answering a set of clinical questions across the prostate cancer's continuum.</AbstractText><AbstractText Label="RESULTS">Our MI-CDM extension has been successfully implemented for the use case of prostate cancer for integrating imaging and curation metadata along with clinical information by using the OMOP-CDM and its oncology extension.</AbstractText><AbstractText Label="CONCLUSION">By using our proposed terminologies and standardized attributes, we demonstrate how diverse imaging modalities can be seamlessly integrated in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kalokyri</LastName><ForeName>Varvara</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-5245-8238</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation of Research and Technology Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondylakis</LastName><ForeName>Haridimos</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-9917-4486</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation of Research and Technology Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sfakianakis</LastName><ForeName>Stelios</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8424-4157</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation of Research and Technology Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nikiforaki</LastName><ForeName>Katerina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-0792-9800</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation of Research and Technology Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karatzanis</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-3909-7503</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation of Research and Technology Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzetti</LastName><ForeName>Simone</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6011-4040</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation of Research and Technology Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgical Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radiology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tachos</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation of Research and Technology Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Institute, Foundation of Research and Technology Hellas, University Campus of Ioannina, Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Regge</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation of Research and Technology Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radiology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fotiadis</LastName><ForeName>Dimitrios I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation of Research and Technology Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Institute, Foundation of Research and Technology Hellas, University Campus of Ioannina, Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marias</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-3783-5223</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation of Research and Technology Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsiknakis</LastName><ForeName>Manolis</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8454-1450</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation of Research and Technology Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JCO Clin Cancer Inform</MedlineTA><NlmUniqueID>101708809</NlmUniqueID><ISSNLinking>2473-4276</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071253" MajorTopicYN="Y">Metadata</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="N">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003952" MajorTopicYN="N">Diagnostic Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="Y">Prostatic Neoplasms</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/cci/author-center. Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments). 
<b>Simone Mazzetti</b>
. <b>Patents, Royalties, Other Intellectual Property:</b> System for the detection of tumoral masses based on magnetic resonance imaging. The computer aided diagnosis (CAD) system allows automatic detection of suspicious areas of prostate cancer starting from magnetic resonance images. For each suspected area the CAD also provides an indication of the PI-RADS and a probability index related to tumor aggressiveness, creating a structured report. 
<b>Daniele Regge</b>
. <b>Honoraria:</b> Radmetrix ($10,000 USD or above in a single calendar year). <b>Consulting or Advisory Role:</b> Health Triage (less than $10,000 USD in a single calendar year). <b>Patents, Royalties, Other Intellectual Property:</b> Patent as the inventor of a tool for prostate cancer diagnosis with MRI. The property of the Patent is of the Candiolo Cancer Institute and of the University of Torino. I will receive compensation following the exploitation of the patent by Health Triage (less than $10,000 USD in a single calendar year). <b>Travel, Accommodations, Expenses:</b> Bracco Diagnostics (less than $10,000 USD in a single calendar year). 
<b>Dimitrios I. Fotiadis</b>
. <b>Employment:</b> PD Neurotechnology Ltd. <b>Leadership:</b> PD Neurotechnology Ltd. <b>Stock and Other Ownership Interests:</b> PD Neurotechnology Ltd. <b>Research Funding:</b> Pfizer. No other potential conflicts of interest were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>13</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>7</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>7</Day><Hour>16</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38061012</ArticleId><ArticleId IdType="pmc">PMC10715775</ArticleId><ArticleId IdType="doi">10.1200/CCI.23.00101</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. : Observational Health Data Sciences and Informatics (OHDSI): Opportunities for observational researchers. Stud Health Technol Inform 216:574-578, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Mildenberger P, Eichelberg M, Martin E: Introduction to the DICOM standard. Eur Radiol 12:920-927, 2002</Citation><ArticleIdList><ArticleId IdType="pubmed">11960249</ArticleId></ArticleIdList></Reference><Reference><Citation>Park C, You SC, Jeon H, et al. : Development and validation of the radiology common data model (R-CDM) for the international standardization of medical imaging data. Yonsei Med J 63:S74-S83, 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8790584</ArticleId><ArticleId IdType="pubmed">35040608</ArticleId></ArticleIdList></Reference><Reference><Citation>ProCAncer-I Project: ProCAncer-I: An AI platform integrating imaging data and models, supporting precision care through prostate cancer's continuum. https://www.procancer-i.eu/</Citation></Reference><Reference><Citation>Noy NF, McGuinness DL: Ontology Development 101: A Guide to Creating Your First Ontology. Technical Report. Stanford, CA, Stanford University, 2001</Citation></Reference><Reference><Citation>Belenkaya R, Gurley MJ, Golozar A, et al. : Extending the OMOP common data model and standardized vocabularies to support observational cancer research. JCO Clin Cancer Inform 5:12-20, 2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8140810</ArticleId><ArticleId IdType="pubmed">33411620</ArticleId></ArticleIdList></Reference><Reference><Citation>Channin DS, Mongkolwat P, Kleper V, et al. : The caBIG annotation and image Markup project. J Digit Imaging 23:217-225, 2010</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2837161</ArticleId><ArticleId IdType="pubmed">19294468</ArticleId></ArticleIdList></Reference><Reference><Citation>Digital Imaging and Communications in Medicine/National Electrical Manufacturers Association: DICOM PS3.3 2023b&#x2014;Information Object Definitions - C.7.2.1 general study module. https://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.7.2.html</Citation></Reference><Reference><Citation>Bender D, Sartipi K: HL7 FHIR: An Agile and RESTful approach to healthcare information exchange. Proceedings of the 26th IEEE International Symposium on Computer-Based Medical Systems, Porto, Portugal, 2013, pp 326-331</Citation></Reference><Reference><Citation>Genereaux BW, Dennison DK, Ho K, et al. : DICOMweb&#x2122;: Background and application of the web standard for medical imaging. J Digit Imaging 31:321-326, 2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5959831</ArticleId><ArticleId IdType="pubmed">29748852</ArticleId></ArticleIdList></Reference><Reference><Citation>Langlotz CP: RadLex: A new method for indexing online educational materials. Radiographics 26:1595-1597, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">17102038</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Soest J, Lustberg T, Grittner D, et al. : Towards a semantic PACS: Using Semantic Web technology to represent imaging data. Stud Health Technol Inform 205:166-170, 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5119276</ArticleId><ArticleId IdType="pubmed">25160167</ArticleId></ArticleIdList></Reference><Reference><Citation>Vreeman DJ, Abhyankar S, Wang KC, et al. : The LOINC RSNA radiology playbook&#x2014;A unified terminology for radiology procedures. J Am Med Inform Assoc 25:885-893, 2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6016707</ArticleId><ArticleId IdType="pubmed">29850823</ArticleId></ArticleIdList></Reference><Reference><Citation>Digital Imaging and Communications in Medicine/National Electrical Manufacturers Association: NEMA PS3/ISO 12052, Digital Imaging and Communications in Medicine (DICOM) Standard, PS3.3 2020b Information Object Definitions - C.8.20.2 segmentation image module. https://dicom.nema.org/medical/dicom/2020b/output/chtml/part03/sect_C.8.20.2.html</Citation></Reference><Reference><Citation>Purysko AS, Rosenkrantz AB, Turkbey IB, et al. : RadioGraphics update: PI-RADS version 2.1--a pictorial update. Radiographics 40:E33-E37, 2020</Citation><ArticleIdList><ArticleId IdType="pubmed">33136475</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalokyri V: MI-CDM. https://github.com/vkalokyri/MI-CDM</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38062352</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2288</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>07</Day></PubDate></JournalIssue><Title>BMC medical research methodology</Title><ISOAbbreviation>BMC Med Res Methodol</ISOAbbreviation></Journal><ArticleTitle>Attention-based neural networks for clinical prediction modelling on electronic health records.</ArticleTitle><Pagination><StartPage>285</StartPage><MedlinePgn>285</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">285</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12874-023-02112-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Deep learning models have had a lot of success in various fields. However, on structured data they have struggled. Here we apply four state-of-the-art supervised deep learning models using the attention mechanism and compare against logistic regression and XGBoost using discrimination, calibration and clinical utility.</AbstractText><AbstractText Label="METHODS">We develop the models using a general practitioners database. We implement a recurrent neural network, a transformer with and without reverse distillation and a graph neural network. We measure discrimination using the area under the receiver operating characteristic curve (AUC) and the area under the precision recall curve (AUPRC). We assess smooth calibration using restricted cubic splines and clinical utility with decision curve analysis.</AbstractText><AbstractText Label="RESULTS">Our results show that deep learning approaches can improve discrimination up to 2.5% points AUC and 7.4% points AUPRC. However, on average the baselines are competitive. Most models are similarly calibrated as the baselines except for the graph neural network. The transformer using reverse distillation shows the best performance in clinical utility on two out of three prediction problems over most of the prediction thresholds.</AbstractText><AbstractText Label="CONCLUSION">In this study, we evaluated various approaches in supervised learning using neural networks and attention. Here we do a rigorous comparison, not only looking at discrimination but also calibration and clinical utility. There is value in using deep learning models on electronic health record data since it can improve discrimination and clinical utility while providing good calibration. However, good baseline methods are still competitive.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fridgeirsson</LastName><ForeName>Egill A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands. e.fridgeirsson@erasmusmc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sontag</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Medical Engineering &amp; Science, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>806968</GrantID><Agency>the Innovative Medicines Initiative 2 Joint Undertak</Agency><Country/></Grant><Grant><GrantID>806968</GrantID><Agency>the Innovative Medicines Initiative 2 Joint Undertak</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Res Methodol</MedlineTA><NlmUniqueID>100968545</NlmUniqueID><ISSNLinking>1471-2288</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="Y">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical prediction models</Keyword><Keyword MajorTopicYN="N">Deep learning</Keyword><Keyword MajorTopicYN="N">Electronic health records</Keyword></KeywordList><CoiStatement>DS was a consultant for and has equity in CureAI and ASAPP and has received compensation from speaking at Genentech. DS has a grant from Takeda. EF and PR work for a research group who received unconditional research grants from Boehringer-Ingelheim, GSK, Janssen Research &amp; Development, Novartis, Pfizer, Yamanouchi, Servier. None of these grants result in a conflict of interest to the content of this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>13</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>8</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>7</Day><Hour>23</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38062352</ArticleId><ArticleId IdType="pmc">PMC10701944</ArticleId><ArticleId IdType="doi">10.1186/s12874-023-02112-2</ArticleId><ArticleId IdType="pii">10.1186/s12874-023-02112-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goldstein BA, Navar AM, Pencina MJ, Ioannidis JPA. Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review. J Am Med Inform Assoc. 2017;24(1):198&#x2013;208. doi: 10.1093/jamia/ocw042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocw042</ArticleId><ArticleId IdType="pmc">PMC5201180</ArticleId><ArticleId IdType="pubmed">27189013</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Kors JA, Ioannou S, John LH, Markus AF, Rekkas A et al. Trends in the conduct and reporting of clinical prediction model development and validation: a systematic review. J Am Med Inform Assoc. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9006694</ArticleId><ArticleId IdType="pubmed">35045179</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. In: Studies in Health Technology and Informatics. 2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayaz M, Pasha MF, Alzahrani MY, Budiarto R, Stiawan D. The fast Health Interoperability resources (FHIR) Standard: Systematic Literature Review of Implementations, applications, challenges and opportunities. JMIR Med Inform. 2021;9(7):e21929. doi: 10.2196/21929.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/21929</ArticleId><ArticleId IdType="pmc">PMC8367140</ArticleId><ArticleId IdType="pubmed">34328424</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB, Rijnbeek PR. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc. 2018;25(8):969&#x2013;75. doi: 10.1093/jamia/ocy032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy032</ArticleId><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteva A, Robicquet A, Ramsundar B, Kuleshov V, DePristo M, Chou K, et al. A guide to deep learning in healthcare. Nat Med 2019 251. 2019;25(1):24&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30617335</ArticleId></ArticleIdList></Reference><Reference><Citation>LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521(7553):436&#x2013;44. doi: 10.1038/nature14539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14539</ArticleId><ArticleId IdType="pubmed">26017442</ArticleId></ArticleIdList></Reference><Reference><Citation>Borisov V, Leemann T, Se&#xdf;ler K, Haug J, Pawelczyk M, Kasneci G. Deep Neural Networks and Tabular Data: A Survey. CoRR [Internet]. 2021;abs/2110.01889. Available from: https://arxiv.org/abs/2110.01889.</Citation><ArticleIdList><ArticleId IdType="pubmed">37015381</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorishniy Y, Rubachev I, Khrulkov V, Babenko A. Revisiting Deep Learning Models for Tabular Data. 2021 Jun 22 [cited 2021 Aug 19]; Available from: https://arxiv.org/abs/2106.11959v1.</Citation></Reference><Reference><Citation>Shwartz-Ziv R, Armon A. Tabular Data: Deep Learning is Not All You Need. 2021 Jun 6 [cited 2021 Dec 2]; Available from: https://arxiv.org/abs/2106.03253v2.</Citation></Reference><Reference><Citation>Choi E, Taha Bahadori M, Kulas JA, Schuetz A, Stewart WF, Sun J et al. RETAIN: an interpretable predictive model for Healthcare using reverse time attention mechanism. Vol. 29, Advances in Neural Information Processing Systems. 2016.</Citation></Reference><Reference><Citation>Kodialam RS, Boiarsky R, Lim J, Dixit N, Sai A, Sontag D. Deep Contextual Clinical Prediction with Reverse Distillation. Proc AAAI Conf Artif Intell. 2020;35(1):249&#x2013;58.</Citation></Reference><Reference><Citation>Zhu W, Razavian N. Variationally regularized graph-based representation learning for electronic health records. In: ACM CHIL 2021 - Proceedings of the 2021 ACM Conference on Health, Inference, and Learning [Internet]. arXiv; 2021 [cited 2021 Mar 5]. p.&#xa0;1&#x2013;13. Available from: http://arxiv.org/abs/1912.03761.</Citation></Reference><Reference><Citation>Vaswani A, Shazeer N, Parmar N, Uszkoreit J, Jones L, Gomez AN et al. Attention is all you need. In: Advances in Neural Information Processing Systems. 2017. p.&#xa0;5999&#x2013;6009.</Citation></Reference><Reference><Citation>de Ridder MAJ, de Wilde M, de Ben C, Leyba AR, Mosseveld BMT, Verhamme KMC, et al. Data Resource Profile: the Integrated Primary Care Information (IPCI) database, the Netherlands. Int J Epidemiol. 2022;2022:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749682</ArticleId><ArticleId IdType="pubmed">35182144</ArticleId></ArticleIdList></Reference><Reference><Citation>John LH, Kors JA, Fridgeirsson EA, Reps JM, Rijnbeek PR. External validation of existing Dementia prediction models on observational health data. BMC Med Res Methodol. 2022;22(1):311. doi: 10.1186/s12874-022-01793-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-022-01793-5</ArticleId><ArticleId IdType="pmc">PMC9720950</ArticleId><ArticleId IdType="pubmed">36471238</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul [Internet]. 2013 Jan 1 [cited 2022 Feb 2];23(1). 10.1145/2414416.2414791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Grinsztajn L, Oyallon E, Varoquaux G. Why do tree-based models still outperform deep learning on typical tabular data? In 2022 [cited 2022 Dec 7]. Available from: https://openreview.net/forum?id=Fp7__phQszn.</Citation></Reference><Reference><Citation>Bergstra J, Bardenet R, Bengio Y, K&#xe9;gl B. Algorithms for hyper-parameter optimization. In: Advances in Neural Information Processing Systems 24: 25th Annual Conference on Neural Information Processing Systems 2011, NIPS 2011. 2011.</Citation></Reference><Reference><Citation>Sun X, Xu W. Fast implementation of DeLong&#x2019;s algorithm for comparing the areas under correlated receiver operating characteristic curves. IEEE Signal Process Lett. 2014;21(11).</Citation></Reference><Reference><Citation>Boyd K, Eng KH, Page CD. Area under the precision-recall curve: Point estimates and confidence intervals. In: Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 2013. p.&#xa0;451&#x2013;66.</Citation></Reference><Reference><Citation>Niculescu-Mizil A, Caruana R. Predicting good probabilities with supervised learning. In: ICML 2005 - Proceedings of the 22nd International Conference on Machine Learning. 2005. p.&#xa0;625&#x2013;32.</Citation></Reference><Reference><Citation>Platt JC, Platt JC. Probabilistic outputs for support vector machines and comparisons to regularized likelihood methods. Adv LARGE MARGIN Classif. 1999;61&#x2013;74.</Citation></Reference><Reference><Citation>Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2577036</ArticleId><ArticleId IdType="pubmed">17099194</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg SM. A Unified Approach to Interpreting Model Predictions. 31st Conf Neural Inf Process Syst NIPS 2017. 2019;32(2):1208&#x2013;17.</Citation></Reference><Reference><Citation>Vickers AJ, Van Calster B, Steyerberg EW. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests. BMJ [Internet]. 2016 Jan 25 [cited 2022 Mar 2];352. Available from: https://pubmed.ncbi.nlm.nih.gov/26810254/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4724785</ArticleId><ArticleId IdType="pubmed">26810254</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultan S, Taimuri U, Basnan SA, Ai-Orabi WK, Awadallah A, Almowald F, et al. Low Vitamin D and its association with cognitive impairment and Dementia. J Aging Res. 2020;2020:e6097820. doi: 10.1155/2020/6097820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/6097820</ArticleId><ArticleId IdType="pmc">PMC7210535</ArticleId><ArticleId IdType="pubmed">32399297</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou WP, Chang YH, Lin HC, Chang YH, Chen YY, Ko CH. Thiamine for preventing Dementia development among patients with Alcohol Use Disorder: a nationwide population-based cohort study. Clin Nutr. 2019;38(3):1269&#x2013;73. doi: 10.1016/j.clnu.2018.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2018.05.009</ArticleId><ArticleId IdType="pubmed">29843940</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Li Y, Li X, Zhang S, Zhao J, Zhu X, et al. Head Injury as a risk factor for Dementia and Alzheimer&#x2019;s Disease: a systematic review and Meta-analysis of 32 observational studies. PLoS ONE. 2017;12(1):e0169650. doi: 10.1371/journal.pone.0169650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0169650</ArticleId><ArticleId IdType="pmc">PMC5221805</ArticleId><ArticleId IdType="pubmed">28068405</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala Solares JR, Diletta Raimondi FE, Zhu Y, Rahimian F, Canoy D, Tran J, et al. Deep learning for electronic health records: a comparative review of multiple deep neural architectures. J Biomed Inform. 2020;101:103337. doi: 10.1016/j.jbi.2019.103337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103337</ArticleId><ArticleId IdType="pubmed">31916973</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkomar A, Oren E, Chen K, Dai AM, Hajaj N, Hardt M, et al. Scalable and accurate deep learning with electronic health records. Npj Digit Med. 2018;1(1):18. doi: 10.1038/s41746-018-0029-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-018-0029-1</ArticleId><ArticleId IdType="pmc">PMC6550175</ArticleId><ArticleId IdType="pubmed">31304302</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Calster B, McLernon DJ, Van Smeden M, Wynants L, Steyerberg EW, Bossuyt P, et al. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019;17(1):1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6912996</ArticleId><ArticleId IdType="pubmed">31842878</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito T, Rehmsmeier M. The Precision-Recall plot is more informative than the ROC plot when evaluating Binary classifiers on Imbalanced datasets. PLoS ONE. 2015;10(3):e0118432. doi: 10.1371/journal.pone.0118432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0118432</ArticleId><ArticleId IdType="pmc">PMC4349800</ArticleId><ArticleId IdType="pubmed">25738806</ArticleId></ArticleIdList></Reference><Reference><Citation>Hravnak M, Pellathy T, Chen L, Dubrawski A, Wertz A, Clermont G, et al. A call to alarms: current state and future directions in the battle against alarm fatigue. J Electrocardiol. 2018;51(6):S44&#x2013;8. doi: 10.1016/j.jelectrocard.2018.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2018.07.024</ArticleId><ArticleId IdType="pmc">PMC6263784</ArticleId><ArticleId IdType="pubmed">30077422</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley RD, Ensor J, Snell KIE, Debray TPA, Altman DG, Moons KGM et al. External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges. BMJ [Internet]. 2016 Jun 22 [cited 2022 Mar 2];353. Available from: https://www.bmj.com/content/353/bmj.i3140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4916924</ArticleId><ArticleId IdType="pubmed">27334381</ArticleId></ArticleIdList></Reference><Reference><Citation>Prins A, Hemke F, Pols J, van Charante EPM. Diagnosing Dementia in Dutch general practice: a qualitative study of GPs&#x2019; practices and views. Br J Gen Pract. 2016;66(647):e416&#x2013;22. doi: 10.3399/bjgp16X685237.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp16X685237</ArticleId><ArticleId IdType="pmc">PMC4871307</ArticleId><ArticleId IdType="pubmed">27114209</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38064251</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2369-2960</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><PubDate><Year>2023</Year><Month>Dec</Month><Day>08</Day></PubDate></JournalIssue><Title>JMIR public health and surveillance</Title><ISOAbbreviation>JMIR Public Health Surveill</ISOAbbreviation></Journal><ArticleTitle>Patient-Centered Economic Burden of Exudative Age-Related Macular Degeneration: Retrospective Cohort Study.</ArticleTitle><Pagination><StartPage>e49852</StartPage><MedlinePgn>e49852</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e49852</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/49852</ELocationID><Abstract><AbstractText Label="BACKGROUND">Exudative age-related macular degeneration (AMD), one of the leading causes of blindness, requires expensive drugs such as anti-vascular endothelial growth factor (VEGF) agents. The long-term regular use of effective but expensive drugs causes an economic burden for patients with exudative AMD. However, there are no studies on the long-term patient-centered economic burden of exudative AMD after reimbursement of anti-VEGFs.</AbstractText><AbstractText Label="OBJECTIVE">This study aimed to evaluate the patient-centered economic burden of exudative AMD for 2 years, including nonreimbursement and out-of-pocket costs, compared with nonexudative AMD using the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM).</AbstractText><AbstractText Label="METHODS">This retrospective cohort study was conducted using the OMOP CDM, which included 2,006,478 patients who visited Seoul National University Bundang Hospital from June 2003 to July 2019. We defined the exudative AMD group as patients aged &gt;50 years with a diagnosis of exudative AMD and a prescription for anti-VEGFs or verteporfin. The control group was defined as patients aged &gt;50 years without a diagnosis of exudative AMD or a prescription for anti-VEGFs or verteporfin. To adjust for selection bias, controls were matched by propensity scores using regularized logistic regression with a Laplace prior. We measured any medical cost occurring in the hospital as the economic burden of exudative AMD during a 2-year follow-up period using 4 categories: total medical cost, reimbursement cost, nonreimbursement cost, and out-of-pocket cost. To estimate the average cost by adjusting the confounding variable and overcoming the positive skewness of costs, we used an exponential conditional model with a generalized linear model.</AbstractText><AbstractText Label="RESULTS">We identified 931 patients with exudative AMD and matched 783 (84.1%) with 2918 patients with nonexudative AMD. In the exponential conditional model, the total medical, reimbursement, nonreimbursement, and out-of-pocket incremental costs were estimated at US $3426, US $3130, US $366, and US $561, respectively, in the first year and US $1829, US $1461, US $373, and US $507, respectively, in the second year. All incremental costs in the exudative AMD group were 1.89 to 4.25 and 3.50 to 5.09 times higher in the first and second year, respectively, than those in the control group (P&lt;.001 in all cases).</AbstractText><AbstractText Label="CONCLUSIONS">Exudative AMD had a significantly greater economic impact (P&lt;.001) for 2 years on reimbursement, nonreimbursement, and out-of-pocket costs than nonexudative AMD after adjusting for baseline demographic and clinical characteristics using the OMOP CDM. Although economic policies could relieve the economic burden of patients with exudative AMD over time, the out-of-pocket cost of exudative AMD was still higher than that of nonexudative AMD for 2 years. Our findings support the need for expanding reimbursement strategies for patients with exudative AMD given the significant economic burden faced by patients with incurable and fatal diseases both in South Korea and worldwide.</AbstractText><CopyrightInformation>&#xa9;Kyungseon Choi, Sang Jun Park, Sola Han, Yongseok Mun, Da Yun Lee, Dong-Jin Chang, Seok Kim, Sooyoung Yoo, Se Joon Woo, Kyu Hyung Park, Hae Sun Suh. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 08.12.2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Choi</LastName><ForeName>Kyungseon</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-6616-6842</Identifier><AffiliationInfo><Affiliation>Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Regulatory Innovation Through Science, Kyung Hee University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Park</LastName><ForeName>Sang Jun</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0003-0542-2758</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Sola</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6269-172X</Identifier><AffiliationInfo><Affiliation>Health Outcomes Division, College of Pharmacy, University of Texas at Austin, Austin, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mun</LastName><ForeName>Yongseok</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-0123-0361</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Da Yun</ForeName><Initials>DY</Initials><Identifier Source="ORCID">0000-0002-9604-8337</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Dong-Jin</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0002-4763-1219</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Science, Yeouido St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seok</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4996-8613</Identifier><AffiliationInfo><Affiliation>Healthcare ICT Research Center, Office of eHealth Research and Businesses, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Sooyoung</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8620-4925</Identifier><AffiliationInfo><Affiliation>Healthcare ICT Research Center, Office of eHealth Research and Businesses, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woo</LastName><ForeName>Se Joon</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0003-3692-7169</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Kyu Hyung</ForeName><Initials>KH</Initials><Identifier Source="ORCID">0000-0002-5516-8121</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suh</LastName><ForeName>Hae Sun</ForeName><Initials>HS</Initials><Identifier Source="ORCID">0000-0003-3445-6607</Identifier><AffiliationInfo><Affiliation>Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Regulatory Innovation Through Science, Kyung Hee University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Public Health Surveill</MedlineTA><NlmUniqueID>101669345</NlmUniqueID><ISSNLinking>2369-2960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0X9PA28K43</RegistryNumber><NameOfSubstance UI="D000077362">Verteporfin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086522" MajorTopicYN="Y">Financial Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008268" MajorTopicYN="Y">Macular Degeneration</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018802" MajorTopicYN="N">Patient-Centered Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077362" MajorTopicYN="N">Verteporfin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">age-related macular degeneration</Keyword><Keyword MajorTopicYN="N">blindness</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">cost of illness</Keyword><Keyword MajorTopicYN="N">economic burden</Keyword><Keyword MajorTopicYN="N">retrospective cohort study</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>8</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>8</Day><Hour>11</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38064251</ArticleId><ArticleId IdType="pmc">PMC10746973</ArticleId><ArticleId IdType="doi">10.2196/49852</ArticleId><ArticleId IdType="pii">v9i1e49852</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guymer RH, Campbell TG. Age-related macular degeneration. Lancet. 2023 Apr 29;401(10386):1459&#x2013;72. doi: 10.1016/S0140-6736(22)02609-5.S0140-6736(22)02609-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)02609-5</ArticleId><ArticleId IdType="pubmed">36996856</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Chen Y, Gordon I, Safi S, Lingham G, Evans J, Keel S, He M. A systematic review of clinical practice guidelines for age-related macular degeneration. Ophthalmic Epidemiol. 2023 Jun;30(3):213&#x2013;20. doi: 10.1080/09286586.2022.2059812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09286586.2022.2059812</ArticleId><ArticleId IdType="pubmed">35417274</ArticleId></ArticleIdList></Reference><Reference><Citation>Studni&#x10d;ka J, &#x158;&#xed;hov&#xe1; B, Rencov&#xe1; E, Rozs&#xed;val P, Dubsk&#xe1; Z, Chrapek O, Kol&#xe1;&#x159; P, Kandrnal V, Demlov&#xe1; R, Pitrov&#xe1; &#x160;, &#x158;eh&#xe1;k J. Cost and effectiveness of therapy for wet age-related macular degeneration in routine clinical practice. Ophthalmologica. 2013;230(1):34&#x2013;42. doi: 10.1159/000350802.000350802</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000350802</ArticleId><ArticleId IdType="pubmed">23751929</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen CL, Oh LJ, Wong E, Wei J, Chilov M. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration: a meta-analysis of randomized controlled trials. BMC Ophthalmol. 2018 May 30;18(1):130. doi: 10.1186/s12886-018-0785-3. 
 
10.1186/s12886-018-0785-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12886-018-0785-3</ArticleId><ArticleId IdType="doi">10.1186/s12886-018-0785-3</ArticleId><ArticleId IdType="pmc">PMC5975529</ArticleId><ArticleId IdType="pubmed">29843663</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser SM, Arepalli S, Ehlers JP. Current and future anti-VEGF agents for neovascular age-related macular degeneration. J Exp Pharmacol. 2021 Sep 29;13:905&#x2013;12. doi: 10.2147/JEP.S259298. 
 
259298</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JEP.S259298</ArticleId><ArticleId IdType="pmc">PMC8488047</ArticleId><ArticleId IdType="pubmed">34616189</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg D, Deonarain DM, Gould J, Sothivannan A, Phillips MR, Sarohia GS, Sivaprasad S, Wykoff CC, Cheung CM, Sarraf D, Bakri SJ, Chaudhary V. Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis. Eye (Lond) 2023 Jan;37(1):6&#x2013;16. doi: 10.1038/s41433-022-02020-7.10.1038/s41433-022-02020-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41433-022-02020-7</ArticleId><ArticleId IdType="pmc">PMC9829919</ArticleId><ArticleId IdType="pubmed">35396574</ArticleId></ArticleIdList></Reference><Reference><Citation>Wecker T, Grundel B, Reichl S, Stech M, Lange C, Agostini H, B&#xf6;hringer D, Stahl A. Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment. Sci Rep. 2019 Mar 01;9(1):3301. doi: 10.1038/s41598-019-38934-8. doi: 10.1038/s41598-019-38934-8.10.1038/s41598-019-38934-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-38934-8</ArticleId><ArticleId IdType="doi">10.1038/s41598-019-38934-8</ArticleId><ArticleId IdType="pmc">PMC6397189</ArticleId><ArticleId IdType="pubmed">30824721</ArticleId></ArticleIdList></Reference><Reference><Citation>Almony A, Keyloun KR, Shah-Manek B, Multani JK, McGuiness CB, Chen C, Campbell JH. Clinical and economic burden of neovascular age-related macular degeneration by disease status: a US claims-based analysis. J Manag Care Spec Pharm. 2021 Sep;27(9):1260&#x2013;72. doi: 10.18553/jmcp.2021.27.9.1260. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.18553/jmcp.2021.27.9.1260</ArticleId><ArticleId IdType="pmc">PMC10391196</ArticleId><ArticleId IdType="pubmed">34464210</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonastre J, Le Pen C, Anderson P, Ganz A, Berto P, Berdeaux G. The epidemiology, economics and quality of life burden of age-related macular degeneration in France, Germany, Italy and the United Kingdom. Eur J Health Econ. 2002;3(2):94&#x2013;102. doi: 10.1007/s10198-002-0104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10198-002-0104-y</ArticleId><ArticleId IdType="pubmed">15609135</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MM, Brown GC, Lieske HB, Tran I, Turpcu A, Colman S. Societal costs associated with neovascular age-related macular degeneration in the united states. Retina. 2016 Feb;36(2):285&#x2013;98. doi: 10.1097/IAE.0000000000000717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/IAE.0000000000000717</ArticleId><ArticleId IdType="pubmed">26428606</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruess AF, Zlateva G, Xu X, Soubrane G, Pauleikhoff D, Lotery A, Mones J, Buggage R, Schaefer C, Knight T, Goss TF. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study. Pharmacoeconomics. 2008;26(1):57&#x2013;73. doi: 10.2165/00019053-200826010-00006.2616</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00019053-200826010-00006</ArticleId><ArticleId IdType="pubmed">18088159</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon H, Lee H, Yoon D, Lee Y, Kim JH, Jee D, Shin J. Burden of diabetic macular oedema in patients receiving antivascular endothelial growth factor therapy in South Korea: a healthcare resource use and cost analysis. BMJ Open. 2020 Dec 29;10(12):e042484. doi: 10.1136/bmjopen-2020-042484. 
 
bmjopen-2020-042484</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-042484</ArticleId><ArticleId IdType="pmc">PMC7778761</ArticleId><ArticleId IdType="pubmed">33376178</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Park SJ, Byun SJ, Park KH, Suh HS. Incremental economic burden associated with exudative age-related macular degeneration: a population-based study. BMC Health Serv Res. 2019 Nov 12;19(1):828. doi: 10.1186/s12913-019-4666-0. 
 
10.1186/s12913-019-4666-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-019-4666-0</ArticleId><ArticleId IdType="doi">10.1186/s12913-019-4666-0</ArticleId><ArticleId IdType="pmc">PMC6852978</ArticleId><ArticleId IdType="pubmed">31718629</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotery A, Xu X, Zlatava G, Loftus J. Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study. Br J Ophthalmol. 2007 Oct;91(10):1303&#x2013;7. doi: 10.1136/bjo.2007.116939. 
 
bjo.2007.116939</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjo.2007.116939</ArticleId><ArticleId IdType="pmc">PMC2000983</ArticleId><ArticleId IdType="pubmed">17504847</ArticleId></ArticleIdList></Reference><Reference><Citation>Spooner KL, Mhlanga CT, Hong TH, Broadhead GK, Chang AA. The burden of neovascular age-related macular degeneration: a patient's perspective. Clin Ophthalmol. 2018;12:2483&#x2013;91. doi: 10.2147/OPTH.S185052. 
 
opth-12-2483</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OPTH.S185052</ArticleId><ArticleId IdType="pmc">PMC6287411</ArticleId><ArticleId IdType="pubmed">30584267</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54&#x2013;60. doi: 10.1136/amiajnl-2011-000376. 
 
amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Huser V, DeFalco FJ, Schuemie M, Ryan PB, Shang N, Velez M, Park RW, Boyce RD, Duke J, Khare R, Utidjian L, Bailey C. Multisite evaluation of a data quality tool for patient-level clinical data sets. EGEMS (Wash DC) 2016 Nov 30;4(1):1239. doi: 10.13063/2327-9214.1239. 
 
egems1239</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1239</ArticleId><ArticleId IdType="pmc">PMC5226382</ArticleId><ArticleId IdType="pubmed">28154833</ArticleId></ArticleIdList></Reference><Reference><Citation>Huser V, Kahn MG, Brown JS, Gouripeddi R. Methods for examining data quality in healthcare integrated data repositories. Pac Symp Biocomput. 2018;23:628&#x2013;33. 
 
9789813235533_0059</Citation><ArticleIdList><ArticleId IdType="pubmed">29218922</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi K. HERMES: a health resources econometric analysis tool. GitHub. 2023.  [2023-08-29].  
 https://github.com/kyseonchoi/HERMES/tree/main
.</Citation></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul. 2013 Jan;23(1):1&#x2013;17. doi: 10.1145/2414416.2414791. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2414416.2414791</ArticleId><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Schuemie MJ, Suchard MA. Evaluating large-scale propensity score performance through real-world and synthetic data experiments. Int J Epidemiol. 2018 Dec 01;47(6):2005&#x2013;14. doi: 10.1093/ije/dyy120. 
 
5043131</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyy120</ArticleId><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001 Jul;20(4):461&#x2013;94. doi: 10.1016/s0167-6296(01)00086-8.S0167629601000868</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0167-6296(01)00086-8</ArticleId><ArticleId IdType="pubmed">11469231</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauhoff S. Self-report bias in estimating cross-sectional and treatment effects. In: Michalos AC, editor. Encyclopedia of Quality of Life and Well-Being Research. Dordrecht, Netherlands: Springer; 2014. pp. 5798&#x2013;800.</Citation></Reference><Reference><Citation>van Asten F, Michels CT, Hoyng CB, van der Wilt GJ, Klevering BJ, Rovers MM, Grutters JP. The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration-a cost-effectiveness analysis from a societal perspective. PLoS One. 2018 May 17;13(5):e0197670. doi: 10.1371/journal.pone.0197670. 
 
PONE-D-16-12333</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0197670</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0197670</ArticleId><ArticleId IdType="pmc">PMC5957378</ArticleId><ArticleId IdType="pubmed">29772018</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenfeld PJ, Windsor MA, Feuer WJ, Sun SJ, Frick KD, Swanson EA, Huang D. Estimating medicare and patient savings from the use of bevacizumab for the treatment of exudative age-related macular degeneration. Am J Ophthalmol. 2018 Jul;191:135&#x2013;9. doi: 10.1016/j.ajo.2018.04.008.S0002-9394(18)30168-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajo.2018.04.008</ArticleId><ArticleId IdType="pubmed">29655642</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung HW, Kwon YD, Noh J. How public and private health insurance coverage mitigates catastrophic health expenditures in Republic of Korea. BMC Health Serv Res. 2022 Aug 16;22(1):1042. doi: 10.1186/s12913-022-08405-4. 
 
10.1186/s12913-022-08405-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-022-08405-4</ArticleId><ArticleId IdType="doi">10.1186/s12913-022-08405-4</ArticleId><ArticleId IdType="pmc">PMC9377807</ArticleId><ArticleId IdType="pubmed">35971176</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S. Medical service utilization and out-of-pocket spending among near-poor National Health Insurance members in South Korea. BMC Health Serv Res. 2021 Aug 28;21(1):886. doi: 10.1186/s12913-021-06881-8. 
 
10.1186/s12913-021-06881-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-021-06881-8</ArticleId><ArticleId IdType="doi">10.1186/s12913-021-06881-8</ArticleId><ArticleId IdType="pmc">PMC8399721</ArticleId><ArticleId IdType="pubmed">34454499</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Burn E, Duarte-Salles T, Yin C, Reich C, Delmestri A, Verhamme K, Rijnbeek P, Suchard MA, Li K, Mosseveld M, John LH, Mayer M, Ramirez-Anguita J, Cohet C, Strauss V, Prieto-Alhambra D. Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US. BMJ. 2022 Oct 26;379:e071594. doi: 10.1136/bmj-2022-071594. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071594</ArticleId><ArticleId IdType="pmc">PMC9597610</ArticleId><ArticleId IdType="pubmed">36288813</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo SI, Park CH, You SC, Kim JY, Lee KJ, Kim J, Kim Y, Yoo JJ, Seo W, Lee HS, Shin WG. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea. Gut. 2021 Nov 11;70(11):2066&#x2013;75. doi: 10.1136/gutjnl-2020-323845.gutjnl-2020-323845</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323845</ArticleId><ArticleId IdType="pubmed">33975868</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC, Rho Y, Bikdeli B, Kim J, Siapos A, Weaver J, Londhe A, Cho J, Park J, Schuemie M, Suchard MA, Madigan D, Hripcsak G, Gupta A, Reich CG, Ryan PB, Park RW, Krumholz HM. Association of ticagrelor vs clopidogrel with net adverse clinical events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. JAMA. 2020 Oct 27;324(16):1640&#x2013;50. doi: 10.1001/jama.2020.16167. 
 
2772280</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.16167</ArticleId><ArticleId IdType="pmc">PMC7592033</ArticleId><ArticleId IdType="pubmed">33107944</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38105303</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>18</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Implementation of inclusion and exclusion criteria in clinical studies in OHDSI ATLAS software.</ArticleTitle><Pagination><StartPage>22457</StartPage><MedlinePgn>22457</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">22457</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-49560-w</ELocationID><Abstract><AbstractText>Clinical trials are essential parts of a medical study process, but studies are often cancelled due to a lack of participants. Clinical Trial Recruitment Support Systems are systems that help to increase the number of participants by seeking more suitable subjects. The software ATLAS (developed by Observational Health Data Sciences and Informatics) can support the launch of a clinical trial by building cohorts of patients who fulfill certain criteria. The correct use of medical classification systems aiming at clearly defined inclusion and exclusion criteria in the studies is an important pillar of this software. The aim of this investigation was to determine whether ATLAS can be used in a Clinical Trial Recruitment Support System to portray the eligibility criteria of clinical studies. Our analysis considered the number of criteria feasible for integration with ATLAS and identified its strengths and weaknesses. Additionally, we investigated whether nonrepresentable criteria were associated with the utilized terminology systems. We analyzed ATLAS using 223 objective eligibility criteria from 30 randomly selected trials conducted in the last 10&#xa0;years. In the next step, we&#xa0;selected appropriate ICD, OPS, LOINC, or ATC codes to feed the software. We classified each criterion and study based on its implementation capability in the software, ensuring a clear and logical progression of information. Based on our observations, 51% of the analyzed inclusion criteria were fully implemented in ATLAS. Within our selected example set, 10% of the studies were classified as fully portrayable, and 73% were portrayed to some extent. Additionally, we conducted an evaluation of the software regarding its technical limitations and interaction with medical classification systems. To improve and expand the scope of criteria within a cohort definition in a practical setting, it is recommended to work closely with personnel involved in the study to define the criteria precisely and to carefully select terminology systems. The chosen criteria should be combined according to the specific setting. Additional work is needed to specify the significance and amount of the extracted criteria.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blasini</LastName><ForeName>Romina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Medical Informatics, Justus Liebig University, Giessen, Germany. romina.blasini@informatik.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buchowicz</LastName><ForeName>Kornelia Marta</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Institute of Medical Informatics, Justus Liebig University, Giessen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health Sciences, University of Applied Sciences, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Henning</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Medical Informatics, Justus Liebig University, Giessen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health Sciences, University of Applied Sciences, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samans</LastName><ForeName>Birgit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, University of Applied Sciences, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sohrabi</LastName><ForeName>Keywan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Medical Informatics, Justus Liebig University, Giessen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health Sciences, University of Applied Sciences, Giessen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FKZ 01ZZ1801D</GrantID><Agency>German Ministry of Education and Research</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>18</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>23</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38105303</ArticleId><ArticleId IdType="pmc">PMC10725886</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-49560-w</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-49560-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carlisle B, Kimmelman J, Ramsay T, MacKinnon N. Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials. Clin. Trials. Lond. Engl. 2015;12(1):77&#x2013;83. doi: 10.1177/1740774514558307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1740774514558307</ArticleId><ArticleId IdType="pmc">PMC4516407</ArticleId><ArticleId IdType="pubmed">25475878</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai M. Recruitment and retention of participants in clinical studies: Critical issues and challenges. Perspect. Clin. Res. 2020;11(2):51&#x2013;53. doi: 10.4103/picr.PICR_6_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/picr.PICR_6_20</ArticleId><ArticleId IdType="pmc">PMC7342339</ArticleId><ArticleId IdType="pubmed">32670827</ArticleId></ArticleIdList></Reference><Reference><Citation>Sully BGO, Julious SA, Nicholl J. A reinvestigation of recruitment to randomised, controlled, multicenter trials: A review of trials funded by two UK funding agencies. Trials. 2013;14(1):166. doi: 10.1186/1745-6215-14-166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1745-6215-14-166</ArticleId><ArticleId IdType="pmc">PMC3691846</ArticleId><ArticleId IdType="pubmed">23758961</ArticleId></ArticleIdList></Reference><Reference><Citation>Thadani SR, Weng C, Bigger JT, Ennever JF, Wajngurt D. Electronic screening improves efficiency in clinical trial recruitment. J. Am. Med. Inform. Assoc. 2009;16(6):869&#x2013;873. doi: 10.1197/jamia.M3119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M3119</ArticleId><ArticleId IdType="pmc">PMC3002129</ArticleId><ArticleId IdType="pubmed">19717797</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinczek B, K&#xf6;pcke F, Leusch T, et al. Design and multicentric Implementation of a generic software architecture for patient recruitment systems re-using existing his tools and routine patient data. Appl. Clin. Inform. 2014;05(01):264&#x2013;283. doi: 10.4338/ACI-2013-07-RA-0047.</Citation><ArticleIdList><ArticleId IdType="doi">10.4338/ACI-2013-07-RA-0047</ArticleId><ArticleId IdType="pmc">PMC3974260</ArticleId><ArticleId IdType="pubmed">24734138</ArticleId></ArticleIdList></Reference><Reference><Citation>Penberthy L, Brown R, Puma F, Dahman B. Automated matching software for clinical trials eligibility: measuring efficiency and flexibility. Contemp. Clin. Trials. 2010;31(3):207&#x2013;217. doi: 10.1016/j.cct.2010.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2010.03.005</ArticleId><ArticleId IdType="pmc">PMC4387843</ArticleId><ArticleId IdType="pubmed">20230913</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzer K, Haeuslschmid R, Blasini R, et al. Patient recruitment system for clinical trials: mixed methods study about requirements at Ten University Hospitals. JMIR Med. Inform. 2022;10(4):e28696. doi: 10.2196/28696.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/28696</ArticleId><ArticleId IdType="pmc">PMC9069280</ArticleId><ArticleId IdType="pubmed">35442203</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich, C., Ostropolets, A. <i>Chapter 5 Standardized Vocabularies | The Book of OHDSI</i>. OHDSI; 2019. Accessed November 7, 2022. https://ohdsi.github.io/TheBookOfOhdsi/</Citation></Reference><Reference><Citation>Prokosch HU, Sedlmayr M. Datenaustausch in der Forschung via OMOP/OHDSI [Data exchange in research via OMOP/OHDSI] EHealth.com. 2018;2018:34&#x2013;37.</Citation></Reference><Reference><Citation>Reinecke I, Gulden C, K&#xfc;mmel M, Nassirian A, Blasini R, Sedlmayr M. Design for a modular clinical trial recruitment support system based on FHIR and OMOP. Stud. Health. Technol. Inform. 2020;270:158&#x2013;162. doi: 10.3233/SHTI200142.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI200142</ArticleId><ArticleId IdType="pubmed">32570366</ArticleId></ArticleIdList></Reference><Reference><Citation>Meystre SM, Heider PM, Kim Y, Aruch DB, Britten CD. Automatic trial eligibility surveillance based on unstructured clinical data. Int. J. Med. Inf. 2019;129:13&#x2013;19. doi: 10.1016/j.ijmedinf.2019.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2019.05.018</ArticleId><ArticleId IdType="pmc">PMC6717538</ArticleId><ArticleId IdType="pubmed">31445247</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational health data sciences and informatics (OHDSI): Opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornet R, Chute CG. Health concept and knowledge management: Twenty-five years of evolution. Yearb. Med. Inform. 2016;Suppl 1(Suppl 1):S32&#x2013;41. doi: 10.15265/IYS-2016-s037.</Citation><ArticleIdList><ArticleId IdType="doi">10.15265/IYS-2016-s037</ArticleId><ArticleId IdType="pmc">PMC5171511</ArticleId><ArticleId IdType="pubmed">27488404</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiker NR, Bakken S, Casey A, Hoy D. Formal nursing terminology systems: A means to an end. J. Biomed. Inform. 2002;35(5&#x2013;6):298&#x2013;305. doi: 10.1016/s1532-0464(03)00002-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1532-0464(03)00002-9</ArticleId><ArticleId IdType="pubmed">12968778</ArticleId></ArticleIdList></Reference><Reference><Citation>Regenstrief Institute, Inc. LOINC. LOINC. Accessed August 24, 2022. https://loinc.org/</Citation></Reference><Reference><Citation>SNOMED International. SNOMED International Browser. Accessed August 24, 2022. https://browser.ihtsdotools.org/</Citation></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J. Biomed. Inform. 2016;64:333&#x2013;341. doi: 10.1016/j.jbi.2016.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.10.016</ArticleId><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson KJ, Jiang G, Brue SM, Liu H. Leveraging terminology services for extract-transform-load processes: A user-centered approach. AMIA Annu. Symp. Proc. 2017;2016:1010&#x2013;1019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333225</ArticleId><ArticleId IdType="pubmed">28269898</ArticleId></ArticleIdList></Reference><Reference><Citation>Chondrogiannis E, Andronikou V, Tagaris A, Karanastasis E, Varvarigou T, Tsuji M. A novel semantic representation for eligibility criteria in clinical trials. J. Biomed. Inform. 2017;69:10&#x2013;23. doi: 10.1016/j.jbi.2017.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2017.03.013</ArticleId><ArticleId IdType="pubmed">28336477</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang T, Zhang S, Tang Y, et al. EliIE: An open-source information extraction system for clinical trial eligibility criteria. J. Am. Med. Inform. Assoc. 2017;24(6):1062&#x2013;1071. doi: 10.1093/jamia/ocx019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx019</ArticleId><ArticleId IdType="pmc">PMC6259668</ArticleId><ArticleId IdType="pubmed">28379377</ArticleId></ArticleIdList></Reference><Reference><Citation>National Library of Medicine (NLM). Home - ClinicalTrials.gov. Accessed August 24, 2022. https://clinicaltrials.gov/</Citation></Reference><Reference><Citation>Luo Z, Yetisgen-Yildiz M, Weng C. Dynamic categorization of clinical research eligibility criteria by hierarchical clustering. J. Biomed. Inform. 2011;44(6):927&#x2013;935. doi: 10.1016/j.jbi.2011.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2011.06.001</ArticleId><ArticleId IdType="pmc">PMC3183114</ArticleId><ArticleId IdType="pubmed">21689783</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesinstitut f&#xfc;r Arzneimittel und Medizinprodukte (BfArM). BfArM - ICD-10-GM Version&#xa0;2022. Accessed August 24, 2022. https://www.dimdi.de/static/de/klassifikationen/icd/icd-10-gm/kode-suche/htmlgm2022/</Citation></Reference><Reference><Citation>Bundesinstitut f&#xfc;r Arzneimittel und Medizinprodukte (BfArM). BfArM - OPS Version&#xa0;2022. Accessed August 24, 2022. https://www.dimdi.de/static/de/klassifikationen/ops/kode-suche/opshtml2022/</Citation></Reference><Reference><Citation>Vidal MMI Germany GmbH. ATC Codes von A bis Z | Gelbe Liste. Accessed August 24, 2022. https://www.gelbe-liste.de/atc</Citation></Reference><Reference><Citation>Reich, C. GitHub - OHDSI/Vocabulary-v5.0: Build process for the OHDSI Standardized Vocabularies. Accessed September 17, 2023. https://github.com/OHDSI/Vocabulary-v5.0</Citation></Reference><Reference><Citation>Kostka, K. <i>Chapter 10 Defining Cohorts | The Book of OHDSI</i>. Accessed August 29, 2023. https://ohdsi.github.io/TheBookOfOhdsi/</Citation></Reference><Reference><Citation>Maier C, Lang L, Storf H, et al. Towards implementation of OMOP in a German university hospital consortium. Appl Clin Inform. 2018;09(1):54&#x2013;61. doi: 10.1055/s-0037-1617452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1617452</ArticleId><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Introduction. In: <i>The WHO Application of ICD-10 to Deaths during the Perinatal Period: ICD-PM</i>. World Health Organization; 2016. Accessed September 10, 2023. https://apps.who.int/iris/handle/10665/249515</Citation></Reference><Reference><Citation>Thun S, Dewenter H. ICD-11, ICHI und SNOMED CT &#x2013; was bedeuten die Systematiken f&#xfc;r E-Health-Anwendungen? Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 2018;61(7):812&#x2013;820. doi: 10.1007/s00103-018-2759-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00103-018-2759-2</ArticleId><ArticleId IdType="pubmed">29846742</ArticleId></ArticleIdList></Reference><Reference><Citation>Orphanet Nomenclature for coding &#x2013; Orphadata. Accessed September 22, 2023. https://www.orphadata.com/orphanet-nomenclature-for-coding/</Citation></Reference><Reference><Citation>Zoch, M., Reinecke, I., Peng, Y., Sedlmayr, M., Henke, E. Erweiterung der ETL-Strecke FHIR-to-OMOP f&#xfc;r Seltene Erkrankungen. Published online September 15, 2023. doi:10.3205/23GMDS158</Citation></Reference><Reference><Citation>Verweij J, Hendriks HR, Zwierzina H. Cancer drug development forum. Innovation in oncology clinical trial design. Cancer Treat. Rev. 2019;74:15&#x2013;20. doi: 10.1016/j.ctrv.2019.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctrv.2019.01.001</ArticleId><ArticleId IdType="pubmed">30665053</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan C, Ryan PB, Ta C, et al. Criteria2Query: A natural language interface to clinical databases for cohort definition. J. Am. Med. Inform. Assoc. 2019;26(4):294&#x2013;305. doi: 10.1093/jamia/ocy178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy178</ArticleId><ArticleId IdType="pmc">PMC6402359</ArticleId><ArticleId IdType="pubmed">30753493</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, X., Hersch, G. L., Khalil, I., Devarakonda, M. Clinical trial information extraction with BERT. In: <i>2021 IEEE 9th International Conference on Healthcare Informatics (ICHI)</i>. IEEE; 2021:505&#x2013;506. 10.1109/ICHI52183.2021.00092</Citation></Reference><Reference><Citation>Tseo Y, Salkola MI, Mohamed A, Kumar A, Abnousi F. Information extraction of clinical trial eligibility criteria. Published Online. 2020 doi: 10.48550/ARXIV.2006.07296.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/ARXIV.2006.07296</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang B, Yoon J, Kim HY, Jo SJ, Lee Y, Kam HJ. Deep-learning-based automated terminology mapping in OMOP-CDM. J. Am. Med. Inform Assoc. JAMIA. 2021;28(7):1489&#x2013;1496. doi: 10.1093/jamia/ocab030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocab030</ArticleId><ArticleId IdType="pmc">PMC8279781</ArticleId><ArticleId IdType="pubmed">33987667</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinecke I, Zoch M, Reich C, Sedlmayr M, Bathelt F. The usage of OHDSI OMOP - a scoping review. Stud. Health Technol. Inform. 2021;283:95&#x2013;103. doi: 10.3233/SHTI210546.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI210546</ArticleId><ArticleId IdType="pubmed">34545824</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross J, Tu S, Carini S, Sim I. Analysis of eligibility criteria complexity in clinical trials. Summit. Transl. Bioinforma. 2010;2010:46&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041539</ArticleId><ArticleId IdType="pubmed">21347148</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;ttler C, Prokosch HU, Sedlmayr M, Sedlmayr B. Evaluation of three feasibility tools for identifying patient data and biospecimen availability: Comparative usability study. JMIR Med. Inform. 2021;9(7):e25531. doi: 10.2196/25531.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/25531</ArticleId><ArticleId IdType="pmc">PMC8339981</ArticleId><ArticleId IdType="pubmed">34287211</ArticleId></ArticleIdList></Reference><Reference><Citation>EHDEN Academy. Accessed September 17, 2023. https://academy.ehden.eu/</Citation></Reference><Reference><Citation>Van Spall HGC, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: A systematic sampling review. JAMA. 2007;297(11):1233&#x2013;1240. doi: 10.1001/jama.297.11.1233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.297.11.1233</ArticleId><ArticleId IdType="pubmed">17374817</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleixandre-Benavent R, Valderrama Zuri&#xe1;n JC, Bueno-Ca&#xf1;igral FJ. Proper use of medical language: Main problems and solutions. Rev Clin Esp. 2015;215(7):396&#x2013;400. doi: 10.1016/j.rce.2015.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rce.2015.04.001</ArticleId><ArticleId IdType="pmc">PMC7094488</ArticleId><ArticleId IdType="pubmed">25982421</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38113207</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2767-3170</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>PLOS digital health</Title><ISOAbbreviation>PLOS Digit Health</ISOAbbreviation></Journal><ArticleTitle>From data strategy to implementation to advance cancer research and cancer care: A French comprehensive cancer center experience.</ArticleTitle><Pagination><StartPage>e0000415</StartPage><MedlinePgn>e0000415</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0000415</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pdig.0000415</ELocationID><Abstract><AbstractText>In a comprehensive cancer center, effective data strategies are essential to evaluate practices, and outcome, understanding the disease and prognostic factors, identifying disparities in cancer care, and overall developing better treatments. To achieve these goals, the Center L&#xe9;on B&#xe9;rard (CLB) considers various data collection strategies, including electronic medical records (EMRs), clinical trial data, and research projects. Advanced data analysis techniques like natural language processing (NLP) can be used to extract and categorize information from these sources to provide a more complete description of patient data. Data sharing is also crucial for collaboration across comprehensive cancer centers, but it must be done securely and in compliance with regulations like GDPR. To ensure data is shared appropriately, CLB should develop clear data sharing policies and share data in a controlled, standardized format like OSIRIS RWD, OMOP and FHIR. The UNICANCER initiative has launched the CONSORE project to support the development of a structured and standardized repository of patient data to improve cancer research and patient outcomes. Real-world data (RWD) studies are vital in cancer research as they provide a comprehensive and accurate picture of patient outcomes and treatment patterns. By incorporating RWD into data collection, analysis, and sharing strategies, comprehensive cancer centers can take a more comprehensive and patient-centered approach to cancer research. In conclusion, comprehensive cancer centers must take an integrated approach to data collection, analysis, and sharing to enhance their understanding of cancer and improve patient outcomes. Leveraging advanced data analytics techniques and developing effective data sharing policies can help cancer centers effectively harness the power of data to drive progress in cancer research.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Heudel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heudel</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-2155-549X</Identifier><AffiliationInfo><Affiliation>Department of Medical Oncology, Centre L&#xe9;on B&#xe9;rard, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crochet</LastName><ForeName>Hugo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Data and Artificial Intelligence Team, Centre L&#xe9;on B&#xe9;rard, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durand</LastName><ForeName>Thierry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Data protection officer, Centre L&#xe9;on B&#xe9;rard, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zrounba</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, Centre L&#xe9;on B&#xe9;rard, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blay</LastName><ForeName>Jean-Yves</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Centre L&#xe9;on B&#xe9;rard, Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>General Director, Centre L&#xe9;on B&#xe9;rard, Lyon, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLOS Digit Health</MedlineTA><NlmUniqueID>9918335064206676</NlmUniqueID><ISSNLinking>2767-3170</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>19</Day><Hour>19</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>19</Day><Hour>19</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>19</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38113207</ArticleId><ArticleId IdType="pmc">PMC10729983</ArticleId><ArticleId IdType="doi">10.1371/journal.pdig.0000415</ArticleId><ArticleId IdType="pii">PDIG-D-23-00112</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wagner LI, Sweet J, Butt Z, et al. Using the science of team science to enhance team-based cancer care. Journal of the National Cancer Institute Monographs. 2019;2019(53):98&#x2013;106. doi: 10.1093/jncimonographs/lgz018</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jncimonographs/lgz018</ArticleId><ArticleId IdType="pmc">PMC6750168</ArticleId><ArticleId IdType="pubmed">31532526</ArticleId></ArticleIdList></Reference><Reference><Citation>Moslehi JJ, Deininger M. Cancer treatment as a team sport: Multidisciplinary care in oncology. The Journal of the American Medical Association. 2017;318(4):343&#x2013;344. doi: 10.1001/jama.2017.79363</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.79363</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas CR, Harlan LC. The Role of NCI-Designated Cancer Centers in Cancer Research and Cancer Care. The Oncologist. 2019;24(3):283&#x2013;288. doi: 10.1634/theoncologist.2018-0122</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.2018-0122</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Wang J, Wang M, et al. The Role of Hospital Data Management in Quality Improvement. Journal of Healthcare Engineering. 2018;2018:1&#x2013;10. doi: 10.1155/2018/2173863</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/2173863</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng X, Tan X, Tang J, et al. Electronic Medical Record Systems in China: The Role of Hospital Data Management in Quality Improvement. Healthcare Informatics Research. 2016;22(3):214&#x2013;220. doi: 10.4258/hir.2016.22.3.214</Citation><ArticleIdList><ArticleId IdType="doi">10.4258/hir.2016.22.3.214</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruland P, McGee M. The Importance of a Data Strategy for Healthcare. Healthcare Informatics Research. 2019;25(3):137&#x2013;140. doi: 10.4258/hir.2019.25.3.137</Citation><ArticleIdList><ArticleId IdType="doi">10.4258/hir.2019.25.3.137</ArticleId></ArticleIdList></Reference><Reference><Citation>Nambiar D, Agarwal A, Gupta G. Building a Data Strategy for Health: A Case Study of the Health Data Management System in India. Journal of Health Management. 2020;22(3):351&#x2013;364. doi: 10.1177/0972063420937022</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0972063420937022</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. New data strategy for England aims to rebuild public trust. BMJ. 2022. Jun 14;377:o1455. doi: 10.1136/bmj.o1455</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o1455</ArticleId><ArticleId IdType="pubmed">35700998</ArticleId></ArticleIdList></Reference><Reference><Citation>Martani A, Genevi&#xe8;ve LD, Egli SM, Erard F, Wangmo T, Elger BS. Evolution or Revolution? Recommendations to Improve the Swiss Health Data Framework.Front Public Health. 2021. May 31;9:668386. doi: 10.3389/fpubh.2021.668386 eCollection 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.668386</ArticleId><ArticleId IdType="pmc">PMC8200489</ArticleId><ArticleId IdType="pubmed">34136456</ArticleId></ArticleIdList></Reference><Reference><Citation>Kish LJ, Topol EJ. Unpatients&#x2014;why patients should own their medical data. Nat Biotechnol. (2015) 33:921&#x2013;4. doi: 10.1038/nbt.3340</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3340</ArticleId><ArticleId IdType="pubmed">26348958</ArticleId></ArticleIdList></Reference><Reference><Citation>Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019. Jan;25(1):44&#x2013;56. doi: 10.1038/s41591-018-0300-7 Epub 2019 Jan 7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0300-7</ArticleId><ArticleId IdType="pubmed">30617339</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehnke JR, Rutherford C. Using feedback tools to enhance the quality and experience of care. Qual Life Res. 2021. Nov;30(11):3007&#x2013;3013. doi: 10.1007/s11136-021-03008-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-021-03008-8</ArticleId><ArticleId IdType="pubmed">34635961</ArticleId></ArticleIdList></Reference><Reference><Citation>Vayena E, Dzenowagis J, Brownstein JS, Sheikh A. Policy implications of big data in the health sector. Bull World Health Organ. 2018. Jan 1;96(1):66&#x2013;68. doi: 10.2471/BLT.17.197426 Epub 2017 Nov 23.</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.17.197426</ArticleId><ArticleId IdType="pmc">PMC5791870</ArticleId><ArticleId IdType="pubmed">29403102</ArticleId></ArticleIdList></Reference><Reference><Citation>Heudel P, Livartowski A, Arveux P, Willm E, Jamain C. The ConSoRe project supports the implementation of big data in oncology. Bull Cancer. 2016. Nov;103(11):949&#x2013;950. doi: 10.1016/j.bulcan.2016.10.001 Epub 2016 Nov 2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bulcan.2016.10.001</ArticleId><ArticleId IdType="pubmed">27816168</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu&#xe9;rin J, Laizet Y, Le Texier V, Chanas L, Rance B, Koeppel F, Lion F, Gourgou S, Martin AL, Tejeda M, Toulmonde M, Cox S, Hess E, Rousseau-Tsangaris M, Jouhet V, Saintigny P. OSIRIS: A Minimum Data Set for Data Sharing and Interoperability in Oncology. JCO Clin Cancer Inform. 2021. Mar;5:256&#x2013;265. doi: 10.1200/CCI.20.00094</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/CCI.20.00094</ArticleId><ArticleId IdType="pmc">PMC8140800</ArticleId><ArticleId IdType="pubmed">33720747</ArticleId></ArticleIdList></Reference><Reference><Citation>Centre Leon B&#xe9;rard. Available online: https://www.centreleonberard.fr/patient-proche/vous-accompagner/vos-droits/vos-donnees-de-sante. Accessed on August 2023.</Citation></Reference><Reference><Citation>Wilkinson MD, Dumontier M, Aalbersberg IJ, Appleton G, Axton M, Baak A, Blomberg N, Boiten JW, da Silva Santos LB, Bourne PE, Bouwman J, Brookes AJ, Clark T, Crosas M, Dillo I, Dumon O, Edmunds S, Evelo CT, Finkers R, Gonzalez-Beltran A, Gray AJ, Groth P, Goble C, Grethe JS, Heringa J, &#x2019;t Hoen PA, Hooft R, Kuhn T, Kok R, Kok J, Lusher SJ, Martone ME, Mons A, Packer AL, Persson B, Rocca-Serra P, Roos M, van Schaik R, Sansone SA, Schultes E, Sengstag T, Slater T, Strawn G, Swertz MA, Thompson M, van der Lei, van Mulligen, Velterop, Waagmeester, Wittenburg P, Wolstencroft K, Zhao J, Mons B The FAIR Guiding Principles for scientific data management and stewardship. Sci Data. 2016. Mar 15;3:160018. doi: 10.1038/sdata.2016.18</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2016.18</ArticleId><ArticleId IdType="pmc">PMC4792175</ArticleId><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>CepiDc.INSERM.fr [internet]. Institut national de la sant&#xe9; et de la recherche m&#xe9;dicale; c2023 [cited 2023 Mar 23]. Available from https://www.cepidc.inserm.fr/</Citation></Reference><Reference><Citation>Tr&#xe9;dan O, Wang Q, Pissaloux D, Cassier P, de la Fouchardi&#xe8;re A, Fayette J, Desseigne F, Ray-Coquard I, de la Fouchardi&#xe8;re C, Frappaz D, Heudel PE, Bonneville-Levard A, Fl&#xe9;chon A, Sarabi M, Guibert P, Bachelot T, P&#xe9;rol M, You B, Bonnin N, Collard O, Leyronnas C, Attignon V, Baudet C, Sohier E, Villemin JP, Viari A, Boyault S, Lantuejoul S, Paindavoine S, Treillleux I, Rodriguez C, Agrapart V, Corset V, Garin G, Chabaud S, P&#xe9;rol D, Blay JY; ProfiLER investigators.Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial. Ann Oncol. 2019. May 1;30(5):757&#x2013;765. doi: 10.1093/annonc/mdz080</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/annonc/mdz080</ArticleId><ArticleId IdType="pubmed">30865223</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO.int [internet]. World Health Organization; c2023 [cited 2023 Mar 23]. Available from https://www.who.int/standards/classifications/other-classifications/international-classification-of-diseases-for-oncology</Citation></Reference><Reference><Citation>Tang M, Pearson SA, Simes RJ, Chua BH. Harnessing Real-World Evidence to Advance Cancer Research. Curr Oncol. 2023. Feb 2;30(2):1844&#x2013;1859. doi: 10.3390/curroncol30020143</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/curroncol30020143</ArticleId><ArticleId IdType="pmc">PMC9955401</ArticleId><ArticleId IdType="pubmed">36826104</ArticleId></ArticleIdList></Reference><Reference><Citation>Prince RM, Atenafu EG, Krzyzanowska MK. Hospitalizations During Systemic Therapy for Metastatic Lung Cancer: A Systematic Review of Real World vs Clinical Trial Outcomes. JAMA Oncol. 2015. Dec;1(9):1333&#x2013;9. doi: 10.1001/jamaoncol.2015.3440</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2015.3440</ArticleId><ArticleId IdType="pubmed">26378774</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Franco A, Hodgson C, Raja H, Carter M, Lindsay C, Hughes S, Cove-Smith L, Taylor P, Summers Y, Blackhall F, Califano R. Real-World Data on Pembrolizumab for Pretreated Non-Small-Cell Lung Cancer: Clinical Outcome and Relevance of the Lung Immune Prognostic Index. Target Oncol. 2022. Jul;17(4):453&#x2013;465. doi: 10.1007/s11523-022-00889-8 Epub 2022 Jul 4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11523-022-00889-8</ArticleId><ArticleId IdType="pubmed">35781861</ArticleId></ArticleIdList></Reference><Reference><Citation>Heudel P, Favier B, Assaad S, Zrounba P, Blay JY.Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients. Ann Oncol. 2021. Nov;32(11):1443&#x2013;1444. doi: 10.1016/j.annonc.2021.07.012 Epub 2021 Jul 30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annonc.2021.07.012</ArticleId><ArticleId IdType="pmc">PMC8321960</ArticleId><ArticleId IdType="pubmed">34333128</ArticleId></ArticleIdList></Reference><Reference><Citation>Heudel P, Favier B, Solodky ML, Assaad S, Chaumard N, Tredan O, Bachelot T, Ray-Coquard I, Russias B, Fournier ML, Mastroianni B, Avrillon V, Michallet AS, Zrounba P, Chabaud S, Perol D, Blay JY.Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients. Eur J Cancer. 2022. Apr;165:174&#x2013;183. doi: 10.1016/j.ejca.2022.01.035 Epub 2022 Feb 10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejca.2022.01.035</ArticleId><ArticleId IdType="pmc">PMC8828434</ArticleId><ArticleId IdType="pubmed">35245864</ArticleId></ArticleIdList></Reference><Reference><Citation>Heudel PE, Fervers B, Durand T, Chabaud S, Michallet AS, Gomez F, Rivoire M, Bachelot T, Claude L, Chassagne-Clement C, Pilleul F, Mognetti T, Russias B, Soubirou JL, Chvetzoff G, P&#xe9;rol D, Blay JY. Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer center. Int J Clin Oncol. 2021. Oct;26(10):1793&#x2013;1804. doi: 10.1007/s10147-021-01963-3 Epub 2021 Jun 5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10147-021-01963-3</ArticleId><ArticleId IdType="pubmed">34091824</ArticleId></ArticleIdList></Reference><Reference><Citation>Heudel P, Chabaud S, Perol D, Ray-Coquard I, Blay JY.Reduced risk of second primary cancer in patients treated with immune checkpoint inhibitors for a first cancer. Ann Oncol. 2020. Dec;31(12):1773&#x2013;1775. doi: 10.1016/j.annonc.2020.09.001 Epub 2020 Sep 9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annonc.2020.09.001</ArticleId><ArticleId IdType="pubmed">32916266</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuggia M, Combes S. The French Health Data Hub and the German Medical Informatics Initiatives: Two National Projects to Promote Data Sharing in Healthcare. Yearb Med Inform. 2019. Aug;28(1):195&#x2013;202. doi: 10.1055/s-0039-1677917 Epub 2019 Aug 16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-1677917</ArticleId><ArticleId IdType="pmc">PMC6697511</ArticleId><ArticleId IdType="pubmed">31419832</ArticleId></ArticleIdList></Reference><Reference><Citation>DEEPSARC. Available online: https://www.health-data-hub.fr/partenariats/deepsarc. Accessed on August 2023</Citation></Reference><Reference><Citation>Health data hub. Available online: https://www.health-data-hub.fr/actualites/le-centre-leon-berard-inria-et-sanofi-sassocient-avec-le-health-data-hub-pour-mieux. Accessed on August 2023</Citation></Reference><Reference><Citation>UNIBASE. Available online https://www.centreleonberard.fr/institution/actualites/2-projets-de-recherche-du-centre-leon-berard-laureats-dunibase. Accessed on August 2023</Citation></Reference><Reference><Citation>Ogier du Terrail J, Leopold A, Joly C, B&#xe9;guier C, Andreux M, Maussion C, Schmauch B, Tramel EW, Bendjebbar E, Zaslavskiy M, Wainrib G, Milder M, Gervasoni J, Guerin J, Durand T, Livartowski A, Moutet K, Gautier C, Djafar I, Moisson AL, Marini C, Galtier M, Balazard F, Dubois R, Moreira J, Simon A, Drubay D, Lacroix-Triki M, Franchet C, Bataillon G, Heudel PE. Federated learning for predicting histological response to neoadjuvant chemotherapy in triple-negative breast cancer.Nat Med. 2023. Jan;29(1):135&#x2013;146. doi: 10.1038/s41591-022-02155-w Epub 2023 Jan 19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02155-w</ArticleId><ArticleId IdType="pubmed">36658418</ArticleId></ArticleIdList></Reference><Reference><Citation>Galateau Salle F, Le Stang N, Tirode F, Courtiol P, Nicholson AG, Tsao MS, Tazelaar HD, Churg A, Dacic S, Roggli V, Pissaloux D, Maussion C, Moarii M, Beasley MB, Begueret H, Chapel DB, Copin MC, Gibbs AR, Klebe S, Lantuejoul S, Nabeshima K, Vignaud JM, Attanoos R, Brcic L, Capron F, Chirieac LR, Damiola F, Sequeiros R, Cazes A, Damotte D, Foulet A, Giusiano-Courcambeck S, Hiroshima K, Hofman V, Husain AN, Kerr K, Marchevsky A, Paindavoine S, Picquenot JM, Rouquette I, Sagan C, Sauter J, Thivolet F, Brevet M, Rouvier P, Travis WD, Planchard G, Weynand B, Clozel T, Wainrib G, Fernandez-Cuesta L, Pairon JC, Rusch V, Girard N.Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center. J Thorac Oncol. 2020. Jun;15(6):1037&#x2013;1053. doi: 10.1016/j.jtho.2020.01.025 Epub 2020 Mar 9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtho.2020.01.025</ArticleId><ArticleId IdType="pmc">PMC8864581</ArticleId><ArticleId IdType="pubmed">32165206</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer MA, Moesel C. Interoperability with multiple Fast Healthcare Interoperability Resources (FHIR) profiles and versions. JAMIA Open. 2023. Feb 7;6(1):ooad001. doi: 10.1093/jamiaopen/ooad001 eCollection 2023 Apr.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamiaopen/ooad001</ArticleId><ArticleId IdType="pmc">PMC9904180</ArticleId><ArticleId IdType="pubmed">36762126</ArticleId></ArticleIdList></Reference><Reference><Citation>Frid S, Pastor Duran X, Bracons Cuc&#xf3; G, Pedrera-Jim&#xe9;nez M, Serrano-Balazote P, Mu&#xf1;oz Carrero A, Lozano-Rub&#xed; R. An Ontology-Based Approach for Consolidating Patient Data Standardized With European Norm/International Organization for Standardization 13606 (EN/ISO 13606) Into Joint Observational Medical Outcomes Partnership (OMOP) Repositories: Description of a Methodology. JMIR Med Inform. 2023. Mar 8;11:e44547. doi: 10.2196/44547</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/44547</ArticleId><ArticleId IdType="pmc">PMC10034609</ArticleId><ArticleId IdType="pubmed">36884279</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwala V, Khozin S, Singal G, O&#x2019;Connell C, Kuk D, Li G, Gossai A, Miller V, Abernethy AP.Real-World Evidence In Support Of Precision Medicine: Clinico-Genomic Cancer Data As A Case Study. Health Aff (Millwood). 2018. May;37(5):765&#x2013;772. doi: 10.1377/hlthaff.2017.1579</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2017.1579</ArticleId><ArticleId IdType="pubmed">29733723</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Symons J, Agapow P, Teo JT, Paxton CA, Abdi J, Mattie H, Davie C, Torres AZ, Folarin A, Sood H, Celi LA, Halamka J, Eapen S, Budhdeo S. Best practices in the real-world data life cycle. PLOS Digit Health. 2022. Jan 18;1(1):e0000003. doi: 10.1371/journal.pdig.0000003 eCollection 2022 Jan.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pdig.0000003</ArticleId><ArticleId IdType="pmc">PMC9931348</ArticleId><ArticleId IdType="pubmed">36812509</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovera G, Fariselli P, Deandreis D. Development of a REDCap-based workflow for high-volume relational data analysis on real-time data in a medical department using open source software. Comput Methods Programs Biomed. 2022. Nov;226:107111. doi: 10.1016/j.cmpb.2022.107111 Epub 2022 Sep 6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2022.107111</ArticleId><ArticleId IdType="pubmed">36108572</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung T, Lugiano D, Chambers R, et al. Defining a Data Strategy for Health Care: A Practitioner&#x2019;s Guide. Journal of Healthcare Information Management. 2021;35(1):3&#x2013;9.</Citation></Reference><Reference><Citation>Bentzen HB, Olav HK, Ursin G.Maximizing the GDPR potential for data transfers: first in Europe. Lancet Reg Health Eur. 2023. Mar 6;27:100600. doi: 10.1016/j.lanepe.2023.100600 eCollection 2023 Apr.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100600</ArticleId><ArticleId IdType="pmc">PMC10009713</ArticleId><ArticleId IdType="pubmed">36923519</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawlor RT.The impact of GDPR on data sharing for European cancer research. Lancet Oncol. 2023. Jan;24(1):6&#x2013;8. doi: 10.1016/S1470-2045(22)00653-2 Epub 2022 Nov 16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(22)00653-2</ArticleId><ArticleId IdType="pubmed">36400103</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabetta M, Alloni A, Polce F, Lanzola G, Parimbelli E, Barbarini N.Development of a FHIR Layer on Top of the OMOP Common Data Model for the CAPABLE Project. Stud Health Technol Inform. 2021. Nov 18;287:28&#x2013;29. doi: 10.3233/SHTI210804</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI210804</ArticleId><ArticleId IdType="pubmed">34795073</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38222329</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2023</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Mapping Clinical Documents to the <i>Logical Observation Identifiers, Names and Codes</i> (LOINC) Document Ontology using Electronic Health Record Systems Structured Metadata.</ArticleTitle><Pagination><StartPage>1017</StartPage><EndPage>1026</EndPage><MedlinePgn>1017-1026</MedlinePgn></Pagination><Abstract><AbstractText>As Electronic Health Record (EHR) systems increase in usage, organizations struggle to maintain and categorize clinical documentation so it can be used for clinical care and research. While prior research has often employed natural language processing techniques to categorize free text documents, there are shortcomings relative to computational scalability and the lack of key metadata within notes' text. This study presents a framework that can allow institutions to map their notes to the LOINC document ontology using a Bag of Words approach. After preliminary manual value- set mapping, an automated pipeline that leverages key dimensions of metadata from structured EHR fields aligns the notes with the dimensions of the document ontology. This framework resulted in 73.4% coverage of EHR documents, while also mapping 132 million notes in less than 2 hours; an order of magnitude more efficient than NLP based methods.</AbstractText><CopyrightInformation>&#xa9;2023 AMIA - All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Huzaifa</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>MU Institute of Data Science and Informatics, University of Missouri-Columbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Management and Informatics, School of Medicine, University of Missouri-Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosa</LastName><ForeName>Abu Saleh Mohammad</ForeName><Initials>ASM</Initials><AffiliationInfo><Affiliation>Department of Health Management and Informatics, School of Medicine, University of Missouri-Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paka</LastName><ForeName>Vyshnavi</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Health Management and Informatics, School of Medicine, University of Missouri-Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rana</LastName><ForeName>Md Kamruz Zaman</ForeName><Initials>MKZ</Initials><AffiliationInfo><Affiliation>Department of Health Management and Informatics, School of Medicine, University of Missouri-Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandhadi</LastName><ForeName>Vasanthi</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Health Management and Informatics, School of Medicine, University of Missouri-Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Islam</LastName><ForeName>Soliman</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health Management and Informatics, School of Medicine, University of Missouri-Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Consortium, Natural Language Processing Working Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McClay</LastName><ForeName>James C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Health Management and Informatics, School of Medicine, University of Missouri-Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarker</LastName><ForeName>Sraboni</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Electrical and Computer Science, School of Engineering, University of Missouri-Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Praveen</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Electrical and Computer Science, School of Engineering, University of Missouri-Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waitman</LastName><ForeName>Lemuel R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Department of Health Management and Informatics, School of Medicine, University of Missouri-Columbia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 DK092950</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039703" MajorTopicYN="Y">Logical Observation Identifiers Names and Codes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071253" MajorTopicYN="N">Metadata</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004282" MajorTopicYN="N">Documentation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>15</Day><Hour>4</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38222329</ArticleId><ArticleId IdType="pmc">PMC10785913</ArticleId><ArticleId IdType="pii">1116</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Frazier P, Rossi-Mori A, Dolin RH, Alschuler L, Huff SM. The creation of an ontology of clinical document names . Studies in Health Technology and Informatics. 2001;84:94&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11604713</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyun S, Ventura R, Johnson SB, Bakken S. Is the Health Level 7/LOINC document ontology adequate for representing nursing documents? Studies in health technology and informatics. 2006;122:527&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">17102314</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyun S, Shapiro JS, Melton G, Schlegel C, Stetson PD, Johnson SB, et al. Iterative evaluation of the health level 7-logical observation identifiers names and codes clinical document ontology for representing Clinical Document Names: A case report. Journal of the American Medical Informatics Association. 2009;16(3):395&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2732231</ArticleId><ArticleId IdType="pubmed">19261945</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong IC, Rijnbeek PR, Van Der Lei J. InMEDINFO 2015: eHealth-enabled Health. IOS Press; 2015. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers; pp. pp. 574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Qualls LG, Phillips TA, Hammill BG, Topping J, Louzao DM, Brown JS, Curtis LH, Marsolo K. Evaluating foundational data quality in the national patient-centered clinical research network (PCORnet&#xae;) Egems. 2018;6(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5983028</ArticleId><ArticleId IdType="pubmed">29881761</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson AR, Bodenreider O, Demner-Fushman D, Wah Fung K, Lee VK, Mork JG, et al. From indexing the biomedical literature to coding clinical text: experience with MTI and machine learning approaches. Proceedings of the Workshop on BioNLP 2007 Biological, Translational, and Clinical Language Processing. 2007. pp. 105&#x2013;12.</Citation></Reference><Reference><Citation>Parr SK, Shotwell MS, Jeffery AD, Lasko TA, Matheny ME. Automated mapping of laboratory tests to LOINC codes using noisy labels in a National Electronic Health Record System Database. Journal of the American Medical Informatics Association. 2018;25(10):1292&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7646911</ArticleId><ArticleId IdType="pubmed">30137378</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo X., Li J., Zhao B., Zhou Y., Dong X., Duke J., Natarajan K., Hripcsak G., Shah N., Banda J. M., Reeves R., Miller T., Xu H. Normalizing Clinical Document Titles to LOINC Document Ontology: an Initial Study. AMIA ... Annual Symposium proceedings. AMIA Symposium. 2021;2020:1441&#x2013;1450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8075502</ArticleId><ArticleId IdType="pubmed">33936520</ArticleId></ArticleIdList></Reference><Reference><Citation>Shraboni Sarker, Md Kamruz Zaman Rana, Yahia Mohamed, Vasanti Mandhadi, Xing Song, Abu S, Mosa M., Waitman Russ, Rao Praveen. AMIA 2022 Annual Symposium. Washington, D.C.: 2022. &#x201c;Mapping Clinical Notes to LOINC Document Ontology Using EHR Data.&#x201d;. Poster.</Citation></Reference><Reference><Citation>Vreeman DJ, McDonald CJ. A Comparison of Intelligent Mapper and Document Similarity Scores for Mapping Local Radiology Terms to LOINC. AMIA Annual Symposium proceedings. 2006. pp. 809&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1839677</ArticleId><ArticleId IdType="pubmed">17238453</ArticleId></ArticleIdList></Reference><Reference><Citation>Juluru K, Shih H-H, Keshava Murthy KN, Elnajjar P. Bag-of-words technique in natural language processing: A Primer for radiologists. RadioGraphics. 2021;41(5):1420&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8415041</ArticleId><ArticleId IdType="pubmed">34388050</ArticleId></ArticleIdList></Reference><Reference><Citation>Pires R, Jelinek HF, Wainer J, Valle E, Rocha A. Advancing bag-of-visual-words representations for lesion classification in retinal images. PLoS ONE. 2014;9(6)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4041723</ArticleId><ArticleId IdType="pubmed">24886780</ArticleId></ArticleIdList></Reference><Reference><Citation>HaCohen-Kerner Y, Miller D, Yigal Y. The influence of preprocessing on text classification using a bag-of-words representation. PLOS ONE. 2020;15(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194364</ArticleId><ArticleId IdType="pubmed">32357164</ArticleId></ArticleIdList></Reference><Reference><Citation>Waitman LR, Aaronson LS, Nadkarni PM, Connolly DW, Campbell JR. The Greater Plains Collaborative: a PCORnet Clinical Research Data Network. J Am Med Inform Assoc. 2014 Jul-Aug;21(4):637&#x2013;41. doi: 10.1136/amiajnl-2014-002756. Epub 2014 Apr 28. PMID: 24778202; PMCID: PMC4078294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078294</ArticleId><ArticleId IdType="pubmed">24778202</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38222375</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2023</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Computational Phenotyping of OMOP CDM Normalized EHR for Prenatal and Postpartum Episodes: An Informatics Framework and Clinical Implementation on All of Us.</ArticleTitle><Pagination><StartPage>1096</StartPage><EndPage>1104</EndPage><MedlinePgn>1096-1104</MedlinePgn></Pagination><Abstract><AbstractText>The use of Electronic Health Records (EHR) in pregnancy care and obstetrics-gynecology (OB/GYN) research has increased in recent years. In pregnancy, timing is important because clinical characteristics, risks, and patient management are different in each stage of pregnancy. However, the difficulty of accurately differentiating pregnancy episodes and temporal information of clinical events presents unique challenges for EHR phenotyping. In this work, we introduced the concept of time relativity and proposed a comprehensive framework of computational phenotyping for prenatal and postpartum episodes based on the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). We implemented it on the All of Us national EHR database and identified 6,280 pregnancies with accurate start and end dates among 5,399 female patients. With the ability to identify different episodes in pregnancy care, this framework provides new opportunities for phenotyping complex clinical events and gestational morbidities for pregnant women, thus improving maternal and infant health.</AbstractText><CopyrightInformation>&#xa9;2023 AMIA - All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lyu</LastName><ForeName>Tianchu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of South Carolina, Columbia, South Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of South Carolina, Columbia, South Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institutes of Health, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OT2 OD026556</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U2C OD023196</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD025315</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026551</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 OD023121</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026552</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026549</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD025337</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD025277</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026555</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026550</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026553</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD023205</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD025276</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026557</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026554</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 OD023163</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD023206</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 OD023176</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026548</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075485" MajorTopicYN="Y">Population Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048088" MajorTopicYN="N">Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049590" MajorTopicYN="N">Postpartum Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>15</Day><Hour>4</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38222375</ArticleId><ArticleId IdType="pmc">PMC10785883</ArticleId><ArticleId IdType="pii">1162</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>CDC  Pregnancy mortality surveillance system 2022 [updated June 22, 2022.  Available from:  https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mortality-surveillance-system.htm.</Citation></Reference><Reference><Citation>Hoyert DL. Maternal mortality rates in the United States, 2020. 2022.</Citation></Reference><Reference><Citation>Brewer SE, Barnard J, Pyrzanowski J, O&#x2019;Leary ST, Dempsey AF. Use of Electronic Health Records to Improve Maternal Vaccination. Women&#x2019;s Health Issues. 2019;29(4):341&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31186144</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao C, Osmundson S, Yan X, Edwards DV, Malin BA, Chen Y. Learning to Identify Severe Maternal Morbidity from Electronic Health Records. Stud Health Technol Inform. 2019;264:143&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337420</ArticleId><ArticleId IdType="pubmed">31437902</ArticleId></ArticleIdList></Reference><Reference><Citation>Huennekens K, Oot A, Lantos E, Yee LM, Feinglass J. Using Electronic Health Record and Administrative Data to Analyze Maternal and Neonatal Delivery Complications. The Joint Commission Journal on Quality and Patient Safety. 2020;46(11):623&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">32921579</ArticleId></ArticleIdList></Reference><Reference><Citation>Shara N, Anderson KM, Falah N, Ahmad MF, Tavazoei D, Hughes JM, et al. Early Identification of Maternal Cardiovascular Risk Through Sourcing and Preparing Electronic Health Record Data: Machine Learning Study. JMIR Med Inform. 2022;10(2):e34932.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8874927</ArticleId><ArticleId IdType="pubmed">35142637</ArticleId></ArticleIdList></Reference><Reference><Citation>Syed S, Gonzalez-Izquierdo A, Allister J, Feder G, Li L, Gilbert R. Identifying adverse childhood experiences with electronic health records of linked mothers and children in England: a multistage development and validation study. The Lancet Digital Health. 2022;4(7):e482&#x2013;e96.</Citation><ArticleIdList><ArticleId IdType="pubmed">35595677</ArticleId></ArticleIdList></Reference><Reference><Citation>Angras K, Boyd VE, Gray C, Young AJ, Paglia MJ, Mackeen AD. Retrospective application of algorithms to improve identification of pregnancy outcomes from the electronic health record. Journal of Perinatology. 2023;43(1):10&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">36050515</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu T, Liang C, Liu J, Hung P, Zhang J, Campbell B, et al. Risk for Stillbirth among Pregnant Individuals with SARS-CoV-2 Infection Varied by Gestational Age. American Journal of Obstetrics and Gynecology. 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9970919</ArticleId><ArticleId IdType="pubmed">36858096</ArticleId></ArticleIdList></Reference><Reference><Citation>Meghea CI, Corser W, You Z. Electronic Medical Record Use and Maternal and Child Care and Health. Maternal and Child Health Journal. 2016;20(4):819&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">26676978</ArticleId></ArticleIdList></Reference><Reference><Citation>Canel&#xf3;n SP, Burris HH, Levine LD, Boland MR. Development and evaluation of MADDIE: Method to Acquire Delivery Date Information from Electronic health records. International Journal of Medical Informatics. 2021;145:104339.</Citation><ArticleIdList><ArticleId IdType="pubmed">33232918</ArticleId></ArticleIdList></Reference><Reference><Citation>Artzi NS, Shilo S, Hadar E, Rossman H, Barbash-Hazan S, Ben-Haroush A, et al. Prediction of gestational diabetes based on nationwide electronic health records. Nature medicine. 2020;26(1):71&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">31932807</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao C, Osmundson S, Edwards DRV, Jackson GP, Malin BA, Chen Y. Deep learning predicts extreme preterm birth from electronic health records. Journal of biomedical informatics. 2019;100:103334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6899197</ArticleId><ArticleId IdType="pubmed">31678588</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu H, Yu H-Y, Wang L-Y, Yao Q, Wu S-N, Yin C, et al. Electronic Health Record Driven Prediction for Gestational Diabetes Mellitus in Early Pregnancy. Scientific Reports. 2017;7(1):16417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5703904</ArticleId><ArticleId IdType="pubmed">29180800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar M. Development of National and Sub-national Electronic Health Records to Enable Health Data Exchange for Improved Maternal Health Service Delivery and Program: The Case of a Tertiary Care State Government Hospital in India. 2021.</Citation></Reference><Reference><Citation>Salam RA, Lassi ZS, Das JK, Bhutta ZA. Evidence from district level inputs to improve quality of care for maternal and newborn health: interventions and findings. Reproductive Health. 2014;11(2):S3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4160920</ArticleId><ArticleId IdType="pubmed">25208460</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang L, Gu H, Ye S, Xu B, Jing K, Zhang N, et al. Rural&#x2013;urban disparities in caesarean section rates in minority areas in China: evidence from electronic health records. Journal of International Medical Research. 2020;48(2):0300060519877996.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7607187</ArticleId><ArticleId IdType="pubmed">31566034</ArticleId></ArticleIdList></Reference><Reference><Citation>The Potential for Health Information Technology Tools to Reduce Racial Disparities in Maternal Morbidity and Mortality. Journal of Women&#x2019;s Health. 2021;30(2):274&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8020554</ArticleId><ArticleId IdType="pubmed">33211604</ArticleId></ArticleIdList></Reference><Reference><Citation>Patzelt EH, Hartley CA, Gershman SJ. Computational Phenotyping: Using Models to Understand Individual Differences in Personality, Development, and Mental Illness. Personal Neurosci. 2018;1:e18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7219680</ArticleId><ArticleId IdType="pubmed">32435735</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Z, Deng Y, Li X, Naumann T, Luo Y. Natural language processing for EHR-based computational phenotyping. IEEE/ACM transactions on computational biology and bioinformatics. 2018;16(1):139&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6388621</ArticleId><ArticleId IdType="pubmed">29994486</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ. Next-generation phenotyping of electronic health records. Journal of the American Medical Informatics Association. 2013;20(1):117&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Smoller JW. The use of electronic health records for psychiatric phenotyping and genomics. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2018;177(7):601&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6440216</ArticleId><ArticleId IdType="pubmed">28557243</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Varghese P, Stephenson E, Tu K, Gronsbell J. Machine learning approaches for electronic health records phenotyping: a methodical review. Journal of the American Medical Informatics Association. 2023;30(2):367&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9846699</ArticleId><ArticleId IdType="pubmed">36413056</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham A, Le B, Kosti I, Straub P, Velez-Edwards DR, Davis LK, et al. Dense phenotyping from electronic health records enables machine learning-based prediction of preterm birth. BMC medicine. 2022;20(1):333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9516830</ArticleId><ArticleId IdType="pubmed">36167547</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson L, Boland MR. Towards deep phenotyping pregnancy: a systematic review on artificial intelligence and machine learning methods to improve pregnancy outcomes. Briefings in Bioinformatics. 2021;22(5):bbaa369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8424395</ArticleId><ArticleId IdType="pubmed">33406530</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu T, Liang C, Liu J, Campbell B, Hung P, Shih Y-W, et al. Temporal events detector for pregnancy care (TED-PC): a rule-based algorithm to infer gestational age and delivery date from electronic health records of pregnant women with and without COVID-19. PloS one. 2022;17(10):e0276923.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9621451</ArticleId><ArticleId IdType="pubmed">36315520</ArticleId></ArticleIdList></Reference><Reference><Citation>APA  Calculating Conception.  [Available from:  https://americanpregnancy.org/getting-pregnant/calculating-conception/#:~:text=For%20a%20woman%20with%20a,day%20of%20the%20last%20period.</Citation></Reference><Reference><Citation>Li F, Du J, He Y, Song H-Y, Madkour M, Rao G, et al. Time event ontology (TEO): to support semantic representation and reasoning of complex temporal relations of clinical events. Journal of the American Medical Informatics Association. 2020;27(7):1046&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7647306</ArticleId><ArticleId IdType="pubmed">32626903</ArticleId></ArticleIdList></Reference><Reference><Citation>The &#x201c;All of Us&#x201d; Research Program. New England Journal of Medicine. 2019;381(7):668&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8291101</ArticleId><ArticleId IdType="pubmed">31412182</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang C, Gong Y, editors. On Building an Ontological Knowledge Base for Managing Patient Safety Events. MedInfo. 2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">26262039</ArticleId></ArticleIdList></Reference><Reference><Citation>Amith M, Manion F, Liang C, Harris M, Wang D, He Y, et al., editors. 2018 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) IEEE; 2018. OntoKeeper: Semiotic-driven ontology evaluation tool for biomedical ontologists.</Citation></Reference><Reference><Citation>Rea S, Pathak J, Savova G, Oniki TA, Westberg L, Beebe CE, et al. Building a robust, scalable and standards-driven infrastructure for secondary use of EHR data: the SHARPn project. Journal of biomedical informatics. 2012;45(4):763&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4905766</ArticleId><ArticleId IdType="pubmed">22326800</ArticleId></ArticleIdList></Reference><Reference><Citation>Gehrmann S, Dernoncourt F, Li Y, Carlson ET, Wu JT, Welt J, et al. Comparing rule-based and deep learning models for patient phenotyping. arXiv preprint arXiv:170308705. 2017.</Citation></Reference><Reference><Citation>Banda JM, Seneviratne M, Hernandez-Boussard T, Shah NH. Advances in electronic phenotyping: from rule-based definitions to machine learning models. Annual review of biomedical data science. 2018;1:53&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6583807</ArticleId><ArticleId IdType="pubmed">31218278</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38222429</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2023</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Standardizing Multi-site Clinical Note Titles to LOINC Document Ontology: A Transformer-based Approach.</ArticleTitle><Pagination><StartPage>834</StartPage><EndPage>843</EndPage><MedlinePgn>834-843</MedlinePgn></Pagination><Abstract><AbstractText>The types of clinical notes in electronic health records (EHRs) are diverse and it would be great to standardize them to ensure unified data retrieval, exchange, and integration. The LOINC Document Ontology (DO) is a subset of LOINC that is created specifically for naming and describing clinical documents. Despite the efforts of promoting and improving this ontology, how to efficiently deploy it in real-world clinical settings has yet to be explored. In this study we evaluated the utility of LOINC DO by mapping clinical note titles collected from five institutions to the LOINC DO and classifying the mapping into three classes based on semantic similarity between note t<i>itl</i>es and LOINC DO codes. Additionally, we developed a standardization pipeline that automatically maps clinical note titles from multiple sites to suitable LOINC DO codes, without accessing the content of clinical notes. The pipeline can be initialized with different large language models, and we compared the performances between them. The results showed that our automated pipeline achieved an accuracy of 0.90. By comparing the manual and automated mapping results, we analyzed the coverage of LOINC DO in describing multi-site clinical note titles and summarized the potential scope for extension.</AbstractText><CopyrightInformation>&#xa9;2023 AMIA - All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zuo</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yujia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duke</LastName><ForeName>Jon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Georgia Institute of Technology, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Consortium, Natural Language Processing Working Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Columbia University, New York City, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Consortium, Natural Language Processing Working Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Consortium, Natural Language Processing Working Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Georgia State University, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Consortium, Natural Language Processing Working Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reeves</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Consortium, Natural Language Processing Working Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Boston Children's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Consortium, Natural Language Processing Working Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waitman</LastName><ForeName>Lemuel R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>University of Missouri, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Columbia University, New York City, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Consortium, Natural Language Processing Working Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Consortium, Natural Language Processing Working Group.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG080429</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG072799</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U2C OD023196</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039703" MajorTopicYN="Y">Logical Observation Identifiers Names and Codes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012660" MajorTopicYN="N">Semantics</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Dr. Hua Xu has research-related financial interests in Melax Technologies, Inc.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>15</Day><Hour>4</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38222429</ArticleId><ArticleId IdType="pmc">PMC10785935</ArticleId><ArticleId IdType="pii">917</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jensen PB, Jensen LJ, Brunak S. Mining electronic health records: towards better research applications and clinical care. Nat Rev Genet. 2012 Jun;13(6):395&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">22549152</ArticleId></ArticleIdList></Reference><Reference><Citation>Apathy NC, Vest JR, Adler-Milstein J, Blackburn J, Dixon BE, Harle CA. Practice and market factors associated with provider volume of health information exchange. Journal of the American Medical Informatics Association. 2021 Jul 14;28(7):1451&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8279783</ArticleId><ArticleId IdType="pubmed">33674854</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics (OHDSI))  Standardized Data: The OMOP Common Data Model [Internet] [cited 2023 Mar 19].  Available from:  https://www.ohdsi.org/data-standardization/</Citation></Reference><Reference><Citation>Regenstrief Institute, Inc.  LOINC Document Ontology [Internet] LOINC Document Ontology. 2023 [cited 2023 Mar 18].  Available from:  https://loinc.org/document-ontology/</Citation></Reference><Reference><Citation>Li L, Morrey CP, Baorto D. Cross-mapping clinical notes between hospitals: an application of the LOINC Document Ontology. AMIA Annu Symp Proc. 2011;2011:777&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243240</ArticleId><ArticleId IdType="pubmed">22195135</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen ES, Melton GB, Engelstad ME, Sarkar IN. Standardizing Clinical Document Names Using the HL7/LOINC Document Ontology and LOINC Codes. AMIA Annu Symp Proc. 2010 Nov 13;2010:101&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041326</ArticleId><ArticleId IdType="pubmed">21346949</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyun S, Bakken S. Toward the creation of an ontology for nursing document sections: mapping section names to the LOINC semantic model. AMIA Annu Symp Proc. 2006;2006:364&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1839622</ArticleId><ArticleId IdType="pubmed">17238364</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Pakhomov S, Dale JL, Chen ES, Melton GB. Application of HL7/LOINC Document Ontology to a University-Affiliated Integrated Health System Research Clinical Data Repository. AMIA Jt Summits Transl Sci Proc. 2014;2014:230&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419769</ArticleId><ArticleId IdType="pubmed">25954591</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajamani S, Chen ES, Akre ME, Wang Y, Melton GB. Assessing the adequacy of the HL7/LOINC Document Ontology Role axis. Journal of the American Medical Informatics Association. 2015 May 1;22(3):615&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901117</ArticleId><ArticleId IdType="pubmed">25352569</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajamani S, Chen ES, Wang Y, Melton GB. Extending the HL7/LOINC Document Ontology Settings of Care. AMIA Annu Symp Proc. 2014;2014:994&#x2013;1001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419877</ArticleId><ArticleId IdType="pubmed">25954408</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves RM, FitzHenry F, Brown SH, Kotter K, Gobbel GT, Montella D, et al. Who said it? Establishing professional attribution among authors of Veterans&#x2019; Electronic Health Records. AMIA Annu Symp Proc. 2012;2012:753&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3540586</ArticleId><ArticleId IdType="pubmed">23304349</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo X, Li J, Zhao B, Zhou Y, Dong X, Duke J, et al. Normalizing Clinical Document Titles to LOINC Document Ontology: an Initial Study. AMIA Annu Symp Proc. 2020;2020:1441&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8075502</ArticleId><ArticleId IdType="pubmed">33936520</ArticleId></ArticleIdList></Reference><Reference><Citation>French E, McInnes BT. An overview of biomedical entity linking throughout the years. Journal of Biomedical Informatics. 2023 Jan;137:104252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9845184</ArticleId><ArticleId IdType="pubmed">36464228</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson S, Zaragoza H. The Probabilistic Relevance Framework: BM25 and Beyond. FNT in Information Retrieval. 2009;3(4):333&#x2013;89.</Citation></Reference><Reference><Citation>Liu T-Y. Learning to Rank for Information Retrieval. FNT in Information Retrieval. 2007;3(3):225&#x2013;331.</Citation></Reference><Reference><Citation>Devlin J, Chang M-W, Lee K, Toutanova K. BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding. arXiv:181004805 [cs] [Internet] 2019 May 24 [cited 2021 Dec 14].  Available from:  http://arxiv.org/abs/1810.04805.</Citation></Reference><Reference><Citation>Devlin J, Chang M-W, Lee K, Toutanova K. BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding. 2018 [cited 2023 Mar 18].  Available from:  https://arxiv.org/abs/1810.04805.</Citation></Reference><Reference><Citation>Lee J, Yoon W, Kim S, Kim D, Kim S, So CH, et al. Wren J, editor. BioBERT: a pre-trained biomedical language representation model for biomedical text mining. Bioinformatics. 2020 Feb 15;36(4):1234&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7703786</ArticleId><ArticleId IdType="pubmed">31501885</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K, Altosaar J, Ranganath R. ClinicalBERT: Modeling Clinical Notes and Predicting Hospital Readmission. 2019 [cited 2023 Mar 18].  Available from:  https://arxiv.org/abs/1904.05342.</Citation></Reference><Reference><Citation>Luo Y-F, Henry S, Wang Y, Shen F, Uzuner O, Rumshisky A. The 2019 n2c2/UMass Lowell shared task on clinical concept normalization. Journal of the American Medical Informatics Association. 2020 Oct 1;27(10):1529&#x2013;e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7647359</ArticleId><ArticleId IdType="pubmed">32968800</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Roberts K, Datta S, Du J, Ji Z, Si Y, et al. Deep learning in clinical natural language processing: a methodical review. Journal of the American Medical Informatics Association. 2020 Mar 1;27(3):457&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7025365</ArticleId><ArticleId IdType="pubmed">31794016</ArticleId></ArticleIdList></Reference><Reference><Citation>Tutubalina E, Kadurin A, Miftahutdinov Z.  Proceedings of the 28th International Conference on Computational Linguistics [Internet] Barcelona, Spain (Online): International Committee on Computational Linguistics; 2020 [cited 2023 Mar 19]. Fair Evaluation in Concept Normalization: a Large-scale Comparative Analysis for BERT-based Models; pp. p. 6710&#x2013;6. Available from:  https://aclanthology.org/2020.coling-main.588.</Citation></Reference><Reference><Citation>Ji Z, Wei Q, Xu H. BERT-based Ranking for Biomedical Entity Normalization. AMIA Jt Summits Transl Sci Proc. 2020 May 30;2020:269&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233044</ArticleId><ArticleId IdType="pubmed">32477646</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn S, Comeau DC, Kim W, Wilbur WJ. Abbreviation definition identification based on automatic precision estimates. BMC Bioinformatics. 2008 Dec;9(1):402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2576267</ArticleId><ArticleId IdType="pubmed">18817555</ArticleId></ArticleIdList></Reference><Reference><Citation>Reimers N, Gurevych I. Sentence-BERT: Sentence Embeddings using Siamese BERT-Networks. 2019 [cited 2023 Mar 18].  Available from:  https://arxiv.org/abs/1908.10084.</Citation></Reference><Reference><Citation>Gu Y, Tinn R, Cheng H, Lucas M, Usuyama N, Liu X, et al. Domain-Specific Language Model Pretraining for Biomedical Natural Language Processing. ACM Trans Comput Healthcare. 2022 Jan 31;3(1):1&#x2013;23.</Citation></Reference><Reference><Citation>Alsentzer E, Murphy JR, Boag W, Weng W-H, Jin D, Naumann T, et al.  Publicly Available Clinical BERT Embeddings. 2019 [cited 2023 Mar 18].  Available from:  https://arxiv.org/abs/1904.03323.</Citation></Reference><Reference><Citation>Cer D, Diab M, Agirre E, Lopez-Gazpio I, Specia L.  Proceedings of the 11th International Workshop on Semantic Evaluation (SemEval-2017) [Internet] Vancouver, Canada: Association for Computational Linguistics; 2017 [cited 2023 Mar 18]. SemEval-2017 Task 1: Semantic Textual Similarity Multilingual and Crosslingual Focused Evaluation; pp. p. 1&#x2013;14. Available from:  https://aclanthology.org/S17-2001.</Citation></Reference><Reference><Citation>Yanshan Wang, Afzal N, Sijia Liu, Rastegar-Mojarad M, Liwei Wang, Feichen Shen, et al.  Overview of BioCreative/OHNLP Challenge 2018 Task 2: Clinical Semantic Textual Similarity. 2018 [cited 2023 Mar 18].  Available from:  http://rgdoi.net/10.13140/RG.2.2.26682.24006.</Citation><ArticleIdList><ArticleId IdType="doi">10.13140/RG.2.2.26682.24006</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Fu S, Shen F, Henry S, Uzuner O, Liu H. The 2019 n2c2/OHNLP Track on Clinical Semantic Textual Similarity: Overview. JMIR Med Inform. 2020 Nov 27;8(11):e23375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7732706</ArticleId><ArticleId IdType="pubmed">33245291</ArticleId></ArticleIdList></Reference><Reference><Citation>So&#x11f;anc&#x131;o&#x11f;lu G, &#xd6;zt&#xfc;rk H, &#xd6;zg&#xfc;r A. BIOSSES: a semantic sentence similarity estimation system for the biomedical domain. Bioinformatics. 2017 Jul 15;33(14):i49&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5870675</ArticleId><ArticleId IdType="pubmed">28881973</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur N, Reimers N, Daxenberger J, Gurevych I. Augmented SBERT: Data Augmentation Method for Improving Bi-Encoders for Pairwise Sentence Scoring Tasks. 2020 [cited 2023 Mar 18].  Available from:  https://arxiv.org/abs/2010.08240.</Citation></Reference><Reference><Citation>All of Us Research Program Investigators. Denny JC, Rutter JL, Goldstein DB, Philippakis A, Smoller JW, et al. The &#x201c;All of Us&#x201d; Research Program. N Engl J Med. 2019 Aug 15;381(7):668&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8291101</ArticleId><ArticleId IdType="pubmed">31412182</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38235322</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1482-1826</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques</Title><ISOAbbreviation>J Pharm Pharm Sci</ISOAbbreviation></Journal><ArticleTitle>Comparing broad and narrow phenotype algorithms: differences in performance characteristics and immortal time incurred.</ArticleTitle><Pagination><StartPage>12095</StartPage><MedlinePgn>12095</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12095</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/jpps.2023.12095</ELocationID><Abstract><AbstractText><b>Introduction:</b> When developing phenotype algorithms for observational research, there is usually a trade-off between definitions that are sensitive or specific. The objective of this study was to estimate the performance characteristics of phenotype algorithms designed for increasing specificity and to estimate the immortal time associated with each algorithm. <b>Materials and methods:</b> We examined algorithms for 11 chronic health conditions. The analyses were from data from five databases. For each health condition, we created five algorithms to examine performance (sensitivity and positive predictive value (PPV)) differences: one broad algorithm using a single code for the health condition and four narrow algorithms where a second diagnosis code was required 1-30&#xa0;days, 1-90&#xa0;days, 1-365&#xa0;days, or 1- all days in a subject's continuous observation period after the first code. We also examined the proportion of immortal time relative to time-at-risk (TAR) for four outcomes. The TAR's were: 0-30&#xa0;days after the first condition occurrence (the index date), 0-90&#xa0;days post-index, 0-365&#xa0;days post-index, and 0-1,095&#xa0;days post-index. Performance of algorithms for chronic health conditions was estimated using PheValuator (V2.1.4) from the OHDSI toolstack. Immortal time was calculated as the time from the index date until the first of the following: 1) the outcome; 2) the end of the outcome TAR; 3) the occurrence of the second code for the chronic health condition. <b>Results:</b> In the first analysis, the narrow phenotype algorithms, i.e., those requiring a second condition code, produced higher estimates for PPV and lower estimates for sensitivity compared to the single code algorithm. In all conditions, increasing the time to the required second code increased the sensitivity of the algorithm. In the second analysis, the amount of immortal time increased as the window used to identify the second diagnosis code increased. The proportion of TAR that was immortal was highest in the 30&#xa0;days TAR analyses compared to the 1,095&#xa0;days TAR analyses. <b>Conclusion:</b> Attempting to increase the specificity of a health condition algorithm by adding a second code is a potentially valid approach to increase specificity, albeit at the cost of incurring immortal time.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Swerdel and Conover.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Swerdel</LastName><ForeName>Joel N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Global Epidemiology, Janssen Research and Development, Titusville, NJ, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conover</LastName><ForeName>Mitchell M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Global Epidemiology, Janssen Research and Development, Titusville, NJ, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Pharm Pharm Sci</MedlineTA><NlmUniqueID>9807281</NlmUniqueID><ISSNLinking>1482-1826</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038062" MajorTopicYN="Y">Upper Extremity Deformities, Congenital</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bias</Keyword><Keyword MajorTopicYN="N">immortal time</Keyword><Keyword MajorTopicYN="N">observational data</Keyword><Keyword MajorTopicYN="N">phenotype algorithms</Keyword><Keyword MajorTopicYN="N">validation</Keyword></KeywordList><CoiStatement>JS and MC are employees of Johnson and Johnson and own stock in the company.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>18</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38235322</ArticleId><ArticleId IdType="pmc">PMC10791821</ArticleId><ArticleId IdType="doi">10.3389/jpps.2023.12095</ArticleId><ArticleId IdType="pii">12095</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>O'Neal WT, Sandesara PB, Claxton JS, MacLehose RF, Chen LY, Bengtson LGS, et al. Influence of sociodemographic factors and provider specialty on anticoagulation prescription fill patterns and outcomes in atrial fibrillation. Am J Cardiol (2018) 122(3):388&#x2013;94. 10.1016/j.amjcard.2018.04.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2018.04.022</ArticleId><ArticleId IdType="pmc">PMC6215489</ArticleId><ArticleId IdType="pubmed">29961563</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson LE, Luo X, Li X, Mardekian J, Garcia Reeves AB, Skinner A. Clinical outcomes and treatment patterns among Medicare patients with nonvalvular atrial fibrillation (NVAF) and chronic kidney disease. PLoS One (2019) 14(11):e0225052. 10.1371/journal.pone.0225052</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0225052</ArticleId><ArticleId IdType="pmc">PMC6855694</ArticleId><ArticleId IdType="pubmed">31725743</ArticleId></ArticleIdList></Reference><Reference><Citation>Willey V, Franchino-Elder J, Fu AC, Wang C, Sander S, Tan H, et al. Treatment and persistence with oral anticoagulants among newly diagnosed patients with non-valvular atrial fibrillation: a retrospective observational study in a US commercially insured and medicare advantage population. BMJ Open (2018) 8(6):e020676. 10.1136/bmjopen-2017-020676</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-020676</ArticleId><ArticleId IdType="pmc">PMC6042605</ArticleId><ArticleId IdType="pubmed">29961012</ArticleId></ArticleIdList></Reference><Reference><Citation>Suissa S. Immortal time bias in pharmacoepidemiology. Am J Epidemiol (2008) 167(4):492&#x2013;9. 10.1093/aje/kwm324</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwm324</ArticleId><ArticleId IdType="pubmed">18056625</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal P, Moshier E, Ru M, Ohri N, Ennis R, Rosenzweig K, et al. Immortal time bias in observational studies of time-to-event outcomes: assessing effects of postmastectomy radiation therapy using the national cancer database. Cancer Control (2018) 25(1):107327481878935. 10.1177/1073274818789355</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073274818789355</ArticleId><ArticleId IdType="pmc">PMC6053873</ArticleId><ArticleId IdType="pubmed">30021466</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdel JN, Schuemie M, Murray G, Ryan PB. PheValuator 2.0: methodological improvements for the PheValuator approach to semi-automated phenotype algorithm evaluation. J Biomed Inform (2022) 135:104177. 10.1016/j.jbi.2022.104177</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2022.104177</ArticleId><ArticleId IdType="pubmed">35995107</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdel J, Conover M, editors. Comparing broad and narrow phenotype algorithms: differences in performance characteristics and immortal time incurred. Bethesda, MD: OHDSI Sympoium; (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10791821</ArticleId><ArticleId IdType="pubmed">38235322</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding BN, Weiss NS. Point: immortal time bias&#x2014;what are the determinants of its magnitude? Am J Epidemiol (2019) 188(6):1013&#x2013;5. 10.1093/aje/kwz067</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwz067</ArticleId><ArticleId IdType="pubmed">31155675</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe9;vesque LE, Hanley JA, Kezouh A, Suissa S. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ (2010) 340:b5087. 10.1136/bmj.b5087</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b5087</ArticleId><ArticleId IdType="pubmed">20228141</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Weinhandl ED, Gilbertson DT, Collins AJ, St Peter WL. Issues regarding &#x2018;immortal time' in the analysis of the treatment effects in observational studies. Kidney Int (2012) 81(4):341&#x2013;50. 10.1038/ki.2011.388</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.388</ArticleId><ArticleId IdType="pubmed">22089946</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang C, Seeger JD, Dore DD. Implications of immortal person-time when outcomes are nonfatal. Ann Epidemiol (2016) 26(3):212&#x2013;7. 10.1016/j.annepidem.2015.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annepidem.2015.12.004</ArticleId><ArticleId IdType="pubmed">26847051</ArticleId></ArticleIdList></Reference><Reference><Citation>Lash TL, Fox MP, Fink AK. Applying quantitative bias analysis to epidemiologic data. New York, NY: Springer; (2009).</Citation></Reference><Reference><Citation>Tyree PT, Lind BK, Lafferty WE. Challenges of using medical insurance claims data for utilization analysis. Am J Med Qual (2006) 21(4):269&#x2013;75. 10.1177/1062860606288774</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1062860606288774</ArticleId><ArticleId IdType="pmc">PMC1533763</ArticleId><ArticleId IdType="pubmed">16849784</ArticleId></ArticleIdList></Reference><Reference><Citation>Peabody JW, Luck J, Jain S, Bertenthal D, Glassman P. Assessing the accuracy of administrative data in health information systems. Med Care (2004) 42(11):1066&#x2013;72. 10.1097/00005650-200411000-00005</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-200411000-00005</ArticleId><ArticleId IdType="pubmed">15586833</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdel JN, Hripcsak G, Ryan PB. PheValuator: development and evaluation of a phenotype algorithm evaluator. J Biomed Inform (2019) 97:103258. 10.1016/j.jbi.2019.103258</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103258</ArticleId><ArticleId IdType="pmc">PMC7736922</ArticleId><ArticleId IdType="pubmed">31369862</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38283835</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshop.</ArticleTitle><Pagination><StartPage>1289365</StartPage><MedlinePgn>1289365</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1289365</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2023.1289365</ELocationID><Abstract><AbstractText><b>Introduction:</b> Real-world evidence (RWE) in health technology assessment (HTA) holds significant potential for informing healthcare decision-making. A multistakeholder workshop was organised by the European Health Data and Evidence Network (EHDEN) and the GetReal Institute to explore the status, challenges, and opportunities in incorporating RWE into HTA, with a focus on learning from regulatory initiatives such as the European Medicines Agency (EMA) Data Analysis and Real World Interrogation Network (DARWIN EU<sup>&#xae;</sup>). <b>Methods:</b> The workshop gathered key stakeholders from regulatory agencies, HTA organizations, academia, and industry for three panel discussions on RWE and HTA integration. Insights and recommendations were collected through panel discussions and audience polls. The workshop outcomes were reviewed by authors to identify key themes, challenges, and recommendations. <b>Results:</b> The workshop discussions revealed several important findings relating to the use of RWE in HTA. Compared with regulatory processes, its adoption in HTA to date has been slow. Barriers include limited trust in RWE, data quality concerns, and uncertainty about best practices. Facilitators include multidisciplinary training, educational initiatives, and stakeholder collaboration, which could be facilitated by initiatives like EHDEN and the GetReal Institute. Demonstrating the impact of "driver projects" could promote RWE adoption in HTA. <b>Conclusion:</b> To enhance the integration of RWE in HTA, it is crucial to address known barriers through comprehensive training, stakeholder collaboration, and impactful exemplar research projects. By upskilling users and beneficiaries of RWE and those that generate it, promoting collaboration, and conducting "driver projects," can strengthen the HTA evidence base for more informed healthcare decisions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Claire, Elvidge, Hanif, Goovaerts, Rijnbeek, J&#xf3;nsson, Facey and Dawoud.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Claire</LastName><ForeName>Ravinder</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>National Institute for Health and Care Excellence, Manchester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elvidge</LastName><ForeName>Jamie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Institute for Health and Care Excellence, Manchester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanif</LastName><ForeName>Shahid</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>GetReal Institute, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goovaerts</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Pfizer nv/sa, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xf3;nsson</LastName><ForeName>P&#xe1;ll</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>National Institute for Health and Care Excellence, Manchester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Facey</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Edinburgh, Member Scottish Health Technologies Group Council, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawoud</LastName><ForeName>Dalia</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Institute for Health and Care Excellence, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Pharmacy Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">federated data network</Keyword><Keyword MajorTopicYN="N">health technology assessment</Keyword><Keyword MajorTopicYN="N">real world data</Keyword><Keyword MajorTopicYN="N">real world evidence</Keyword><Keyword MajorTopicYN="N">regulatory</Keyword></KeywordList><CoiStatement>Author HG was employed by Pfizer nv/sa. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>29</Day><Hour>4</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38283835</ArticleId><ArticleId IdType="pmc">PMC10811058</ArticleId><ArticleId IdType="doi">10.3389/fphar.2023.1289365</ArticleId><ArticleId IdType="pii">1289365</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Claire R., Elvidge J., Read C., Debray T., Newby D., Burn E., et al. (2022). RWD147 demonstrating the application of real-world evidence for health technology assessment using a federated data network. Value Health 25, S478. 10.1016/j.jval.2022.09.2372</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2022.09.2372</ArticleId></ArticleIdList></Reference><Reference><Citation>
EHDEN (2018). European health data evidence network [WWW document]. Available at: https://www.ehden.eu/ (Accessed February 7, 2023).</Citation></Reference><Reference><Citation>
EMA (2021). Data analysis and real world interrogation network (Darwin EU) [WWW document]. Netherlands: European Medicines Agency. Available at: https://www.ema.europa.eu/en/about-us/how-we-work/big-data/data-analysis-real-world-interrogation-network-darwin-eu (Accessed February 7, 2023).</Citation></Reference><Reference><Citation>
EMA (2023). Use of real-world evidence in regulatory decision making &#x2013; EMA publishes review its studies [WWW Document]. European Medicines Agency. Available at: https://www.ema.europa.eu/en/news/use-real-world-evidence-regulatory-decision-making-ema-publishes-review-its-studies (Accessed March 8, 2023).</Citation></Reference><Reference><Citation>Facey K. M., Rannanheimo P., Batchelor L., Borchardt M., de Cock J. (2020). Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU-actions for stakeholders. Int. J. Technol. Assess. Health Care 36, 459&#x2013;468. 10.1017/S026646232000063X</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S026646232000063X</ArticleId><ArticleId IdType="pubmed">32878663</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogervorst M. A., Pont&#xe9;n J., Vreman R. A., Mantel-Teeuwisse A. K., Goettsch W. G. (2022). Real world data in health technology assessment of complex health technologies. Front. Pharmacol. 13, 837302. 10.3389/fphar.2022.837302</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.837302</ArticleId><ArticleId IdType="pmc">PMC8866967</ArticleId><ArticleId IdType="pubmed">35222045</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G., Duke J. D., Shah N. H., Reich C. G., Huser V., Schuemie M. J., et al. (2015). Observational health data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud. Health Technol. Inf. 216, 574&#x2013;578. 10.3233/978-1-61499-564-7-574</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/978-1-61499-564-7-574</ArticleId><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>
IMI (2018). IMI innovative Medicines initiative | EHDEN | European health data and evidence network [WWW document]. Belgium: Innovative Medicines Initiative. Available at: http://www.imi.europa.eu/projects-results/project-factsheets/ehden (Accessed February 7, 2023).</Citation></Reference><Reference><Citation>Kent S., Burn E., Dawoud D., Jonsson P., &#xd8;stby J. T., Hughes N., et al. (2021). Common problems, common data model solutions: evidence generation for health technology assessment. PharmacoEconomics 39, 275&#x2013;285. 10.1007/s40273-020-00981-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-020-00981-9</ArticleId><ArticleId IdType="pmc">PMC7746423</ArticleId><ArticleId IdType="pubmed">33336320</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke B., Oortwijn W., Schuller T. International Joint Task Group (2020). The new definition of health technology assessment: a milestone in international collaboration. Int. J. Technol. Assess. Health Care 36, 187&#x2013;190. 10.1017/S0266462320000215</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0266462320000215</ArticleId><ArticleId IdType="pubmed">32398176</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36461620</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1930-613X</ISSN><JournalIssue CitedMedium="Internet"><Volume>189</Volume><Issue>3-4</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>27</Day></PubDate></JournalIssue><Title>Military medicine</Title><ISOAbbreviation>Mil Med</ISOAbbreviation></Journal><ArticleTitle>Illustration of Continuous Enrollment and Beneficiary Categorization in DoD and VA Infrastructure for Clinical Intelligence.</ArticleTitle><Pagination><StartPage>466</StartPage><EndPage>474</EndPage><MedlinePgn>466-474</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/milmed/usac352</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The DoD and VA Infrastructure for Clinical Intelligence (DaVINCI) data-sharing initiative has bridged the gap between DoD and VA data. DaVINCI utilizes the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) to map DoD and VA-specific health care codes to a standardized terminology. Although OMOP CDM provides a standardized longitudinal view of health care concepts, it fails in capturing multiple and changing relationships beneficiaries have with DoD and VA as it has a static (vs. yearly) person characteristic table. Furthermore, DoD and VA utilize different policies and terminology to identify their respective beneficiaries, which makes it difficult to track patients longitudinally. The primary purpose of this report is to provide a methodology for categorizing beneficiaries and creating continuous longitudinal patient records to maximize the use of the joint DoD and VA data in DaVINCI.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">For calendar year 2000-2020, we combined DoD and VA OMOP CDM and source databases to uniquely categorize beneficiaries into the following hierarchical groups: Active Duty, Guard, and Reserve Service Members (ADSMs); Separatees; Retirees; Veterans; and Deceased. Once the cohorts were identified, we examined calendar year 2020 health care utilization data using the OMOP VISIT_OCCURRENCE, DRUG_EXPOSURE, MEASUREMENT, and PROCEDURE tables. We also used the Defense Enrollment and Eligibility Reporting System source table to derive enrollment periods for DoD beneficiaries. As VA does not have enrollment plans, we utilized the VA's priority groups (1-5) in the SPATIENT source table to crosswalk the DoD's enrollment concept to the VA. We then assessed lengths of continuous enrollments in DoD and VA and the impact of appending the longitudinal records together.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The majority of the ADSMs utilized the DoD system, but about 60,557 (3%) were seen in the VA for varied types of care. The market share of care provided to ADSMs by the VA varied by specialty and location. For Retirees, the split between DoD (1,625,874 [75%]) and VA (895,992 [41%]) health care utilization was more significant. The value added for utilizing DaVINCI in longitudinal studies was the highest for researchers normally limited to DoD data only. For beneficiaries who had 5&#x2009;years of continuous enrollment, DaVINCI increased the potential study population by over 202% compared to using DoD data alone and by over 14% compared to VA data alone. Among beneficiaries with 20&#x2009;years of continuous enrollment, DaVINCI increased the potential study population by over 133% compared to DoD data and by nearly 39% compared to VA data.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">DaVINCI has successfully combined DoD and VA data and utilized OMOP CDM to standardize health care concepts. However, to fully maximize the potential of DaVINCI's DoD and VA OMOP databases, researchers must uniquely categorize the DaVINCI cohort and build longitudinal patient records across DoD and VA. Because of the low other health insurance rates among DoD enrollees and their choice to enroll to a DoD Primary Care Manager, we believe this population to be the least censored in the DoD. Applying a similar concept through VA's priority groups (1-5) would enable researchers to follow ADSMs as they transition from the military.</AbstractText><CopyrightInformation>&#xa9; The Association of Military Surgeons of the United States 2022. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pav</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Kennell and Associates Inc., Falls Church, VA 22042, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burns</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Alqimi Technology Solutions, Inc., Rockville, MD 20850, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colahan</LastName><ForeName>Courtney</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Kennell and Associates Inc., Falls Church, VA 22042, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robison</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT 84148, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kean</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT 84148, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT 84148, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>U.S. Department of Veterans Affairs</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mil Med</MedlineTA><NlmUniqueID>2984771R</NlmUniqueID><ISSNLinking>0026-4075</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014728" MajorTopicYN="Y">Veterans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008889" MajorTopicYN="Y">Military Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007360" MajorTopicYN="N">Intelligence</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>29</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>3</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36461620</ArticleId><ArticleId IdType="doi">10.1093/milmed/usac352</ArticleId><ArticleId IdType="pii">6867769</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37169362</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2005-7563</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Korean journal of anesthesiology</Title><ISOAbbreviation>Korean J Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Perioperative adverse cardiac events and mortality after non-cardiac surgery: a multicenter study.</ArticleTitle><Pagination><StartPage>66</StartPage><EndPage>76</EndPage><MedlinePgn>66-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4097/kja.23043</ELocationID><Abstract><AbstractText Label="BACKGROUND">Perioperative adverse cardiac events (PACE), a composite of myocardial infarction, coronary revascularization, congestive heart failure, arrhythmic attack, acute pulmonary embolism, cardiac arrest, and stroke during 30-day postoperative period, is associated with long-term mortality, but with limited clinical evidence. We compared long-term mortality with PACE using data from nationwide multicenter electronic health records.</AbstractText><AbstractText Label="METHODS">Data from 7 hospitals, converted to Observational Medical Outcomes Partnership Common Data Model, were used. We extracted records of 277,787 adult patients over 18 years old undergoing non-cardiac surgery for the first time at the hospital and had medical records for more than 180 days before surgery. We performed propensity score matching and then an aggregated meta&#x2011;analysis.</AbstractText><AbstractText Label="RESULTS">After 1:4 propensity score matching, 7,970 patients with PACE and 28,807 patients without PACE were matched. The meta&#x2011;analysis showed that PACE was associated with higher one-year mortality risk (hazard ratio [HR]: 1.33, 95% CI [1.10, 1.60], P = 0.005) and higher three-year mortality (HR: 1.18, 95% CI [1.01, 1.38], P = 0.038). In subgroup analysis, the risk of one-year mortality by PACE became greater with higher-risk surgical procedures (HR: 1.20, 95% CI [1.04, 1.39], P = 0.020 for low-risk surgery; HR: 1.69, 95% CI [1.45, 1.96], P &lt; 0.001 for intermediate-risk; and HR: 2.38, 95% CI [1.47, 3.86], P = 0.034 for high-risk).</AbstractText><AbstractText Label="CONCLUSIONS">A nationwide multicenter study showed that PACE was significantly associated with increased one-year mortality. This association was stronger in high-risk surgery, older, male, and chronic kidney disease subgroups. Further studies to improve mortality associated with PACE are needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Byungjin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Ah Ran</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Kangwon National University Hospital, Chuncheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jungchan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jong-Hwan</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Kwangmo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health Promotion, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Dong Yun</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhee</LastName><ForeName>Sang Youl</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Sang-Soo</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Kangdong Sacred Heart Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seung Do</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sun Hack</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Pusan National University Hospital, Busan, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>Chang Won</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Central Research Center of Biomedical Research Institute, Wonkwang University Hospital, Iksan, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Bumhee</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office of Biostatistics, Medical Research Collaborating Center, Ajou Research Institute for Innovative Medicine, Ajou University Medical Center, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seol</LastName><ForeName>Soobeen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seunghwa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Wiltse Memorial Hospital, Suwon, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>20003883</GrantID><Agency>Ministry of Trade, Industry and Energy</Agency><Country/></Grant><Grant><GrantID>20005021</GrantID><Agency>Ministry of Trade, Industry and Energy</Agency><Country/></Grant><Grant><GrantID>HR16C0001</GrantID><Agency>Ministry of Health and Welfare</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Korean J Anesthesiol</MedlineTA><NlmUniqueID>101502451</NlmUniqueID><ISSNLinking>2005-6419</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Korean J Anesthesiol. 2024 Feb;77(1):3-4. doi: 10.4097/kja.24038.</RefSource><PMID Version="1">38267834</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="Y">Heart Arrest</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac arrhythmias</Keyword><Keyword MajorTopicYN="N">Cardiovascular diseases</Keyword><Keyword MajorTopicYN="N">Embolism</Keyword><Keyword MajorTopicYN="N">General surgery</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Myocardial infarction.</Keyword></KeywordList><CoiStatement>
<b>Conflicts of Interest</b>
. No potential conflict of interest relevant to this article was reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>11</Day><Hour>20</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37169362</ArticleId><ArticleId IdType="pmc">PMC10834726</ArticleId><ArticleId IdType="doi">10.4097/kja.23043</ArticleId><ArticleId IdType="pii">kja.23043</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Devereaux PJ, Sessler DI. Cardiac complications in patients undergoing major noncardiac surgery. N Engl J Med. 2015;373:2258&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">26630144</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, et al. Mortality after surgery in Europe: a 7 day cohort study. Lancet. 2012;380:1059&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3493988</ArticleId><ArticleId IdType="pubmed">22998715</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh SR, Tang T, Wijewardena C, Yarham SI, Boyle JR, Gaunt ME. Postoperative arrhythmias in general surgical patients. Ann R Coll Surg Engl. 2007;89:91&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1964549</ArticleId><ArticleId IdType="pubmed">17346395</ArticleId></ArticleIdList></Reference><Reference><Citation>Poise Study Group. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371:1839&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">18479744</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh AR, Park J, Lee JH, Kim H, Yang K, Choi JH, et al. Association between perioperative adverse cardiac events and mortality during one-year follow-up after noncardiac surgery. J Am Heart Assoc. 2022;11:e024325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9238468</ArticleId><ArticleId IdType="pubmed">35411778</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen R, Pratt N, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019;394:1816&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo WW, Seo SI, Kim Y, Yoo JJ, Shin WG, Kim J, et al. Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases. Cardiovasc Diabetol. 2022;21:82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9128291</ArticleId><ArticleId IdType="pubmed">35606846</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan CJ. Reducing bias using propensity score matching. J Nucl Cardiol. 2018;25:404&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">28776312</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004;57:1288&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">15617955</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristensen SD, Knuuti J, Saraste A, Anker S, B&#xf8;tker HE, Hert SD, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA) Eur Heart J. 2014;35:2383&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pubmed">25086026</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong PW, Westerhout CM. Composite end points in clinical research: a time for reappraisal. Circulation. 2017;135:2299&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">28584030</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankoh AJ, Li H, D&#x2019;Agostino RB Sr. Use of composite endpoints in clinical trials. Stat Med. 2014;33:4709&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">24833282</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta NN, Yu Y, Pinnelas R, Krishnamoorthy P, Shin DB, Troxel AB, et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med. 2011;124:775.e1-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3146037</ArticleId><ArticleId IdType="pubmed">21787906</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhave PD, Goldman LE, Vittinghoff E, Maselli J, Auerbach A. Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery. Am Heart J. 2012;164:918&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4096141</ArticleId><ArticleId IdType="pubmed">23194493</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh SR, Tang T, Gaunt ME, Schneider HJ. New arrhythmias after non-cardiothoracic surgery. BMJ. 2006;333:715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1592375</ArticleId><ArticleId IdType="pubmed">17023439</ArticleId></ArticleIdList></Reference><Reference><Citation>Albini A, Malavasi VL, Vitolo M, Imberti JF, Marietta M, Lip GY, et al. Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: a systematic review and metanalysis. Eur J Intern Med. 2021;85:27&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">33402281</ArticleId></ArticleIdList></Reference><Reference><Citation>Afzal S, Arshad A. Ethical issues among healthcare workers using electronic medical records: a systematic review. Comput Methods Programs Biomed Update. 2021;1:100030.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37414703</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-7560</ISSN><JournalIssue CitedMedium="Internet"><Volume>85</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>European urology</Title><ISOAbbreviation>Eur Urol</ISOAbbreviation></Journal><ArticleTitle>Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data.</ArticleTitle><Pagination><StartPage>457</StartPage><EndPage>465</EndPage><MedlinePgn>457-465</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eururo.2023.06.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0302-2838(23)02944-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Conservative management is an option for prostate cancer (PCa) patients either with the objective of delaying or even avoiding curative therapy, or to wait until palliative treatment is needed. PIONEER, funded by the European Commission Innovative Medicines Initiative, aims at improving PCa care across Europe through the application of big data analytics.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To describe the clinical characteristics and long-term outcomes of PCa patients on conservative management by using an international large network of real-world data.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="METHODS">From an initial cohort of &gt;100&#xa0;000&#xa0;000 adult individuals included in eight databases evaluated during a virtual study-a-thon hosted by PIONEER, we identified newly diagnosed PCa cases (n&#xa0;=&#xa0;527&#xa0;311). Among those, we selected patients who did not receive curative or palliative treatment within 6 mo from diagnosis (n&#xa0;=&#xa0;123&#xa0;146).</AbstractText><AbstractText Label="OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS" NlmCategory="METHODS">Patient and disease characteristics were reported. The number of patients who experienced the main study outcomes was quantified for each stratum and the overall cohort. Kaplan-Meier analyses were used to estimate the distribution of time to event data.</AbstractText><AbstractText Label="RESULTS AND LIMITATIONS" NlmCategory="CONCLUSIONS">The most common comorbidities were hypertension (35-73%), obesity (9.2-54%), and type 2 diabetes (11-28%). The rate of PCa-related symptomatic progression ranged between 2.6% and 6.2%. Hospitalization (12-25%) and emergency department visits (10-14%) were common events during the 1st year of follow-up. The probability of being free from both palliative and curative treatments decreased during follow-up. Limitations include a lack of information on patients and disease characteristics and on treatment intent.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results allow us to better understand the current landscape of patients with PCa managed with conservative treatment. PIONEER offers a unique opportunity to characterize the baseline features and outcomes of PCa patients managed conservatively using real-world data.</AbstractText><AbstractText Label="PATIENT SUMMARY" NlmCategory="RESULTS">Up to 25% of men with prostate cancer (PCa) managed conservatively experienced hospitalization and emergency department visits within the 1st year after diagnosis; 6% experienced PCa-related symptoms. The probability of receiving therapies for PCa decreased according to time elapsed after the diagnosis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gandaglia</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy. Electronic address: Gandaglia.giorgio@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellegrino</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golozar</LastName><ForeName>Asieh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, New York, NY, USA; OHDSI Center, Northeastern University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Meulder</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Association EISBM, Vourles, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbott</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Astellas Pharma, Inc., Northbrook, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Achtman</LastName><ForeName>Ariel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Movember Foundation, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imran Omar</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Academic Urology Unit, University of Aberdeen, Scotland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Riyadh Elm University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Areia</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asiimwe</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Bayer AG, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beyer</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Translational Oncology and Urology Research, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bjartell</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Translational Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campi</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Unit of Urological Robotic Surgery and Renal Transplantation, University of Florence, Careggi Hospital, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cornford</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Liverpool University Hospitals, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Astellas Pharma, Inc., Northbrook, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Mengchun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nanfang Hospital, Southern Medical University, Guangzhou, China; DHC Technologies, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrera</LastName><ForeName>Ronald</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bayer AG, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Nigel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Epidemiology, Janssen R&amp;D, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hulsen</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Philips Research, Department of Hospital Services &amp; Informatics, Eindhoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinnaird</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Alberta, Edmonton, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Lana Y H</ForeName><Initials>LYH</Initials><AffiliationInfo><Affiliation>University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maresca</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Urology, NHS Grampian, Scotland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mottet</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Guidelines Office, European Association of Urology, Arnhem, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oja</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Tartu, Estonia; STACC, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prinsen</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Netherlands Comprehensive Cancer Organization, Eindhoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IQVIA, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Remmers</LastName><ForeName>Sebastiaan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Erasmus University Medical Centre, Cancer Institute, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roobol</LastName><ForeName>Monique J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Erasmus University Medical Centre, Cancer Institute, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakalis</LastName><ForeName>Vasileios</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Urology, General Hospital of Thessaloniki Agios Pavlos, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seager</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>RWS, IQVIA, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Emma J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Guidelines Office, European Association of Urology, Arnhem, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snijder</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Astellas Pharma, Inc., Northbrook, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinbeisser</LastName><ForeName>Carl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bayer AG, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thurin</LastName><ForeName>Nicolas H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>INSERM CIC-P 1401, Bordeaux PharmacoEpi, Universit&#xe9; de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hijazy</LastName><ForeName>Ayman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Association EISBM, Vourles, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Bochove</LastName><ForeName>Kees</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The Hyve, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van den Bergh</LastName><ForeName>Roderick C N</ForeName><Initials>RCN</Initials><AffiliationInfo><Affiliation>St Antonius Hospital, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Hemelrijck</LastName><ForeName>Mieke</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Translational Oncology and Urology Research, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willemse</LastName><ForeName>Peter-Paul</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Department of Urology, Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>The Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zounemat Kermani</LastName><ForeName>Nazanin</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Computing, Data Science Institute, Imperial College London, London, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans-Axelsson</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bayer AG, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briganti</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N'Dow</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Academic Urology Unit, University of Aberdeen, Scotland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PIONEER Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Eur Urol</MedlineTA><NlmUniqueID>7512719</NlmUniqueID><ISSNLinking>0302-2838</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="N">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="Y">Prostatic Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Big data</Keyword><Keyword MajorTopicYN="N">Conservative management</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">PIONEER</Keyword><Keyword MajorTopicYN="N">Prostate cancer</Keyword><Keyword MajorTopicYN="N">Survival</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>16</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>7</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>6</Day><Hour>22</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37414703</ArticleId><ArticleId IdType="doi">10.1016/j.eururo.2023.06.012</ArticleId><ArticleId IdType="pii">S0302-2838(23)02944-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37710363</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1557</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Pharmacoepidemiology and drug safety</Title><ISOAbbreviation>Pharmacoepidemiol Drug Saf</ISOAbbreviation></Journal><ArticleTitle>MetaLAB-HOI: Template standardization of health outcomes enable massive and accurate detection of adverse drug reactions from electronic health records.</ArticleTitle><Pagination><StartPage>e5694</StartPage><MedlinePgn>e5694</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pds.5694</ELocationID><Abstract><AbstractText Label="PURPOSE">This study aimed to advance the MetaLAB algorithm and verify its performance with multicenter data to effectively detect major adverse drug reactions (ADRs), including drug-induced liver injury.</AbstractText><AbstractText Label="METHODS">Based on MetaLAB, we created an optimal scenario for detecting ADRs by considering demographic and clinical records. MetaLAB-HOI was developed to identify ADR signals using common model-based multicenter electronic health record (EHR) data from the clinical health outcomes of interest (HOI) template and design for drug-exposed and nonexposed groups. In this study, we calculated the odds ratio of 101 drugs for HOI in Konyang University Hospital, Seoul National University Hospital, Chungbuk National University Hospital, and Seoul National University Bundang Hospital.</AbstractText><AbstractText Label="RESULTS">The overlapping drugs in four medical centers are amlodipine, aspirin, bisoprolol, carvedilol, clopidogrel, clozapine, digoxin, diltiazem, methotrexate, and rosuvastatin. We developed MetaLAB-HOI, an algorithm that can detect ADRs more efficiently using EHR. We compared the detection results of four medical centers, with drug-induced liver injuries as representative ADRs.</AbstractText><AbstractText Label="CONCLUSIONS">MetaLAB-HOI's strength lies in fully utilizing the patient's clinical information, such as prescription, procedure, and laboratory results, to detect ADR signals. Considering changes in the patient's condition over time, we created an algorithm based on a scenario that accounted for each drug exposure and onset period supervised by specialists for HOI. We determined that when a template capable of detecting ADR based on clinical evidence is developed and manualized, it can be applied in medical centers for new drugs with insufficient data.</AbstractText><CopyrightInformation>&#xa9; 2023 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Suehyun</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0651-6481</Identifier><AffiliationInfo><Affiliation>Department of Computer Engineering, Gachon University, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Hyunah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Healthcare Data Science Center, Konyang University Hospital, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choe</LastName><ForeName>Seon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Seoul National University Biomedical Informatics (SNUBI), Division of Biomedical Informatics, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Min-Gyu</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Subdivision of Allergy, Chungbuk National University Hospital and Chungbuk National College of Medicine, Cheongju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sae-Hoon</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Dong Yoon</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Ulsan University Hospital, Ulsan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ju Han</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Seoul National University Biomedical Informatics (SNUBI), Division of Biomedical Informatics, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HI18C2386</GrantID><Agency>Ministry of Health and Welfare in the Republic of Korea</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacoepidemiol Drug Saf</MedlineTA><NlmUniqueID>9208369</NlmUniqueID><ISSNLinking>1053-8569</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="N">Adverse Drug Reaction Reporting Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056486" MajorTopicYN="Y">Chemical and Drug Induced Liver Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="Y">Drug-Related Side Effects and Adverse Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MetaLAB</Keyword><Keyword MajorTopicYN="N">OMOP-CDM</Keyword><Keyword MajorTopicYN="N">adverse drug reaction</Keyword><Keyword MajorTopicYN="N">drug-induced liver injury</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>15</Day><Hour>0</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37710363</ArticleId><ArticleId IdType="doi">10.1002/pds.5694</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Alexander J et al. World Health Organization-technical report series: introduction. World Health Organization-Technical Report Series. 2010;959:1-105.</Citation></Reference><Reference><Citation>Juntti-Patinen L, Neuvonen P. Drug-related deaths in a university central hospital. Eur J Clin Pharmacol. 2002;58(7):479-482.</Citation></Reference><Reference><Citation>Bouvy JC, De Bruin ML, Koopmanschap MA. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf. 2015;38(5):437-453.</Citation></Reference><Reference><Citation>Lazorou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA. 1998;279(15):1200-1205.</Citation></Reference><Reference><Citation>Alsaleh FM, Alzaid SW, Abahussain EA, Bayoud T, Lemay J. Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait. Saudi Pharm J. 2017;25(6):830-837.</Citation></Reference><Reference><Citation>Lee S, Choi J, Kim H-S, et al. Standard-based comprehensive detection of adverse drug reaction signals from nursing statements and laboratory results in electronic health records. J Am Med Inform Assoc. 2017;24(4):697-708.</Citation></Reference><Reference><Citation>Park MY, Yoon D, Lee KY, et al. A novel algorithm for detection of adverse drug reaction signals using a hospital electronic medical record database. Pharmacoepidemiol Drug Saf. 2011;20(6):598-607.</Citation></Reference><Reference><Citation>Yoon D, Park MY, Choi NK, Park BJ, Kim JH, Park RW. Detection of adverse drug reaction signals using an electronic health records database: comparison of the laboratory extreme abnormality ratio (CLEAR) algorithm. Clin Pharmacol Ther. 2012;91(3):467-474.</Citation></Reference><Reference><Citation>Ennis RH, Norris SP. Critical thinking assessment: status, issues, needs. Cognitive Assessment of Language and Math Outcomes. 1990;36:1.</Citation></Reference><Reference><Citation>Harpaz R, DuMochel W, Shah NH. Big data and adverse drug reaction detection. Clin Pharmacol Ther. 2016;99(3):268-270.</Citation></Reference><Reference><Citation>Stang PE, Ryan PB, Dusetzina SB, et al. Health outcomes of interest in observational data: issues in identifying definitions in the literature. Health Outcomes Research in Medicine. 2012;3(1):e37-e44.</Citation></Reference><Reference><Citation>Haerian K, Salmasian H, Friedman C. Methods for identifying suicide or suicidal ideation in EHRs. AMIA Annu Symp Proc. 2012;2012:1244-1253.</Citation></Reference><Reference><Citation>Fox BI, Hollingsworth JC, Gray MD, Hollingsworth ML, Gao J, Hansen RA. Developing an expert panel process to refine health outcome definitions in observational data. J Biomed Inform. 2013;46(5):795-804.</Citation></Reference><Reference><Citation>Devarbhavi H. An update on drug-induced liver injury. J Clin Exp Hepatol. 2012;2(3):247-259.</Citation></Reference><Reference><Citation>Sandhu N, Navarro V. Drug-induced liver injury in GI practice. Hepatol Commun. 2020;4(5):631-645.</Citation></Reference><Reference><Citation>Suk KT, Baik SK, Yoon JH, et al. Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol. 2012;18(1):1-21.</Citation></Reference><Reference><Citation>Brinker AD, Lyndly J, Tonning J, et al. Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA adverse event reporting system (FAERS) database. Drug Saf. 2013;36(12):1169-1178.</Citation></Reference><Reference><Citation>Billioti de Gage S, Collin C, Le-Tri T, et al. Antidepressants and hepatotoxicity: a cohort study among 5 million individuals registered in the French National Health Insurance Database. CNS Drugs. 2018;32(7):673-684.</Citation></Reference><Reference><Citation>Lin ND, Norman H, Regev A, et al. Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database. BMC Gastroenterol. 2015;15(1):1-13.</Citation></Reference><Reference><Citation>Overby CL, Pathak J, Gottesman O, et al. A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury. J Am Med Inform Assoc. 2013;20(e2):e243-e252.</Citation></Reference><Reference><Citation>Kang Y, Kim S-H, Park S-Y, et al. Evaluation of drug-induced liver injury developed during hospitalization using electronic health record (EHR)-based algorithm. Allergy, Asthma Immunol Res. 2020;12(3):430-442.</Citation></Reference><Reference><Citation>Yeboah-Korang A, Louissaint J, Tsung I, Prabhu S, Fontana RJ. Utility of a computerized ICD-10 algorithm to identify idiosyncratic drug-induced liver injury cases in the electronic medical record. Drug Saf. 2020;43(4):371-377.</Citation></Reference><Reference><Citation>Consolidated List of Products Whose Consumption and/or Sale Have Been Banned, Withdrawn, Severely Restricted or Not Approved by Governments. United Nations Publication; 2009.</Citation></Reference><Reference><Citation>Ninan, B, Wertheimer AI. Withdrawing Drugs in the US Versus Other Countries. University of Minnesota, College of Pharmacy; 2012.</Citation></Reference><Reference><Citation>Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716-2724.</Citation></Reference><Reference><Citation>Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 medical expenditure panel survey. JAMA. 2001;286(22):2823-2829.</Citation></Reference><Reference><Citation>ICH E1. Clinical investigation of medicinal products in the paediatric population. Note for guidance on clinicalinvestigation of medicinal products in the paediatric population (CPMP/ICH/2711/99). London. 2000.</Citation></Reference><Reference><Citation>Taketomo CK, Hurlburt Hodding J, Kraus DM. Pediatric and Neonatal Dosage Handbook. Lexi Comp; 2010.</Citation></Reference><Reference><Citation>Kliegman RM et al. Nelson Textbook of Pediatrics e-Book. Elsevier Health Sciences; 2007.</Citation></Reference><Reference><Citation>Shin H, Lee S. An OMOP-CDM based pharmacovigilance data-processing pipeline (PDP) providing active surveillance for ADR signal detection from real-world data sources. BMC Med Inform Decis Mak. 2021;21(1):1-11.</Citation></Reference><Reference><Citation>Xu Y, Zhou X, Suehs BT, et al. A comparative assessment of observational medical outcomes partnership and mini-sentinel common data models and analytics: implications for active drug safety surveillance. Drug Saf. 2015;38(8):749-765.</Citation></Reference><Reference><Citation>Alessandrino F, Qin L, Cruz G, et al. 5-fluorouracil induced liver toxicity in patients with colorectal cancer: role of computed tomography texture analysis as a potential biomarker. Abdom Radiol. 2019;44(9):3099-3106.</Citation></Reference><Reference><Citation>Rho MJ et al. Development common data model for adverse drug signal detection based on multi-center emr systems. 2013 International Conference on Information Science and Applications (ICISA). IEEE; 2013.</Citation></Reference><Reference><Citation>Zhou X, Murugesan S, Bhullar H, et al. An evaluation of the THIN database in the OMOP common data model for active drug safety surveillance. Drug Saf. 2013;36(2):119-134.</Citation></Reference><Reference><Citation>Rho MJ, Kim SR, Park SH, et al. Common data model for decision support system of adverse drug reaction to extract knowledge from multi-center database. Inf Technol Manag. 2016;17(1):57-66.</Citation></Reference><Reference><Citation>Rathi C, Pipaliya N, Patel R, Ingle M, Phadke A, Sawant P. Drug induced liver injury at a tertiary hospital in India: etiology, clinical features and predictors of mortality. Ann Hepatol. 2017;16(3):442-450.</Citation></Reference><Reference><Citation>David S, Hamilton JP. Drug-induced liver injury. US Gastroenterol Hepatol Rev. 2010;6:73.</Citation></Reference><Reference><Citation>Verma S, Kaplowitz N. Diagnosis, management and prevention of drug-induced liver injury. Gut. 2009;58(11):1555-1564.</Citation></Reference><Reference><Citation>Kuhn M, Letunic I, Jensen LJ, Bork P. The SIDER database of drugs and side effects. Nucleic Acids Res. 2016;44(D1):D1075-D1079.</Citation></Reference><Reference><Citation>Laster J, Satoskar R. Aspirin-induced acute liver injury. ACG Case Rep J. 2014;2(1):48-49.</Citation></Reference><Reference><Citation>Rua J, Prata AR, Marques R, et al. Carvedilol-induced liver injury, a rare cause of mixed hepatitis: a clinical case. GE-Port J Gastroenterol. 2019;26(3):196-201.</Citation></Reference><Reference><Citation>Valentino MA, Danaf JADA, Frisch D. Digoxin toxicity caused by an interaction with the novel hepatitis C medication ledipasvir/sofosbuvir. J Innov Card Rhythm Manag. 2016;7(4):2343-2347.</Citation></Reference><Reference><Citation>Cano A, Cifuentes L, Amariles P. Toxicidad hep&#xe1;tica causada por medicamentos: revisi&#xf3;n estructurada. Revista Colombiana de Gastroenterolog&#xed;a. 2017;32(4):337-348.</Citation></Reference><Reference><Citation>Cure E, Kirbas A, Tumkaya L, et al. Protective effect of infliximab on methotrexate-induced liver injury in rats: unexpected drug interaction. J Cancer Res Ther. 2015;11(1):164-169.</Citation></Reference><Reference><Citation>Langman G, Hall PDLM, Todd G. Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury. J Gastroenterol Hepatol. 2001;16(12):1395-1401.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37876360</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1557</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Pharmacoepidemiology and drug safety</Title><ISOAbbreviation>Pharmacoepidemiol Drug Saf</ISOAbbreviation></Journal><ArticleTitle>IncidencePrevalence: An R package to calculate population-level incidence rates and prevalence using the OMOP common data model.</ArticleTitle><Pagination><StartPage>e5717</StartPage><MedlinePgn>e5717</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pds.5717</ELocationID><Abstract><AbstractText Label="PURPOSE">Real-world data (RWD) offers a valuable resource for generating population-level disease epidemiology metrics. We aimed to develop a well-tested and user-friendly R package to compute incidence rates and prevalence in data mapped to the observational medical outcomes partnership (OMOP) common data model (CDM).</AbstractText><AbstractText Label="MATERIALS AND METHODS">We created IncidencePrevalence, an R package to support the analysis of population-level incidence rates and point- and period-prevalence in OMOP-formatted data. On top of unit testing, we assessed the face validity of the package. To do so, we calculated incidence rates of COVID-19 using RWD from Spain (SIDIAP) and the United Kingdom (CPRD Aurum), and replicated two previously published studies using data from the Netherlands (IPCI) and the United Kingdom (CPRD Gold). We compared the obtained results to those previously published, and measured execution times by running a benchmark analysis across databases.</AbstractText><AbstractText Label="RESULTS">IncidencePrevalence achieved high agreement to previously published data in CPRD Gold and IPCI, and showed good performance across databases. For COVID-19, incidence calculated by the package was similar to public data after the first-wave of the pandemic.</AbstractText><AbstractText Label="CONCLUSION">For data mapped to the OMOP CDM, the IncidencePrevalence R package can support descriptive epidemiological research. It enables reliable estimation of incidence and prevalence from large real-world data sets. It represents a simple, but extendable, analytical framework to generate estimates in a reproducible and timely manner.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Pharmacoepidemiology and Drug Safety published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ravent&#xf3;s</LastName><ForeName>Berta</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-4668-2970</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Bellaterra (Cerdanyola del Vall&#xe8;s), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catal&#xe0;</LastName><ForeName>Mart&#xed;</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3308-9905</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Mike</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9517-8834</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Yuchen</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-0847-4855</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Adam</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5576-8701</Identifier><AffiliationInfo><Affiliation>Odysseus Data Services, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inberg</LastName><ForeName>Ger</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8993-8748</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xintong</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-6872-5804</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-G&#xfc;ell</LastName><ForeName>Kim</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-8462-8668</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newby</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3001-1478</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Ridder</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6555-2741</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barboza</LastName><ForeName>Cesar</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0002-4453-3071</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8274-0357</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verhamme</LastName><ForeName>Katia</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8162-4904</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0621-1979</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3950-6346</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burn</LastName><ForeName>Edward</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9286-1128</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>European Medicines Agency</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacoepidemiol Drug Saf</MedlineTA><NlmUniqueID>9208369</NlmUniqueID><ISSNLinking>1053-8569</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079803" MajorTopicYN="Y">Data Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">R package</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">incidence</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>25</Day><Hour>3</Hour><Minute>48</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37876360</ArticleId><ArticleId IdType="doi">10.1002/pds.5717</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Rassen JA, Bartels DB, Schneeweiss S, Patrick AR, Murk W. Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases. Clin Epidemiol. 2018;11:1-15.</Citation></Reference><Reference><Citation>Roberts AW, Dusetzina SB, Farley JF. Revisiting the washout period in the incident user study design: why 6-12 months may not be sufficient. J Comp Eff Res. 2015;4(1):27-35.</Citation></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54-60.</Citation></Reference><Reference><Citation>Wickham H, Danenberg P, Cs&#xe1;rdi G, et al. roxygen2: In-Line Documentation for R (version 7.2.3). 2022 https://CRAN.R-project.org/package=roxygen2</Citation></Reference><Reference><Citation>Lang M, Bischl B, T&#xf3;th D. checkmate: Fast and Versatile Argument Check; (version 2.1.0). 2022 https://CRAN.R-project.org/package=checkmate</Citation></Reference><Reference><Citation>Cs&#xe1;rdi G, Wickham H, M&#xfc;ller K. cli: Helpers for Developing Command Line Interfaces; (version 3.6.0). 2023 https://cran.r-project.org/web/packages/cli/index.html</Citation></Reference><Reference><Citation>Wickham H, Girlich M, Ruiz E. dbplyr: A &#x2018;dplyr&#x2019; Back End for Databases; (version 2.1.1). 2022 https://CRAN.R-project.org/package=dbplyr</Citation></Reference><Reference><Citation>Wickham H, Fran&#xe7;ois R, Henry L, M&#xfc;ller K. dplyr: A Grammar of Data Manipulation; (version 1.0.10). 2022 https://CRAN.R-project.org/package=dplyr</Citation></Reference><Reference><Citation>Spinu V, Grolemund G, Wickham H, et al. lubridate: Make Dealing with Dates a Little Easier; (version 1.9.0). 2022 https://CRAN.R-project.org/package=lubridate</Citation></Reference><Reference><Citation>Hester J, Bryan J. glue: Interpreted String Literals; (version 1.6.2). 2022 https://CRAN.R-project.org/package=glue</Citation></Reference><Reference><Citation>Milton Bache S, Wickham H, Henry L. magrittr: A Forward-Pipe Operator for R; (version 2.0.3). 2022 https://CRAN.R-project.org/package=magrittr</Citation></Reference><Reference><Citation>Henry L, Wickham H. rlang: Functions for Base Types and Core R and &#x2018;Tidyverse&#x2019; Features; (version 1.0.6). 2022 https://CRAN.R-project.org/package=rlang</Citation></Reference><Reference><Citation>Wickham H, Henry L. purrr: Functional Programming Tools; (version 1.0.1). 2023 https://CRAN.R-project.org/package=purrr</Citation></Reference><Reference><Citation>Wickham H, Girlich M. tidy r: Tidy Messy Data; (version 1.2.1). 2022 https://CRAN.R-project.org/package=tidyr</Citation></Reference><Reference><Citation>Henry L, Wickham H. tidyselect: Select from a Set of Strings; (version 1.2.0). 2022 https://CRAN.R-project.org/package=tidyselect</Citation></Reference><Reference><Citation>Wickham H. stringr: Simple, Consistent Wrappers for Common String Operations; (version 1.5.0). 2022 https://CRAN.R-project.org/package=stringr</Citation></Reference><Reference><Citation>Cs&#xe1;rdi G, Podg&#xf3;rski K, Geldreich R. zip: Cross-Platform &#x2018;zip&#x2019; Compression; (version 2.2.2). 2022 https://CRAN.R-project.org/package=zip</Citation></Reference><Reference><Citation>Ravent&#xf3;s B, Fern&#xe1;ndez-Bertol&#xed;n S, Arag&#xf3;n M, et al. Transforming the information system for research in primary care (SIDIAP) in Catalonia to the OMOP common data model and its use for COVID-19 research. Clin Epidemiol. 2023;15:969-986.</Citation></Reference><Reference><Citation>Junior EPP, Normando P, Flores-Ortiz R, et al. Integrating real-world data from Brazil and Pakistan into the OMOP common data model and standardized health analytics framework to characterize COVID-19 in the global south. J Am Med Inform Assoc. 2023;30(4):643-655.</Citation></Reference><Reference><Citation>Papez V, Moinat M, Voss EA, et al. Transforming and evaluating the UK Biobank to the OMOP common data model for COVID-19 research and beyond. J Am Med Inform Assoc. (published correction appears in J Am Med Inform Assoc. 2023 Apr 19;30(5):1006). 2022;30(1):103-111.</Citation></Reference><Reference><Citation>R Special Interest Group on Databases (R-SIG-DB), Wickham H, M&#xfc;ller K. DBI: R Database Interface; (version 1.1.3). 2022 https://CRAN.R-project.org/package=DBI</Citation></Reference><Reference><Citation>Black A. CDMConnector: Connect to an OMOP Common Data Model; (version 1.0.0). 2022 https://cran.r-project.org/web/packages/CDMConnector/index.html</Citation></Reference><Reference><Citation>Wickham H. Testthat: get started with testing. R J. 2011;3(1):5-10.</Citation></Reference><Reference><Citation>Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26:404-413.</Citation></Reference><Reference><Citation>Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc. 1927;22(158):209-212.</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. The Book of OHDSI. 2019 https://ohdsi.github.io/TheBookOfOhdsi/</Citation></Reference><Reference><Citation>UK Coronavirus Dashboard. UK Health Security Agency. Accessed January 2023 https://api.coronavirus.data.gov.uk/v2/data?areaType=region&amp;metric=newCasesBySpecimenDate&amp;format=csv</Citation></Reference><Reference><Citation>Dades COVID. Generalitat de Catalunya. Accessed January 2023 https://www.dadescovid.cat</Citation></Reference><Reference><Citation>Li X, Ostropolets A, Makadia R, et al. Characterising the background incidence rates of adverse events of special interest for COVID-19 vaccines in eight countries: multinational network cohort study. BMJ. 2021;373:n1435.</Citation></Reference><Reference><Citation>Verhamme K, Rijnbeek P, de Ridder M. Ranitidine and Other Histamine-H2-Receptor antagonist - A Drug Utilisation Study. 2023. Accessed April 3, 2023 https://www.encepp.eu/encepp/openAttachment/studyResult/39070;jsessionid=zE6hWB4IKJqtXhO0lOvz6lyTpFXdYTQeZ3jgv_OV8U5oJuxZ0FjF!-2033451844</Citation></Reference><Reference><Citation>Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44(3):827-836.</Citation></Reference><Reference><Citation>Wolf A, Dedman D, Campbell J, et al. Data resource profile: clinical practice research datalink (CPRD) Aurum. Int J Epidemiol. 2019;48(6):1740-1740g.</Citation></Reference><Reference><Citation>de Ridder MAJ, de Wilde M, de Ben C, et al. Data resource profile: the integrated primary care information (IPCI) database, The Netherlands. Int J Epidemiol. 2022;51(6):e314-e323.</Citation></Reference><Reference><Citation>Recalde M, Rodr&#xed;guez C, Burn E, et al. Data resource profile: the information system for research in primary care (SIDIAP). Int J Epidemiol. 2022;51(6):e324-e336.</Citation></Reference><Reference><Citation>Burn E, Fern&#xe1;ndez-Bertol&#xed;n S, Voss EA, et al. Establishing and characterising large COVID-19 cohorts after mapping the information system for research in primary care in Catalonia to the OMOP common data model. medRxiv. 2021:21266734.</Citation></Reference><Reference><Citation>Office for National Statistics (ONS). Statistical bulletin, Population estimates for the UK, England, Wales, Scotland and Northern Ireland: mid-2021. 2022. Accessed April 2023 https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/bulletins/annualmidyearpopulationestimates/mid2021</Citation></Reference><Reference><Citation>Statistical Institute of Catalonia. Population on 1 January. 2022. Accessed April 2023 https://www.idescat.cat/indicadors/?id=aec&amp;n=15223&amp;lang=en</Citation></Reference><Reference><Citation>Blacketer C, Defalco FJ, Ryan PB, Rijnbeek PR. Increasing trust in real-world evidence through evaluation of observational data quality. J Am Med Inform Assoc. 2021;28(10):2251-2257.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38009855</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1464-5491</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Diabetic medicine : a journal of the British Diabetic Association</Title><ISOAbbreviation>Diabet Med</ISOAbbreviation></Journal><ArticleTitle>Continuous glucose monitoring in older adults with diabetes: Data from the diabetes prospective follow-up (DPV) registry.</ArticleTitle><Pagination><StartPage>e15261</StartPage><MedlinePgn>e15261</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/dme.15261</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To analyse predictors for continuous glucose monitoring (CGM) use in people with diabetes aged &#x2265;60&#x2009;years using insulin therapy and to assess the rates of CGM use during recent years (2019-2021).</AbstractText><AbstractText Label="RESEARCH DESIGN AND METHODS" NlmCategory="METHODS">Prospective study including 6849 individuals with diabetes and insulin therapy (type 2 diabetes: n&#x2009;=&#x2009;5320; type 1 diabetes: n&#x2009;=&#x2009;1529) aged &#x2265;60&#x2009;years. Data from 129 treatment centres were retrieved from the Diabetes Prospective Follow-up Registry (DPV) in March 2023.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sensor use in individuals aged &#x2265;60&#x2009;years has increased in type 1 (2019: 28%, 2020: 39%, 2021: 45%) and type 2 diabetes (2019: 10%, 2020: 16%, 2021: 18%). Predictors for sensor use in older individuals with type 1 diabetes are younger age and CSII use (p&#x2009;&lt;&#x2009;0.001). Predictors in older individuals with type 2 diabetes are younger age, longer diabetes duration, higher BMI and CSII use (p&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CGM has become more common in older adults with diabetes and will presumably increase further. Age is a predictor for sensor use in older adults with diabetes. Age-related physical barriers and insufficient usability of devices, lack of interest in technologies, but possibly also effects of prejudice on the grounds of age may contribute to this finding.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Diabetic Medicine published by John Wiley &amp; Sons Ltd on behalf of Diabetes UK.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grammes</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5894-6734</Identifier><AffiliationInfo><Affiliation>Health Psychology, Johannes Gutenberg University, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmid</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Epidemiology and Medical Biometry, CAQM, University of Ulm, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Diabetes Research (DZD), Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozkurt</LastName><ForeName>Latife</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3079-9226</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine III and Karl Landsteiner Institute for Metabolic Disorders and Nephrology, Clinic Hietzing, Vienna Health Care Group, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heinemann</LastName><ForeName>Lutz</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2493-1304</Identifier><AffiliationInfo><Affiliation>Science-Consulting in Diabetes GmbH, Kaarst, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hess</LastName><ForeName>Gregor</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Diabetology Private Practice, Worms, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubiak</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0095-9265</Identifier><AffiliationInfo><Affiliation>Health Psychology, Johannes Gutenberg University, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xfc;stner</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Diabetology Clinic, Offenbach, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Priesterroth</LastName><ForeName>Lilli-Sophie</ForeName><Initials>LS</Initials><Identifier Source="ORCID">0000-0001-8010-5475</Identifier><AffiliationInfo><Affiliation>Diabetology Clinic, Bad Mergentheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stahl</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Diabetology Clinic, Neumarkt, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holl</LastName><ForeName>Reinhard W</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0003-1395-4842</Identifier><AffiliationInfo><Affiliation>Institute of Epidemiology and Medical Biometry, CAQM, University of Ulm, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Diabetes Research (DZD), Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>DPV initiative</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>The DPV initiative is supported through the German Center for Diabetes Research (DZD, grant number 82DZD14E03), the German Diabetes Association (DDG), the Robert-Koch-Institute (RKI Berlin) and EU IMI projects (DIRECT, INNODIA, EHDEN, SOPHIA).</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Diabet Med</MedlineTA><NlmUniqueID>8500858</NlmUniqueID><ISSNLinking>0742-3071</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095583" MajorTopicYN="N">Continuous Glucose Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="N">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CGM</Keyword><Keyword MajorTopicYN="N">DPV registry</Keyword><Keyword MajorTopicYN="N">continuous glucose monitoring</Keyword><Keyword MajorTopicYN="N">elderly</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword><Keyword MajorTopicYN="N">type 2 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>27</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>27</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38009855</ArticleId><ArticleId IdType="doi">10.1111/dme.15261</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Teo E, Hassan N, Tam W, Koh S. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis. Diabetologia. 2022;65:604-619. doi:10.1007/s00125-021-05648-4</Citation></Reference><Reference><Citation>Ida S, Kaneko R, Murata K. Utility of real-time and retrospective continuous glucose monitoring in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. J Diabetes Res. 2019;2019:4684815. doi:10.1155/2019/4684815</Citation></Reference><Reference><Citation>Lanzinger S, Best F, Bergmann T, et&#xa0;al. Dynamics of hemoglobin A1c, body mass index, and rates of severe hypoglycemia in 4434 adults with type 1 or type 2 diabetes after initiation of continuous glucose monitoring. Diabetes Technol Ther. 2022;24(10):763-769. doi:10.1089/dia.2022.0063</Citation></Reference><Reference><Citation>Gavin JR, Clifford J, Bailey CJ. Real-world studies support use of continuous glucose monitoring in type 1 and type 2 diabetes independently of treatment regimen. Diabetes Technol Ther. 2021;23(3):19-27.</Citation></Reference><Reference><Citation>Sinclair A, Saeedi P, Kaundal A, Karuranga S, Malanda B, Williams R. Diabetes and global ageing among 65-99-year-old adults: findings from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 2020;162:108078.</Citation></Reference><Reference><Citation>Bispham JA, Hughes AS, Driscoll KA, McAuliffe-Fogarty AH. Novel challenges in aging with type 1 diabetes. Curr Diab Rep. 2020;20(5):15. doi:10.1007/s11892-020-01298-9</Citation></Reference><Reference><Citation>Lacy ME, Gilsanz P, Eng C, Beeri MS, Karter AJ, Whitmer RA. Severe hypoglycemia and cognitive function in older adults with type 1 diabetes: the study of longevity in diabetes (SOLID). Diabetes Care. 2020;43:541-548.</Citation></Reference><Reference><Citation>Standl E, Stevens SR, Lokhnygina Y, et&#xa0;al. Confirming the bidirectional nature of the association between severe hypoglycemic and cardiovascular events in type 2 diabetes: insights from EXSCEL. Diabetes Care. 2020;43:643-652.</Citation></Reference><Reference><Citation>Prasad-Reddy L, Godina A, Chetty A, Isaacs D. Use of continuous glucose monitoring in older adults: a review of benefits, challenges and future directions. touchREV Endocrinol. 2022;18(2):116-121. doi:10.17925/EE.2022.18.2.116</Citation></Reference><Reference><Citation>Toschi E, Slyne C, Sifre K, O'Donnell R, Greenberg J, Atakov-Castillo A. The relationship between CGM-derived metrics, A1C, and risk of hypoglycemia in older adults with type 1 diabetes. Diabetes Care 1. 2020;43(10):2349-2354.</Citation></Reference><Reference><Citation>American Diabetes Association Professional Practice Committee, Draznin B, Aroda VR, et&#xa0;al. 13. Older adults: standards of medical Care in Diabetes-2022. Diabetes Care. 2022;45(1):195-207. doi:10.2337/dc22-S013</Citation></Reference><Reference><Citation>Pratley RE, Kanapka LG, Rickels MR, et&#xa0;al. Wireless innovation for seniors with diabetes mellitus (WISDM) study group. Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. Jama. 2020;323:2397-2406.</Citation></Reference><Reference><Citation>Miller KM, Kanapka LG, Rickels MR, et&#xa0;al. Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes. Diabetes Technol Ther. 2022;24(6):424-434. doi:10.1089/dia.2021.0503</Citation></Reference><Reference><Citation>Bao S, Bailey R, Calhoun P, Beck RW. Effectiveness of continuous glucose monitoring in older adults with type 2 diabetes treated with basal insulin. Diabetes Technol Ther. 2022;24(5):299-306. doi:10.1089/dia.2021.0494</Citation></Reference><Reference><Citation>Ruedy KJ, Parkin CG, Riddlesworth TD, Graham C, DIAMOND Study Group. Continuous glucose monitoring in older adults with type 1 and type 2 diabetes using multiple Daily injections of insulin: results from the DIAMOND trial. J Diabetes Sci Technol. 2017;11(6):1138-1146. doi:10.1177/1932296817704445</Citation></Reference><Reference><Citation>American Diabetes Association professional practice committee; 13. Older adults: standards of medical Care in Diabetes-2022. Diabetes Care. 2022;45(Supplement_1):S195-S207.</Citation></Reference><Reference><Citation>Battelino T, Danne T, Bergenstal RM, et&#xa0;al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593-1603.</Citation></Reference><Reference><Citation>Grunberger G, Sherr J, Allende M, Blevins T, Bode B. American Association of Clinical Endocrinology Clinical Practice Guideline: the use of advanced technology in the management of persons with diabetes mellitus. Endocr Pract. 2021;27:505-537.</Citation></Reference><Reference><Citation>Sandig D, Grimsmann J, Reinauer C, et&#xa0;al. Continuous glucose monitoring in adults with type 1 diabetes: real-world data from the German/Austrian prospective diabetes follow-up registry. Diabetes Technol Ther. 2020;22(8):602-612.</Citation></Reference><Reference><Citation>Addala A, Auzanneau M, Miller K, et&#xa0;al. A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: a transatlantic comparison. Diabetes Care. 2021;44(1):133-140. doi:10.2337/dc20-0257</Citation></Reference><Reference><Citation>DeSalvo DJ, Miller KM, Hermann JM, et&#xa0;al. T1D exchange and DPV registries. Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: international comparison from the T1D exchange and DPV initiative. Pediatr Diabetes. 2018;19(7):1271-1275. doi:10.1111/pedi.12711</Citation></Reference><Reference><Citation>Miller KM, Hermann J, Foster N, et&#xa0;al. T1D exchange and DPV registries. Longitudinal changes in continuous glucose monitoring use among individuals with type 1 diabetes: international comparison in the German and Austrian DPV and U.S. T1D exchange registries. Diabetes Care. 2020;43(1):e1-e2. doi:10.2337/dc19-1214</Citation></Reference><Reference><Citation>Foster NC, Beck RW, Miller KM, et&#xa0;al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018. Diabetes Technol Ther. 2019;21(2):66-72.</Citation></Reference><Reference><Citation>Weinstein JM, Kahkoska AR. Association of continuous glucose monitoring use and hemoglobin A1c levels across the lifespan among individuals with type 1 diabetes in the US. JAMA Netw Open. 2022;5(7):e2223942. doi:10.1001/jamanetworkopen.2022.23942</Citation></Reference><Reference><Citation>Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, et&#xa0;al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.</Citation></Reference><Reference><Citation>American Diabetes Association. Defining and reporting hypoglycemia in diabetes a report from the American Diabetes Association workgroup on hypoglycemia. Diabetes Care. 2005;28:1245-1249.</Citation></Reference><Reference><Citation>Desalvo D, Lanzinger S, Noor N, et&#xa0;al. CGM use and A1C: a transatlantic comparison of the DPV initiative and T1D exchange quality improvement collaborative (T1DX-QI) (poster). Diabetes. 2021;70:616. doi:10.2337/db21-616-P</Citation></Reference><Reference><Citation>Auzanneau M, Eckert AJ, Meyh&#xf6;fer SM, et&#xa0;al. Area deprivation and demographic factors associated with diabetes technology use in adults with type 1 diabetes in Germany. Front Endocrinol (Lausanne). 2023;14:1191138.</Citation></Reference><Reference><Citation>Huang ES, Sinclair A, Conlin PR, et&#xa0;al. The growing role of Technology in the Care of older adults with diabetes. Diabetes Care. 2023;46(8):1455-1463. doi:10.2337/dci23-0021</Citation></Reference><Reference><Citation>Petrie JR, Peters AL, Bergenstal RM, Holl RW, Fleming GA, Heinemann L. Improving the clinical value and utility of CGM systems: issues and recommendations: a joint statement of the European Association for the Study of diabetes and the American Diabetes Association diabetes technology working group. Diabetologia. 2017;60(12):2319-2328.</Citation></Reference><Reference><Citation>Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of diabetes and the American Diabetes Association diabetes technology working group. Diabetes Care. 2015;38(4):716-722.</Citation></Reference><Reference><Citation>Munshi MN. Continuous glucose monitoring use in older adults for optimal diabetes management. Diabetes Technol Ther. 2023;25(S3):S56-S64. doi:10.1089/dia.2023.0111 PMID: 37306446.</Citation></Reference><Reference><Citation>WHO. Ageing: Ageism. 2021 https://www.who.int/news-room/questions-and-answers/item/ageing-ageism</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38010062</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-0258</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>30</Day></PubDate></JournalIssue><Title>Statistics in medicine</Title><ISOAbbreviation>Stat Med</ISOAbbreviation></Journal><ArticleTitle>Bayesian safety surveillance with adaptive bias correction.</ArticleTitle><Pagination><StartPage>395</StartPage><EndPage>418</EndPage><MedlinePgn>395-418</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/sim.9968</ELocationID><Abstract><AbstractText>Postmarket safety surveillance is an integral part of mass vaccination programs. Typically relying on sequential analysis of real-world health data as they accrue, safety surveillance is challenged by sequential multiple testing and by biases induced by residual confounding in observational data. The current standard approach based on the maximized sequential probability ratio test (MaxSPRT) fails to satisfactorily address these practical challenges and it remains a rigid framework that requires prespecification of the surveillance schedule. We develop an alternative Bayesian surveillance procedure that addresses both aforementioned challenges using a more flexible framework. To mitigate bias, we jointly analyze a large set of negative control outcomes that are adverse events with no known association with the vaccines in order to inform an empirical bias distribution, which we then incorporate into estimating the effect of vaccine exposure on the adverse event of interest through a Bayesian hierarchical model. To address multiple testing and improve on flexibility, at each analysis timepoint, we update a posterior probability in favor of the alternative hypothesis that vaccination induces higher risks of adverse events, and then use it for sequential detection of safety signals. Through an empirical evaluation using six US observational healthcare databases covering more than 360 million patients, we benchmark the proposed procedure against MaxSPRT on testing errors and estimation accuracy, under two epidemiological designs, the historical comparator and the self-controlled case series. We demonstrate that our procedure substantially reduces Type 1 error rates, maintains high statistical power and fast signal detection, and provides considerably more accurate estimation than MaxSPRT. Given the extensiveness of the empirical study which yields more than 7 million sets of results, we present all results in a public R ShinyApp. As an effort to promote open science, we provide full implementation of our method in the open-source R package EvidenceSynthesis.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Statistics in Medicine published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bu</LastName><ForeName>Fan</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3697-1477</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of Michigan-Ann Arbor, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-0817-5361</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishimura</LastName><ForeName>Akihiko</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Louisa H</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, Northeastern University, Portland, Maine, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The OHDSI Center at the Roux Institute, Northeastern University, Portland, Maine, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The OHDSI Center at the Roux Institute, Northeastern University, Portland, Maine, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLeggon</LastName><ForeName>Jody-Ann</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG068002</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG068002</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Stat Med</MedlineTA><NlmUniqueID>8215016</NlmUniqueID><ISSNLinking>0277-6715</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="Y">Adverse Drug Reaction Reporting Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011336" MajorTopicYN="N">Probability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011358" MajorTopicYN="Y">Product Surveillance, Postmarketing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bayesian sequential testing</Keyword><Keyword MajorTopicYN="N">postmarket safety surveillance</Keyword><Keyword MajorTopicYN="N">real-world evidence</Keyword><Keyword MajorTopicYN="N">systematic error</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>27</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>27</Day><Hour>9</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38010062</ArticleId><ArticleId IdType="doi">10.1002/sim.9968</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Anderson Roy M, May RM. Directly transmitted infections diseases: control by vaccination. Science. 1982;215:1053-1060.</Citation></Reference><Reference><Citation>Francis Donald P, Hadler Stephen C, Thompson Sumner E, et al. The prevention of hepatitis B with vaccine: report of the Centers for Disease Control multi-center efficacy trial among homosexual men. Ann Intern Med. 1982;97:362-366.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. National Immunization Program (Centers for Disease Control and Prevention), Education and Information and Partnership Branch National Immunization Program (Centers for Disease Control and Prevention). Epidemiology and Prevention of Vaccine-Preventable Diseases. Atlanta, GA: Department of Health &amp; Human Services, Public Health Service, Centers for Disease Control and Prevention; 2005.</Citation></Reference><Reference><Citation>Nowak Glen J, Kristine S, Kelli B, Smith Teresa M, Michelle B. Promoting influenza vaccination: insights from a qualitative meta-analysis of 14&#x2009;years of influenza-related communications research by US Centers for Disease Control and Prevention (CDC). Vaccine. 2015;33:2741-2756.</Citation></Reference><Reference><Citation>Thomas V, Frank DS, Chen Robert T, Elizabeth M. Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines. Expert Rev Vaccines. 2003;2:21-29.</Citation></Reference><Reference><Citation>Lieu Tracy A, Martin K, Davis Robert L, et al. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care. 2007;45:S89-S95.</Citation></Reference><Reference><Citation>Baker Meghan A, Michael N, Cole David V, Lee Grace M, Lieu TA. Post-licensure rapid immunization safety monitoring program (PRISM) data characterization. Vaccine. 2013;31:K98-K112.</Citation></Reference><Reference><Citation>Andreia L, Andrews Nick J, Thomas SL. Near real-time vaccine safety surveillance using electronic health records-a systematic review of the application of statistical methods. Pharmacoepidemiol Drug Saf. 2016;25:225-237.</Citation></Reference><Reference><Citation>Moro Pedro L, Rongxia L, Penina H, Eric W, Maria C. Surveillance systems and methods for monitoring the post-marketing safety of influenza vaccines at the Centers for Disease Control and Prevention. Expert Opin Drug Saf. 2016;15:1175-1183.</Citation></Reference><Reference><Citation>Lee Grace M, Romero Jos&#xe9; R, Bell BP. Postapproval vaccine safety surveillance for COVID-19 vaccines in the US. JAMA. 2020;324:1937-1938.</Citation></Reference><Reference><Citation>EMA European Medicine Agency. Pharmacovigilance Plan of the EU Regulatory Network for COVID-19 Vaccines (EMA/333964/2020). 2020. https://www.ema.europa.eu/en/documents/other/pharmacovigilance-plan-eu-regulatory-network-covid-19-vaccines_en.pdf</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention VAERS. Vaccine Adverse Event Reporting System (VAERS). 2021. https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vaers/index.html</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention VSD. Vaccine Safety Datalink (VSD). 2021. https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vsd/index.html</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention CISA. Clinical Immunization Safety Assessment (CISA) Project. 2021. https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/cisa/index.%html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvaccinesafety%2Factivities2FCISA.html</Citation></Reference><Reference><Citation>World Health Organization (WHO). Establishing Surveillance Systems in Countries Using COVID-19 Vaccines. 2021. https://cdn.who.int/media/docs/default-source/covid-19-vaccines-safety-surveillance-manual/training-slides_covid-19_vs_surveillance_systemsafa53e9c-0bde-4765-90fa-2dedf3b6da72.pdf?sfvrsn=6ccff509_5&amp;Status=Master</Citation></Reference><Reference><Citation>Rodrigues LC, Smith PG. Use of the case-control approach in vaccine evaluation: efficacy and adverse effects. Epidemiol Rev. 1999;21:56-72.</Citation></Reference><Reference><Citation>Glanz Jason M, McClure David L, Stanley X, et al. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. J Clin Epidemiol. 2006;59:808-818.</Citation></Reference><Reference><Citation>Newcomer Sophia R, Martin K, Stan X, et al. Bias from outcome misclassification in immunization schedule safety research. Pharmacoepidemiol Drug Saf. 2018;27:221-228.</Citation></Reference><Reference><Citation>Martin K, Davis RL, Margarette K, Edwin L, Tracy L, Richard P. A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance. Seq Anal. 2011;30:58-78.</Citation></Reference><Reference><Citation>Schuemie Martijn J, Faaizah A, Nicole P, et al. Vaccine Safety Surveillance Using Routinely Collected Healthcare Data-An Empirical Evaluation of Epidemiological Designs. Front Pharmacol. 2022;13:2532.</Citation></Reference><Reference><Citation>Schuemie Martijn J, Fan B, Akihiko N, Suchard Marc A. Adjusting for both sequential testing and systematic error in safety surveillance using observational data: Empirical calibration and MaxSPRT. Stat Med. 2023;42:619-631.</Citation></Reference><Reference><Citation>Barnard GA. Sequential tests in industrial statistics. Suppl J R Stat Soc. 1946;8:1-21.</Citation></Reference><Reference><Citation>Wetherill GB. Bayesian sequential analysis. Biometrika. 1961;48:281-292.</Citation></Reference><Reference><Citation>Berger James O, Brown Lawrence D, Wolpert RL. A unified conditional frequentist and Bayesian test for fixed and sequential simple hypothesis testing. Ann Stat. 1994;22:1787-1807.</Citation></Reference><Reference><Citation>Berger James O, Wolpert RL. The likelihood principle. Institute of Mathematical Statistics Lecture Notes-Monograph. Beachwood, OH: IMS; 1988.</Citation></Reference><Reference><Citation>Berger James O, Ben B, Yinping W. Unified frequentist and Bayesian testing of a precise hypothesis. Stat Sci. 1997;12:133-160.</Citation></Reference><Reference><Citation>Berger James O, Benzion B, Yinping W. Simultaneous Bayesian-frequentist sequential testing of nested hypotheses. Biometrika. 1999;86:79-92.</Citation></Reference><Reference><Citation>Jha Sumit K, Clarke Edmund M, Langmead Christopher J, Axel L, Andr&#xe9; P, Paolo Z. A bayesian approach to model checking biological systems. International Conference on Computational Methods in Systems Biology. Hanover, PA: Springer; 2009:218-234.</Citation></Reference><Reference><Citation>Jerome C. A Bayesian test of some classical hypotheses-with applications to sequential clinical trials. J Am Stat Assoc. 1966;61:577-594.</Citation></Reference><Reference><Citation>Thall Peter F, Simon Richard M, Estey EH. Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes. Stat Med. 1995;14:357-379.</Citation></Reference><Reference><Citation>Smith Michael K, Ieuan J, Morris Mark F, Grieve Andrew P, Keith T. Implementation of a Bayesian adaptive design in a proof of concept study. Pharm Stat J Appl Stat Pharm Ind. 2006;5:39-50.</Citation></Reference><Reference><Citation>Xian Z, Suyu L, Kim Edward S, Herbst Roy S, Jack LJ. Bayesian adaptive design for targeted therapy development in lung cancer-a step toward personalized medicine. Clin Trials. 2008;5:181-193.</Citation></Reference><Reference><Citation>Berry Scott M, Carlin Bradley P, Jack LJ, Peter M. Bayesian adaptive methods for clinical trials. Boca Raton, FL: CRC press; 2010.</Citation></Reference><Reference><Citation>Rongxia L, Brock S, Charles R. A Bayesian approach to sequential analysis in post-licensure vaccine safety surveillance. Pharm Stat. 2020;19:291-302.</Citation></Reference><Reference><Citation>Belongia Edward A, Irving Stephanie A, Shui Irene M, et al. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J. 2010;29:1-5.</Citation></Reference><Reference><Citation>Xintong L, Anna O, Rupa M, et al. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study. BMJ. 2021;373.</Citation></Reference><Reference><Citation>Klein Nicola P, Ned L, Kristin G, et al. Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA. 2021;326:1390-1399.</Citation></Reference><Reference><Citation>Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med. 2006;25:1768-1797.</Citation></Reference><Reference><Citation>Paddy F, Rush M, Miller E, et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet. 1995;345:567-569.</Citation></Reference><Reference><Citation>Farrington CP. Control without separate controls: evaluation of vaccine safety using case-only methods. Vaccine. 2004;22:2064-2070.</Citation></Reference><Reference><Citation>Tchetgen E. The control outcome calibration approach for causal inference with unobserved confounding. Am J Epidemiol. 2014;179:633-640.</Citation></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat Med. 2014;33:209-218.</Citation></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Robust empirical calibration of p-values using observational data. Stat Med. 2016;35:3883-3888.</Citation></Reference><Reference><Citation>George H, Duke Jon D, Shah Nigam H, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. MEDINFO 2015: eHealth-enabled Health. Amsterdam, the Netherlands: IOS Press; 2015:574-578.</Citation></Reference><Reference><Citation>Overhage J, Marc RPB, Reich Christian G, Hartzema Abraham G, Stang Paul E. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19:54-60.</Citation></Reference><Reference><Citation>Schuemie Martijn J, Ryan Patrick B, George H, David M, Suchard MA. Improving reproducibility by using high-throughput observational studies with empirical calibration. Philos Transact A Math Phys Eng Sci. 2018;376:20170356.</Citation></Reference><Reference><Citation>Ravi G, Bradley L, Jonathan D, et al. Risk of Guillain-Barr&#xe9; Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries. JAMA Intern Med. 2021;181:1623-1630.</Citation></Reference><Reference><Citation>Anna O, George H. COVID-19 vaccination effectiveness rates by week and sources of bias: a retrospective cohort study. BMJ Open. 2022;12:e061126.</Citation></Reference><Reference><Citation>Suchard Marc A, Schuemie Martijn J, Krumholz Harlan M, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019;394:1816-1826.</Citation></Reference><Reference><Citation>George H, Ryan Patrick B, Duke Jon D, et al. Characterizing treatment pathways at scale using the OHDSI network. Proceedings of the National Academy of Sciences. Washington, D.C: National Academy of Sciences, Vol 113; 2016:7329-7336.</Citation></Reference><Reference><Citation>Clair B, Defalco Frank J, Ryan Patrick B, Rijnbeek Peter R. Increasing trust in real-world evidence through evaluation of observational data quality. J Am Med Inform Assoc. 2021;28:2251-2257.</Citation></Reference><Reference><Citation>Steven B, Juhani E, Claire-Anne S, et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet. 2009;374:2115-2122.</Citation></Reference><Reference><Citation>Katherine YW, Nordin James D, Martin K, et al. An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. Vaccine. 2009;27:4257-4262.</Citation></Reference><Reference><Citation>Katherine YW, Martin K, Fireman Bruce H, et al. Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project. Pediatrics. 2011;127:S54-S64.</Citation></Reference><Reference><Citation>Buttery JP, Danchin MH, Lee KJ, et al. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine. 2011;29:3061-3066.</Citation></Reference><Reference><Citation>Leonoor W, Coralie L, Corinne V, et al. The incidence of narcolepsy in Europe: before, during, and after the influenza A (H1N1) pdm09 pandemic and vaccination campaigns. Vaccine. 2013;31:1246-1254.</Citation></Reference><Reference><Citation>Barker Charlotte IS, Snape MD. Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action. Lancet Infect Dis. 2014;14:227-238.</Citation></Reference><Reference><Citation>Salmon Daniel A, Michael P, Richard F, et al. Association between Guillain-Barr&#xe9; syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet. 2013;381:1461-1468.</Citation></Reference><Reference><Citation>Cl&#xe9;mence G, Pauline B, J&#xe9;r&#xe9;mie R, et al. Seasonal influenza vaccine and Guillain-Barr&#xe9; syndrome: a self-controlled case series study. Neurology. 2020;94:e2168-e2179.</Citation></Reference><Reference><Citation>Faaizah A, Schuemie Martijn J, Fan B, et al. Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance. Drug Saf. 2023;797-807:1-11.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38035971</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>149</Volume><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Convert-Pheno: A software toolkit for the interconversion of standard data models for phenotypic data.</ArticleTitle><Pagination><StartPage>104558</StartPage><MedlinePgn>104558</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2023.104558</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(23)00279-4</ELocationID><Abstract><AbstractText>Efficient sharing and integration of phenotypic data is crucial for advancing biomedical research and enhancing patient outcomes in precision medicine and public health. To achieve this, the health data community has developed standards to promote the harmonization of variable names and values. However, the use of diverse standards across different research centers can hinder progress. Here we present Convert-Pheno, an open-source software toolkit that enables the interconversion of common data models for phenotypic data such as Beacon v2 Models, CDISC-ODM, OMOP-CDM, Phenopackets v2, and REDCap. Along with the software, we have created a detailed documentation that includes information on deployment and installation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rueda</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centro Nacional de An&#xe1;lisis Gen&#xf3;mico, C/Baldiri Reixac 4, 08028 Barcelona, Spain; Universitat de Barcelona (UB), Barcelona, Spain. Electronic address: manuel.rueda@cnag.eu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leist</LastName><ForeName>Ivo C</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Centro Nacional de An&#xe1;lisis Gen&#xf3;mico, C/Baldiri Reixac 4, 08028 Barcelona, Spain; Universitat de Barcelona (UB), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gut</LastName><ForeName>Ivo G</ForeName><Initials>IG</Initials><AffiliationInfo><Affiliation>Centro Nacional de An&#xe1;lisis Gen&#xf3;mico, C/Baldiri Reixac 4, 08028 Barcelona, Spain; Universitat de Barcelona (UB), Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004282" MajorTopicYN="N">Documentation</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>30</Day><Hour>21</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38035971</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2023.104558</ArticleId><ArticleId IdType="pii">S1532-0464(23)00279-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38158381</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1557</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Pharmacoepidemiology and drug safety</Title><ISOAbbreviation>Pharmacoepidemiol Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration's Adverse Event Reporting System.</ArticleTitle><Pagination><StartPage>e5743</StartPage><MedlinePgn>e5743</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pds.5743</ELocationID><Abstract><AbstractText Label="BACKGROUND">Medication errors (MEs) are a major public health concern which can cause harm and financial burden within the healthcare system. Characterizing MEs is crucial to develop strategies to mitigate MEs in the future.</AbstractText><AbstractText Label="OBJECTIVES">To characterize ME-associated reports, and investigate signals of disproportionate reporting (SDRs) on MEs in the Food and Drug Administration's Adverse Event Reporting System (FAERS).</AbstractText><AbstractText Label="METHODS">FAERS data from 2004 to 2020 was used. ME reports were identified with the narrow Standardised Medical Dictionary for Regulatory Activities&#xae; (MedDRA&#xae;) Query (SMQ) for MEs. Drug names were converted to the Anatomical Therapeutic Chemical (ATC) classification. SDRs were investigated using the reporting odds ratio (ROR).</AbstractText><AbstractText Label="RESULTS">In total 488&#x2009;470 ME reports were identified, mostly (59%) submitted by consumers and mainly (55%) associated with females. Median age at time of ME was 57&#x2009;years (interquartile range: 37-70&#x2009;years). Approximately 1 out of 3 reports stated a serious health outcome. The most prevalent reported drug class was "antineoplastic and immunomodulating agents" (25%). The most common ME type was "incorrect dose administered" (9%). Of the 1659 SDRs obtained, adalimumab was the most common drug associated with MEs, noting a ROR of 1.22 (95% confidence interval: 1.21-1.24).</AbstractText><AbstractText Label="CONCLUSION">This study offers a first of its kind characterization of MEs as reported to FAERS. Reported MEs are frequent and may be associated with serious health outcomes. This FAERS data provides insights on ME prevention and offers possibilities for additional in-depth analyses.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Pharmacoepidemiology and Drug Safety published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pera</LastName><ForeName>Victor</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-0786-4712</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Vaerenbergh</LastName><ForeName>Frauke</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-7709-7651</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioanalysis, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kors</LastName><ForeName>Jan A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0002-4929-026X</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Mulligen</LastName><ForeName>Erik M</ForeName><Initials>EM</Initials><Identifier Source="ORCID">0000-0003-1377-9386</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parry</LastName><ForeName>Rowan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Wilde</LastName><ForeName>Marcel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lahousse</LastName><ForeName>Lies</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3494-4363</Identifier><AffiliationInfo><Affiliation>Department of Bioanalysis, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Lei</LastName><ForeName>Johan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9203-3410</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><Identifier Source="ORCID">0000-0003-0621-1979</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verhamme</LastName><ForeName>Katia M C</ForeName><Initials>KMC</Initials><Identifier Source="ORCID">0000-0001-8162-4904</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioanalysis, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>European Health Data and Evidence Network (EHDEN) project</Agency><Country/></Grant><Grant><GrantID>806968</GrantID><Agency>Innovative Medicines Initiative 2 Joint Undertaking (JU)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacoepidemiol Drug Saf</MedlineTA><NlmUniqueID>9208369</NlmUniqueID><ISSNLinking>1053-8569</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004364">Pharmaceutical Preparations</NameOfSubstance></Chemical><Chemical><RegistryNumber>FYS6T7F842</RegistryNumber><NameOfSubstance UI="D000068879">Adalimumab</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004364" MajorTopicYN="N">Pharmaceutical Preparations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014486" MajorTopicYN="N">United States Food and Drug Administration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="Y">Adverse Drug Reaction Reporting Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008508" MajorTopicYN="Y">Medication Errors</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068879" MajorTopicYN="N">Adalimumab</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060735" MajorTopicYN="N">Pharmacovigilance</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">disproportionality analysis</Keyword><Keyword MajorTopicYN="N">medication errors</Keyword><Keyword MajorTopicYN="N">pharmacovigilance</Keyword><Keyword MajorTopicYN="N">spontaneous reporting</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>2</Day><Hour>11</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>29</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38158381</ArticleId><ArticleId IdType="doi">10.1002/pds.5743</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>rxr@usp.org. About Medication Errors. NCC MERP. Published July 18, 2014. Accessed January 18, 2021. https://www.nccmerp.org/about-medication-errors</Citation></Reference><Reference><Citation>Research C for DE and. Working to Reduce Medication Errors. FDA. Published online August 23, 2019. Accessed September 17, 2021. https://www.fda.gov/drugs/information-consumers-and-patients-drugs/working-reduce-medication-errors</Citation></Reference><Reference><Citation>Research C for DE and. Medication Errors Related to CDER-Regulated Drug Products. FDA. Published August 25, 2023. Accessed November 10, 2023. https://www.fda.gov/drugs/drug-safety-and-availability/medication-errors-related-cder-regulated-drug-products</Citation></Reference><Reference><Citation>WHO | Medication Without Harm. Published 2022. Accessed January 13, 2021. https://www.who.int/initiatives/medication-without-harm</Citation></Reference><Reference><Citation>Aitken M, Gorokhovich L. Advancing the responsible use of medicines: applying levers for change. Social Sci Res Netw. 2012. doi:10.2139/ssrn.2222541</Citation></Reference><Reference><Citation>Assiri GA, Shebl NA, Mahmoud MA, et al. What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts? A systematic review of the international literature. BMJ Open. 2018;8(5):e019101. doi:10.1136/bmjopen-2017-019101</Citation></Reference><Reference><Citation>Lisby M. Department of Quality Improvement and Patient Safety AUH Aarhus,Denmark, Department of Clinical Pharmacology AUH Aarhus,Denmark, et al. how are medication errors defined? A systematic literature review of definitions and characteristics. International J Qual Health Care. 2020;22(6):507-518. doi:10.1093/intqhc/mzq059</Citation></Reference><Reference><Citation>Elliott RA, Camacho E, Jankovic D, Sculpher MJ, Faria R. Economic analysis of the prevalence and clinical and economic burden of medication error in England. BMJ Qual Saf. 2021;30:96-105. doi:10.1136/bmjqs-2019-010206</Citation></Reference><Reference><Citation>Rodwin BA, Bilan VP, Merchant NB, et al. Rate of preventable mortality in hospitalized patients: a systematic review and meta-analysis. J Gen Intern Med. 2020;35(7):2099-2106. doi:10.1007/s11606-019-05592-5</Citation></Reference><Reference><Citation>Tariq RA, Vashisht R, Sinha A, Scherbak Y. Medication dispensing errors and prevention. StatPearls. StatPearls Publishing; 2020 Accessed January 13, 2021. http://www.ncbi.nlm.nih.gov/books/NBK519065/</Citation></Reference><Reference><Citation>Newbould V, Le Meur S, Goedecke T, Kurz X. Medication errors: a characterisation of spontaneously reported cases in EudraVigilance. Drug Saf. 2017;40(12):1241-1248. doi:10.1007/s40264-017-0569-3</Citation></Reference><Reference><Citation>Carnovale C, Mazhar F, Pozzi M, Gentili M, Clementi E, Radice S. A characterization and disproportionality analysis of medication error related adverse events reported to the FAERS database. Expert Opin Drug Saf. 2018;17(12):1161-1169. doi:10.1080/14740338.2018.1550069</Citation></Reference><Reference><Citation>Wong CK, Ho SS, Saini B, Hibbs DE, Fois RA. Standardisation of the FAERS database: a systematic approach to manually recoding drug name variants. Pharmacoepidemiol Drug Saf. 2015;24(7):731-737. doi:10.1002/pds.3805</Citation></Reference><Reference><Citation>Questions and Answers on FDA's Adverse Event Reporting System (FAERS). FDA. Published May 22, 2019. Accessed July 9, 2021. https://www.fda.gov/drugs/surveillance/questions-and-answers-fdas-adverse-event-reporting-system-faers</Citation></Reference><Reference><Citation>MedWatch Online Voluntary Reporting Form. Published 2019. Accessed July 9, 2021. https://www.accessdata.fda.gov/scripts/medwatch/index.cfm</Citation></Reference><Reference><Citation>Food and Drug Administration. FAERS Quarterly Data Extract Files. Published 2021. Accessed July 9, 2021. https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html</Citation></Reference><Reference><Citation>FAIRsharing Team. FAIRsharing record for: FDA's Adverse Event Reporting System. Published online 2022 10.25504/FAIRSHARING.AB1BD6</Citation></Reference><Reference><Citation>Banda JM, Evans L, Vanguri RS, Tatonetti NP, Ryan PB, Shah NH. A curated and standardized adverse drug event resource to accelerate drug safety research. Sci Data. 2016;3(1):160026. doi:10.1038/sdata.2016.26</Citation></Reference><Reference><Citation>ltscomputingllc/faersdbstats. Published online February 24, 2021. Accessed July 7, 2021 https://github.com/ltscomputingllc/faersdbstats</Citation></Reference><Reference><Citation>Parry R. AEOLUS. https://github.com/mi-erasmusmc/faersdbstats. Published online 2021. Accessed July 26, 2022. https://github.com/mi-erasmusmc/faersdbstats</Citation></Reference><Reference><Citation>Parry R. AIOLI. https://github.com/mi-erasmusmc/aioli. Published online 2021. Accessed July 7, 2021. https://github.com/mi-erasmusmc/aioli</Citation></Reference><Reference><Citation>List of SMQ topics. Published online September 2020. Accessed January 11, 2021. https://admin.new.meddra.org/sites/default/files/page/documents/List%20of%20SMQ%20topics%20September%202020.pdf</Citation></Reference><Reference><Citation>Standardised MedDRA Queries | MedDRA. Published 2021. Accessed January 11, 2021. https://www.meddra.org/standardised-meddra-queries</Citation></Reference><Reference><Citation>Office of the Commissioner. Reporting Serious Problems to FDA. FDA. Published September 9, 2020. Accessed March 25, 2022. https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program/reporting-serious-problems-fda</Citation></Reference><Reference><Citation>European Medicines Agency. Screening for adverse reactions in EudraVigilance. Published online December 19, 2016. Accessed July 8, 2021. https://www.ema.europa.eu/en/documents/other/screening-adverse-reactions-eudravigilance_en.pdf</Citation></Reference><Reference><Citation>Affordable Care Act (ACA) - HealthCare.gov Glossary. HealthCare.gov. Published 2021. Accessed November 9, 2021. https://www.healthcare.gov/glossary/affordable-care-act/</Citation></Reference><Reference><Citation>Glied S, Ma S, Borja AA. Effect of the affordable care act on health care access. Issue Brief Commonw Fund. 2017;13:1-11.</Citation></Reference><Reference><Citation>Percent insured. Peterson-KFF Health System Tracker. Published 2021. Accessed November 9, 2021. https://www.healthsystemtracker.org/indicator/access-affordability/percent-insured/</Citation></Reference><Reference><Citation>Toki T, Ono S. Spontaneous reporting on adverse events by consumers in the United States: an analysis of the Food and Drug Administration adverse event reporting system database. Drugs - Real World Outcomes. 2018;5(2):117-128. doi:10.1007/s40801-018-0134-0</Citation></Reference><Reference><Citation>Recognize and Report It. Oncology Nursing News. Published October 12, 2018. Accessed November 9, 2021. https://www.oncnursingnews.com/view/recognize-and-report-it</Citation></Reference><Reference><Citation>Uppsala Monitoring Centre | #MedSafetyWeek. Published November 8, 2021. Accessed November 9, 2021. https://www.who-umc.org/global-pharmacovigilance/pharmacovigilance-communications/medsafetyweek/</Citation></Reference><Reference><Citation>Stergiopoulos S, Brown CA, Felix T, Grampp G, Getz KA. A survey of adverse event reporting practices among US healthcare professionals. Drug Saf. 2016;39(11):1117-1127. doi:10.1007/s40264-016-0455-4</Citation></Reference><Reference><Citation>Al Dweik R, Stacey D, Kohen D, Yaya S. Factors affecting patient reporting of adverse drug reactions: a systematic review. Br J Clin Pharmacol. 2017;83(4):875-883. doi:10.1111/bcp.13159</Citation></Reference><Reference><Citation>The Use of Medicines in the U.S. - Spending and usage trends and outlook. 2025 Published online May 2021. https://www.iqvia.com/-/media/iqvia/pdfs/institute-reports/the-use-of-medicines-in-the-us/iqi-the-use-of-medicines-in-the-us-05-21-forweb.pdf</Citation></Reference><Reference><Citation>Bureau UC. The U.S. Joins Other Countries With Large Aging Populations. Census.gov. Published October 2019. Accessed November 10, 2021. https://www.census.gov/library/stories/2018/03/graying-america.html</Citation></Reference><Reference><Citation>Smith M, Saunders R, Stuckhardt L, McGinnis JM, America C, on the LHCS in, Medicine I of. Imperative: Managing Rapidly Increasing Complexity. National Academies Press; 2013 Accessed November 10, 2021. https://www.ncbi.nlm.nih.gov/books/NBK207221/</Citation></Reference><Reference><Citation>Quinn KJ, Shah NH. A dataset quantifying polypharmacy in the United States. Sci Data. 2017;4:170167. doi:10.1038/sdata.2017.167</Citation></Reference><Reference><Citation>Oktora MP, Denig P, Bos JHJ, Schuiling-Veninga CCM, Hak E. Trends in polypharmacy and dispensed drugs among adults in The Netherlands as compared to the United States. PLoS One. 2019;14(3):e0214240. doi:10.1371/journal.pone.0214240</Citation></Reference><Reference><Citation>Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the United States from 1999-2012. JAMA. 2015;314(17):1818-1831. doi:10.1001/jama.2015.13766</Citation></Reference><Reference><Citation>Manteuffel M, Williams S, Chen W, Verbrugge RR, Pittman DG, Steinkellner A. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. J Womens Health. 2014;23(2):112-119. doi:10.1089/jwh.2012.3972</Citation></Reference><Reference><Citation>Osika Friberg I, Krantz G, M&#xe4;&#xe4;tt&#xe4; S, J&#xe4;rbrink K. Sex differences in health care consumption in Sweden: a register-based cross-sectional study. Scand J Public Health. 2016;44(3):264-273. doi:10.1177/1403494815618843</Citation></Reference><Reference><Citation>Rinke ML, Bundy DG, Velasquez CA, et al. Interventions to reduce pediatric medication errors: a systematic review. Pediatrics. 2014;134(2):338-360. doi:10.1542/peds.2013-3531</Citation></Reference><Reference><Citation>Ferrah N, Lovell JJ, Ibrahim JE. Systematic review of the prevalence of medication errors resulting in hospitalization and death of nursing home residents. J Am Geriatr Soc. 2017;65(2):433-442. doi:10.1111/jgs.14683</Citation></Reference><Reference><Citation>Suh Y, Ah YM, Lee E, Lee JY. Association of inappropriate polypharmacy with emergency department visits in older patients receiving anti-neoplastic therapy: a population-based study. Support Care Cancer. 2021;29(6):3025-3034. doi:10.1007/s00520-020-05759-5</Citation></Reference><Reference><Citation>Schlichtig K, D&#xfc;rr P, D&#xf6;rje F, Fromm MF. Medication errors during treatment with new Oral anticancer agents: consequences for clinical practice based on the AMBORA study. Clin Pharmacol Ther. 2021;110(4):1075-1086. doi:10.1002/cpt.2338</Citation></Reference><Reference><Citation>Dorothy A, Yadesa TM, Atukunda E. Prevalence of medication errors and the associated factors: a prospective observational study among cancer patients at Mbarara regional referral hospital. Cancer Manag Res. 2021;13:3739-3748. doi:10.2147/CMAR.S307001</Citation></Reference><Reference><Citation>Laatikainen O, Sneck S, Turpeinen M. The risks and outcomes resulting from medication errors reported in the Finnish tertiary care units. Front Pharmacol. 2020;10:1571. doi:10.3389/fphar.2019.01571</Citation></Reference><Reference><Citation>Berdot S, Sabatier B, Gillaizeau F, Caruba T, Prognon P, Durieux P. Evaluation of drug administration errors in a teaching hospital. BMC Health Serv Res. 2012;12:60. doi:10.1186/1472-6963-12-60</Citation></Reference><Reference><Citation>Tobiasz A, Nowicka D, Szepietowski JC. Acne vulgaris-novel treatment options and factors affecting therapy adherence: a narrative review. J Clin Med. 2022;11(24):7535. doi:10.3390/jcm11247535</Citation></Reference><Reference><Citation>Moradi Tuchayi S, Alexander TM, Nadkarni A, Feldman SR. Interventions to increase adherence to acne treatment. Patient Prefer Adherence. 2016;10:2091-2096. doi:10.2147/PPA.S117437</Citation></Reference><Reference><Citation>Mahler LJ. On-body injector: an administration device for pegfilgrastim. Clin J Oncol Nurs. 2017;21(1):121-122. doi:10.1188/17.CJON.121-122</Citation></Reference><Reference><Citation>Joshi RS, Egbuna OI, Cairns AS, et al. Performance of the pegfilgrastim on-body injector as studied with placebo buffer in healthy volunteers. Curr Med Res Opin. 2017;33(2):379-384. doi:10.1080/03007995.2016.1257980</Citation></Reference><Reference><Citation>Stuessy P, Sanchez FA, Schober M. Retrospective review of pegfilgrastim on-body injector delivery rates in a large health system. J Clin Oncol. 2017;35(15_suppl):e18273. doi:10.1200/JCO.2017.35.15_suppl.e18273</Citation></Reference><Reference><Citation>Nicole MMP. Comparing grade 4 neutropenia associated with pegfilgrastim administered via the onpro device versus manual injection with a prefilled syringe. Published Online September 18, 2018. Accessed May 26, 2023. https://jhoponline.com/issue-archive/2018-issues/jhop-september-2018-vol-8-no-3/17561-comparing-grade-4-neutropenia-associated-with-pegfilgrastim-administered-via-the-onpro-device-versus-manual-injection-with-a-prefilled-syringe</Citation></Reference><Reference><Citation>Maahs L, Tang A, Saheli ZA, Jacob B, Polasani R, Hwang C. Real-world effectiveness of the pegfilgrastim on-body injector in preventing severe neutropenia. J Oncol Pharm Pract. 2022;28(1):17-23. doi:10.1177/1078155220980517</Citation></Reference><Reference><Citation>Gursoy UK, Bostanc&#x131; V, Kosger HH. Palatal mucosa necrosis because of accidental sodium hypochlorite injection instead of anaesthetic solution. Int Endod J. 2006;39(2):157-161. doi:10.1111/j.1365-2591.2006.01067.x</Citation></Reference><Reference><Citation>Marroni M, Menichetti F. Accidental intravenous infusion of sodium hypochlorite. DICP Ann Pharmacother. 1991;25(9):1008-1009. doi:10.1177/106002809102500919</Citation></Reference><Reference><Citation>Peck BW, Workeneh B, Kadikoy H, Abdellatif A. Sodium hypochlorite-induced acute kidney injury. Saudi J Kidney Dis Transplant. 2014;25(2):381-384. doi:10.4103/1319-2442.128553</Citation></Reference><Reference><Citation>Pontes F, Pontes H, Adachi P, Rodini C, Almeida D, Pinto D Jr. Gingival and bone necrosis caused by accidental sodium hypochlorite injection instead of anaesthetic solution. Int Endod J. 2008;41(3):267-270. doi:10.1111/j.1365-2591.2007.01340.x</Citation></Reference><Reference><Citation>Zhou AY, Trujillo JM. Comparison of usability, accuracy, preference, and satisfaction among three once-weekly GLP-1 receptor agonist pen devices. Diabetes Spectr Publ Am Diabetes Assoc. 2018;31(4):359-366. doi:10.2337/ds17-0048</Citation></Reference><Reference><Citation>Eperzan&#x25bc;(albiglutide): global discontinuation of medicine. Published online September 9, 2017.</Citation></Reference><Reference><Citation>Usmani OS, Lavorini F, Marshall J, et al. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res. 2018;19:10. doi:10.1186/s12931-017-0710-y</Citation></Reference><Reference><Citation>Sulku J, Br&#xf6;ms K, H&#xf6;gman M, et al. Critical inhaler technique errors in Swedish patients with COPD: a cross-sectional study analysing video-recorded demonstrations. NPJ Prim Care Respir Med. 2021;31:5. doi:10.1038/s41533-021-00218-y</Citation></Reference><Reference><Citation>Plaza V, Giner J, Rodrigo GJ, Dolovich MB, Sanchis J. Errors in the use of inhalers by health care professionals: a systematic review. J Allergy Clin Immunol Pract. 2018;6(3):987-995. doi:10.1016/j.jaip.2017.12.032</Citation></Reference><Reference><Citation>Sanchis J, Gich I, Pedersen S. Systematic review of errors in inhaler use: has patient technique improved over time? Chest. 2016;150(2):394-406. doi:10.1016/j.chest.2016.03.041</Citation></Reference><Reference><Citation>Rutledge DN, Retrosi T, Ostrowski G. Barriers to medication error reporting among hospital nurses. J Clin Nurs. 2018;27(9-10):1941-1949. doi:10.1111/jocn.14335</Citation></Reference><Reference><Citation>Rishoej RM, Hallas J, Juel Kjeldsen L, Thybo Christesen H, Almarsd&#xf3;ttir AB. Likelihood of reporting medication errors in hospitalized children: a survey of nurses and physicians. Ther Adv Drug Saf. 2018;9(3):179-192. doi:10.1177/2042098617746053</Citation></Reference><Reference><Citation>Alatawi YM, Hansen RA. Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). Expert Opin Drug Saf. 2017;16(7):761-767. doi:10.1080/14740338.2017.1323867</Citation></Reference><Reference><Citation>Schroll JB, Maund E, G&#xf8;tzsche PC. Challenges in coding adverse events in clinical trials: a systematic review. PLoS One. 2012;7(7):e41174. doi:10.1371/journal.pone.0041174</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38166330</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2638-6100</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Radiology. Artificial intelligence</Title><ISOAbbreviation>Radiol Artif Intell</ISOAbbreviation></Journal><ArticleTitle>The Scottish Medical Imaging Archive: 57.3 Million Radiology Studies Linked to Their Medical Records.</ArticleTitle><Pagination><StartPage>e220266</StartPage><MedlinePgn>e220266</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e220266</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1148/ryai.220266</ELocationID><Abstract><AbstractText><b>Keywords:</b> MRI, Imaging Sequences, Ultrasound, Mammography, CT, Angiography, Conventional Radiography Published under a CC BY 4.0 license. See also the commentary by Whitman and Vining in this issue.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baxter</LastName><ForeName>Rob</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3693-8725</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nind</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sutherland</LastName><ForeName>James</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4939-2335</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McAllister</LastName><ForeName>Gordon</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-1435-1317</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardy</LastName><ForeName>Douglas</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hume</LastName><ForeName>Ally</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8322-9182</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacLeod</LastName><ForeName>Ruairidh</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2641-2543</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caldwell</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3506-2936</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krueger</LastName><ForeName>Susan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5219-1959</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tramma</LastName><ForeName>Leandro</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3432-3978</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teviotdale</LastName><ForeName>Ross</ForeName><Initials>R</Initials><Identifier Source="ORCID">0009-0005-7609-2102</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gillen</LastName><ForeName>Kenny</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scobbie</LastName><ForeName>Donald</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2540-3565</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baillie</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brooks</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8837-3201</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prodan</LastName><ForeName>Bianca</ForeName><Initials>B</Initials><Identifier Source="ORCID">0009-0005-3603-1225</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerr</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sloan-Murphy</LastName><ForeName>Dominic</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-6524-8539</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrera</LastName><ForeName>Juan F R</ForeName><Initials>JFR</Initials><Identifier Source="ORCID">0000-0002-6085-8549</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Beek</LastName><ForeName>Edwin J R</ForeName><Initials>EJR</Initials><Identifier Source="ORCID">0000-0002-2777-5071</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reel</LastName><ForeName>Parminder Singh</ForeName><Initials>PS</Initials><Identifier Source="ORCID">0000-0001-7796-1457</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reel</LastName><ForeName>Smarti</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6092-9175</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mansouri-Benssassi</LastName><ForeName>Esma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mudie</LastName><ForeName>Roy</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7930-7256</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steele</LastName><ForeName>Douglas</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doney</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trucco</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-5055-0794</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Carole</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-8150-8217</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parsons</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jefferson</LastName><ForeName>Emily</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-2992-7582</Identifier><AffiliationInfo><Affiliation>From the EPCC, University of Edinburgh, Edinburgh, Scotland, United Kingdom (R.B., A.H., R.M., D.S., A.B., B.P., W.K., D.S.M., J.F.R.H., M.P.); Health Informatics Centre (T.N., J.S., G.M., D.H., S.K., L.T., R.T., K.G., P.S.R., S.R., E.M.B., R.M., E.J.), Division of Imaging Science and Technology (D.S.), Division of Population Health and Genomics (A.D.), and Department of Computing (E.T.), University of Dundee, Dundee DD1&#x2009;4HN, Scotland; Public Health Scotland, Edinburgh, Scotland (J.C., I.B., C.M., R.W.); University of Edinburgh Brain Research Imaging Centre, Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, Scotland (E.J.R.v.B.); Health Data Research UK, London, England (A.M., E.J.).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S010351/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Radiol Artif Intell</MedlineTA><NlmUniqueID>101746556</NlmUniqueID><ISSNLinking>2638-6100</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D011859" MajorTopicYN="N">Radiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008327" MajorTopicYN="Y">Mammography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008499" MajorTopicYN="N">Medical Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011871" MajorTopicYN="Y">Radiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012606" MajorTopicYN="N" Type="Geographic">Scotland</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Angiography</Keyword><Keyword MajorTopicYN="N">CT</Keyword><Keyword MajorTopicYN="N">Conventional Radiography</Keyword><Keyword MajorTopicYN="N">Imaging Sequences</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">Mammography</Keyword><Keyword MajorTopicYN="N">Ultrasound</Keyword></KeywordList><CoiStatement><b>Disclosures of conflicts of interest: </b><b>R.B.</b> The Medical Research Council (MRC) grant no. MR/M501633/1
and the Wellcome Trust grant no. WT086113 through the Scottish Health
Informatics Programme (SHIP); the PICTURES 5-year program grant from the MRC
and EPSRC (grant no. MR/S010351/1); the Chief Scientist Office of the
Scottish Government Health and Social Care Directorates via a leverage grant
made to Farr Scotland; The Scottish Government through the &#x201c;Imaging
AI&#x201d; grant award; Health Data Research (HDR) UK, which receives its
funding from HDR UK Ltd (HDR-5012) funded by the UK MRC, Engineering and
Physical Sciences Research Council, Economic and Social Research Council,
Department of Health and Social Care (England), Chief Scientist Office of
the Scottish Government Health and Social Care Directorates, Health and
Social Care Research and Development Division (Welsh Government), Public
Health Agency (Northern Ireland), British Heart Foundation (BHF), and the
Wellcome Trust; The Edinburgh and South-East Scotland City Region Deal, the
University of Edinburgh, and UK charities. <b>T.N.</b> No relevant
relationships. <b>J.S.</b> The Medical Research Council (MRC) grant
no. MR/M501633/1 and the Wellcome Trust grant no. WT086113 through the
Scottish Health Informatics Programme (SHIP); the PICTURES 5-year programme
grant from the MRC and EPSRC (grant no. MR/S010351/1); Chief Scientist
Office of the Scottish Government Health and Social Care Directorates via a
leverage grant made to Farr Scotland; the Scottish Government through the
&#x201c;Imaging AI&#x201d; grant award; Health Data Research (HDR) UK, which
receives its funding from HDR UK Ltd (HDR-5012) funded by the UK MRC,
Engineering and Physical Sciences Research Council, Economic and Social
Research Council, Department of Health and Social Care (England), Chief
Scientist Office of the Scottish Government Health and Social Care
Directorates, Health and Social Care Research and Development Division
(Welsh Government), Public Health Agency (Northern Ireland), British Heart
Foundation (BHF), and the Wellcome Trust; the Edinburgh and South-East
Scotland City Region Deal, the University of Edinburgh, and UK charities.
(Grants received by author's employer, the University of Dundee,
and/or partners the University of Edinburgh). <b>G.M.</b> No relevant
relationships. <b>D.H.</b> Support from University of Dundee.
<b>A.H.</b> No relevant relationships. <b>R.M.</b> The
PICTURES 5-year program grant from the MRC and EPSRC (grant no.
MR/S010351/1) to institution. <b>J.C.</b> No relevant relationships.
<b>S.K.</b> UK Research and Innovation, Medical Research Council
(MRC) grant number MR/S010351/1 - under which The Scottish Medical Imaging
Archive was established (the topic of this manuscript). <b>L.T.</b> No
relevant relationships. <b>R.T.</b> No relevant relationships.
<b>K.G.</b> No relevant relationships. <b>D.S.</b> No
relevant relationships. <b>I.B.</b> No relevant relationships.
<b>A.B.</b> University of Edinburgh (employer). <b>B.P.</b>
The Medical Research Council (MRC) grant no. MR/M501633/1. <b>W.K.</b>
No relevant relationships. <b>D.S.M.</b> Employee of University of
Edinburgh EPCC at time of writing. <b>J.F.R.H.</b> The Farr Institute
(Scotland). <b>E.J.R.v.B.</b> No relevant relationships.
<b>P.S.R.</b> No relevant relationships. <b>S.R.</b> No
relevant relationships. <b>E.M.B.</b> No relevant relationships.
<b>R.M.</b> Salary from University of Dundee Public Health
Scotland, support from University of Dundee for travel. <b>D.S.</b>
MRC (MR/S010351/1), &#xa3;4.4M Program Grant, &#x2018;MICA:
Interdisciplinary Collaboration for efficient and effective use of clinical
images in big heath care research: PICTURES&#x2019;. <b>A.D.</b> No
relevant relationships. <b>E.T.</b> No relevant relationships.
<b>C.M.</b> No relevant relationships. <b>R.W.</b> No
relevant relationships. <b>A.M.</b> No relevant relationships.
<b>M.P.</b> No relevant relationships. <b>E.J.</b> MRC,
EPSRC, CSO, Aidence (company - leveraged), Scottish Government &#x2013;
Programme for Government: supporting Artificial Intelligence (AI) research
using clinical images at scale. 2019-2020. Funder: Scottish Government
&#x2013; Programme for Government. PI. Total award: &#xa3;80,000;
interdisciplinary Collaboration for efficient and effective Use of clinical
images in big data health care Research: PICTURES. 2019-2024. Funder: MRC
and EPSRC Programme Grant. PI. Total award: &#xa3;2.9M + &#xa3;900k
leveraged funds from industry; Scottish Research Images Repository.
Informatics research to develop a software platform for processing,
anonymizing, and provision in a Safe Haven environment all of the routinely
collected images stored in the National PACS system. 2013&#x2013;2018.
Funder: MRC (The Scottish eHealth Informatics Research Centre
(E-HIRCs)/Farr) &amp; CSO (several separate grants). Responsible for
delivery rather than Co-I as obtained before author's academic
contract. Award: ~&#xa3;540k; NHS Education for Scotland, Health
Foundation, SODOH, CSO, MRC, GSK, NHS Fife Endowment Fund, HDR UK - Research
Councils, EU, DataLab, Health Foundation, NIHR, EPSRC, EHDEN, NHSX, Tenovus:
Guidelines and Resources for AI Model Access from TrusTEd Research
environments (GRAIMATTER). 2022-2022 (sprint). Funder: MRC &#x2013; DARE. PI
(&#xa3;315,488); Trusted Research Environment and Enclave for Hosting Open
Original Science Exploration (TREEHOOSE). 2022-2022 (sprint). Funder: MRC
&#x2013; DARE. Co-I (&#xa3;202,664); Alleviate: Hub for Pain (Pain
Research Data Hub &#x2013; UKRI and Versus Arthritis Strategic Priority Fund
(SPF) Advanced Pain Discovery Platform). 2021-2024. Funder: MRC. Co-PI.
Total Award: &#xa3;2,000,000; CO-CONNECT: COVID - Curated and open
analysis and research platform. 2020-2022. Funder: MRC. Co-PI. Total Award:
&#xa3;4,091,229; Linking and Mapping Primary Care Data for Studying
COVID-19 in the Community (COVID-19 call). 2020-2021. Funder: Tenovus.
Co-PI. Awarded amount: &#xa3;20,000; National COVID-19 Chest Imaging
Database (NCCID). 2020-2021. Funder: NHSX. Collaborator. Award to Dundee
&#xa3;30,000; World Class Labs (Multiomics) Capital Award. 2020-2021.
Funder: HDR UK. PI. Total award: &#xa3;400,000; creating a national
platform for powerful molecular studies of multiple conditions: the HDRUK
multiomics consortium. 2020-2022. Funder: MRC/HDR UK. Co-I and Workstream
lead (Responsible for &#xa3;73,860). Total Award: &#xa3;1,088,605; The
Safe Haven Metadata (SHEMA) Project. 2020-2021. Funder: Chief Scientist
Office (CSO). PI. Total award: &#xa3;20,000 (initial phase, next phase
&#xa3;100k); data standardization using the OMOP common data model.
2020-2022. Funder: European Health Data &amp; Evidence Network (EHDEN).
Co-PI. Total award: &#xa3;86,489; Cambridge Mathematics of Information in
Healthcare (CMIH). 2020-2023. Funder: EPSRC. Co-I (Responsible for
&#xa3;56,000). Total Award: &#xa3;1,275,504; Centre for Antimicrobial
Resistance. 2019-2022. Funder: NIHR. Co-I and Workstream lead (Responsible
for &#xa3;260,369). Total Award: &#xa3;2,253,124; Primary Care &#x2013;
Improved Data for Improved Outcomes. 2019-2021. Funder: Health Foundation.
PI (Responsible for &#xa3;69,336). Total Award: &#xa3;190,009; Building
the Knowledge Graph for UK Healthcare Data Science. 2019-2020. Funder: HDR
UK. Co-I (Responsible for &#xa3;64,449). Total award: &#xa3;272,657;
Multimorbidity and clinical guidelines: using epidemiology to quantify the
applicability of trial evidence to inform guideline development. 2019-2020.
Funder: Chief Scientist Office (CSO) Scotland. Co-I and Workstream lead
(Responsible for &#xa3;143,218). Total award: &#xa3;356,667; Learning
healthcare system for stroke precision medicine pathway (P4Me). 2019-2022.
Funder: DataLab. Co-I (Responsible for &#xa3;79,933). Total award:
&#xa3;94,690; Integration of Knowledge and Biobank Resources in
Comprehensive Translational Approach for Personalized Prevention and
Treatment of Metabolic Disorders (INTEGROMED). 2019-2021. Funder: EU. Co-I
(Responsible for &#xa3;9,257). Total award: &#xa3;124,778; Graph Based
Data Federation for Healthcare Data Science. 2019-2020. Funder: HDR UK. Co-I
and workstream lead (Responsible for (&#xa3;76,000)). Total Award:
&#xa3;272,657; Defining &amp; Redefining Disease Using Multimodal Data on
a National Scale: the HDR UK Phenomics Resource. 2019-2022. Funder: MRC/HDR
UK. Co-I and Workstream lead (Responsible for &#xa3;119,466). Total Award:
&#xa3;1,087,168; Health Data Research UK Scottish Substantive Site.
2018-2023. Funder: Research Councils. Co-I (Responsible for
&#xa3;366,000). Total award: &#xa3;5,151,421; Enabling Learning NHS Care
Systems utilising Electronic Medical Records (ELectra) in Fife. Innovative
and opportunities to support NHS Fife Clinical Strategy. 2018-2019. Funder:
NHS Fife Endowment Fund. Co-I and Workstream lead (Responsible for:
&#xa3;91,505). Total award: &#xa3;174,636; Omic-Based Strategies for
Improved Diagnosis and Treatment of Endocrine Hypertension (ENSAT-HT).
2015-2022. Funder: EU-H2020 Societal Challenges SC1 - Health and Wellbeing.
Co-I and Workstream lead (Responsible for: &#xa3;857,423). Total award:
&#xa3;7,418,982; Utilising Routinely Collected Electronic Medical Records
to Predict Dementia. 2015. Funder: CSO. PI. Award: &#xa3;36,877; Discovery
of Novel Disease Mechanisms through Advanced Biomedical Informatics.
2015-2019. Funder: MRC Case PhD Studentship in collaboration with GSK. PI.
Award: &#xa3;127,774; Scottish Improvement Science Research, Development
and Knowledge Translation Collaborating Centre (SISCC). 2014-2021. Funders:
NHS Education for Scotland, Health Foundation, SODOH-CSO. Co-I (Responsible
for &#xa3;600,000). Award: &#xa3;2,764,551; consulting fees from
Wellcome Trust, Pain Data Prize (grant scoping, &#xa3;3000);
payment/honoraria from Pfizer for lunch and learn (&#xa3;1125 Overcoming
the Challenges of Providing Access to Population Scale, Routinely Collected
Health and Imaging Data for AI Development whilst Protecting Patient
Confidentiality); support for travel for MRC panels (quarterly meeting for
two panels - &#xa3;80 per meeting).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>4</Day><Hour>11</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>3</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>2</Day><Hour>16</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38166330</ArticleId><ArticleId IdType="pmc">PMC10831519</ArticleId><ArticleId IdType="doi">10.1148/ryai.220266</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
ISD
Services 
. 
Electronic Data
Research and Innovation Service (eDRIS)
. 
ISD
Scotland
. 
https://www.isdscotland.org/Products-and-Services/eDRIS/.
Accessed November 9, 2022.
</Citation></Reference><Reference><Citation>
Scottish Medical Imaging (SMI)
Research Dataset
. 
https://web.www.healthdatagateway.org/dataset/1c49a822-6432-468b-8ba5-6aab534654b9.
Accessed November 9, 2022.
</Citation></Reference><Reference><Citation>Nind T , Sutherland J , McAllister G , et al. . An extensible big data software architecture managing a research resource of real-world clinical radiology data linked to other health data from the whole Scottish population . Gigascience 2020. ; 9 ( 10 ): giaa095 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7523405</ArticleId><ArticleId IdType="pubmed">32990744</ArticleId></ArticleIdList></Reference><Reference><Citation>
PICTURES 
. 
Supporting
the use of data for health care research - Image on a Mission.
Pictures
. 
https://www.imageonamission.ac.uk/. Accessed November 9,
2022.
</Citation></Reference><Reference><Citation>
Research Data Management
Platform
. 
HicServices
. 
https://github.com/HicServices/RDMP. Published 2023.
Accessed May 9, 2023.
</Citation></Reference><Reference><Citation>
The Scottish Medical Imaging
Project
(SMI)
. 
GitHub
. 
https://github.com/SMI. Accessed November 9,
2022.
</Citation></Reference><Reference><Citation>
ISD
Services 
. 
National Data
Catalogue
. 
ISD
Scotland
. 
https://www.ndc.scot.nhs.uk/. Accessed November 9,
2022.
</Citation></Reference><Reference><Citation>UK Health Data Research Alliance . NHSX . Building Trusted Research Environments - Principles and Best Practices; Towards TRE ecosystems . Zenodo; . Published December 8, 2021. Accessed May 21, 2022.</Citation></Reference><Reference><Citation>
Scottish
Government 
. 
Charter for Safe
Havens in Scotland: Handling Unconsented Data from National Health Service
Patient Records to Support Research and
Statistics
. 
http://www.gov.scot/publications/charter-safe-havens-scotland-handling-unconsented-data-national-health-service-patient-records-support-research-statistics/.
Accessed May 21, 2022.
</Citation></Reference><Reference><Citation>Mair G , Alzahrani A , Lindley RI , Sandercock PAG , Wardlaw JM . Feasibility and diagnostic accuracy of using brain attenuation changes on CT to estimate time of ischemic stroke onset . Neuroradiology 2021. ; 63 ( 6 ): 869 &#x2013; 878 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8128810</ArticleId><ArticleId IdType="pubmed">33128140</ArticleId></ArticleIdList></Reference><Reference><Citation>
Whole population automated
reading of brain imaging reports in linked electronic health records
(WARBLER)
. 
The University of
Edinburgh
. 
https://www.ed.ac.uk/usher/clinical-natural-language-processing/our-research/whole-population-automated-reading-brain-imaging.
Published 2020. Accessed May 18, 2023.
</Citation></Reference><Reference><Citation>
SCONe 
. 
The
University of Edinburgh
. 
https://www.ed.ac.uk/clinical-sciences/ophthalmology/scone.
Published 2023. Accessed May 18, 2023.
</Citation></Reference><Reference><Citation>Russell ER , Stewart K , Mackay DF , MacLean J , Pell JP , Stewart W . Football's InfluencE on Lifelong health and Dementia risk (FIELD): protocol for a retrospective cohort study of former professional footballers . BMJ Open 2019. ; 9 ( 5 ): e028654 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6538057</ArticleId><ArticleId IdType="pubmed">31123003</ArticleId></ArticleIdList></Reference><Reference><Citation>
National COVID-19 Chest Imaging Database
(NCCID) 
. 
NHS Transformation
Directorate
. 
https://transform.england.nhs.uk/covid-19-response/data-and-covid-19/national-covid-19-chest-imaging-database-nccid/.
Accessed May 18, 2023.
</Citation></Reference><Reference><Citation>
Population by Country of Birth and
Nationality. Scotland, July 2020 to June
2021
. 
National Records of
Scotland 
. 
National Records of
Scotland
. 
https://www.nrscotland.gov.uk/statistics-and-data/statistics/statistics-by-theme/population/population-estimates/population-by-country-of-birth-and-nationality/jul-20-jun-21.
Published 2022. Accessed November 9, 2022.
</Citation></Reference><Reference><Citation>
Tackling Health Inequalities
&#x2013; an NHS Response
. 
https://www.sehd.scot.nhs.uk/nationalframework/documents/tackling%20healthinequalities240505.pdf.
Accessed November 24, 2022.
</Citation></Reference><Reference><Citation>Jefferson E , Liley J , Malone M , et al. . GRAIMATTER Green Paper: Recommendations for disclosure control of trained Machine Learning (ML) models from Trusted Research Environments (TREs) . Zenodo . Published September 21, 2022. Accessed November 9, 2022.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38175665</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>OHDSI Standardized Vocabularies-a large-scale centralized reference ontology for international data harmonization.</ArticleTitle><Pagination><StartPage>583</StartPage><EndPage>590</EndPage><MedlinePgn>583-590</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocad247</ELocationID><Abstract><AbstractText Label="IMPORTANCE">The Observational Health Data Sciences and Informatics (OHDSI) is the largest distributed data network in the world encompassing more than 331 data sources with 2.1 billion patient records across 34 countries. It enables large-scale observational research through standardizing the data into a common data model (CDM) (Observational Medical Outcomes Partnership [OMOP] CDM) and requires a comprehensive, efficient, and reliable ontology system to support data harmonization.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We created the OHDSI Standardized Vocabularies-a common reference ontology mandatory to all data sites in the network. It comprises imported and de novo-generated ontologies containing concepts and relationships between them, and the praxis of converting the source data to the OMOP CDM based on these. It enables harmonization through assigned domains according to clinical categories, comprehensive coverage of entities within each domain, support for commonly used international coding schemes, and standardization of semantically equivalent concepts.</AbstractText><AbstractText Label="RESULTS">The OHDSI Standardized Vocabularies comprise over 10 million concepts from 136 vocabularies. They are used by hundreds of groups and several large data networks. More than 8600 users have performed 50&#x200a;000 downloads of the system. This open-source resource has proven to address an impediment of large-scale observational research-the dependence on the context of source data representation. With that, it has enabled efficient phenotyping, covariate construction, patient-level prediction, population-level estimation, and standard reporting.</AbstractText><AbstractText Label="DISCUSSION AND CONCLUSION">OHDSI has made available a comprehensive, open vocabulary system that is unmatched in its ability to support global observational research. We encourage researchers to exploit it and contribute their use cases to this dynamic resource.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-3641-055X</Identifier><AffiliationInfo><Affiliation>Coordinating Center, Observational Health Data Sciences and Informatics, New York City NY 10032, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Center at the Roux Institute, Northeastern University, Portland ME 04101, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Coordinating Center, Observational Health Data Sciences and Informatics, New York City NY 10032, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York City NY 10032, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Odysseus Data Services, Cambridge MA 02142, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Coordinating Center, Observational Health Data Sciences and Informatics, New York City NY 10032, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York City NY 10032, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research &amp; Development, Titusville NJ 08560, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Coordinating Center, Observational Health Data Sciences and Informatics, New York City NY 10032, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Coordinating Center, Observational Health Data Sciences and Informatics, New York City NY 10032, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research &amp; Development, Titusville NJ 08560, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davydov</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Coordinating Center, Observational Health Data Sciences and Informatics, New York City NY 10032, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Odysseus Data Services, Cambridge MA 02142, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dymshyts</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Coordinating Center, Observational Health Data Sciences and Informatics, New York City NY 10032, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research &amp; Development, Titusville NJ 08560, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Coordinating Center, Observational Health Data Sciences and Informatics, New York City NY 10032, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York City NY 10032, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077488" MajorTopicYN="Y">Data Science</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014825" MajorTopicYN="N">Vocabulary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="Y">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">controlled vocabulary</Keyword><Keyword MajorTopicYN="N">observational data</Keyword></KeywordList><CoiStatement>All authors declare no competing interests relevant to this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>4</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>4</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38175665</ArticleId><ArticleId IdType="pmc">PMC10873827</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocad247</ArticleId><ArticleId IdType="pii">7510741</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Popovic JR. Distributed data networks: a blueprint for Big Data sharing and healthcare analytics: distributed data networks. Ann N Y Acad Sci. 2017;1387(1):105-111. 10.1111/nyas.13287</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.13287</ArticleId><ArticleId IdType="pubmed">27862002</ArticleId></ArticleIdList></Reference><Reference><Citation>Coloma PM, Trifir&#xf2; G, Schuemie MJ, et al.; EU-ADR Consortium. Electronic healthcare databases for active drug safety surveillance: is there enough leverage?: healthcare databases and power to detect safety signals. Pharmacoepidemiol Drug Saf. 2012;21(6):611-621. 10.1002/pds.3197</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3197</ArticleId><ArticleId IdType="pubmed">22315152</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown J, Lane K, Moore K, et al.Defining and Evaluating Possible Database Models to Implement the FDA Sentinel Initiative. Food and Drug Administration; 2009.</Citation></Reference><Reference><Citation>Wilcox A, Randhawa G, Embi P, et al.Sustainability considerations for health research and analytic data infrastructures. EGEMS (Wash DC). 2014;2(2):8. 10.13063/2327-9214.1113</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1113</ArticleId><ArticleId IdType="pmc">PMC4371522</ArticleId><ArticleId IdType="pubmed">25848610</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Batson D, Schilling LM.. Data model considerations for clinical effectiveness researchers. Med Care. 2012;50Suppl:S60-S67. 10.1097/MLR.0b013e318259bff4</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e318259bff4</ArticleId><ArticleId IdType="pmc">PMC3824370</ArticleId><ArticleId IdType="pubmed">22692260</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, et al.Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016;64:333-341. 10.1016/j.jbi.2016.10.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.10.016</ArticleId><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B, Brochhausen M.. Establishing and harmonizing ontologies in an interdisciplinary health care and clinical research environment. Stud Health Technol Inform. 2008;134:219-233.</Citation><ArticleIdList><ArticleId IdType="pubmed">18376049</ArticleId></ArticleIdList></Reference><Reference><Citation>Belenkaya R, Gurley MJ, Golozar A, et al.Extending the OMOP common data model and standardized vocabularies to support observational cancer research. JCO Clin Cancer Inform. 2021;5:12-20. 10.1200/CCI.20.00079</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/CCI.20.00079</ArticleId><ArticleId IdType="pmc">PMC8140810</ArticleId><ArticleId IdType="pubmed">33411620</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Joss MAH, Embree K, et al.Data model harmonization for the all of US research program: transforming i2b2 data into the OMOP common data model. PLoS One. 2019;14(2):e0212463. 10.1371/journal.pone.0212463</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0212463</ArticleId><ArticleId IdType="pmc">PMC6380544</ArticleId><ArticleId IdType="pubmed">30779778</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimino JJ. Desiderata for controlled medical vocabularies in the twenty-first century. Methods Inf Med. 1998;37(04/05):394-403. 10.1055/s-0038-1634558</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0038-1634558</ArticleId><ArticleId IdType="pmc">PMC3415631</ArticleId><ArticleId IdType="pubmed">9865037</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Levine ME, Shang N, et al.Effect of vocabulary mapping for conditions on phenotype cohorts. JAMIA. 2018;25(12):1618-1625. 10.1093/jamia/ocy124</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy124</ArticleId><ArticleId IdType="pmc">PMC6289550</ArticleId><ArticleId IdType="pubmed">30395248</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicaid program. Medicaid management information system requirements for physician and supplier services&#x2014;HCFA. Final notice. Fed Regist. 1985;50:40895-40899.</Citation><ArticleIdList><ArticleId IdType="pubmed">10300362</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicaid program. Medicaid management information system proposed system requirements&#x2014;HCFA. Proposed notice. Fed Regist. 1983;48:16750-16754.</Citation><ArticleIdList><ArticleId IdType="pubmed">10299047</ArticleId></ArticleIdList></Reference><Reference><Citation>Miriovsky BJ, Shulman LN, Abernethy AP.. Importance of health information technology, electronic health records, and continuously aggregating data to comparative effectiveness research and learning health care. J Clin Oncol. 2012;30(34):4243-4248. 10.1200/JCO.2012.42.8011</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2012.42.8011</ArticleId><ArticleId IdType="pubmed">23071233</ArticleId></ArticleIdList></Reference><Reference><Citation>Siska MH, Tribble DA.. Opportunities and challenges related to technology in supporting optimal pharmacy practice models in hospitals and health systems. Am J Health Syst Pharm. 2011;68(12):1116-1126. 10.2146/ajhp110059</Citation><ArticleIdList><ArticleId IdType="doi">10.2146/ajhp110059</ArticleId><ArticleId IdType="pubmed">21642575</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezin J, Duong M, Lassalle R, et al.The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2017;26(8):954-962. 10.1002/pds.4233</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4233</ArticleId><ArticleId IdType="pubmed">28544284</ArticleId></ArticleIdList></Reference><Reference><Citation>Trifir&#xf2; G, Coloma PM, Rijnbeek PR, et al.Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how? J Intern Med. 2014;275(6):551-561. 10.1111/joim.12159</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12159</ArticleId><ArticleId IdType="pubmed">24635221</ArticleId></ArticleIdList></Reference><Reference><Citation>Avillach P, Coloma PM, Gini R, et al.; EU-ADR Consortium. Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project. J AMIA. 2013;20(1):184-192. 10.1136/amiajnl-2012-000933</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2012-000933</ArticleId><ArticleId IdType="pmc">PMC3555316</ArticleId><ArticleId IdType="pubmed">22955495</ArticleId></ArticleIdList></Reference><Reference><Citation>
Sachson C, Ryan P, Kostka K, et al. Our Journey. Where the OHDSI Community Has Been and Where We Are Going. Accessed December 23, 2023. https://www.ohdsi.org/wp-content/uploads/2022/10/OHDSI-OurJourney-2022.pdf.</Citation></Reference><Reference><Citation>Sankar PL, Parker LS.. The precision medicine initiative&#x2019;s all of US research program: an agenda for research on its ethical, legal, and social issues. Genet Med. 2017;19(7):743-750. 10.1038/gim.2016.183</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2016.183</ArticleId><ArticleId IdType="pubmed">27929525</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman O, Kuivaniemi H, Tromp G, et al.; and The eMERGE Network. The electronic medical records and genomics (eMERGE) network: past, present, and future. Genet Med. 2013;15(10):761-771. 10.1038/gim.2013.72</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2013.72</ArticleId><ArticleId IdType="pmc">PMC3795928</ArticleId><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes N, Rijnbeek P, Van Speybroeck M.. The European Health Data and Evidence Network (EHDEN)&#x2014;Liberating Evidence Via Harmonisation of EU Real World Data. European ODHSI Symposium; 2018.</Citation></Reference><Reference><Citation>Haendel MA, Chute CG, Bennett TD, et al.; N3C Consortium. The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment. JAMIA. 2021;28(3):427-443. 10.1093/jamia/ocaa196</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa196</ArticleId><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphreys BL, Lindberg DA, Hole WT.. Assessing and enhancing the value of the UMLS knowledge sources. Proc Annu Symp Comput Appl Med Care. 1991:78-82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2247499</ArticleId><ArticleId IdType="pubmed">1807711</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing X. The unified medical language system at 30 years and how it is used and published: systematic review and content analysis. JMIR Med Inform. 2021; 279(8):e20675. 10.2196/20675</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/20675</ArticleId><ArticleId IdType="pmc">PMC8433943</ArticleId><ArticleId IdType="pubmed">34236337</ArticleId></ArticleIdList></Reference><Reference><Citation>
OMOP Common Data Model. GitHub. Accessed December 23, 2023. https://ohdsi.github.io/CommonDataModel/.</Citation></Reference><Reference><Citation>PALLAS: Build process for OMOP Standardized Vocabularies. 2020. Accessed December 23, 2023. https://github.com/OHDSI/Vocabulary-v5.0.</Citation></Reference><Reference><Citation>Athena. Accessed December 23, 2023. http://athena.ohdsi.org/search-terms/terms.</Citation></Reference><Reference><Citation>Ryan PB, Madigan D, Stang PE, et al.Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the observational medical outcomes partnership. Stat Med. 2012;31(30):4401-4415. 10.1002/sim.5620</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5620</ArticleId><ArticleId IdType="pubmed">23015364</ArticleId></ArticleIdList></Reference><Reference><Citation>Musen MA, Noy NF, Shah NH, NCBO Team, et al.The national center for biomedical ontology. JAMIA. 2012;19(2):190-195. 10.1136/amiajnl-2011-000523</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000523</ArticleId><ArticleId IdType="pmc">PMC3277625</ArticleId><ArticleId IdType="pubmed">22081220</ArticleId></ArticleIdList></Reference><Reference><Citation>Moskovitch R, Martins SB, Behiri E, et al.A comparative evaluation of full-text, concept-based, and context-sensitive search. JAMIA. 2007;14(2):164-174. 10.1197/jamia.M1953</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M1953</ArticleId><ArticleId IdType="pmc">PMC2213470</ArticleId><ArticleId IdType="pubmed">17213502</ArticleId></ArticleIdList></Reference><Reference><Citation>Modaresnezhad M, Vahdati A, Nemati H, et al.A rule-based semantic approach for data integration, standardization and dimensionality reduction utilizing the UMLS: application to predicting bariatric surgery outcomes. Comput Biol Med. 2019;106:84-90. 10.1016/j.compbiomed.2019.01.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2019.01.019</ArticleId><ArticleId IdType="pubmed">30708220</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashyap M, Seneviratne M, Banda JM,. et al. Development and validation of phenotype classifiers across multiple sites in the observational health data sciences and informatics network. J Am Med Inform Assoc. 2020;27(6):877-883. 10.1093/jamia/ocaa032</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa032</ArticleId><ArticleId IdType="pmc">PMC7309227</ArticleId><ArticleId IdType="pubmed">32374408</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, et al.Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci USA. 2016;113(27):7329-7336. 10.1073/pnas.1510502113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1510502113</ArticleId><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke JD, Ryan PB, Suchard MA, et al.Risk of angioedema associated with levetiracetam compared with phenytoin: findings of the observational health data sciences and informatics research network. Epilepsia. 2017;58(8):e101-e106. 10.1111/epi.13828</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.13828</ArticleId><ArticleId IdType="pmc">PMC6632067</ArticleId><ArticleId IdType="pubmed">28681416</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan You S, Krumholz HM, Suchard MA, et al.Comprehensive comparative effectiveness and safety of first-line &#x3b2;-blocker monotherapy in hypertensive patients: a large-scale multicenter observational study. Hypertension. 2021;77(5):1528-1538. 10.1161/HYPERTENSIONAHA.120.16402</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.16402</ArticleId><ArticleId IdType="pmc">PMC8035236</ArticleId><ArticleId IdType="pubmed">33775125</ArticleId></ArticleIdList></Reference><Reference><Citation>Khera R, Schuemie MJ, Lu Y, et al.Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies. BMJ Open. 2022;12(6):e057977. 10.1136/bmjopen-2021-057977</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-057977</ArticleId><ArticleId IdType="pmc">PMC9185490</ArticleId><ArticleId IdType="pubmed">35680274</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Pratt N, et al.Large-scale evidence generation and evaluation across a network of databases (LEGEND): assessing validity using hypertension as a case study. JAMIA. 2020;27(8):1268-1277. 10.1093/jamia/ocaa124</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa124</ArticleId><ArticleId IdType="pmc">PMC7481033</ArticleId><ArticleId IdType="pubmed">32827027</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Reps JM, Kostka KF, et al.Development and validation of a prognostic model predicting symptomatic hemorrhagic transformation in acute ischemic stroke at scale in the OHDSI network. PLoS One. 2020;15(1):e0226718. 10.1371/journal.pone.0226718</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0226718</ArticleId><ArticleId IdType="pmc">PMC6946584</ArticleId><ArticleId IdType="pubmed">31910437</ArticleId></ArticleIdList></Reference><Reference><Citation>Vashisht R, Jung K, Schuler A, et al.Association of hemoglobin a1c levels with use of sulfonylureas, dipeptidyl peptidase 4 inhibitors, and thiazolidinediones in patients with type 2 diabetes treated with metformin: analysis from the observational health data sciences and informatics initiative. JAMA Netw Open. 2018;1(4):e181755. 10.1001/jamanetworkopen.2018.1755</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2018.1755</ArticleId><ArticleId IdType="pmc">PMC6324274</ArticleId><ArticleId IdType="pubmed">30646124</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostka K, Duarte-Salles T, Prats-Uribe A, et al.Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS. Clin Epidemiol. 2022;14:369-384. 10.2147/CLEP.S323292</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S323292</ArticleId><ArticleId IdType="pmc">PMC8957305</ArticleId><ArticleId IdType="pubmed">35345821</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostropolets A, Reich C, Ryan P, et al.Characterizing database granularity using SNOMED-CT hierarchy. AMIA Annu Symp Proc. 2020;2020:983-992.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8075504</ArticleId><ArticleId IdType="pubmed">33936474</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC, Jung S, Swerdel JN, et al.Comparison of first-line dual combination treatments in hypertension: real-world evidence from multinational heterogeneous cohorts. Korean Circ J. 2020;50(1):52-68. 10.4070/kcj.2019.0173</Citation><ArticleIdList><ArticleId IdType="doi">10.4070/kcj.2019.0173</ArticleId><ArticleId IdType="pmc">PMC6923236</ArticleId><ArticleId IdType="pubmed">31642211</ArticleId></ArticleIdList></Reference><Reference><Citation>Prieto-Alhambra D, Bourke A, Burkard T, et al.Development and external validation of a patient-level prediction model for 60-day mortality following total knee arthroplasty: a multinational cohort study. Osteoporosis Int. 2019;30:S178-S179.</Citation></Reference><Reference><Citation>Brauer R, Wong ICK, Man KK, et al.Application of a Common Data Model (CDM) to rank the paediatric user and prescription prevalence of 15 different drug classes in South Korea, Hong Kong, Taiwan, Japan and Australia: an observational, descriptive study. BMJ Open. 2020;10(1):e032426. 10.1136/bmjopen-2019-032426</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2019-032426</ArticleId><ArticleId IdType="pmc">PMC7044847</ArticleId><ArticleId IdType="pubmed">31937652</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, You SC, Sena AG,. et al. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat Commun. 2020;11(1):5009. 10.1038/s41467-020-18849-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18849-z</ArticleId><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A, Ryan P, Fife D, et al.Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug Saf. 2014;37(11):945-959. 10.1007/s40264-014-0214-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0214-3</ArticleId><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Candore G, Hedenmalm K, Slattery J, et al.Can we rely on results from IQVIA medical research data UK converted to the observational medical outcome partnership common data model?: a validation study based on prescribing codeine in children. Clin Pharmacol Ther. 2020;107(4):915-925. 10.1002/cpt.1785</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.1785</ArticleId><ArticleId IdType="pmc">PMC7158210</ArticleId><ArticleId IdType="pubmed">31956997</ArticleId></ArticleIdList></Reference><Reference><Citation>
Dymshyts D, Ostropolets A, Reich C. International RxNorm Extension to support the expansion of the OHDSI research network beyond the US. 2017.&#xa0;Accessed December 23, 2023. https://www.ohdsi.org/web/wiki/lib/exe/fetch.php?media=resources:rxe_poster_2017.pdf</Citation></Reference><Reference><Citation>
American Society for Quality. What is a Quality Management System (QMS)? | ASQ. Accessed December 23, 2023. https://asq.org/quality-resources/quality-management-system.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38219763</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-2619</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The Lancet. Respiratory medicine</Title><ISOAbbreviation>Lancet Respir Med</ISOAbbreviation></Journal><ArticleTitle>The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia.</ArticleTitle><Pagination><StartPage>225</StartPage><EndPage>236</EndPage><MedlinePgn>225-236</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2213-2600(23)00414-9</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2600(23)00414-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although vaccines have proved effective to prevent severe COVID-19, their effect on preventing long-term symptoms is not yet fully understood. We aimed to evaluate the overall effect of vaccination to prevent long COVID symptoms and assess comparative effectiveness of the most used vaccines (ChAdOx1 and BNT162b2).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a staggered cohort study using primary care records from the UK (Clinical Practice Research Datalink [CPRD] GOLD and AURUM), Catalonia, Spain (Information System for Research in Primary Care [SIDIAP]), and national health insurance claims from Estonia (CORIVA database). All adults who were registered for at least 180 days as of Jan 4, 2021 (the UK), Feb 20, 2021 (Spain), and Jan 28, 2021 (Estonia) comprised the source population. Vaccination status was used as a time-varying exposure, staggered by vaccine rollout period. Vaccinated people were further classified by vaccine brand according to their first dose received. The primary outcome definition of long COVID was defined as having at least one of 25 WHO-listed symptoms between 90 and 365 days after the date of a PCR-positive test or clinical diagnosis of COVID-19, with no history of that symptom 180 days before SARS-Cov-2 infection. Propensity score overlap weighting was applied separately for each cohort to minimise confounding. Sub-distribution hazard ratios (sHRs) were calculated to estimate vaccine effectiveness against long COVID, and empirically calibrated using negative control outcomes. Random effects meta-analyses across staggered cohorts were conducted to pool overall effect estimates.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">A total of 1&#x2009;618 395 (CPRD GOLD), 5&#x2009;729 800 (CPRD AURUM), 2&#x2009;744&#x2009;821 (SIDIAP), and 77&#x2009;603 (CORIVA) vaccinated people and 1&#x2009;640&#x2009;371 (CPRD GOLD), 5&#x2009;860&#x2009;564 (CPRD AURUM), 2&#x2009;588&#x2009;518 (SIDIAP), and 302&#x2009;267 (CORIVA) unvaccinated people were included. Compared with unvaccinated people, overall HRs for long COVID symptoms in people vaccinated with a first dose of any COVID-19 vaccine were 0&#xb7;54 (95% CI 0&#xb7;44-0&#xb7;67) in CPRD GOLD, 0&#xb7;48 (0&#xb7;34-0&#xb7;68) in CPRD AURUM, 0&#xb7;71 (0&#xb7;55-0&#xb7;91) in SIDIAP, and 0&#xb7;59 (0&#xb7;40-0&#xb7;87) in CORIVA. A slightly stronger preventative effect was seen for the first dose of BNT162b2 than for ChAdOx1 (sHR 0&#xb7;85 [0&#xb7;60-1&#xb7;20] in CPRD GOLD and 0&#xb7;84 [0&#xb7;74-0&#xb7;94] in CPRD AURUM).</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Vaccination against COVID-19 consistently reduced the risk of long COVID symptoms, which highlights the importance of vaccination to prevent persistent COVID-19 symptoms, particularly in adults.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">National Institute for Health and Care Research.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Catal&#xe0;</LastName><ForeName>Mart&#xed;</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology Group, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mercad&#xe9;-Besora</LastName><ForeName>N&#xfa;ria</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolde</LastName><ForeName>Raivo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trinh</LastName><ForeName>Nhung T H</ForeName><Initials>NTH</Initials><AffiliationInfo><Affiliation>Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roel</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burn</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology Group, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rathod-Mistry</LastName><ForeName>Trishna</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology Group, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology Group, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Man</LastName><ForeName>Wai Yi</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology Group, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delmestri</LastName><ForeName>Antonella</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology Group, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nordeng</LastName><ForeName>Hedvig M E</ForeName><Initials>HME</Initials><AffiliationInfo><Affiliation>Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway; Department of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uusk&#xfc;la</LastName><ForeName>Anneli</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina, Barcelona, Spain; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology Group, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Oxford National Institute for Health and Care Research Biomedical Research Centre, University of Oxford, Oxford, UK; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands. Electronic address: daniel.prietoalhambra@ndorms.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xf6;dicke</LastName><ForeName>Annika M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology Group, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Respir Med</MedlineTA><NlmUniqueID>101605555</NlmUniqueID><ISSNLinking>2213-2600</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000090982">BNT162 Vaccine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000090982" MajorTopicYN="N">BNT162 Vaccine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004957" MajorTopicYN="N" Type="Geographic">Estonia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests DP-A's department has received grants from Amgen, Chiesi-Taylor, Lilly, Janssen, Novartis, UCB Biopharma, the European Medicines Agency, and the Innovative Medicines Initiative. DP-A's research group has received consultancy fees from Astra Zeneca and UCB Biopharma. DP-A's department has organised training programmes funded or supported by Amgen, Astellas, Janssen, Synapse Management Partners, and UCB Biopharma. RK's research group has received consultancy fees from AstraZeneca and the Estonian Ministry of Social Affairs through RITA CORIVA and RITA MAITT (Machine learning and AI powered public services) projects. AU reports funding from the European Regional Development Fund (RITA 1/02&#x2013;120) for her institution (Department of Family Medicine and Public Health, University of Tartu). HMEN reports support from the European Health Data and Evidence Network project grant, Innovative Medicines Initiative 2 Joint Undertaking (grant agreement 806968) for harmonisation of the Norwegian registry data into the Observational Medical Outcomes Partnership (OMOP) common data model (CDM). TD-S reports funding from the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement 806968) for the institute to map the SIDIAP data to the OMOP CDM. This initiative received support from the EU Horizon 2020 research and innovation programme and European Federation of Pharmaceutical Industries and Associations. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>15</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>14</Day><Hour>18</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38219763</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(23)00414-9</ArticleId><ArticleId IdType="pii">S2213-2600(23)00414-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38269685</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>310</Volume><PubDate><Year>2024</Year><Month>Jan</Month><Day>25</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Prediction Models for Readmission Using Home Healthcare Notes and OMOP-CDM.</ArticleTitle><Pagination><StartPage>1438</StartPage><EndPage>1439</EndPage><MedlinePgn>1438-1439</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI231233</ELocationID><Abstract><AbstractText>This study developed readmission prediction models using Home Healthcare (HHC) documents via natural language processing (NLP). An electronic health record of Ajou University Hospital was used to develop prediction models (A reference model using only structured data, and an NLP-enriched model with structured and unstructured data). Among 573 patients, 63 were readmitted to the hospital. Five topics were extracted from HHC documents and improved the model performance (AUROC 0.740).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gan</LastName><ForeName>Sujin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Chungsoo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Dong Yun</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010359" MajorTopicYN="N">Patient Readmission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008511" MajorTopicYN="Y">Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006699" MajorTopicYN="Y">Home Care Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Readmission</Keyword><Keyword MajorTopicYN="N">home healthcare</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">prediction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>5</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38269685</ArticleId><ArticleId IdType="doi">10.3233/SHTI231233</ArticleId><ArticleId IdType="pii">SHTI231233</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38269763</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>310</Volume><PubDate><Year>2024</Year><Month>Jan</Month><Day>25</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Multi-Institutional Collaborative Research Using Ophthalmic Medical Image Data Standardized by Radiology Common Data Model (R-CDM).</ArticleTitle><Pagination><StartPage>48</StartPage><EndPage>52</EndPage><MedlinePgn>48-52</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI230925</ELocationID><Abstract><AbstractText>Observational Medical Outcome Partners - Common Data Model (OMOP-CDM) is an international standard model for standardizing electronic medical record data. However, unstructured data such as medical image data which is beyond the scope of standardization by the current OMOP-CDM is difficult to be used in multi-institutional collaborative research. Therefore, we developed the Radiology-CDM (R-CDM) which standardizes medical imaging data. As a proof of concept, 737,500 Optical Coherence Tomography (OCT) data from two tertiary hospitals in South Korea is standardized in the form of R-CDM. The relationship between chronic disease and retinal thickness was analyzed by using the R-CDM. Central macular thickness and retinal nerve fiber layer (RNFL) thickness were significantly thinner in the patients with hypertension compared to the control cohort. It is meaningful in that multi-institutional collaborative research using medical image data and clinical data simultaneously can be conducted very efficiently.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>ChulHyoung</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sang Jun</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Da Yun</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedicine Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Kihwang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005145" MajorTopicYN="Y">Face</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011859" MajorTopicYN="N">Radiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011871" MajorTopicYN="Y">Radiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012160" MajorTopicYN="N">Retina</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Medical imaging data</Keyword><Keyword MajorTopicYN="N">data standardization</Keyword><Keyword MajorTopicYN="N">ophthalmology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>5</Hour><Minute>46</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38269763</ArticleId><ArticleId IdType="doi">10.3233/SHTI230925</ArticleId><ArticleId IdType="pii">SHTI230925</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38269767</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>310</Volume><PubDate><Year>2024</Year><Month>Jan</Month><Day>25</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Promoting Learning Health System Cycles by Optimizing EHR Data Clinical Concept Encoding Processes.</ArticleTitle><Pagination><StartPage>68</StartPage><EndPage>73</EndPage><MedlinePgn>68-73</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI230929</ELocationID><Abstract><AbstractText>Electronic health records (EHRs) and other real-world data (RWD) are critical to accelerating and scaling care improvement and transformation. To efficiently leverage it for secondary uses, EHR/RWD should be optimally managed and mapped to industry standard concepts (ISCs). Inherent challenges in concept encoding usually result in inefficient and costly workflows and resultant metadata representation structures outside the EHR. Using three related projects to map data to ISCs, we describe the development of standard, repeatable processes for precisely and unambiguously representing EHR data using appropriate ISCs within the EHR platform lifecycle and mappings specific to SNOMED-CT for Demographics, Specialty and Services. Mappings in these 3 areas resulted in ISC mappings of 779 data elements requiring 90 new concept requests to SNOMED-CT and 738 new ISCs mapped into the workflow within an accessible, enterprise-wide EHR resource with supporting processes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ranallo</LastName><ForeName>Piper</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Fairview Health Services, Minneapolis, MN USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Southwell</LastName><ForeName>Bronwyn</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University of Minnesota, Minneapolis, MN USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tignanelli</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Minnesota, Minneapolis, MN USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Steven G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>University of Minnesota, Minneapolis, MN USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krueger</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Fairview Health Services, Minneapolis, MN USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sevareid-Groth</LastName><ForeName>Tess</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fairview Health Services, Minneapolis, MN USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvel</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fairview Health Services, Minneapolis, MN USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melton</LastName><ForeName>Genevieve B</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Fairview Health Services, Minneapolis, MN USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Minnesota, Minneapolis, MN USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000080891" MajorTopicYN="Y">Learning Health System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007221" MajorTopicYN="N">Industry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008511" MajorTopicYN="Y">Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071253" MajorTopicYN="N">Metadata</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">Semantic interoperability</Keyword><Keyword MajorTopicYN="N">process improvement</Keyword><Keyword MajorTopicYN="N">terminology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>5</Hour><Minute>46</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38269767</ArticleId><ArticleId IdType="doi">10.3233/SHTI230929</ArticleId><ArticleId IdType="pii">SHTI230929</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38269786</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>310</Volume><PubDate><Year>2024</Year><Month>Jan</Month><Day>25</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Toward Real-World Reproducibility: Verifying Value Sets for Clinical Research.</ArticleTitle><Pagination><StartPage>164</StartPage><EndPage>168</EndPage><MedlinePgn>164-168</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI230948</ELocationID><Abstract><AbstractText>Standardized operational definitions are an important tool to improve reproducibility of research using secondary real-world healthcare data. This approach was leveraged for studies evaluating the effectiveness of AZD7442 as COVID-19 pre-exposure prophylaxis across multiple healthcare systems. Value sets were defined, grouped, and mapped. Results of this exercise were reviewed and recorded. Value sets were updated to reflect findings.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Veterans Affairs, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parker</LastName><ForeName>Craig G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Navidence, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shields</LastName><ForeName>Amanda R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Quanten LLC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alba</LastName><ForeName>Patrick R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>University of Utah, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Veterans Affairs, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamauu</LastName><ForeName>Aaron W C</ForeName><Initials>AWC</Initials><AffiliationInfo><Affiliation>Navidence, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006268" MajorTopicYN="N">Health Facilities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065129" MajorTopicYN="Y">Pre-Exposure Prophylaxis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">RWD</Keyword><Keyword MajorTopicYN="N">operational definitions</Keyword><Keyword MajorTopicYN="N">value sets</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>5</Hour><Minute>46</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38269786</ArticleId><ArticleId IdType="doi">10.3233/SHTI230948</ArticleId><ArticleId IdType="pii">SHTI230948</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38269823</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>310</Volume><PubDate><Year>2024</Year><Month>Jan</Month><Day>25</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Development of Integrated Data Quality Management System for Observational Medical Outcomes Partnership Common Data Model.</ArticleTitle><Pagination><StartPage>349</StartPage><EndPage>353</EndPage><MedlinePgn>349-353</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI230985</ELocationID><Abstract><AbstractText>The amount of research on the gathering and handling of healthcare data keeps growing. To support multi-center research, numerous institutions have sought to create a common data model (CDM). However, data quality issues continue to be a major obstacle in the development of CDM. To address these limitations, a data quality assessment system was created based on the representative data model OMOP CDM v5.3.1. Additionally, 2,433 advanced evaluation rules were created and incorporated into the system by mapping the rules of existing OMOP CDM quality assessment systems. The data quality of six hospitals was verified using the developed system and an overall error rate of 0.197% was confirmed. Finally, we proposed a plan for high-quality data generation and the evaluation of multi-center CDM quality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Seol Whan</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedicine &amp;Health Sciences, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Soo Jeong</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedicine &amp;Health Sciences, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Im</LastName><ForeName>Yun Seon</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedicine &amp;Health Sciences, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Surin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Bo Yeon</ForeName><Initials>BY</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedicine &amp;Health Sciences, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jae Yoon</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedicine &amp;Health Sciences, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sunghyeon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedicine &amp;Health Sciences, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Wona</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>In Young</ForeName><Initials>IY</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000068598" MajorTopicYN="Y">Data Accuracy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079803" MajorTopicYN="Y">Data Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006268" MajorTopicYN="N">Health Facilities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data quality</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">data quality management system</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>5</Hour><Minute>47</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38269823</ArticleId><ArticleId IdType="doi">10.3233/SHTI230985</ArticleId><ArticleId IdType="pii">SHTI230985</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38269952</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>310</Volume><PubDate><Year>2024</Year><Month>Jan</Month><Day>25</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Health-Analytics Data to Evidence Suite (HADES): Open-Source Software for Observational Research.</ArticleTitle><Pagination><StartPage>966</StartPage><EndPage>970</EndPage><MedlinePgn>966-970</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI231108</ELocationID><Abstract><AbstractText>The Health-Analytics Data to Evidence Suite (HADES) is an open-source software collection developed by Observational Health Data Sciences and Informatics (OHDSI). It executes directly against healthcare data such as electronic health records and administrative claims, that have been converted to the Observational Medical Outcomes Partnership (OMOP) Common Data Model. Using advanced analytics, HADES performs characterization, population-level causal effect estimation, and patient-level prediction, potentially across a federated data network, allowing patient-level data to remain locally while only aggregated statistics are shared. Designed to run across a wide array of technical environments, including different operating systems and database platforms, HADES uses continuous integration with a large set of unit tests to maintain reliability. HADES implements OHDSI best practices, and is used in almost all published OHDSI studies, including some that have directly informed regulatory decisions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Observational Health Data Science and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Analytics, Johnson &amp; Johnson, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Observational Health Data Science and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Analytics, Johnson &amp; Johnson, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Observational Health Data Science and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Odysseus Data Services Inc., Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Defalco</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Observational Health Data Science and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Analytics, Johnson &amp; Johnson, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Lee</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Observational Health Data Science and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LTS Computing LLC, West Chester, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fridgeirsson</LastName><ForeName>Egill</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Observational Health Data Science and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilbert</LastName><ForeName>James P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Observational Health Data Science and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Analytics, Johnson &amp; Johnson, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knoll</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Observational Health Data Science and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Analytics, Johnson &amp; Johnson, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lavallee</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Observational Health Data Science and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Virginia Commonwealth University, Richmond, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Gowtham A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Observational Health Data Science and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Analytics, Johnson &amp; Johnson, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Observational Health Data Science and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadowski</LastName><ForeName>Katy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Observational Health Data Science and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>TrialSpark Inc., New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Observational Health Data Science and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Analytics, Johnson &amp; Johnson, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swerdel</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Observational Health Data Science and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Analytics, Johnson &amp; Johnson, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Ross D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Observational Health Data Science and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Observational Health Data Science and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI153044</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG006139</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077488" MajorTopicYN="Y">Data Science</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Observational research</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">open-source</Keyword><Keyword MajorTopicYN="N">software</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>5</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38269952</ArticleId><ArticleId IdType="mid">NIHMS1965136</ArticleId><ArticleId IdType="pmc">PMC10868467</ArticleId><ArticleId IdType="doi">10.3233/SHTI231108</ArticleId><ArticleId IdType="pii">SHTI231108</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong IC, Rijnbeek PR, van der Lei J, Pratt N, Nor&#xe9;n GN, Li YC, Stang PE, Madigan D, Ryan PB. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012. Jan-Feb;19(1):54&#x2013;60, doi: 10.1136/amiajnl-2011-000376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data. Proc Natl Acad Sci U S A. 2018. Mar;115(11):2571&#x2013;2577, doi: 10.1073/pnas.1708282114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1708282114</ArticleId><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="pubmed">29531023</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat Med. 2014. Jan;33(2):209&#x2013;18, doi: 10.1002/sim.5925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5925</ArticleId><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB, Rijnbeek PR. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc. 2018. Aug;25(8):969&#x2013;975, doi: 10.1093/jamia/ocy032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy032</ArticleId><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul. 2013. Jan;23(1):10.1145/2414416.2414791, doi: 10.1145/2414416.2414791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2414416.2414791</ArticleId><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang W, Cheng J, Allaire J, Sievert C, Schloerke B, Xie Y, Allen J, McPherson J, Dipert A, and Borges B, Shiny: Web Application Framework for R, in, 2022.</Citation></Reference><Reference><Citation>R.C. Team, R: A Language and Environment for Statistical Computing, in, R Foundation for Statistical Computing, Vienna, Austria, 2022</Citation></Reference><Reference><Citation>Swerdel JN, Schuemie M, Murray G, Ryan PB. PheValuator 2.0: Methodological improvements for the PheValuator approach to semi-automated phenotype algorithm evaluation. J Biomed Inform. 2022. Nov;135:104177, doi: 10.1016/j.jbi.2022.104177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2022.104177</ArticleId><ArticleId IdType="pubmed">35995107</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacketer C, Defalco FJ, Ryan PB, Rijnbeek PR. Increasing trust in real-world evidence through evaluation of observational data quality. J Am Med Inform Assoc. 2021. Sep;28(10):2251&#x2013;2257, doi: 10.1093/jamia/ocab132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocab132</ArticleId><ArticleId IdType="pmc">PMC8449628</ArticleId><ArticleId IdType="pubmed">34313749</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Schuemie MJ, Suchard MA. Evaluating large-scale propensity score performance through real-world and synthetic data experiments. Int J Epidemiol. 2018. Dec;47(6):2005&#x2013;2014, doi: 10.1093/ije/dyy120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyy120</ArticleId><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Wang Y, Schuemie MJ, Blei DM, Hripcsak G. Adjusting for indirectly measured confounding using large-scale propensity score. J Biomed Inform. 2022. Oct;134:104204, doi: 10.1016/j.jbi.2022.104204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2022.104204</ArticleId><ArticleId IdType="pmc">PMC9692203</ArticleId><ArticleId IdType="pubmed">36108816</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Chen Y, Madigan D, Suchard MA. Combining cox regressions across a heterogeneous distributed research network facing small and zero counts. Stat Methods Med Res. 2022. Mar;31(3):438&#x2013;450, doi: 10.1177/09622802211060518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09622802211060518</ArticleId><ArticleId IdType="pubmed">34841975</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen R, Pratt N, Reich CG, Duke J, Madigan D, Hripcsak G, Ryan PB. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019. Nov;394(10211):1816&#x2013;1826, doi: 10.1016/S0140-6736(19)32317-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32317-7</ArticleId><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams RD, Markus AF, Yang C, Duarte-Salles T, DuVall SL, Falconer T, Jonnagaddala J, Kim C, Rho Y, Williams AE, Machado AA, An MH, Arag&#xf3;n M, Areia C, Burn E, Choi YH, Drakos I, Abrah&#xe3;o MTF, Fern&#xe1;ndez-Bertol&#xed;n S, Hripcsak G, Kaas-Hansen BS, Kandukuri PL, Kors JA, Kostka K, Liaw ST, Lynch KE, Machnicki G, Matheny ME, Morales D, Nyberg F, Park RW, Prats-Uribe A, Pratt N, Rao G, Reich CG, Rivera M, Seinen T, Shoaibi A, Spotnitz ME, Steyerberg EW, Suchard MA, You SC, Zhang L, Zhou L, Ryan PB, Prieto-Alhambra D, Reps JM, Rijnbeek PR. Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network. BMC Med Res Methodol. 2022. Jan;22(1):35, doi: 10.1186/s12874-022-01505-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-022-01505-z</ArticleId><ArticleId IdType="pmc">PMC8801189</ArticleId><ArticleId IdType="pubmed">35094685</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane JCE, Weaver J, Kostka K, Duarte-Salles T, Abrahao MTF, Alghoul H, Alser O, Alshammari TM, Biedermann P, Banda JM, Burn E, Casajust P, Conover MM, Culhane AC, Davydov A, DuVall SL, Dymshyts D, Fernandez-Bertolin S, Fi&#x161;ter K, Hardin J, Hester L, Hripcsak G, Kaas-Hansen BS, Kent S, Khosla S, Kolovos S, Lambert CG, van der Lei J, Lynch KE, Makadia R, Margulis AV, Matheny ME, Mehta P, Morales DR, Morgan-Stewart H, Mosseveld M, Newby D, Nyberg F, Ostropolets A, Park RW, Prats-Uribe A, Rao GA, Reich C, Reps J, Rijnbeek P, Sathappan SMK, Schuemie M, Seager S, Sena AG, Shoaibi A, Spotnitz M, Suchard MA, Torre CO, Vizcaya D, Wen H, de Wilde M, Xie J, You SC, Zhang L, Zhuk O, Ryan P, Prieto-Alhambra D; OHDSI-COVID-19 consortium. Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lancet Rheumatol. 2020. Nov;2(11):e698&#x2013;e711, doi: 10.1016/S2665-9913(20)30276-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30276-9</ArticleId><ArticleId IdType="pmc">PMC7442425</ArticleId><ArticleId IdType="pubmed">32864627</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales DR, Conover MM, You SC, Pratt N, Kostka K, Duarte-Salles T, Fern&#xe1;ndez-Bertol&#xed;n S, Arag&#xf3;n M, DuVall SL, Lynch K, Falconer T, van Bochove K, Sung C, Matheny ME, Lambert CG, Nyberg F, Alshammari TM, Williams AE, Park RW, Weaver J, Sena AG, Schuemie MJ, Rijnbeek PR, Williams RD, Lane JCE, Prats-Uribe A, Zhang L, Areia C, Krumholz HM, Prieto-Alhambra D, Ryan PB, Hripcsak G, Suchard MA. Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis. Lancet Digit Health. 2021. Feb;3(2):e98&#x2013;e114, doi: 10.1016/S2589-7500(20)30289-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(20)30289-2</ArticleId><ArticleId IdType="pmc">PMC7834915</ArticleId><ArticleId IdType="pubmed">33342753</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency, The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) Guide on Methodological Standards in Pharmacoepidemiology (Revision 8), in, Amsterdam, the Netherlands, 2021.</Citation></Reference><Reference><Citation>Schuemie MJ, Cepeda MS, Suchard MA, Yang J, Tian Y, Schuler A, Ryan PB, Madigan D, Hripcsak G. How Confident Are We about Observational Findings in Healthcare: A Benchmark Study. Harv Data Sci Rev. 2020;2(1):10.1162/99608f92.147cc28e, doi: 10.1162/99608f92.147cc28e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1162/99608f92.147cc28e</ArticleId><ArticleId IdType="pmc">PMC7755157</ArticleId><ArticleId IdType="pubmed">33367288</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Arshad F, Pratt N, Nyberg F, Alshammari TM, Hripcsak G, Ryan P, Prieto-Alhambra D, Lai LYH, Li X, Fortin S, Minty E, Suchard MA. Vaccine Safety Surveillance Using Routinely Collected Healthcare Data-An Empirical Evaluation of Epidemiological Designs. Front Pharmacol. 2022. Jul;13:893484, doi: 10.3389/fphar.2022.893484.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.893484</ArticleId><ArticleId IdType="pmc">PMC9299244</ArticleId><ArticleId IdType="pubmed">35873596</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38270038</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>310</Volume><PubDate><Year>2024</Year><Month>Jan</Month><Day>25</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Feasibility of Applying the OMOP Common Data Model to Traditional Eastern Asian Medicine Dataset.</ArticleTitle><Pagination><StartPage>1349</StartPage><EndPage>1351</EndPage><MedlinePgn>1349-1351</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI231189</ELocationID><Abstract><AbstractText>To evaluate the feasibility of applying the Observational Medical Outcome Partnership (OMOP) Common Data Model (CDM) to databases of traditional East Asian medicine (TEAM), we composed a TEAM dataset and transformed it to the OMOP CDM. We found that some important TEAM information entities could not be transformed to the OMOP CDM (version 6.0) data fields. We suggest to develop data fields and guideline for transforming TEAM data to the OMOP CDM.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cha</LastName><ForeName>Jiyun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Korea Institute of Oriental Medicine, Daejeon, 34054, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Eun Kyoung</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Korea Institute of Oriental Medicine, Daejeon, 34054, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Young-Heum</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>National Institute for Korean Medicine Development, Seoul, 04516, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Man Young</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Korea Institute of Oriental Medicine, Daejeon, 34054, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Korean medicine</Keyword><Keyword MajorTopicYN="N">Observational medical outcome partnership (OMOP)</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">traditional Eastern Asia medicine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>5</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38270038</ArticleId><ArticleId IdType="doi">10.3233/SHTI231189</ArticleId><ArticleId IdType="pii">SHTI231189</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38280887</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>27</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>A comparative patient-level prediction study in OMOP CDM: applicative potential and insights from synthetic data.</ArticleTitle><Pagination><StartPage>2287</StartPage><MedlinePgn>2287</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2287</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-52723-y</ELocationID><Abstract><AbstractText>The emergence of collaborations, which standardize and combine multiple clinical databases across different regions, provide a wealthy source of data, which is fundamental for clinical prediction models, such as patient-level predictions. With the aid of such large data pools, researchers are able to develop clinical prediction models for improved disease classification, risk assessment, and beyond. To fully utilize this potential, Machine Learning (ML) methods are commonly required to process these large amounts of data on disease-specific patient cohorts. As a consequence, the Observational Health Data Sciences and Informatics (OHDSI) collaborative develops a framework to facilitate the application of ML models for these standardized patient datasets by using the Observational Medical Outcomes Partnership (OMOP) common data model (CDM). In this study, we compare the feasibility of current web-based OHDSI approaches, namely ATLAS and "Patient-level Prediction" (PLP), against a native solution (R based) to conduct such ML-based patient-level prediction analyses in OMOP. This will enable potential users to select the most suitable approach for their investigation. Each of the applied ML solutions was individually utilized to solve the same patient-level prediction task. Both approaches went through an exemplary benchmarking analysis to assess the weaknesses and strengths of the PLP R-Package. In this work, the performance of this package was subsequently compared versus the commonly used native R-package called Machine Learning in R 3 (mlr3), and its sub-packages. The approaches were evaluated on performance, execution time, and ease of model implementation. The results show that the PLP package has shorter execution times, which indicates great scalability, as well as intuitive code implementation, and numerous possibilities for visualization. However, limitations in comparison to native packages were depicted in the implementation of specific ML classifiers (e.g., Lasso), which may result in a decreased performance for real-world prediction problems. The findings here contribute to the overall effort of developing ML-based prediction models on a clinical scale and provide a snapshot for future studies that explicitly aim to develop patient-level prediction models in OMOP CDM.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ahmadi</LastName><ForeName>Najia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, Technische Universit&#xe4;t Dresden, 01307, Dresden, Germany. najia.ahmadi@tu-dresden.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Nguyen</LastName><ForeName>Quang Vu</ForeName><Initials>QV</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, Technische Universit&#xe4;t Dresden, 01307, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, Technische Universit&#xe4;t Dresden, 01307, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolfien</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, Technische Universit&#xe4;t Dresden, 01307, Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Scalable Data Analytics and Artificial Intelligence (ScaDS.AI), Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FKZ: ZMI1-2520DAT02C</GrantID><Agency>Federal Ministry of Health (BMG)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="Y">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>28</Day><Hour>7</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>27</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38280887</ArticleId><ArticleId IdType="pmc">PMC10821926</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-52723-y</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-52723-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit. Med. 2020;3(1):1&#x2013;10. doi: 10.1038/s41746-020-0221-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-0221-y</ArticleId><ArticleId IdType="pmc">PMC7005290</ArticleId><ArticleId IdType="pubmed">32047862</ArticleId></ArticleIdList></Reference><Reference><Citation>Blake JN, Kerr DV, Gammack JG. Streamlining patient consultations for sleep disorders with a knowledge-based CDSS. Inf. Syst. 2016;1(56):109&#x2013;119. doi: 10.1016/j.is.2015.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.is.2015.08.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB, Rijnbeek PR. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J. Am. Med. Inf. Assoc. 2018;25(8):969&#x2013;975. doi: 10.1093/jamia/ocy032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy032</ArticleId><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational health data sciences and informatics (OHDSI): Opportunities for observational researchers. Stud. Health Technol. Inf. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Data Standardization &#x2013; OHDSI [Internet]. [cited 2023 Jan 2]. Available from: https://www.ohdsi.org/data-standardization/.</Citation></Reference><Reference><Citation>GitHub [Internet]. [cited 2022 Feb 25]. PatientLevelPrediction/R at main &#xb7; OHDSI/PatientLevelPrediction. Available from: https://github.com/OHDSI/PatientLevelPrediction.</Citation></Reference><Reference><Citation>PatientLevelPrediction-GitHub [Internet]. Observational Health Data Sciences and Informatics; 2023 [cited 2023 Feb 1]. Available from: https://github.com/OHDSI/PatientLevelPrediction.</Citation></Reference><Reference><Citation>mlr3 [Internet]. mlr-org; 2023 [cited 2023 Jan 2]. Available from: https://github.com/mlr-org/mlr3.</Citation></Reference><Reference><Citation>CMS 2008-2010 Data Entrepreneurs&#x2019; Synthetic Public Use File (DE-SynPUF) | CMS [Internet]. [cited 2023 Jan 2]. Available from: https://www.cms.gov/Research-Statistics-Data-and-Systems/Downloadable-Public-Use-Files/SynPUFs/DE_Syn_PUF.</Citation></Reference><Reference><Citation>ATLAS: Home [Internet]. [cited 2023 Jan 2]. Available from: https://atlas-demo.ohdsi.org/#/home.</Citation></Reference><Reference><Citation>ATLAS&#x2014;A unified interface for the OHDSI tools &#x2013; OHDSI [Internet]. [cited 2022 Jun 30]. Available from: https://www.ohdsi.org/atlas-a-unified-interface-for-the-ohdsi-tools/.</Citation></Reference><Reference><Citation>Kuhn, M. The caret Package [Internet]. [cited 2023 Jan 31]. Available from: https://topepo.github.io/caret/.</Citation></Reference><Reference><Citation>Liu X, Jiang J, Wei L, Xing W, Shang H, Liu G, et al. Prediction of all-cause mortality in coronary artery disease patients with atrial fibrillation based on machine learning models. BMC Cardiovasc. Disord. 2021;21(1):499. doi: 10.1186/s12872-021-02314-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-021-02314-w</ArticleId><ArticleId IdType="pmc">PMC8520292</ArticleId><ArticleId IdType="pubmed">34656086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi N. Benchmarking-Analysis-of-PLP-vs-MLR3 [Internet]. 2023 [cited 2023 Jan 30]. Available from: https://github.com/NajiaAhmadi/Benchmarking-Analysis-of-PLP-vs-MLR3.</Citation></Reference><Reference><Citation>R Database Interface [Internet]. [cited 2023 Jan 17]. Available from: https://dbi.r-dbi.org/.</Citation></Reference><Reference><Citation>An Introduction to &#x2018;glmnet&#x2019; [Internet]. [cited 2023 Jan 17]. Available from: https://glmnet.stanford.edu/articles/glmnet.html.</Citation></Reference><Reference><Citation>Rijnbeek P, Reps J. Chapter 13 Patient-Level Prediction | The Book of OHDSI [Internet]. 2021 [cited 2022 Jan 25]. Available from: https://ohdsi.github.io/TheBookOfOhdsi/.</Citation></Reference><Reference><Citation>Tibshirani R. Regression shrinkage and selection via the lasso. J. R. Stat. Soc. Ser. B (Methodological). 1996;58(1):267&#x2013;288.</Citation></Reference><Reference><Citation>Reps JM, Williams RD, Schuemie MJ, Ryan PB, Rijnbeek PR. Learning patient-level prediction models across multiple healthcare databases: Evaluation of ensembles for increasing model transportability. BMC Med. Inf. Decis. Mak. 2022;22(1):142. doi: 10.1186/s12911-022-01879-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-022-01879-6</ArticleId><ArticleId IdType="pmc">PMC9134686</ArticleId><ArticleId IdType="pubmed">35614485</ArticleId></ArticleIdList></Reference><Reference><Citation>Cyclops [Internet]. Observational health data sciences and informatics; 2022 [cited 2023 Jan 3]. Available from: https://github.com/OHDSI/Cyclops.</Citation></Reference><Reference><Citation>Bischl, B., Binder, M., Lang, M., Pielok, T., Richter, J., Coors, S., et al. Hyperparameter optimization: Foundations, algorithms, best practices and open challenges [Internet]. arXiv; 2021 [cited 2023 Jan 11]. Available from: http://arxiv.org/abs/2107.05847.</Citation></Reference><Reference><Citation>Chawla NV, Bowyer KW, Hall LO, Kegelmeyer WP. SMOTE: Synthetic minority over-sampling technique. J. Artif. Intell. Res. 2002;1(16):321&#x2013;357. doi: 10.1613/jair.953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1613/jair.953</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman, M. M., &amp; Davis, D. N. Addressing the class imbalance problem in medical datasets. IJMLC. 224&#x2013;228 (2013).</Citation></Reference><Reference><Citation>Japkowicz N. Assessment metrics for imbalanced learning. in: imbalanced learning [Internet]. John Wiley &amp; Sons, Ltd [cited 2023 Jan 2]. p. 187&#x2013;206. 10.1002/9781118646106.ch8 (2013).</Citation></Reference><Reference><Citation>Silva Filho T, Song H, Perello-Nieto M, Santos-Rodriguez R, Kull M, Flach P. Classifier calibration: A survey on how to assess and improve predicted class probabilities. Mach. Learn. 2023;112(9):3211&#x2013;3260. doi: 10.1007/s10994-023-06336-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10994-023-06336-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Bej S, Davtyan N, Wolfien M, Nassar M, Wolkenhauer O. LoRAS: An oversampling approach for imbalanced datasets. Mach. Learn. 2021;110(2):279&#x2013;301. doi: 10.1007/s10994-020-05913-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10994-020-05913-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Web Application Framework for R [Internet]. [cited 2023 Jan 17]. Available from: https://rstudio.github.io/shiny/index.html.</Citation></Reference><Reference><Citation>scikit-learn: machine learning in Python&#x2014;scikit-learn 1.3.1 documentation [Internet]. [cited 2023 Oct 11]. Available from: https://scikit-learn.org/stable/.</Citation></Reference><Reference><Citation>Data Base Backend for mlr3 [Internet]. [cited 2023 Oct 23]. Available from: https://mlr3db.mlr-org.com/.</Citation></Reference><Reference><Citation>OHDSI Forums [Internet]. 2015 [cited 2023 Feb 15]. 1K sample of simulated CMS SynPUF data in CDMV5 format available for download&#x2014;Developers. Available from: https://forums.ohdsi.org/t/1k-sample-of-simulated-cms-synpuf-data-in-cdmv5-format-available-for-download/728.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38315345</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2948-2933</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of imaging informatics in medicine</Title><ISOAbbreviation>J Imaging Inform Med</ISOAbbreviation></Journal><ArticleTitle>Development of Medical Imaging Data Standardization for Imaging-Based Observational Research: OMOP Common Data Model Extension.</ArticleTitle><Pagination><StartPage>899</StartPage><EndPage>908</EndPage><MedlinePgn>899-908</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10278-024-00982-6</ELocationID><Abstract><AbstractText>The rapid growth of artificial intelligence (AI) and deep learning techniques require access to large inter-institutional cohorts of data to enable the development of robust models, e.g., targeting the identification of disease biomarkers&#xa0;and quantifying disease progression and treatment&#xa0;efficacy. The Observational Medical Outcomes Partnership Common Data Model (OMOP CDM) has been designed to accommodate a harmonized representation of observational healthcare data. This study proposes the Medical Imaging CDM (MI-CDM) extension, adding two new tables and two vocabularies to the OMOP CDM to address the structural and semantic requirements to support imaging research. The tables provide the capabilities of linking DICOM data sources as well as tracking the provenance of imaging features derived from those images. The implementation of the extension enables phenotype definitions using imaging features and expanding standardized computable imaging biomarkers.&#xa0;This proposal offers a comprehensive and unified approach for conducting imaging research and outcome studies utilizing imaging features.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Park</LastName><ForeName>Woo Yeon</ForeName><Initials>WY</Initials><Identifier Source="ORCID">0000-0001-9932-1485</Identifier><AffiliationInfo><Affiliation>Biomedical Informatics and Data Science, Johns Hopkins University, 855 N Wolfe St, Rangos 616, Baltimore, MD, USA. wpark11@jhu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jeon</LastName><ForeName>Kyulee</ForeName><Initials>K</Initials><Identifier Source="ORCID">0009-0008-6338-5522</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Innovation in Digital Healthcare, Yonsei University, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Teri Sippel</ForeName><Initials>TS</Initials><Identifier Source="ORCID">0009-0003-6092-7182</Identifier><AffiliationInfo><Affiliation>Biomedical Informatics and Data Science, Johns Hopkins University, 855 N Wolfe St, Rangos 616, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondylakis</LastName><ForeName>Haridimos</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-9917-4486</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation of Research &amp; Technology-Hellas (FORTH), Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alkasab</LastName><ForeName>Tarik</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4433-9482</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dewey</LastName><ForeName>Blake E</ForeName><Initials>BE</Initials><Identifier Source="ORCID">0000-0003-4554-5058</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-5052-6399</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Innovation in Digital Healthcare, Yonsei University, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagy</LastName><ForeName>Paul</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-5108-7749</Identifier><AffiliationInfo><Affiliation>Biomedical Informatics and Data Science, Johns Hopkins University, 855 N Wolfe St, Rangos 616, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T15 LM013979</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Imaging Inform Med</MedlineTA><NlmUniqueID>9918663679206676</NlmUniqueID><ISSNLinking>2948-2925</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003952" MajorTopicYN="Y">Diagnostic Imaging</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="Y">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="N">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065709" MajorTopicYN="Y">Common Data Elements</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data collection [MeSH]</Keyword><Keyword MajorTopicYN="N">Data integration</Keyword><Keyword MajorTopicYN="N">Data standardization</Keyword><Keyword MajorTopicYN="N">Multimodal data analysis</Keyword><Keyword MajorTopicYN="N">Observational research</Keyword></KeywordList><CoiStatement>The authors have no relevant financial interests to disclose. Non-financial interest: Dr. Seng Chan You serves as a Chief Technology Officer at PHI Digital Healthcare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>5</Day><Hour>14</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>5</Day><Hour>14</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>5</Day><Hour>11</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38315345</ArticleId><ArticleId IdType="pmc">PMC11031512</ArticleId><ArticleId IdType="doi">10.1007/s10278-024-00982-6</ArticleId><ArticleId IdType="pii">10.1007/s10278-024-00982-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soenksen LR, Ma Y, Zeng C, et al. Integrated multimodal artificial intelligence framework for healthcare applications. Npj Digit Med. 2022;5(1):149. doi: 10.1038/s41746-022-00689-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-022-00689-4</ArticleId><ArticleId IdType="pmc">PMC9489871</ArticleId><ArticleId IdType="pubmed">36127417</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SC, Pareek A, Seyyedi S, Banerjee I, Lungren MP. Fusion of medical imaging and electronic health records using deep learning: a systematic review and implementation guidelines. Npj Digit Med. 2020;3(1):136. doi: 10.1038/s41746-020-00341-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-00341-z</ArticleId><ArticleId IdType="pmc">PMC7567861</ArticleId><ArticleId IdType="pubmed">33083571</ArticleId></ArticleIdList></Reference><Reference><Citation>Gietzelt M, L&#xf6;pprich M, Karmen C, Ganzinger M. Models and Data Sources Used in Systems Medicine: A Systematic Literature Review. Methods Inf Med. 2016;55(02):107&#x2013;113. doi: 10.3414/ME15-01-0151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME15-01-0151</ArticleId><ArticleId IdType="pubmed">26846174</ArticleId></ArticleIdList></Reference><Reference><Citation>Makadia R, Ryan PB. Transforming the Premier Perspective&#xae; hospital database to the OMOP Common Data Model. EGEMs Gener Evid Methods Improve Patient Outcomes. 2014;2(1):15. doi: 10.13063/2327-9214.1110.</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1110</ArticleId><ArticleId IdType="pmc">PMC4371500</ArticleId><ArticleId IdType="pubmed">25848597</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Park C, You SC, Jeon H, Jeong CW, Choi JW, Park RW. Development and Validation of the Radiology Common Data Model (R-CDM) for the International Standardization of Medical Imaging Data. Yonsei Med J. 2022;63(Suppl):S74. doi: 10.3349/ymj.2022.63.S74.</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2022.63.S74</ArticleId><ArticleId IdType="pmc">PMC8790584</ArticleId><ArticleId IdType="pubmed">35040608</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel MA, Chute CG, Robinson PN. Classification, Ontology, and Precision Medicine. Phimister EG, ed. N Engl J Med. 2018;379(15):1452-1462. 10.1056/NEJMra1615014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6503847</ArticleId><ArticleId IdType="pubmed">30304648</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Science and Informatics. OMOP Common Data Model Conventions. Accessed May 29, 2023. http://ohdsi.github.io/CommonDataModel/dataModelConventions.html#Data_Model_Conventions</Citation></Reference><Reference><Citation>Mildenberger P, Eichelberg M, Martin E. Introduction to the DICOM standard. Eur Radiol. 2002;12(4):920&#x2013;927. doi: 10.1007/s003300101100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s003300101100</ArticleId><ArticleId IdType="pubmed">11960249</ArticleId></ArticleIdList></Reference><Reference><Citation>DICOM Standard. DICOM Part 6. Accessed May 31, 2023. https://dicom.nema.org/medical/dicom/current/output/html/part06.html</Citation></Reference><Reference><Citation>DICOM Standard. DICOM Part 16. Accessed May 31, 2023. https://dicom.nema.org/medical/dicom/current/output/html/part16.html</Citation></Reference><Reference><Citation>Shore MW, Rubin DL, Kahn CE. Integration of Imaging Signs into RadLex. J Digit Imaging. 2012;25(1):50&#x2013;55. doi: 10.1007/s10278-011-9386-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10278-011-9386-x</ArticleId><ArticleId IdType="pmc">PMC3264717</ArticleId><ArticleId IdType="pubmed">21494902</ArticleId></ArticleIdList></Reference><Reference><Citation>RSNA/ACR. RadElements. Accessed May 31, 2023. https://www.radelement.org/about/</Citation></Reference><Reference><Citation>Keloth VK, Banda JM, Gurley M, et al. Representing and utilizing clinical textual data for real world studies: An OHDSI approach. J Biomed Inform. 2023;142:104343. doi: 10.1016/j.jbi.2023.104343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2023.104343</ArticleId><ArticleId IdType="pmc">PMC10428170</ArticleId><ArticleId IdType="pubmed">36935011</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipton P, Nagy P, Sevinc G. Leveraging Internet Technologies with DICOM WADO. J Digit Imaging. 2012;25(5):646&#x2013;652. doi: 10.1007/s10278-012-9469-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10278-012-9469-3</ArticleId><ArticleId IdType="pmc">PMC3447090</ArticleId><ArticleId IdType="pubmed">22411061</ArticleId></ArticleIdList></Reference><Reference><Citation>Chard R, Li Z, Chard K, DLHub: Model and Data Serving for Science. In, , et al. IEEE International Parallel and Distributed Processing Symposium (IPDPS) IEEE. 2019;2019:283&#x2013;292. doi: 10.1109/IPDPS.2019.00038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/IPDPS.2019.00038</ArticleId></ArticleIdList></Reference><Reference><Citation>Lekadir K, Osuala R, Gallin C, et al. FUTURE-AI: Guiding Principles and Consensus Recommendations for Trustworthy Artificial Intelligence in Medical Imaging. Published online. 2021 doi: 10.48550/ARXIV.2109.09658.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/ARXIV.2109.09658</ArticleId></ArticleIdList></Reference><Reference><Citation>Floridi L. Establishing the rules for building trustworthy AI. Nat Mach Intell. 2019;1(6):261&#x2013;262. doi: 10.1038/s42256-019-0055-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42256-019-0055-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Belenkaya R, Gurley MJ, Golozar A, et al. Extending the OMOP Common Data Model and Standardized Vocabularies to Support Observational Cancer Research. JCO Clin Cancer Inform. 2021;5:CCI.20.00079. 10.1200/CCI.20.00079</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8140810</ArticleId><ArticleId IdType="pubmed">33411620</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38326827</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6947</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>Suppl 4</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>07</Day></PubDate></JournalIssue><Title>BMC medical informatics and decision making</Title><ISOAbbreviation>BMC Med Inform Decis Mak</ISOAbbreviation></Journal><ArticleTitle>Evaluating MedDRA-to-ICD terminology mappings.</ArticleTitle><Pagination><StartPage>299</StartPage><MedlinePgn>299</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">299</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12911-023-02375-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In this era of big data, data harmonization is an important step to ensure reproducible, scalable, and collaborative research. Thus, terminology mapping is a necessary step to harmonize heterogeneous data. Take the Medical Dictionary for Regulatory Activities (MedDRA) and International Classification of Diseases (ICD) for example, the mapping between them is essential for drug safety and pharmacovigilance research. Our main objective is to provide a quantitative and qualitative analysis of the mapping status between MedDRA and ICD. We focus on evaluating the current mapping status between MedDRA and ICD through the Unified Medical Language System (UMLS) and Observational Medical Outcomes Partnership Common Data Model (OMOP CDM). We summarized the current mapping statistics and evaluated the quality of the current MedDRA-ICD mapping; for unmapped terms, we used our self-developed algorithm to rank the best possible mapping candidates for additional mapping coverage.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The identified MedDRA-ICD mapped pairs cover 27.23% of the overall MedDRA preferred terms (PT). The systematic quality analysis demonstrated that, among the mapped pairs provided by UMLS, only 51.44% are considered an exact match. For the 2400 sampled unmapped terms, 56 of the 2400 MedDRA Preferred Terms (PT) could have exact match terms from ICD.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Some of the mapped pairs between MedDRA and ICD are not exact matches due to differences in granularity and focus. For 72% of the unmapped PT terms, the identified exact match pairs illustrate the possibility of identifying additional mapped pairs. Referring to its own mapping standard, some of the unmapped terms should qualify for the expansion of MedDRA to ICD mapping in UMLS.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xinyuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>McWilliam School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yixue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>McWilliam School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>McWilliam School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tahseen</LastName><ForeName>Danyal</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hinojosa</LastName><ForeName>Ezekiel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Cui</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4267-1924</Identifier><AffiliationInfo><Affiliation>McWilliam School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, TX, USA. Cui.Tao@uth.tmc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Artificial Intelligence and Informatics, Mayo Clinic, Jacksonville, FL, USA. Cui.Tao@uth.tmc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI130460</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG072799</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01AI130460</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Inform Decis Mak</MedlineTA><NlmUniqueID>101088682</NlmUniqueID><ISSNLinking>1472-6947</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038801" MajorTopicYN="Y">International Classification of Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="Y">Adverse Drug Reaction Reporting Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017432" MajorTopicYN="N">Unified Medical Language System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060735" MajorTopicYN="N">Pharmacovigilance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">International classification of diseases (ICD)</Keyword><Keyword MajorTopicYN="N">Observational medical outcomes partnership common data model (OMOP CDM)</Keyword><Keyword MajorTopicYN="N">Terminology mapping</Keyword><Keyword MajorTopicYN="N">The medical dictionary for regulatory activities (MedDRA)</Keyword><Keyword MajorTopicYN="N">Unified medical language system (UMLS)</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>8</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>8</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>7</Day><Hour>23</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38326827</ArticleId><ArticleId IdType="pmc">PMC10851449</ArticleId><ArticleId IdType="doi">10.1186/s12911-023-02375-1</ArticleId><ArticleId IdType="pii">10.1186/s12911-023-02375-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alkhamisi AO, Saleh M. Ontology Opportunities and Challenges: Discussions from Semantic Data Integration Perspectives. Proc - 2020 6th Conf Data Sci Mach Learn Appl CDMA 2020; 2020. pp. 134&#x2013;140.</Citation></Reference><Reference><Citation>Miller DAW, Pacifici K, Sanderlin JS, et al. The recent past and promising future for data integration methods to estimate species&#x2019; distributions. Methods Ecol Evol. 2019;10:22&#x2013;37. doi: 10.1111/2041-210X.13110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/2041-210X.13110</ArticleId></ArticleIdList></Reference><Reference><Citation>Isaac NJB, Jarzyna MA, Keil P, et al. Data integration for large-scale models of species distributions. Trends Ecol Evol. 2020;35:56&#x2013;67. doi: 10.1016/J.TREE.2019.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.TREE.2019.08.006</ArticleId><ArticleId IdType="pubmed">31676190</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaman S, Sarntivijai S, Abernethy DR. Use of biomedical ontologies for integration of biological knowledge for learning and prediction of adverse drug reactions. Gene Regul Syst Bio. 2017;11 10.1177/1177625017696075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5398297</ArticleId><ArticleId IdType="pubmed">28469412</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich C, Ryan PB, Stang PE, et al. Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases. J Biomed Inform. 2012;45:689&#x2013;696. doi: 10.1016/j.jbi.2012.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2012.05.002</ArticleId><ArticleId IdType="pubmed">22683994</ArticleId></ArticleIdList></Reference><Reference><Citation>Declerck G, Souvignet J, Rodrigues JM, et al. Automatic annotation of ICD-to-MedDRA mappings with SKOS predicates. Stud Health Technol Inform. 2014;205:1013&#x2013;1017. doi: 10.3233/978-1-61499-432-9-1013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/978-1-61499-432-9-1013</ArticleId><ArticleId IdType="pubmed">25160341</ArticleId></ArticleIdList></Reference><Reference><Citation>Painter JL. Enhanced Biomedical Taxonomy Mapping Through Use of A Semantic Measure of Proximity. http://omop.fnih.org/ ().</Citation></Reference><Reference><Citation>Jiang G, Liu H, Solbrig HR, et al. ADEpedia 2.0: Integration of Normalized Adverse Drug Events (ADEs) Knowledge from the UMLS. AMIA Jt Summits Transl Sci proceedings AMIA Jt Summits Transl Sci. 2013;2013:100&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3845793</ArticleId><ArticleId IdType="pubmed">24303245</ArticleId></ArticleIdList></Reference><Reference><Citation>Painter JL, Kleiner KM, Merrill GH. Inter-translation of biomedical coding schemes using UMLS (extended abstract) 2006.</Citation></Reference><Reference><Citation>Robinson J, de Lusignan S, Kostkova P, et al. Using UMLS to map from a library to a clinical classification: improving the functionality of a digital library. Stud Health Technol Inform. 2006;121:86&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">17095807</ArticleId></ArticleIdList></Reference><Reference><Citation>Mougin F, Dupuch M, Grabar N. Improving the mapping between MedDRA and SNOMED CT. Lect Notes Comput Sci (including Subser Lect Notes Artif Intell Lect Notes Bioinformatics) 2011;6747 LNAI:220&#x2013;4. doi:10.1007/978-3-642-22218-4_27</Citation></Reference><Reference><Citation>Unified Medical Language System (UMLS) n.d. https://www.nlm.nih.gov/research/umls (accessed 4 Sep 2018).</Citation></Reference><Reference><Citation>Aronson AR. Effective mapping of biomedical text to the UMLS Metathesaurus: the MetaMap program. Proc AMIA Symp. 2001:17&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2243666</ArticleId><ArticleId IdType="pubmed">11825149</ArticleId></ArticleIdList></Reference><Reference><Citation>Amos L, Anderson D, Brody S, et al. UMLS users and uses: a current overview. J Am Med Informatics Assoc. 2021;27:1606&#x2013;1611. doi: 10.1093/JAMIA/OCAA084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/JAMIA/OCAA084</ArticleId><ArticleId IdType="pmc">PMC7580803</ArticleId><ArticleId IdType="pubmed">32683453</ArticleId></ArticleIdList></Reference><Reference><Citation>Mougin F, Grabar N. Lecture notes in computer science (including subseries lecture notes in artificial intelligence and lecture notes in bioinformatics) Springer Verlag; 2013. Using a cross-language approach to acquire new mappings between two biomedical terminologies; pp. 221&#x2013;226.</Citation></Reference><Reference><Citation>Bousquet C, Sadou &#xc9;, Souvignet J, et al. Formalizing MedDRA to support semantic reasoning on adverse drug reaction terms. Published Online First. 2014; 10.1016/j.jbi.2014.03.012.</Citation><ArticleIdList><ArticleId IdType="pubmed">24680984</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadkarni PM, Darer JD. Determining correspondences between high-frequency MedDRA concepts and SNOMED: a case study. BMC Med Inform Decis Mak. 2010;10:66. doi: 10.1186/1472-6947-10-66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6947-10-66</ArticleId><ArticleId IdType="pmc">PMC2988705</ArticleId><ArticleId IdType="pubmed">21029418</ArticleId></ArticleIdList></Reference><Reference><Citation>Bousquet C, Souvignet J, Sadou &#xc9;, et al. Ontological and non-ontological resources for associating medical dictionary for regulatory activities terms to SNOMED clinical terms with semantic properties. Front Pharmacol. 2019:10. 10.3389/fphar.2019.00975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6747929</ArticleId><ArticleId IdType="pubmed">31551780</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J. Mapping SNOMED CT to ICD-10-CM. Published Online First. 2016. 10.7282/T3H70HVK.</Citation></Reference><Reference><Citation>OMOP Common Data Model &#x2013; OHDSI. https://www.ohdsi.org/data-standardization/the-common-data-model/ (accessed 12 Dec 2019).</Citation></Reference><Reference><Citation>Hersh W, Price S, Donohoe L. Assessing Thesaurus-Based Query Expansion Using the UMLS Metathesaurus. American Medical Informatics Association 2000. /pmc/articles/PMC2244120/?report=abstract ().</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2244120</ArticleId><ArticleId IdType="pubmed">11079902</ArticleId></ArticleIdList></Reference><Reference><Citation>Gro&#xdf; A, Pruski C, Rahm E. Evolution of biomedical ontologies and mappings: overview of recent approaches. Comput Struct Biotechnol J. 2016;14:333&#x2013;340. doi: 10.1016/j.csbj.2016.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2016.08.002</ArticleId><ArticleId IdType="pmc">PMC5018063</ArticleId><ArticleId IdType="pubmed">27642503</ArticleId></ArticleIdList></Reference><Reference><Citation>Saitwal H, Qing D, Jones S, et al. Cross-terminology mapping challenges: a demonstration using medication terminological systems. J Biomed Inform. 2012;45:613&#x2013;625. doi: 10.1016/j.jbi.2012.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2012.06.005</ArticleId><ArticleId IdType="pmc">PMC4398308</ArticleId><ArticleId IdType="pubmed">22750536</ArticleId></ArticleIdList></Reference><Reference><Citation>Research C. For DE and. Questions and Answers on FDA&#x2019;s Adverse Event Reporting System (FAERS).</Citation></Reference><Reference><Citation>Questions and Answers on FDA&#x2019;s Adverse Event Reporting System (FAERS) | FDA. https://www.fda.gov/drugs/surveillance/questions-and-answers-fdas-adverse-event-reporting-system-faers (accessed 12 Dec 2019).</Citation></Reference><Reference><Citation>Bodenreider O. Using SNOMED CT in combination with MedDRA for reporting signal detection and adverse drug reactions reporting. AMIA. Annu Symp proceedings AMIA Symp. 2009;2009:45&#x2013;49. http://www.ncbi.nlm.nih.gov/pubmed/20351820. Accessed 10 Dec 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815504</ArticleId><ArticleId IdType="pubmed">20351820</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan P, Painter J, Information GM-P presented at the 44th AD, et al. Defining medical conditions by mapping ICD-9 to MedDRA: a systematic approach to integrating disparate observational data sources for enabling.</Citation></Reference><Reference><Citation>Hripcsak G, Levine ME, Shang N, et al. Effect of vocabulary mapping for conditions on phenotype cohorts. J Am Med Informatics Assoc. 2018;25:1618&#x2013;1625. doi: 10.1093/jamia/ocy124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy124</ArticleId><ArticleId IdType="pmc">PMC6289550</ArticleId><ArticleId IdType="pubmed">30395248</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbreviations Used in Data Elements - 2020AA Release. https://www.nlm.nih.gov/research/umls/knowledge_sources/metathesaurus/release/abbreviations.html (accessed 17 Sep 2020).</Citation></Reference><Reference><Citation>Ji Z, Wei Q, Xu H. BERT-based Ranking for Biomedical Entity Normalization. AMIA 2020 Informatics Summit Published Online First: 9 August 2019.http://arxiv.org/abs/1908.03548 (accessed 22 Jan 2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233044</ArticleId><ArticleId IdType="pubmed">32477646</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Lee H-J, Ji Z, et al. UTH_CCB system for adverse drug reaction extraction from drug labels at TAC-ADR 2017. Proceedings of Text Analysis Conference; 2017.</Citation></Reference><Reference><Citation>Ji Z, Lu Z, Li H. An Information Retrieval Approach to Short Text Conversation. http://arxiv.org/abs/14086988 2014.</Citation></Reference><Reference><Citation>Wang Q, Ji Z, Wang J, et al. A study of entity-linking methods for normalizing Chinese diagnosis and procedure terms to ICD codes. Elsevierhttps://www.sciencedirect.com/science/article/pii/S1532046420300460 ().</Citation><ArticleIdList><ArticleId IdType="pubmed">32298846</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson SE, Walker S, Jones S, et al. Okapi at TREC-3. In: Proceedings of TREC. 1995:109&#x2013;26.</Citation></Reference><Reference><Citation>Ruskey F, Weston M. A survey of Venn diagrams. Electron J Comb. 1997;4(3)</Citation></Reference><Reference><Citation>MedDRA Distribution File Format Document. 2014.</Citation></Reference><Reference><Citation>Zhao-Wong A. MedDRA Coding, Analysis, and Mappings with Other Terminologies International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Legal Notice MedDRA Coding, Analysis, and Mappings with Other Terminologie.</Citation></Reference><Reference><Citation>UMLS Metathesaurus - ICD9CM (International Classification of Diseases, Ninth Revision, Clinical Modification) - Synopsis. https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/ICD9CM/index.html ().</Citation></Reference><Reference><Citation>ICD - ICD-9 - International Classification of Diseases, Ninth Revision. https://www.cdc.gov/nchs/icd/icd9.htm (accessed 17 Sep 2020).</Citation></Reference><Reference><Citation>Steindel SJ. International classification of diseases, 10th edition, clinical modification and procedure coding system: descriptive overview of the next generation HIPAA code sets. J Am Med Informatics Assoc. 2010;17:274&#x2013;282. doi: 10.1136/jamia.2009.001230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.001230</ArticleId><ArticleId IdType="pmc">PMC2995704</ArticleId><ArticleId IdType="pubmed">20442144</ArticleId></ArticleIdList></Reference><Reference><Citation>Metathesaurus - Rich Release Format (RRF) - UMLS&#xae; Reference Manual - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK9685/ (accessed 23 Sep 2020).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38347885</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2673-253X</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in digital health</Title><ISOAbbreviation>Front Digit Health</ISOAbbreviation></Journal><ArticleTitle>INSPIRE datahub: a pan-African integrated suite of services for harmonising longitudinal population health data using OHDSI tools.</ArticleTitle><Pagination><StartPage>1329630</StartPage><MedlinePgn>1329630</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1329630</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fdgth.2024.1329630</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Population health data integration remains a critical challenge in low- and middle-income countries (LMIC), hindering the generation of actionable insights to inform policy and decision-making. This paper proposes a pan-African, Findable, Accessible, Interoperable, and Reusable (FAIR) research architecture and infrastructure named the INSPIRE datahub. This cloud-based Platform-as-a-Service (PaaS) and on-premises setup aims to enhance the discovery, integration, and analysis of clinical, population-based surveys, and other health data sources.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The INSPIRE datahub, part of the Implementation Network for Sharing Population Information from Research Entities (INSPIRE), employs the Observational Health Data Sciences and Informatics (OHDSI) open-source stack of tools and the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) to harmonise data from African longitudinal population studies. Operating on Microsoft Azure and Amazon Web Services cloud platforms, and on on-premises servers, the architecture offers adaptability and scalability for other cloud providers and technology infrastructure. The OHDSI-based tools enable a comprehensive suite of services for data pipeline development, profiling, mapping, extraction, transformation, loading, documentation, anonymization, and analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The INSPIRE datahub's "On-ramp" services facilitate the integration of data and metadata from diverse sources into the OMOP CDM. The datahub supports the implementation of OMOP CDM across data producers, harmonizing source data semantically with standard vocabularies and structurally conforming to OMOP table structures. Leveraging OHDSI tools, the datahub performs quality assessment and analysis of the transformed data. It ensures FAIR data by establishing metadata flows, capturing provenance throughout the ETL processes, and providing accessible metadata for potential users. The ETL provenance is documented in a machine- and human-readable Implementation Guide (IG), enhancing transparency and usability.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The pan-African INSPIRE datahub presents a scalable and systematic solution for integrating health data in LMICs. By adhering to FAIR principles and leveraging established standards like OMOP CDM, this architecture addresses the current gap in generating evidence to support policy and decision-making for improving the well-being of LMIC populations. The federated research network provisions allow data producers to maintain control over their data, fostering collaboration while respecting data privacy and security concerns. A use-case demonstrated the pipeline using OHDSI and other open-source tools.</AbstractText><CopyrightInformation>&#xa9; 2024 Bhattacharjee, Kiwuwa-Muyingo, Kanjala, Maoyi, Amadi, Ochola, Kadengye, Gregory, Kiragga, Taylor, Greenfield, Slaymaker, Todd and INSPIRE Network.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bhattacharjee</LastName><ForeName>Tathagata</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Population Health, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiwuwa-Muyingo</LastName><ForeName>Sylvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>African Population and Health Research Center (APHRC), Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanjala</LastName><ForeName>Chifundo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Population Health, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UNICEF (Malawi), Lilongwe, Malawi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maoyi</LastName><ForeName>Molulaqhooa L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>South African Population Research Infrastructure Network (SAPRIN), South African Medical Research Council, Durban, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amadi</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Population Health, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ochola</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>African Population and Health Research Center (APHRC), Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kadengye</LastName><ForeName>Damazo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>African Population and Health Research Center (APHRC), Nairobi, Kenya.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Economics and Statistics, Kabale University, Kabale, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregory</LastName><ForeName>Arofan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Committee on Data of the International Science Council (CODATA), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiragga</LastName><ForeName>Agnes</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>African Population and Health Research Center (APHRC), Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Amelia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Malawi University of Business and Applied Sciences, Blantyre, Malawi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenfield</LastName><ForeName>Jay</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Economics and Statistics, Kabale University, Kabale, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slaymaker</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Population Health, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Todd</LastName><ForeName>Jim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Population Health, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>INSPIRE Network</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Digit Health</MedlineTA><NlmUniqueID>101771889</NlmUniqueID><ISSNLinking>2673-253X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Common Data Model (CDM)</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">data harmonisation</Keyword><Keyword MajorTopicYN="N">data hub</Keyword><Keyword MajorTopicYN="N">longitudinal population health data</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>13</Day><Hour>3</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38347885</ArticleId><ArticleId IdType="pmc">PMC10859396</ArticleId><ArticleId IdType="doi">10.3389/fdgth.2024.1329630</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>O&#x2019;Neill D, Benzeval M, Boyd A, Calderwood L, Copper C, Corti L, et al. Data resource profile: cohort and longitudinal studies enhancement resources (CLOSER). Int J Epidemiol. (2019) 48(3):675&#x2013;676i. 10.1093/ije/dyz004</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyz004</ArticleId><ArticleId IdType="pmc">PMC6659357</ArticleId><ArticleId IdType="pubmed">30789213</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L, Zeng N, Kim M, Mueller R, Hankosky E, Redline S, et al. X-search: an open access interface for cross-cohort exploration of the national sleep research resource. BMC Med Inform Decis Mak. (2018) 18(1):99. 10.1186/s12911-018-0682-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-018-0682-y</ArticleId><ArticleId IdType="pmc">PMC6234631</ArticleId><ArticleId IdType="pubmed">30424756</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortier I, Raina P, Van Den Heuvel E, Griffith L, Craig C, Saliba M, et al. Maelstrom research guidelines for rigorous retrospective data harmonization. Int J Epidemiol. (2017) 46(1):103&#x2013;5. 10.1093/ije/dyw075</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw075</ArticleId><ArticleId IdType="pmc">PMC5407152</ArticleId><ArticleId IdType="pubmed">27272186</ArticleId></ArticleIdList></Reference><Reference><Citation>Reniers G, Wamukoya M, Urassa M, Nyaguara A, Nakiyingi-Miiro J, Lutalo T, et al. Data resource profile: network for analysing longitudinal population-based HIV/AIDS data on Africa (ALPHA network). Int J Epidemiol. (2016) 45(1):83&#x2013;93. 10.1093/ije/dyv343</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyv343</ArticleId><ArticleId IdType="pmc">PMC5823235</ArticleId><ArticleId IdType="pubmed">26968480</ArticleId></ArticleIdList></Reference><Reference><Citation>Herbst K, Juvekar S, Bhattacharjee T, Bangha M, Patharia N, Tei T, et al. The INDEPTH data repository: an international resource for longitudinal population and health data from health and demographic surveillance systems. J Empir Res Hum Res Ethics. (2015) 10(3):324&#x2013;33. 10.1177/1556264615594600</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1556264615594600</ArticleId><ArticleId IdType="pmc">PMC4547208</ArticleId><ArticleId IdType="pubmed">26297754</ArticleId></ArticleIdList></Reference><Reference><Citation>Doiron D, Burton P, Marcon Y, Gaye A, Wolffenbuttel B, Perola M, et al. Data harmonization and federated analysis of population-based studies: the BioSHaRE project. Emerg Themes Epidemiol. (2013) 10(1):12. 10.1186/1742-7622-10-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-7622-10-12</ArticleId><ArticleId IdType="pmc">PMC4175511</ArticleId><ArticleId IdType="pubmed">24257327</ArticleId></ArticleIdList></Reference><Reference><Citation>Adhikari K, Patten S, Patel A, Premji S, Tough S, Letourneau N, et al. Data harmonization and data pooling from cohort studies: a practical approach for data management. Int J Popul Data Sci. (2021) 6(1):2. 10.23889/ijpds.v6i1.1680</Citation><ArticleIdList><ArticleId IdType="doi">10.23889/ijpds.v6i1.1680</ArticleId><ArticleId IdType="pmc">PMC8631396</ArticleId><ArticleId IdType="pubmed">34888420</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson MD, Dumontier M, Aalbersberg I, Appleton G, Axton M, Baak A, et al. The FAIR guiding principles for scientific data management and stewardship. Sci Data. (2016) 3(1):160018. 10.1038/sdata.2016.18</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2016.18</ArticleId><ArticleId IdType="pmc">PMC4792175</ArticleId><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortier I, Dragieva N, Saliba M, Craig C, Robson PJ. Harmonization of the health and risk factor questionnaire data of the Canadian partnership for tomorrow project: a descriptive analysis. CMAJ Open. (2019) 7(2):E272&#x2013;82. 10.9778/cmajo.20180062</Citation><ArticleIdList><ArticleId IdType="doi">10.9778/cmajo.20180062</ArticleId><ArticleId IdType="pmc">PMC6498449</ArticleId><ArticleId IdType="pubmed">31018973</ArticleId></ArticleIdList></Reference><Reference><Citation>Doiron D, Marcon Y, Fortier I, Burton P, Ferretti V. Software application profile: opal and mica: open-source software solutions for epidemiological data management, harmonization and dissemination. Int J Epidemiol. (2017) 46(5):1372&#x2013;8. 10.1093/ije/dyx180</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyx180</ArticleId><ArticleId IdType="pmc">PMC5837212</ArticleId><ArticleId IdType="pubmed">29025122</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankoh O, Byass P. The INDEPTH network: filling vital gaps in global epidemiology. Int J Epidemiol. (2012) 41(3):579&#x2013;88. 10.1093/ije/dys081</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dys081</ArticleId><ArticleId IdType="pmc">PMC3396316</ArticleId><ArticleId IdType="pubmed">22798690</ArticleId></ArticleIdList></Reference><Reference><Citation>Collinson MA, Mudzana T, Mutevedzi T, Kahn K, Maimela E, G&#xf3;mez-Oliv&#xe9; FX, et al. Cohort profile: South African population research infrastructure network (SAPRIN). Int J Epidemiol. (2022) 51(4):e206&#x2013;16. 10.1093/ije/dyab261</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyab261</ArticleId><ArticleId IdType="pmc">PMC9365637</ArticleId><ArticleId IdType="pubmed">34966919</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanjala C. Provenance of &#x2018;after the fact&#x2019; harmonised community-based demographic and HIV surveillance data from ALPHA cohorts. [Internet]. LSHTM Research Online. (2020) 4655994:31&#x2013;2. 10.17037/PUBS.04655994</Citation><ArticleIdList><ArticleId IdType="doi">10.17037/PUBS.04655994</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, Ma Q, Knoll C, Schuemie M, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. (2015) 22(3):553&#x2013;64. 10.1093/jamia/ocu023</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocu023</ArticleId><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Balch JA, Ruppert MM, Loftus TJ, Guan Z, Ren Y, Upchurch GR, et al. Machine learning&#x2013;enabled clinical information systems using fast healthcare interoperability resources data standards: scoping review. JMIR Med Inform. (2023) 11:e48297&#x2013;e48297. 10.2196/48297</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/48297</ArticleId><ArticleId IdType="pmc">PMC10468818</ArticleId><ArticleId IdType="pubmed">37646309</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest CB, McTigue KM, Hernandez AF, Cohen LW, Cruz H, Haynes K, et al. PCORnet&#xae; 2020: current state, accomplishments, and future directions. J Clin Epidemiol. (2021) 129:60&#x2013;7. 10.1016/j.jclinepi.2020.09.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2020.09.036</ArticleId><ArticleId IdType="pmc">PMC7521354</ArticleId><ArticleId IdType="pubmed">33002635</ArticleId></ArticleIdList></Reference><Reference><Citation>Puttmann D, De Keizer N, Cornet R, Van Der Zwan E, Bakhshi-Raiez F. FAIRifying a quality registry using OMOP CDM: challenges and solutions. In: S&#xe9;roussi B, Weber P, Dhombres F, Grouin C, Liebe J-D, Pelayo S, Pinna A, Rance B, Sacchi L, Ugon A, Benis A, Gallos P, editors. Studies in Health Technology and Informatics. Amsterdam: IOS Press; (2022). p. 367&#x2013;71. 10.3233/SHTI220476</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI220476</ArticleId><ArticleId IdType="pubmed">35612098</ArticleId></ArticleIdList></Reference><Reference><Citation>Beimborn D, Miletzki T, Wenzel S. Platform as a service (PaaS). WIRTSCHAFTSINFORMATIK. (2011) 53(6):371&#x2013;5. 10.1007/s11576-011-0294-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11576-011-0294-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharjee T. ALPHA to OMOP Data and Vocabulary Mapping. Available online at: Available at:
https://docs.google.com/document/d/1oDke4GWmDXZf2VSewOV_D0H2Ms_mD-Bt/edit</Citation></Reference><Reference><Citation>Greenfield J. INSPIRE Data Hub: High-Level Architecture and Data and Metadata Flows. Available online at: Available at:
https://docs.google.com/document/d/1vPz90Jpm_T5A-5y9q52V-7a3OpFarK5P/edit</Citation></Reference><Reference><Citation>Making Data Work for Cross-Domain Grand Challenges: the CODATA Decadal Programme. Available online at: Available at:
https://codata.org/initiatives/decadal-programme2/</Citation></Reference><Reference><Citation>The Book of OHDSI. Available online at:
https://ohdsi.github.io/TheBookOfOhdsi/</Citation></Reference><Reference><Citation>OHDSI Software Tools. Available online at: Available at:
https://ohdsi.org/software-tools/</Citation></Reference><Reference><Citation>Nishimwe A, Ruranga C, Musanabaganwa C, Mugeni R, Semakula M, Nzabanita J, et al. Leveraging artificial intelligence and data science techniques in harmonizing, sharing, accessing and analyzing SARS-COV-2/COVID-19 data in Rwanda (LAISDAR project): study design and rationale. BMC Med Inform Decis Mak. (2022) 22(1):214. 10.1186/s12911-022-01965-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-022-01965-9</ArticleId><ArticleId IdType="pmc">PMC9372951</ArticleId><ArticleId IdType="pubmed">35962355</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyobutungi C. Nairobi HDSS INDEPTH Core Dataset 2003&#x2013;2015 (Release 2018). Accra: INDEPTH Network; (2018). 10.7796/INDEPTH.KE031.CMD2015.V2</Citation><ArticleIdList><ArticleId IdType="doi">10.7796/INDEPTH.KE031.CMD2015.V2</ArticleId></ArticleIdList></Reference><Reference><Citation>Changalucha J, INDEPTH Network. Magu HDSS INDEPTH Core Dataset 1994&#x2013;2012 Release 2015. Accra: INDEPTH Network; (2015).</Citation></Reference><Reference><Citation>Herbst K. South Africa-Africa Health Research Institute INDEPTH Core Dataset 2000&#x2013;2017 (residents only)-release 2019. Accra: INDEPTH Network; (2019). 10.7796/INDEPTH.ZA031.CMD2017.V1</Citation><ArticleIdList><ArticleId IdType="doi">10.7796/INDEPTH.ZA031.CMD2017.V1</ArticleId></ArticleIdList></Reference><Reference><Citation>INDEPTH Data Repository. Available online at: Available at:
https://indepth-ishare.org/</Citation></Reference><Reference><Citation>PostgreSQL. Available online at:
https://www.postgresql.org/</Citation></Reference><Reference><Citation>Pentaho Data Integration Community Edition. Available online at: Available at:
https://www.hitachivantara.com/en-us/products/pentaho-platform/data-integration-analytics/pentaho-community-edition.html</Citation></Reference><Reference><Citation>OMOP Common Data Model v5.4. Available online at: Available at:
https://ohdsi.github.io/CommonDataModel/cdm54.html</Citation></Reference><Reference><Citation>FitzHenry F, Resnic FS, Robbins SL, Denton J, Nookala L, Meeker D, et al. Creating a common data model for comparative effectiveness with the observational medical outcomes partnership. Appl Clin Inform. (2015) 06(03):536&#x2013;47. 10.4338/ACI-2014-12-CR-0121</Citation><ArticleIdList><ArticleId IdType="doi">10.4338/ACI-2014-12-CR-0121</ArticleId><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharjee T. INSPIRE EA IT Infrastructure on the Cloud. Available online at: Available at:
https://docs.google.com/document/d/1LSdBtuKcDgWrQuUwEqlNpB_CDgZztE8l/edit</Citation></Reference><Reference><Citation>Applying the OMOP Common Data Model to Survey Data. Available online at: Available at:
https://www.ohdsi.org/web/wiki/lib/exe/fetch.php?media=resources:using_the_omop_cdm_with_survey_and_registry_data_v6.0.pdf/</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38349850</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>03</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Transformer-based time-to-event prediction for chronic kidney disease deterioration.</ArticleTitle><Pagination><StartPage>980</StartPage><EndPage>990</EndPage><MedlinePgn>980-990</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocae025</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Deep-learning techniques, particularly the Transformer model, have shown great potential in enhancing the prediction performance of longitudinal health records. Previous methods focused on fixed-time risk prediction, however, time-to-event prediction is often more appropriate for clinical scenarios. Here, we present STRAFE, a generalizable survival analysis Transformer-based architecture for electronic health records.</AbstractText><AbstractText Label="MATERIALS AND METHODS">The input for STRAFE is a sequence of visits with SNOMED-CT codes in OMOP-CDM format. A Transformer-based architecture was developed to calculate probabilities of the occurrence of the event in each of 48 months. Performance was evaluated using a real-world claims dataset of over 130&#xa0;000 individuals with stage 3 chronic kidney disease (CKD).</AbstractText><AbstractText Label="RESULTS">STRAFE showed improved mean absolute error (MAE) compared to other time-to-event algorithms in predicting the time to deterioration to stage 5 CKD. Additionally, STRAFE showed an improved area under the receiver operating curve compared to binary outcome algorithms. We show that STRAFE predictions can improve the positive predictive value of high-risk patients by 3-fold. Finally, we suggest a novel visualization approach to predictions on a per-patient basis.</AbstractText><AbstractText Label="DISCUSSION">Time-to-event predictions are the most appropriate approach for clinical predictions. Our deep-learning algorithm outperformed not only other time-to-event prediction algorithms but also fixed-time algorithms, possibly due to its ability to train on censored data. We demonstrated possible clinical usage by identifying the highest-risk patients.</AbstractText><AbstractText Label="CONCLUSIONS">The ability to accurately identify patients at high risk and prioritize their needs can result in improved health outcomes, reduced costs, and more efficient use of resources.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zisser</LastName><ForeName>Moshe</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Data and Decision Sciences, Technion-Israel Institute of Technology, Haifa, 3200003, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aran</LastName><ForeName>Dvir</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Faculty of Biology, Technion-Israel Institute of Technology, Haifa, 3200003, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Taub Faculty of Computer Science, Technion-Israel Institute of Technology, Haifa, 3200003, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="Y">Renal Insufficiency, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011336" MajorTopicYN="N">Probability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039061" MajorTopicYN="N">Systematized Nomenclature of Medicine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic kidney disease</Keyword><Keyword MajorTopicYN="N">clinical data</Keyword><Keyword MajorTopicYN="N">deep-learning</Keyword><Keyword MajorTopicYN="N">survival analysis</Keyword><Keyword MajorTopicYN="N">transformer</Keyword></KeywordList><CoiStatement>D.A. reports consulting fees from Carelon Digital Platforms. M.Z. has no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>13</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>13</Day><Hour>13</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>2</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38349850</ArticleId><ArticleId IdType="pmc">PMC10990547</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocae025</ArticleId><ArticleId IdType="pii">7607207</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vayena E, Dzenowagis J, Brownstein J, Sheikh SA.. Policy implications of big data in the health sector. Bulletin of the World Health Organisation. 2017;96(1):11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5791870</ArticleId><ArticleId IdType="pubmed">29403102</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghupathi W, Raghupathi V.. Big data analytics in healthcare: promise and potential. Health Inf. Sci. Syst. 2014;2(1):3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4341817</ArticleId><ArticleId IdType="pubmed">25825667</ArticleId></ArticleIdList></Reference><Reference><Citation>
Vaswani A, Shazeer N, Parmar N, et al.2017. Attention is all you need. https://arxiv.org/abs/1706.03762, preprint: not peer reviewed.</Citation></Reference><Reference><Citation>
Moerschbacher A, He Z.. 
2021. Building prediction models for 30-day readmissions among icu patients using both structured and unstructured data in electronic health records. medRxiv. https://www.medrxiv.org/content/early/2021/08/11/2021.08.10.21261858, preprint: not peer reviewed.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11271049</ArticleId><ArticleId IdType="pubmed">39055130</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng G, Zhuang J, Huang H, Gao Y, Liu Y, Yu X. Continuous prediction of acute kidney injury from patients with sepsis in ICU settings: a sequential transduction model based on attention. In: Proceedings of the 2022 International Conference on Intelligent Medicine and Health, ser. ICIMH &#x2019;22. New York, NY, USA: Association for Computing Machinery, 2022, p. 31&#x2013;37. 10.1145/3560071.3560077</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/3560071.3560077</ArticleId></ArticleIdList></Reference><Reference><Citation>
Rao S, Li Y, Ramakrishnan R, et al.2021. An explainable transformer-based deep learning model for the prediction of incident heart failure. https://arxiv.org/abs/2101.11359, preprint: not peer reviewed.</Citation><ArticleIdList><ArticleId IdType="pubmed">35130176</ArticleId></ArticleIdList></Reference><Reference><Citation>
Kodialam RS, Boiarsky R, Lim J, Dixit N, Sai A, Sontag D.. 
2020. Deep contextual clinical prediction with reverse distillation. https://arxiv.org/abs/2007.05611, preprint: not peer reviewed.</Citation></Reference><Reference><Citation>
Chen Z, Zhang Z, Zhu R, Xiang Y, Harrington PB.. 
2016. Diagnosis of patients with chronic kidney disease by using two fuzzy classifiers. Chemom Intell Lab Syst. 153:140-145. https://www.sciencedirect.com/science/article/pii/S0169743916300405</Citation></Reference><Reference><Citation>Subasi A, Alickovic E, Kevric J.. Diagnosis of chronic kidney disease by using random forest. In: Badnjevic A, ed. Cmbebih 2017. Singapore: Springer Singapore; 2017:589-594.</Citation></Reference><Reference><Citation>Chen Z, Zhang X, Zhang Z.. Clinical risk assessment of patients with chronic kidney disease by using clinical data and multivariate models. Int Urol Nephrol. 2016;48(12):2069-2075.</Citation><ArticleIdList><ArticleId IdType="pubmed">27334750</ArticleId></ArticleIdList></Reference><Reference><Citation>
Dutta S, Bandyopadhyay SK. Chronic kidney disease prediction using neural approach. medRxiv, 2020. https://www.medrxiv.org/content/early/2020/06/29/2020.06.28.20142034, preprint: not peer reviewed.</Citation></Reference><Reference><Citation>Anupama C, Sivaram M, Lydia EL, Gupta D, Shankar K.. Synergic deep learning model&#x2013;based automated detection and classification of brain intracranial hemorrhage images in wearable networks. Pers Ubiquitous Comput. 2020;26(1):1-10.</Citation></Reference><Reference><Citation>Khamparia A, Saini G, Pandey B, Tiwari S, Gupta D, Khanna A.. Kdsae: chronic kidney disease classification with multimedia data learning using deep stacked autoencoder network. Multimed Tools Appl. 2020;79(47-48):35425-35440. no.</Citation></Reference><Reference><Citation>
Wang Y, Guan Z, Hou W, Wang F.. 
2020. Trace: Early detection of chronic kidney disease onset with transformer-enhanced feature embedding. https://arxiv.org/abs/2012.03729, preprint: not peer reviewed.</Citation></Reference><Reference><Citation>Luke DA. Charting the process of change: a primer on survival analysis. Am J Community Psychol. 1993;21(2):203-246.</Citation><ArticleIdList><ArticleId IdType="pubmed">8279458</ArticleId></ArticleIdList></Reference><Reference><Citation>Giunchiglia E, Nemchenko A, van der Schaar M.. Rnn-surv: a deep recurrent model for survival analysis. In: K&#x16f;rkov&#xe1; V, Manolopoulos Y, Hammer B, Iliadis L, Maglogiannis I, eds. Artificial Neural Networks and Machine Learning &#x2013; ICANN 2018. Cham: Springer International Publishing; 2018:23-32.</Citation></Reference><Reference><Citation>
Lee C, Zame W, Yoon J, van der Schaar M.. 
2018. Deephit: a deep learning approach to survival analysis with competing risks. AAAI. 32(1). https://ojs.aaai.org/index.php/AAAI/article/view/11842</Citation><ArticleIdList><ArticleId IdType="pubmed">30951460</ArticleId></ArticleIdList></Reference><Reference><Citation>
Ren K, Qin J, Zheng L, et al.2018. Deep recurrent survival analysis. https://arxiv.org/abs/1809.02403, preprint: not peer reviewed.</Citation></Reference><Reference><Citation>Huang Z, Chai H, Wang R, Wang H, Yang Y, Hejun W. Integration of patch features through self-supervised learning and transformer for survival analysis on whole slide images. In: de Bruijne M, Cattin PC, Cotin S, et al., eds. Medical Image Computing and Computer Assisted Intervention &#x2013; MICCAI 2021. MICCAI 2021. Lecture Notes in Computer Science, Vol. 12908. Cham: Springer; 2021:561-570. 10.1007/978-3-030-87237-3_54</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-87237-3_54</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu S, Fridgeirsson E, van Wingen G, Welling M.. Transformer-based deep survival analysis. In: Proceedings of AAAI Spring Symposium on Survival Prediction - Algorithms, Challenges, and Applications 2021. PMLR; 2021;146:132&#x2013;148.</Citation></Reference><Reference><Citation>
Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS.. 
Random survival forests. Ann Appl Stat. 2008;2(3):841&#x2013;860. https://doi.org/10.1214%2F08-aoas169</Citation></Reference><Reference><Citation>Hochreiter S, Schmidhuber J.. Long short-term memory. Neural Comput. 1997;9(8):1735-1780.</Citation><ArticleIdList><ArticleId IdType="pubmed">9377276</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;nen M, Heller G.. Concordance probability and discriminatory power in proportional hazards regression. Biometrika. 2005;92(4):965-970.</Citation></Reference><Reference><Citation>
Mikolov T, Sutskever I, Chen K, Corrado G, Dean J.. 
2013. Distributed representations of words and phrases and their compositionality. https://arxiv.org/abs/1310.4546, preprint: not peer reviewed.</Citation></Reference><Reference><Citation>Kaplan EL, Meier P.. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457-481.</Citation></Reference><Reference><Citation>
OHDSI. The Book of OHDSI: Observational Health Data Sciences and Informatics. OHDSI; 2019. https://books.google.co.il/books?id=JxpnzQEACAAJ</Citation></Reference><Reference><Citation>Rehurek R, Sojka P.. Gensim&#x2013;python framework for vector space modelling. NLP Centre, Faculty of Informatics, Masaryk University, Brno, Czech Republic, 2011;3(2: ).</Citation></Reference><Reference><Citation>
Kingma DP, Ba J. Adam: a method for stochastic optimization. https://arxiv.org/abs/1412.6980, 2014, preprint: not peer reviewed.</Citation></Reference><Reference><Citation>P&#xf6;lsterl S. scikit-survival: a library for time-to-event analysis built on top of scikit-learn. J Mach Learn Res. 2020;21(212):1-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38357585</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1179-1349</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Clinical epidemiology</Title><ISOAbbreviation>Clin Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States.</ArticleTitle><Pagination><StartPage>71</StartPage><EndPage>89</EndPage><MedlinePgn>71-89</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/CLEP.S448980</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Few studies have examined how the absolute risk of thromboembolism with COVID-19 has evolved over time across different countries. Researchers from the European Medicines Agency, Health Canada, and the United States (US) Food and Drug Administration established a collaboration to evaluate the absolute risk of arterial (ATE) and venous thromboembolism (VTE) in the 90 days after diagnosis of COVID-19 in the ambulatory (eg, outpatient, emergency department, nursing facility) setting from seven countries across North America (Canada, US) and Europe (England, Germany, Italy, Netherlands, and Spain) within periods before and during COVID-19 vaccine availability.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="UNASSIGNED">We conducted cohort studies of patients initially diagnosed with COVID-19 in the ambulatory setting from the seven specified countries. Patients were followed for 90 days after COVID-19 diagnosis. The primary outcomes were ATE and VTE over 90 days from diagnosis date. We measured country-level estimates of 90-day absolute risk (with 95% confidence intervals) of ATE and VTE.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The seven cohorts included 1,061,565 patients initially diagnosed with COVID-19 in the ambulatory setting before COVID-19 vaccines were available (through November 2020). The 90-day absolute risk of ATE during this period ranged from 0.11% (0.09-0.13%) in Canada to 1.01% (0.97-1.05%) in the US, and the 90-day absolute risk of VTE ranged from 0.23% (0.21-0.26%) in Canada to 0.84% (0.80-0.89%) in England. The seven cohorts included 3,544,062 patients with COVID-19 during vaccine availability (beginning December 2020). The 90-day absolute risk of ATE during this period ranged from 0.06% (0.06-0.07%) in England to 1.04% (1.01-1.06%) in the US, and the 90-day absolute risk of VTE ranged from 0.25% (0.24-0.26%) in England to 1.02% (0.99-1.04%) in the US.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">There was heterogeneity by country in 90-day absolute risk of ATE and VTE after ambulatory COVID-19 diagnosis both before and during COVID-19 vaccine availability.</AbstractText><CopyrightInformation>&#xa9; 2024 Lo Re III et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Lo Re Iii</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-7955-0600</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Cocoros</LastName><ForeName>Noelle M</ForeName><Initials>NM</Initials><Identifier Source="ORCID">0000-0001-7090-2761</Identifier><AffiliationInfo><Affiliation>Department of Population Medicine, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Pilgrim Healthcare Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hubbard</LastName><ForeName>Rebecca A</ForeName><Initials>RA</Initials><Identifier Source="ORCID">0000-0003-0879-0994</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dutcher</LastName><ForeName>Sarah K</ForeName><Initials>SK</Initials><Identifier Source="ORCID">0000-0003-0574-2890</Identifier><AffiliationInfo><Affiliation>Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newcomb</LastName><ForeName>Craig W</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Connolly</LastName><ForeName>John G</ForeName><Initials>JG</Initials><Identifier Source="ORCID">0000-0003-1916-557X</Identifier><AffiliationInfo><Affiliation>Department of Population Medicine, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Pilgrim Healthcare Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez-Vilar</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1272-1502</Identifier><AffiliationInfo><Affiliation>Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carbonari</LastName><ForeName>Dean M</ForeName><Initials>DM</Initials><Identifier Source="ORCID">0000-0003-0310-270X</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kempner</LastName><ForeName>Maria E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Population Medicine, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Pilgrim Healthcare Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Mu&#xf1;oz</LastName><ForeName>Jos&#xe9; J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0002-2553-3159</Identifier><AffiliationInfo><Affiliation>Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrone</LastName><ForeName>Andrew B</ForeName><Initials>AB</Initials><Identifier Source="ORCID">0000-0001-8413-6236</Identifier><AffiliationInfo><Affiliation>Department of Population Medicine, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Pilgrim Healthcare Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pishko</LastName><ForeName>Allyson M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0001-9997-454X</Identifier><AffiliationInfo><Affiliation>Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogers Driscoll</LastName><ForeName>Meighan E</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0003-1371-9658</Identifier><AffiliationInfo><Affiliation>Department of Population Medicine, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Pilgrim Healthcare Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brash</LastName><ForeName>James T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>IQVIA, Real World Solutions, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burnett</LastName><ForeName>Sean</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Canadian Network for Observational Drug Effect Studies (CNODES), Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Therapeutics Initiative, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohet</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0022-7251</Identifier><AffiliationInfo><Affiliation>Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahl</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Canadian Network for Observational Drug Effect Studies (CNODES), Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Manitoba Centre for Health Policy, University of Manitoba, Winnipeg, Manitoba, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeFor</LastName><ForeName>Terese A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>HealthPartners Institute, Bloomington, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delmestri</LastName><ForeName>Antonella</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0388-3403</Identifier><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Djibo</LastName><ForeName>Djeneba Audrey</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0003-3378-0691</Identifier><AffiliationInfo><Affiliation>CVS Health, Blue Bell, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8274-0357</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrington</LastName><ForeName>Laura B</ForeName><Initials>LB</Initials><Identifier Source="ORCID">0000-0001-5951-8291</Identifier><AffiliationInfo><Affiliation>Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kampman</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Health Canada, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuntz</LastName><ForeName>Jennifer L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-0017-6853</Identifier><AffiliationInfo><Affiliation>Kaiser Permanente Northwest Center for Health Research, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurz</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-9838-7754</Identifier><AffiliationInfo><Affiliation>Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mercad&#xe9;-Besora</LastName><ForeName>N&#xfa;ria</ForeName><Initials>N</Initials><Identifier Source="ORCID">0009-0006-7948-3747</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pawloski</LastName><ForeName>Pamala A</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0002-1005-5764</Identifier><AffiliationInfo><Affiliation>HealthPartners Institute, Bloomington, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><Identifier Source="ORCID">0000-0003-0621-1979</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seager</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IQVIA, Real World Solutions, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steiner</LastName><ForeName>Claudia A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Colorado Institute for Health Research, Aurora, CO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Colorado Permanente Medical Group, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verhamme</LastName><ForeName>Katia</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8162-4904</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Fangyun</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Canadian Network for Observational Drug Effect Studies (CNODES), Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ICES, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yunping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Humana Healthcare Research, Inc., Louisville, KY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burn</LastName><ForeName>Edward</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9286-1128</Identifier><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Paterson</LastName><ForeName>J Michael</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0001-5995-1714</Identifier><AffiliationInfo><Affiliation>Canadian Network for Observational Drug Effect Studies (CNODES), Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ICES, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3950-6346</Identifier><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Clin Epidemiol</MedlineTA><NlmUniqueID>101531700</NlmUniqueID><ISSNLinking>1179-1349</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">ischemic stroke</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">thromboembolism</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList><CoiStatement>VLR III reports research grants to his institution from the US Food and Drug Administration (FDA) and the National Institutes of Health (NIH); consulting fees from Entasis, Takeda, and Urovant Sciences; and participation on the FDA Drug Safety and Risk Management Advisory Committee. NMC reports research funding from FDA via a Department of Health and Human Services (HHS) contract during the conduct of the study and funding from HPHCI (a non-profit organization that conducts work for government and private organizations, including pharmaceutical companies) outside the submitted work. RAH reports grants from FDA, NIH, and Merck. AMP reports royalties from UpToDate (including for an article on anticoagulation), consulting fees via advisory board from BioMarin LLC outside the submitted work, and speaker honorarium from the American Society of Hematology. DAD reports stock options in CVS Health. JLK reports unrelated research grants to her institution from Vir Biotechnology, Pfizer, Novartis, and the Centers for Disease Control and Prevention. PRR reports unrelated research grants to his institution from Chiesi, UCB, Amgen, Johnson &amp; Johnson,&#xa0;Innovative Medicines Initiative, and the European Medicines Agency. KV reports unrelated research grants to her institution from Chiesi, UCB, Amgen, Johnson &amp; Johnson, and the European Medicines Agency. DPA reports research grants to his institution from Amgen, Chiesi-Taylor, Lilly, Janssen, Novartis, and UCB Biopharma as well as consulting fees from Astra Zeneca and UCB Biopharma. The authors report no other conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>15</Day><Hour>4</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38357585</ArticleId><ArticleId IdType="pmc">PMC10865892</ArticleId><ArticleId IdType="doi">10.2147/CLEP.S448980</ArticleId><ArticleId IdType="pii">448980</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med. 2020;382(17):e38. doi:10.1056/NEJMc2007575</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2007575</ArticleId><ArticleId IdType="pmc">PMC7161262</ArticleId><ArticleId IdType="pubmed">32268022</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Samkari H, Karp Leaf RS, Dzik WH, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136(4):489&#x2013;500. doi:10.1182/blood.2020006520</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020006520</ArticleId><ArticleId IdType="pmc">PMC7378457</ArticleId><ArticleId IdType="pubmed">32492712</ArticleId></ArticleIdList></Reference><Reference><Citation>Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18(7):1738&#x2013;1742. doi:10.1111/jth.14850</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14850</ArticleId><ArticleId IdType="pmc">PMC9906150</ArticleId><ArticleId IdType="pubmed">32302438</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiezia L, Boscolo A, Poletto F, et al. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost. 2020;120(6):998&#x2013;1000. doi:10.1055/s-0040-1714350</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1714350</ArticleId><ArticleId IdType="pmc">PMC7295272</ArticleId><ArticleId IdType="pubmed">32316063</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033&#x2013;2040. doi:10.1182/blood.2020006000</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020006000</ArticleId><ArticleId IdType="pmc">PMC7273827</ArticleId><ArticleId IdType="pubmed">32339221</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, Duarte-Salles T, Fernandez-Bertolin S, et al. Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study. Lancet Infect Dis. 2022;22(8):1142&#x2013;1152. doi:10.1016/S1473-3099(22)00223-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00223-7</ArticleId><ArticleId IdType="pmc">PMC9106320</ArticleId><ArticleId IdType="pubmed">35576963</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Re V 3rd, Dutcher SK, Connolly JG, et al. Association of COVID-19 vs influenza with risk of arterial and venous thrombotic events among hospitalized patients. JAMA. 2022;328(7):637&#x2013;651. doi:10.1001/jama.2022.13072</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.13072</ArticleId><ArticleId IdType="pmc">PMC9382447</ArticleId><ArticleId IdType="pubmed">35972486</ArticleId></ArticleIdList></Reference><Reference><Citation>International Coalition of Medicines Regulatory Authorities. COVID-19; 2023. Available from: https://www.icmra.info/drupal/en/covid-19. Accessed July
19, 2023.</Citation></Reference><Reference><Citation>Suissa S, Henry D, Caetano P, et al. CNODES: the Canadian Network for Observational Drug Effect Studies. Open Med. 2012;6(4):e134&#x2013;140. doi:10.1038/clpt.1985.188</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/clpt.1985.188</ArticleId><ArticleId IdType="pmc">PMC3654509</ArticleId><ArticleId IdType="pubmed">23687528</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf A, Dedman D, Campbell J, et al. Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum. Int J Epidemiol. 2019;48(6):1740&#x2013;1740g. doi:10.1093/ije/dyz034</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyz034</ArticleId><ArticleId IdType="pmc">PMC6929522</ArticleId><ArticleId IdType="pubmed">30859197</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathmann W, Bongaerts B, Carius HJ, Kruppert S, Kostev K. Basic characteristics and representativeness of the German Disease Analyzer database. Int J Clin Pharmacol Ther. 2018;56(10):459&#x2013;466. doi:10.5414/CP203320</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/CP203320</ArticleId><ArticleId IdType="pubmed">30168417</ArticleId></ArticleIdList></Reference><Reference><Citation>Agostoni E, Barbanti P, Frediani F, et al. Real-world insights on the management of migraine patients: an Italian nationwide study. Curr Med Res Opin. 2019;35(9):1545&#x2013;1554. doi:10.1080/03007995.2019.1602032</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2019.1602032</ArticleId><ArticleId IdType="pubmed">30924392</ArticleId></ArticleIdList></Reference><Reference><Citation>de Ridder MAJ, de Wilde M, de Ben C, et al. Data resource profile: the Integrated Primary Care Information (IPCI) database, the Netherlands. Int J Epidemiol. 2022;51(6):e314&#x2013;e323. doi:10.1093/ije/dyac026</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyac026</ArticleId><ArticleId IdType="pmc">PMC9749682</ArticleId><ArticleId IdType="pubmed">35182144</ArticleId></ArticleIdList></Reference><Reference><Citation>Recalde M, Rodriguez C, Burn E, et al. Data resource profile: the Information System for Research in Primary Care (SIDIAP). Int J Epidemiol. 2022;51(6):e324&#x2013;e336. doi:10.1093/ije/dyac068</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyac068</ArticleId><ArticleId IdType="pmc">PMC9749711</ArticleId><ArticleId IdType="pubmed">35415748</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis LH, Weiner MG, Boudreau DM, et al. Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf. 2012;21 Suppl 1(S1):23&#x2013;31. doi:10.1002/pds.2336</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.2336</ArticleId><ArticleId IdType="pubmed">22262590</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54&#x2013;60. doi:10.1136/amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministerio de Sanidad. Hospital discharge records in the National Health System; 2023. Avaialable from: https://www.sanidad.gob.es/en/estadEstudios/estadisticas/cmbdhome.htm. Accessed July
19, 2023.</Citation></Reference><Reference><Citation>Cocoros NM, Fuller CC, Adimadhyam S, et al. A COVID-19-ready public health surveillance system: the Food and Drug Administration&#x2019;s Sentinel System. Pharmacoepidemiol Drug Saf. 2021;30(7):827&#x2013;837. doi:10.1002/pds.5240</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.5240</ArticleId><ArticleId IdType="pmc">PMC8250843</ArticleId><ArticleId IdType="pubmed">33797815</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosati K, Jorgensen N, Soliz M, Evans BJ
Sentinel Initiative principles and policies: HIPAA and Common Rule compliance in the Sentinel Initiative; 2021. Available from: https://www.sentinelinitiative.org/sites/default/files/communications/publications-presentations/HIPAA-Common-Rule-Compliance-in-Sentinel-Initiative.pdf. Accessed October
31, 2021.</Citation></Reference><Reference><Citation>Basic HHS policy for protection of human research subjects, 45 CFR &#xa7;46.102(l)(2); 2021. Available from: https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-A/part-46/subpart-A#46.102. Accessed on November
2, 2021.</Citation></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28(7):1461&#x2013;1467. doi:10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Re V, Dutcher SK, Connolly JG, et al. Risk of admission to hospital with arterial or venous thromboembolism among patients diagnosed in the ambulatory setting with covid-19 compared with influenza: retrospective cohort study. BMJ Med. 2023;2(1):e000421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10254785</ArticleId><ArticleId IdType="pubmed">37303490</ArticleId></ArticleIdList></Reference><Reference><Citation>Haynes K. Preparing for COVID-19 vaccine safety surveillance: a United States perspective. Pharmacoepidemiol Drug Saf. 2020;29(12):1529&#x2013;1531. doi:10.1002/pds.5142</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.5142</ArticleId><ArticleId IdType="pmc">PMC7537525</ArticleId><ArticleId IdType="pubmed">32978861</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Re V, Klungel OH, Chan KA, Panozzo CA, Zhou W, Winterstein AG. Global covid-19 vaccine rollout and safety surveillance-how to keep pace. BMJ. 2021;373:n1416. doi:10.1136/bmj.n1416</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1416</ArticleId><ArticleId IdType="pubmed">34144957</ArticleId></ArticleIdList></Reference><Reference><Citation>Roumie CL, Mitchel E, Gideon PS, Varas-Lorenzo C, Castellsague J, Griffin MR. Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data. Pharmacoepidemiol Drug Saf. 2008;17(1):20&#x2013;26. doi:10.1002/pds.1518</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.1518</ArticleId><ArticleId IdType="pubmed">17979142</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahl PM, Rodgers K, Schneeweiss S, et al. Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population. Pharmacoepidemiol Drug Saf. 2010;19(6):596&#x2013;603. doi:10.1002/pds.1924</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.1924</ArticleId><ArticleId IdType="pubmed">20140892</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutrona SL, Toh S, Iyer A, et al. Validation of acute myocardial infarction in the Food and Drug Administration&#x2019;s Mini-Sentinel program. Pharmacoepidemiol Drug Saf. 2013;22(1):40&#x2013;54. doi:10.1002/pds.3310</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3310</ArticleId><ArticleId IdType="pmc">PMC3601831</ArticleId><ArticleId IdType="pubmed">22745038</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammann EM, Schweizer ML, Robinson JG, et al. Chart validation of inpatient ICD-9-CM administrative diagnosis codes for acute myocardial infarction (AMI) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database. Pharmacoepidemiol Drug Saf. 2018;27(4):398&#x2013;404. doi:10.1002/pds.4398</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4398</ArticleId><ArticleId IdType="pmc">PMC6410350</ArticleId><ArticleId IdType="pubmed">29446185</ArticleId></ArticleIdList></Reference><Reference><Citation>Yih WK, Greene SK, Zichittella L, et al. Evaluation of the risk of venous thromboembolism after quadrivalent human papillomavirus vaccination among US females. Vaccine. 2016;34(1):172&#x2013;178. doi:10.1016/j.vaccine.2015.09.087</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.09.087</ArticleId><ArticleId IdType="pubmed">26549364</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammann EM, Cuker A, Carnahan RM, et al. Chart validation of inpatient International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) administrative diagnosis codes for venous thromboembolism (VTE) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database. Medicine. 2018;97(8):e9960. doi:10.1097/MD.0000000000009960</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000009960</ArticleId><ArticleId IdType="pmc">PMC5841980</ArticleId><ArticleId IdType="pubmed">29465588</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, Li X, Kostka K, et al. Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf. 2022;31(5):495&#x2013;510. doi:10.1002/pds.5419</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.5419</ArticleId><ArticleId IdType="pmc">PMC9088543</ArticleId><ArticleId IdType="pubmed">35191114</ArticleId></ArticleIdList></Reference><Reference><Citation>Madigan D, Ryan PB, Schuemie M, et al. Evaluating the impact of database heterogeneity on observational study results. Am J Epidemiol. 2013;178(4):645&#x2013;651. doi:10.1093/aje/kwt010</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwt010</ArticleId><ArticleId IdType="pmc">PMC3736754</ArticleId><ArticleId IdType="pubmed">23648805</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottegard A, Kurz X, Moore N, Christiansen CF, Klungel O. Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic. Pharmacoepidemiol Drug Saf. 2020;29(8):825&#x2013;831. doi:10.1002/pds.5029</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.5029</ArticleId><ArticleId IdType="pubmed">32369865</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Health Security Agency. Coronavirus (COVID-19) in the UK; 2023. Available from: https://coronavirus.data.gov.uk/details/cases?areaType=nation&amp;areaName=England. Accessed July
16, 2023.</Citation></Reference><Reference><Citation>Catala M, Coma E, Alonso S, et al. Transmissibility, hospitalization, and intensive care admissions due to omicron compared to delta variants of SARS-CoV-2 in Catalonia: a cohort study and ecological analysis. Front Public Health. 2022;10:961030. doi:10.3389/fpubh.2022.961030</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.961030</ArticleId><ArticleId IdType="pmc">PMC9412031</ArticleId><ArticleId IdType="pubmed">36033822</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J, Prats-Uribe A, Feng Q, et al. Clinical and genetic risk factors for acute incident venous thromboembolism in ambulatory patients with COVID-19. JAMA Intern Med. 2022;182(10):1063&#x2013;1070. doi:10.1001/jamainternmed.2022.3858</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2022.3858</ArticleId><ArticleId IdType="pmc">PMC9389434</ArticleId><ArticleId IdType="pubmed">35980616</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercad&#xe9;-Besora N, Li X, Kolde R, et al. The role of COVID-19 vaccines in preventing post COVID-19 thromboembolic and cardiovascular complications: a multinational cohort study; 2023. Available from: https://www.medrxiv.org/content/10.1101/2023.06.28.23291997v1. Accessed August
29, 2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.06.28.23291997v1</ArticleId><ArticleId IdType="pmc">PMC11041555</ArticleId><ArticleId IdType="pubmed">38471729</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO coronavirus (COVID-19) Dashboard; 2023. Available from: https://covid19.who.int/data. Accessed August
9, 2023.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38365848</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1745-6215</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>Trials</Title><ISOAbbreviation>Trials</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of IT-supported patient recruitment: study protocol for an interrupted time series study at ten German university hospitals.</ArticleTitle><Pagination><StartPage>125</StartPage><MedlinePgn>125</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">125</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13063-024-07918-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">As part of the German Medical Informatics Initiative, the MIRACUM project establishes data integration centers across ten German university hospitals. The embedded MIRACUM Use Case "Alerting in Care - IT Support for Patient Recruitment", aims to support the recruitment into clinical trials by automatically querying the repositories for patients satisfying eligibility criteria and presenting them as screening candidates. The objective of this study is to investigate whether the developed recruitment tool has a positive effect on study recruitment within a multi-center environment by increasing the number of participants. Its secondary objective is the measurement of organizational burden and user satisfaction of the provided IT solution.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study uses an Interrupted Time Series Design with a duration of 15 months. All trials start in the control phase of randomized length with regular recruitment and change to the intervention phase with additional IT support. The intervention consists of the application of a recruitment-support system which uses patient data collected in general care for screening according to specific criteria. The inclusion and exclusion criteria of all selected trials are translated into a machine-readable format using the OHDSI ATLAS tool. All patient data from the data integration centers is regularly checked against these criteria. The primary outcome is the number of participants recruited per trial and week standardized by the targeted number of participants per week and the expected recruitment duration of the specific trial. Secondary outcomes are usability, usefulness, and efficacy of the recruitment support. Sample size calculation based on simple parallel group assumption can demonstrate an effect size of d=0.57 on a significance level of 5% and a power of 80% with a total number of 100 trials (10 per site). Data describing the included trials and the recruitment process is collected at each site. The primary analysis will be conducted using linear mixed models with the actual recruitment number per week and trial standardized by the expected recruitment number per week and trial as the dependent variable.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The application of an IT-supported recruitment solution developed in the MIRACUM consortium leads to an increased number of recruited participants in studies at German university hospitals. It supports employees engaged in the recruitment of trial participants and is easy to integrate in their daily work.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boeker</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Medical Biometry and Statistics, Medical Faculty and Medical Center, University of Freiburg, Freiburg im Breisgau, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chair of Medical Informatics, Institute of Artificial Intelligence and Informatics in Medicine, Klinikum rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Z&#xf6;ller</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Medical Biometry and Statistics, Medical Faculty and Medical Center, University of Freiburg, Freiburg im Breisgau, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blasini</LastName><ForeName>Romina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Medical Informatics, Justus-Liebig-University Gie&#xdf;en, Gie&#xdf;en, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macho</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), Mainz University Medical Center, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helfer</LastName><ForeName>Sven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behrens</LastName><ForeName>Max</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Medical Biometry and Statistics, Medical Faculty and Medical Center, University of Freiburg, Freiburg im Breisgau, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prokosch</LastName><ForeName>Hans-Ulrich</ForeName><Initials>HU</Initials><AffiliationInfo><Affiliation>Chair of Medical Informatics, Department of Medical Informatics, Biometrics and Epidemiology, Friedrich-Alexander Universit&#xe4;t Erlangen-N&#xfc;rnberg, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gulden</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Chair of Medical Informatics, Department of Medical Informatics, Biometrics and Epidemiology, Friedrich-Alexander Universit&#xe4;t Erlangen-N&#xfc;rnberg, Erlangen, Germany. christian.gulden@fau.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trials</MedlineTA><NlmUniqueID>101263253</NlmUniqueID><ISSNLinking>1745-6215</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065186" MajorTopicYN="Y">Interrupted Time Series Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="Y">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical trial</Keyword><Keyword MajorTopicYN="N">Clinical trial recruitment support</Keyword><Keyword MajorTopicYN="N">Hospital information system</Keyword><Keyword MajorTopicYN="N">Patient recruitment</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>17</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>16</Day><Hour>23</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38365848</ArticleId><ArticleId IdType="pmc">PMC10870691</ArticleId><ArticleId IdType="doi">10.1186/s13063-024-07918-z</ArticleId><ArticleId IdType="pii">10.1186/s13063-024-07918-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bowling, Ann. 2014. Research Methods in Health: Investigating Health and Health Services McGraw-hill education (UK).</Citation></Reference><Reference><Citation>Friedman LM, Furberg C, DeMets DL, Reboussin DM, Granger CB. Fundamentals of Clinical Trials. Fifth Edition. Springer; 2015.</Citation></Reference><Reference><Citation>Carlisle B, Kimmelman J, Ramsay T, MacKinnon N. Unsuccessful Trial Accrual and Human Subjects Protections: An Empirical Analysis of Recently Closed Trials. Clin Trials: J Soc Clin Trials. 2015;12(1):77&#x2013;83. doi: 10.1177/1740774514558307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1740774514558307</ArticleId><ArticleId IdType="pmc">PMC4516407</ArticleId><ArticleId IdType="pubmed">25475878</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogel DB. Factors Associated with Clinical Trials That Fail and Opportunities for Improving the Likelihood of Success: A Review. Contemp Clin Trials Commun. 2018;11(September):156&#x2013;164. doi: 10.1016/j.conctc.2018.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conctc.2018.08.001</ArticleId><ArticleId IdType="pmc">PMC6092479</ArticleId><ArticleId IdType="pubmed">30112460</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilts DM, Sandler AB. Invisible Barriers to Clinical Trials: The Impact of Structural, Infrastructural, and Procedural Barriers to Opening Oncology Clinical Trials. J Clin Oncol. 2006;24(28):4545&#x2013;4552. doi: 10.1200/JCO.2005.05.0104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2005.05.0104</ArticleId><ArticleId IdType="pubmed">17008693</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald AM, Knight RC, Campbell MK, Entwistle VA, Grant AM, Cook JA, Elbourne DR, et al. What Influences Recruitment to Randomised Controlled Trials? A Review of Trials Funded by Two UK Funding Agencies. Trials. 2006;7(1):9. doi: 10.1186/1745-6215-7-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1745-6215-7-9</ArticleId><ArticleId IdType="pmc">PMC1475627</ArticleId><ArticleId IdType="pubmed">16603070</ArticleId></ArticleIdList></Reference><Reference><Citation>Winn RJ. Obstacles to the Accrual of Patients to Clinical Trials in the Community Setting. Sem Oncol. 1994;21(4 Suppl 7):112&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">8091236</ArticleId></ArticleIdList></Reference><Reference><Citation>Gul RB, Ali PA. Clinical Trials: The Challenge of Recruitment and Retention of Participants. J Clin Nurs. 2010;19(1&#x2013;2):227&#x2013;233. doi: 10.1111/j.1365-2702.2009.03041.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2702.2009.03041.x</ArticleId><ArticleId IdType="pubmed">20500260</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JR, Lee J, Zhou Z, Cheung YK, Hripcsak G, Weng C. Contemporary Use of Real-World Data for Clinical Trial Conduct in the United States: A Scoping Review. J Am Med Inform Assoc. 2021;28(1):144&#x2013;154. doi: 10.1093/jamia/ocaa224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa224</ArticleId><ArticleId IdType="pmc">PMC7810452</ArticleId><ArticleId IdType="pubmed">33164065</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiweis B, Trinczek B, K&#xf6;pcke F, Leusch T, Majeed RW, Wenk J, Bergh B, et al. Comparison of Electronic Health Record System Functionalities to Support the Patient Recruitment Process in Clinical Trials. Int J Med Inform. 2014;83(11):860&#x2013;868. doi: 10.1016/j.ijmedinf.2014.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2014.08.005</ArticleId><ArticleId IdType="pubmed">25189709</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivade C, Raghavan P, Fosler-Lussier E, Embi PJ, Elhadad N, Johnson SB, Lai AM. A Review of Approaches to Identifying Patient Phenotype Cohorts Using Electronic Health Records. J Am Med Inform Assoc. 2014;21(2):221&#x2013;230. doi: 10.1136/amiajnl-2013-001935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-001935</ArticleId><ArticleId IdType="pmc">PMC3932460</ArticleId><ArticleId IdType="pubmed">24201027</ArticleId></ArticleIdList></Reference><Reference><Citation>Doods J, Bache R, McGilchrist M, Daniel C, Dugas M, Fritz F. Piloting the EHR4CR Feasibility Platform across Europe. Method Inform Med. 2014;53(04):264&#x2013;268. doi: 10.3414/ME13-01-0134.</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME13-01-0134</ArticleId><ArticleId IdType="pubmed">24954881</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;pcke F, Kraus S, Scholler A, Nau C, Sch&#xfc;ttler J, Prokosch H-U, Ganslandt T. Secondary Use of Routinely Collected Patient Data in a Clinical Trial: An Evaluation of the Effects on Patient Recruitment and Data Acquisition. Int J Med Inform. 2013;82(3):185&#x2013;192. doi: 10.1016/j.ijmedinf.2012.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2012.11.008</ArticleId><ArticleId IdType="pubmed">23266063</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;pcke F, Prokosch H-U. Employing Computers for the Recruitment into Clinical Trials: A Comprehensive Systematic Review. J Med Int Res. 2014;16(7):e161. doi: 10.2196/jmir.3446.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.3446</ArticleId><ArticleId IdType="pmc">PMC4128959</ArticleId><ArticleId IdType="pubmed">24985568</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuggia M, Besana P, Glasspool D. Comparing Semi-Automatic Systems for Recruitment of Patients to Clinical Trials. Int J Med Inform. 2011;80(6, 371):&#x2013;88. 10.1016/j.ijmedinf.2011.02.003.</Citation><ArticleIdList><ArticleId IdType="pubmed">21459664</ArticleId></ArticleIdList></Reference><Reference><Citation>Prokosch H-U, Acker T, Bernarding J, Binder H, Boeker M, Boerries M, Daumke P, et al. MIRACUM: Medical Informatics in Research and Care in University Medicine: A Large Data Sharing Network to Enhance Translational Research and Medical Care. Method Inform Med. 2018;57(S 01):e82&#x2013;e91. doi: 10.3414/ME17-02-0025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME17-02-0025</ArticleId><ArticleId IdType="pmc">PMC6178200</ArticleId><ArticleId IdType="pubmed">30016814</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler S, Wissing F, Heyder R. German Medical Informatics Initiative: A National Approach to Integrating Health Data from Patient Care and Medical Research. Method Inform Med. 2018;57(S 01):e50&#x2013;e56. doi: 10.3414/ME18-03-0003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME18-03-0003</ArticleId><ArticleId IdType="pmc">PMC6178199</ArticleId><ArticleId IdType="pubmed">30016818</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinecke I, Gulden C, K&#xfc;mmel M, Nassirian A, Blasini R, Sedlmayr M. Design for a Modular Clinical Trial Recruitment Support System Based on FHIR and OMOP. Stud Health Technol Inform. 2020;270:158&#x2013;162. doi: 10.3233/SHTI200142.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI200142</ArticleId><ArticleId IdType="pubmed">32570366</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan A-W, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, et al. SPIRIT 2013 Explanation and Elaboration: Guidance for Protocols of Clinical Trials. BMJ. 2013;346(jan08 15):e7586. doi: 10.1136/bmj.e7586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.e7586</ArticleId><ArticleId IdType="pmc">PMC3541470</ArticleId><ArticleId IdType="pubmed">23303884</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz M, Bender M, Ombao H. A Robust Interrupted Time Series Model for Analyzing Complex Health Care Intervention Data: A Robust Interrupted Time Series Model for Analyzing Complex Health Care Intervention Data. Statist Med. 2017;36(29):4660&#x2013;4676. doi: 10.1002/sim.7443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.7443</ArticleId><ArticleId IdType="pubmed">28850683</ArticleId></ArticleIdList></Reference><Reference><Citation>Fok CC, Ting DH, Allen J. Research Designs for Intervention Research with Small Samples II: Stepped Wedge and Interrupted Time-Series Designs. Prevent Sci. 2015;16(7):967&#x2013;977. doi: 10.1007/s11121-015-0569-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11121-015-0569-4</ArticleId><ArticleId IdType="pmc">PMC4581909</ArticleId><ArticleId IdType="pubmed">26017633</ArticleId></ArticleIdList></Reference><Reference><Citation>Meystre SM, Heider PM, Kim Y, Aruch DB, Britten CD. Automatic Trial Eligibility Surveillance Based on Unstructured Clinical Data. Int J Med Inform. 2019;129(September):13&#x2013;19. doi: 10.1016/j.ijmedinf.2019.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2019.05.018</ArticleId><ArticleId IdType="pmc">PMC6717538</ArticleId><ArticleId IdType="pubmed">31445247</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan C, Ryan PB, Ta C, Guo Y, Li Z, Hardin J, Makadia R, et al. Criteria2Query: A Natural Language Interface to Clinical Databases for Cohort Definition. J Am Med Inform Assoc. 2019;26(4):294&#x2013;305. doi: 10.1093/jamia/ocy178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy178</ArticleId><ArticleId IdType="pmc">PMC6402359</ArticleId><ArticleId IdType="pubmed">30753493</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooke J. SUS: A Quick and Dirty Usability Scale. Usability Eval. Ind.; 1995.</Citation></Reference><Reference><Citation>Schrepp M, Thomaschewski J, Hinderks A. Design and Evaluation of a Short Version of the User Experience Questionnaire (UEQ-S) Int J Interact Multim Artif Intellig. 2017;4(Regular Issue):103&#x2013;108.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38387992</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2632-1009</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>21</Day></PubDate></JournalIssue><Title>BMJ health &amp; care informatics</Title><ISOAbbreviation>BMJ Health Care Inform</ISOAbbreviation></Journal><ArticleTitle>Seamless EMR data access: Integrated governance, digital health and the OMOP-CDM.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e100953</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjhci-2023-100953</ELocationID><Abstract><AbstractText><b>Objectives</b> In this overview, we describe theObservational Medical Outcomes Partnership Common Data Model (OMOP-CDM), the established governance processes employed in EMR data repositories, and demonstrate how OMOP transformed data provides a lever for more efficient and secure access to electronic medical record (EMR) data by health service providers and researchers.<b>Methods</b> Through pseudonymisation and common data quality assessments, the OMOP-CDM provides a robust framework for converting complex EMR data into a standardised format. This allows for the creation of shared end-to-end analysis packages without the need for direct data exchange, thereby enhancing data security and privacy. By securely sharing de-identified and aggregated data and conducting analyses across multiple OMOP-converted databases, patient-level data is securely firewalled within its respective local site.<b>Results</b> By simplifying data management processes and governance, and through the promotion of interoperability, the OMOP-CDM supports a wide range of clinical, epidemiological, and translational research projects, as well as health service operational reporting.<b>Discussion</b> Adoption of the OMOP-CDM internationally and locally enables conversion of vast amounts of complex, and heterogeneous EMR data into a standardised structured data model, simplifies governance processes, and facilitates rapid repeatable cross-institution analysis through shared end-to-end analysis packages, without the sharing of data.<b>Conclusion</b> The adoption of the OMOP-CDM has the potential to transform health data analytics by providing a common platform for analysing EMR data across diverse healthcare settings.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hallinan</LastName><ForeName>Christine Mary</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0002-0471-4444</Identifier><AffiliationInfo><Affiliation>Health and Biomedical Informatics Centre, Research Information Technology Unit (HaBIC R2), Department of General Practice and Primary Care, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia hallinan@unimelb.edu.au dboyle@unimelb.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Roger</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Health and Biomedical Informatics Centre, Research Information Technology Unit (HaBIC R2), Department of General Practice and Primary Care, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hart</LastName><ForeName>Graeme K</ForeName><Initials>GK</Initials><AffiliationInfo><Affiliation>School of Computing and Information Systems, Faculty of Engineering and Information Technology, Centre for the Digital Transformation of Health, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sullivan</LastName><ForeName>Clair</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Queensland Digital Health Centre (QDHeC), Centre for Health Services Research, The University of Queensland Faculty of Medicine, Woolloongabba, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pratt</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Ashley P</ForeName><Initials>AP</Initials><Identifier Source="ORCID">0000-0001-9690-0879</Identifier><AffiliationInfo><Affiliation>Clinical Haematology Department, The Royal Melbourne Hospital, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sir Peter MacCallum Department of Oncology, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capurro</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Computing and Information Systems, Faculty of Engineering and Information Technology, Centre for the Digital Transformation of Health, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Medicine, The Royal Melbourne Hospital, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Der Vegt</LastName><ForeName>Anton</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Queensland Digital Health Centre (QDHeC), Centre for Health Services Research, The University of Queensland Faculty of Medicine, Herston, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liaw</LastName><ForeName>Siaw-Teng</ForeName><Initials>ST</Initials><Identifier Source="ORCID">0000-0001-5989-3614</Identifier><AffiliationInfo><Affiliation>School of Population Health, UNSW, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daly</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>School of Computing and Information Systems, Faculty of Engineering and Information Technology, Centre for the Digital Transformation of Health, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luxan</LastName><ForeName>Blanca Gallego</ForeName><Initials>BG</Initials><AffiliationInfo><Affiliation>Centre for Big Data Research in Health (CBDRH), UNSW, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bunker</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Queensland Digital Health Centre (QDHeC), Centre for Health Services Research, The University of Queensland Faculty of Medicine, Herston, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyle</LastName><ForeName>Douglas</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Health and Biomedical Informatics Centre, Research Information Technology Unit (HaBIC R2), Department of General Practice and Primary Care, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia hallinan@unimelb.edu.au dboyle@unimelb.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Health Care Inform</MedlineTA><NlmUniqueID>101745500</NlmUniqueID><ISSNLinking>2632-1009</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000097103" MajorTopicYN="Y">Digital Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079803" MajorTopicYN="N">Data Management</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical Governance</Keyword><Keyword MajorTopicYN="N">Electronic Data Processing</Keyword><Keyword MajorTopicYN="N">Electronic Health Records</Keyword><Keyword MajorTopicYN="N">Information Systems</Keyword><Keyword MajorTopicYN="N">Medical Informatics</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>22</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38387992</ArticleId><ArticleId IdType="pmc">PMC10882353</ArticleId><ArticleId IdType="doi">10.1136/bmjhci-2023-100953</ArticleId><ArticleId IdType="pii">bmjhci-2023-100953</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Safran C, Bloomrosen M, Hammond WE, et al. . Toward a national framework for the secondary use of health data: an American medical informatics association white paper. J Am Med Inform Assoc 2007;14:1&#x2013;9. 10.1197/jamia.M2273</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M2273</ArticleId><ArticleId IdType="pmc">PMC2329823</ArticleId><ArticleId IdType="pubmed">17077452</ArticleId></ArticleIdList></Reference><Reference><Citation>Danciu I, Cowan JD, Basford M, et al. . Secondary use of clinical data: the vanderbilt approach. J Biomed Inform 2014;52:28&#x2013;35. 10.1016/j.jbi.2014.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2014.02.003</ArticleId><ArticleId IdType="pmc">PMC4133331</ArticleId><ArticleId IdType="pubmed">24534443</ArticleId></ArticleIdList></Reference><Reference><Citation>Budrionis A, Bellika JG. The learning healthcare system: where are we now? A systematic review. J Biomed Inform 2016;64:87&#x2013;92. 10.1016/j.jbi.2016.09.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.09.018</ArticleId><ArticleId IdType="pubmed">27693565</ArticleId></ArticleIdList></Reference><Reference><Citation>Park K, Cho M, Song M, et al. . Exploring the potential of OMOP common data model for process mining in healthcare. PLoS One 2023;18:e0279641. 10.1371/journal.pone.0279641</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0279641</ArticleId><ArticleId IdType="pmc">PMC9810199</ArticleId><ArticleId IdType="pubmed">36595527</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Weng C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. J Am Med Inform Assoc 2013;20:144&#x2013;51. 10.1136/amiajnl-2011-000681</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000681</ArticleId><ArticleId IdType="pmc">PMC3555312</ArticleId><ArticleId IdType="pubmed">22733976</ArticleId></ArticleIdList></Reference><Reference><Citation>Jean-Baptiste L, Mouazer A, Sedki K, et al. . Translating the observational medical outcomes partnership - common data model (OMOP-CDM) electronic health records to an OWL ontology. Stud Health Technol Inform 2022;290:76&#x2013;80. 10.3233/SHTI220035</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI220035</ArticleId><ArticleId IdType="pubmed">35672974</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RS. Electronic health records: then, now, and in the future. Yearb Med Inform 2016;Suppl 1(Suppl 1):S48&#x2013;61. 10.15265/IYS-2016-s006</Citation><ArticleIdList><ArticleId IdType="doi">10.15265/IYS-2016-s006</ArticleId><ArticleId IdType="pmc">PMC5171496</ArticleId><ArticleId IdType="pubmed">27199197</ArticleId></ArticleIdList></Reference><Reference><Citation>
OHDSI . Observational health data sciences and Informatics data standardization 2021. 2021. 
Available: https://www.ohdsi.org/data-standardization/the-common-data-model/
</Citation></Reference><Reference><Citation>
SNOMED CT . SNOMED International leading Healthcare terminology, worldwide 2022. 2022. Available: https://www.snomed.org/
</Citation></Reference><Reference><Citation>
LOINC . LOINC the International standard for identifying health measurements, observations, and documents 2022. 2022. Available: https://loinc.org/
</Citation></Reference><Reference><Citation>
National Library of Medicine . Unified medical language system Rxnorm. 2022. Available: https://www.nlm.nih.gov/research/umls/rxnorm/index.html
</Citation></Reference><Reference><Citation>OHDSI . Our journey: where the OHDSI community has been and where we are going observational health data sciences and Informatics; 2022.</Citation></Reference><Reference><Citation>Electronic medical records National data asset (Internet). 2022. Available: 10.26188/6295c4a5d7c5c</Citation><ArticleIdList><ArticleId IdType="doi">10.26188/6295c4a5d7c5c</ArticleId></ArticleIdList></Reference><Reference><Citation>
Electronic Practice Based Research Network. Centre for Primary Health Care and Equity, UNSW Sydney, Available: https://cphce.unsw.edu.au/research/electronic-practice-based-research-network
</Citation></Reference><Reference><Citation>
Boyle D, Sanci L, Emery J, et al. . PATRON Primary Care Research Data Repository, . 2019. 
Available: https://medicine.unimelb.edu.au/school-structure/general-practice-and-primary-care/research/data-for-decisions
</Citation></Reference><Reference><Citation>Kahn MG, Callahan TJ, Barnard J, et al. . A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data. EGEMS (Wash DC) 2016;4:1244. 10.13063/2327-9214.1244</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1244</ArticleId><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>
OHDSI . Observational health data sciences and Informatics ACHILLES for data characterization 2022. n.d.
Available: https://www.ohdsi.org/analytic-tools/achilles-for-data-characterization/
</Citation></Reference><Reference><Citation>Wilkinson MD, Dumontier M, Jan Aalbersberg I, et al. . Addendum: the fair guiding principles for scientific data management and stewardship. Sci Data 2019;6:6. 10.1038/s41597-019-0009-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41597-019-0009-6</ArticleId><ArticleId IdType="pmc">PMC6427092</ArticleId><ArticleId IdType="pubmed">30890711</ArticleId></ArticleIdList></Reference><Reference><Citation>
The Global Indigenous Data Alliance . CARE principles for indigenous data governance. 2022. Available: https://www.gida-global.org/care
</Citation></Reference><Reference><Citation>
ABS . Five safes framework Australian Bureau of Statistics Canberra: Australia. n.d.
Available: https://www.abs.gov.au/about/data-services/data-confidentiality-guide/five-safes-framework
</Citation></Reference><Reference><Citation>Biedermann P, Ong R, Davydov A, et al. . Standardizing registry data to the OMOP common data model: experience from three pulmonary hypertension databases. BMC Med Res Methodol 2021;21:238. 10.1186/s12874-021-01434-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-021-01434-3</ArticleId><ArticleId IdType="pmc">PMC8565035</ArticleId><ArticleId IdType="pubmed">34727871</ArticleId></ArticleIdList></Reference><Reference><Citation>
OHDSI . The book of OHDSI: observational health data sciences and Informatics. 2023. Available: https://ohdsi.github.io/TheBookOfOhdsi/
</Citation></Reference><Reference><Citation>Blacketer C, Defalco FJ, Ryan PB, et al. . Increasing trust in real-world evidence through evaluation of observational data quality. J Am Med Inform Assoc 2021;28:2251&#x2013;7. 10.1093/jamia/ocab132</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocab132</ArticleId><ArticleId IdType="pmc">PMC8449628</ArticleId><ArticleId IdType="pubmed">34313749</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacketer C, Voss EA, DeFalco F, et al. . Using the data quality dashboard to improve the EHDEN network. Applied Sciences 1192;11:11920. 10.3390/app112411920</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app112411920</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J-W, Kim C, Kim K-H, et al. . Scalable infrastructure supporting reproducible nationwide healthcare data analysis toward FAIR stewardship. Sci Data 2023;10:674. 10.1038/s41597-023-02580-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41597-023-02580-7</ArticleId><ArticleId IdType="pmc">PMC10550904</ArticleId><ArticleId IdType="pubmed">37794003</ArticleId></ArticleIdList></Reference><Reference><Citation>NHMRC . National Stnational statement on ethical conduct in human research (2007) - updated 2018; 2018. National health and medical research Council</Citation></Reference><Reference><Citation>
UNSW . The electronic practice based research network Sydney: centre for primary health care and equity medicine. 2021. Available: https://cphce.unsw.edu.au/research/electronic-practice-based-research-network
</Citation></Reference><Reference><Citation>Hripcsak G, Mirhaji P, Low AF, et al. . Preserving temporal relations in clinical data while maintaining privacy. J Am Med Inform Assoc 2016;23:1040&#x2013;5. 10.1093/jamia/ocw001</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocw001</ArticleId><ArticleId IdType="pmc">PMC5070517</ArticleId><ArticleId IdType="pubmed">27013522</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Pratt N, et al. . Principles of Large-scale Evidence Generation and Evaluation across a Network of Databases (LEGEND). J Am Med Inform Assoc 2020;27:1331&#x2013;7. 10.1093/jamia/ocaa103</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa103</ArticleId><ArticleId IdType="pmc">PMC7481029</ArticleId><ArticleId IdType="pubmed">32909033</ArticleId></ArticleIdList></Reference><Reference><Citation>Porsdam Mann S, Savulescu J, Sahakian BJ. Facilitating the ethical use of health data for the benefit of society: electronic health records, consent and the duty of easy rescue. Phil Trans R Soc A 2016;374:20160130. 10.1098/rsta.2016.0130</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsta.2016.0130</ArticleId><ArticleId IdType="pmc">PMC5124071</ArticleId><ArticleId IdType="pubmed">28336803</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu K, Sarkadi Kristiansson R, Gronsbell J, et al. . Changes in primary care visits arising from the COVID-19 pandemic: an international comparative study by the International consortium of primary care big data researchers (INTRePID). BMJ Open 2022;12:e059130. 10.1136/bmjopen-2021-059130</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-059130</ArticleId><ArticleId IdType="pmc">PMC9086267</ArticleId><ArticleId IdType="pubmed">35534063</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Van Zandt M, Liu Y, et al. . Analysis of dual combination therapies used in treatment of hypertension in a multinational cohort. JAMA Netw Open 2022;5:e223877. 10.1001/jamanetworkopen.2022.3877</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.3877</ArticleId><ArticleId IdType="pmc">PMC8948532</ArticleId><ArticleId IdType="pubmed">35323951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi N, Peng Y, Wolfien M, et al. . OMOP CDM can facilitate data-driven studies for cancer prediction: a systematic review. Int J Mol Sci 2022;23:19. 10.3390/ijms231911834</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231911834</ArticleId><ArticleId IdType="pmc">PMC9569469</ArticleId><ArticleId IdType="pubmed">36233137</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane JCE, Weaver J, Kostka K, et al. . Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lancet Rheumatol 2020;2:e698&#x2013;711. 10.1016/S2665-9913(20)30276-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30276-9</ArticleId><ArticleId IdType="pmc">PMC7442425</ArticleId><ArticleId IdType="pubmed">32864627</ArticleId></ArticleIdList></Reference><Reference><Citation>Ploug T. In Defence of informed consent for health record research - why arguments from &#x201c;easy rescue&#x201d;, &#x201c;no harm&#x201d; and &#x201c;consent bias&#x201d; fail. BMC Med Ethics 2020;21:75. 10.1186/s12910-020-00519-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12910-020-00519-w</ArticleId><ArticleId IdType="pmc">PMC7441538</ArticleId><ArticleId IdType="pubmed">32819343</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller SHA, Kalkman S, van Thiel G, et al. . The social licence for data-intensive health research: towards co-creation, public value and trust. BMC Med Ethics 2021;22:110. 10.1186/s12910-021-00677-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12910-021-00677-5</ArticleId><ArticleId IdType="pmc">PMC8353823</ArticleId><ArticleId IdType="pubmed">34376204</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkman S, van Delden J, Banerjee A, et al. . Patients&#x2019; and public views and attitudes towards the sharing of health data for research: a narrative review of the empirical evidence. J Med Ethics 2022;48:3&#x2013;13. 10.1136/medethics-2019-105651</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/medethics-2019-105651</ArticleId><ArticleId IdType="pmc">PMC8717474</ArticleId><ArticleId IdType="pubmed">31719155</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38408983</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6947</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>BMC medical informatics and decision making</Title><ISOAbbreviation>BMC Med Inform Decis Mak</ISOAbbreviation></Journal><ArticleTitle>Conceptual design of a generic data harmonization process for OMOP common data model.</ArticleTitle><Pagination><StartPage>58</StartPage><MedlinePgn>58</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">58</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12911-024-02458-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To gain insight into the real-life care of patients in the healthcare system, data from hospital information systems and insurance systems are required. Consequently, linking clinical data with claims data is necessary. To ensure their syntactic and semantic interoperability, the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) from the Observational Health Data Sciences and Informatics (OHDSI) community was chosen. However, there is no detailed guide that would allow researchers to follow a generic process for data harmonization, i.e. the transformation of local source data into the standardized OMOP CDM format. Thus, the aim of this paper is to conceptualize a generic data harmonization process for OMOP CDM.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">For this purpose, we conducted a literature review focusing on publications that address the harmonization of clinical or claims data in OMOP CDM. Subsequently, the process steps used and their chronological order as well as applied OHDSI tools were extracted for each included publication. The results were then compared to derive a generic sequence of the process steps.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">From 23 publications included, a generic data harmonization process for OMOP CDM was conceptualized, consisting of nine process steps: dataset specification, data profiling, vocabulary identification, coverage analysis of vocabularies, semantic mapping, structural mapping, extract-transform-load-process, qualitative and quantitative data quality analysis. Furthermore, we identified seven OHDSI tools which supported five of the process steps.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The generic data harmonization process can be used as a step-by-step guide to assist other researchers in harmonizing source data in OMOP CDM.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Henke</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, 01307, Dresden, Germany. elisa.henke@tu-dresden.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoch</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, 01307, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, 01307, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinecke</LastName><ForeName>Ines</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Data Integration Center, Center for Medical Informatics, University Hospital Carl Gustav Carus Dresden, 01307, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, 01307, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bathelt</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Thiem-Research GmbH, 03048, Cottbus, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Inform Decis Mak</MedlineTA><NlmUniqueID>101088682</NlmUniqueID><ISSNLinking>1472-6947</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014825" MajorTopicYN="Y">Vocabulary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077488" MajorTopicYN="N">Data Science</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012660" MajorTopicYN="N">Semantics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="Y">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Claims data</Keyword><Keyword MajorTopicYN="N">Clinical data</Keyword><Keyword MajorTopicYN="N">Data harmonization</Keyword><Keyword MajorTopicYN="N">Interoperability</Keyword><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>27</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>26</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38408983</ArticleId><ArticleId IdType="pmc">PMC10895818</ArticleId><ArticleId IdType="doi">10.1186/s12911-024-02458-7</ArticleId><ArticleId IdType="pii">10.1186/s12911-024-02458-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Semler SC, Wissing F, Heyder R. German Medical Informatics Initiative - A National Approach To Integrating Health Data from Patient Care and Medical Research. Methods Inf Med. 2018;57(Suppl 1):e50&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6178199</ArticleId><ArticleId IdType="pubmed">30016818</ArticleId></ArticleIdList></Reference><Reference><Citation>Green LA, Fryer GE, Yawn BP, Lanier D, Dovey SM. The Ecology of Medical Care Revisited. N Engl J Med. 2001;344(26):2021&#x2013;5. doi: 10.1056/NEJM200106283442611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200106283442611</ArticleId><ArticleId IdType="pubmed">11430334</ArticleId></ArticleIdList></Reference><Reference><Citation>Thun S, Dewenter H. Syntaktische und semantische Interoperabilit&#xe4;t. In: M&#xfc;ller-Mielitz S, Lux T, editors. E-Health-&#xd6;konomie [Internet]. Wiesbaden: Springer Fachmedien; 2017 [cited 2023 Mar 14]. p. 669&#x2013;82. 10.1007/978-3-658-10788-8_34.</Citation></Reference><Reference><Citation>Kumar G, Basri S, Imam AA, Khowaja SA, Capretz LF, Balogun AO. Data harmonization for heterogeneous datasets: a systematic literature review. Appl Sci. 2021;11(17):8275. doi: 10.3390/app11178275.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app11178275</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inf. 2016;64:333&#x2013;41. doi: 10.1016/j.jbi.2016.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.10.016</ArticleId><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinecke I, Zoch M, Reich C, Sedlmayr M, Bathelt F. The usage of OHDSI OMOP - A Scoping Review. Stud Health Technol Inf. 2021;283:95&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">34545824</ArticleId></ArticleIdList></Reference><Reference><Citation>EHDEN. European Health Data &amp; Evidence Network [Internet]. 2022 [cited 2022 May 20]. Available from: https://www.ehden.eu/.</Citation></Reference><Reference><Citation>European Medical Agency. Data Analysis and Real World Interrogation Network (DARWIN EU) [Internet]. 2023 [cited 2022 May 20]. Available from: https://www.ema.europa.eu/en/about-us/how-we-work/big-data/data-analysis-real-world-interrogation-network-darwin-eu.</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. HL7 International and OHDSI Announce Collaboration to Provide Single Common Data Model for Sharing Information in Clinical Care and Observational Research [Internet]. 2021 [cited 2022 May 6]. Available from: https://www.ohdsi.org/ohdsi-hl7-collaboration/.</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. The Book of OHDSI. In: The Book of OHDSI [Internet]. 2021 [cited 2022 Apr 19]. Available from: https://ohdsi.github.io/TheBookOfOhdsi/.</Citation></Reference><Reference><Citation>Peng Y, Henke E, Reinecke I, Zoch M, Sedlmayr M, Bathelt F. An ETL-process design for data harmonization to participate in international research with German real-world data based on FHIR and OMOP CDM. Int J Med Informatics. 2023;169:104925. doi: 10.1016/j.ijmedinf.2022.104925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2022.104925</ArticleId><ArticleId IdType="pubmed">36395615</ArticleId></ArticleIdList></Reference><Reference><Citation>Digital Scholar. Zotero [Internet]. Zotero. 2023 [cited 2023 Mar 31]. Available from: https://www.zotero.org/.</Citation></Reference><Reference><Citation>Fleiss JL. Measuring nominal scale agreement among many raters. Psychol Bull. 1971;76(5):378&#x2013;82. doi: 10.1037/h0031619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/h0031619</ArticleId></ArticleIdList></Reference><Reference><Citation>Signorell A, Aho K, Alfons A, Anderegg N, Aragon T, Arachchige C et al. DescTools: Tools for Descriptive Statistics [Internet]. 2023 [cited 2023 Oct 25]. Available from: https://cran.r-project.org/web/packages/DescTools/index.html.</Citation></Reference><Reference><Citation>Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis. Campbell Syst Reviews. 2022;18(2):e1230. doi: 10.1002/cl2.1230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cl2.1230</ArticleId><ArticleId IdType="pmc">PMC8958186</ArticleId><ArticleId IdType="pubmed">36911350</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, G&#xf8;tzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. doi: 10.1136/bmj.b2700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Joss MAH, Embree K, Murphy SN. Data model harmonization for the all of Us Research Program: transforming i2b2 data into the OMOP common data model. PLoS ONE. 2019;14(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6380544</ArticleId><ArticleId IdType="pubmed">30779778</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamer A, Abou-Arab O, Bourgeois A, Parrot A, Popoff B, Beuscart JB, et al. Development and Usability Study. J Med Internet Res. 2021;23(10):e29259. Transforming Anesthesia Data Into the Observational Medical Outcomes Partnership Common Data Model:.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8590192</ArticleId><ArticleId IdType="pubmed">34714250</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Shang N, Peissig PL, Rasmussen LV, Liu C, Benoit B et al. Facilitating phenotype transfer using a common data model. J Biomed Inform. 2019;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6697565</ArticleId><ArticleId IdType="pubmed">31325501</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Jiang G, Brandt E, Forsyth T, Dhruva SS, Zhang S et al. Integrating real-world data to assess cardiac ablation device outcomes in a multicenter study using the OMOP common data model for regulatory decisions: implementation and evaluation. JAMIA OPEN. 2023;6(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9831049</ArticleId><ArticleId IdType="pubmed">36632328</ArticleId></ArticleIdList></Reference><Reference><Citation>Papez V, Moinat M, Payralbe S, Asselbergs FW, Lumbers RT, Hemingway H et al. Transforming and evaluating electronic health record disease phenotyping algorithms using the OMOP common data model: a case study in heart failure. JAMIA OPEN. 2021;4(3).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8423424</ArticleId><ArticleId IdType="pubmed">34514354</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan HX, Teo DCH, Lee D, Kim C, Neo JW, Sung C, et al. Healthc Inf Res. 2022;28(2):112&#x2013;22. Applying the OMOP Common Data Model to Facilitate Benefit-Risk Assessments of Medicinal Products Using Real-World Data from Singapore and South Korea.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9117808</ArticleId><ArticleId IdType="pubmed">35576979</ArticleId></ArticleIdList></Reference><Reference><Citation>Papez V, Moinat M, Voss EA, Bazakou S, Van Winzum A, Peviani A, et al. Transforming and evaluating the UK Biobank to the OMOP Common Data Model for COVID-19 research and beyond. Volume 30. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION; 2022. pp. 103&#x2013;11. 1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9619789</ArticleId><ArticleId IdType="pubmed">36227072</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung H, Yoo S, Kim S, Heo E, Kim B, Lee HY, et al. Patient-level fall risk prediction using the Observational Medical Outcomes Partnership&#x2019;s Common Data Model. Volume 10. Pilot Feasibility Study. JMIR MEDICAL INFORMATICS; 2022. 3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8957002</ArticleId><ArticleId IdType="pubmed">35275076</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida JR, Silva JF, Matos S, Oliveira JL. A two-stage workflow to extract and harmonize drug mentions from clinical notes into observational databases. J Biomed Inform. 2021;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">34214696</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima DM, Rodrigues-Jr JF, Traina AJM, Pires FA, Gutierrez MA. Transforming two decades of ePR Data to OMOP CDM for Clinical Research. In: OhnoMachado L, Seroussi B, editors. MEDINFO 2019: HEALTH AND WELLBEING E-NETWORKS FOR ALL. NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM. NETHERLANDS: IOS; 2019. pp. 233&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">31437920</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji H, Kim S, Yi S, Hwang H, Kim JW, Yoo S. Converting clinical document architecture documents to the common data model for incorporating health information exchange data in observational health studies: CDA to CDM. J Biomed Inform. 2020;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">32470694</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JW, Kim S, Ryu B, Song W, Lee HY, Yoo S. Transforming electronic health record polysomnographic data into the Observational Medical Outcome Partnership&#x2019;s Common Data Model: a pilot feasibility study. Sci Rep. 2021;11(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007756</ArticleId><ArticleId IdType="pubmed">33782494</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacketer C, Voss EA, DeFalco F, Hughes N, Schuemie MJ, Moinat M, et al. Using the Data Quality Dashboard to improve the EHDEN Network. Appl SCIENCES-BASEL. 2021;11:24.</Citation></Reference><Reference><Citation>Rinner C, Gezgin D, Wendl C, Gall W. A Clinical Data Warehouse based on OMOP and i2b2 for Austrian Health Claims Data. In: Schreier G, Hayn D, editors. HEALTH INFORMATICS MEETS EHEALTH: BIOMEDICAL MEETS EHEALTH - FROM SENSORS TO DECISIONS. NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM. NETHERLANDS: IOS; 2018. pp. 94&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29726424</ArticleId></ArticleIdList></Reference><Reference><Citation>Haberson A, Rinner C, Sch&#xf6;berl A, Gall W. J Med Syst. 2019;43(10):314. Feasibility of Mapping Austrian Health Claims Data to the OMOP Common Data Model.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6732152</ArticleId><ArticleId IdType="pubmed">31494719</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathappan SMK, Jeon YS, Dang TK, Lim SC, Shao YM, Tai ES, et al. Transformation of Electronic Health Records and Questionnaire Data to OMOP CDM: a feasibility study using SG_T2DM dataset. Appl Clin Inf. 2021;12(4):757&#x2013;67. doi: 10.1055/s-0041-1732301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1732301</ArticleId><ArticleId IdType="pmc">PMC8357458</ArticleId><ArticleId IdType="pubmed">34380168</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael CL, Sholle ET, Wulff RT, Roboz GJ, Campion TR. Mapping Local Biospecimen Records to the OMOP Common Data Model. AMIA Jt Summits Transl Sci Proc. 2020;2020:422&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233045</ArticleId><ArticleId IdType="pubmed">32477663</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong N, Zhang N, Wu H, Lu S, Yu Y, Hou L, et al. Preliminary exploration of survival analysis using the OHDSI common data model: a case study of intrahepatic cholangiocarcinoma. Volume 18. BMC MEDICAL INFORMATICS AND DECISION MAKING; 2018. 5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6284277</ArticleId><ArticleId IdType="pubmed">30526572</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamer A, Depas N, Doutreligne M, Parrot A, Verloop D, Defebvre MM, et al. Transforming French Electronic Health Records into the Observational Medical Outcome Partnership&#x2019;s Common Data Model: a feasibility study. Appl Clin Inf. 2020;11(1):13&#x2013;22. doi: 10.1055/s-0039-3402754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-3402754</ArticleId><ArticleId IdType="pmc">PMC6949163</ArticleId><ArticleId IdType="pubmed">31914471</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenert LA, Ilatovskiy AV, Agnew J, Rudisill P, Jacobs J, Weatherston D, et al. Automated production of research data marts from a canonical fast healthcare interoperability resource data repository: applications to COVID-19 research. J Am Med Inf Assoc. 2021;28(8):1605&#x2013;11. doi: 10.1093/jamia/ocab108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocab108</ArticleId><ArticleId IdType="pmc">PMC8243354</ArticleId><ArticleId IdType="pubmed">33993254</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohler S, Bosc&#xe1; D, K&#xe4;rcher F, Haarbrandt B, Prinz M, Marschollek M, et al. Eos and OMOCL: towards a seamless integration of openEHR records into the OMOP Common Data Model. J Biomed Inf. 2023;144:104437. doi: 10.1016/j.jbi.2023.104437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2023.104437</ArticleId><ArticleId IdType="pubmed">37442314</ArticleId></ArticleIdList></Reference><Reference><Citation>Oniani D, Parmanto B, Saptono A, Bove A, Freburger J, Visweswaran S, et al. ReDWINE: a clinical datamart with text analytical capabilities to facilitate rehabilitation research. Int J Med Inf. 2023;177:105144. doi: 10.1016/j.ijmedinf.2023.105144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2023.105144</ArticleId><ArticleId IdType="pmc">PMC10528160</ArticleId><ArticleId IdType="pubmed">37459703</ArticleId></ArticleIdList></Reference><Reference><Citation>Frid S, Pastor Duran X, Bracons Cuc&#xf3; G, Pedrera-Jim&#xe9;nez M, Serrano-Balazote P, Mu&#xf1;oz Carrero A, et al. An ontology-based Approach for consolidating patient data standardized with European Norm/International Organization for standardization 13606 (EN/ISO 13606) into Joint Observational Medical Outcomes Partnership (OMOP) repositories: description of a methodology. JMIR Med Inf. 2023;11:e44547. doi: 10.2196/44547.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/44547</ArticleId><ArticleId IdType="pmc">PMC10034609</ArticleId><ArticleId IdType="pubmed">36884279</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. White Rabbit [Internet]. 2022 [cited 2022 Nov 11]. Available from: http://ohdsi.github.io/WhiteRabbit/WhiteRabbit.html.</Citation></Reference><Reference><Citation>Kahn MG, Callahan TJ, Barnard J, Bauck AE, Brown J, Davidson BN, et al. A Harmonized Data Quality Assessment Terminology and Framework for the Secondary Use of Electronic Health Record Data. EGEMS (Wash DC) 2016;4(1):1244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. Achilles [Internet]. Observational Health Data Sciences and Informatics; 2022 [cited 2023 Apr 12]. Available from: https://github.com/OHDSI/Achilles.</Citation></Reference><Reference><Citation>Blacketer C, Defalco FJ, Ryan PB, Rijnbeek PR. Increasing trust in real-world evidence through evaluation of observational data quality. J Am Med Inform Assoc. 2021;28(10):2251&#x2013;7. doi: 10.1093/jamia/ocab132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocab132</ArticleId><ArticleId IdType="pmc">PMC8449628</ArticleId><ArticleId IdType="pubmed">34313749</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. Atlas [Internet]. Observational Health Data Sciences and Informatics; 2023 [cited 2023 Apr 12]. Available from: https://github.com/OHDSI/Atlas.</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. Athena [Internet]. Athena&#x2013; OHDSI Vocabularies Repository. 2023 [cited 2022 Nov 25]. Available from: https://athena.ohdsi.org/.</Citation></Reference><Reference><Citation>Schuemie M. Usagi [Internet]. Usagi. 2021. Available from: http://ohdsi.github.io/Usagi/.</Citation></Reference><Reference><Citation>Fischer P, Stoehr MR, Gall H, Michel-Backofen A, Majeed RW. Data Integration into OMOP CDM for Heterogeneous Clinical Data collections via HL7 FHIR bundles and XSLT. In: PapeHaugaard L, Lovis C, Madsen I, Weber P, Nielsen P, Scott P, editors. DIGITAL PERSONALIZED HEALTH AND MEDICINE. NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM. NETHERLANDS: IOS; 2020. pp. 138&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">32570362</ArticleId></ArticleIdList></Reference><Reference><Citation>Biedermann P, Ong R, Davydov A, Orlova A, Solovyev P, Sun H et al. Standardizing registry data to the OMOP Common Data Model: experience from three pulmonary hypertension databases. BMC Med Res Methodol. 2021;21(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8565035</ArticleId><ArticleId IdType="pubmed">34727871</ArticleId></ArticleIdList></Reference><Reference><Citation>Sentinel Initiative. Sentinel Common Data Model [Internet]. 2024 [cited 2024 Jan 11]. Available from: https://sentinelinitiative.org/methods-data-tools/sentinel-common-data-model.</Citation></Reference><Reference><Citation>i2b2 TranSMART Foundation. i2b2: Informatics for Integrating Biology &amp; the Bedside [Internet]. 2024 [cited 2024 Jan 11]. Available from: https://www.i2b2.org/.</Citation></Reference><Reference><Citation>The National Patient-Centered Clinical Research Network. The National Patient-Centered Clinical Research Network - Data [Internet]. The National Patient-Centered Clinical Research Network. 2024 [cited 2024 Jan 11]. Available from: https://pcornet.org/data/.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38412331</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>19</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Towards global model generalizability: independent cross-site feature evaluation for patient-level risk prediction models using the&#xa0;OHDSI network.</ArticleTitle><Pagination><StartPage>1051</StartPage><EndPage>1061</EndPage><MedlinePgn>1051-1061</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocae028</ELocationID><Abstract><AbstractText Label="BACKGROUND">Predictive models show promise in healthcare, but their successful deployment is challenging due to limited generalizability. Current external validation often focuses on model performance with restricted feature use from the original training data, lacking insights into their suitability at external sites. Our study introduces an innovative methodology for evaluating features during both the development phase and the validation, focusing on creating and validating predictive models for post-surgery patient outcomes with improved generalizability.</AbstractText><AbstractText Label="METHODS">Electronic health records (EHRs) from 4 countries (United States, United Kingdom, Finland, and Korea) were mapped to the OMOP Common Data Model (CDM), 2008-2019. Machine learning (ML) models were developed to predict post-surgery prolonged opioid use (POU) risks using data collected 6 months before surgery. Both local and cross-site feature selection methods were applied in the development and external validation datasets. Models were developed using Observational Health Data Sciences and Informatics (OHDSI) tools and validated on separate patient cohorts.</AbstractText><AbstractText Label="RESULTS">Model development included 41&#xa0;929 patients, 14.6% with POU. The external validation included 31&#xa0;932 (UK), 23&#xa0;100 (US), 7295 (Korea), and 3934 (Finland) patients with POU of 44.2%, 22.0%, 15.8%, and 21.8%, respectively. The top-performing model, Lasso logistic regression, achieved an area under the receiver operating characteristic curve (AUROC) of 0.75 during local validation and 0.69 (SD&#x2009;=&#x2009;0.02) (averaged) in external validation. Models trained with cross-site feature selection significantly outperformed those using only features from the development site through external validation (P&#x2009;&lt;&#x2009;.05).</AbstractText><AbstractText Label="CONCLUSIONS">Using EHRs across four countries mapped to the OMOP CDM, we developed generalizable predictive models for POU. Our approach demonstrates the significant impact of cross-site feature selection in improving model performance, underscoring the importance of incorporating diverse feature sets from various clinical settings to enhance the generalizability and utility of predictive healthcare models.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Naderalvojoud</LastName><ForeName>Behzad</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-4429-5341</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA 94305, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curtin</LastName><ForeName>Catherine M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanover</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>KI Research Institute, Kfar Malal, 4592000, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Hay</LastName><ForeName>Tal</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>KI Research Institute, Kfar Malal, 4592000, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Byungjin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University Graduate School of Medicine, Suwon, 16499, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University Graduate School of Medicine, Suwon, 16499, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabuenca</LastName><ForeName>Javier Gracia</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, 00014, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reeve</LastName><ForeName>Mary Pat</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, 00014, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY 10032, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humphreys</LastName><ForeName>Keith</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and the Behavioral Sciences, Stanford University, Stanford, CA 94305, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Innovation to Implementation, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asch</LastName><ForeName>Steven M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA 94305, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Innovation to Implementation, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez-Boussard</LastName><ForeName>Tina</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-6553-3455</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA 94305, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM013362</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01LM013362</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077488" MajorTopicYN="Y">Data Science</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="Y">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005387" MajorTopicYN="N" Type="Geographic">Finland</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">feature selection</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">model generalizability</Keyword><Keyword MajorTopicYN="N">opioid risk</Keyword><Keyword MajorTopicYN="N">prolonged opioid use</Keyword><Keyword MajorTopicYN="N">surgery</Keyword></KeywordList><CoiStatement>The authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>27</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>27</Day><Hour>15</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>2</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38412331</ArticleId><ArticleId IdType="pmc">PMC11031239</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocae028</ArticleId><ArticleId IdType="pii">7614966</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eche T, Schwartz LH, Mokrane FZ, Dercle L.. Toward generalizability in the deployment of artificial intelligence in radiology: role of computation stress testing to overcome underspecification. Radiol Artif Intell. 2021;3(6):e210097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8637230</ArticleId><ArticleId IdType="pubmed">34870222</ArticleId></ArticleIdList></Reference><Reference><Citation>Leming MJ, Bron EE, Bruffaerts R, et al.Challenges of implementing computer-aided diagnostic models for neuroimages in a clinical setting. NPJ Digit Med. 2023;6(1):129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10345121</ArticleId><ArticleId IdType="pubmed">37443276</ArticleId></ArticleIdList></Reference><Reference><Citation>Pumplun L, Fecho M, Wahl N, Peters F, Buxmann P.. Adoption of machine learning systems for medical diagnostics in clinics: qualitative interview study. J Med Internet Res. 2021;23(10):e29301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8556641</ArticleId><ArticleId IdType="pubmed">34652275</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A, Otles E, Donnelly JP, et al.External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients. JAMA Intern Med. 2021;181(8):1065-1070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8218233</ArticleId><ArticleId IdType="pubmed">34152373</ArticleId></ArticleIdList></Reference><Reference><Citation>Noseworthy PA, Attia ZI, Brewer LC, et al.Assessing and mitigating bias in medical artificial intelligence: the effects of race and ethnicity on a deep learning model for ECG analysis. Circ Arrhythm Electrophysiol. 2020;13(3):e007988.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158877</ArticleId><ArticleId IdType="pubmed">32064914</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyyed-Kalantari L, Zhang H, McDermott MB, Chen IY, Ghassemi M.. Underdiagnosis bias of artificial intelligence algorithms applied to chest radiographs in under-served patient populations. Nat Med. 2021;27(12):2176-2182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8674135</ArticleId><ArticleId IdType="pubmed">34893776</ArticleId></ArticleIdList></Reference><Reference><Citation>de Hond AA, Shah VB, Kant IM, Van Calster B, Steyerberg EW, Hernandez-Boussard T.. Perspectives on validation of clinical predictive algorithms. NPJ Digit Med. 2023;6(1):86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10163568</ArticleId><ArticleId IdType="pubmed">37149704</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen HK, Ogink PT, Huang CC, et al.A machine learning algorithm for predicting prolonged postoperative opioid prescription after lumbar disc herniation surgery. An external validation study using 1,316 patients from a Taiwanese cohort. Spine J. 2022;22(7):1119-1130.</Citation><ArticleIdList><ArticleId IdType="pubmed">35202784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandran U, Reps J, Yang R, Vachani A, Maldonado F, Kalsekar I.. Machine learning and real-world data to predict lung cancer risk in routine care. Cancer Epidemiol Biomarkers Prev. 2023;32(3):337-343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9986687</ArticleId><ArticleId IdType="pubmed">36576991</ArticleId></ArticleIdList></Reference><Reference><Citation>John LH, Kors JA, Fridgeirsson EA, Reps JM, Rijnbeek PR.. External validation of existing dementia prediction models on observational health data. BMC Med Res Methodol. 2022;22(1):311-312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9720950</ArticleId><ArticleId IdType="pubmed">36471238</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalid S, Yang C, Blacketer C, et al.A standardized analytics pipeline for reliable and rapid development and validation of prediction models using observational health data. Comput Methods Programs Biomed. 2021;211:106394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420135</ArticleId><ArticleId IdType="pubmed">34560604</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams RD, Reps JM, Kors JA, et al.Using iterative pairwise external validation to contextualize prediction model performance: a use case predicting 1-year heart failure risk in patients with diabetes across five data sources. Drug Saf. 2022;45(5):563-570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9114056</ArticleId><ArticleId IdType="pubmed">35579818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C, You SC, Reps JM, Cheong JY, Park RW.. Machine-learning model to predict the cause of death using a stacking ensemble method for observational data. J Am Med Inform Assoc. 2021;28(6):1098-1107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8200274</ArticleId><ArticleId IdType="pubmed">33211841</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Cepeda MS, Ryan PB.. Wisdom of the CROUD: development and validation of a patient-level prediction model for opioid use disorder using population-level claims data. PLoS One. 2020;15(2):e0228632.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7017997</ArticleId><ArticleId IdType="pubmed">32053653</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandran U, Reps J, Stang PE, Ryan PB.. Inferring disease severity in rheumatoid arthritis using predictive modeling in administrative claims databases. PLoS One. 2019;14(12):e0226255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6919633</ArticleId><ArticleId IdType="pubmed">31851711</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Reps JM, Kostka KF, et al.Development and validation of a prognostic model predicting symptomatic hemorrhagic transformation in acute ischemic stroke at scale in the OHDSI network. PLoS One. 2020;15(1):e0226718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6946584</ArticleId><ArticleId IdType="pubmed">31910437</ArticleId></ArticleIdList></Reference><Reference><Citation>Nestsiarovich A, Reps JM, Matheny ME, et al.Predictors of diagnostic transition from major depressive disorder to bipolar disorder: a retrospective observational network study. Transl Psychiatry. 2021;11(1):642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8688463</ArticleId><ArticleId IdType="pubmed">34930903</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Kim C, Williams RD, et al.Implementation of the COVID-19 vulnerability index across an international network of health care data sets: collaborative external validation study. JMIR Med Inform. 2021;9(4):e21547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023380</ArticleId><ArticleId IdType="pubmed">33661754</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin S, Kostka K, Posada JD, et al.Prediction of major depressive disorder following beta-blocker therapy in patients with cardiovascular diseases. J Pers Med. 2020;10(4):288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7766565</ArticleId><ArticleId IdType="pubmed">33352870</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams RD, Reps JM, Rijnbeek PR, Ryan PB, Prieto-Alhambra D; OHDSI/EHDEN Knee Arthroplasty Group. 90-Day all-cause mortality can be predicted following a total knee replacement: an international, network study to develop and validate a prediction model. Knee Surg Sports Traumatol Arthrosc. 2022;30(9):3068-3075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9418076</ArticleId><ArticleId IdType="pubmed">34870731</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo G. A roadmap for boosting model generalizability for predicting hospital encounters for asthma. JMIR Med Inform. 2022;10(3):e33044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8924785</ArticleId><ArticleId IdType="pubmed">35230246</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed Y, Song X, McMahon TM, et al.; Greater Plains Collaborative. Electronic health record data quality variability across a multistate clinical research network. J Clin Transl Sci. 2023;7(1):e130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10308424</ArticleId><ArticleId IdType="pubmed">37396818</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;&#xf6;sli E, Bozkurt S, Hernandez-Boussard T.. Peeking into a black box, the fairness and generalizability of a MIMIC-III benchmarking model. Sci Data. 2022;9(1):24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786878</ArticleId><ArticleId IdType="pubmed">35075160</ArticleId></ArticleIdList></Reference><Reference><Citation>Naderalvojoud B, Hernandez-Boussard T. Improving machine learning with ensemble learning on observational healthcare data. In: AMIA Annual Symposium Proceedings (Vol. 2023, p. 521). American Medical Informatics Association; 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10785929</ArticleId><ArticleId IdType="pubmed">38222353</ArticleId></ArticleIdList></Reference><Reference><Citation>Zammit A, Coquet J, Hah J, et al.Postoperative opioid prescribing patients with diabetes: Opportunities for personalized pain management. PLoS One. 2023;18(8):e0287697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10449216</ArticleId><ArticleId IdType="pubmed">37616195</ArticleId></ArticleIdList></Reference><Reference><Citation>Katona C, Peveler R, Dowrick C, et al.Pain symptoms in depression: definition and clinical significance. Clin Med (Lond). 2005;5(4):390-395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4954214</ArticleId><ArticleId IdType="pubmed">16138496</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer NM, Gazelka HM, Thompson VH, Batsis JA, Swetz KM.. Challenges to safe and effective pain management in patients with super obesity: case report and literature review. J Pain Symptom Manage. 2018;55(3):1047-1052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6457255</ArticleId><ArticleId IdType="pubmed">29155287</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Rijnbeek P, Cuthbert A, Ryan PB, Pratt N, Schuemie M.. An empirical analysis of dealing with patients who are lost to follow-up when developing prognostic models using a cohort design. BMC Med Inform Decis Mak. 2021;21(1):43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7866757</ArticleId><ArticleId IdType="pubmed">33549087</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward A, Jani T, De Souza E, Scheinker D, Bambos N, Anderson TA.. Prediction of prolonged opioid use after surgery in adolescents: insights from machine learning. Anesth Analg. 2021;133(2):304-313.</Citation><ArticleIdList><ArticleId IdType="pubmed">33939656</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson SP, Chung KC, Zhong L, et al.Risk of prolonged opioid use among opioid-na&#xef;ve patients following common hand surgery procedures. J Hand Surg Am. 2016;41(10):947-957.e3.</Citation><ArticleIdList><ArticleId IdType="pubmed">27692801</ArticleId></ArticleIdList></Reference><Reference><Citation>Naderalvojoud B, Sezer EA, Ucan A. Imbalanced text categorization based on positive and negative term weighting approach. In: Text, Speech, and Dialogue: 18th International Conference, TSD 2015, Pilsen, Czech Republic, September 14&#x2013;17, 2015, Proceedings 18, 2015 (pp. 325&#x2013;333). Springer International Publishing.</Citation></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB, Rijnbeek PR.. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc. 2018;25(8):969-975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen KJ, Moons KG, Kalkman CJ, Grobbee DE, Vergouwe Y.. Updating methods improved the performance of a clinical prediction model in new patients. J Clin Epidemiol. 2008;61(1):76-86.</Citation><ArticleIdList><ArticleId IdType="pubmed">18083464</ArticleId></ArticleIdList></Reference><Reference><Citation>Maleki F, Ovens K, Gupta R, Reinhold C, Spatz A, Forghani R.. Generalizability of machine learning models: quantitative evaluation of three methodological pitfalls. Radiol Artif Intell. 2022;5(1):e220028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9885377</ArticleId><ArticleId IdType="pubmed">36721408</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J, Zhang X, Shahinian V, et al.Generalizability of an acute kidney injury prediction model across health systems. Nat Mach Intell. 2022;4(12):1121-1129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10751025</ArticleId><ArticleId IdType="pubmed">38148789</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Soltan AA, Clifton DA.. Machine learning generalizability across healthcare settings: insights from multi-site COVID-19 screening. NPJ Digit Med. 2022;5(1):69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9174159</ArticleId><ArticleId IdType="pubmed">35672368</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard FM, Dolezal J, Kochanny S, et al.The impact of site-specific digital histology signatures on deep learning model accuracy and bias. Nat Commun. 2021;12(1):4423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8292530</ArticleId><ArticleId IdType="pubmed">34285218</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu AJ, Romero-Brufau S, Qian R, et al.Assessing the generalizability of a clinical machine learning model across multiple emergency departments. Mayo Clin Proc Innov Qual Outcomes. 2022;6(3):193-199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9062323</ArticleId><ArticleId IdType="pubmed">35517246</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosal I, Hooker G.. Boosting random forests to reduce bias; one-step boosted forest and its variance estimate. J Comput Graph Stat. 2020;30(2):493-502.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38413124</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2052-4439</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>27</Day></PubDate></JournalIssue><Title>BMJ open respiratory research</Title><ISOAbbreviation>BMJ Open Respir Res</ISOAbbreviation></Journal><ArticleTitle>Real-world treatment trajectories of adults with newly diagnosed asthma or COPD.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e002127</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjresp-2023-002127</ELocationID><Abstract><AbstractText Label="BACKGROUND">There is a lack of knowledge on how patients with asthma or chronic obstructive pulmonary disease (COPD) are globally treated in the real world, especially with regard to the initial pharmacological treatment of newly diagnosed patients and the different treatment trajectories. This knowledge is important to monitor and improve clinical practice.</AbstractText><AbstractText Label="METHODS">This retrospective cohort study aims to characterise treatments using data from four claims (drug dispensing) and four electronic health record (EHR; drug prescriptions) databases across six countries and three continents, encompassing 1.3&#x2009;million patients with asthma or COPD. We analysed treatment trajectories at drug class level from first diagnosis and visualised these in sunburst plots.</AbstractText><AbstractText Label="RESULTS">In four countries (USA, UK, Spain and the Netherlands), most adults with asthma initiate treatment with short-acting &#xdf;2 agonists monotherapy (20.8%-47.4% of first-line treatments). For COPD, the most frequent first-line treatment varies by country. The largest percentages of untreated patients (for asthma and COPD) were found in claims databases (14.5%-33.2% for asthma and 27.0%-52.2% for COPD) from the USA as compared with EHR databases (6.9%-15.2% for asthma and 4.4%-17.5% for COPD) from European countries. The treatment trajectories showed step-up as well as step-down in treatments.</AbstractText><AbstractText Label="CONCLUSION">Real-world data from claims and EHRs indicate that first-line treatments of asthma and COPD vary widely across countries. We found evidence of a stepwise approach in the pharmacological treatment of asthma and COPD, suggesting that treatments may be tailored to patients' needs.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Markus</LastName><ForeName>Aniek F</ForeName><Initials>AF</Initials><Identifier Source="ORCID">0000-0001-5779-4794</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands a.markus@erasmusmc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><Identifier Source="ORCID">0000-0003-0621-1979</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kors</LastName><ForeName>Jan A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burn</LastName><ForeName>Edward</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9286-1128</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la Recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8274-0357</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la Recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haug</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0935-3307</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Chungsoo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1802-1777</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolde</LastName><ForeName>Raivo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2886-6298</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Youngsoo</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-8918-9353</Identifier><AffiliationInfo><Affiliation>Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Hae-Sim</ForeName><Initials>HS</Initials><Identifier Source="ORCID">0000-0003-2614-0303</Identifier><AffiliationInfo><Affiliation>Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0003-4989-3287</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3950-6346</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes</LastName><ForeName>Carlen</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-8486-3265</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la Recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishnan</LastName><ForeName>Jerry A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0001-5525-4778</Identifier><AffiliationInfo><Affiliation>Breathe Chicago Center, Division of Pulmonary, Critical Care, Sleep, and Allergy, University of Illinois Chicago, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Brusselle</LastName><ForeName>Guy G</ForeName><Initials>GG</Initials><Identifier Source="ORCID">0000-0001-7021-8505</Identifier><AffiliationInfo><Affiliation>Departments of Clinical Epidemiology and Respiratory Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Verhamme</LastName><ForeName>Katia Mc</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0001-8162-4904</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection Control &amp; Epidemiology, OLV Hospital, Aalst, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open Respir Res</MedlineTA><NlmUniqueID>101638061</NlmUniqueID><ISSNLinking>2052-4439</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001993">Bronchodilator Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058666">Adrenergic beta-2 Receptor Agonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001993" MajorTopicYN="N">Bronchodilator Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058666" MajorTopicYN="N">Adrenergic beta-2 Receptor Agonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="Y">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Asthma Pharmacology</Keyword><Keyword MajorTopicYN="N">COPD Pharmacology</Keyword></KeywordList><CoiStatement>Competing interests: AFM, PRR, JAK and KMV work for a department that receives/received unconditional research grants from Amgen, Chiesi, Johnson and Johnson, UCB Biopharma, the European Medicines Agency and the Innovative Medicines Initiative. DP-A&#x2019;s department has received grants from Amgen, Chiesi-Taylor, Lilly, Johnson and Johnson, Novartis, UCB Biopharma, the European Medicines Agency, and the Innovative Medicines Initiative. DP-A&#x2019;s research group has received consultancy fees from Astra Zeneca and UCB Biopharma. DP-A&#x2019;s department has organised training programmes funded or supported by Amgen, Astellas, Johnson and Johnson, Synapse Management Partners, and UCB Biopharma. JK&#x2019;s institute has received grants from the American Lung Association, COPD Foundation, National Heart Lung and Blood institute, PCORI, Regeneron, Sergey Brin Family Foundation and US National Institutes of Health. JK has received consultancy fees from AstraZeneca, BData and GlaxoSmithKline. JK has received honoraria from University of Chicago, University of Washington/VA Puget Sound and travel support from the Global Initiative for Asthma, American Thoracic Society. GBB&#x2019;s institute has received grants from Merck Sharp &amp; Dohme. GBB has received honoraria from AstraZeneca, Boehringer-Ingelheim, Chiesi, GlaxoSmithKline, Novartis and Sanofi. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>28</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>27</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38413124</ArticleId><ArticleId IdType="pmc">PMC10900306</ArticleId><ArticleId IdType="doi">10.1136/bmjresp-2023-002127</ArticleId><ArticleId IdType="pii">11/1/e002127</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vos T, Lim SS, Abbafati C, et al. . Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet 2020;396:1204&#x2013;22. 10.1016/S0140-6736(20)30925-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30925-9</ArticleId><ArticleId IdType="pmc">PMC7567026</ArticleId><ArticleId IdType="pubmed">33069326</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelkes M, de Ridder MA, Svensson E, et al. . Multinational cohort study of mortality in patients with asthma and severe asthma. Respir Med 2020;165:105919. 10.1016/j.rmed.2020.105919</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.105919</ArticleId><ArticleId IdType="pubmed">32174450</ArticleId></ArticleIdList></Reference><Reference><Citation>
Global Initiative for Asthma . Global strategy for asthma management and prevention. 2021. Available: https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf [Accessed Jun 2021].</Citation></Reference><Reference><Citation>
NHLBI . 2020 focused updates to the asthma management guidelines: a report from the National asthma education and prevention program coordinating committee expert panel working group. 2020. Available: https://www.nhlbi.nih.gov/sites/default/files/publications/AsthmaManagementGuidelinesReport-2-4-21.pdf [Accessed Jun 2021].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7924476</ArticleId><ArticleId IdType="pubmed">33280709</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institute for Health and Care Excellence . Asthma: diagnosis, monitoring and chronic asthma management. 2017. Available: https://www.nice.org.uk/guidance/ng80/resources/asthma-diagnosis-monitoring-and-chronic-asthma-management-pdf-1837687975621 [Accessed Jun 2021].</Citation><ArticleIdList><ArticleId IdType="pubmed">32755129</ArticleId></ArticleIdList></Reference><Reference><Citation>
BMJ Best Practice . Acute exacerbation of chronic obstructive pulmonary disease. 2021. Available: https://bestpractice.bmj.com/topics/en-us/8 [Accessed Jun 2022].</Citation></Reference><Reference><Citation>
Global Initiative for Chronic Obstructive Lung Disease . Global strategy for prevention, diagnosis and management of copd. 2021. Available: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf [Accessed Jun 2021].</Citation></Reference><Reference><Citation>Nici L, Mammen MJ, Charbek E, et al. . Pharmacologic management of chronic obstructive pulmonary disease. an official American thoracic society clinical practice guideline. Am J Respir Crit Care Med 2020;201:e56&#x2013;69. 10.1164/rccm.202003-0625ST</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202003-0625ST</ArticleId><ArticleId IdType="pmc">PMC7193862</ArticleId><ArticleId IdType="pubmed">32283960</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institute for Health and Care Excellence . Chronic obstructive pulmonary disease in over 16S: diagnosis and management. 2018. Available: https://www.nice.org.uk/guidance/ng115/resources/chronic-obstructive-pulmonary-disease-in-over-16s-diagnosis-and-management-pdf-66141600098245 [Accessed Jun 2021].</Citation><ArticleIdList><ArticleId IdType="pubmed">31211541</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, et al. . Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc 2012;19:54&#x2013;60. 10.1136/amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, et al. . Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet 2019;394:1816&#x2013;26. 10.1016/S0140-6736(19)32317-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32317-7</ArticleId><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, You SC, Sena AG, et al. . Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat Commun 2020;11:5009. 10.1038/s41467-020-18849-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18849-z</ArticleId><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Ostropolets A, Makadia R, et al. . Characterising the background incidence rates of adverse events of special interest for COVID-19 vaccines in eight countries: multinational network cohort study. BMJ 2021;373:n1435. 10.1136/bmj.n1435</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1435</ArticleId><ArticleId IdType="pmc">PMC8193077</ArticleId><ArticleId IdType="pubmed">35727911</ArticleId></ArticleIdList></Reference><Reference><Citation>Waljee AK, Rogers MAM, Lin P, et al. . Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ 2017;357:j1415. 10.1136/bmj.j1415</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j1415</ArticleId><ArticleId IdType="pmc">PMC6284230</ArticleId><ArticleId IdType="pubmed">28404617</ArticleId></ArticleIdList></Reference><Reference><Citation>Broder MS, Raimundo K, Ngai KM, et al. . Cost and health care utilization in patients with asthma and high oral corticosteroid use. Ann Allergy Asthma Immunol 2017;118:638&#x2013;9. 10.1016/j.anai.2017.02.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2017.02.023</ArticleId><ArticleId IdType="pubmed">28477795</ArticleId></ArticleIdList></Reference><Reference><Citation>Markus AF, Verhamme KMC, Kors JA, et al. . TreatmentPatterns: an R package to facilitate the standardized development and analysis of treatment patterns across disease domains. Comput Methods Programs Biomed 2022;225:107081. 10.1016/j.cmpb.2022.107081</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2022.107081</ArticleId><ArticleId IdType="pubmed">36084453</ArticleId></ArticleIdList></Reference><Reference><Citation>Markus AF, Strauss VY, Burn E, et al. . Characterising the treatment of thromboembolic events after COVID-19 vaccination in 4 European countries and the us: an international network cohort study. Front Pharmacol 2023;14:1118203. 10.3389/fphar.2023.1118203</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2023.1118203</ArticleId><ArticleId IdType="pmc">PMC10079887</ArticleId><ArticleId IdType="pubmed">37033631</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen VN, Nguyen QN, Le An P, et al. . Implementation of GINA guidelines in asthma management by primary care physicians in Vietnam. Int J Gen Med 2017;10:347&#x2013;55. 10.2147/IJGM.S147752</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S147752</ArticleId><ArticleId IdType="pmc">PMC5634369</ArticleId><ArticleId IdType="pubmed">29042809</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldacci S, Simoni M, Maio S, et al. . Prescriptive adherence to GINA guidelines and asthma control: an Italian cross sectional study in general practice. Respir Med 2019;146:10&#x2013;7. 10.1016/j.rmed.2018.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2018.11.001</ArticleId><ArticleId IdType="pubmed">30665506</ArticleId></ArticleIdList></Reference><Reference><Citation>Surani S, Aiyer A, Eikermann S, et al. . Adoption and adherence to chronic obstructive pulmonary disease GOLD guidelines in a primary care setting. SAGE Open Med 2019;7:2050312119842221. 10.1177/2050312119842221</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2050312119842221</ArticleId><ArticleId IdType="pmc">PMC6452427</ArticleId><ArticleId IdType="pubmed">31057794</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran TN, MacLachlan S, Hicks W, et al. . Oral corticosteroid treatment patterns of patients in the United States with persistent asthma. J Allergy Clin Immunol Pract 2021;9:338&#x2013;46. 10.1016/j.jaip.2020.06.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2020.06.019</ArticleId><ArticleId IdType="pubmed">32569754</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E, Kim A, Ye Y-M, et al. . Increasing prevalence and mortality of asthma with age in Korea, 2002&#x2013;2015: a nationwide, population-based study. Allergy Asthma Immunol Res 2020;12:467. 10.4168/aair.2020.12.3.467</Citation><ArticleIdList><ArticleId IdType="doi">10.4168/aair.2020.12.3.467</ArticleId><ArticleId IdType="pmc">PMC7061163</ArticleId><ArticleId IdType="pubmed">32141260</ArticleId></ArticleIdList></Reference><Reference><Citation>
Global Initiative for Asthma . Global strategy for asthma management and prevention. 2014. Available: https://ginasthma.org/wp-content/uploads/2019/01/2014-GINA.pdf [Accessed Jun 2021].</Citation></Reference><Reference><Citation>Diab N, Gershon AS, Sin DD, et al. . Underdiagnosis and overdiagnosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2018;198:1130&#x2013;9. 10.1164/rccm.201804-0621CI</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201804-0621CI</ArticleId><ArticleId IdType="pubmed">29979608</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaron SD, Boulet LP, Reddel HK, et al. . Underdiagnosis and overdiagnosis of asthma. Am J Respir Crit Care Med 2018;198:1012&#x2013;20. 10.1164/rccm.201804-0682CI</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201804-0682CI</ArticleId><ArticleId IdType="pubmed">29756989</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinaiko AD, Gaye M, Wu AC, et al. . Out-of-pocket spending for asthma-related care among commercially insured patients, 2004-2016. J Allergy Clin Immunol Pract 2021;9:4324&#x2013;31. 10.1016/j.jaip.2021.07.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2021.07.054</ArticleId><ArticleId IdType="pubmed">34481128</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrecheguren M, Monteagudo M, Ferrer J, et al. . Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study. Respir Med 2016;111:47&#x2013;53. 10.1016/j.rmed.2015.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2015.12.004</ArticleId><ArticleId IdType="pubmed">26758585</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J-K, Rhee CK, Kim K, et al. . Prescription status and clinical outcomes of methylxanthines and leukotriene receptor antagonists in mild-to-moderate chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2019;14:2639&#x2013;47. 10.2147/COPD.S216326</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S216326</ArticleId><ArticleId IdType="pmc">PMC6885559</ArticleId><ArticleId IdType="pubmed">31819397</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38421482</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1432-1262</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>29</Day></PubDate></JournalIssue><Title>International journal of colorectal disease</Title><ISOAbbreviation>Int J Colorectal Dis</ISOAbbreviation></Journal><ArticleTitle>Prediction of 30-day, 90-day, and 1-year mortality after colorectal cancer surgery using a data-driven approach.</ArticleTitle><Pagination><StartPage>31</StartPage><MedlinePgn>31</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">31</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00384-024-04607-w</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To develop prediction models for short-term mortality risk assessment following colorectal cancer surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data was harmonized from four Danish observational health databases into the Observational Medical Outcomes Partnership Common Data Model. With a data-driven approach using the Least Absolute Shrinkage and Selection Operator logistic regression on preoperative data, we developed 30-day, 90-day, and 1-year mortality prediction models. We assessed discriminative performance using the area under the receiver operating characteristic and precision-recall curve and calibration using calibration slope, intercept, and calibration-in-the-large. We additionally assessed model performance in subgroups of curative, palliative, elective, and emergency surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 57,521 patients were included in the study population, 51.1% male and with a median age of 72&#xa0;years. The model showed good discrimination with an area under the receiver operating characteristic curve of 0.88, 0.878, and 0.861 for 30-day, 90-day, and 1-year mortality, respectively, and a calibration-in-the-large of 1.01, 0.99, and 0.99. The overall incidence of mortality were 4.48% for 30-day mortality, 6.64% for 90-day mortality, and 12.8% for 1-year mortality, respectively. Subgroup analysis showed no improvement of discrimination or calibration when separating the cohort into cohorts of elective surgery, emergency surgery, curative surgery, and palliative surgery.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We were able to train prediction models for the risk of short-term mortality on a data set of four combined national health databases with good discrimination and calibration. We found that one cohort including all operated patients resulted in better performing models than cohorts based on several subgroups.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Br&#xe4;uner</LastName><ForeName>Karoline Bendix</ForeName><Initials>KB</Initials><Identifier Source="ORCID">0000-0003-2833-3870</Identifier><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Lykkeb&#xe6;kvej 1, 4600, K&#xf8;ge, Denmark. karob@regionsjaelland.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsouchnika</LastName><ForeName>Andi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Lykkeb&#xe6;kvej 1, 4600, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mashkoor</LastName><ForeName>Maliha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Lykkeb&#xe6;kvej 1, 4600, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Ross</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD, Rotterdam, Holland, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosen</LastName><ForeName>Andreas Weinberger</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Lykkeb&#xe6;kvej 1, 4600, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartwig</LastName><ForeName>Morten Frederik Schlaikj&#xe6;r</ForeName><Initials>MFS</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Lykkeb&#xe6;kvej 1, 4600, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bulut</LastName><ForeName>Mustafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Lykkeb&#xe6;kvej 1, 4600, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Copenhagen, The Faculty of Health Science, Blegdamsvej 6, 2200, Copenhagen N, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dohrn</LastName><ForeName>Niclas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Lykkeb&#xe6;kvej 1, 4600, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Copenhagen University Hospital, Herlev &amp; Gentofte, Borgmester Ib Juuls vej 1, 2730, Herlev, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD, Rotterdam, Holland, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;genur</LastName><ForeName>Ismail</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Lykkeb&#xe6;kvej 1, 4600, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Copenhagen, The Faculty of Health Science, Blegdamsvej 6, 2200, Copenhagen N, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>806968</GrantID><Agency>Innovative Medicines Initiative 2 Joint Undertaking (JU)</Agency><Country/></Grant><Grant><GrantID>NNF21OC0069821</GrantID><Agency>Novo Nordisk Fonden</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Int J Colorectal Dis</MedlineTA><NlmUniqueID>8607899</NlmUniqueID><ISSNLinking>0179-1958</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013505" MajorTopicYN="Y">Digestive System Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002138" MajorTopicYN="N">Calibration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="Y">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Colorectal cancer</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Postoperative</Keyword><Keyword MajorTopicYN="N">Prediction model</Keyword></KeywordList><CoiStatement>All authors have approved the submission of this paper. All authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>29</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>29</Day><Hour>11</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38421482</ArticleId><ArticleId IdType="pmc">PMC10904562</ArticleId><ArticleId IdType="doi">10.1007/s00384-024-04607-w</ArticleId><ArticleId IdType="pii">10.1007/s00384-024-04607-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Center MM, Jemal A, Smith RA, Ward E (2010) Worldwide variations in colorectal cancer. Dis Colon Rectum 53:1099. 10.1007/DCR.0b013e3181d60a51</Citation></Reference><Reference><Citation>World Health Organization (2020) WHO cancer 2020.&#xa0;https://www.who.int/news-room/fact-sheets/detail/c</Citation></Reference><Reference><Citation>Knight SR, Shaw CA, Pius R, Drake TM, Norman L, Ademuyiwa AO et al (2021) Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries. The Lancet 397:387&#x2013;397. 10.1016/S0140-6736(21)00001-5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7846817</ArticleId><ArticleId IdType="pubmed">33485461</ArticleId></ArticleIdList></Reference><Reference><Citation>Iversen LH, Ingeholm P, G&#xf6;genur I, Laurberg S (2014) Major reduction in 30-day mortality after elective colorectal cancer surgery: a nationwide population-based study in Denmark 2001&#x2013;2011. Ann Surg Oncol 21:2267&#x2013;2273. 10.1245/s10434-014-3596-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24585408</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojesen RD, Degett TH, Dalton SO, G&#xf6;genur I (2021) High World Heath Organization performance status is associated with short and long-term outcomes after colorectal cancer surgery. Dis Colon Rectum 58&#x2013;66. 10.1097/DCR.0000000000001982</Citation><ArticleIdList><ArticleId IdType="pubmed">34086001</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaud Maturana M, English WJ, Nandakumar M, Li Chen J, Dvorkin L (2021) The impact of frailty on clinical outcomes in colorectal cancer surgery: a systematic literature review. ANZ J Surg 91:2322&#x2013;2329. 10.1111/ans.16941</Citation><ArticleIdList><ArticleId IdType="pubmed">34013571</ArticleId></ArticleIdList></Reference><Reference><Citation>Ommundsen N, Wyller TB, Nesbakken A, Bakka AO, Jordh&#xf8;y MS, Skovlund E et al (2018) Preoperative geriatric assessment and tailored interventions in frail older patients with colorectal cancer: a randomized controlled trial. Colorectal Dis 20:16&#x2013;25. 10.1111/codi.13785</Citation><ArticleIdList><ArticleId IdType="pubmed">28649755</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandit V, Khan M, Martinez C, Jehan F, Zeeshan M, Koblinski J et al (2018) A modified frailty index predicts adverse outcomes among patients with colon cancer undergoing surgical intervention. Am J Surg 216:1090&#x2013;1094. 10.1016/j.amjsurg.2018.07.006</Citation><ArticleIdList><ArticleId IdType="pubmed">30017310</ArticleId></ArticleIdList></Reference><Reference><Citation>Valls JC, Brau NB, Bernat MJ, Iglesias P, Reig L, Pascual L et al (2018) Colorectal carcinoma in the frail surgical patient. Implementation of a work area focused on the complex surgical patient improves postoperative outcome. Cir Esp 96:155&#x2013;61. 10.1016/j.ciresp.2017.09.015</Citation><ArticleIdList><ArticleId IdType="pubmed">29233580</ArticleId></ArticleIdList></Reference><Reference><Citation>Lees J, Chan A (2011) Polypharmacy in elderly patients with cancer: clinical implications and management. Lancet Oncol 12:1249&#x2013;1257. 10.1016/S1470-2045(11)70040-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21741307</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasi PM, Shahjehan F, Cochuyt JJ, Li Z, Colibaseanu DT, Merchea A (2019) Rising proportion of young individuals with rectal and colon cancer. Clin Colorectal Cancer 18:e87-95. 10.1016/j.clcc.2018.10.002</Citation><ArticleIdList><ArticleId IdType="pubmed">30420120</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojesen RD, Ravn J, Rasmus E, Vogelsang P, Grube C, Lyng J et al (2021) The dynamic effects of preoperative intravenous iron in anaemic patients undergoing surgery for colorectal cancer 2550&#x2013;2558. 10.1111/codi.15789</Citation><ArticleIdList><ArticleId IdType="pubmed">34166572</ArticleId></ArticleIdList></Reference><Reference><Citation>Okuyama M, Ikeda K, Shibata T, Tsukahara Y, Kitada M, Shimano T (2005) Preoperative iron supplementation and intraoperative transfusion during colorectal cancer surgery. Surg Today 35:36&#x2013;40. 10.1007/s00595-004-2888-0</Citation><ArticleIdList><ArticleId IdType="pubmed">15622462</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojesen RD, J&#xf8;rgensen LB, Grube C, Skou ST, Johansen C, Dalton SO et al (2022) Fit for surgery &#x2014; feasibility of short-course multimodal individualized prehabilitation in high-risk frail colon cancer patients prior to surgery. Pilot Feasibility Stud 1&#x2013;13. 10.1186/s40814-022-00967-8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8781359</ArticleId><ArticleId IdType="pubmed">35063042</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkel AEM, Bongers BC, Kotte H, Weltevreden P, de Jongh FHC, Eijsvogel MMM et al (2021) Effects of community-based exercise prehabilitation for patients scheduled for colorectal surgery with high risk for postoperative complications. Ann Surg; Publish Ah. 10.1097/sla.0000000000004702</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8746915</ArticleId><ArticleId IdType="pubmed">33443905</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberan-Garcia A, Ubr&#xe9; M, Roca J, Lacy AM, Burgos F, Risco R et al (2018) Personalised prehabilitation in high-risk patients undergoing elective major abdominal surgery: a randomized blinded controlled trial. Ann Surg 267:50&#x2013;56. 10.1097/SLA.0000000000002293</Citation><ArticleIdList><ArticleId IdType="pubmed">28489682</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojesen RD (2022) Effect of modifying high-risk factors and prehabilitation on the outcomes of colorectal cancer surgery: controlled before and after study</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9154067</ArticleId><ArticleId IdType="pubmed">35639564</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalabi M, Fanchi LF, Dijkstra KK, Van den Berg JG, Aalbers AG, Sikorska K et al (2020) Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat Med 26:566&#x2013;576. 10.1038/s41591-020-0805-8</Citation><ArticleIdList><ArticleId IdType="pubmed">32251400</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingeholm P, G&#xf6;genur I, Iversen LH (2016) Danish colorectal cancer group database. Clin Epidemiol 8:465&#x2013;468. 10.2147/CLEP.S99481</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5094575</ArticleId><ArticleId IdType="pubmed">27822086</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein MF, G&#xf6;genur I, Ingeholm P, Njor SH, Iversen LH, Emmertsen KJ (2020) Validation of the Danish Colorectal Cancer Group (DCCG.dk) database - on behalf of the Danish Colorectal Cancer Group. Colorectal Dis 22:2057&#x2013;67. 10.1111/codi.15352</Citation><ArticleIdList><ArticleId IdType="pubmed">32894818</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, S&#xf8;rensen HT (2015) The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol 7:449&#x2013;490. 10.2147/CLEP.S91125</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4655913</ArticleId><ArticleId IdType="pubmed">26604824</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendt JFH, Hansen AT, Ladefoged SA, S&#xf8;rensen HT, Pedersen L, Adelborg K (2020) Existing data sources in clinical epidemiology: laboratory information system databases in Denmark. Clin Epidemiol 12:469&#x2013;475. 10.2147/CLEP.S245060</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7244445</ArticleId><ArticleId IdType="pubmed">32547238</ArticleId></ArticleIdList></Reference><Reference><Citation>Potteg&#xe5;rd A, Schmidt SAJ, Wallach-Kildemoes H, S&#xf8;rensen HT, Hallas J, Schmidt M (2017) Data resource profile: the Danish national prescription registry. Int J Epidemiol 46:798. 10.1093/ije/dyw213</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5837522</ArticleId><ArticleId IdType="pubmed">27789670</ArticleId></ArticleIdList></Reference><Reference><Citation>National Committee on Health Research Ethics (2022) What to notify? https://en.nvk.dk/how-to-notify/what-to-notify</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics (2019) The Book of OHDSI 1&#x2013;470</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Martijn J et al (2015) Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers 574&#x2013;8. 10.3233/978-1-61499-564-7-574</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI, Reps J, Schumie M, Rijnbeek P, Suchard M, Williams R (2022) Patient level prediction. GitHub. https://github.com/OHDSI/PatientLevelPrediction</Citation></Reference><Reference><Citation>Reps J, Schuemie MJ, Ryan PB, Rijnbeek PR (2020) Building patient-level predictive models 1&#x2013;45</Citation></Reference><Reference><Citation>Vogelsang RP, Bojesen RD, Hoelmich ER, Orhan A, Buzquurz F, Cai L et al (2021) Prediction of 90-day mortality after surgery for colorectal cancer using standardized nationwide quality-assurance data. BJS Open 5. 10.1093/bjsopen/zrab023</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8105588</ArticleId><ArticleId IdType="pubmed">33963368</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams RD, Markus AF, Yang C, Duarte-Salles T, DuVall SL, Falconer T et al (2022) Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network. BMC Med Res Methodol 22:1&#x2013;13. 10.1186/s12874-022-01505-z</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8801189</ArticleId><ArticleId IdType="pubmed">35094685</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams RD, Reps JM, Rijnbeek PR, Ryan PB, Prieto-Alhambra D, Sena AG et al (2021) 90-Day all-cause mortality can be predicted following a total knee replacement: an international, network study to develop and validate a prediction model. Knee Surgery, Sports Traumatology, Arthroscopy. 10.1007/s00167-021-06799-y</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9418076</ArticleId><ArticleId IdType="pubmed">34870731</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#xe4;uner KB, Rosen AW, Tsouchnika A, Walbech JS, G&#xf6;genur M, Lin VA, Clausen JSR, G&#xf6;genur I (2022) Developing prediction models for short-term mortality after surgery for colorectal cancer using a Danish national quality assurance database. Int J Colorectal Dis 1&#x2013;15</Citation><ArticleIdList><ArticleId IdType="pubmed">35849195</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin V, Tsouchnika A, Allakhverdiiev E, Rosen AW, G&#xf6;genur M, Clausen JSR et al (2022) Training prediction models for individual risk assessment of postoperative complications after surgery for colorectal cancer. Tech Coloproctol. 10.1007/s10151-022-02624-x</Citation><ArticleIdList><ArticleId IdType="pubmed">35593971</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Calster B, Nieboer D, Vergouwe Y, De Cock B, Pencina MJ, Steyerberg EW et al (n.d.) A calibration hierarchy for risk models was defined: from utopia to empirical data</Citation><ArticleIdList><ArticleId IdType="pubmed">26772608</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, Reitsma JB, Altman DG, Moons KGM (2015) Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med 162:55&#x2013;63. 10.7326/M14-0697</Citation><ArticleIdList><ArticleId IdType="pubmed">25560714</ArticleId></ArticleIdList></Reference><Reference><Citation>James G, Witten D, Hastie T, Tibshirani R (2021) An introduction to statistical learning. vol. 1. Springer texts in statistics</Citation></Reference><Reference><Citation>Poon AIF, Sung JJY (2021) Opening the black box of AI-Medicine. J Gastroenterol Hepatol (Aust) 36:581&#x2013;4. 10.1111/jgh.15384</Citation><ArticleIdList><ArticleId IdType="pubmed">33709609</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar C (n.d.) Interpretable machine learning a guide for making black box models explainable</Citation></Reference><Reference><Citation>McMahon KR, Allen KD, Afzali A, Husain S (2020) Predicting post-operative complications in Crohn&#x2019;s disease: an appraisal of clinical scoring systems and the NSQIP surgical risk calculator. J Gastrointest Surg 24:88&#x2013;97. 10.1007/s11605-019-04348-0</Citation><ArticleIdList><ArticleId IdType="pubmed">31432326</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma M, Liu Y, Gotoh M, Takahashi A, Marubashi S, Seto Y et al (2021) Validation study of the ACS NSQIP surgical risk calculator for two procedures in Japan. Am J Surg 222:877&#x2013;881. 10.1016/j.amjsurg.2021.06.008</Citation><ArticleIdList><ArticleId IdType="pubmed">34175114</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Hulst HC, Dekker JWT, Bastiaannet E, van der Bol JM, van den Bos F, Hamaker ME et al (2022) Validation of the ACS NSQIP surgical risk calculator in older patients with colorectal cancer undergoing elective surgery. J Geriatr Oncol. 10.1016/j.jgo.2022.04.004</Citation><ArticleIdList><ArticleId IdType="pubmed">35466078</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Kors JA, Ioannou S, John LH, Markus AF, Rekkas A et al (2015) Trends in the development and validation of patient-level prediction models using electronic health record data: a systematic review</Citation></Reference><Reference><Citation>Cowley LE, Farewell DM, Maguire S, Kemp AM (2019) Methodological standards for the development and evaluation of clinical prediction rules: a review of the literature. Diagn Progn Res 3:1&#x2013;23. 10.1186/s41512-019-0060-y</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6704664</ArticleId><ArticleId IdType="pubmed">31463368</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott I, Carter S, Coiera E (2021) Clinician checklist for assessing suitability of machine learning applications in healthcare. BMJ Health Care Inform 28. 10.1136/bmjhci-2020-100251</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7871244</ArticleId><ArticleId IdType="pubmed">33547086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghassemi M, Oakden-Rayner L, Beam AL (2021) The false hope of current approaches to explainable artificial intelligence in health care. Lancet Digit Health 3:e745&#x2013;e750. 10.1016/S2589-7500(21)00208-9</Citation><ArticleIdList><ArticleId IdType="pubmed">34711379</ArticleId></ArticleIdList></Reference><Reference><Citation>IKNL. Netherlands Cancer Registry (2023) https://iknl.nl/en/ncr</Citation></Reference><Reference><Citation>CRN. Cancer Register of Norway (2023) https://www.kreftregisteret.no/en/</Citation></Reference><Reference><Citation>Sinha P, Delucchi KL, McAuley DF, O&#x2019;Kane CM, Matthay MA, Calfee CS (2020) Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials. Lancet Respir Med 8:247&#x2013;257. 10.1016/S2213-2600(19)30369-8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543720</ArticleId><ArticleId IdType="pubmed">31948926</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandokji I, Yamamoto Y, Biswas A, Arora T, Ugwuowo U, Simonov M et al (2020) A time-updated, parsimonious model to predict AKI in hospitalized children. J Am Soc Nephrol 31:1348&#x2013;1357. 10.1681/ASN.2019070745</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269342</ArticleId><ArticleId IdType="pubmed">32381598</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38425704</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2574-2531</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>JAMIA open</Title><ISOAbbreviation>JAMIA Open</ISOAbbreviation></Journal><ArticleTitle>A framework for understanding an open scientific community using automated harvesting of public artifacts.</ArticleTitle><Pagination><StartPage>ooae017</StartPage><MedlinePgn>ooae017</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ooae017</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamiaopen/ooae017</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The Observational Health Data Sciences and Informatics (OHDSI) community has emerged as a leader in observational research on real-world clinical data for promoting evidence for healthcare and decision-making. The community has seen rapid growth in publications, citations, and the number of authors. Components of its successful uptake have been attributed to an open science and collaborative culture for research and development. Investigating the adoption of OHDSI as a field of study provides an opportunity to understand how communities embrace new ideas, onboard new members, and enhance their impact.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To track, study, and evaluate an open scientific community's growth and impact.</AbstractText><AbstractText Label="METHOD" NlmCategory="UNASSIGNED">We present a modern architecture leveraging open application programming interfaces to capture publicly available data (PubMed, YouTube, and EHDEN) on open science activities (publication, teaching, and engagement).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Three interactive dashboard were implemented for each publicly available artifact (PubMed, YouTube, and EHDEN). Each dashboard provides longitudinal summary analysis and has a searchable table, which differs in the available features related to each public artifact.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">We discuss the insights enabled by our approach to monitor the growth and impact of the OHDSI community by capturing artifacts of learning, teaching, and creation. We share the implications for different users based on their functional needs. As other scientific networks adopt open-source frameworks, our framework serves as a model for tracking the growth of their community, driving the perception of their development, engaging their members, and attaining higher impact.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Star</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7587-7451</Identifier><AffiliationInfo><Affiliation>Biomedical Informatics and Data Science, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golozar</LastName><ForeName>Asieh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>OHDSI Center at the Roux Institute, Northeastern University, Boston, MA 04101, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Odysseus Data Services, Cambridge, MA 02142, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buesgens</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Biomedical Informatics and Data Science, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLeggon</LastName><ForeName>Jody-Ann</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Biomedical Informatics, Columbia University, New York, NY 10032, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, Cambridge, MA 02142, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagy</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Biomedical Informatics and Data Science, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMIA Open</MedlineTA><NlmUniqueID>101730643</NlmUniqueID><ISSNLinking>2574-2531</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">information management</Keyword><Keyword MajorTopicYN="N">information storage and retrieval</Keyword><Keyword MajorTopicYN="N">software</Keyword><Keyword MajorTopicYN="N">web browser</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>1</Day><Hour>3</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38425704</ArticleId><ArticleId IdType="pmc">PMC10903973</ArticleId><ArticleId IdType="doi">10.1093/jamiaopen/ooae017</ArticleId><ArticleId IdType="pii">ooae017</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al.Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574-578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>
Observational Health Data Sciences and Informatics. Accessed April 24, 2023. https://ohdsi.org/</Citation></Reference><Reference><Citation>
European Health Data Evidence Network. Accessed April 24, 2023. https://www.ehden.eu/</Citation></Reference><Reference><Citation>
European Health Data Evidence Network. EHDEN Academy. 2023. Accessed April 24, 2023. https://academy.ehden.eu/</Citation></Reference><Reference><Citation>
Entrez Programming Utilities Help. 2010. Accessed April 24, 2023. https://www.ncbi.nlm.nih.gov/books/NBK25501/</Citation></Reference><Reference><Citation>
UMLS API Home. Accessed April 24, 2023. https://documentation.uts.nlm.nih.gov/rest/home.html</Citation></Reference><Reference><Citation>Bodenreider O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res. 2004;32(Database issue):D267-D270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, King D, Beltagy I, Ammar W. ScispaCy: Fast and Robust Models for Biomedical Natural Language Processing. In: Proceedings of the 18th BioNLP Workshop and Shared Task. February 20, 2019:abs/1902.07669.</Citation></Reference><Reference><Citation>SerpApi: Google Search API. Accessed April 24, 2023. https://serpapi.com/</Citation></Reference><Reference><Citation>
Bachmann M. Levenshtein 0.21.0 documentation. 2021. Accessed April 24, 2023. https://maxbachmann.github.io/Levenshtein/</Citation></Reference><Reference><Citation>
YouTube Data API. https://developers.google.com/youtube/v3</Citation></Reference><Reference><Citation>
Depoix J. YouTube transcript/subtitle API. 2023. Accessed April 24, 2023. https://github.com/jdepoix/youtube-transcript-api</Citation></Reference><Reference><Citation>
Python Release Python 3.7.0. Accessed April 24, 2023. https://www.python.org/downloads/release/python-370/</Citation></Reference><Reference><Citation>
Cloud Computing Services | Microsoft Azure. Accessed April 24, 2023. https://azure.microsoft.com/en-us</Citation></Reference><Reference><Citation>
Pallets. Flask. Accessed April 24, 2023. https://github.com/pallets/flask</Citation></Reference><Reference><Citation>
Plotly Technologies Inc. Dash Python. Accessed Apr 24, 2023. https://dash.plotly.com/</Citation></Reference><Reference><Citation>Schimanski LA, Alperin JP.. The evaluation of scholarship in academic promotion and tenure processes: past, present, and future. F1000Res. 2018;7:1605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6325612</ArticleId><ArticleId IdType="pubmed">30647909</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamiseishvili K, Miller MT, Lee D.. Beyond teaching and research: faculty perceptions of service roles at research universities. Innov High Educ. 2015;41(4):273-285.</Citation></Reference><Reference><Citation>Foos A, Holmes MA, Oconnell S.. What does it take to get tenure? Geotimes. 2004;49.</Citation></Reference><Reference><Citation>Piwowar H. Altmetrics: Value all research products. Nature (London). 2013;493(7431):159.</Citation><ArticleIdList><ArticleId IdType="pubmed">23302843</ArticleId></ArticleIdList></Reference><Reference><Citation>Genshaft J, Wickert J, Gray-Little B, et al.Consideration of technology transfer in tenure and promotion. Technol Innov. 2016;17(4):197-204.</Citation></Reference><Reference><Citation>Diamond RM, Adam BE. Changing priorities at research universities: 1991&#x2013;1996. Syracuse University, Carnegie Foundation for the Advancement of Teaching; 1998.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38432534</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>152</Volume><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Creating a computer assisted ICD coding system: Performance metric choice and use of the ICD hierarchy.</ArticleTitle><Pagination><StartPage>104617</StartPage><MedlinePgn>104617</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2024.104617</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(24)00035-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Machine learning methods hold the promise of leveraging available data and generating higher-quality data while alleviating the data collection burden on healthcare professionals. International Classification of Diseases (ICD) diagnoses data, collected globally for billing and epidemiological purposes, represents a valuable source of structured information. However, ICD coding is a challenging task. While numerous previous studies reported promising results in automatic ICD classification, they often describe input data specific model architectures, that are heterogeneously evaluated with different performance metrics and ICD code subsets. This study aims to explore the evaluation and construction of more effective Computer Assisted Coding (CAC) systems using generic approaches, focusing on the use of ICD hierarchy, medication data and a feed forward neural network architecture.</AbstractText><AbstractText Label="METHODS">We conduct comprehensive experiments using the MIMIC-III clinical database, mapped to the OMOP data model. Our evaluations encompass various performance metrics, alongside investigations into multitask, hierarchical, and imbalanced learning for neural networks.</AbstractText><AbstractText Label="RESULTS">We introduce a novel metric, , tailored to the ICD coding task, which offers interpretable insights for healthcare informatics practitioners, aiding them in assessing the quality of assisted coding systems. Our findings highlight that selectively cherry-picking ICD codes diminish retrieval performance without performance improvement over the selected subset. We show that optimizing for metrics such as NDCG and AUPRC outperforms traditional F1-based metrics in ranking performance. We observe that Neural Network training on different ICD levels simultaneously offers minor benefits for ranking and significant runtime gains. However, our models do not derive benefits from hierarchical or class imbalance correction techniques for ICD code retrieval.</AbstractText><AbstractText Label="CONCLUSION">This study offers valuable insights for researchers and healthcare practitioners interested in developing and evaluating CAC systems. Using a straightforward sequential neural network model, we confirm that medical prescriptions are a rich data source for CAC systems, providing competitive retrieval capabilities for a fraction of the computational load compared to text-based models. Our study underscores the importance of metric selection and challenges existing practices related to ICD code sub-setting for model training and evaluation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marcou</LastName><ForeName>Quentin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Aix-Marseille Universit&#xe9;, Facult&#xe9; des sciences m&#xe9;dicales et param&#xe9;dicales, Marseille, France; Aix-Marseille Universit&#xe9;, UMR7020 CNRS, Laboratoire d'Informatique et Syst&#xe8;mes (LIS), Marseille, France. Electronic address: qm.sci@protonmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berti-Equille</LastName><ForeName>Laure</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IRD, UMR 228 ESPACE-DEV, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novelli</LastName><ForeName>No&#xeb;l</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Aix-Marseille Universit&#xe9;, UMR7020 CNRS, Laboratoire d'Informatique et Syst&#xe8;mes (LIS), Marseille, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038801" MajorTopicYN="Y">International Classification of Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003201" MajorTopicYN="N">Computers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059019" MajorTopicYN="N">Clinical Coding</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hierarchical Multilabel Classification (HMC)</Keyword><Keyword MajorTopicYN="N">International Classification of Diseases (ICD)</Keyword><Keyword MajorTopicYN="N">MIMIC-III</Keyword><Keyword MajorTopicYN="N">Medication</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">Recommender systems</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>4</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>3</Day><Hour>19</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38432534</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2024.104617</ArticleId><ArticleId IdType="pii">S1532-0464(24)00035-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38433286</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-7979</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><PubDate><Year>2024</Year><Month>Mar</Month><Day>04</Day></PubDate></JournalIssue><Title>Epidemiology and psychiatric sciences</Title><ISOAbbreviation>Epidemiol Psychiatr Sci</ISOAbbreviation></Journal><ArticleTitle>Incidence of mental health diagnoses during the COVID-19 pandemic: a multinational network study.</ArticleTitle><Pagination><StartPage>e9</StartPage><MedlinePgn>e9</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/S2045796024000088</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Population-wide restrictions during the COVID-19 pandemic may create barriers to mental health diagnosis. This study aims to examine changes in the number of incident cases and the incidence rates of mental health diagnoses during the COVID-19 pandemic.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">By using electronic health records from France, Germany, Italy, South Korea and the UK and claims data from the US, this study conducted interrupted time-series analyses to compare the monthly incident cases and the incidence of depressive disorders, anxiety disorders, alcohol misuse or dependence, substance misuse or dependence, bipolar disorders, personality disorders and psychoses diagnoses before (January 2017 to February 2020) and after (April 2020 to the latest available date of each database [up to November 2021]) the introduction of COVID-related restrictions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 629,712,954 individuals were enrolled across nine databases. Following the introduction of restrictions, an immediate decline was observed in the number of incident cases of all mental health diagnoses in the US (rate ratios (RRs) ranged from 0.005 to 0.677) and in the incidence of all conditions in France, Germany, Italy and the US (RRs ranged from 0.002 to 0.422). In the UK, significant reductions were only observed in common mental illnesses. The number of incident cases and the incidence began to return to or exceed pre-pandemic levels in most countries from mid-2020 through 2021.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Healthcare providers should be prepared to deliver service adaptations to mitigate burdens directly or indirectly caused by delays in the diagnosis and treatment of mental health conditions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chai</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-9191-2341</Identifier><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Hong Kong Jockey Club Centre for Suicide Research and Prevention, The University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Man</LastName><ForeName>Kenneth K C</ForeName><Initials>KKC</Initials><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The Hong Kong Jockey Club Centre for Suicide Research and Prevention, The University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Social Work and Social Administration, The University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sau Po Centre on Ageing, The University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torre</LastName><ForeName>Carmen Olga</ForeName><Initials>CO</Initials><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Real World Data Sciences, Roche, Welwyn Garden City, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Science and Engineering, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wing</LastName><ForeName>Yun Kwok</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>Li Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayes</LastName><ForeName>Joseph F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Division of Psychiatry, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Camden and Islington NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osborn</LastName><ForeName>David P J</ForeName><Initials>DPJ</Initials><AffiliationInfo><Affiliation>Division of Psychiatry, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Camden and Islington NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Wing Chung</ForeName><Initials>WC</Initials><Identifier Source="ORCID">0000-0002-3581-8895</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Xiaoyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Real-World Solutions, IQVIA, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Can</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Real-World Solutions, IQVIA, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Esther W</ForeName><Initials>EW</Initials><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Hong Kong Shenzhen Institute of Research and Innovation, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>Ivan C H</ForeName><Initials>ICH</Initials><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fortin</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Observation Health Data Analytics, Janssen Research &amp; Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kern</LastName><ForeName>David M</ForeName><Initials>DM</Initials><Identifier Source="ORCID">0000-0001-5417-3925</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Janssen Research &amp; Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Dong Yun</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Jae-Won</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Neurology, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Real-World Solutions, IQVIA, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seager</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Real-World Solutions, IQVIA, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Wallis C Y</ForeName><Initials>WCY</Initials><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Ian C K</ForeName><Initials>ICK</Initials><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Epidemiol Psychiatr Sci</MedlineTA><NlmUniqueID>101561091</NlmUniqueID><ISSNLinking>2045-7960</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="N">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001008" MajorTopicYN="N">Anxiety Disorders</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">mental health</Keyword><Keyword MajorTopicYN="N">psychiatric disorder</Keyword></KeywordList><CoiStatement>K. Man reports grants from the CW Maplethorpe Fellowship, National Institute of Health Research, UK, Hong Kong Research Grant Council and the European Commission Horizon 2020 Framework, personal fees from IQVIA and grants from Amgen and GlaxoSmithKline, outside the submitted work; H. Luo reports grants from Research Grants Council of Hong Kong, outside the submitted work; J. Hayes reports grants from UKRI, NIHR UCLH Biomedical Research Centre, and Wellcome Trust and Consultancy Fees from Wellcome Trust and juli Health, outside the submitted work; E. Chan reports grants from Research Grants Council of Hong Kong, Research Fund Secretariat of the Food and Health Bureau of Hong Kong, National Natural Science Fund of China, Wellcome Trust, Bayer, Bristol-Myers Squibb, Pfizer, Janssen, Amgen, Takeda and Narcotics Division of the Security Bureau of Hong Kong; honorarium from Hospital Authority; outside the submitted work; S. Fortin is an employee of Johnson and Johnson and owns stock in Johnson and Johnson; D. Kern is an employee of Janssen R&amp;D, a subsidiary of Johnson and Johnson, and owns stock in Johnson and Johnson; W. Lau reports receiving grants from AIR@InnoHK administered by the Innovation and Technology Commission of Hong Kong outside the submitted work; I. Wong reports grants from Amgen, Bristol-Myers Squibb, Pfizer, Janssen, Bayer, GSK and Novartis, the Hong Kong RGC, and the Hong Kong Health and Medical Research Fund in Hong Kong, National Institute for Health Research in England, European Commission, National Health and Medical Research Council in Australia, consulting fees from IQVIA, payment for expert testimony and is an independent non-executive director of Jacobson Medical in Hong Kong, outside of the submitted work; no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>4</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>3</Day><Hour>23</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38433286</ArticleId><ArticleId IdType="pmc">PMC10940053</ArticleId><ArticleId IdType="doi">10.1017/S2045796024000088</ArticleId><ArticleId IdType="pii">S2045796024000088</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmed N, Barnett P, Greenburgh A, Pemovska T, Stefanidou T, Lyons N, Ikhtabi S, Talwar S, Francis ER, Harris SM, Shah P, Machin K, Jeffreys S, Mitchell L, Lynch C, Foye U, Schlief M, Appleton R, Saunders KRK, Baldwin H, Allan SM, Sheridan-Rains L, Kharboutly O, Kular A, Goldblatt P, Stewart R, Kirkbride JB, Lloyd-Evans B and Johnson S (2023) Mental health in Europe during the COVID-19 pandemic: A systematic review. The Lancet Psychiatry 10(7), 537&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10259832</ArticleId><ArticleId IdType="pubmed">37321240</ArticleId></ArticleIdList></Reference><Reference><Citation>Aknin LB, De Neve JE, Dunn EW, Fancourt DE, Goldberg E, Helliwell JF, Jones SP, Karam E, Layard R, Lyubomirsky S, Rzepa A, Saxena S, Thornton EM, VanderWeele TJ, Whillans AV, Zaki J, Karadag O and Ben Amor Y (2022) Mental health during the first year of the COVID-19 pandemic: A review and recommendations for moving forward. Perspectives on Psychological Science 17(4), 915&#x2013;936.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9274782</ArticleId><ArticleId IdType="pubmed">35044275</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson KN, Radhakrishnan L, Lane RI, Sheppard M, DeVies J, Azondekon R, Smith AR, Bitsko RH, Hartnett KP, Lopes-Cardozo B, Leeb RT, van Santen KL, Carey K, Crossen S, Dias TP, Wotiz S, Adjemian J, Rodgers L, Njai R and Thomas C (2022) Changes and inequities in adult mental health&#x2013;related emergency department visits during the COVID-19 pandemic in the US. JAMA Psychiatry 79(5), 475&#x2013;485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8928092</ArticleId><ArticleId IdType="pubmed">35293958</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaskaran K, Gasparrini A, Hajat S, Smeeth L and Armstrong B (2013) Time series regression studies in environmental epidemiology. International Journal of Epidemiology 42(4), 1187&#x2013;1195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3780998</ArticleId><ArticleId IdType="pubmed">23760528</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohlken J, Kostev K, Riedel-Heller S, Hoffmann W and Michalowsky B (2021) Effect of the COVID-19 pandemic on stress, anxiety, and depressive disorders in German primary care: A cross-sectional study. Journal of Psychiatric Research 143, 43&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8522351</ArticleId><ArticleId IdType="pubmed">34450524</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr MJ, Steeg S, Webb RT, Kapur N, Chew-Graham CA, Abel KM, Hope H, Pierce M and Ashcroft DM (2021) Effects of the COVID-19 pandemic on primary care-recorded mental illness and self-harm episodes in the UK: A population-based cohort study. The Lancet Public Health 6(2), e124&#x2013;e135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7843955</ArticleId><ArticleId IdType="pubmed">33444560</ArticleId></ArticleIdList></Reference><Reference><Citation>C&#xe9;nat JM, Blais-Rochette C, Kokou-Kpolou CK, Noorishad PG, Mukunzi JN, McIntee SE, Dalexis RD, Goulet MA and Labelle PR (2021) Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress disorder, and psychological distress among populations affected by the COVID-19 pandemic: A systematic review and meta-analysis. Psychiatry Research 295, 113599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7689353</ArticleId><ArticleId IdType="pubmed">33285346</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai Y, Luo H, Wong GHY, Tang JYM, Lam TC, Wong ICK and Yip PSF (2020) Risk of self-harm after the diagnosis of psychiatric disorders in Hong Kong, 2000&#x2013;10: A nested case-control study. The Lancet Psychiatry 7(2), 135&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">31974072</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Domenico L, Pullano G, Sabbatini CE, Bo&#xeb;lle P-Y and Colizza V (2020) Impact of lockdown on COVID-19 epidemic in &#xce;le-de-France and possible exit strategies. BMC Medicine 18(1), 240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391016</ArticleId><ArticleId IdType="pubmed">32727547</ArticleId></ArticleIdList></Reference><Reference><Citation>Gooden TE, Gardner M, Wang J, Chandan JS, Beane A, Haniffa R, Taylor S, Greenfield S, Manaseki-Holland S, Thomas GN and Nirantharakumar K (2022) The risk of mental illness in people living with HIV in the UK: A propensity score-matched cohort study. The Lancet HIV 9(3), e172&#x2013;e181.</Citation><ArticleIdList><ArticleId IdType="pubmed">35123667</ArticleId></ArticleIdList></Reference><Reference><Citation>Hale T, Angrist N, Goldszmidt R, Kira B, Petherick A, Phillips T, Webster S, Cameron-Blake E, Hallas L, Majumdar S and Tatlow H (2021) A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker). Nature Human Behaviour 5(4), 529&#x2013;538.</Citation><ArticleIdList><ArticleId IdType="pubmed">33686204</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong IC, Rijnbeek PR, van der Lei J, Pratt N, Nor&#xe9;n GN, Li YC, Stang PE, Madigan D and Ryan PB (2015) Observational Health Data Sciences and Informatics (OHDSI): Opportunities for observational researchers. Studies in Health Technology and Informatics 216, 574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaehn P, Holmberg C, Uhlenbrock G, Pohl A, Finkenzeller T, Pawlik MT, Quack I, Ernstberger A, Rockmann F and Schreyer AG (2021) Differential trends of admissions in accident and emergency departments during the COVID-19 pandemic in Germany. BMC Emergency Medicine 21(1), 42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8022298</ArticleId><ArticleId IdType="pubmed">33823795</ArticleId></ArticleIdList></Reference><Reference><Citation>Jouaville SL, Miotti H, Coffin G, Sarfati B and Meihoc A (2015) Validity and limitations of the longitudinal patient database France for use in pharmacoepidemiological and pharmacoeconomics studies. Value in Health 18(3), A18.</Citation></Reference><Reference><Citation>Kisely S, Scott A, Denney J and Simon G (2006) Duration of untreated symptoms in common mental disorders: Association with outcomes: International study. British Journal of Psychiatry 189(1), 79&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">16816310</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostka K, Duarte-Salles T, Prats-Uribe A, Sena AG, Pistillo A, Khalid S, Lai LYH, Golozar A, Alshammari TM, Dawoud DM, Nyberg F, Wilcox AB, Andryc A, Williams A, Ostropolets A, Areia C, Jung CY, Harle CA, Reich CG, Blacketer C, Morales DR, Dorr DA, Burn E, Roel E, Tan EH, Minty E, DeFalco F, de Maeztu G, Lipori G, Alghoul H, Zhu H, Thomas JA, Bian J, Park J, Mart&#xed;nez Rold&#xe1;n J, Posada JD, Banda JM, Horcajada JP, Kohler J, Shah K, Natarajan K, Lynch KE, Liu L, Schilling LM, Recalde M, Spotnitz M, Gong M, Matheny ME, Valveny N, Weiskopf NG, Shah N, Alser O, Casajust P, Park RW, Schuff R, Seager S, DuVall SL, You SC, Song S, Fern&#xe1;ndez-Bertol&#xed;n S, Fortin S, Magoc T, Falconer T, Subbian V, Huser V, Ahmed WU, Carter W, Guan Y, Galvan Y, He X, Rijnbeek PR, Hripcsak G, Ryan PB, Suchard MA and Prieto-Alhambra D (2022) Unraveling COVID-19: A large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS. Journal of Clinical Epidemiology 22(14), 369&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8957305</ArticleId><ArticleId IdType="pubmed">35345821</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai EC, Ryan P, Zhang Y, Schuemie M, Hardy NC, Kamijima Y, Kimura S, Kubota K, Man KK, Cho SY, Park RW, Stang P, Su CC, Wong IC, Kao YY and Setoguchi S (2018) Applying a common data model to Asian databases for multinational pharmacoepidemiologic studies: Opportunities and challenges. Clinical Epidemiology 10, 875&#x2013;885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6067778</ArticleId><ArticleId IdType="pubmed">30100761</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau WCY, Torre CO, Man KKC, Stewart HM, Seager S, Van Zandt M, Reich C, Li J, Brewster J, Lip GYH, Hingorani AD, Wei L and Wong ICK (2022) Comparative effectiveness and safety between apixaban, dabigatran, edoxaban, and rivaroxaban among patients with atrial fibrillation: A multinational population-based cohort study. Annals of Internal Medicine 175(11), 1515&#x2013;1524.</Citation><ArticleIdList><ArticleId IdType="pubmed">36315950</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Ostropolets A, Makadia R, Shoaibi A, Rao G, Sena AG, Martinez-Hernandez E, Delmestri A, Verhamme K, Rijnbeek PR, Duarte-Salles T, Suchard MA, Ryan PB, Hripcsak G and Prieto-Alhambra D (2021) Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: Multinational network cohort study. BMJ 373, n1435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8193077</ArticleId><ArticleId IdType="pubmed">35727911</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H, Lau WCY, Chai Y, Torre CO, Howard R, Liu KY, Lin X, Yin C, Fortin S, Kern DM, Lee DY, Park RW, Jang J-W, Chui CSL, Li J, Reich C, Man KKC and Wong ICK (2023) Rates of antipsychotic drug prescribing among people living with dementia during the COVID-19 pandemic. JAMA Psychiatry 80(3), 211&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9878427</ArticleId><ArticleId IdType="pubmed">36696128</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansfield KE, Mathur R, Tazare J, Henderson AD, Mulick AR, Carreira H, Matthews AA, Bidulka P, Gayle A, Forbes H, Cook S, Wong AYS, Strongman H, Wing K, Warren-Gash C, Cadogan SL, Smeeth L, Hayes JF, Quint JK, McKee M and Langan SM (2021) Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: A population-based study. The Lancet Digital Health 3(4), e217&#x2013;e230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7985613</ArticleId><ArticleId IdType="pubmed">33612430</ArticleId></ArticleIdList></Reference><Reference><Citation>Miles DK, Stedman M and Heald AH (2021) &#x201c;Stay at Home, Protect the National Health Service, Save Lives&#x201d;: A cost benefit analysis of the lockdown in the United Kingdom. International Journal of Clinical Practice 75(3), e13674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7435525</ArticleId><ArticleId IdType="pubmed">32790942</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno C, Wykes T, Galderisi S, Nordentoft M, Crossley N, Jones N, Cannon M, Correll CU, Byrne L, Carr S, Chen EYH, Gorwood P, Johnson S, K&#xe4;rkk&#xe4;inen H, Krystal JH, Lee J, Lieberman J, L&#xf3;pez-Jaramillo C, M&#xe4;nnikk&#xf6; M, Phillips MR, Uchida H, Vieta E, Vita A and Arango C (2020) How mental health care should change as a consequence of the COVID-19 pandemic. The Lancet Psychiatry 7(9), 813&#x2013;824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7365642</ArticleId><ArticleId IdType="pubmed">32682460</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulholland RH, Wood R, Stagg HR, Fischbacher C, Villacampa J, Simpson CR, Vasileiou E, McCowan C, Stock SJ, Docherty AB, Ritchie LD, Agrawal U, Robertson C, Murray JLK, MacKenzie F and Sheikh A (2020) Impact of COVID-19 on accident and emergency attendances and emergency and planned hospital admissions in Scotland: An interrupted time-series analysis. Journal of the Royal Society of Medicine 113(11), 444&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7686524</ArticleId><ArticleId IdType="pubmed">33012218</ArticleId></ArticleIdList></Reference><Reference><Citation>Nourazari S, Davis SR, Granovsky R, Austin R, Straff DJ, Joseph JW and Sanchez LD (2021) Decreased hospital admissions through emergency departments during the COVID-19 pandemic. The American Journal of Emergency Medicine 42, 203&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7676321</ArticleId><ArticleId IdType="pubmed">33279331</ArticleId></ArticleIdList></Reference><Reference><Citation>Nu&#xf1;ez JH, Sallent A, Lakhani K, Guerra-Farfan E, Vidal N, Ekhtiari S and Minguell J (2020) Impact of the COVID-19 pandemic on an emergency traumatology service: Experience at a tertiary trauma centre in Spain. Injury 51(7), 1414&#x2013;1418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7219366</ArticleId><ArticleId IdType="pubmed">32405089</ArticleId></ArticleIdList></Reference><Reference><Citation>Percudani M, Corradin M, Moreno M, Indelicato A and Vita A (2020) Mental health services in Lombardy during COVID-19 outbreak. Psychiatry Research 288, 112980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7152889</ArticleId><ArticleId IdType="pubmed">32315881</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin P (2011) The impact of psychiatric illness on suicide: Differences by diagnosis of disorders and by sex and age of subjects. Journal of Psychiatric Research 45(11), 1445&#x2013;1452.</Citation><ArticleIdList><ArticleId IdType="pubmed">21722920</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team (2022) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.</Citation></Reference><Reference><Citation>Rennert-May E, Leal J, Thanh NX, Lang E, Dowling S, Manns B, Wasylak T and Ronksley PE (2021) The impact of COVID-19 on hospital admissions and emergency department visits: A population-based study. PLoS One 16(6), e0252441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168854</ArticleId><ArticleId IdType="pubmed">34061888</ArticleId></ArticleIdList></Reference><Reference><Citation>Santomauro DF, Mantilla Herrera AM, Shadid J, Zheng P, Ashbaugh C, Pigott DM, Abbafati C, Adolph C, Amlag JO, Aravkin AY, Bang-Jensen BL, Bertolacci GJ, Bloom SS, Castellano R, Castro E, Chakrabarti S, Chattopadhyay J, Cogen RM, Collins JK, Dai X, Dangel WJ, Dapper C, Deen A, Erickson M, Ewald SB, Flaxman AD, Frostad JJ, Fullman N, Giles JR, Giref AZ, Guo G, He J, Helak M, Hulland EN, Idrisov B, Lindstrom A, Linebarger E, Lotufo PA, Lozano R, Magistro B, Malta DC, M&#xe5;nsson JC, Marinho F, Mokdad AH, Monasta L, Naik P, Nomura S, O&#x2019;Halloran JK, Ostroff SM, Pasovic M, Penberthy L, Reiner RC Jr, Reinke G, Ribeiro ALP, Sholokhov A, Sorensen RJD, Varavikova E, Vo AT, Walcott R, Watson S, Wiysonge CS, Zigler B, Hay SI, Vos T, Murray CJL, Whiteford HA and Ferrari AJ (2021) Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet 398(10312), 1700&#x2013;1712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500697</ArticleId><ArticleId IdType="pubmed">34634250</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaramuzza A, Tagliaferri F, Bonetti L, Soliani M, Morotti F, Bellone S, Cavalli C and Rabbone I (2020) Changing admission patterns in paediatric emergency departments during the COVID-19 pandemic. Archives of Disease in Childhood 105(7), 704.</Citation><ArticleIdList><ArticleId IdType="pubmed">32461213</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheridan Rains L, Johnson S, Barnett P, Steare T, Needle JJ, Carr S, Lever Taylor B, Bentivegna F, Edbrooke-Childs J, Scott HR, Rees J, Shah P, Lomani J, Chipp B, Barber N, Dedat Z, Oram S, Morant N, Simpson A, Papamichail A, Moore A, Jeffery A, De Estrada BS-MD, Hallam B, Lloyd-Evans B, Contreras CY, Serna CE, Ntephe C, Lamirel D, Cooke E, Pearce E, Lemmel F, Koutsoubelis F, Cragnolini G, Harju-Sepp&#xe4;nen J, Wang J, Botham J, Abdou K, Krause K, Turner KJ, Poursanidou K, Gruenwald L, Jagmetti L, Mazzocchi L, Tomaskova M, Montagnese M, Mah&#xe9; M, Schlief M, G&#xfc;nak MM, Leverton M, Lyons N, Vera N, Gao Q, Griffiths R, Lane R, Busato R, Ledden S, Mac-Ginty S, Hardt S, Orlando S, Gillard S, Jeynes T, Ondru&#x161;kov&#xe1; T, Stefanidou T, Foye U, Tzouvara V and Cavero V and The C-MHPRUG (2021) Early impacts of the COVID-19 pandemic on mental health care and on people with mental health conditions: Framework synthesis of international experiences and responses. Social Psychiatry &amp; Psychiatric Epidemiology 56(1), 13&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429938</ArticleId><ArticleId IdType="pubmed">32804258</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Wu Y, Fan S, Dal Santo T, Li L, Jiang X, Li K, Wang Y, Tasleem A, Krishnan A, He C, Bonardi O, Boruff JT, Rice DB, Markham S, Levis B, Azar M, Thombs-Vite I, Neupane D, Agic B, Fahim C, Martin MS, Sockalingam S, Turecki G, Benedetti A and Thombs BD (2023) Comparison of mental health symptoms before and during the covid-19 pandemic: Evidence from a systematic review and meta-analysis of 134 cohorts. BMJ 380, e074224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9992728</ArticleId><ArticleId IdType="pubmed">36889797</ArticleId></ArticleIdList></Reference><Reference><Citation>Troglio da Silva FC and Neto MLR (2021) Psychiatric disorders in health professionals during the COVID-19 pandemic: A systematic review with meta-analysis. Journal of Psychiatric Research 140, 474&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7990799</ArticleId><ArticleId IdType="pubmed">34153902</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner SL, Forbes AB, Karahalios A, Taljaard M and McKenzie JE (2021a) Evaluation of statistical methods used in the analysis of interrupted time series studies: A simulation study. BMC Medical Research Methodology 21(1), 181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8403376</ArticleId><ArticleId IdType="pubmed">34454418</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM and McKenzie JE (2021b) Comparison of six statistical methods for interrupted time series studies: Empirical evaluation of 190 published series. BMC Medical Research Methodology 21(1), 134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8235830</ArticleId><ArticleId IdType="pubmed">34174809</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams R, Jenkins DA, Ashcroft DM, Brown B, Campbell S, Carr MJ, Cheraghi-sohi S, Kapur N, Thomas O, Webb RT and Peek N (2020) Diagnosis of physical and mental health conditions in primary care during the COVID-19 pandemic: A retrospective cohort study. The Lancet Public Health 5(10), e543&#x2013;e550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7511209</ArticleId><ArticleId IdType="pubmed">32979305</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (2022) WHO coronavirus (COVID-19) dashboard. https://covid19.who.int/data (accessed 1
April
2023).</Citation></Reference><Reference><Citation>Wu T, Jia X, Shi H, Niu J, Yin X, Xie J and Wang X (2021) Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis. Journal of Affective Disorders 281, 91&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7710473</ArticleId><ArticleId IdType="pubmed">33310451</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang YT, Zhao YJ, Liu ZH, Li XH, Zhao N, Cheung T and Ng CH (2020) The COVID-19 outbreak and psychiatric hospitals in China: Managing challenges through mental health service reform. International Journal of Biological Sciences 16(10), 1741&#x2013;1744.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7098035</ArticleId><ArticleId IdType="pubmed">32226293</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong J, Lipsitz O, Nasri F, Lui LMW, Gill H, Phan L, Chen-Li D, Iacobucci M, Ho R, Majeed A and McIntyre RS (2020) Impact of COVID-19 pandemic on mental health in the general population: A systematic review. Journal of Affective Disorders 277, 55&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7413844</ArticleId><ArticleId IdType="pubmed">32799105</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38472144</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>19</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Markov modeling for cost-effectiveness using federated health data network.</ArticleTitle><Pagination><StartPage>1093</StartPage><EndPage>1101</EndPage><MedlinePgn>1093-1101</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocae044</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To introduce 2 R-packages that facilitate conducting health economics research on OMOP-based data networks, aiming to standardize and improve the reproducibility, transparency, and transferability of health economic models.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We developed the software tools and demonstrated their utility by replicating a UK-based heart failure data analysis across 5 different international databases from Estonia, Spain, Serbia, and the United States.</AbstractText><AbstractText Label="RESULTS">We examined treatment trajectories of 47 163 patients. The overall incremental cost-effectiveness ratio (ICER) for telemonitoring relative to standard of care was 57 472 &#x20ac;/QALY. Country-specific ICERs were 60 312 &#x20ac;/QALY in Estonia, 58 096 &#x20ac;/QALY in Spain, 40 372 &#x20ac;/QALY in Serbia, and 90 893 &#x20ac;/QALY in the US, which surpassed the established willingness-to-pay thresholds.</AbstractText><AbstractText Label="DISCUSSION">Currently, the cost-effectiveness analysis lacks standard tools, is performed in ad-hoc manner, and relies heavily on published information that might not be specific for local circumstances. Published results often exhibit a narrow focus, central to a single site, and provide only partial decision criteria, limiting their generalizability and comprehensive utility.</AbstractText><AbstractText Label="CONCLUSION">We created 2 R-packages to pioneer cost-effectiveness analysis in OMOP CDM data networks. The first manages state definitions and database interaction, while the second focuses on Markov model learning and profile synthesis. We demonstrated their utility in a multisite heart failure study, comparing telemonitoring and standard care, finding telemonitoring not cost-effective.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haug</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0935-3307</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Tartu 51009, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oja</LastName><ForeName>Marek</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3650-8194</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Tartu 51009, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pajusalu</LastName><ForeName>Maarja</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Tartu 51009, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mooses</LastName><ForeName>Kerli</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Tartu 51009, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reisberg</LastName><ForeName>Sulev</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6835-9632</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Tartu 51009, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vilo</LastName><ForeName>Jaak</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5604-4107</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Tartu 51009, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gim&#xe9;nez</LastName><ForeName>Antonio Fern&#xe1;ndez</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Biomedical Research Institute, IIS INCLIVA, Valencia 46010, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Columbia University Irving Medical Center, New York, NY 10032, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danilovi&#x107;</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>KBC Zvezdara, Belgrade 11000, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maljkovic</LastName><ForeName>Filip</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Health Information Systems, Heliant, Belgrade 11000, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawoud</LastName><ForeName>Dalia</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Institute for Health and Care Excellence, London WC1V 6NA, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolde</LastName><ForeName>Raivo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Tartu 51009, Estonia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PRG1844</GrantID><Agency>Estonian Research Council</Agency><Country/></Grant><Grant><GrantID>RITA 1/02-120</GrantID><Agency>European Regional Development Fund</Agency><Country/></Grant><Grant><Agency>European Social Fund</Agency><Country/></Grant><Grant><Agency>European Union's Horizon 2020</Agency><Country/></Grant><Grant><Agency>European Federation of Pharmaceutical Industries and Associations</Agency><Country/></Grant><Grant><GrantID>806968</GrantID><Agency>European Regional Development Fund</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094703" MajorTopicYN="Y">Cost-Effectiveness Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018803" MajorTopicYN="N">Models, Economic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008390" MajorTopicYN="N">Markov Chains</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Markov chains</Keyword><Keyword MajorTopicYN="N">OHDSI CDM</Keyword><Keyword MajorTopicYN="N">cost-effectiveness</Keyword><Keyword MajorTopicYN="N">observational data</Keyword><Keyword MajorTopicYN="N">treatment trajectories</Keyword></KeywordList><CoiStatement>There is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>13</Day><Hour>0</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38472144</ArticleId><ArticleId IdType="pmc">PMC11031209</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocae044</ArticleId><ArticleId IdType="pii">7627292</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kobelt G. Health Economics: An Introduction to Economic Evaluation. 3rd ed. OHE Monograph; 2013.</Citation></Reference><Reference><Citation>Romeu J. A Markov chain model for Covid-19 survival analysis; 2020. Accessed January 31, 2024. 10.13140/RG.2.2.36349.18408</Citation><ArticleIdList><ArticleId IdType="doi">10.13140/RG.2.2.36349.18408</ArticleId></ArticleIdList></Reference><Reference><Citation>Soper B, Nyg&#xe5;rd M, Abdulla G, et al.A hidden Markov model for population-level cervical cancer screening data. Stat Med. 2020;39(25):3569-3590.</Citation><ArticleIdList><ArticleId IdType="pubmed">32854166</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S, Dang D, Wang W, et al.Concentration optimization of combinatorial drugs using Markov chain-based models. BMC Bioinformatics. 2021;22(1):451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8456646</ArticleId><ArticleId IdType="pubmed">34548014</ArticleId></ArticleIdList></Reference><Reference><Citation>Thokala P, Dodd P, Baalbaki H, et al.Developing Markov models from real-world data: a case study of heart failure modeling using administrative data. Value Health. 2020;23(6):743-750.</Citation><ArticleIdList><ArticleId IdType="pubmed">32540232</ArticleId></ArticleIdList></Reference><Reference><Citation>Burcu M, Dreyer NA, Franklin JM, et al.Real-world evidence to support regulatory decision-making for medicines: considerations for external control arms. Pharmacoepidemiol Drug Saf. 2020;29(10):1228-1235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7687199</ArticleId><ArticleId IdType="pubmed">32162381</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent S, Burn E, Dawoud D, et al.Common problems, common data model solutions: evidence generation for health technology assessment. Pharmacoeconomics. 2021;39(3):275-285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7746423</ArticleId><ArticleId IdType="pubmed">33336320</ArticleId></ArticleIdList></Reference><Reference><Citation>Cave A, Kurz X, Arlett P.. Real-world data for regulatory decision making: challenges and possible solutions for Europe. Clin Pharmacol Ther. 2019;106(1):36-39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6617710</ArticleId><ArticleId IdType="pubmed">30970161</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SV, Sreedhara SK, Schneeweiss S; REPEAT Initiative Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions. Nat Commun. 2022;13(1):5126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9430007</ArticleId><ArticleId IdType="pubmed">36045130</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub WS, Cohen DJ.. The limits of cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes. 2009;2(1):55-58.</Citation><ArticleIdList><ArticleId IdType="pubmed">20031813</ArticleId></ArticleIdList></Reference><Reference><Citation>Husereau D, Drummond M, Augustovski F, et al.Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. Int J Technol Assess Health Care. 2022;25(1):3-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">35007499</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaksa A, Arena PJ, Chan KKW, et al.Transferability of real-world data across borders for regulatory and health technology assessment decision-making. Front Med (Lausanne). 2022;9:1073678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9709526</ArticleId><ArticleId IdType="pubmed">36465931</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al.Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574-578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinecke I, Zoch M, Reich C, et al.The usage of OHDSI OMOP&#x2014;a scoping review. Stud Health Technol Inform. 2021;283:95-103.</Citation><ArticleIdList><ArticleId IdType="pubmed">34545824</ArticleId></ArticleIdList></Reference><Reference><Citation>
OHDSI. The book of OHDSI: observational health data sciences and informatics; 2021. Accessed January 31, 2024. https://ohdsi.github.io/TheBookOfOhdsi/</Citation></Reference><Reference><Citation>
European Medicines Agency. HMA-EMA Joint Big Data Taskforce Phase II report: evolving data-driven regulation; 2020. Accessed January 31, 2024. https://www.ema.europa.eu/en/documents/other/hma-ema-joint-big-data-taskforce-phase-ii-report-evolving-data-driven-regulation_en.pdf</Citation></Reference><Reference><Citation>Incerti D, Jansen JP. Hesim: health economic simulation modeling and decision analysis; 2021. Accessed January 31, 2024. 10.48550/arXiv.2102.09437</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2102.09437</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C. Multi-state models for panel data: the msm Package for R. J Stat Softw. 2011;38(8):1-29.</Citation></Reference><Reference><Citation>
Haug M. Cohort2Trajectory, v1.1.3. GitHub; 2023. Accessed January 31, 2024. https://github.com/HealthInformaticsUT/Cohort2Trajectory/releases/tag/v1.1.3</Citation></Reference><Reference><Citation>
Haug M. TrajectoryMarkovAnalysis, v1.0.5. GitHub; 2023. Accessed January 31, 2024. https://github.com/HealthInformaticsUT/TrajectoryMarkovAnalysis/releases/tag/v1.0.5</Citation></Reference><Reference><Citation>
Haug M. HeartFailureTrajectoryCostStudy. GitHub; 2023. Accessed January 31, 2024. https://github.com/HealthInformaticsUT/HeartFailureTrajectoryCostStudy</Citation></Reference><Reference><Citation>Rosa C, Ito M, Vieira A, et al. Modelling and mining of patient pathways: a scoping review; 2022. Accessed January 31, 2024. 10.48550/arXiv.2206.01980</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2206.01980</ArticleId></ArticleIdList></Reference><Reference><Citation>Markus AF, Verhamme KMC, Kors JA, et al.TreatmentPatterns: an R package to facilitate the standardized development and analysis of treatment patterns across disease domains. Comput Methods Programs Biomed. 2022;225:107081.</Citation><ArticleIdList><ArticleId IdType="pubmed">36084453</ArticleId></ArticleIdList></Reference><Reference><Citation>
Pajusalu M. TrajectoryViz. GitHub; 2022. Accessed January 31, 2024. https://github.com/HealthInformaticsUT/TrajectoryViz</Citation></Reference><Reference><Citation>Norris J. Markov chains. Cambridge University Press; 1998;55-56.</Citation></Reference><Reference><Citation>Schoenfeld D. The asymptotic properties of nonparametric tests for comparing survival distributions. Biometrika. 1981;68(1):316-319.</Citation></Reference><Reference><Citation>Pandor A, Thokala P, Gomersall T, et al.Home telemonitoring or structured telephone support programmes aper recent discharge in patients with heart failure: systematic review and economic evaluation. Health Technol Assess. 2013;17(32):1-207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4781365</ArticleId><ArticleId IdType="pubmed">23927840</ArticleId></ArticleIdList></Reference><Reference><Citation>OECD Data Warehouse. OECD.Stat (Database); 2023. Accessed January 31, 2024. 10.1787/data-00900-en</Citation><ArticleIdList><ArticleId IdType="doi">10.1787/data-00900-en</ArticleId></ArticleIdList></Reference><Reference><Citation>The Government of the Republic of Estonia. List of healthcare services of the Estonian Health Insurance Fund. Riigi Teataja; 2021.</Citation></Reference><Reference><Citation>
Estonian Health Insurance Fund. Cost-effectiveness and medical insurance budget impact assessment &#x201c;Telemetric ECG monitoring&#x201d;; 2019. Accessed January 31, 2024. https://www.tervisekassa.ee/sites/default/files/TTL/2019/1377_KTH_2019_avalik.pdf</Citation></Reference><Reference><Citation>Edejer TTT, Baltussen R, Adam T, et al., eds. Making Choices in Health: WHO Guide to Cost Effectiveness Analysis. World Health Organization; 2003;237-259.</Citation></Reference><Reference><Citation>
Pokrovski M, et al. Summary of the meeting of the committee on the list of health care services. Estonian Health Insurance Fund; 2019. Accessed January 31, 2024. https://www.tervisekassa.ee/sites/default/files/TTL/2019/TTL_komisjon_20191009_protokoll.pdf</Citation></Reference><Reference><Citation>Vallejo-Torres L, Garc&#xed;a-Lorenzo B, Serrano-Aguilar P.. Estimating a cost-effectiveness threshold for the Spanish NHS. Health Econ. 2018;27(4):746-761.</Citation><ArticleIdList><ArticleId IdType="pubmed">29282798</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmier JK, Ong KL, Fonarow GC.. Cost-effectiveness of remote cardiac monitoring with the CardioMEMS Heart Failure System. Clin Cardiol. 2017;40(7):430-436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6490396</ArticleId><ArticleId IdType="pubmed">28272808</ArticleId></ArticleIdList></Reference><Reference><Citation>Naugler C, Church DL.. Automation and artificial intelligence in the clinical laboratory. Crit Rev Clin Lab Sci. 2019;56(2):98-110.</Citation><ArticleIdList><ArticleId IdType="pubmed">30922144</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilberberg MD, Shorr AF.. Understanding cost-effectiveness. Clin Microbiol Infect. 2010;16(12):1707-1712.</Citation><ArticleIdList><ArticleId IdType="pubmed">20673258</ArticleId></ArticleIdList></Reference><Reference><Citation>Nidhi G, Rohan V, Radha KD, et al.Cost-effectiveness analysis and decision modelling: a tutorial for clinicians. J Clin Exp Hepatol. 2020;10(2):177-184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7068010</ArticleId><ArticleId IdType="pubmed">32189934</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaeli DT, Michaeli JC, Boch T, et al.Cost-effectiveness of lipid-lowering therapies for cardiovascular prevention in Germany. Cardiovasc Drugs Ther. 2023;37(4):683-694.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10397126</ArticleId><ArticleId IdType="pubmed">35015186</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Zhang C, Gu ZC.. Cost-effectiveness analysis of direct oral anticoagulants vs. Vitamin k antagonists in the elderly with atrial fibrillation: insights from the evidence in a real-world setting. Front Cardiovasc Med. 2021;8:675200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8275875</ArticleId><ArticleId IdType="pubmed">34268343</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38501749</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1751-7176</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of clinical hypertension (Greenwich, Conn.)</Title><ISOAbbreviation>J Clin Hypertens (Greenwich)</ISOAbbreviation></Journal><ArticleTitle>Comparative safety and effectiveness of angiotensin converting enzyme inhibitors and thiazides and thiazide-like diuretics under strict monotherapy.</ArticleTitle><Pagination><StartPage>425</StartPage><EndPage>430</EndPage><MedlinePgn>425-430</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jch.14793</ELocationID><Abstract><AbstractText>Previous work comparing safety and effectiveness outcomes for new initiators of angiotensin converting-enzyme inhibitors (ACEi) and thiazides demonstrated more favorable outcomes for thiazides, although cohort definitions allowed for addition of a second antihypertensive medication after a week of monotherapy. Here, we modify the monotherapy definition, imposing exit from cohorts upon addition of another antihypertensive medication. We determine hazard ratios (HR) for 55 safety and effectiveness outcomes over six databases and compare results to earlier findings. We find, for all primary outcomes, statistically significant differences in effectiveness between ACEi and thiazides were not replicated (HRs: 1.11, 1.06, 1.12 for acute myocardial infarction, hospitalization with heart failure and stroke, respectively). While statistical significance is similarly lost for several safety outcomes, the safety profile of thiazides remains more favorable. Our results indicate a less striking difference in effectiveness of thiazides compared to ACEi and reflect some sensitivity to the monotherapy cohort definition modification.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Anand</LastName><ForeName>Tara V</ForeName><Initials>TV</Initials><Identifier Source="ORCID">0000-0002-2551-867X</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bu</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Epidemiology, Johnson &amp; Johnson, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, US Department of Veterans Affairs, Salt Lake City, Utah, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL169954</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL169954</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM007079</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM007079</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Hypertens (Greenwich)</MedlineTA><NlmUniqueID>100888554</NlmUniqueID><ISSNLinking>1524-6175</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000959">Antihypertensive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004232">Diuretics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D049993">Sodium Chloride Symporter Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D049971">Thiazides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000806" MajorTopicYN="Y">Angiotensin-Converting Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000959" MajorTopicYN="N">Antihypertensive Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004232" MajorTopicYN="N">Diuretics</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049993" MajorTopicYN="N">Sodium Chloride Symporter Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049971" MajorTopicYN="N">Thiazides</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">angiotensin&#x2010;converting enzyme inhibitor</Keyword><Keyword MajorTopicYN="N">anti&#x2010;hypertensive therapy</Keyword><Keyword MajorTopicYN="N">comparative effectiveness</Keyword><Keyword MajorTopicYN="N">diuretic</Keyword><Keyword MajorTopicYN="N">hypertension</Keyword><Keyword MajorTopicYN="N">monotherapy</Keyword><Keyword MajorTopicYN="N">thiazide</Keyword></KeywordList><CoiStatement>M.J.S. is an employee of Johnson &amp; Johnson. M.A.S. has received grant funding from Janssen Research &amp; Development, a subsidiary of Johnson &amp; Johnson to support methods research not directly related to this study. Johnson &amp; Johnson and Janssen did not have input in the design, execution, interpretation of results or decision to publish. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>19</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>19</Day><Hour>8</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38501749</ArticleId><ArticleId IdType="pmc">PMC11007801</ArticleId><ArticleId IdType="doi">10.1111/jch.14793</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hripcsak G, Schuemie MJ, Madigan D. Drawing reproducible conclusions from observational clinical data with OHDSI. Yearb Med Inform. 2021;30(1):283&#x2010;289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8416226</ArticleId><ArticleId IdType="pubmed">33882595</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, et&#xa0;al. Comprehensive comparative effectiveness and safety of first&#x2010;line antihypertensive drug classes. Lancet. 2019;394(10211):1816&#x2010;1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Gruber S, et&#xa0;al. Empirical performance of a new user cohort method: lessons for developing a risk identification and analysis system. Drug Saf. 2013;36(1):S59&#x2010;S72. Suppl.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166224</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;n MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 2016;183(8):758&#x2010;764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4832051</ArticleId><ArticleId IdType="pubmed">26994063</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Schuemie MJ, Suchard MA. Evaluating large&#x2010;scale propensity score performance through real&#x2010;world and synthetic data experiments. Int J Epidemiol. 2018;47(6):2005&#x2010;2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et&#xa0;al. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2010;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41.</Citation></Reference><Reference><Citation>Walker AM, Patrick AR, Lauer MS, et&#xa0;al. A tool for assessing the feasibility of comparative effectiveness research. Comp Effect Res. 2013;3:11&#x2010;20.</Citation></Reference><Reference><Citation>Messerli FH, Nussberger J. Vasopeptidase inhibition and angio&#x2010;oedema. Lancet. 2000;356(9230):608&#x2010;660.</Citation><ArticleIdList><ArticleId IdType="pubmed">10968427</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38509500</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-244X</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>20</Day></PubDate></JournalIssue><Title>BMC psychiatry</Title><ISOAbbreviation>BMC Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Developing a clinical decision support system software prototype that assists in the management of patients with self-harm in the emergency department: protocol of the PERMANENS project.</ArticleTitle><Pagination><StartPage>220</StartPage><MedlinePgn>220</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">220</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12888-024-05659-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Self-harm presents a significant public health challenge. Emergency departments (EDs) are crucial healthcare settings in managing self-harm, but clinician uncertainty in risk assessment may contribute to ineffective care. Clinical Decision Support Systems (CDSSs) show promise in enhancing care processes, but their effective implementation in self-harm management remains unexplored.</AbstractText><AbstractText Label="METHODS">PERMANENS comprises a combination of methodologies and study designs aimed at developing a CDSS prototype that assists clinicians in the personalized assessment and management of ED patients presenting with self-harm. Ensemble prediction models will be constructed by applying machine learning techniques on electronic registry data from four sites, i.e., Catalonia (Spain), Ireland, Norway, and Sweden. These models will predict key adverse outcomes including self-harm repetition, suicide, premature death, and lack of post-discharge care. Available registry data include routinely collected electronic health record data, mortality data, and administrative data, and will be harmonized using the OMOP Common Data Model, ensuring consistency in terminologies, vocabularies and coding schemes. A clinical knowledge base of effective suicide prevention interventions will be developed rooted in a systematic review of clinical practice guidelines, including quality assessment of guidelines using the AGREE II tool. The CDSS software prototype will include a backend that integrates the prediction models and the clinical knowledge base to enable accurate patient risk stratification and subsequent intervention allocation. The CDSS frontend will enable personalized risk assessment and will provide tailored treatment plans, following a tiered evidence-based approach. Implementation research will ensure the CDSS' practical functionality and feasibility, and will include periodic meetings with user-advisory groups, mixed-methods research to identify currently unmet needs in self-harm risk assessment, and small-scale usability testing of the CDSS prototype software.</AbstractText><AbstractText Label="DISCUSSION">Through the development of the proposed CDSS software prototype, PERMANENS aims to standardize care, enhance clinician confidence, improve patient satisfaction, and increase treatment compliance. The routine integration of CDSS for self-harm risk assessment within healthcare systems holds significant potential in effectively reducing suicide mortality rates by facilitating personalized and timely delivery of effective interventions on a large scale for individuals at risk of suicide.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mortier</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hospital del Mar Research Institute, Barcelona Biomedical Research Park (PRBB), Carrer Doctor Aiguader, 88, 08003, Barcelona, Spain. pmortier@researchmar.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Epidemiology and Public Health, Carlos III Health Institute (CIBERESP, ISCIII), Madrid, Spain. pmortier@researchmar.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amigo</LastName><ForeName>Franco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hospital del Mar Research Institute, Barcelona Biomedical Research Park (PRBB), Carrer Doctor Aiguader, 88, 08003, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Epidemiology and Public Health, Carlos III Health Institute (CIBERESP, ISCIII), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhargav</LastName><ForeName>Madhav</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Public Health &amp; National Suicide Research Foundation, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conde</LastName><ForeName>Susana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital del Mar Research Institute, Barcelona Biomedical Research Park (PRBB), Carrer Doctor Aiguader, 88, 08003, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrer</LastName><ForeName>Montse</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital del Mar Research Institute, Barcelona Biomedical Research Park (PRBB), Carrer Doctor Aiguader, 88, 08003, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Epidemiology and Public Health, Carlos III Health Institute (CIBERESP, ISCIII), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flygare</LastName><ForeName>Oskar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, &amp; Stockholm Health Care Services, Region Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kizilaslan</LastName><ForeName>Busenur</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>National Centre for Suicide Research and Prevention, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latorre Moreno</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hospital del Mar Research Institute, Barcelona Biomedical Research Park (PRBB), Carrer Doctor Aiguader, 88, 08003, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leis</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Research Institute, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>Miguel Angel</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Research Institute, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez-Sola</LastName><ForeName>V&#xed;ctor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Neuropsychiatry and Drug Addiction Institute, Barcelona MAR Health Park Consortium PSMAR, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Mental Health and Carlos III Health Institute (CIBERSAM, ISCIII), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics, Obstetrics and Gynaecology and Preventive Medicine and Public Health Department, Universitat Aut&#xf2;noma de Barcelona (UAB), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Portillo-Van Diest</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital del Mar Research Institute, Barcelona Biomedical Research Park (PRBB), Carrer Doctor Aiguader, 88, 08003, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Epidemiology and Public Health, Carlos III Health Institute (CIBERESP, ISCIII), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram&#xed;rez-Anguita</LastName><ForeName>Juan Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Research Institute, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanz</LastName><ForeName>Ferran</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Research Institute, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Bioinformatics Institute - ELIXIR-ES (IMPaCT-Data-ISCIII), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vilagut</LastName><ForeName>Gemma</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital del Mar Research Institute, Barcelona Biomedical Research Park (PRBB), Carrer Doctor Aiguader, 88, 08003, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Epidemiology and Public Health, Carlos III Health Institute (CIBERESP, ISCIII), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alonso</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital del Mar Research Institute, Barcelona Biomedical Research Park (PRBB), Carrer Doctor Aiguader, 88, 08003, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Epidemiology and Public Health, Carlos III Health Institute (CIBERESP, ISCIII), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehlum</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>National Centre for Suicide Research and Prevention, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arensman</LastName><ForeName>Ella</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Public Health &amp; National Suicide Research Foundation, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bjureberg</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, &amp; Stockholm Health Care Services, Region Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastor</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Research Institute, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>National Centre for Suicide Research and Prevention, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AC22/00006; AC22/00045</GrantID><Agency>Instituto de Salud Carlos III (ISCIII) and by the European Union NextGenerationEU, Mecanismo para la Recuperaci&#xf3;n y la Resiliencia</Agency><Country/></Grant><Grant><GrantID>AC22/00006; AC22/00045</GrantID><Agency>Instituto de Salud Carlos III (ISCIII) and by the European Union NextGenerationEU, Mecanismo para la Recuperaci&#xf3;n y la Resiliencia</Agency><Country/></Grant><Grant><GrantID>AC22/00006; AC22/00045</GrantID><Agency>Instituto de Salud Carlos III (ISCIII) and by the European Union NextGenerationEU, Mecanismo para la Recuperaci&#xf3;n y la Resiliencia</Agency><Country/></Grant><Grant><GrantID>AC22/00006; AC22/00045</GrantID><Agency>Instituto de Salud Carlos III (ISCIII) and by the European Union NextGenerationEU, Mecanismo para la Recuperaci&#xf3;n y la Resiliencia</Agency><Country/></Grant><Grant><GrantID>AC22/00006; AC22/00045</GrantID><Agency>Instituto de Salud Carlos III (ISCIII) and by the European Union NextGenerationEU, Mecanismo para la Recuperaci&#xf3;n y la Resiliencia</Agency><Country/></Grant><Grant><GrantID>AC22/00006; AC22/00045</GrantID><Agency>Instituto de Salud Carlos III (ISCIII) and by the European Union NextGenerationEU, Mecanismo para la Recuperaci&#xf3;n y la Resiliencia</Agency><Country/></Grant><Grant><GrantID>AC22/00006; AC22/00045</GrantID><Agency>Instituto de Salud Carlos III (ISCIII) and by the European Union NextGenerationEU, Mecanismo para la Recuperaci&#xf3;n y la Resiliencia</Agency><Country/></Grant><Grant><GrantID>AC22/00006; AC22/00045</GrantID><Agency>Instituto de Salud Carlos III (ISCIII) and by the European Union NextGenerationEU, Mecanismo para la Recuperaci&#xf3;n y la Resiliencia</Agency><Country/></Grant><Grant><GrantID>AC22/00006; AC22/00045</GrantID><Agency>Instituto de Salud Carlos III (ISCIII) and by the European Union NextGenerationEU, Mecanismo para la Recuperaci&#xf3;n y la Resiliencia</Agency><Country/></Grant><Grant><GrantID>AC22/00006; AC22/00045</GrantID><Agency>Instituto de Salud Carlos III (ISCIII) and by the European Union NextGenerationEU, Mecanismo para la Recuperaci&#xf3;n y la Resiliencia</Agency><Country/></Grant><Grant><GrantID>AC22/00006; AC22/00045</GrantID><Agency>Instituto de Salud Carlos III (ISCIII) and by the European Union NextGenerationEU, Mecanismo para la Recuperaci&#xf3;n y la Resiliencia</Agency><Country/></Grant><Grant><GrantID>ESF+; CP21/00078</GrantID><Agency>ISCIII-FSE Miguel Servet co-funded by the European Social Fund Plus</Agency><Country/></Grant><Grant><GrantID>PI22/00107</GrantID><Agency>ISCIII and co-funded by the European Union</Agency><Country/></Grant><Grant><GrantID>PI22/00107</GrantID><Agency>ISCIII and co-funded by the European Union</Agency><Country/></Grant><Grant><GrantID>PI22/00107</GrantID><Agency>ISCIII and co-funded by the European Union</Agency><Country/></Grant><Grant><GrantID>202220-30-31</GrantID><Agency>Fundaci&#xf3;n la Marat&#xf3; de TV3</Agency><Country/></Grant><Grant><GrantID>202220-30-31</GrantID><Agency>Fundaci&#xf3;n la Marat&#xf3; de TV3</Agency><Country/></Grant><Grant><GrantID>202220-30-31</GrantID><Agency>Fundaci&#xf3;n la Marat&#xf3; de TV3</Agency><Country/></Grant><Grant><GrantID>202220-30-31</GrantID><Agency>Fundaci&#xf3;n la Marat&#xf3; de TV3</Agency><Country/></Grant><Grant><GrantID>202220-30-31</GrantID><Agency>Fundaci&#xf3;n la Marat&#xf3; de TV3</Agency><Country/></Grant><Grant><GrantID>202220-30-31</GrantID><Agency>Fundaci&#xf3;n la Marat&#xf3; de TV3</Agency><Country/></Grant><Grant><GrantID>202220-30-31</GrantID><Agency>Fundaci&#xf3;n la Marat&#xf3; de TV3</Agency><Country/></Grant><Grant><GrantID>202220-30-31</GrantID><Agency>Fundaci&#xf3;n la Marat&#xf3; de TV3</Agency><Country/></Grant><Grant><GrantID>FI23/00004</GrantID><Agency>PFIS ISCIII</Agency><Country/></Grant><Grant><GrantID>FI23/00004</GrantID><Agency>PFIS ISCIII</Agency><Country/></Grant><Grant><GrantID>SGR 00624</GrantID><Agency>the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya AGAUR 2021</Agency><Country/></Grant><Grant><GrantID>SGR 00624</GrantID><Agency>the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya AGAUR 2021</Agency><Country/></Grant><Grant><GrantID>SGR 00624</GrantID><Agency>the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya AGAUR 2021</Agency><Country/></Grant><Grant><GrantID>SGR 00624</GrantID><Agency>the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya AGAUR 2021</Agency><Country/></Grant><Grant><GrantID>SGR 00624</GrantID><Agency>the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya AGAUR 2021</Agency><Country/></Grant><Grant><GrantID>SGR 00624</GrantID><Agency>the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya AGAUR 2021</Agency><Country/></Grant><Grant><GrantID>SGR 00624</GrantID><Agency>the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya AGAUR 2021</Agency><Country/></Grant><Grant><GrantID>SGR 00624</GrantID><Agency>the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya AGAUR 2021</Agency><Country/></Grant><Grant><GrantID>CIBERESP; CB06/02/0046</GrantID><Agency>CIBER of Epidemiology &amp;amp; Public Health</Agency><Country/></Grant><Grant><GrantID>CIBERESP; CB06/02/0046</GrantID><Agency>CIBER of Epidemiology &amp;amp; Public Health</Agency><Country/></Grant><Grant><GrantID>CIBERESP; CB06/02/0046</GrantID><Agency>CIBER of Epidemiology &amp;amp; Public Health</Agency><Country/></Grant><Grant><GrantID>CIBERESP; CB06/02/0046</GrantID><Agency>CIBER of Epidemiology &amp;amp; Public Health</Agency><Country/></Grant><Grant><GrantID>CIBERESP; CB06/02/0046</GrantID><Agency>CIBER of Epidemiology &amp;amp; Public Health</Agency><Country/></Grant><Grant><GrantID>CIBERESP; CB06/02/0046</GrantID><Agency>CIBER of Epidemiology &amp;amp; Public Health</Agency><Country/></Grant><Grant><GrantID>ERAPERMED2022</GrantID><Agency>the Health Research Board Ireland</Agency><Country/></Grant><Grant><GrantID>ERAPERMED2022</GrantID><Agency>the Health Research Board Ireland</Agency><Country/></Grant><Grant><GrantID>no. 2022-00549</GrantID><Agency>the Swedish Innovation Agency</Agency><Country/></Grant><Grant><GrantID>no. 2022-00549</GrantID><Agency>the Swedish Innovation Agency</Agency><Country/></Grant><Grant><GrantID>project no. 342386</GrantID><Agency>the Research Council of Norway</Agency><Country/></Grant><Grant><GrantID>project no. 342386</GrantID><Agency>the Research Council of Norway</Agency><Country/></Grant><Grant><GrantID>project no. 342386</GrantID><Agency>the Research Council of Norway</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Psychiatry</MedlineTA><NlmUniqueID>100968559</NlmUniqueID><ISSNLinking>1471-244X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="Y">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000359" MajorTopicYN="N">Aftercare</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016728" MajorTopicYN="Y">Self-Injurious Behavior</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical decision support system</Keyword><Keyword MajorTopicYN="N">Hospital Emergency Service</Keyword><Keyword MajorTopicYN="N">Intentional self-harm</Keyword><Keyword MajorTopicYN="N">Knowledge bases user-Centred Design.</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Risk Assessment</Keyword><Keyword MajorTopicYN="N">Routinely Collected Health data</Keyword><Keyword MajorTopicYN="N">Suicide</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>21</Day><Hour>0</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38509500</ArticleId><ArticleId IdType="pmc">PMC10956300</ArticleId><ArticleId IdType="doi">10.1186/s12888-024-05659-6</ArticleId><ArticleId IdType="pii">10.1186/s12888-024-05659-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global Burden of Disease Collaborative Network. Global burden of disease study 2019 (GBD 2019) results. Seattle U S. Published Online First: 2019.</Citation></Reference><Reference><Citation>Ribeiro JD, Franklin JC, Fox KR, et al. Self-injurious thoughts and behaviors as risk factors for future suicide ideation, attempts, and death: a meta-analysis of longitudinal studies. Psychol Med. 2016;46:225&#x2013;36. doi: 10.1017/S0033291715001804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291715001804</ArticleId><ArticleId IdType="pmc">PMC4774896</ArticleId><ArticleId IdType="pubmed">26370729</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B-P, Lunde KB, Jia C-X, et al. The short-term rate of non-fatal and fatal repetition of deliberate self-harm: a systematic review and meta-analysis of longitudinal studies. J Affect Disord. 2020;273:597&#x2013;603. doi: 10.1016/j.jad.2020.05.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2020.05.072</ArticleId><ArticleId IdType="pubmed">32560959</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Swaraj S, Chung D, et al. Meta-analysis of suicide rates among people discharged from non&#x2010;psychiatric settings after presentation with suicidal thoughts or behaviours. Acta Psychiatr Scand. 2019;139:472&#x2013;83. doi: 10.1111/acps.13023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acps.13023</ArticleId><ArticleId IdType="pubmed">30864183</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergen H, Hawton K, Waters K, et al. Premature death after self-harm: a multicentre cohort study. Lancet. 2012;380:1568&#x2013;74. doi: 10.1016/S0140-6736(12)61141-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61141-6</ArticleId><ArticleId IdType="pubmed">22995670</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr MJ, Ashcroft DM, Kontopantelis E, et al. Premature death among primary care patients with a history of self-harm. Ann Fam Med. 2017;15:246&#x2013;54. doi: 10.1370/afm.2054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1370/afm.2054</ArticleId><ArticleId IdType="pmc">PMC5422086</ArticleId><ArticleId IdType="pubmed">28483890</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation (WHO). Suicide: Key Facts. Suicide. 2019. https://www.who.int/news-room/fact-sheets/detail/suicide (accessed 16 November 2023).</Citation></Reference><Reference><Citation>Naghavi M. Global burden of Disease Self-Harm collaborators. Global, regional, and national burden of suicide mortality 1990 to 2016: systematic analysis for the global burden of Disease Study 2016. BMJ. 2019;364:l94. doi: 10.1136/bmj.l94.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l94</ArticleId><ArticleId IdType="pmc">PMC6598639</ArticleId><ArticleId IdType="pubmed">31339847</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerel J, Brown MM, Maple M, et al. How many people are exposed to suicide? Not six. Suicide Life Threat Behav. 2019;49:529&#x2013;34. doi: 10.1111/sltb.12450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sltb.12450</ArticleId><ArticleId IdType="pubmed">29512876</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobsen SG, Nielsen T, Larsen CP, et al. Definitions and incidence rates of self-harm and suicide attempts in Europe: a scoping review. J Psychiatr Res. 2023;164:28&#x2013;36. doi: 10.1016/j.jpsychires.2023.05.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2023.05.066</ArticleId><ArticleId IdType="pubmed">37311401</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasiliadis H-M, Ngamini-Ngui A, Lesage A. Factors Associated with suicide in the Month following contact with Different Types of Health Services in Quebec. Psychiatr Serv. 2015;66:121&#x2013;6. doi: 10.1176/appi.ps.201400133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ps.201400133</ArticleId><ArticleId IdType="pubmed">25270296</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison KB, Laing L. Adults&#x2019; use of health services in the year before death by suicide in Alberta. Health Rep. 2011;22:15&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">22106785</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmedani BK, Simon GE, Stewart C, et al. Health care contacts in the year before suicide death. J Gen Intern Med. 2014;29:870&#x2013;7. doi: 10.1007/s11606-014-2767-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-014-2767-3</ArticleId><ArticleId IdType="pmc">PMC4026491</ArticleId><ArticleId IdType="pubmed">24567199</ArticleId></ArticleIdList></Reference><Reference><Citation>Asarnow JR, Babeva K, Horstmann E. The Emergency Department: challenges and opportunities for suicide Prevention. Child Adolesc Psychiatr Clin N Am. 2017;26:771&#x2013;83. doi: 10.1016/j.chc.2017.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chc.2017.05.002</ArticleId><ArticleId IdType="pmc">PMC6768433</ArticleId><ArticleId IdType="pubmed">28916013</ArticleId></ArticleIdList></Reference><Reference><Citation>Larkin GL, Beautrais AL. Emergency departments are underutilized sites for suicide prevention. Crisis. 2010;31:1&#x2013;6. doi: 10.1027/0227-5910/a000001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1027/0227-5910/a000001</ArticleId><ArticleId IdType="pubmed">20197251</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JJ, Michel CA, Auerbach RP. Improving suicide Prevention through evidence-based strategies: a systematic review. Am J Psychiatry. 2021;178:611&#x2013;24. doi: 10.1176/appi.ajp.2020.20060864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2020.20060864</ArticleId><ArticleId IdType="pmc">PMC9092896</ArticleId><ArticleId IdType="pubmed">33596680</ArticleId></ArticleIdList></Reference><Reference><Citation>Doupnik SK, Rudd B, Schmutte T, et al. Association of Suicide Prevention Interventions with subsequent suicide attempts, linkage to follow-up care, and Depression symptoms for Acute Care settings: a systematic review and Meta-analysis. JAMA Psychiatry. 2020;77:1021&#x2013;30. doi: 10.1001/jamapsychiatry.2020.1586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2020.1586</ArticleId><ArticleId IdType="pmc">PMC7301305</ArticleId><ArticleId IdType="pubmed">32584936</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor RC, Worthman CM, Abanga M, et al. Gone too soon: priorities for action to prevent premature mortality associated with mental illness and mental distress. Lancet Psychiatry. 2023;10:452&#x2013;64. doi: 10.1016/S2215-0366(23)00058-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(23)00058-5</ArticleId><ArticleId IdType="pubmed">37182526</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrigon ML, Courtet P, Oquendo M, et al. Precision Medicine and suicide: an opportunity for Digital Health. Curr Psychiatry Rep. 2019;21:131. doi: 10.1007/s11920-019-1119-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11920-019-1119-8</ArticleId><ArticleId IdType="pubmed">31776806</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler RC, Bernecker SL, Bossarte RM et al. The Role of Big Data Analytics in Predicting Suicide. In: Passos IC, Mwangi B, Kapczinski F, eds. Personalized Psychiatry: Big Data Analytics in Mental Health. Cham: Springer International Publishing 2019:77&#x2013;98. 10.1007/978-3-030-03553-2_5</Citation></Reference><Reference><Citation>Witt K, McGill K, Leckning B, et al. Global prevalence of psychiatric in- and out-patient treatment following hospital-presenting self-harm: a systematic review and meta-analysis. EClinicalMedicine. 2023;65:102295. doi: 10.1016/j.eclinm.2023.102295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102295</ArticleId><ArticleId IdType="pmc">PMC10641155</ArticleId><ArticleId IdType="pubmed">37965430</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin P, Stanley B, Melle I, et al. Association of Psychiatric Services Referral and Attendance Following Treatment for Deliberate self-harm with prospective mortality in Norwegian patients. JAMA Psychiatry. 2022;79:651. doi: 10.1001/jamapsychiatry.2022.1124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.1124</ArticleId><ArticleId IdType="pmc">PMC9118082</ArticleId><ArticleId IdType="pubmed">35583901</ArticleId></ArticleIdList></Reference><Reference><Citation>Uddin T, Pitman A, Benson G et al. Attitudes toward and experiences of clinical and non-clinical services among individuals who self-harm or attempt suicide: a systematic review. Psychol Med. 2023;1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">37772412</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald S, Sampson C, Turley R, et al. Patients&#x2019; experiences of Emergency Hospital Care following Self-Harm: systematic review and thematic synthesis of qualitative research. Qual Health Res. 2020;30:471&#x2013;85. doi: 10.1177/1049732319886566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1049732319886566</ArticleId><ArticleId IdType="pubmed">31933427</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindgren B-M, Svedin CG, Werk&#xf6; S. A systematic literature review of experiences of Professional Care and Support among people who Self-Harm. Arch Suicide Res off J Int Acad Suicide Res. 2018;22:173&#x2013;92. doi: 10.1080/13811118.2017.1319309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13811118.2017.1319309</ArticleId><ArticleId IdType="pubmed">28426393</ArticleId></ArticleIdList></Reference><Reference><Citation>Swedish Council on Health Technology Assessment. Self-harm: Patients&#x2019; Experiences and Perceptions of Professional Care and Support. Stockholm: Swedish Council on Health Technology Assessment (SBU) 2015. http://www.ncbi.nlm.nih.gov/books/NBK448037/ (accessed 17 November 2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">28876728</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees N, Rapport F, Thomas G, et al. Perceptions of paramedic and emergency care workers of those who self harm: a systematic review of the quantitative literature. J Psychosom Res. 2014;77:449&#x2013;56. doi: 10.1016/j.jpsychores.2014.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2014.09.006</ArticleId><ArticleId IdType="pubmed">25263398</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor TL, Hawton K, Fortune S, et al. Attitudes towards clinical services among people who self-harm: systematic review. Br J Psychiatry J Ment Sci. 2009;194:104&#x2013;10. doi: 10.1192/bjp.bp.107.046425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.bp.107.046425</ArticleId><ArticleId IdType="pubmed">19182168</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavers G, Andriessen K, Krysinska K. A systematic review of the experiences and Support needs of Informal caregivers for people who have attempted suicide or experienced suicidal ideation. Int J Environ Res Public Health. 2022;19:5181. doi: 10.3390/ijerph19095181.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19095181</ArticleId><ArticleId IdType="pmc">PMC9102006</ArticleId><ArticleId IdType="pubmed">35564578</ArticleId></ArticleIdList></Reference><Reference><Citation>Graney J, Hunt IM, Quinlivan L, et al. Suicide risk assessment in UK mental health services: a national mixed-methods study. Lancet Psychiatry. 2020;7:1046&#x2013;53. doi: 10.1016/S2215-0366(20)30381-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30381-3</ArticleId><ArticleId IdType="pubmed">33189221</ArticleId></ArticleIdList></Reference><Reference><Citation>Cully G, Leahy D, Shiely F, et al. Patients&#x2019; experiences of Engagement with Healthcare Services following a high-risk self-harm presentation to a Hospital Emergency Department: a mixed methods study. Arch Suicide Res off J Int Acad Suicide Res. 2022;26:91&#x2013;111. doi: 10.1080/13811118.2020.1779153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13811118.2020.1779153</ArticleId><ArticleId IdType="pubmed">32576083</ArticleId></ArticleIdList></Reference><Reference><Citation>Ness J, Hawton K, Bergen H, et al. High-volume repeaters of self-harm. Crisis. 2016;37:427&#x2013;37. doi: 10.1027/0227-5910/a000428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1027/0227-5910/a000428</ArticleId><ArticleId IdType="pubmed">27733063</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazel S, Runeson B, Suicide N Engl J Med. 2020;382:266&#x2013;74. doi: 10.1056/NEJMra1902944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1902944</ArticleId><ArticleId IdType="pmc">PMC7116087</ArticleId><ArticleId IdType="pubmed">31940700</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin JC, Ribeiro JD, Fox KR, et al. Risk factors for suicidal thoughts and behaviors: a meta-analysis of 50 years of research. Psychol Bull. 2017;143:187&#x2013;232. doi: 10.1037/bul0000084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/bul0000084</ArticleId><ArticleId IdType="pubmed">27841450</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodford R, Spittal MJ, Milner A, et al. Accuracy of clinician predictions of future Self-Harm: a systematic review and Meta-analysis of Predictive studies. Suicide Life Threat Behav. 2019;49:23&#x2013;40. doi: 10.1111/sltb.12395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sltb.12395</ArticleId><ArticleId IdType="pubmed">28972271</ArticleId></ArticleIdList></Reference><Reference><Citation>Corke M, Mullin K, Angel-Scott H, et al. Meta-analysis of the strength of exploratory suicide prediction models; from clinicians to computers. BJPsych Open. 2021;7:e26. doi: 10.1192/bjo.2020.162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjo.2020.162</ArticleId><ArticleId IdType="pmc">PMC8058929</ArticleId><ArticleId IdType="pubmed">33407984</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabbay J, le May A. Evidence based guidelines or collectively constructed &#x2018;mindlines?&#x2019; Ethnographic study of knowledge management in primary care. BMJ. 2004;329:1013. doi: 10.1136/bmj.329.7473.1013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.329.7473.1013</ArticleId><ArticleId IdType="pmc">PMC524553</ArticleId><ArticleId IdType="pubmed">15514347</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy W, Roaten K, Downs D, et al. Suicide risk Assessment and Management: real-world experience and perceptions of Emergency Medicine Physicians. Arch Suicide Res. 2017;21:365&#x2013;78. doi: 10.1080/13811118.2016.1199987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13811118.2016.1199987</ArticleId><ArticleId IdType="pubmed">27309841</ArticleId></ArticleIdList></Reference><Reference><Citation>Derblom K, Lindgren B-M, Johansson A, et al. Engagement, responsibility, collaboration, and abandonment: nurses&#x2019; experiences of assessing suicide risk in Psychiatric Inpatient Care. Issues Ment Health Nurs. 2021;42:776&#x2013;83. doi: 10.1080/01612840.2020.1864686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01612840.2020.1864686</ArticleId><ArticleId IdType="pubmed">33443452</ArticleId></ArticleIdList></Reference><Reference><Citation>McClatchey K, Murray J, Chouliara Z, et al. Suicide risk assessment in the emergency department: an investigation of current practice in Scotland. Int J Clin Pract. 2019;73:e13342. doi: 10.1111/ijcp.13342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13342</ArticleId><ArticleId IdType="pubmed">30859674</ArticleId></ArticleIdList></Reference><Reference><Citation>Sequeira L, Strudwick G, De Luca V, et al. Exploring uniformity of Clinical Judgment: a Vignette Approach to understanding Healthcare professionals&#x2019; suicide risk Assessment practices. J Patient Saf. 2022;18:e962&#x2013;70. doi: 10.1097/PTS.0000000000000973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PTS.0000000000000973</ArticleId><ArticleId IdType="pubmed">35085164</ArticleId></ArticleIdList></Reference><Reference><Citation>Chacko M, Job A, Kim DJ, et al. Examination of physician factors influencing psychiatric assessment of acutely suicidal patients. Psychiatry Res. 2021;297:113736. doi: 10.1016/j.psychres.2021.113736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2021.113736</ArticleId><ArticleId IdType="pubmed">33486272</ArticleId></ArticleIdList></Reference><Reference><Citation>Waern M, Kaiser N, Renberg ES. Psychiatrists&#x2019; experiences of suicide assessment. BMC Psychiatry. 2016;16:440. doi: 10.1186/s12888-016-1147-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-016-1147-4</ArticleId><ArticleId IdType="pmc">PMC5148860</ArticleId><ArticleId IdType="pubmed">27938368</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter G, Milner A, McGill K, et al. Predicting suicidal behaviours using clinical instruments: systematic review and meta-analysis of positive predictive values for risk scales. Br J Psychiatry J Ment Sci. 2017;210:387&#x2013;95. doi: 10.1192/bjp.bp.116.182717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.bp.116.182717</ArticleId><ArticleId IdType="pubmed">28302700</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan JL, Lo L, Ferguson J, et al. Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials. BMJ. 2020;370:m3216. doi: 10.1136/bmj.m3216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3216</ArticleId><ArticleId IdType="pmc">PMC7495041</ArticleId><ArticleId IdType="pubmed">32943437</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton RT, Pincock D, Baumgart DC, et al. An overview of clinical decision support systems: benefits, risks, and strategies for success. Npj Digit Med. 2020;3:1&#x2013;10. doi: 10.1038/s41746-020-0221-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-0221-y</ArticleId><ArticleId IdType="pmc">PMC7005290</ArticleId><ArticleId IdType="pubmed">32047862</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer KM, Kennedy G, Gallyer A, et al. A direct comparison of theory-driven and machine learning prediction of suicide: a meta-analysis. PLoS ONE. 2021;16:e0249833. doi: 10.1371/journal.pone.0249833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0249833</ArticleId><ArticleId IdType="pmc">PMC8041204</ArticleId><ArticleId IdType="pubmed">33844698</ArticleId></ArticleIdList></Reference><Reference><Citation>Demuth S, M&#xfc;ller J, Quenardelle V, et al. Strokecopilot: a literature-based clinical decision support system for acute ischemic stroke treatment. J Neurol. 2023;270:6113&#x2013;23. doi: 10.1007/s00415-023-11979-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-023-11979-6</ArticleId><ArticleId IdType="pubmed">37668701</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X, He J, Lin M, et al. Comparative effectiveness of Team-Based Care with and without a clinical decision support system for Diabetes Management: a Cluster Randomized Trial. Ann Intern Med. 2023;176:49&#x2013;58. doi: 10.7326/M22-1950.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M22-1950</ArticleId><ArticleId IdType="pubmed">36469915</ArticleId></ArticleIdList></Reference><Reference><Citation>Chekin N, Ayatollahi H, Karimi Zarchi M. A clinical decision support system for assessing the risk of Cervical Cancer: development and evaluation study. JMIR Med Inf. 2022;10:e34753. doi: 10.2196/34753.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/34753</ArticleId><ArticleId IdType="pmc">PMC9260527</ArticleId><ArticleId IdType="pubmed">35731549</ArticleId></ArticleIdList></Reference><Reference><Citation>Anchala R, Kaptoge S, Pant H, et al. Evaluation of effectiveness and cost-effectiveness of a clinical decision support system in managing hypertension in resource constrained primary health care settings: results from a cluster randomized trial. J Am Heart Assoc. 2015;4:e001213. doi: 10.1161/JAHA.114.001213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.114.001213</ArticleId><ArticleId IdType="pmc">PMC4330052</ArticleId><ArticleId IdType="pubmed">25559011</ArticleId></ArticleIdList></Reference><Reference><Citation>Abell B, Naicker S, Rodwell D, et al. Identifying barriers and facilitators to successful implementation of computerized clinical decision support systems in hospitals: a NASSS framework-informed scoping review. Implement Sci. 2023;18:32. doi: 10.1186/s13012-023-01287-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13012-023-01287-y</ArticleId><ArticleId IdType="pmc">PMC10373265</ArticleId><ArticleId IdType="pubmed">37495997</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentley KH, Zuromski KL, Fortgang RG, et al. Implementing machine learning models for suicide risk prediction in clinical practice: Focus Group Study with Hospital Providers. JMIR Form Res. 2022;6:e30946. doi: 10.2196/30946.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/30946</ArticleId><ArticleId IdType="pmc">PMC8956996</ArticleId><ArticleId IdType="pubmed">35275075</ArticleId></ArticleIdList></Reference><Reference><Citation>Kar Ray M, Wyder M, Crompton D, et al. Relational safety based suicide prevention training frameworks. Int J Ment Health Nurs. 2020;PROTECT:533&#x2013;43. doi: 10.1111/inm.12685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/inm.12685</ArticleId><ArticleId IdType="pubmed">31880076</ArticleId></ArticleIdList></Reference><Reference><Citation>Barak-Corren Y, Castro VM, Nock MK, et al. Validation of an Electronic Health Record-based suicide risk prediction modeling Approach across multiple Health Care systems. JAMA Netw Open. 2020;3:e201262. doi: 10.1001/jamanetworkopen.2020.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.1262</ArticleId><ArticleId IdType="pmc">PMC11136522</ArticleId><ArticleId IdType="pubmed">32211868</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripperger MA, Kolli J, Wilimitis D, et al. External validation and updating of a statistical civilian-based suicide risk model in US Naval Primary Care. JAMA Netw Open. 2023;6:e2342750. doi: 10.1001/jamanetworkopen.2023.42750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.42750</ArticleId><ArticleId IdType="pmc">PMC10632956</ArticleId><ArticleId IdType="pubmed">37938841</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilimitis D, Turer RW, Ripperger M, et al. Integration of Face-to-face Screening with Real-time machine learning to Predict risk of suicide among adults. JAMA Netw Open. 2022;5:e2212095. doi: 10.1001/jamanetworkopen.2022.12095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.12095</ArticleId><ArticleId IdType="pmc">PMC9107032</ArticleId><ArticleId IdType="pubmed">35560048</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon GE, Johnson E, Lawrence JM, et al. Predicting suicide attempts and Suicide Deaths Following Outpatient Visits Using Electronic Health Records. Am J Psychiatry. 2018;175:951&#x2013;60. doi: 10.1176/appi.ajp.2018.17101167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2018.17101167</ArticleId><ArticleId IdType="pmc">PMC6167136</ArticleId><ArticleId IdType="pubmed">29792051</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross EL, Zuromski KL, Reis BY, et al. Accuracy requirements for cost-effective suicide risk prediction among primary care patients in the US. JAMA Psychiatry. 2021;78:642&#x2013;50. doi: 10.1001/jamapsychiatry.2021.0089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2021.0089</ArticleId><ArticleId IdType="pmc">PMC7970389</ArticleId><ArticleId IdType="pubmed">33729432</ArticleId></ArticleIdList></Reference><Reference><Citation>Matarazzo BB, Eagan A, Landes SJ, et al. The Veterans Health Administration REACH VET program: suicide predictive modeling in practice. Psychiatr Serv. 2023;74:206&#x2013;9. doi: 10.1176/appi.ps.202100629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ps.202100629</ArticleId><ArticleId IdType="pubmed">36039552</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler RC, Hwang I, Hoffmire CA, et al. Developing a practical suicide risk prediction model for targeting high-risk patients in the veterans health administration. Int J Methods Psychiatr Res. 2017;26:e1575. doi: 10.1002/mpr.1575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mpr.1575</ArticleId><ArticleId IdType="pmc">PMC5614864</ArticleId><ArticleId IdType="pubmed">28675617</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimeff LA, Jobes DA, Koerner K, et al. Using a tablet-based app to deliver evidence-based practices for suicidal patients in the Emergency Department: pilot randomized controlled trial. JMIR Ment Health. 2021;8:e23022. doi: 10.2196/23022.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/23022</ArticleId><ArticleId IdType="pmc">PMC7961404</ArticleId><ArticleId IdType="pubmed">33646129</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkington KS, Wasserman GA, Ryan ME, et al. E-Connect: linking probation youth at risk for suicide to behavioral health services. J Consult Clin Psychol. 2023;91:547&#x2013;57. doi: 10.1037/ccp0000824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/ccp0000824</ArticleId><ArticleId IdType="pmc">PMC10526689</ArticleId><ArticleId IdType="pubmed">37261738</ArticleId></ArticleIdList></Reference><Reference><Citation>OxRisk| Oxford Forensic Psychiatry Risk Tools. OxRisk. https://oxrisk.com/home-2/ (accessed 27 November 2023).</Citation></Reference><Reference><Citation>Fazel S, Vazquez-Montes MDLA, Molero Y, et al. Risk of death by suicide following self-harm presentations to healthcare: development and validation of a multivariable clinical prediction rule (OxSATS) BMJ Ment Health. 2023;26:e300673. doi: 10.1136/bmjment-2023-300673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjment-2023-300673</ArticleId><ArticleId IdType="pmc">PMC10335583</ArticleId><ArticleId IdType="pubmed">37385664</ArticleId></ArticleIdList></Reference><Reference><Citation>Botchway S, Tsiachristas A, Pollard J, et al. Cost-effectiveness of implementing a suicide prediction tool (OxMIS) in severe mental illness: economic modeling study. Eur Psychiatry J Assoc Eur Psychiatr. 2022;66:e6. doi: 10.1192/j.eurpsy.2022.2354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/j.eurpsy.2022.2354</ArticleId><ArticleId IdType="pmc">PMC9879904</ArticleId><ArticleId IdType="pubmed">36529858</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouch J, Marshall JJ. Suicide risk: structured professional judgement. Adv Psychiatr Treat. 2005;11:84&#x2013;91. doi: 10.1192/apt.11.2.84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/apt.11.2.84</ArticleId></ArticleIdList></Reference><Reference><Citation>Self-Harm Registry&#x2013; National Suicide Research Foundation. https://www.nsrf.ie/self-harm-registry/ (accessed 13 December 2023).</Citation></Reference><Reference><Citation>P&#xe9;rez V, Elices M, Prat B, et al. The Catalonia suicide risk code: a secondary prevention program for individuals at risk of suicide. J Affect Disord. 2020;268:201&#x2013;5. doi: 10.1016/j.jad.2020.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2020.03.009</ArticleId><ArticleId IdType="pubmed">32174478</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang PE, Ryan PB, Racoosin JA, et al. Advancing the science for active surveillance: Rationale and Design for the Observational Medical Outcomes Partnership. Ann Intern Med. 2010;153:600&#x2013;6. doi: 10.7326/0003-4819-153-9-201011020-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-153-9-201011020-00010</ArticleId><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>Informatics OHDS. and. The Book of OHDSI. https://ohdsi.github.io/TheBookOfOhdsi/ (accessed 13 December 2023).</Citation></Reference><Reference><Citation>McMahan HB, Moore E, Ramage D et al. Communication-Efficient Learning of Deep Networks from Decentralized Data. 2023. 10.48550/arXiv.1602.05629</Citation></Reference><Reference><Citation>Ludwig H, Baracaldo N, Thomas G et al. IBM Federated Learning: an Enterprise Framework White Paper V0.1. 2020. 10.48550/arXiv.2007.10987</Citation></Reference><Reference><Citation>Qin P, Mehlum L. Deliberate self-harm: case identification and incidence estimate upon data from national patient registry. PLoS ONE. 2020;15:e0231885. doi: 10.1371/journal.pone.0231885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0231885</ArticleId><ArticleId IdType="pmc">PMC7185602</ArticleId><ArticleId IdType="pubmed">32339191</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon GE, Shortreed SM, Boggs JM, et al. Accuracy of ICD-10-CM encounter diagnoses from health records for identifying self-harm events. J Am Med Inf Assoc JAMIA. 2022;29:2023&#x2013;31. doi: 10.1093/jamia/ocac144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocac144</ArticleId><ArticleId IdType="pmc">PMC9667165</ArticleId><ArticleId IdType="pubmed">36018725</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown LA, Benhamou K, May AM, et al. Machine learning algorithms in suicide Prevention: clinician interpretations as barriers to implementation. J Clin Psychiatry. 2020;81:19m12970. doi: 10.4088/JCP.19m12970.</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.19m12970</ArticleId><ArticleId IdType="pubmed">32316078</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwers MC, Kho ME, Browman GP, et al. Development of the AGREE II, part 2: assessment of validity of items and tools to support application. CMAJ Can Med Assoc J J Assoc Medicale Can. 2010;182:E472&#x2013;478. doi: 10.1503/cmaj.091716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.091716</ArticleId><ArticleId IdType="pmc">PMC2900368</ArticleId><ArticleId IdType="pubmed">20513779</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwers MC, Kho ME, Browman GP, et al. Development of the AGREE II, part 1: performance, usefulness and areas for improvement. CMAJ Can Med Assoc J J Assoc Medicale Can. 2010;182:1045&#x2013;52. doi: 10.1503/cmaj.091714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.091714</ArticleId><ArticleId IdType="pmc">PMC2900328</ArticleId><ArticleId IdType="pubmed">20513780</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ Can Med Assoc J J Assoc Medicale Can. 2010;182:E839&#x2013;842. doi: 10.1503/cmaj.090449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.090449</ArticleId><ArticleId IdType="pmc">PMC3001530</ArticleId><ArticleId IdType="pubmed">20603348</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38519026</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2468-6530</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Ophthalmology. Retina</Title><ISOAbbreviation>Ophthalmol Retina</ISOAbbreviation></Journal><ArticleTitle>Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab: An Observational Health Data Sciences and Informatics Network Study.</ArticleTitle><Pagination><StartPage>733</StartPage><EndPage>743</EndPage><MedlinePgn>733-743</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.oret.2024.03.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2468-6530(24)00118-0</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To characterize the incidence of kidney failure associated with intravitreal anti-VEGF exposure; and compare the risk of kidney failure in patients treated with ranibizumab, aflibercept, or bevacizumab.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cohort study across 12 databases in the Observational Health Data Sciences and Informatics (OHDSI) network.</AbstractText><AbstractText Label="SUBJECTS" NlmCategory="METHODS">Subjects aged &#x2265; 18 years with &#x2265; 3 monthly intravitreal anti-VEGF medications for a blinding disease (diabetic retinopathy, diabetic macular edema, exudative age-related macular degeneration, or retinal vein occlusion).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The standardized incidence proportions and rates of kidney failure while on treatment with anti-VEGF were calculated. For each comparison (e.g., aflibercept versus ranibizumab), patients from each group were matched 1:1 using propensity scores. Cox proportional hazards models were used to estimate the risk of kidney failure while on treatment. A random effects meta-analysis was performed to combine each database's hazard ratio (HR) estimate into a single network-wide estimate.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Incidence of kidney failure while on anti-VEGF treatment, and time from cohort entry to kidney failure.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 6.1 million patients with blinding diseases, 37 189 who received ranibizumab, 39 447 aflibercept, and 163 611 bevacizumab were included; the total treatment exposure time was 161 724 person-years. The average standardized incidence proportion of kidney failure was 678 per 100 000 persons (range, 0-2389), and incidence rate 742 per 100 000 person-years (range, 0-2661). The meta-analysis HR of kidney failure comparing aflibercept with ranibizumab was 1.01 (95% confidence interval [CI], 0.70-1.47; P&#xa0;= 0.45), ranibizumab with bevacizumab 0.95 (95% CI, 0.68-1.32; P&#xa0;= 0.62), and aflibercept with bevacizumab 0.95 (95% CI, 0.65-1.39; P&#xa0;= 0.60).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There was no substantially different relative risk of kidney failure between those who received ranibizumab, bevacizumab, or aflibercept. Practicing ophthalmologists and nephrologists should be aware of the risk of kidney failure among patients receiving intravitreal anti-VEGF medications and that there is little empirical evidence to preferentially choose among the specific intravitreal anti-VEGF agents.</AbstractText><AbstractText Label="FINANCIAL DISCLOSURES" NlmCategory="BACKGROUND">Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 American Academy of Ophthalmology. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Cindy X</ForeName><Initials>CX</Initials><AffiliationInfo><Affiliation>Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland. Electronic address: ccai6@jhmi.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishimura</LastName><ForeName>Akihiko</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowring</LastName><ForeName>Mary G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westlund</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Diep</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Jia H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Division of Kidney Diseases and Hypertension, Donald and Barbara School of Medicine at Hofstra/Northwell, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagy</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics and Data Science, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Johns Hopkins University, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLeggon</LastName><ForeName>Jody-Ann</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, US Department of Veterans Affairs, Salt Lake City, Utah; Department of Internal Medicine Division of Epidemiology, University of Utah School of Medicine, Salt Lake City, Utah.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, Tennessee Valley Healthcare System, Nashville, Tennessee; Department of Biomedical Informatics, Vanderbilt University, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golozar</LastName><ForeName>Asieh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, Inc., Cambridge, Massachusetts; OHDSI Center at the Roux Institute, Northeastern University, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, Inc., Cambridge, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minty</LastName><ForeName>Evan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>O'Brien Center for Public Health, Department of Medicine, University of Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Priya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Technology / Digital Solutions, Stanford Health Care and Stanford University School of Medicine, Palo Alto, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bu</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of California - Los Angeles, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toy</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Roski Eye Institute, Keck School of Medicine, University of Southern California; Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hribar</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Eye Institute, National Institutes of Health, Bethesda, Maryland; Casey Eye Institute, Oregon Health &amp; Science University, Portland, Oregon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Linying</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawrence-Archer</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, Inc., Cambridge, Massachusetts; OHDSI Center at the Roux Institute, Northeastern University, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boland</LastName><ForeName>Michael V</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Mass Eye and Ear, and Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goetz</LastName><ForeName>Kerry</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Eye Institute, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoaibi</LastName><ForeName>Azza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Anthony G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, New Jersey; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blacketer</LastName><ForeName>Clair</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swerdel</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jhaveri</LastName><ForeName>Kenar D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Glomerular Center at Northwell Health, Division of Kidney Diseases and Hypertension, Donald and Barbara School of Medicine at Hofstra/Northwell, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Roski Eye Institute, Keck School of Medicine, University of Southern California; Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilbert</LastName><ForeName>Zachary</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Roski Eye Institute, Keck School of Medicine, University of Southern California; Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeger</LastName><ForeName>Scott L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crews</LastName><ForeName>Deidra C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, US Department of Veterans Affairs, Salt Lake City, Utah; Department of Biostatistics, University of California - Los Angeles, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U24 HD113136</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F30 HL168842</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 EY032985</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM013426</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003098</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 DK132459</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 EY033440</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG068002</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 HL148181</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ophthalmol Retina</MedlineTA><NlmUniqueID>101695048</NlmUniqueID><ISSNLinking>2468-6530</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>15C2VL427D</RegistryNumber><NameOfSubstance UI="C533178">aflibercept</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020533">Angiogenesis Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>2S9ZZM9Q9V</RegistryNumber><NameOfSubstance UI="D000068258">Bevacizumab</NameOfSubstance></Chemical><Chemical><RegistryNumber>ZL1R02VT79</RegistryNumber><NameOfSubstance UI="D000069579">Ranibizumab</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D040262">Receptors, Vascular Endothelial Growth Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020533" MajorTopicYN="Y">Angiogenesis Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068258" MajorTopicYN="Y">Bevacizumab</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001766" MajorTopicYN="N">Blindness</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003930" MajorTopicYN="N">Diabetic Retinopathy</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058449" MajorTopicYN="N">Intravitreal Injections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008269" MajorTopicYN="N">Macular Edema</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069579" MajorTopicYN="Y">Ranibizumab</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040262" MajorTopicYN="Y">Receptors, Vascular Endothelial Growth Factor</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051437" MajorTopicYN="Y">Renal Insufficiency</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012170" MajorTopicYN="N">Retinal Vein Occlusion</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042461" MajorTopicYN="Y">Vascular Endothelial Growth Factor A</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anti-vascular endothelial growth factor</Keyword><Keyword MajorTopicYN="N">Big data</Keyword><Keyword MajorTopicYN="N">Informatics</Keyword><Keyword MajorTopicYN="N">Kidney failure</Keyword><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword></KeywordList><CoiStatement>Cai: Grant support from Regeneron. Ng: J.H. Ng received consultancy fees from Vifor Pharmaceuticals. She is the founder of PublishedMD Consulting LLC. DuVall: Dr. DuVall reports grants from Alnylam Pharmaceuticals, Inc., Astellas Pharma, Inc., AstraZeneca Pharmaceuticals LP, Biodesix, Inc, Celgene Corporation, Cerner Enviza, GSK PLC, IQVIA Inc., Janssen Pharmaceuticals, Inc., Novartis International AG, Parexel International Corporation through the University of Utah or Western Institute for Veteran Research outside the submitted work within the past 24 months. Matheny: VA ORD research infrastructure funding for VINCI. Golozar: Employee of Odysseus Data Servicees. Minty: Previous: Janssen (analytics consulting, outside the scope of this work); Orpyx Medical Technologies (outside scope). Toy: Alimera (Advisory board), Eyepoint (Advisory board). Boland: Carl Zeiss Meditec (consulting, speaking);Topcon Healthcare (consulting); Janssen (consulting); Allergan (consulting). Hall: Employee of and shareholder of Johnson &amp; Johnson. Shoaibi: Employee and stockholder of janssen pharmaceutics. Reps: Employee of and shareholder of Johnson &amp; Johnson. Sena: Employee of and shareholder of Johnson &amp; Johnson. Blacketer: Employee of and shareholder of Johnson &amp; Johnson. Swerdel: Employee of and shareholder of Johnson &amp; Johnson. Jhaveri: Consultant for GSK, PMV pharma, Calliditas, George Clinicals. Crews: Baxter (research grant funding). Suchard: MAS receives grants and contracts from the US Food &amp; Drug Administration and Janssen Research &amp; Development outside the scope of this work. Ryan: Employee of and shareholder of Johnson &amp; Johnson</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>4</Day><Hour>13</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>23</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>22</Day><Hour>20</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38519026</ArticleId><ArticleId IdType="mid">NIHMS1981458</ArticleId><ArticleId IdType="pmc">PMC11298306</ArticleId><ArticleId IdType="doi">10.1016/j.oret.2024.03.014</ArticleId><ArticleId IdType="pii">S2468-6530(24)00118-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>GBD 2019 Blindness and Vision Impairment Collaborators, Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9(2):e144&#x2013;e160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820391</ArticleId><ArticleId IdType="pubmed">33275949</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin DF. Evolution of Intravitreal Therapy for Retinal Diseases-From CMV to CNV: The LXXIV Edward Jackson Memorial Lecture. Am J Ophthalmol. 2018;191:xli&#x2013;lviii.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6014888</ArticleId><ArticleId IdType="pubmed">29339063</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna RM, Barsoum M, Arman F, Selamet U, Hasnain H, Kurtz I. Nephrotoxicity induced by intravitreal vascular endothelial growth factor inhibitors: emerging evidence. Kidney Int. 2019;96(3):572&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pubmed">31229276</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurevich F, Perazella MA. Renal effects of anti-angiogenesis therapy: update for the internist. Am J Med. 2009;122(4):322&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pubmed">19332223</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzedine H, Escudier B, Lhomme C, et al. Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center. Medicine. 2014;93(24):333&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4602430</ArticleId><ArticleId IdType="pubmed">25500702</ArticleId></ArticleIdList></Reference><Reference><Citation>Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63(4):1468&#x2013;1474.</Citation><ArticleIdList><ArticleId IdType="pubmed">12631363</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA. 2010;303(5):423&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pubmed">20124537</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CY, Chinchilli VM, Coca S, et al. Post-Acute Kidney Injury Proteinuria and Subsequent Kidney Disease Progression: The Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Study. JAMA Intern Med. 2020;180(3):402&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6990681</ArticleId><ArticleId IdType="pubmed">31985750</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Peng L, Zhou Y, et al. Do intravitreal anti-vascular endothelial growth factor agents lead to renal adverse events? A pharmacovigilance real-world study. Front Med. 2023;10:1100397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9972674</ArticleId><ArticleId IdType="pubmed">36865057</ArticleId></ArticleIdList></Reference><Reference><Citation>Avery RL, Castellarin AA, Steinle NC, et al. SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB. Retina. 2017;37(10):1847&#x2013;1858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5642319</ArticleId><ArticleId IdType="pubmed">28106709</ArticleId></ArticleIdList></Reference><Reference><Citation>Avery RL, Castellarin AA, Steinle NC, et al. Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD. Br J Ophthalmol. 2014;98(12):1636&#x2013;1641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4251300</ArticleId><ArticleId IdType="pubmed">25001321</ArticleId></ArticleIdList></Reference><Reference><Citation>Phadke G, Hanna RM, Ferrey A, et al. Review of intravitreal VEGF inhibitor toxicity and report of collapsing FSGS with TMA in a patient with age-related macular degeneration. Clin Kidney J. 2021;14(10):2158&#x2013;2165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8483684</ArticleId><ArticleId IdType="pubmed">34603693</ArticleId></ArticleIdList></Reference><Reference><Citation>Zafar S, Walder A, Virani S, et al. Systemic Adverse Events Among Patients With Diabetes Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections. JAMA Ophthalmol. 2023;141(7):658&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10236327</ArticleId><ArticleId IdType="pubmed">37261816</ArticleId></ArticleIdList></Reference><Reference><Citation>Kameda Y, Babazono T, Uchigata Y, Kitano S. Renal function after intravitreal administration of vascular endothelial growth factor inhibitors in patients with diabetes and chronic kidney disease. J Diabetes Investig. 2018;9(4):937&#x2013;939.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6031523</ArticleId><ArticleId IdType="pubmed">29108104</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neill RA, Gallagher P, Douglas T, et al. Evaluation of long-term intravitreal anti-vascular endothelial growth factor injections on renal function in patients with and without diabetic kidney disease. BMC Nephrol. 2019;20(1):478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6933625</ArticleId><ArticleId IdType="pubmed">31878889</ArticleId></ArticleIdList></Reference><Reference><Citation>Lees JS, Dobbin SJH, Elyan BMP, et al. A systematic review and meta-analysis of the effect of intravitreal VEGF inhibitors on cardiorenal outcomes. Nephrol Dial Transplant. 2023;38(7):1666&#x2013;1681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10310520</ArticleId><ArticleId IdType="pubmed">36318455</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi D, McGeehan B, VanderBeek BL. Evaluation of Long-Term Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Injections on Renal Function. Invest Ophthalmol Vis Sci. 2022;63(7):1332&#x2013;F0166.</Citation></Reference><Reference><Citation>Tsao YC, Chen TY, Wang LA, et al. Acute Kidney Injury from Intravitreal Anti-vascular Endothelial Growth Factor Drugs: A Systematic Review and Meta-analysis of Randomized Controlled Trials. BioDrugs. Published online September 7, 2023. doi: 10.1007/s40259-023-00621-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40259-023-00621-6</ArticleId><ArticleId IdType="pubmed">37676536</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna RM, Lopez EA, Hasnain H, et al. Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension. Clin Kidney J. 2019;12(1):92&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6366143</ArticleId><ArticleId IdType="pubmed">30746134</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetic Retinopathy Clinical Research Network, Wells JA, Glassman AR, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13):1193&#x2013;1203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4422053</ArticleId><ArticleId IdType="pubmed">25692915</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassman AR, Liu D, Jampol LM, Sun JK, Diabetic Retinopathy Clinical Research Network. Changes in Blood Pressure and Urine Albumin-Creatinine Ratio in a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema. Invest Ophthalmol Vis Sci. 2018;59(3):1199&#x2013;1205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5837671</ArticleId><ArticleId IdType="pubmed">29625440</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Software Tools. Accessed
December 21, 2023. https://www.ohdsi.org/software-tools/</Citation></Reference><Reference><Citation>GitHub - ohdsi-studies/AntiVegfKidneyFailure. GitHub. Accessed
April 22, 2023. https://github.com/ohdsi-studies/AntiVegfKidneyFailure</Citation></Reference><Reference><Citation>Ostropolets A, Ryan P, Hripcsak G. Phenotyping in distributed data networks: selecting the right codes for the right patients. AMIA Annu Symp Proc. 2022;2022:826&#x2013;835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10148372</ArticleId><ArticleId IdType="pubmed">37128407</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetic Retinopathy Clinical Research Network, Writing Committee, Aiello LP, et al. Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Ophthalmology. 2011;118(12):e5&#x2013;e14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3253487</ArticleId><ArticleId IdType="pubmed">22136692</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Eckardt KU, Dorman NM, et al. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 2020;97(6):1117&#x2013;1129.</Citation><ArticleIdList><ArticleId IdType="pubmed">32409237</ArticleId></ArticleIdList></Reference><Reference><Citation>Outcomes KDI. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease; 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">23989362</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostropolets A, Reich C, Ryan P, Shang N, Hripcsak G, Weng C. Adapting electronic health records-derived phenotypes to claims data: Lessons learned in using limited clinical data for phenotyping. J Biomed Inform. 2020;102:103363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390483</ArticleId><ArticleId IdType="pubmed">31866433</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdel JN, Hripcsak G, Ryan PB. PheValuator: Development and evaluation of a phenotype algorithm evaluator. J Biomed Inform. 2019;97:103258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736922</ArticleId><ArticleId IdType="pubmed">31369862</ArticleId></ArticleIdList></Reference><Reference><Citation>GitHub - OHDSI/Strategus: [Under development] An R packages for coordinating and executing analytics using HADES modules. GitHub. Accessed
April 30, 2023. https://github.com/OHDSI/Strategus</Citation></Reference><Reference><Citation>The R Project for Statistical Computing. Accessed
December 21, 2023. https://www.R-project.org/</Citation></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul. 2013;23(1). doi: 10.1145/2414416.2414791</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2414416.2414791</ArticleId><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI Analysis Viewer. Accessed
August 27, 2023. https://data.ohdsi.org/AntiVegfKidneyFailure/</Citation></Reference><Reference><Citation>Glasheen WP, Renda A, Dong Y. Diabetes Complications Severity Index (DCSI)-Update and ICD-10 translation. J Diabetes Complications. 2017;31(6):1007&#x2013;1013.</Citation><ArticleIdList><ArticleId IdType="pubmed">28416120</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075&#x2013;1079; discussion 1081&#x2013;1090.</Citation><ArticleIdList><ArticleId IdType="pubmed">8410092</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083&#x2013;3107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3472075</ArticleId><ArticleId IdType="pubmed">19757444</ArticleId></ArticleIdList></Reference><Reference><Citation>Standardized Rates of Disease. Accessed
July 14, 2023. https://sphweb.bumc.bu.edu/otlt/mph-modules/ep/ep713_standardizedrates/ep713_standardizedrates_print.html</Citation></Reference><Reference><Citation>US Census Bureau. Age and Sex Composition in the United States: 2015. Published online January 18, 2022. Accessed
July 14, 2023. https://www.census.gov/data/tables/2015/demo/age-and-sex/2015-age-sex-composition.html</Citation></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019;394(10211):1816&#x2013;1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Schuemie MJ, Suchard MA. Evaluating large-scale propensity score performance through real-world and synthetic data experiments. Int J Epidemiol. 2018;47(6):2005&#x2013;2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Wang Y, Schuemie MJ, Blei DM, Hripcsak G. Adjusting for indirectly measured confounding using large-scale propensity score. J Biomed Inform. 2022;134:104204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9692203</ArticleId><ArticleId IdType="pubmed">36108816</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Chen Y, Madigan D, Suchard MA. Combining cox regressions across a heterogeneous distributed research network facing small and zero counts. Stat Methods Med Res. 2022;31(3):438&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pubmed">34841975</ArticleId></ArticleIdList></Reference><Reference><Citation>Annual Data Report. USRDS. Accessed
August 27, 2023. https://adr.usrds.org/</Citation></Reference><Reference><Citation>2018 Annual Data Report. National Institute of Diabetes and Digestive and Kidney Diseases. Accessed
August 16, 2023. https://www.niddk.nih.gov/about-niddk/strategic-plans-reports/usrds/prior-data-reports/2018</Citation></Reference><Reference><Citation>Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72(3):247&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">17568785</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross EL, Hutton DW, Stein JD, et al. Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment: Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial. JAMA Ophthalmol. 2016;134(8):888&#x2013;896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6648661</ArticleId><ArticleId IdType="pubmed">27280850</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Moujahed A, Vail D, Do DV. Racial Differences in Anti-VEGF Intravitreal Injections Among Commercially Insured Beneficiaries. Ophthalmic Surg Lasers Imaging Retina. 2021;52(4):208&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">34039186</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahr MA, Hodge DO, Erie JC. Racial Differences in Age-Related Macular Degeneration and Associated Anti-Vascular Endothelial Growth Factor Intravitreal Injections among Medicare Beneficiaries. Ophthalmol Retina. 2018;2(12):1188&#x2013;1195.</Citation><ArticleIdList><ArticleId IdType="pubmed">31047189</ArticleId></ArticleIdList></Reference><Reference><Citation>Annual Data Report. USRDS. Accessed
August 27, 2023. https://adr.usrds.org/</Citation></Reference><Reference><Citation>Avery RL, Gordon GM. Systemic Safety of Prolonged Monthly Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema: A Systematic Review and Meta-analysis. JAMA Ophthalmol. 2016;134(1):21&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">26513684</ArticleId></ArticleIdList></Reference><Reference><Citation>Virgili G, Parravano M, Evans JR, Gordon I, Lucenteforte E. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. Cochrane Database Syst Rev. 2017;6(6):CD007419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6481463</ArticleId><ArticleId IdType="pubmed">28639415</ArticleId></ArticleIdList></Reference><Reference><Citation>VanderBeek BL. Difficulty in Assessing the Systemic Adverse Effects of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy. JAMA Ophthalmol. 2023;141(7):666&#x2013;667.</Citation><ArticleIdList><ArticleId IdType="pubmed">37261809</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstein RB, Ryan P, Berlin JA, et al. Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and Implications. Drug Saf. 2017;40(12):1279&#x2013;1292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5688206</ArticleId><ArticleId IdType="pubmed">28780741</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstein RB, Ryan PB, Berlin JA, Schuemie MJ, Swerdel J, Fife D. Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen. Drug Saf. 2020;43(9):927&#x2013;942.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434801</ArticleId><ArticleId IdType="pubmed">32500272</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data. Proc Natl Acad Sci U S A. 2018;115(11):2571&#x2013;2577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="pubmed">29531023</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsitch M, Tchetgen Tchetgen E, Cohen T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology. 2010;21(3):383&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3053408</ArticleId><ArticleId IdType="pubmed">20335814</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38556812</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1099-1557</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Pharmacoepidemiology and drug safety</Title><ISOAbbreviation>Pharmacoepidemiol Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Increase transparency and reproducibility of real-world evidence in rare diseases through disease-specific Federated Data Networks.</ArticleTitle><Pagination><StartPage>e5778</StartPage><MedlinePgn>e5778</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pds.5778</ELocationID><Abstract><AbstractText Label="PURPOSE">In rare diseases, real-world evidence (RWE) generation is often restricted due to small patient numbers and global geographic distribution. A federated data network (FDN) approach brings together multiple data sources harmonized for collaboration to increase the power of observational research. In this paper, we review how to increase reproducibility and transparency of RWE studies in rare diseases through disease-specific FDNs.</AbstractText><AbstractText Label="METHOD">To be successful, a multiple stakeholder scientific FDN collaboration requires a strong governance model in place. In such a model, each database owner remains in full control regarding the use of and access to patient-level data and is responsible for data privacy, ethical, and legal compliance. Provided that all this is well documented and good database descriptions are in place, such a governance model results in increased transparency, while reproducibility is achieved through data curation and harmonization, and distributed analytical methods.</AbstractText><AbstractText Label="RESULTS">Leveraging the OHDSI community set of methods and tools, two rare disease-specific FDNs are discussed in more detail. For multiple myeloma, HONEUR-the Haematology Outcomes Network in Europe-has built a strong community among the data partners dedicated to scientific exchange and research. To advance scientific knowledge in pulmonary hypertension (PH) an FDN, called PHederation, was established to form a partnership of research institutions with PH databases coming from diverse origins.</AbstractText><CopyrightInformation>&#xa9; 2024 Actelion Pharmaceuticals Ltd. Pharmacoepidemiology and Drug Safety published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van Baalen</LastName><ForeName>Valerie</ForeName><Initials>V</Initials><Identifier Source="ORCID">0009-0006-9021-0387</Identifier><AffiliationInfo><Affiliation>Global Epidemiology, Office of the Chief Medical Officer, Johnson &amp; Johnson, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Didden</LastName><ForeName>Eva-Maria</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Global Epidemiology, Office of the Chief Medical Officer, Johnson &amp; Johnson, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenberg</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Global Epidemiology, Office of the Chief Medical Officer, Johnson &amp; Johnson, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bardenheuer</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Health Economics, Market Access and Reimbursement, EMEA Real-World Evidence and Value-based Health Care, Johnson &amp; Johnson, Neuss, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Speybroeck</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Data Science, IT EMEA, Johnson &amp; Johnson Technology, Beerse, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brand</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Global Epidemiology, Office of the Chief Medical Officer, Johnson &amp; Johnson, Basel, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Johnson and Johnson</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacoepidemiol Drug Saf</MedlineTA><NlmUniqueID>9208369</NlmUniqueID><ISSNLinking>1053-8569</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035583" MajorTopicYN="Y">Rare Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">federated data network</Keyword><Keyword MajorTopicYN="N">governance</Keyword><Keyword MajorTopicYN="N">rare disease</Keyword><Keyword MajorTopicYN="N">real&#x2010;world evidence</Keyword><Keyword MajorTopicYN="N">reproducibility</Keyword><Keyword MajorTopicYN="N">transparency</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>1</Day><Hour>2</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38556812</ArticleId><ArticleId IdType="doi">10.1002/pds.5778</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>About Rare Diseases. Orphanet. 2012 https://www.orpha.net/consor/cgi-bin/Education_AboutRareDiseases.php?lng=EN</Citation></Reference><Reference><Citation>FDA. Rare Diseases: Natural History Studies for Drug Development. 2019.</Citation></Reference><Reference><Citation>ENCePP. The European network of centres for pharmacoepidemiology and pharmacovigilance. Guide on Methodological Standards in Pharmacoepidemiology (Revision 11). EMA/95098/2010; 2010.</Citation></Reference><Reference><Citation>Rath A, Olry A, Dhombres F, Brandt MM, Urbero B, Ayme S. Representation of rare diseases in health information systems: the orphanet approach to serve a wide range of end users. Hum Mutat. 2012;33:803&#x2010;808. doi:10.1002/humu.22078</Citation></Reference><Reference><Citation>EUPAS4523. Disease characteristics and outcomes of pulmonary arterial hypertension in children and adolescents in real&#x2010;world clinical settings: systematic review of prospective, observational registries. https://catalogues.ema.europa.eu/node/1697/administrative-details</Citation></Reference><Reference><Citation>Hunger M, Bardenheuer K, Passey A, Schade R, Sharma R, Hague C. The value of federated data networks in oncology: what research questions do they answer? Outcomes from a systematic literature review. Value Health. 2021;25(5):855&#x2010;868.</Citation></Reference><Reference><Citation>Heimbigner D, McLeod D. A federated architecture for information management. ACM Trans Inf Syst. 1985;3:253&#x2010;278.</Citation></Reference><Reference><Citation>Hallock H, Marshall SE, 't Hoen PAC, et al. Federated networks for distributed analysis of health data. Front Public Health. 2021;9:712569. doi:10.3389/fpubh.2021.712569</Citation></Reference><Reference><Citation>Sentinel Distributed Database. https://www.sentinelinitiative.org/about/key-database-statistics</Citation></Reference><Reference><Citation>EHDEN. The European Health Data &amp; Evidence Network. https://www.ehden.eu/</Citation></Reference><Reference><Citation>Data Analysis and Real World Interrogation Network (DARWIN EU&#xae;). https://darwin-eu.org/</Citation></Reference><Reference><Citation>Swiss Personalized Health Network (SPHN). https://sphn.ch/</Citation></Reference><Reference><Citation>ATHENA (Augmenting THerapeutic Effectiveness through Novel Analytics). https://portal.athenafederation.org/</Citation></Reference><Reference><Citation>EURACAN, the European Reference Network for all rare adult solid cancers. https://euracan.eu/</Citation></Reference><Reference><Citation>The OPTIMA consortium. https://www.optima-oncology.eu/</Citation></Reference><Reference><Citation>BioGrid Australia Ltd. https://www.biogrid.org.au/</Citation></Reference><Reference><Citation>Health care systems research network. http://www.hcsrn.org/</Citation></Reference><Reference><Citation>Haematology outcomes network in Europe. https://portal.honeur.org/</Citation></Reference><Reference><Citation>Pulmonary hypertension federated data network. https://portal.phederation.org/</Citation></Reference><Reference><Citation>TriNetX international hospital EHR network. https://trinetx.com/</Citation></Reference><Reference><Citation>Campion TR, Sholle ET, Abedian S, et al. Implementation of a commercial federated network of electronic health record data to enable sponsor&#x2010;initiated clinical trials at an academic medical center. Int J Med Inform. 2024;182:105322.</Citation></Reference><Reference><Citation>OHDSI Observational Health Data Sciences and Informatics. https://www.ohdsi.org/</Citation></Reference><Reference><Citation>Sernadela P, Gonz&#xe1;lez&#x2010;Castro L, Carta C, et al. Linked registries: connecting rare diseases patient registries through a semantic web layer. Biomed Res Int. 2017;2017:1&#x2010;13. doi:10.1155/2017/8327980</Citation></Reference><Reference><Citation>Sentinel common data model. https://www.sentinelinitiative.org/methods-data-tools/sentinel-common-data-model</Citation></Reference><Reference><Citation>OHDSI, Observational Health Data Sciences and Informatics. Standardized Data: The OMOP Common Data Model. https://www.ohdsi.org/data-standardization/</Citation></Reference><Reference><Citation>Kent S, Burn E, Dawoud D, et al. Common problems, common data model solutions: evidence generation for health technology assessment. Pharmacoeconomics. 2021;39(3):275&#x2010;285. doi:10.1007/s40273&#x2010;020&#x2010;00981&#x2010;9</Citation></Reference><Reference><Citation>ATLAS, cohort builder. https://github.com/OHDSI/Atlas</Citation></Reference><Reference><Citation>OHDSI, Workgroups. https://www.ohdsi.org/workgroups/</Citation></Reference><Reference><Citation>Handbook for PH registries to OMOP CDM conversion. GitHub. https://github.com/OHDSI/ETL-PulmonaryHypertensionRegistries</Citation></Reference><Reference><Citation>Gatto NM, Campbell UB, Rubinstein E, et al. The structured process to identify fit&#x2010;for&#x2010;purpose data: a data feasibility assessment framework. Clin Pharmacol Ther. 2022;111(1):122&#x2010;134. doi:10.1002/cpt.2466</Citation></Reference><Reference><Citation>Passey A, Perualilia NJ, Bardenheuer K, Verbeke T, Nassiri V, Van Speybroeck M. HONEUR (Heamatology outcomes network in Europe)&#x2014;distributed statistics in a federated model to support real world data research in hematology. HemaSphere. 2019;3(S1):654.</Citation></Reference><Reference><Citation>Joane J, Verstraete H, Halvorsen L, van Speybroeck M. Patinet Similarity Analysis and Visualizaion in Multiple Myeloma. EHA; 2020.</Citation></Reference><Reference><Citation>Spicka I, Lapidot I, Merz M, et al. P944: Real&#x2010;World Patient Characteristics and Survival Outcomes of Lenalidomide Refractory Vs. Lenalidomide Exposed RRMM Patients in the HONEUR Federated Data Network. EHA; 2023.</Citation></Reference><Reference><Citation>Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma. Technology appraisal guidance. Reference number: TA897. 2023 https://www.nice.org.uk/guidance/ta897</Citation></Reference><Reference><Citation>Humbert M, Kovacs G, Hoeper MM, et al. ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2022;2023:2200879. doi:10.1183/13993003.00879&#x2010;2022</Citation></Reference><Reference><Citation>Schuemie MJ, Chen Y, Madigan D, Suchard MA. Combining cox regressions across a heterogeneous distributed research network facing small and zero counts. Stat Methods Med Res. 2022;31(3):438&#x2010;450. doi:10.1177/09622802211060518</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38572301</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-1683</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>European urology open science</Title><ISOAbbreviation>Eur Urol Open Sci</ISOAbbreviation></Journal><ArticleTitle>Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER Platform.</ArticleTitle><Pagination><StartPage>81</StartPage><EndPage>88</EndPage><MedlinePgn>81-88</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.euros.2024.02.019</ELocationID><Abstract><AbstractText>Combination therapies in metastatic hormone-sensitive prostate cancer (mHSPC), which include the addition of an androgen receptor signaling inhibitor and/or docetaxel to androgen deprivation therapy, have been a game changer in the management of this disease stage. However, these therapies come with their fair share of toxicities and side effects. The goal of this observational study is to report drug-related adverse events (AEs), which are correlated with systemic combination therapies for mHSPC. Determining the optimal treatment option requires large cohorts to estimate the tolerability and AEs of these combination therapies in "real-life" patients with mHSPC, as provided in this study. We use a network of databases that includes population-based registries, electronic health records, and insurance claims, containing the overall target population and subgroups of patients defined by unique certain characteristics, demographics, and comorbidities, to compute the incidence of common AEs associated with systemic therapies in the setting of mHSPC. These data sources are standardised using the Observational Medical Outcomes Partnership Common Data Model. We perform the descriptive statistics as well as calculate the AE incidence rate separately for each treatment group, stratified by age groups and index year. The time until the first event is estimated using the Kaplan-Meier method within each age group. In the case of episodic events, the anticipated mean cumulative counts of events are calculated. Our study will allow clinicians to tailor optimal therapies for mHSPC patients, and they will serve as a basis for comparative method studies.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rajwa</LastName><ForeName>Pawel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Urology, Medical University of Silesia, Zabrze, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borkowetz</LastName><ForeName>Angelika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Urology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbott</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>European Association of Urology, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alberti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unit of Urological Robotic Surgery and Renal Transplantation, University of Florence, Careggi Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bjartell</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Translational Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brash</LastName><ForeName>James T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>IQVIA, Real World Solutions, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campi</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unit of Urological Robotic Surgery and Renal Transplantation, University of Florence, Careggi Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chilelli</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Astellas Pharma Europe Ltd, Surrey, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conover</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Constantinovici</LastName><ForeName>Niculae</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Bayer AG, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Eleanor</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>IQVIA, Real World Solutions, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Meulder</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Association EISBM, Vourles, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eid</LastName><ForeName>Sherrine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>SAS Institute, Cary, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gacci</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unit of Urological Robotic Surgery and Renal Transplantation, University of Florence, Careggi Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golozar</LastName><ForeName>Asieh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Center, Northeastern University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hafeez</LastName><ForeName>Haroon</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Shaukat Khanum Memorial Cancer Hospital &amp; Research Centre, Peshawar, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haque</LastName><ForeName>Samiul</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>SAS Institute, Cary, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hijazy</LastName><ForeName>Ayman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Association EISBM, Vourles, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hulsen</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Hospital Services &amp; Informatics, Philips Research, Eindhoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Josefsson</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wallenberg Center for Molecular Medicine, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalid</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolde</LastName><ForeName>Raivo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotik</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Advanced Systems Understanding, G&#xf6;rlitz, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurki</LastName><ForeName>Samu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bayer OY, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambrecht</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>SAS Institute, Cary, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>Chi-Ho</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>SAS Institute, Cary, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicoletti</LastName><ForeName>Rossella</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unit of Urological Robotic Surgery and Renal Transplantation, University of Florence, Careggi Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieboer</LastName><ForeName>Daan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Erasmus MC University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oja</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palanisamy</LastName><ForeName>Soundarya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>SAS Institute, Cary, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prinsen</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Center, Northeastern University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raffaele Resta</LastName><ForeName>Giulio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unit of Urological Robotic Surgery and Renal Transplantation, University of Florence, Careggi Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribal</LastName><ForeName>Maria J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Uro-Oncology Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez Rivas</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Urology, Hospital Clinico San Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Guidelines Office, European Association of Urology, Arnhem, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snijder</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinbeisser</LastName><ForeName>Carl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Collaborate Project Management, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandenberghe</LastName><ForeName>Frederik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>SAS Institute, Cary, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cornford</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Liverpool University Hospitals NHS Trust, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans-Axelsson</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bayer AG, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N'Dow</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Academic Urology Unit, University of Aberdeen, Aberdeen, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willemse</LastName><ForeName>Peter-Paul M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Urology, Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur Urol Open Sci</MedlineTA><NlmUniqueID>101771568</NlmUniqueID><ISSNLinking>2666-1683</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Androgen receptor signaling inhibitor</Keyword><Keyword MajorTopicYN="N">Big data</Keyword><Keyword MajorTopicYN="N">Docetaxel</Keyword><Keyword MajorTopicYN="N">Hormone sensitive</Keyword><Keyword MajorTopicYN="N">Metastatic</Keyword><Keyword MajorTopicYN="N">PIONEER</Keyword><Keyword MajorTopicYN="N">Prostate cancer</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>4</Day><Hour>4</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38572301</ArticleId><ArticleId IdType="pmc">PMC10987796</ArticleId><ArticleId IdType="doi">10.1016/j.euros.2024.02.019</ArticleId><ArticleId IdType="pii">S2666-1683(24)00333-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yanagisawa T., Rajwa P., Thibault C., et al. Androgen receptor signaling inhibitors in addition to docetaxel with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis. Eur Urol. 2022;82:584&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pubmed">35995644</ArticleId></ArticleIdList></Reference><Reference><Citation>Riaz I.B., Naqvi S.A.A., He H., et al. First-line systemic treatment options for metastatic castration-sensitive prostate cancer: a living systematic review and network meta-analysis. JAMA Oncol. 2023;9:635&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9982744</ArticleId><ArticleId IdType="pubmed">36862387</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathianathen N.J., Koschel S., Thangasamy I.A., et al. Indirect comparisons of efficacy between combination approaches in metastatic hormone-sensitive prostate cancer: a systematic review and network meta-analysis. Eur Urol. 2020;77:365&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pubmed">31679970</ArticleId></ArticleIdList></Reference><Reference><Citation>Fizazi K., Foulon S., Carles J., et al. Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 &#xd7; 2 factorial design. Lancet. 2022;399:1695&#x2013;1707.</Citation><ArticleIdList><ArticleId IdType="pubmed">35405085</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith M.R., Hussain M., Saad F., et al. Darolutamide and survival in metastatic, hormone-sensitive prostate cancer. N Engl J Med. 2022;386:1132&#x2013;1142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9844551</ArticleId><ArticleId IdType="pubmed">35179323</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowakowska M.K., Ortega R.M., Wehner M.R., Nead K.T. Association of second-generation antiandrogens with cognitive and functional toxic effects in randomized clinical trials: a systematic review and meta-analysis. JAMA Oncol. 2023;9:930&#x2013;937.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214180</ArticleId><ArticleId IdType="pubmed">37227736</ArticleId></ArticleIdList></Reference><Reference><Citation>De Nunzio C., Lombardo R., Tema G., et al. Adverse events related to abiraterone and enzalutamide treatment: analysis of the EudraVigilance database and meta-analysis of registrational phase III studies. Prostate Cancer Prostatic Dis. 2020;23:199&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">31685981</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai L.Y., Oerline M.K., Caram M.E.V., et al. Risk of metabolic and cardiovascular adverse events with abiraterone or enzalutamide among men with advanced prostate cancer. J Natl Cancer Inst. 2022;114:1127&#x2013;1134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9360470</ArticleId><ArticleId IdType="pubmed">35417024</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjartell A., Costa L., Kramer G., et al. Real-world treatment sequencing in patients with metastatic castration-resistant prostate cancer: results from the prospective, international, observational Prostate Cancer Registry. Eur Urol Open Sci. 2022;45:12&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9637537</ArticleId><ArticleId IdType="pubmed">36353661</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjartell A., Lumen N., Maroto P., et al. Real-world safety and efficacy outcomes with abiraterone acetate plus prednisone or prednisolone as the first- or second-line treatment for metastatic castration-resistant prostate cancer: data from the Prostate Cancer Registry. Target Oncol. 2021;16:357&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8105236</ArticleId><ArticleId IdType="pubmed">33826036</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury S., Oudard S., Uemura H., et al. Apalutamide compared with darolutamide for the treatment of non-metastatic castration-resistant prostate cancer: efficacy and tolerability in a matching-adjusted indirect comparison. Adv Ther. 2022;39:518&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8799579</ArticleId><ArticleId IdType="pubmed">34797506</ArticleId></ArticleIdList></Reference><Reference><Citation>Conover M.M., Weaver J., Fan B., et al. Cardiovascular outcomes among patients with castration-resistant prostate cancer: a comparative safety study using US administrative claims data. Prostate. 2023;83:729&#x2013;739.</Citation><ArticleIdList><ArticleId IdType="pubmed">36879362</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandaglia G, Pellegrino F, Golozar A, et al. Clinical characterization of patients diagnosed with prostate cancer and undergoing conservative management: a PIONEER analysis based on big data. Eur Urol. In press. 10.1016/j.eururo.2023.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2023.06.012</ArticleId><ArticleId IdType="pubmed">37414703</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer K., Moris L., Lardas M., et al. Updating and integrating core outcome sets for localised, locally advanced, metastatic, and nonmetastatic castration-resistant prostate cancer: an update from the PIONEER Consortium. Eur Urol. 2022;81:503&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pubmed">35184906</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti M.M., Gandaglia G., Sisca E.S., et al. A systematic review to evaluate patient-reported outcome measures (PROMs) for metastatic prostate cancer according to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) methodology. Cancers (Basel) 2022;14:5120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9600015</ArticleId><ArticleId IdType="pubmed">36291905</ArticleId></ArticleIdList></Reference><Reference><Citation>Omar M.I., Roobol M.J., Ribal M.J., et al. Introducing PIONEER: a project to harness big data in prostate cancer research. Nat Rev Urol. 2020;17:351&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pubmed">32461687</ArticleId></ArticleIdList></Reference><Reference><Citation>Omar M.I., MacLennan S., Ribal M.J., et al. Unanswered questions in prostate cancer - findings of an international multi-stakeholder consensus by the PIONEER consortium. Nat Rev Urol. 2023;20:494&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pubmed">37012441</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez Rivas J., Nicoletti R., Ib&#xe1;&#xf1;ez L., et al. Research protocol to identify progression and death amongst patients with metastatic hormone-sensitive prostate cancer treated with available treatments: PIONEER IMI&#x2019;s &#x201c;big data for better outcomes&#x201d; program. Int J Surg Protoc. 2023;27:122&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10688536</ArticleId><ArticleId IdType="pubmed">38046899</ArticleId></ArticleIdList></Reference><Reference><Citation>CohortDiagnostics. Diagnostics for OHDSI cohorts. https://ohdsi.github.io/CohortDiagnostics, https://github.com/OHDSI/CohortDiagnostics.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38590890</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2405-8440</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>Heliyon</Title><ISOAbbreviation>Heliyon</ISOAbbreviation></Journal><ArticleTitle>A federated authentication schema among multiple identity providers.</ArticleTitle><Pagination><StartPage>e28560</StartPage><MedlinePgn>e28560</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e28560</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.heliyon.2024.e28560</ELocationID><Abstract><AbstractText>Single Sign-On (SSO) methods are the primary solution to authenticate users across multiple web systems. These mechanisms streamline the authentication procedure by avoiding duplicate developments of authentication modules for each application. Besides, these mechanisms also provide convenience to the end-user by keeping the user authenticated when switching between different contexts. To ensure this cross-application authentication, SSO relies on an Identity Provider (IdP), which is commonly set up and managed by each institution that needs to enforce SSO internally. However, the solution is not so straightforward when several institutions need to cooperate in a unique ecosystem. This could be tackled by centralizing the authentication mechanisms in one of the involved entities, a solution raising responsibilities that may be difficult for peers to accept. Moreover, this solution is not appropriate for dynamic groups, where peers may join or leave frequently. In this paper, we propose an architecture that uses a trusted third-party service to authenticate multiple entities, ensuring the isolation of the user's attributes between this service and the institutional SSO systems. This architecture was validated in the EHDEN Portal, which includes web tools and services of this European health project, to establish a Federated Authentication schema.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Almeida</LastName><ForeName>Jo&#xe3;o Rafael</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>DETI/IEETA, LASI, University of Aveiro, Aveiro, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computation, University of A Coru&#xf1;a, A Coru&#xf1;a, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Z&#xfa;quete</LastName><ForeName>Andr&#xe9;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>DETI/IEETA, LASI, University of Aveiro, Aveiro, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pazos</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Computation, University of A Coru&#xf1;a, A Coru&#xf1;a, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Jos&#xe9; Lu&#xed;s</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>DETI/IEETA, LASI, University of Aveiro, Aveiro, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heliyon</MedlineTA><NlmUniqueID>101672560</NlmUniqueID><ISSNLinking>2405-8440</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ELIXIR AAI</Keyword><Keyword MajorTopicYN="N">Federated authentication</Keyword><Keyword MajorTopicYN="N">IdP</Keyword><Keyword MajorTopicYN="N">OAuth 2.0</Keyword><Keyword MajorTopicYN="N">SSO</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>9</Day><Hour>3</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38590890</ArticleId><ArticleId IdType="pmc">PMC10999912</ArticleId><ArticleId IdType="doi">10.1016/j.heliyon.2024.e28560</ArticleId><ArticleId IdType="pii">S2405-8440(24)04591-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wilson Y., Hingnikar A. Solving Identity Management in Modern Applications. Springer; 2019. Single sign-on; pp. 151&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4842-5095-2_11</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J., Sun Q., Chen H. 2010 3rd IEEE International Conference on Broadband Network and Multimedia Technology (IC-BNMT) IEEE; 2010. Application of single sign-on (SSO) in digital campus; pp. 725&#x2013;727.</Citation></Reference><Reference><Citation>Bhosale S.K. 2008. Architecture of a Single Sign on (SSO) for Internet Banking.</Citation></Reference><Reference><Citation>Radha V., Reddy D.H. A survey on single sign-on techniques. Proc. Technol. 2012;4:134&#x2013;139.</Citation></Reference><Reference><Citation>Armando A., Carbone R., Compagna L., Cuellar J., Tobarra L. Proceedings of the 6th ACM Workshop on Formal Methods in Security Engineering. 2008. Formal analysis of SAML 2.0 web browser single sign-on: breaking the SAML-based single sign-on for Google apps; pp. 1&#x2013;10.</Citation></Reference><Reference><Citation>Pandey P., Nisha T. Challenges in single sign-on. J. Phys. Conf. Ser. 2021;1964:042016. doi: 10.1088/1742-6596/1964/4/042016. IOP Publishing.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/1742-6596/1964/4/042016</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabrizchi H., Kuchaki Rafsanjani M. A survey on security challenges in cloud computing: issues, threats, and solutions. J. Supercomput. 2020;76:9493&#x2013;9532.</Citation></Reference><Reference><Citation>Ates M., Fayolle J., Gravier C., Lardon J. Proceedings of the 5th International Conference on Soft Computing as Transdisciplinary Science and Technology. 2008. Complex federation architectures: stakes, tricks &amp; issues; pp. 152&#x2013;157.</Citation></Reference><Reference><Citation>Weing&#xe4;rtner R., Westphall C.M. SECURWARE 2014, 93. 2014. Enhancing privacy on identity providers.</Citation></Reference><Reference><Citation>Carretero J., Izquierdo-Moreno G., Vasile-Cabezas M., Garcia-Blas J. Federated identity architecture of the European eID system. IEEE Access. 2018;6:75302&#x2013;75326.</Citation></Reference><Reference><Citation>Chadwick D.W. Foundations of Security Analysis and Design V. Springer; 2009. Federated identity management; pp. 96&#x2013;120.</Citation></Reference><Reference><Citation>Cantor S., Moreh J., Philpott R., Maler E. 2005. Metadata for the OASIS Security Assertion Markup Language (SAML) V2.0.</Citation></Reference><Reference><Citation>Hardt D., et al. 2012. The OAuth 2.0 Authorization Framework.</Citation></Reference><Reference><Citation>Sakimura N., Bradley J., Jones M., De Medeiros B., Mortimore C. 2014. Openid Connect Core 1.0, The OpenID Foundation; p. S3.</Citation></Reference><Reference><Citation>Naik N., Jenkins P. 2017 11th International Conference on Research Challenges in Information Science (RCIS) IEEE; 2017. Securing digital identities in the cloud by selecting an apposite federated identity management from SAML, OAuth and OpenID connect; pp. 163&#x2013;174.</Citation></Reference><Reference><Citation>Hughes J., Maler E. 2005. Security assertion markup language (SAML) v2.0 technical overview, OASIS SSTC Working Draft 13.</Citation></Reference><Reference><Citation>Halpin H., Cook B. Annual Privacy Forum. Springer; 2012. Federated identity as capabilities; pp. 125&#x2013;139.</Citation></Reference><Reference><Citation>Alonso A., Pozo A., Choque J., Bueno G., Salvach&#xfa;a J., Diez L., Mar&#xed;n J., Alonso P.L.C. An identity framework for providing access to FIWARE OAuth 2.0-based services according to the eIDAS European regulation. IEEE Access. 2019;7:88435&#x2013;88449.</Citation></Reference><Reference><Citation>Fett D., K&#xfc;sters R., Schmitz G. Proceedings of the 2016 ACM SIGSAC Conference on Computer and Communications Security. 2016. A comprehensive formal security analysis of OAuth 2.0; pp. 1204&#x2013;1215.</Citation></Reference><Reference><Citation>Linden M., Proch&#xe1;zka M., Lappalainen I., Bucik D., Vyskocil P., Kuba M., Sil&#xe9;n S., Belmann P., Sczyrba A., Newhouse S., et al. F1000Research 7. 2018. Common elixir service for researcher authentication and authorisation.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6124379</ArticleId><ArticleId IdType="pubmed">30254736</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson M.D., Dumontier M., Aalbersberg I.J., Appleton G., Axton M., Baak A., Blomberg N., Boiten J., da Silva Santos L., Bourne P., et al. The FAIR guiding principles for scientific data management and stewardship. Sci. Data. 2016;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4792175</ArticleId><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Eijssen L., Evelo C., Kok R., Mons B., Hooft R., et al. F1000Research 4. 2015. The Dutch techcentre for life sciences: enabling data-intensive life science research in the Netherlands.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4743138</ArticleId><ArticleId IdType="pubmed">26913186</ArticleId></ArticleIdList></Reference><Reference><Citation>Tekle K.M., Gundersen S., Klepper K., Bongo L.A., Raknes I.A., Li X., Zhang W., Andreetta C., Mulugeta T.D., Kala&#x161; M., et al. F1000Research 7. 2018. Norwegian e-infrastructure for life sciences (NeLS)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6137412</ArticleId><ArticleId IdType="pubmed">30271575</ArticleId></ArticleIdList></Reference><Reference><Citation>Baillie Gerritsen V., Palagi P.M., Durinx C. Bioinformatics on a national scale: an example from Switzerland. Brief. Bioinform. 2019;20:361&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6433736</ArticleId><ArticleId IdType="pubmed">29106442</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrow J., Drysdale R., Smith A., Repo S., Lanfear J., Blomberg N. ELIXIR: providing a sustainable infrastructure for life science data at European scale. Bioinformatics. 2021;37:2506&#x2013;2511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8388016</ArticleId><ArticleId IdType="pubmed">34175941</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida J.R., Pazos A., Oliveira J.L. Doctoral Conference on Computing, Electrical and Industrial Systems. Springer; 2023. Clinical data integration strategies for multicenter studies; pp. 175&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-031-36007-7_13</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida J.R., Silva J.M., Oliveira J.L. 2023 IEEE 36th International Symposium on Computer-Based Medical Systems (CBMS) IEEE; 2023. A FAIR approach to real-world health data management and analysis; pp. 892&#x2013;897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/CBMS58004.2023.00338</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida J.R., Oliveira J.L. MONTRA2: a web platform for profiling distributed databases in the health domain. Inform. Med. Unlocked. 2024;45</Citation></Reference><Reference><Citation>Koussa S. Federated identities: openid vs. SAML vs. OAuth. 2013. http://www.softwaresecuredhttp://www.com/2013/07/16/federated-identities-openid-vs-saml-vs-oauth/ (cit. 25.04.2016)</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38593431</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1438-8871</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><PubDate><Year>2024</Year><Month>Apr</Month><Day>09</Day></PubDate></JournalIssue><Title>Journal of medical Internet research</Title><ISOAbbreviation>J Med Internet Res</ISOAbbreviation></Journal><ArticleTitle>Converge or Collide? Making Sense of a Plethora of Open Data Standards in Health Care.</ArticleTitle><Pagination><StartPage>e55779</StartPage><MedlinePgn>e55779</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e55779</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/55779</ELocationID><Abstract><AbstractText>Practitioners of digital health are familiar with disjointed data environments that often inhibit effective communication among different elements of the ecosystem. This fragmentation leads in turn to issues such as inconsistencies in services versus payments, wastage, and notably, care delivered being less than best-practice. Despite the long-standing recognition of interoperable data as a potential solution, efforts in achieving interoperability have been disjointed and inconsistent, resulting in numerous incompatible standards, despite the widespread agreement that fewer standards would enhance interoperability. This paper introduces a framework for understanding health care data needs, discussing the challenges and opportunities of open data standards in the field. It emphasizes the necessity of acknowledging diverse data standards, each catering to specific viewpoints and needs, while proposing a categorization of health care data into three domains, each with its distinct characteristics and challenges, along with outlining overarching design requirements applicable to all domains and specific requirements unique to each domain.</AbstractText><CopyrightInformation>&#xa9;Guy Tsafnat, Rachel Dunscombe, Davera Gabriel, Grahame Grieve, Christian Reich. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 09.04.2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsafnat</LastName><ForeName>Guy</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-4353-2026</Identifier><AffiliationInfo><Affiliation>Evidentli Pty Ltd, Surry Hills, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Health Informatics, Australian Institute of Health Innovation, Macquarie Univeristy, Macquarie Park, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI OMOP + FHIR Working Group, .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dunscombe</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2266-7063</Identifier><AffiliationInfo><Affiliation>openEHR International, St. Helens, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gabriel</LastName><ForeName>Davera</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9041-4597</Identifier><AffiliationInfo><Affiliation>Evidentli Pty Ltd, Surry Hills, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI OMOP + FHIR Working Group, .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Johns Hopkins University, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Grieve</LastName><ForeName>Grahame</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3438-2759</Identifier><AffiliationInfo><Affiliation>Health Level 7 International, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Intersections Pty Ltd, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-3641-055X</Identifier><AffiliationInfo><Affiliation>OHDSI OMOP + FHIR Working Group, .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Odysseus Data Services, Cambridge, MA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Med Internet Res</MedlineTA><NlmUniqueID>100959882</NlmUniqueID><ISSNLinking>1438-8871</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="Y">Delivery of Health Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical data</Keyword><Keyword MajorTopicYN="N">digital health</Keyword><Keyword MajorTopicYN="N">health care</Keyword><Keyword MajorTopicYN="N">health care data</Keyword><Keyword MajorTopicYN="N">interoperability</Keyword><Keyword MajorTopicYN="N">open data standards</Keyword></KeywordList><CoiStatement>Conflicts of Interest: GT is the founder and chairman of Evidentli Pty Ltd and an associate editor of the <i>Journal of Medical Internet Research</i>. RD is the chief executive officer of openEHR International. GG is the founder of Health Intersections Pty Ltd. CR is the chief executive officer of Odysseus Data Services. DG is an employee of Evidentli and serves on the Evidentli Scientific Advisory Board.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>9</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>9</Day><Hour>16</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38593431</ArticleId><ArticleId IdType="pmc">PMC11040436</ArticleId><ArticleId IdType="doi">10.2196/55779</ArticleId><ArticleId IdType="pii">v26i1e55779</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Coiera E. Guide to Health Informatics, 3rd Edition. London: CRC Press; 2015.</Citation></Reference><Reference><Citation>Lehne M, Sass J, Essenwanger A, Schepers J, Thun S. Why digital medicine depends on interoperability. NPJ Digit Med. 2019;2:79. doi: 10.1038/s41746-019-0158-1.158</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-019-0158-1</ArticleId><ArticleId IdType="pmc">PMC6702215</ArticleId><ArticleId IdType="pubmed">31453374</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi N, Zoch M, Kelbert P, Noll R, Schaaf J, Wolfien M, Sedlmayr M. Methods used in the development of common data models for health data: scoping review. JMIR Med Inform. 2023 Aug 03;11:e45116. doi: 10.2196/45116. 
 
v11i1e45116</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/45116</ArticleId><ArticleId IdType="pmc">PMC10436118</ArticleId><ArticleId IdType="pubmed">37535410</ArticleId></ArticleIdList></Reference><Reference><Citation>Handler T, Holtmeier R, Metzger J, Overhage M, Taylor S, Underwood C. HIMSS electronic health record definitional model version 1.0. ResearchGate. 2003.  [2024-04-04].  
 https://www.researchgate.net/publication/247151484_HIMSS_electronic_health_record_definitional_model_version_10
.</Citation></Reference><Reference><Citation>United States Core Data for Interoperability (USCDI) Office of the National Coordinator for Health Information Technology. 2020. Jul,  [2024-04-04].  
 https://www.healthit.gov/isa/sites/isa/files/2020-10/USCDI-Version-1-July-2020-Errata-Final_0.pdf
.</Citation></Reference><Reference><Citation>Coiera E. The standard problem. J Am Med Inform Assoc. 2023 Nov 17;30(12):2086&#x2013;2097. doi: 10.1093/jamia/ocad176.7257695</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocad176</ArticleId><ArticleId IdType="pmc">PMC10654885</ArticleId><ArticleId IdType="pubmed">37654094</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds CJ, Wyatt JC. Open source, open standards, and health care information systems. J Med Internet Res. 2011 Feb 17;13(1):e24. doi: 10.2196/jmir.1521. 
 
v13i1e24</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.1521</ArticleId><ArticleId IdType="pmc">PMC3221346</ArticleId><ArticleId IdType="pubmed">21447469</ArticleId></ArticleIdList></Reference><Reference><Citation>de Mello BH, Rigo SJ, da Costa CA, da Rosa Righi R, Donida B, Bez MR, Schunke LC. Semantic interoperability in health records standards: a systematic literature review. Health Technol (Berl) 2022;12(2):255&#x2013;272. doi: 10.1007/s12553-022-00639-w. 
 
639</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12553-022-00639-w</ArticleId><ArticleId IdType="pmc">PMC8791650</ArticleId><ArticleId IdType="pubmed">35103230</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra D, Beale T, Heard S. The openEHR Foundation. Stud Health Technol Inform. 2005;115:153&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">16160223</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson T, Grieve G. Principles of Health Interoperability: SNOMED CT, HL7 and FHIR (Health Information Technology Standards) Cham: Springer; 2016.</Citation></Reference><Reference><Citation>Hripcsak G, Duke J, Shah N, Reich Christian G, Huser Vojtech, Schuemie Martijn J, Suchard Marc A, Park Rae Woong, Wong Ian Chi Kei, Rijnbeek Peter R, van der Lei Johan, Pratt Nicole, Nor&#xe9;n G Niklas, Li Yu-Chuan, Stang Paul E, Madigan David, Ryan Patrick B. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;nisch Caroline, Keszty&#xfc;s Dorothea, Keszty&#xfc;s Tibor. Harvesting metadata in clinical care: a crosswalk between FHIR, OMOP, CDISC and openEHR metadata. Sci Data. 2022 Oct 28;9(1):659. doi: 10.1038/s41597-022-01792-7.10.1038/s41597-022-01792-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41597-022-01792-7</ArticleId><ArticleId IdType="pmc">PMC9616884</ArticleId><ArticleId IdType="pubmed">36307424</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38596781</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-1683</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>European urology open science</Title><ISOAbbreviation>Eur Urol Open Sci</ISOAbbreviation></Journal><ArticleTitle>Predictive Models for Assessing Patients' Response to Treatment in Metastatic Prostate Cancer: A Systematic Review.</ArticleTitle><Pagination><StartPage>126</StartPage><EndPage>135</EndPage><MedlinePgn>126-135</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.euros.2024.03.012</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE" NlmCategory="UNASSIGNED">The treatment landscape of metastatic prostate cancer (mPCa) has evolved significantly over the past two decades. Despite this, the optimal therapy for patients with mPCa has not been determined. This systematic review identifies available predictive models that assess mPCa patients' response to treatment.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We critically reviewed MEDLINE and CENTRAL in December 2022 according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses statement. Only quantitative studies in English were included with no time restrictions. The quality of the included studies was assessed using the PROBAST tool. Data were extracted following the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews criteria.</AbstractText><AbstractText Label="KEY FINDINGS AND LIMITATIONS" NlmCategory="UNASSIGNED">The search identified 616 citations, of which 15 studies were included in our review. Nine of the included studies were validated internally or externally. Only one study had a low risk of bias and a low risk concerning applicability. Many studies failed to detail model performance adequately, resulting in a high risk of bias. Where reported, the models indicated good or excellent performance.</AbstractText><AbstractText Label="CONCLUSIONS AND CLINICAL IMPLICATIONS" NlmCategory="UNASSIGNED">Most of the identified predictive models require additional evaluation and validation in properly designed studies before these can be implemented in clinical practice to assist with treatment decision-making for men with mPCa.</AbstractText><AbstractText Label="PATIENT SUMMARY" NlmCategory="UNASSIGNED">In this review, we evaluate studies that predict which treatments will work best for which metastatic prostate cancer patients. We found that existing studies need further improvement before these can be used by health care professionals.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lawlor</LastName><ForeName>Ailbhe</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Translational Oncology and Urology Research (TOUR), King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Carol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez Rivas</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Urology, Health Research Institute, Hospital Clinico San Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ib&#xe1;&#xf1;ez</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Urology, Health Research Institute, Hospital Clinico San Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abad L&#xf3;pez</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Urology, Hospital Universitario La Paz, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willemse</LastName><ForeName>Peter-Paul</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Oncological Urology, University Medical Center, Utrecht Cancer Center, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imran Omar</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Academic Urology Unit, University of Aberdeen, Aberdeen, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Remmers</LastName><ForeName>Sebastiaan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cornford</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Liverpool University Hospitals NHS Trust, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajwa</LastName><ForeName>Pawel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Urology, Medical University of Silesia, Zabrze, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicoletti</LastName><ForeName>Rossella</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Biomedical Science, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gandaglia</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Center, Northeastern University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuen-Chun Teoh</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno Sierra</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Urology, Health Research Institute, Hospital Clinico San Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golozar</LastName><ForeName>Asieh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>OHDSI Center, Northeastern University, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Odysseus Data Services, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bjartell</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Translational Medicine, Lund University, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans-Axelsson</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bayer AB, Medical Affairs Oncology, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N'Dow</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>European Association of Urology, Guidelines Office, Arnhem, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zong</LastName><ForeName>Jihong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Bayer Healthcare, Global Medical Affairs Oncology, Whippany, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribal</LastName><ForeName>Maria J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>European Association of Urology, Guidelines Office, Arnhem, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roobol</LastName><ForeName>Monique J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Hemelrijck</LastName><ForeName>Mieke</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Translational Oncology and Urology Research (TOUR), King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beyer</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PIONEER Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur Urol Open Sci</MedlineTA><NlmUniqueID>101771568</NlmUniqueID><ISSNLinking>2666-1683</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adverse events</Keyword><Keyword MajorTopicYN="N">Disease progression</Keyword><Keyword MajorTopicYN="N">Metastatic prostate cancer</Keyword><Keyword MajorTopicYN="N">Overall survival</Keyword><Keyword MajorTopicYN="N">Predictive models</Keyword><Keyword MajorTopicYN="N">Toxicity</Keyword><Keyword MajorTopicYN="N">Treatment discontinuation</Keyword><Keyword MajorTopicYN="N">Treatment selection</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>4</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38596781</ArticleId><ArticleId IdType="pmc">PMC11001619</ArticleId><ArticleId IdType="doi">10.1016/j.euros.2024.03.012</ArticleId><ArticleId IdType="pii">S2666-1683(24)00351-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang G., Zhao D., Spring D.J., DePinho R.A. Genetics and biology of prostate cancer. Genes Dev. 2018;32:1105&#x2013;1140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6120714</ArticleId><ArticleId IdType="pubmed">30181359</ArticleId></ArticleIdList></Reference><Reference><Citation>Prostate Cancer Foundation. Hormone therapy for prostate cancer. https://www.pcf.org/about-prostate-cancer/prostate-cancer-treatment/hormone-therapy-prostate-cancer/#:&#x223c;:text=Hormone%20therapy%20(also%20called%20androgen,acting%20on%20prostate%20cancer%20cellshttps://www.pcf.org/about-prostate-cancer/prostate-cancer-treatment/hormone-therapy-prostate-cancer/#:&#x223c;:text=Hormone%20therapy%20(also%20called%20androgen,acting%20on%20prostate%20cancer%20cells.</Citation></Reference><Reference><Citation>Yamada Y., Beltran H. The treatment landscape of metastatic prostate cancer. Cancer Lett. 2021;519:20&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8403655</ArticleId><ArticleId IdType="pubmed">34153403</ArticleId></ArticleIdList></Reference><Reference><Citation>James N.D., Sydes M.R., Clarke N.W., et al. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Lancet. 2016;387:1163&#x2013;1177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4800035</ArticleId><ArticleId IdType="pubmed">26719232</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi K.M., Agarwal N., Bjartell A., et al. Apalutamide for metastatic, castration-sensitive prostate cancer. N Engl J Med. 2019;381:13&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">31150574</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis I.D., Martin A.J., Stockler M.R., et al. Enzalutamide with standard first-line therapy in metastatic prostate cancer. N Engl J Med. 2019;381:121&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">31157964</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney C.J., Chen Y.-H., Carducci M., et al. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. N Engl J Med. 2015;373:737&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4562797</ArticleId><ArticleId IdType="pubmed">26244877</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandel P., Hoeh B., Wenzel M., et al. Triplet or doublet therapy in metastatic hormone-sensitive prostate cancer patients: a systematic review and network meta-analysis. Eur Urol Focus. 2023;9:96&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">36058809</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez Rivas J., Fern&#xe1;ndez Hern&#xe1;ndez L., Puente V&#xe1;zquez J., et al. Where do we stand in the management of oligometastatic prostate cancer? A comprehensive review. Cancer (Basel) 2022;14:2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9029666</ArticleId><ArticleId IdType="pubmed">35454924</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith M.R., Hussain M., Saad F., et al. Darolutamide and survival in metastatic, hormone-sensitive prostate cancer. N Engl J Med. 2022;386:1132&#x2013;1142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9844551</ArticleId><ArticleId IdType="pubmed">35179323</ArticleId></ArticleIdList></Reference><Reference><Citation>Fizazi K., Foulon S., Carles J., Roubaud G., McDermott R., Fl&#xe9;chon A. Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 &#xd7; 2 factorial design. Lancet. 2022;399:1695&#x2013;1707.</Citation><ArticleIdList><ArticleId IdType="pubmed">35405085</ArticleId></ArticleIdList></Reference><Reference><Citation>Aragon-Ching J.B., Dreicer R. Treatment in hormone-sensitive metastatic prostate cancer: factors to consider when personalizing therapy. Expert Rev Anticancer Ther. 2020;20:4578&#x2013;4586.</Citation><ArticleIdList><ArticleId IdType="pubmed">32406281</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsao P., Caran M.E.V. Factors to guide treatment selection for hormone-sensitive metastatic prostate cancer. Cancer J. 2020;26:76&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">31977389</ArticleId></ArticleIdList></Reference><Reference><Citation>Achard V., Putora P.M., Omlin A., Zilli T., Fischer S. Metastatic prostate cancer: treatment options. Oncology. 2022;100:48&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">34781285</ArticleId></ArticleIdList></Reference><Reference><Citation>Maskrey N. Shared decision making: why the slow progress? An essay by Neal Maskrey. BMJ. 2019;367</Citation><ArticleIdList><ArticleId IdType="pubmed">31806646</ArticleId></ArticleIdList></Reference><Reference><Citation>Omar M.I., Roobol M.J., Ribal M.J., et al. Introducing PIONEER: a project to harness big data in prostate cancer research. Nat Rev Urol. 2020;17:351&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pubmed">32461687</ArticleId></ArticleIdList></Reference><Reference><Citation>van Smeden M., Reitsma J.B., Riley R.D., Collins G.S., Moons K.G. Clinical prediction models: diagnosis versus prognosis. J Clin Epidemiol. 2021;132:142&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">33775387</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamiya N., Suzuki H., Nishimura K., et al. Development of nomogram to non-steroidal antiandrogen sequential alternation in prostate cancer for predictive model. Jpn J Clin Oncol. 2014;44:263&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">24516203</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>European Association of Urology. Prostate cancer. 2023. https://uroweb.org/guidelines/prostate-cancer.</Citation></Reference><Reference><Citation>Moons K.G.M., Wolff R.F., Riley R.D., et al. PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration. Ann Intern Med. 2019;170:W1&#x2013;W.</Citation><ArticleIdList><ArticleId IdType="pubmed">30596876</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyednasrollah F., Koeslter D.C., Wang T., et al. A DREAM challenge to build prediction models for short-term discontinuation of docetaxel in metastatic castration-resistant prostate cancer. JCO Clin Cancer Inform. 2017;1:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6874023</ArticleId><ArticleId IdType="pubmed">30657384</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyoshi Y., Tsutsumi S., Yasui M., et al. A novel prediction model for the completion of six cycles of radium-223 treatment and survival in patients with metastatic castration-resistant prostate cancer. World J Oncol. 2021;39:3323&#x2013;3328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8510910</ArticleId><ArticleId IdType="pubmed">33644830</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons K.G.M., de Groot J.A.H., Bouwmeester W., et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med. 2014;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4196729</ArticleId><ArticleId IdType="pubmed">25314315</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooperberg M.R., Hinotsu S., Namiki M., et al. Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy. J Clin Oncol. 2009;27:4306&#x2013;4313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2744272</ArticleId><ArticleId IdType="pubmed">19667269</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson D., Cadieux B., Higano C.S., et al. Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: a real-world machine learning approach. J Bone Oncol. 2022;34</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8976128</ArticleId><ArticleId IdType="pubmed">35378840</ArticleId></ArticleIdList></Reference><Reference><Citation>Flach P.A., Kull M. In: Advances in neural information processing systems 28. Cortes C.L.N., Lee D.D., Sugiyama M., Garnett R., editors. Massachusetts Institute of Technology (MIT) Press; 2015. Precision-recall-gain curves: PR analysis done right; pp. 838&#x2013;846.</Citation></Reference><Reference><Citation>Choi S.Y., Ryu J., You D., Hong J.H., Ahn H., Kim C.S. Simple risk assessment in prostate cancer patients treated with primary androgen deprivation therapy: The Korean Cancer Study of the Prostate Risk Classification. Int J Urol. 2019;26:62&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">30238513</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoudian M., Seyednasrollah F., Koivu L., Hirvonen O., Jyrkki&#xf6; S., Elo L.L. A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer. F1000Res. 2016;16:2674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6556990</ArticleId><ArticleId IdType="pubmed">31231503</ArticleId></ArticleIdList></Reference><Reference><Citation>Karnes R.J., Bergstralh E.J., Davicioni E., et al. Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population. J Urol. 2013;190:2047&#x2013;2053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4097302</ArticleId><ArticleId IdType="pubmed">23770138</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand A., Morris M., Larson S.M., et al. Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide. EJNMMI Res. 2016;6:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4785173</ArticleId><ArticleId IdType="pubmed">26960325</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei J.J., Zhao Y.X., Jiang Y., Wang J., Yu J.S. Association between contrast-enhanced ultrasound indicators and prostate cancer biochemical recurrence after treatment. Cancer Manag Res. 2020;12:4959&#x2013;4968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7326692</ArticleId><ArticleId IdType="pubmed">32636672</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y.X., Yao G., Sun J., et al. Nomogram incorporating contrast-enhanced ultrasonography predicting time to the development of castration-resistant prostate cancer. Clin Med Insights Oncol. 2021;15:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8504687</ArticleId><ArticleId IdType="pubmed">34646064</ArticleId></ArticleIdList></Reference><Reference><Citation>Rho MJ, Park J, Moon HW, et al. Dr. Answer AI for prostate cancer: clinical outcome prediction model and service. PLoS One 2020;15:e0236553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7406030</ArticleId><ArticleId IdType="pubmed">32756597</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y.J., Lin G.W., Li G.X., et al. External validation and newly development of a nomogram to predict overall survival of abiraterone-treated, castration-resistant patients with metastatic prostate cancer. Asian J Androl. 2018;20:184&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5858105</ArticleId><ArticleId IdType="pubmed">29111539</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini A., Parikh A., Sfakianos J.P., et al. Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-resistant prostate cancer: a pooled analysis of open phase 3 clinical trial data. Prostate Cancer Prostatic Dis. 2021;24:743&#x2013;749.</Citation><ArticleIdList><ArticleId IdType="pubmed">33531652</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Sun G., Liao B., et al. Novel nomograms for castration-resistant prostate cancer and survival outcome in patients with de novo bone metastatic prostate cancer. BJU Int. 2018;122:994&#x2013;1002.</Citation><ArticleIdList><ArticleId IdType="pubmed">29772102</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook N.R. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem. 2008;54:17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">18024533</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer K., Moris L., Lardas M., et al. Diagnostic and prognostic factors in patients with prostate cancer: a systematic review. BMJ Open. 2022;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8981333</ArticleId><ArticleId IdType="pubmed">35379637</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Q., Yang T., Yongmei J., Die Y.M. Prediction models for breast cancer-related lymphedema: a systematic review and critical appraisal. Syst Rev. 2022;11:217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9559764</ArticleId><ArticleId IdType="pubmed">36229876</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo V., Lallo E., Munnia A., et al. Artificial intelligence predictive models of response to cytotoxic chemotherapy alone or combined to targeted therapy for metastatic colorectal cancer patients: a systematic review and meta-analysis. Cancers (Basel) 2022;14:4012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9406544</ArticleId><ArticleId IdType="pubmed">36011003</ArticleId></ArticleIdList></Reference><Reference><Citation>DeBacker J.R., McMillian G.P., Martchenke N., et al. Ototoxicity prognostic models in adult and pediatric cancer patients: a rapid review. J Cancer Surviv. 2023;17:82&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11727884</ArticleId><ArticleId IdType="pubmed">36729346</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer K., Moris L., Lardas M., et al. Updating and integrating core outcome sets for localised, locally advanced, metastatic, and nonmetastatic castration-resistant prostate cancer: an update from the PIONEER Consortium. Eur Urol. 2022;81:503&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pubmed">35184906</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38614106</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-2619</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>The Lancet. Respiratory medicine</Title><ISOAbbreviation>Lancet Respir Med</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway.</ArticleTitle><Pagination><StartPage>e33</StartPage><EndPage>e34</EndPage><MedlinePgn>e33-e34</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2213-2600(24)00082-1</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2600(24)00082-1</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trinh</LastName><ForeName>Nhung Th</ForeName><Initials>NT</Initials><AffiliationInfo><Affiliation>Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway. Electronic address: nhung.trinh@farmasi.uio.no.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xf6;dicke</LastName><ForeName>Annika M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology Group, Health Data Sciences, Botnar Research Centre, NDORMS, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catal&#xe0;</LastName><ForeName>Mart&#xed;</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology Group, Health Data Sciences, Botnar Research Centre, NDORMS, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mercad&#xe9;-Besora</LastName><ForeName>N&#xfa;ria</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology Group, Health Data Sciences, Botnar Research Centre, NDORMS, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayati</LastName><ForeName>Saeed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lupattelli</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology Group, Health Data Sciences, Botnar Research Centre, NDORMS, University of Oxford, Oxford, UK; Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK; Department of Medical Informatics, Erasmus Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nordeng</LastName><ForeName>Hedvig Me</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway; Department of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Respir Med</MedlineTA><NlmUniqueID>101605555</NlmUniqueID><ISSNLinking>2213-2600</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009664" MajorTopicYN="N" Type="Geographic">Norway</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000087507" MajorTopicYN="N">Vaccine Efficacy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>DP-A's department has received grants from Amgen, Chiesi-Taylor, Lilly, Janssen, Novartis, UCB Biopharma, the European Medicines Agency, and the Innovative Medicines Initiative. DP-A's research group has received consultancy fees from Astra Zeneca and UCB Biopharma. DP-A's department has organised training programmes funded or supported by Amgen, Astellas, Janssen, Synapse Management Partners, and UCB Biopharma. HMEN reports support from the European Health Data and Evidence Network project grant, Innovative Medicines Initiative 2 Joint Undertaking (grant agreement 806968) for harmonisation of the Norwegian registry data into the Observational Medical Outcomes Partnership (OMOP) common data model (CDM). This initiative received support from the EU Horizon 2020 research and innovation programme and European Federation of Pharmaceutical Industries and Associations. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>3</Day><Hour>0</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>14</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>13</Day><Hour>18</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38614106</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(24)00082-1</ArticleId><ArticleId IdType="pii">S2213-2600(24)00082-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38626510</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0534</ISSN><JournalIssue CitedMedium="Internet"><Volume>174</Volume><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>Computers in biology and medicine</Title><ISOAbbreviation>Comput Biol Med</ISOAbbreviation></Journal><ArticleTitle>recruIT: A cloud-native clinical trial recruitment support system based on Health Level 7 Fast Healthcare Interoperability Resources (HL7 FHIR) and the Observational Medical Outcomes Partnership Common Data Model (OMOP CDM).</ArticleTitle><Pagination><StartPage>108411</StartPage><MedlinePgn>108411</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.compbiomed.2024.108411</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0010-4825(24)00495-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Clinical trials (CTs) are foundational to the advancement of evidence-based medicine and recruiting a sufficient number of participants is one of the crucial steps to their successful conduct. Yet, poor recruitment remains the most frequent reason for premature discontinuation or costly extension of clinical trials.</AbstractText><AbstractText Label="METHODS">We designed and implemented a novel, open-source software system to support the recruitment process in clinical trials by generating automatic recruitment recommendations. The development is guided by modern, cloud-native design principles and based on Health Level 7 (HL7) Fast Healthcare Interoperability Resources (FHIR) as an interoperability standard with the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) being used as a source of patient data. We evaluated the usability using the system usability scale (SUS) after deploying the application for use by study personnel.</AbstractText><AbstractText Label="RESULTS">The implementation is based on the OMOP CDM as a repository of patient data that is continuously queried for possible trial candidates based on given clinical trial eligibility criteria. A web-based screening list can be used to display the candidates and email notifications about possible new trial participants can be sent automatically. All interactions between services use HL7 FHIR as the communication standard. The system can be installed using standard container technology and supports more sophisticated deployments on Kubernetes clusters. End-users (n&#xa0;=&#xa0;19) rated the system with a SUS score of 79.9/100.</AbstractText><AbstractText Label="CONCLUSION">We contribute a novel, open-source implementation to support the patient recruitment process in clinical trials that can be deployed using state-of-the art technologies. According to the SUS score, the system provides good usability.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gulden</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, Department of Medical Informatics, Biometrics and Epidemiology, Medical Informatics, Erlangen, Germany. Electronic address: christian.gulden@fau.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macho</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medical Informatics, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinecke</LastName><ForeName>Ines</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Carl Gustav Carus Faculty of Medicine, Center for Medical Informatics, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strantz</LastName><ForeName>Cosima</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, Department of Medical Informatics, Biometrics and Epidemiology, Medical Informatics, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prokosch</LastName><ForeName>Hans-Ulrich</ForeName><Initials>HU</Initials><AffiliationInfo><Affiliation>Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, Department of Medical Informatics, Biometrics and Epidemiology, Medical Informatics, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blasini</LastName><ForeName>Romina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Medical Informatics, Justus Liebig University, Giessen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Comput Biol Med</MedlineTA><NlmUniqueID>1250250</NlmUniqueID><ISSNLinking>0010-4825</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067917" MajorTopicYN="Y">Cloud Computing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057208" MajorTopicYN="N">Health Level Seven</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073892" MajorTopicYN="N">Health Information Interoperability</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>28</Day><Hour>7</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>17</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>16</Day><Hour>18</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38626510</ArticleId><ArticleId IdType="doi">10.1016/j.compbiomed.2024.108411</ArticleId><ArticleId IdType="pii">S0010-4825(24)00495-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38635655</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>4</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>The OMOP common data model in Australian primary care data: Building a quality research ready harmonised dataset.</ArticleTitle><Pagination><StartPage>e0301557</StartPage><MedlinePgn>e0301557</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0301557</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0301557</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The use of routinely collected health data for secondary research purposes is increasingly recognised as a methodology that advances medical research, improves patient outcomes, and guides policy. This secondary data, as found in electronic medical records (EMRs), can be optimised through conversion into a uniform data structure to enable analysis alongside other comparable health metric datasets. This can be achieved with the Observational Medical Outcomes Partnership Common Data Model (OMOP-CDM), which employs a standardised vocabulary to facilitate systematic analysis across various observational databases. The concept behind the OMOP-CDM is the conversion of data into a common format through the harmonisation of terminologies, vocabularies, and coding schemes within a unique repository. The OMOP model enhances research capacity through the development of shared analytic and prediction techniques; pharmacovigilance for the active surveillance of drug safety; and 'validation' analyses across multiple institutions across Australia, the United States, Europe, and the Asia Pacific. In this research, we aim to investigate the use of the open-source OMOP-CDM in the PATRON primary care data repository.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We used standard structured query language (SQL) to construct, extract, transform, and load scripts to convert the data to the OMOP-CDM. The process of mapping distinct free-text terms extracted from various EMRs presented a substantial challenge, as many terms could not be automatically matched to standard vocabularies through direct text comparison. This resulted in a number of terms that required manual assignment. To address this issue, we implemented a strategy where our clinical mappers were instructed to focus only on terms that appeared with sufficient frequency. We established a specific threshold value for each domain, ensuring that more than 95% of all records were linked to an approved vocabulary like SNOMED once appropriate mapping was completed. To assess the data quality of the resultant OMOP dataset we utilised the OHDSI Data Quality Dashboard (DQD) to evaluate the plausibility, conformity, and comprehensiveness of the data in the PATRON repository according to the Kahn framework.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Across three primary care EMR systems we converted data on 2.03 million active patients to version 5.4 of the OMOP common data model. The DQD assessment involved a total of 3,570 individual evaluations. Each evaluation compared the outcome against a predefined threshold. A 'FAIL' occurred when the percentage of non-compliant rows exceeded the specified threshold value. In this assessment of the primary care OMOP database described here, we achieved an overall pass rate of 97%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The OMOP CDM's widespread international use, support, and training provides a well-established pathway for data standardisation in collaborative research. Its compatibility allows the sharing of analysis packages across local and international research groups, which facilitates rapid and reproducible data comparisons. A suite of open-source tools, including the OHDSI Data Quality Dashboard (Version 1.4.1), supports the model. Its simplicity and standards-based approach facilitates adoption and integration into existing data processes.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 Ward et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Roger</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Health &amp; Biomedical Research Information Technology Unit (HaBIC R2), Department of General Practice and Primary Care, Faculty of Medicine, Dentistry &amp; Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hallinan</LastName><ForeName>Christine Mary</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0002-0471-4444</Identifier><AffiliationInfo><Affiliation>Health &amp; Biomedical Research Information Technology Unit (HaBIC R2), Department of General Practice and Primary Care, Faculty of Medicine, Dentistry &amp; Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ormiston-Smith</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Health &amp; Biomedical Research Information Technology Unit (HaBIC R2), Department of General Practice and Primary Care, Faculty of Medicine, Dentistry &amp; Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chidgey</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Health &amp; Biomedical Research Information Technology Unit (HaBIC R2), Department of General Practice and Primary Care, Faculty of Medicine, Dentistry &amp; Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyle</LastName><ForeName>Dougie</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Health &amp; Biomedical Research Information Technology Unit (HaBIC R2), Department of General Practice and Primary Care, Faculty of Medicine, Dentistry &amp; Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060735" MajorTopicYN="N">Pharmacovigilance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>18</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>18</Day><Hour>13</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38635655</ArticleId><ArticleId IdType="pmc">PMC11025850</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0301557</ArticleId><ArticleId IdType="pii">PONE-D-23-42485</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jensen PB, Jensen LJ, Brunak S. Mining electronic health records: towards better research applications and clinical care. Nature Reviews Genetics. 2012;13(6):395&#x2013;405. doi: 10.1038/nrg3208</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3208</ArticleId><ArticleId IdType="pubmed">22549152</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh WR. Adding value to the electronic health record through secondary use of data for quality assurance, research, and surveillance. Clin Pharmacol Ther. 2007;81:126&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17567224</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. Journal of the American Medical Informatics Association. 2012;19(1):54&#x2013;60. doi: 10.1136/amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Biedermann P, Ong R, Davydov A, Orlova A, Solovyev P, Sun H, et al.. Standardizing registry data to the OMOP Common Data Model: experience from three pulmonary hypertension databases. BMC medical research methodology. 2021;21(1):238. doi: 10.1186/s12874-021-01434-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-021-01434-3</ArticleId><ArticleId IdType="pmc">PMC8565035</ArticleId><ArticleId IdType="pubmed">34727871</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent S, Burn E, Dawoud D, Jonsson P, &#xd8;stby JT, Hughes N, et al.. Common Problems, Common Data Model Solutions: Evidence Generation for Health Technology Assessment. PharmacoEconomics. 2021;39(3):275&#x2013;85. doi: 10.1007/s40273-020-00981-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-020-00981-9</ArticleId><ArticleId IdType="pmc">PMC7746423</ArticleId><ArticleId IdType="pubmed">33336320</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan HX, Teo DCH, Lee D, Kim C, Neo JW, Sung C, et al.. Applying the OMOP Common Data Model to Facilitate Benefit-Risk Assessments of Medicinal Products Using Real-World Data from Singapore and South Korea. Healthc Inform Res. 2022;28(2):112&#x2013;22. doi: 10.4258/hir.2022.28.2.112</Citation><ArticleIdList><ArticleId IdType="doi">10.4258/hir.2022.28.2.112</ArticleId><ArticleId IdType="pmc">PMC9117808</ArticleId><ArticleId IdType="pubmed">35576979</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. Observational Health Data Sciences and Informatics Data Standardization
2021.  [Available from: https://www.ohdsi.org/data-standardization/the-common-data-model/.</Citation></Reference><Reference><Citation>Ludwick DA, Doucette J. Adopting electronic medical records in primary care: Lessons learned from health information systems implementation experience in seven countries. International Journal of Medical Informatics. 2009;78(1):22&#x2013;31. doi: 10.1016/j.ijmedinf.2008.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2008.06.005</ArticleId><ArticleId IdType="pubmed">18644745</ArticleId></ArticleIdList></Reference><Reference><Citation>Reimer AP, Milinovich A, Madigan EA. Data quality assessment framework to assess electronic medical record data for use in research. International Journal of Medical Informatics. 2016;90:40&#x2013;7. doi: 10.1016/j.ijmedinf.2016.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2016.03.006</ArticleId><ArticleId IdType="pmc">PMC4845906</ArticleId><ArticleId IdType="pubmed">27103196</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Callahan TJ, Barnard J, Bauck AE, Brown J, Davidson BN, et al.. A Harmonized Data Quality Assessment Terminology and Framework for the Secondary Use of Electronic Health Record Data. EGEMS (Wash DC). 2016;4(1):1244. doi: 10.13063/2327-9214.1244</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1244</ArticleId><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle D, Sanci L, Emery J, Gunn J, Hocking JS, Manski-Nankervis J-A, et al.. PATRON Primary Care Research Data Repository. University of Melbourne. Dataset. 2019.  [Available from: https://medicine.unimelb.edu.au/school-structure/general-practice/engagement/data-for-decisions.</Citation></Reference><Reference><Citation>Hallinan CM, Ward R, Hart GK, Sullivan C, Pratt N, Ng AP, et al.. Integrated Data Governance, Digital Health, and the Common Data Model (OMOP-CDM). BMJ Health &amp; Care Informatics. 2024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10882353</ArticleId><ArticleId IdType="pubmed">38387992</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle DI. Middleware Supporting Next Generation Data Analytics in Australia. Stud Health Technol Inform. 2015;216:1019.</Citation><ArticleIdList><ArticleId IdType="pubmed">26262320</ArticleId></ArticleIdList></Reference><Reference><Citation>RACGP. RACGP Standards for general practices 4thEdition ed. East Melbourne, Australia: Royal Australian College of General Practitioners; 2015.</Citation></Reference><Reference><Citation>Boyle D, Sanci L, Emery J, Gunn J, Hocking J. S, Manski-Nankervis J.-A, et al.. Patron Data Governance Framework Department of General Practice Faculty of Medicine, Dentistry &amp; Health Sciences 2019.  [Available from: https://medicine.unimelb.edu.au/__data/assets/pdf_file/0016/3020272/Governance-Framework.pdf.</Citation></Reference><Reference><Citation>Varkey B. Principles of Clinical Ethics and Their Application to Practice. Med Princ Pract. 2021;30(1):17&#x2013;28. doi: 10.1159/000509119</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000509119</ArticleId><ArticleId IdType="pmc">PMC7923912</ArticleId><ArticleId IdType="pubmed">32498071</ArticleId></ArticleIdList></Reference><Reference><Citation>NHMRC. National Statement on Ethical Conduct in Human Research (2007)&#x2014;Updated 2018. National Health and Medical Research Council; 2018.</Citation></Reference><Reference><Citation>Hughes N, John H, Miani M, Soininen I, Tischler R, Ryan P, et al.. EHDEN Academy a global training collaboration with OHDSI. 2022 OHDSI European Symposium; Rotterdam 2022.</Citation></Reference><Reference><Citation>Metke-Jimenez A, Steel J, Hansen D, Lawley M. Ontoserver: a syndicated terminology server. J Biomed Semantics. 2018;9(1):24. doi: 10.1186/s13326-018-0191-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13326-018-0191-z</ArticleId><ArticleId IdType="pmc">PMC6142703</ArticleId><ArticleId IdType="pubmed">30223897</ArticleId></ArticleIdList></Reference><Reference><Citation>Angela W, Rachel D, Sam H, Jennifer C, Samantha I, Venexia W, et al.. Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource. Bmj. 2021;373:n826. doi: 10.1136/bmj.n826</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n826</ArticleId><ArticleId IdType="pmc">PMC8413899</ArticleId><ArticleId IdType="pubmed">33827854</ArticleId></ArticleIdList></Reference><Reference><Citation>Snijders BEP, van der Hoek W, Stirbu I, van der Sande MAB, van Gageldonk-Lafeber AB. General practitioners&#x2019; contribution to the management of community-acquired pneumonia in the Netherlands: a retrospective analysis of primary care, hospital, and national mortality databases with individual data linkage. Primary Care Respiratory Journal. 2013;22(4):400&#x2013;5. doi: 10.4104/pcrj.2013.00085</Citation><ArticleIdList><ArticleId IdType="doi">10.4104/pcrj.2013.00085</ArticleId><ArticleId IdType="pmc">PMC6442853</ArticleId><ArticleId IdType="pubmed">24042173</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouras G, Markar SR, Burns EM, Mackenzie HA, Bottle A, Athanasiou T, et al.. Linked Hospital and Primary Care Database Analysis of the Incidence and Impact of Psychiatric Morbidity Following Gastrointestinal Cancer Surgery in England. Ann Surg. 2016;264(1):93&#x2013;9. doi: 10.1097/SLA.0000000000001415</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000001415</ArticleId><ArticleId IdType="pubmed">26649592</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38658170</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1464-3685</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>11</Day></PubDate></JournalIssue><Title>International journal of epidemiology</Title><ISOAbbreviation>Int J Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Data Resource Profile: Health Insurance Review and Assessment Service Covid-19 Observational Medical Outcomes Partnership (HIRA Covid-19 OMOP) database in South Korea.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">dyae062</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ije/dyae062</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Chungsoo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1802-1777</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Dong Han</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Big Data Department, Health Insurance Assessment and Review Services, Wonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baek</LastName><ForeName>Hyeran</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Big Data Department, Health Insurance Assessment and Review Services, Wonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Jaehyeong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Research, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Innovation in Digital Healthcare, Yonsei University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0003-4989-3287</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Epidemiol</MedlineTA><NlmUniqueID>7802871</NlmUniqueID><ISSNLinking>0300-5771</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007348" MajorTopicYN="N">Insurance, Health</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>25</Day><Hour>0</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>25</Day><Hour>0</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>24</Day><Hour>21</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38658170</ArticleId><ArticleId IdType="doi">10.1093/ije/dyae062</ArticleId><ArticleId IdType="pii">7657790</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38660421</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Health data space nodes for privacy-preserving linkage of medical data to support collaborative secondary analyses.</ArticleTitle><Pagination><StartPage>1301660</StartPage><MedlinePgn>1301660</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1301660</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2024.1301660</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">The potential for secondary use of health data to improve healthcare is currently not fully exploited. Health data is largely kept in isolated data silos and key infrastructure to aggregate these silos into standardized bodies of knowledge is underdeveloped. We describe the development, implementation, and evaluation of a federated infrastructure to facilitate versatile secondary use of health data based on Health Data Space nodes.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">Our proposed nodes are self-contained units that digest data through an extract-transform-load framework that pseudonymizes and links data with privacy-preserving record linkage and harmonizes into a common data model (OMOP CDM). To support collaborative analyses a multi-level feature store is also implemented. A feasibility experiment was conducted to test the infrastructures potential for machine learning operations and deployment of other apps (e.g., visualization). Nodes can be operated in a network at different levels of sharing according to the level of trust within the network.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In a proof-of-concept study, a privacy-preserving registry for heart failure patients has been implemented as a real-world showcase for Health Data Space nodes at the highest trust level, linking multiple data sources including (a) electronical medical records from hospitals, (b) patient data from a telemonitoring system, and (c) data from Austria's national register of deaths. The registry is deployed at the tirol kliniken, a hospital carrier in the Austrian state of Tyrol, and currently includes 5,004 patients, with over 2.9 million measurements, over 574,000 observations, more than 63,000 clinical free text notes, and in total over 5.2 million data points. Data curation and harmonization processes are executed semi-automatically at each individual node according to data sharing policies to ensure data sovereignty, scalability, and privacy. As a feasibility test, a natural language processing model for classification of clinical notes was deployed and tested.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">The presented Health Data Space node infrastructure has proven to be practicable in a real-world implementation in a live and productive registry for heart failure. The present work was inspired by the European Health Data Space initiative and its spirit to interconnect health data silos for versatile secondary use of health data.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Baumgartner, Kreiner, Lauschensky, Jammerbund, Donsa, Hayn, Wiesm&#xfc;ller, Demelius, Modre-Osprian, Neururer, Slamanig, Prantl, Brunelli, Pfeifer, P&#xf6;lzl and Schreier.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baumgartner</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Health and Bioresources, AIT Austrian Institute of Technology, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Neural Engineering, Graz University of Technology, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kreiner</LastName><ForeName>Karl</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for Health and Bioresources, AIT Austrian Institute of Technology, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lauschensky</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Health and Bioresources, AIT Austrian Institute of Technology, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jammerbund</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Center for Health and Bioresources, AIT Austrian Institute of Technology, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donsa</LastName><ForeName>Klaus</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for Health and Bioresources, AIT Austrian Institute of Technology, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayn</LastName><ForeName>Dieter</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Health and Bioresources, AIT Austrian Institute of Technology, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ludwig Boltzmann Institute for Digital Health and Prevention, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiesm&#xfc;ller</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center for Health and Bioresources, AIT Austrian Institute of Technology, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Neural Engineering, Graz University of Technology, Graz, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ludwig Boltzmann Institute for Digital Health and Prevention, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demelius</LastName><ForeName>Lea</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Interactive Systems and Data Science, Graz University of Technology, Graz, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Know-Center GmbH, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Modre-Osprian</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>telbiomed Medizintechnik und IT Service GmbH, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neururer</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Tyrolean Federal Institute for Integrated Care, Tirol Kliniken GmbH, Innsbruck, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division for Digital Health and Telemedicine, UMIT TIROL-Private University for Health Sciences and Technology, Hall in Tyrol, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slamanig</LastName><ForeName>Gerald</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Tirol Kliniken GmbH, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prantl</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tirol Kliniken GmbH, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunelli</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfeifer</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division for Digital Health and Telemedicine, UMIT TIROL-Private University for Health Sciences and Technology, Hall in Tyrol, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tyrolean Federal Institute for Integrated Care, Tirol Kliniken GmbH, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xf6;lzl</LastName><ForeName>Gerhard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schreier</LastName><ForeName>G&#xfc;nter</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Health and Bioresources, AIT Austrian Institute of Technology, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Neural Engineering, Graz University of Technology, Graz, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">European Health Data Space</Keyword><Keyword MajorTopicYN="N">advanced analytics</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">data-driven healthcare</Keyword><Keyword MajorTopicYN="N">interoperability</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">privacy-preservation</Keyword><Keyword MajorTopicYN="N">record linkage</Keyword></KeywordList><CoiStatement>RM-O and GSc hold shares of telbiomed Medizintechnik und IT Service GmbH, where RM-O is also employed as CEO. LD was employed by Know-Center GmbH. SN, GSl, SP, and BP were employed by Tirol Kliniken GmbH. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>25</Day><Hour>4</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38660421</ArticleId><ArticleId IdType="pmc">PMC11039786</ArticleId><ArticleId IdType="doi">10.3389/fmed.2024.1301660</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, et al. . Real-world evidence&#x2014;what is it and what can it tell us? N Engl J Med. (2016) 375:2293&#x2013;7. doi: 10.1056/NEJMsb1609216, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsb1609216</ArticleId><ArticleId IdType="pubmed">27959688</ArticleId></ArticleIdList></Reference><Reference><Citation>Beresniak A, Schmidt A, Proeve J, Bolanos E, Patel N, Ammour N, et al. . Cost-benefit assessment of using electronic health records data for clinical research versus current practices: contribution of the electronic health Records for Clinical Research (EHR4CR) European project. Contemp Clin Trials. (2016) 46:85&#x2013;91. doi: 10.1016/j.cct.2015.11.011, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2015.11.011</ArticleId><ArticleId IdType="pubmed">26600286</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruland P, McGilchrist M, Zapletal E, Acosta D, Proeve J, Askin S, et al. . Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting. BMC Med Res Methodol. (2016) 16:159. doi: 10.1186/s12874-016-0259-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-016-0259-3</ArticleId><ArticleId IdType="pmc">PMC5118882</ArticleId><ArticleId IdType="pubmed">27875988</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers L, Stevens J. Using EHR to conduct outcome and health services research In: Secondary Analysis of Electronic Health Records. ed. Celi L., Charlton P., Ghassemi M. M., Johnson A., Komorowski M., Marshall D., Cham (CH): Springer; (2016). 61&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">31314265</ArticleId></ArticleIdList></Reference><Reference><Citation>Poelzl G, Egelseer-Bruendl T, Pfeifer B, Modre-Osprian R, Welte S, Fetz B, et al. . Feasibility and effectiveness of a multidimensional post-discharge disease management programme for heart failure patients in clinical practice: the HerzMobil Tirol programme. Clin Res Cardiol. (2022) 111:294&#x2013;307. doi: 10.1007/s00392-021-01912-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-021-01912-0</ArticleId><ArticleId IdType="pubmed">34269863</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Boussard T, Monda KL, Crespo BC, Riskin D. Real world evidence in cardiovascular medicine: ensuring data validity in electronic health record-based studies. J Am Med Inform Assoc. (2019) 26:1189&#x2013;94. doi: 10.1093/jamia/ocz119, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocz119</ArticleId><ArticleId IdType="pmc">PMC6798570</ArticleId><ArticleId IdType="pubmed">31414700</ArticleId></ArticleIdList></Reference><Reference><Citation>Kannan V, Fish JS, Mutz JM, Carrington AR, Lai K, Davis LS, et al. . Rapid development of specialty population registries and quality measures from electronic health record data*. An Agile Framework. Methods Inf Med. (2017) 56:e74&#x2013;83. doi: 10.3414/ME16-02-0031, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME16-02-0031</ArticleId><ArticleId IdType="pmc">PMC5608102</ArticleId><ArticleId IdType="pubmed">28930362</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirchev M, Mircheva I, Kerekovska A. The academic viewpoint on patient data ownership in the context of big data: scoping review. J Med Internet Res. (2020) 22:e22214. doi: 10.2196/22214, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/22214</ArticleId><ArticleId IdType="pmc">PMC7463395</ArticleId><ArticleId IdType="pubmed">32808934</ArticleId></ArticleIdList></Reference><Reference><Citation>Miguel Cruz A, Marshall S, Daum C, Perez H, Hirdes J, Liu L. Data silos undermine efforts to characterize, predict, and mitigate dementia-related missing person incidents. Healthc Manag forum. (2022) 35:333&#x2013;8. doi: 10.1177/08404704221106156, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08404704221106156</ArticleId><ArticleId IdType="pmc">PMC9615336</ArticleId><ArticleId IdType="pubmed">35678379</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves J, Meneses R. Silos mentality in healthcare services. In: 11th Annual Conference of the EuroMed Academy of Business. (2018)</Citation></Reference><Reference><Citation>Ammenwerth E, Modre-Osprian R, Fetz B, Gstrein S, Krestan S, D&#xf6;rler J, et al. . HerzMobil, an integrated and collaborative Telemonitoring-based disease management program for patients with heart failure: a feasibility study paving the way to routine care. JMIR Cardio. (2018) 2:e11. doi: 10.2196/cardio.9936, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/cardio.9936</ArticleId><ArticleId IdType="pmc">PMC6857958</ArticleId><ArticleId IdType="pubmed">31758765</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, LaRue EM. Linking the health data system in the U.S.: challenges to the benefits. Int J Nurs Sci. (2017) 4:410&#x2013;7. doi: 10.1016/j.ijnss.2017.09.006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnss.2017.09.006</ArticleId><ArticleId IdType="pmc">PMC6626162</ArticleId><ArticleId IdType="pubmed">31406785</ArticleId></ArticleIdList></Reference><Reference><Citation>Langner I, Riedel O, Czwikla J, Heinze F, Rothgang H, Zeeb H, et al. . Linkage of routine data to other data sources in Germany: a practical example illustrating challenges and solutions. Das Gesundheitswes. (2020) 82:S117&#x2013;21. doi: 10.1055/a-0999-5509</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-0999-5509</ArticleId><ArticleId IdType="pubmed">31791067</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayefi M, Ngo P, Chomutare T, Dalianis H, Salvi E, Budrionis A, et al. . Challenges and opportunities beyond structured data in analysis of electronic health records. WIREs Comput Stat. (2021) 13:e1549. doi: 10.1002/wics.1549</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wics.1549</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizi SAM, Roudsari A. Development of a public health reporting data warehouse: lessons learned. Stud Health Technol Inform. (2013) 192:861&#x2013;5. doi: 10.3233/978-1-61499-289-9-861 PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/978-1-61499-289-9-861</ArticleId><ArticleId IdType="pubmed">23920680</ArticleId></ArticleIdList></Reference><Reference><Citation>Regulation (EU)  2016/679 of the European Parliament and of The Council. (2016) Available at:
https://eur-lex.europa.eu/eli/reg/2016/679/oj</Citation></Reference><Reference><Citation>R&#xe4;dsch T, Reinke A, Weru V, Tizabi MD, Schreck N, Kavur AE, et al. . Labelling instructions matter in biomedical image analysis. Nat Mach Intell. (2023) 5:273&#x2013;83. doi: 10.1038/s42256-023-00625-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42256-023-00625-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Sculley D, Holt G, Golovin D, Davydov E, Phillips T, Ebner D, et al. . Hidden technical debt in machine learning systems. Adv Neural Inf Proces Syst. (2015) 28:2503&#x2013;2511</Citation></Reference><Reference><Citation>Patel J. The democratization of machine learning features. In: 2020 IEEE 21st International Conference on Information Reuse and Integration for Data Science (IRI). (2020). p. 136&#x2013;141.</Citation></Reference><Reference><Citation>Kim M. Software engineering for data analytics. IEEE Softw. (2020) 37:36&#x2013;42. doi: 10.1109/MS.2020.2985775</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/MS.2020.2985775</ArticleId></ArticleIdList></Reference><Reference><Citation>Khattak FK, Subasri V, Krishnan A, Dolatabadi E, Pandya D, Seyyed-Kalantari L. MLHOps: machine learning for healthcare operations. arXiv [Preprint]. arXiv230502474 (2023)</Citation></Reference><Reference><Citation>Gagalova KK, Leon Elizalde MA, Portales-Casamar E, G&#xf6;rges M. What you need to know before implementing a clinical research data warehouse: comparative review of integrated data repositories in health care institutions. JMIR Form Res. (2020) 4:e17687. doi: 10.2196/17687, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/17687</ArticleId><ArticleId IdType="pmc">PMC7484778</ArticleId><ArticleId IdType="pubmed">32852280</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaye A, Marcon Y, Isaeva J, LaFlamme P, Turner A, Jones EM, et al. . DataSHIELD: taking the analysis to the data, not the data to the analysis. Int J Epidemiol. (2014) 43:1929&#x2013;44. doi: 10.1093/ije/dyu188, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyu188</ArticleId><ArticleId IdType="pmc">PMC4276062</ArticleId><ArticleId IdType="pubmed">25261970</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyan O, Choudhury A, Van Soest J, Kohlbacher O, Zimmermann L, Stenzhorn H, et al. . Distributed analytics on sensitive medical data: the personal health train. Data Intell. (2020) 2:96&#x2013;107. doi: 10.1162/dint_a_00032</Citation><ArticleIdList><ArticleId IdType="doi">10.1162/dint_a_00032</ArticleId></ArticleIdList></Reference><Reference><Citation>Marwan M, Kartit A, Ouahmane H. Applying secure multi-party computation to improve collaboration in healthcare cloud. In: 2016 Third International Conference on Systems of Collaboration (SysCo). (2016). p. 1&#x2013;6.</Citation></Reference><Reference><Citation>Alghamdi W, Salama R, Sirija M, Abbas AR, Dilnoza K. Secure multi-party computation for collaborative data analysis. In: E3S Web of Conferences. EDP Sciences (2023). p. 4034</Citation></Reference><Reference><Citation>Tso R, Alelaiwi A, Mizanur Rahman SM, Wu M-E, Hossain MS. Privacy-preserving data communication through secure multi-party computation in healthcare sensor cloud. J Signal Process Syst. (2017) 89:51&#x2013;9. doi: 10.1007/s11265-016-1198-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11265-016-1198-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan K, Wang S, Ren Y, Li H, Yang Y. MedBlock: efficient and secure medical data sharing via Blockchain. J Med Syst. (2018) 42:136. doi: 10.1007/s10916-018-0993-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10916-018-0993-7</ArticleId><ArticleId IdType="pubmed">29931655</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Q, Sifah EB, Asamoah KO, Gao J, Du X, Guizani M. MeDShare: trust-less medical data sharing among cloud service providers via Blockchain. IEEE Access. (2017) 5:14757&#x2013;67. doi: 10.1109/ACCESS.2017.2730843</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/ACCESS.2017.2730843</ArticleId></ArticleIdList></Reference><Reference><Citation>Azaria A, Ekblaw A, Vieira T, Lippman A. MedRec: using Blockchain for medical data access and permission management. In: 2016 2nd International Conference on Open and Big Data (OBD). (2016). p. 25&#x2013;30.</Citation></Reference><Reference><Citation>Cerchione R, Centobelli P, Riccio E, Abbate S, Oropallo E. Blockchain&#x2019;s coming to hospital to digitalize healthcare services: designing a distributed electronic health record ecosystem. Technovation. (2023) 120:102480. doi: 10.1016/j.technovation.2022.102480</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.technovation.2022.102480</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbate S, Centobelli P, Cerchione R, Oropallo E, Riccio E. Blockchain Technology for Embracing Healthcare 4.0. IEEE Trans Eng Manag. (2023) 70:2998&#x2013;3009. doi: 10.1109/TEM.2022.3212007</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TEM.2022.3212007</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumgartner M, Veeranki SPK, Hayn D, Schreier G. Introduction and comparison of novel decentral learning schemes with multiple data pools for privacy-preserving ECG classification. J Healthc Informatics Res. (2023) 7:291&#x2013;312. doi: 10.1007/s41666-023-00142-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41666-023-00142-5</ArticleId><ArticleId IdType="pmc">PMC10449753</ArticleId><ArticleId IdType="pubmed">37637722</ArticleId></ArticleIdList></Reference><Reference><Citation>Haggenm&#xfc;ller S, Schmitt M, Krieghoff-Henning E, Hekler A, Maron RC, Wies C, et al. . Federated learning for decentralized artificial intelligence in melanoma diagnostics. JAMA Dermatol. (2024) 160:303. doi: 10.1001/jamadermatol.2023.5550</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamadermatol.2023.5550</ArticleId><ArticleId IdType="pmc">PMC10851139</ArticleId><ArticleId IdType="pubmed">38324293</ArticleId></ArticleIdList></Reference><Reference><Citation>Tedeschini BC, Savazzi S, Stoklasa R, Barbieri L, Stathopoulos I, Nicoli M, et al. . Decentralized federated learning for healthcare networks: a case study on tumor segmentation. IEEE Access. (2022) 10:8693&#x2013;708. doi: 10.1109/ACCESS.2022.3141913</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/ACCESS.2022.3141913</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth FN, Meurers T, Johns M, Prasser F. Privacy-preserving data sharing infrastructures for medical research: systematization and comparison. BMC Med Inform Decis Mak. (2021) 21:242. doi: 10.1186/s12911-021-01602-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-021-01602-x</ArticleId><ArticleId IdType="pmc">PMC8359765</ArticleId><ArticleId IdType="pubmed">34384406</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin H, Luo Y, Li P, Mathew J. A review of secure and privacy-preserving medical data sharing. IEEE Access. (2019) 7:61656&#x2013;69. doi: 10.1109/ACCESS.2019.2916503</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/ACCESS.2019.2916503</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, Gainer V, Chueh HC, Churchill S, et al. . Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2). J Am Med Inform Assoc. (2010) 17:124&#x2013;30. doi: 10.1136/jamia.2009.000893, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.000893</ArticleId><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Szalma S, Koka V, Khasanova T, Perakslis ED. Effective knowledge management in translational medicine. J Transl Med. (2010) 8:68. doi: 10.1186/1479-5876-8-68, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-8-68</ArticleId><ArticleId IdType="pmc">PMC2914663</ArticleId><ArticleId IdType="pubmed">20642836</ArticleId></ArticleIdList></Reference><Reference><Citation>i2b2 tranSMART Foundation . Available at:
https://i2b2transmart.org/ (n.d.). (Accessed 12 January 2023).</Citation></Reference><Reference><Citation>Doel T, Shakir DI, Pratt R, Aertsen M, Moggridge J, Bellon E, et al. . GIFT-cloud: a data sharing and collaboration platform for medical imaging research. Comput Methods Prog Biomed. (2017) 139:181&#x2013;90. doi: 10.1016/j.cmpb.2016.11.004, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2016.11.004</ArticleId><ArticleId IdType="pmc">PMC5312116</ArticleId><ArticleId IdType="pubmed">28187889</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudini E, Andrews J, Lawrence DM, King-Smith SL, Baker N, Baxter L, et al. . Shariant platform: enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretation. Am J Hum Genet. (2022) 109:1960&#x2013;73. doi: 10.1016/j.ajhg.2022.10.006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9674965</ArticleId><ArticleId IdType="pubmed">36332611</ArticleId></ArticleIdList></Reference><Reference><Citation>Damgov I, Bartosova M, Marinovic I, Istanbuly O, Kieser M, Lambie M, et al. . IMPROVE-PD finder: a web-based platform to search and share peritoneal Dialysis biobank, registry and clinical trial metadata. Kidney Int Rep. (2023) 8:912&#x2013;5. doi: 10.1016/j.ekir.2023.01.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ekir.2023.01.003</ArticleId><ArticleId IdType="pmc">PMC10105041</ArticleId><ArticleId IdType="pubmed">37069973</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruendner J, Schwachhofer T, Sippl P, Wolf N, Erpenbeck M, Gulden C, et al. . KETOS: clinical decision support and machine learning as a service&#x2013;a training and deployment platform based on Docker, OMOP-CDM, and FHIR web services. PLoS One. (2019) 14:e0223010. doi: 10.1371/journal.pone.0223010, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0223010</ArticleId><ArticleId IdType="pmc">PMC6776354</ArticleId><ArticleId IdType="pubmed">31581246</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitzlnader M, Schreier G. Patient identity management for secondary use of biomedical research data in a distributed computing environment. Stud Health Technol Inform. (2014) 198:211&#x2013;8. doi: 10.3233/978-1-61499-397-1-211 PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/978-1-61499-397-1-211</ArticleId><ArticleId IdType="pubmed">24825705</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnell R, Bachteler T, Reiher J. A novel error-tolerant anonymous linking code. SSRN Electr J. (2011):3549247. doi: 10.2139/ssrn.3549247</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3549247</ArticleId></ArticleIdList></Reference><Reference><Citation>Broder AZ. Identifying and filtering near-duplicate documents. In: Annual symposium on combinatorial pattern matching. Springer (2000). p. 1&#x2013;10.</Citation></Reference><Reference><Citation>Baumgartner M, Schreier G, Hayn D, Kreiner K, Haider L, Wiesm&#xfc;ller F, et al. . Impact analysis of De-identification in clinical notes classification. Stud Health Technol Inform. (2022) 293:189&#x2013;96. doi: 10.3233/SHTI220368, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI220368</ArticleId><ArticleId IdType="pubmed">35592981</ArticleId></ArticleIdList></Reference><Reference><Citation>Dempster M, Donnelly M, O&#x2019;Loughlin C. The validity of the MacNew quality of life in heart disease questionnaire. Health Qual Life Outcomes. (2004) 2:6. doi: 10.1186/1477-7525-2-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-2-6</ArticleId><ArticleId IdType="pmc">PMC333433</ArticleId><ArticleId IdType="pubmed">14738566</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreiner K, Hayn D, Schreier G. Twister: A Tool for Reducing Screening Time in Systematic Literature Reviews. Stud Health Technol Inform. (2018) 255:5&#x2013;9. doi: 10.3233/978-1-61499-921-8-5</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/978-1-61499-921-8-5</ArticleId><ArticleId IdType="pubmed">30306896</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. . Scikit-learn: machine learning in Python. J Mach Learn Res. (2011) 12:2825&#x2013;30. doi: 10.48550/arXiv.1201.0490</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1201.0490</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman M, Bach F, Blei D. Online learning for latent dirichlet allocation. Adv Neural Inf Proces Syst. (2010) 23:856&#x2013;864</Citation></Reference><Reference><Citation>Hossain S, Calloway C, Lippa D, Niederhut D, Shupe D. Visualization of bioinformatics data with dash bio. In: Proceedings of the 18th Python in Science Conference. SciPy, Austin, Texas, pp. 126&#x2013;133 (2019).</Citation></Reference><Reference><Citation>Randall SM, Ferrante AM, Boyd JH, Bauer JK, Semmens JB. Privacy-preserving record linkage on large real world datasets. J Biomed Inform. (2014) 50:205&#x2013;12. doi: 10.1016/j.jbi.2013.12.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2013.12.003</ArticleId><ArticleId IdType="pubmed">24333482</ArticleId></ArticleIdList></Reference><Reference><Citation>European Commission . A European Strategy for data. (n.d.). Available at:
https://digital-strategy.ec.europa.eu/en/policies/strategy-data</Citation></Reference><Reference><Citation>Wilkinson MD, Dumontier M, IjJ A, Appleton G, Axton M, Baak A, et al. . The FAIR guiding principles for scientific data management and stewardship. Sci Data. (2016) 3:1&#x2013;9. doi: 10.1038/sdata.2016.18</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2016.18</ArticleId><ArticleId IdType="pmc">PMC4792175</ArticleId><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Court of Justice of the European Union . The court of justice declares that the Commision&#x2019;s US safe harbour decision is invalid. Maximillian Schrems v Data Prot Comm (2015) Judgment in Case C-362/14. Available at: http://curia.europa.eu/jcms/upload/docs/application/pdf/2015-10/cp150117en.pdf</Citation></Reference><Reference><Citation>Court of Justice of the European Union . The court of justice invalidates decision 2016/1250 on the adequacy of the protection provided by the EU-US data protection shield. Data Prot Comm v Faceb Irel Maximillian Schrems (2020) 46:n.p. Available at: https://curia.europa.eu/jcms/upload/docs/application/pdf/2020-07/cp200091en.pdf</Citation></Reference><Reference><Citation>European Commission . European health data space. eHealth Digit Heal care (2023) Available at:
https://health.ec.europa.eu/ehealth-digital-health-and-care/european-health-data-space_en (Accessed 22 May 2023).</Citation></Reference><Reference><Citation>Eclipse Foundation . Eclipse Dataspace Components. (n.d.). Available at:
https://projects.eclipse.org/projects/technology.edc (Accessed 24 August 2023).</Citation></Reference><Reference><Citation>Nast M, Rother B, Golatowski F, Timmermann D, Leveling J, Olms C. Work-in-Progress: towards an international data spaces connector for the internet of things. In: 2020 16th IEEE International Conference on Factory Communication Systems (WFCS). (2020). p. 1&#x2013;4.</Citation></Reference><Reference><Citation>Braud A, Fromentoux G, Radier B, Le GO. The road to European digital sovereignty with Gaia-X and IDSA. IEEE Netw. (2021) 35:4&#x2013;5. doi: 10.1109/MNET.2021.9387709</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/MNET.2021.9387709</ArticleId></ArticleIdList></Reference><Reference><Citation>Venters CC, Jay C, Lau LMS, Griffiths MK, Holmes V, Ward RR, et al. . Software sustainability: the modern tower of babel. In: CEUR Workshop Proceedings CEUR (2014). p. 7&#x2013;12</Citation></Reference><Reference><Citation>Venters C, Lau LMS, Griffiths M, Holmes V, Ward R, Jay C, et al. . The blind men and the elephant: towards an empirical evaluation framework for software sustainability. J Open Res Softw. (2014) 2:1&#x2013;6. doi: 10.5334/jors.ao</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/jors.ao</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38682500</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>313</Volume><PubDate><Year>2024</Year><Month>Apr</Month><Day>26</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Mapping the Bulgarian Diabetes Register to OMOP CDM: Application Results.</ArticleTitle><Pagination><StartPage>28</StartPage><EndPage>33</EndPage><MedlinePgn>28-33</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI240007</ELocationID><Abstract><AbstractText Label="BACKGROUND">The Bulgaria Diabetes Register (BDR) contains more than 380 millions of pseudonymized outpatient records with proprietary data structures and format.</AbstractText><AbstractText Label="OBJECTIVES">This paper presents the application results and experience acquired during the process of mapping such observational health data to OMOP CDM with the objective of publishing it in the European Health Data and Evidence Network (EHDEN) Portal.</AbstractText><AbstractText Label="METHODS">The data mapping follows the activities of the well-structured Extract-Transform-Load process. Unlike other publications, we focus on the need for preprocessing the data structures of raw data, cleaning data and procedures for assuring quality of data.</AbstractText><AbstractText Label="RESULTS">This paper provides quantitative and statistical measures for the records in the CDM database as published in the EHDEN Portal.</AbstractText><AbstractText Label="CONCLUSION">The mapping of data from the BDR to OMOP CDM provides the EHDEN community with opportunities for including these data in large-scale project for evidence generation by applying standard analytical tools.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krastev</LastName><ForeName>Evgeniy</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Sofia University St. Kliment Ohridski, Bulgaria (EFMI institutional member).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Markov</LastName><ForeName>Emanuil</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Technical University, Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abanos</LastName><ForeName>Simeon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sofia University St. Kliment Ohridski, Bulgaria (EFMI institutional member).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krasteva</LastName><ForeName>Ralitsa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Specialized Hospital for Active Treatment of Children's Diseases, Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tcharaktchiev</LastName><ForeName>Dimitar</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Medical University, Sofia, Bulgaria (EFMI institutional member).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002031" MajorTopicYN="N" Type="Geographic">Bulgaria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diabetes Mellitus</Keyword><Keyword MajorTopicYN="N">Electronic Health Records</Keyword><Keyword MajorTopicYN="N">Medical Informatics Applications</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">Registries</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>29</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>29</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38682500</ArticleId><ArticleId IdType="doi">10.3233/SHTI240007</ArticleId><ArticleId IdType="pii">SHTI240007</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38682513</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>313</Volume><PubDate><Year>2024</Year><Month>Apr</Month><Day>26</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Towards an Electronic Health Prevention Record Based on HL7 FHIR and the OMOP Common Data Model.</ArticleTitle><Pagination><StartPage>107</StartPage><EndPage>112</EndPage><MedlinePgn>107-112</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI240020</ELocationID><Abstract><AbstractText Label="BACKGROUND">Approximately 40% of all recorded deaths in Austria are due to behavioral risks. These risks could be avoided with appropriate measures.</AbstractText><AbstractText Label="OBJECTIVES">Extension of the concept of EHR and EMR to an electronic prevention record, focusing on primary and secondary prevention.</AbstractText><AbstractText Label="METHODS">The concept of a structured prevention pathway, based on the principles of P4 Medicine, was developed for a multidisciplinary prevention network. An IT infrastructure based on HL7 FHIR and the OHDSI OMOP common data model was designed.</AbstractText><AbstractText Label="RESULTS">An IT solution supporting a structured and modular prevention pathway was conceptualized. It contained a personalized management of prevention, risk assessment, diagnostic and preventive measures supported by a modular, interoperable IT infrastructure including a health app, prevention record web-service, decision support modules and a smart prevention registry, separating primary and secondary use of data.</AbstractText><AbstractText Label="CONCLUSION">A concept was created on how an electronic health prevention record based on HL7 FHIR and the OMOP common data model can be implemented.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Falgenhauer</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>AIT Austrian Institute of Technology GmbH, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lauschensky</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>AIT Austrian Institute of Technology GmbH, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kreiner</LastName><ForeName>Karl</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>AIT Austrian Institute of Technology GmbH, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beyer</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>AIT Austrian Institute of Technology GmbH, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reiter</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>telbiomed Medizintechnik und IT Service GmbH, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziegl</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>AIT Austrian Institute of Technology GmbH, Graz, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>telbiomed Medizintechnik und IT Service GmbH, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Modre-Osprian</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>telbiomed Medizintechnik und IT Service GmbH, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfeifer</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Tyrolean Federal Institute for Integrated Care, Tirol Kliniken, Innsbruck, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division for Digital Health and Telemedicine, UMIT TIROL - Private University for Health Sciences and Health Technology, Hall (Tyrol), Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neururer</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tyrolean Federal Institute for Integrated Care, Tirol Kliniken, Innsbruck, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division for Digital Health and Telemedicine, UMIT TIROL - Private University for Health Sciences and Health Technology, Hall (Tyrol), Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krestan</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tyrolean Federal Institute for Integrated Care, Tirol Kliniken, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagner</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Tyrolean Federal Institute for Integrated Care, Tirol Kliniken, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huber</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tyrolean Federal Institute for Integrated Care, Tirol Kliniken, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plaikner</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>EUTOPS Institute, University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuppelwieser</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>EUTOPS Institute, University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tirol Kliniken GmbH, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Widschwendter</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>EUTOPS Institute, University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tirol Kliniken GmbH, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schreier</LastName><ForeName>G&#xfc;nter</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>AIT Austrian Institute of Technology GmbH, Graz, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001317" MajorTopicYN="N" Type="Geographic">Austria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057208" MajorTopicYN="Y">Health Level Seven</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011322" MajorTopicYN="N">Primary Prevention</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Electronic Health Records</Keyword><Keyword MajorTopicYN="N">HL7 FHIR</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">Primary Prevention</Keyword><Keyword MajorTopicYN="N">Secondary Prevention</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>29</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>29</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38682513</ArticleId><ArticleId IdType="doi">10.3233/SHTI240020</ArticleId><ArticleId IdType="pii">SHTI240020</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38690224</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2059-8661</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Journal of clinical and translational science</Title><ISOAbbreviation>J Clin Transl Sci</ISOAbbreviation></Journal><ArticleTitle>The Health Equity Explorer: An open-source resource for distributed health equity visualization and research across common data models.</ArticleTitle><Pagination><StartPage>e72</StartPage><MedlinePgn>e72</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e72</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/cts.2024.500</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">There is an urgent need to address pervasive inequities in health and healthcare in the USA. Many areas of health inequity are well known, but there remain important unexplored areas, and for many populations in the USA, accessing data to visualize and monitor health equity is difficult.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We describe the development and evaluation of an open-source, R-Shiny application, the "Health Equity Explorer (H2E)," designed to enable users to explore health equity data in a way that can be easily shared within and across common data models (CDMs).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We have developed a novel, scalable informatics tool to explore a wide variety of drivers of health, including patient-reported Social Determinants of Health (SDoH), using data in an OMOP CDM research data repository in a way that can be easily shared. We describe our development process, data schema, potential use cases, and pilot data for 705,686 people who attended our health system at least once since 2016. For this group, 996,382 unique observations for questions related to food and housing security were available for 324,630 patients (at least one answer for all 46% of patients) with 65,152 (20.1% of patients with at least one visit and answer) reporting food or housing insecurity at least once.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">H2E can be used to support dynamic and interactive explorations that include rich social and environmental data. The tool can support multiple CDMs and has the potential to support distributed health equity research and intervention on a national scale.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adams</LastName><ForeName>William G</ForeName><Initials>WG</Initials><Identifier Source="ORCID">0000-0002-5330-0010</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Boston Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boston University Clinical and Translational Science Institute, Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gasman</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Boston Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beccia</LastName><ForeName>Ariel L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuentes</LastName><ForeName>Liza</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Health Equity Accelerator, Boston Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Clin Transl Sci</MedlineTA><NlmUniqueID>101689953</NlmUniqueID><ISSNLinking>2059-8661</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Common data models</Keyword><Keyword MajorTopicYN="N">R-Shiny</Keyword><Keyword MajorTopicYN="N">distributed analytics</Keyword><Keyword MajorTopicYN="N">health equity</Keyword><Keyword MajorTopicYN="N">open-source software</Keyword><Keyword MajorTopicYN="N">translational informatics</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>1</Day><Hour>3</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38690224</ArticleId><ArticleId IdType="pmc">PMC11058576</ArticleId><ArticleId IdType="doi">10.1017/cts.2024.500</ArticleId><ArticleId IdType="pii">S2059866124005004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Healthy People 2020: Disparities. US Department of Health and Human Services; 2019. https://www.healthypeople.gov/2020/about/foundation-health-measures/Disparities. Accessed December 9, 2023.</Citation></Reference><Reference><Citation>Braveman P, Arkin E, Orleans T, Proctor D, Plough A. What Is Health Equity? And What Difference Does a Definition Make? Princeton, NJ: Robert Wood Johnson Foundation, 2017.</Citation></Reference><Reference><Citation>Institute of Medicine. Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. In: Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington (DC): National Academies Press, 2003.</Citation><ArticleIdList><ArticleId IdType="pubmed">25032386</ArticleId></ArticleIdList></Reference><Reference><Citation>Homan P, Brown TH, King B. Structural intersectionality as a new direction for health disparities research. J Health Soc Behav. 2021;62(3):350&#x2013;370. doi: 10.1177/00221465211032947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00221465211032947</ArticleId><ArticleId IdType="pmc">PMC8628816</ArticleId><ArticleId IdType="pubmed">34355603</ArticleId></ArticleIdList></Reference><Reference><Citation>Adkins-Jackson PB, Chantarat T, Bailey ZD, Ponce NA. Measuring structural racism: a guide for epidemiologists and other health researchers. Am J Epidemiol. 2022;24(4):539&#x2013;547. doi: 10.1093/aje/kwab239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwab239</ArticleId><ArticleId IdType="pmc">PMC9077112</ArticleId><ArticleId IdType="pubmed">34564723</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesko CR, Fox MP, Edwards JK. A framework for descriptive epidemiology. Am J Epidemiol. 2022;191(12):2063&#x2013;2070. doi: 10.1093/aje/kwac115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwac115</ArticleId><ArticleId IdType="pmc">PMC10144679</ArticleId><ArticleId IdType="pubmed">35774001</ArticleId></ArticleIdList></Reference><Reference><Citation>
NBER. National Bureau of Economic Research - Moving to Opportunity, 2023. https://opportunityinsights.org/neighborhoods/. Accessed December 17, 2023.</Citation></Reference><Reference><Citation>Swope CB, Hernandez D. Housing as a determinant of health equity: a conceptual model. Soc Sci Med. 2019;243:112571. doi: 10.1016/j.socscimed.2019.112571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2019.112571</ArticleId><ArticleId IdType="pmc">PMC7146083</ArticleId><ArticleId IdType="pubmed">31675514</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SN, Mendis ME, Berkowitz DA, Kohane I, Chueh HC. Integration of clinical and genetic data in the i2b2 architecture. AMIA Annu Symp Proc. 2006;2006:1040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1839291</ArticleId><ArticleId IdType="pubmed">17238659</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest CB, McTigue KM, Hernandez AF, et al. PCORnet(R) 2020: current state, accomplishments, and future directions. J Clin Epidemiol. 2021;129:60&#x2013;67. doi: 10.1016/j.jclinepi.2020.09.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2020.09.036</ArticleId><ArticleId IdType="pmc">PMC7521354</ArticleId><ArticleId IdType="pubmed">33002635</ArticleId></ArticleIdList></Reference><Reference><Citation>Buitron de la Vega P, Losi S, Sprague Martinez L, et al. Implementing an EHR-based screening and referral system to address social determinants of health in primary care. Med Care. 2019;57(Suppl 2):S133&#x2013;S139. doi: 10.1097/MLR.0000000000001029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0000000000001029</ArticleId><ArticleId IdType="pubmed">31095052</ArticleId></ArticleIdList></Reference><Reference><Citation>Byhoff E, Garg A, Pellicer M, et al. Provider and staff feedback on screening for social and behavioral determinants of health for pediatric patients. J Am Board Fam Med. 2019;32(3):297&#x2013;306. doi: 10.3122/jabfm.2019.03.180276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3122/jabfm.2019.03.180276</ArticleId><ArticleId IdType="pubmed">31068394</ArticleId></ArticleIdList></Reference><Reference><Citation>Cottrell EK, Dambrun K, Cowburn S, et al. Variation in electronic health record documentation of social determinants of health across a national network of community health centers. Am J Prev Med. 2019;57(6 Suppl 1):S65&#x2013;S73. doi: 10.1016/j.amepre.2019.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2019.07.014</ArticleId><ArticleId IdType="pubmed">31753281</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A, Cull W, Olson L, et al. Screening and referral for low-income families&#x2019; social determinants of health by US pediatricians. Acad Pediatr. 2019;19(8):875&#x2013;883. doi: 10.1016/j.acap.2019.05.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acap.2019.05.125</ArticleId><ArticleId IdType="pubmed">31129128</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A, Homer CJ, Dworkin PH. Addressing social determinants of health: challenges and opportunities in a value-based model. Pediatrics. 2019;143(4):10.1542/peds.2018&#x2013;2355.</Citation><ArticleIdList><ArticleId IdType="pubmed">30902829</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera CN, Brochier A, Pellicer M, Garg A, Drainoni ML. Implementing social determinants of health screening at community health centers: clinician and staff perspectives. J Prim Care Community Health. 2019;10:2150132719887260. doi: 10.1177/2150132719887260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2150132719887260</ArticleId><ArticleId IdType="pmc">PMC6843733</ArticleId><ArticleId IdType="pubmed">31702425</ArticleId></ArticleIdList></Reference><Reference><Citation>Phuong J, Zampino E, Dobbins N, et al. Extracting patient-level social determinants of health into the OMOP common data model. AMIA Annu Symp Proc. 2021;2021:989&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8861735</ArticleId><ArticleId IdType="pubmed">35308947</ArticleId></ArticleIdList></Reference><Reference><Citation>Phuong J, Hong S, Palchuk MB, et al. Advancing Interoperability of patient-level social determinants of health data to support COVID-19 research. AMIA Jt Summits Transl Sci Proc. 2022;2022:396&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9285174</ArticleId><ArticleId IdType="pubmed">35854720</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber M, Krauss D, Blake B, Boone E, Almonte R. Balancing value and burden: the centers for medicare &amp; medicaid services electronic clinical quality measure (eCQM) strategy project. J Am Med Inform Assoc. 2021;12(11):2475&#x2013;2482. doi: 10.1093/jamia/ocab013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocab013</ArticleId><ArticleId IdType="pmc">PMC8510288</ArticleId><ArticleId IdType="pubmed">34383912</ArticleId></ArticleIdList></Reference><Reference><Citation>
CMS. Electronic Clinical Quality Measures Basics, 2023. https://www.cms.gov/medicare/regulations-guidance/promoting-interoperability-programs/electronic-clinical-quality-measures-basics. Accessed December 15, 2023.</Citation></Reference><Reference><Citation>
BMC. Boston Medical Center Health Equity Accelerator, 2023. https://www.bmc.org/health-equity-accelerator. Accessed December 15, 2023.</Citation></Reference><Reference><Citation>Cutter S, Boruff B, Shirley W. Social vulnerability to environmental hazards. SSQ. 2003;84(2):242&#x2013;261. doi: 10.1111/1540-6237.8402002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1540-6237.8402002</ArticleId></ArticleIdList></Reference><Reference><Citation>Acevedo-Garcia D, McArdle N, Hardy EF, et al. The child opportunity index: improving collaboration between community development and public health. Health Aff (Millwood). 2014;33(11):1948&#x2013;1957. doi: 10.1377/hlthaff.2014.0679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2014.0679</ArticleId><ArticleId IdType="pubmed">25367989</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanoussi Y, Ahinkorah BO, Banke-Thomas A, Yaya S. Assessing and decomposing inequality of opportunity in access to child health and nutrition in sub-saharan Africa: evidence from three countries with low human development index. Int J Equity Health. 2020;19(1):143. doi: 10.1186/s12939-020-01258-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-020-01258-5</ArticleId><ArticleId IdType="pmc">PMC7507955</ArticleId><ArticleId IdType="pubmed">32843046</ArticleId></ArticleIdList></Reference><Reference><Citation>
Census U. American Community Survey (ACS). Accessed 12/15/2023, 2023. https://www.census.gov/programs-surveys/acs. Accessed December 15, 2023.</Citation></Reference><Reference><Citation>Ferrara P, Cammisa I, Zona M, et al. Child opportunity index: a multidimensional indicator to measure neighborhood conditions influencing children&#x2019;s health. J Pediatr. 2024;264:113649. doi: 10.1016/j.jpeds.2023.113649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2023.113649</ArticleId><ArticleId IdType="pubmed">37517649</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellinek MS, Murphy JM. Screening for psychosocial disorders in pediatric practice. Am J Dis Child. 1988;142(11):1153&#x2013;1157. doi: 10.1001/archpedi.1988.02150110031013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpedi.1988.02150110031013</ArticleId><ArticleId IdType="pubmed">3177320</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellinek MS, Murphy JM, Burns BJ. Brief psychosocial screening in outpatient pediatric practice. J Pediatr. 1986;109(2):371&#x2013;378. doi: 10.1016/s0022-3476(86)80408-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(86)80408-5</ArticleId><ArticleId IdType="pubmed">3734977</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellinek MS, Murphy JM, Little M, Pagano ME, Comer DM, Kelleher KJ. Use of the pediatric symptom checklist to screen for psychosocial problems in pediatric primary care: a national feasibility study. Arch Pediatr Adolesc. 1999;153(3):254&#x2013;260. doi: 10.1001/archpedi.153.3.254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpedi.153.3.254</ArticleId><ArticleId IdType="pmc">PMC3905751</ArticleId><ArticleId IdType="pubmed">10086402</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606&#x2013;613. doi: 10.1046/j.1525-1497.2001.016009606.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>APHA. Racism is a Public Health Crisis. APHA, 2023. https://www.apha.org/Topics-and-Issues/Racial-Equity/Racism-Declarations. Accessed December 17, 2023.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38716090</PMID><DateRevised><Year>2025</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1061-8600</ISSN><JournalIssue CitedMedium="Print"><Volume>33</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Journal of computational and graphical statistics : a joint publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America</Title><ISOAbbreviation>J Comput Graph Stat</ISOAbbreviation></Journal><ArticleTitle>Massive Parallelization of Massive Sample-size Survival Analysis.</ArticleTitle><Pagination><StartPage>289</StartPage><EndPage>302</EndPage><MedlinePgn>289-302</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/10618600.2023.2213279</ELocationID><Abstract><AbstractText>Large-scale observational health databases are increasingly popular for conducting comparative effectiveness and safety studies of medical products. However, increasing number of patients poses computational challenges when fitting survival regression models in such studies. In this paper, we use graphics processing units (GPUs) to parallelize the computational bottlenecks of massive sample-size survival analyses. Specifically, we develop and apply time- and memory-efficient single-pass parallel scan algorithms for Cox proportional hazards models and forward-backward parallel scan algorithms for Fine-Gray models for analysis with and without a competing risk using a cyclic coordinate descent optimization approach. We demonstrate that GPUs accelerate the computation of fitting these complex models in large databases by orders of magnitude as compared to traditional multi-core CPU parallelism. Our implementation enables efficient large-scale observational studies involving millions of patients and thousands of patient characteristics. The above implementation is available in the open-source R package Cyclops (Suchard et al., 2013).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jianxiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Computational Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health at UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Mathematics, Tulane University, New Orleans, Louisiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Computational Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health at UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, US Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI153044</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Comput Graph Stat</MedlineTA><NlmUniqueID>101470926</NlmUniqueID><ISSNLinking>1061-8600</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cox proportional hazards model</Keyword><Keyword MajorTopicYN="N">Fine-Gray model</Keyword><Keyword MajorTopicYN="N">Graphics processing unit</Keyword><Keyword MajorTopicYN="N">Regularized regression</Keyword><Keyword MajorTopicYN="N">Survival analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>3</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38716090</ArticleId><ArticleId IdType="mid">NIHMS1917962</ArticleId><ArticleId IdType="pmc">PMC11070748</ArticleId><ArticleId IdType="doi">10.1080/10618600.2023.2213279</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Barney B et al. (2010). Introduction to parallel computing. Lawrence Livermore National Laboratory, 6(13), 10.</Citation></Reference><Reference><Citation>Beam AL, Ghosh SK, and Doyle J (2016). Fast Hamiltonian Monte Carlo using GPU computing. Journal of Computational and Graphical Statistics, 25(2), 536&#x2013;548.</Citation></Reference><Reference><Citation>Bramante CT, Ingraham NE, Murray TA, Marmor S, Hovertsen S, Gronski J, McNeil C, Feng R, Guzman G, Abdelwahab N, et al. (2021). Metformin and risk of mortality in patients hospitalised with covid-19: a retrospective cohort analysis. The Lancet Healthy Longevity, 2(1), e34&#x2013;e41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832552</ArticleId><ArticleId IdType="pubmed">33521772</ArticleId></ArticleIdList></Reference><Reference><Citation>Casella G, Ghosh M, Gill J, and Kyung M (2010). Penalized regression, standard errors, and bayesian lassos. Bayesian analysis, 5(2), 369&#x2013;411.</Citation></Reference><Reference><Citation>Chatterjee A and Lahiri SN (2011). Bootstrapping lasso estimators. Journal of the American Statistical Association, 106(494), 608&#x2013;625.</Citation></Reference><Reference><Citation>Cox DR (1972). Regression models and life-tables. Journal of the Royal Statistical Society: Series B (Methodological), 34(2), 187&#x2013;202.</Citation></Reference><Reference><Citation>Fine JP and Gray RJ (1999). A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association, 94(446), 496&#x2013;509.</Citation></Reference><Reference><Citation>Genkin A, Lewis DD, and Madigan D (2007). Large-scale bayesian logistic regression for text categorization. Technometrics, 49(3), 291&#x2013;304.</Citation></Reference><Reference><Citation>Harris M, Sengupta S, and Owens JD (2007). Parallel prefix sum (scan) with CUDA. GPU Gems , 3(39), 851&#x2013;876.</Citation></Reference><Reference><Citation>Holbrook AJ, Lemey P, Baele G, Dellicour S, Brockmann D, Rambaut A, and Suchard MA (2021). Massive parallelization boosts big bayesian multidimensional scaling. Journal of Computational and Graphical Statistics, 30(1), 11&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8218718</ArticleId><ArticleId IdType="pubmed">34168419</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, Suchard MA, Schuemie MJ, DeFalco FJ, Perotte A, et al. (2016). Characterizing treatment pathways at scale using the OHDSI network. Proceedings of the National Academy of Sciences, 113(27), 7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawaguchi ES, Shen JI, Suchard MA, and Li G (2020). Scalable algorithms for large competing risks data. Journal of Computational and Graphical Statistics, pages 1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385160</ArticleId><ArticleId IdType="pubmed">35983577</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko S, Zhou H, Zhou JJ, and Won J-H (2022). High-performance statistical computing in the computing environments of the 2020s. Statistical Science, 37(4), 494&#x2013;518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10168006</ArticleId><ArticleId IdType="pubmed">37168541</ArticleId></ArticleIdList></Reference><Reference><Citation>Madigan D, Ryan P, Simpson S, and Zorych I (2010). Bayesian methods in pharmacovigilance. Bayesian Statistics, 9, 421&#x2013;438.</Citation></Reference><Reference><Citation>Madigan D, Stang PE, Berlin JA, Schuemie M, Overhage JM, Suchard MA, Dumouchel B, Hartzema AG, and Ryan PB (2014). A systematic statistical approach to evaluating evidence from observational studies. Annual Review of Statistics and Its Application, 1, 11&#x2013;39.</Citation></Reference><Reference><Citation>Merrill D and Garland M (2016). Single-pass parallel prefix scan with decoupled look-back. NVIDIA, Tech. Rep. NVR-2016-002.</Citation></Reference><Reference><Citation>Micikevicius P (2009). 3D finite difference computation on GPUs using CUDA. In Proceedings of 2nd workshop on general purpose processing on graphics processing units, pages 79&#x2013;84.</Citation></Reference><Reference><Citation>Mittal S, Madigan D, Burd RS, and Suchard MA (2014). High-dimensional, massive sample-size Cox proportional hazards regression for survival analysis. Biostatistics, 15(2), 207&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3944969</ArticleId><ArticleId IdType="pubmed">24096388</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller-Using S, Feldt T, Sarfo FS, and Eberhardt KA (2016). Factors associated with performing tuberculosis screening of hiv-positive patients in ghana: Lasso-based predictor selection in a large public health data set. BMC Public Health, 16(1), 1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4944423</ArticleId><ArticleId IdType="pubmed">27412114</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickolls J, Buck I, Garland M, and Skadron K (2008). Scalable parallel programming with CUDA. Queue, 6(2), 40&#x2013;53.</Citation></Reference><Reference><Citation>Noordzij M, Leffondr&#xe9; K, van Stralen KJ, Zoccali C, Dekker FW, and Jager KJ (2013). When do we need competing risks methods for survival analysis in nephrology? Nephrology Dialysis Transplantation, 28(11), 2670&#x2013;2677.</Citation><ArticleIdList><ArticleId IdType="pubmed">23975843</ArticleId></ArticleIdList></Reference><Reference><Citation>Rennich S (2011). CUDA C/C++ streams and concurrency. In GPU Technology Conference.</Citation></Reference><Reference><Citation>Robins JM and Rotnitzky A (1992). Recovery of information and adjustment for dependent censoring using surrogate markers. In AIDS epidemiology, pages 297&#x2013;331. Springer.</Citation></Reference><Reference><Citation>Shortreed SM and Ertefaie A (2017). Outcome-adaptive lasso: variable selection for causal inference. Biometrics, 73(4), 1111&#x2013;1122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5591052</ArticleId><ArticleId IdType="pubmed">28273693</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Wang Q, Chan C, Frelinger J, Cron A, and West M (2010). Understanding GPU programming for statistical computation: Studies in massively parallel massive mixtures. Journal of Computational and Graphical Statistics, 19(2), 419&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2945379</ArticleId><ArticleId IdType="pubmed">20877443</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, and Madigan D (2013). Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Transactions on Modeling and Computer Simulation (TOMACS) , 23(1), 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen R, Pratt N, Reich CG, Duke J, Madigan D, Hripcsak G, et al. (2019). Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. The Lancet, 394(10211), 1816&#x2013;1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Terenin A, Dong S, and Draper D (2019). GPU-accelerated gibbs sampling: a case study of the horseshoe probit model. Statistics and Computing, 29(2), 301&#x2013;310.</Citation></Reference><Reference><Citation>Wu TT, Lange K, et al. (2008). Coordinate descent algorithms for lasso penalized regression. The Annals of Applied Statistics, 2(1), 224&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3212875</ArticleId><ArticleId IdType="pubmed">22081779</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y and Yin W (2017). A globally convergent algorithm for nonconvex optimization based on block coordinate update. Journal of Scientific Computing, 72(2), 700&#x2013;734.</Citation></Reference><Reference><Citation>Zhou H, Lange K, and Suchard MA (2010). Graphics processing units and high-dimensional optimization. Statistical Science: A Review Journal of the Institute of Mathematical Statistics, 25(3), 311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3155776</ArticleId><ArticleId IdType="pubmed">21847315</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38749529</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2632-1009</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>14</Day></PubDate></JournalIssue><Title>BMJ health &amp; care informatics</Title><ISOAbbreviation>BMJ Health Care Inform</ISOAbbreviation></Journal><ArticleTitle>Taipei Medical University Clinical Research Database: a collaborative hospital EHR database aligned with international common data standards.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e100890</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjhci-2023-100890</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of this paper is to provide a comprehensive overview of the development and features of the Taipei Medical University Clinical Research Database (TMUCRD), a repository of real-world data (RWD) derived from electronic health records (EHRs) and other sources.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">TMUCRD was developed by integrating EHRs from three affiliated hospitals, including Taipei Medical University Hospital, Wan-Fang Hospital and Shuang-Ho Hospital. The data cover over 15 years and include diverse patient care information. The database was converted to the Observational Medical Outcomes Partnership Common Data Model (OMOP CDM) for standardisation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">TMUCRD comprises 89 tables (eg, 29 tables for each hospital and 2 linked tables), including demographics, diagnoses, medications, procedures and measurements, among others. It encompasses data from more than 4.15&#x2009;million patients with various medical records, spanning from the year 2004 to 2021. The dataset offers insights into disease prevalence, medication usage, laboratory tests and patient characteristics.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">TMUCRD stands out due to its unique advantages, including diverse data types, comprehensive patient information, linked mortality and cancer registry data, regular updates and a swift application process. Its compatibility with the OMOP CDM enhances its usability and interoperability.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">TMUCRD serves as a valuable resource for researchers and scholars interested in leveraging RWD for clinical research. Its availability and integration of diverse healthcare data contribute to a collaborative and data-driven approach to advancing medical knowledge and practice.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Phung-Anh</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0002-7436-9041</Identifier><AffiliationInfo><Affiliation>Clinical Data Center, Office of Data Science, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center of Health Care Industry Data Science, College of Management, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Big Data Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Min-Huei</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Office of Data Science, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Tzu-Hao</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Clinical Big Data Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Center for Health Information Technology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Hsuan-Chia</ForeName><Initials>HC</Initials><Identifier Source="ORCID">0000-0001-9198-0697</Identifier><AffiliationInfo><Affiliation>Clinical Big Data Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Center for Health Information Technology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center of Big Data and Meta-Analysis, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chih-Wei</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Center for Health Information Technology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Chia-Te</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Taipei Medical University-Research Center of Urology and Kidney, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Christine Y</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kolling Institute, Faculty of Medicine and Health, The University of Sydney and the Northern Sydney Local Health District, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Jason C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Clinical Data Center, Office of Data Science, Taipei Medical University, Taipei, Taiwan jasonhsu@tmu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center of Health Care Industry Data Science, College of Management, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Big Data Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Ph.D. Program in Biotech and Healthcare Management, College of Management, Taipei Medical Unversity, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Health Care Inform</MedlineTA><NlmUniqueID>101745500</NlmUniqueID><ISSNLinking>2632-1009</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Information Management</Keyword><Keyword MajorTopicYN="N">Medical Record Linkage</Keyword><Keyword MajorTopicYN="N">database management systems</Keyword><Keyword MajorTopicYN="N">evidence-based medicine</Keyword><Keyword MajorTopicYN="N">health information management</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>16</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>16</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>20</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38749529</ArticleId><ArticleId IdType="pmc">PMC11097871</ArticleId><ArticleId IdType="doi">10.1136/bmjhci-2023-100890</ArticleId><ArticleId IdType="pii">bmjhci-2023-100890</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Paul M, Maglaras L, Ferrag MA, et al. . Digitization of Healthcare sector: A study on privacy and security concerns. ICT Express 2023;9:571&#x2013;88. 10.1016/j.icte.2023.02.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.icte.2023.02.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraus S, Schiavone F, Pluzhnikova A, et al. . Digital transformation in Healthcare: analyzing the current state-of-research. J Business Res 2021;123:557&#x2013;67. 10.1016/j.jbusres.2020.10.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbusres.2020.10.030</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J), Qi K, Bai G, et al. . Pre-pandemic assessment: a decade of progress in electronic health record adoption among U.S. hospitals. Health Affairs Scholar 2023;1. 10.1093/haschl/qxad056</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/haschl/qxad056</ArticleId><ArticleId IdType="pmc">PMC10986221</ArticleId><ArticleId IdType="pubmed">38756982</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanelt A, Bohnsack R, Marz D, et al. . A systematic review of the literature on Digital transformation: insights and implications for strategy and organizational change. J Management Studies 2021;58:1159&#x2013;97. 10.1111/joms.12639</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joms.12639</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal R, Prabakaran S. Big data in Digital Healthcare: lessons learnt and recommendations for general practice. Heredity (Edinb) 2020;124:525&#x2013;34. 10.1038/s41437-020-0303-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41437-020-0303-2</ArticleId><ArticleId IdType="pmc">PMC7080757</ArticleId><ArticleId IdType="pubmed">32139886</ArticleId></ArticleIdList></Reference><Reference><Citation>Kickbusch I, Piselli D, Agrawal A, et al. . The lancet and financial times Commission on governing health futures 2030: growing up in a Digital world. Lancet 2021;398:1727&#x2013;76. 10.1016/S0140-6736(21)01824-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01824-9</ArticleId><ArticleId IdType="pubmed">34706260</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern AD, Br&#xf6;nneke J, Debatin JF, et al. . Advancing Digital health applications: priorities for innovation in real-world evidence generation. Lancet Digit Health 2022;4:e200&#x2013;6. 10.1016/S2589-7500(21)00292-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(21)00292-2</ArticleId><ArticleId IdType="pubmed">35216754</ArticleId></ArticleIdList></Reference><Reference><Citation>
Food and Drug Administration . Policy for Device Software Functions and Mobile Medical Applications: Guidance for Industry and Food and Drug Administration Staff 2022, Available: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-device-software-functions-and-mobile-medical-applications
</Citation></Reference><Reference><Citation>World Health Organization . WHO Guideline: Recommendations on Digital Interventions for Health System Strengthening: Evidence and Recommendations. Geneva: World Health Organization, 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">31162915</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh H, Eckelman M, Berwick DM, et al. . Mandatory reporting of emissions to achieve net-zero health care. N Engl J Med 2022;387:2469&#x2013;76. 10.1056/NEJMsb2210022</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsb2210022</ArticleId><ArticleId IdType="pubmed">36516087</ArticleId></ArticleIdList></Reference><Reference><Citation>Makady A, de Boer A, Hillege H, et al. . What is real-world data? A review of definitions based on literature and Stakeholder interviews. Value Health 2017;20:858&#x2013;65. 10.1016/j.jval.2017.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2017.03.008</ArticleId><ArticleId IdType="pubmed">28712614</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrigan-Curay J, Sacks L, Woodcock J. Real-world evidence and real-world data for evaluating drug safety and effectiveness. JAMA 2018;320:867&#x2013;8. 10.1001/jama.2018.10136</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.10136</ArticleId><ArticleId IdType="pubmed">30105359</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth CM, Karim S, Mackillop WJ. Real-world data: towards achieving the achievable in cancer care. Nat Rev Clin Oncol 2019;16:312&#x2013;25. 10.1038/s41571-019-0167-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41571-019-0167-7</ArticleId><ArticleId IdType="pubmed">30700859</ArticleId></ArticleIdList></Reference><Reference><Citation>Khozin S, Blumenthal GM, Pazdur R. Real-world data for clinical evidence generation in oncology. J Natl Cancer Inst 2017;109. 10.1093/jnci/djx187</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djx187</ArticleId><ArticleId IdType="pubmed">29059439</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin JM, Schneeweiss S. When and how can real world data analyses substitute for randomized controlled trials Clin Pharmacol Ther 2017;102:924&#x2013;33. 10.1002/cpt.857</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.857</ArticleId><ArticleId IdType="pubmed">28836267</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartlett VL, Dhruva SS, Shah ND, et al. . Feasibility of using real-world data to Replicate clinical trial evidence. JAMA Netw Open 2019;2:e1912869. 10.1001/jamanetworkopen.2019.12869</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.12869</ArticleId><ArticleId IdType="pmc">PMC6802419</ArticleId><ArticleId IdType="pubmed">31596493</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumfeld Andre E, Reynolds R, Caubel P, et al. . Trial designs using Real&#x2010;World data: the changing landscape of the regulatory approval process. Pharmacoepidemiol Drug Saf 2020;29:1201&#x2013;12. 10.1002/pds.4932</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4932</ArticleId><ArticleId IdType="pmc">PMC7687110</ArticleId><ArticleId IdType="pubmed">31823482</ArticleId></ArticleIdList></Reference><Reference><Citation>Levenson MS. Regulatory-grade clinical trial design using real-world data. Clin Trials 2020;17:377&#x2013;82. 10.1177/1740774520905576</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1740774520905576</ArticleId><ArticleId IdType="pmc">PMC8697198</ArticleId><ArticleId IdType="pubmed">32063037</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lusignan S. Real world evidence to an eHealth tool: the 2017 top ten papers from Journal of innovation in health Informatics. Jhi 2018;24:347. 10.14236/jhi.v24i4.1004</Citation><ArticleIdList><ArticleId IdType="doi">10.14236/jhi.v24i4.1004</ArticleId><ArticleId IdType="pubmed">29334354</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudrapatna VA, Glicksberg BS, Butte AJ. Utility of routinely collected electronic health records data to support effectiveness evaluations in inflammatory bowel disease: a pilot study of tofacitinib. BMJ Health Care Inform 2021;28:e100337. 10.1136/bmjhci-2021-100337</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjhci-2021-100337</ArticleId><ArticleId IdType="pmc">PMC8141436</ArticleId><ArticleId IdType="pubmed">34011632</ArticleId></ArticleIdList></Reference><Reference><Citation>
Dept. of Household Registration . n.d.
Ministry of the interior. Republic of China Taiwan: population Registry section. Available: https://www.ris.gov.tw/app/en/232
</Citation></Reference><Reference><Citation>
Taiwan Cancer Registry Center . Taiwan Cancer Registry, Available: https://twcr.tw/?page_id=1843&amp;lang=en
</Citation></Reference><Reference><Citation>McDonald CJ, Huff SM, Suico JG, et al. . LOINC, a universal standard for identifying laboratory observations: a 5-year update. Clin Chem 2003;49:624&#x2013;33. 10.1373/49.4.624</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/49.4.624</ArticleId><ArticleId IdType="pubmed">12651816</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Library of Medicine . RxNorm Overview 2023, Available: https://www.nlm.nih.gov/research/umls/rxnorm/overview.html
</Citation></Reference><Reference><Citation>
OHDSI . The Book of OHDSI, Available: https://ohdsi.github.io/TheBookOfOhdsi/
</Citation></Reference><Reference><Citation>
Taipei Medical University . Introduction of the Center for Management and Development, Available: https://cmd.tmu.edu.tw/Front/Page.aspx?id=HRZxZfjK1Uo=
</Citation></Reference><Reference><Citation>
Edemekong PF, Annamaraju P, Haydel MJ. n.d.
Health insurance Portability and accountability act 2018. Available: https://www.ncbi.nlm.nih.gov/books/NBK500019
</Citation><ArticleIdList><ArticleId IdType="pubmed">29763195</ArticleId></ArticleIdList></Reference><Reference><Citation>
Taipei Medical University, Office of Data Science, Clinical Data Center . n.d.
TMUCRD catalog 2023. Available: https://sites.google.com/tmu.edu.tw/tmu-crd/%E9%A6%96%E9%A0%81?pli=1&amp;authuser=1
</Citation></Reference><Reference><Citation>
OHDSI . OHDSI vocabulary, Available: https://www.ohdsi.org/web/wiki/doku.php?id=documentation:vocabulary
</Citation></Reference><Reference><Citation>Ji H, Kim S, Yi S, et al. . Converting clinical document architecture documents to the common data model for incorporating health information exchange data in observational health studies: CDA to CDM. J Biomed Inform 2020;107:S1532-0464(20)30087-3. 10.1016/j.jbi.2020.103459</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2020.103459</ArticleId><ArticleId IdType="pubmed">32470694</ArticleId></ArticleIdList></Reference><Reference><Citation>
OHDSI . Save Our Sisyphus Challenge 2023, Available: https://www.ohdsi.org/sos-challenge/
</Citation></Reference><Reference><Citation>Nguyen NTH, Nguyen P-A, Huang C-W, et al. . Renin-angiotensin-aldosterone system inhibitors and development of gynecologic cancers: A 23 million individual population-based study. Int J Mol Sci 2023;24:3814. 10.3390/ijms24043814</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24043814</ArticleId><ArticleId IdType="pmc">PMC9968233</ArticleId><ArticleId IdType="pubmed">36835224</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NTH, Huang C-W, Wang C-H, et al. . Association between proton pump inhibitor use and the risk of female cancers: A nested case-control study of 23 million individuals. Cancers (Basel) 2022;14:6083. 10.3390/cancers14246083</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers14246083</ArticleId><ArticleId IdType="pmc">PMC9776228</ArticleId><ArticleId IdType="pubmed">36551573</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C-H, Huang C-W, Nguyen PA, et al. . Chemopreventive effects of concomitant or individual use of Statins, aspirin, metformin, and angiotensin drugs: A study using claims data of 23 million individuals. Cancers (Basel) 2022;14:1211. 10.3390/cancers14051211</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers14051211</ArticleId><ArticleId IdType="pmc">PMC8909564</ArticleId><ArticleId IdType="pubmed">35267516</ArticleId></ArticleIdList></Reference><Reference><Citation>
Clinical Data Center . Taipei Medical University Clinical Research Database (TMUCRD) Disease-BI (dBI) &amp; catalog, Available: https://ods.tmu.edu.tw/portal_c3_cnt.php?owner_num=c3_75328&amp;button_num=c3&amp;folder_id=4358
</Citation></Reference><Reference><Citation>
Clinical Data Center . TMUCRD application form. n.d.
Available: https://docs.google.com/forms/d/e/1FAIpQLSdbQpg64TUBKfvw6bJ9DhF9KbqLDXEEUa6MYi93cN7LvBkF-A/viewform
</Citation></Reference><Reference><Citation>
Taipei Medical University . TMU Joint Institute Review Board (TMU-eJIRB) system, Available: http://tmujirb.tmu.edu.tw/TMUJIRB/
</Citation></Reference><Reference><Citation>Chou C-L, Chuang N-C, Chiu H-W, et al. . Aminoglycosides use has a risk of acute kidney injury in patients without prior chronic kidney disease. Sci Rep 2022;12:17212. 10.1038/s41598-022-21074-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-21074-x</ArticleId><ArticleId IdType="pmc">PMC9568559</ArticleId><ArticleId IdType="pubmed">36241669</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen QTN, Nguyen P-A, Wang C-J, et al. . Machine learning approaches for predicting 5-year breast cancer survival: A multicenter study. Cancer Sci 2023;114:4063&#x2013;72. 10.1111/cas.15917</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cas.15917</ArticleId><ArticleId IdType="pmc">PMC10551582</ArticleId><ArticleId IdType="pubmed">37489252</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu JC, Nguyen P-A, Phuc PT, et al. . Development and validation of novel deep-learning models using multiple data types for lung cancer survival. Cancers (Basel) 2022;14:5562. 10.3390/cancers14225562</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers14225562</ArticleId><ArticleId IdType="pmc">PMC9688689</ArticleId><ArticleId IdType="pubmed">36428655</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Van Zandt M, Liu Y, et al. . Analysis of dual combination therapies used in treatment of hypertension in a multinational cohort. JAMA Netw Open 2022;5:e223877. 10.1001/jamanetworkopen.2022.3877</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.3877</ArticleId><ArticleId IdType="pmc">PMC8948532</ArticleId><ArticleId IdType="pubmed">35323951</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38767857</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>20</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Comparing penalization methods for linear models on large observational health data.</ArticleTitle><Pagination><StartPage>1514</StartPage><EndPage>1521</EndPage><MedlinePgn>1514-1521</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocae109</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study evaluates regularization variants in logistic regression (L1, L2, ElasticNet, Adaptive L1, Adaptive ElasticNet, Broken adaptive ridge [BAR], and Iterative hard thresholding [IHT]) for discrimination and calibration performance, focusing on both internal and external validation.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We use data from 5 US claims and electronic health record databases and develop models for various outcomes in a major depressive disorder patient population. We externally validate all models in the other databases. We use a train-test split of 75%/25% and evaluate performance with discrimination and calibration. Statistical analysis for difference in performance uses Friedman's test and critical difference diagrams.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 840 models we develop, L1 and ElasticNet emerge as superior in both internal and external discrimination, with a notable AUC difference. BAR and IHT show the best internal calibration, without a clear external calibration leader. ElasticNet typically has larger model sizes than L1. Methods like IHT and BAR, while slightly less discriminative, significantly reduce model complexity.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">L1 and ElasticNet offer the best discriminative performance in logistic regression for healthcare predictions, maintaining robustness across validations. For simpler, more interpretable models, L0-based methods (IHT and BAR) are advantageous, providing greater parsimony and calibration with fewer features. This study aids in selecting suitable regularization techniques for healthcare prediction models, balancing performance, complexity, and interpretability.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fridgeirsson</LastName><ForeName>Egill A</ForeName><Initials>EA</Initials><Identifier Source="ORCID">0000-0001-9085-9369</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Ross</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7723-417X</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0001-9818-479X</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA 90095-1772, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, United States Department of Veterans Affairs, Salt Lake City, UT 84148, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-2970-0778</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research and Development, Titusville, NJ 08560, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Innovative Medicines Initiative</Agency><Country/></Grant><Grant><Agency>European Union's Horizon 2020</Agency><Country/></Grant><Grant><GrantID>806968</GrantID><Agency>Innovative Medicines Initiative 2 Joint Undertaking</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003865" MajorTopicYN="Y">Depressive Disorder, Major</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">calibration</Keyword><Keyword MajorTopicYN="N">discrimination</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword><Keyword MajorTopicYN="N">logistic regression</Keyword><Keyword MajorTopicYN="N">regularization</Keyword></KeywordList><CoiStatement>E.A.F. and P.R. work for a research group who received unconditional research grants from Boehringer-Ingelheim, GSK, Janssen Research &amp; Development, Novartis, Pfizer, Yamanouchi, Servier. None of these grants result in a conflict of interest to the content of this paper. J.M.R. is an employee of Janssen R&amp;D and shareholder of JNJ. M.A.S. receives contracts and grants from the US National Institutes of Health, the US Food &amp; Drug Administration and Janssen Research &amp; Development, all outside the scope of this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>20</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>20</Day><Hour>11</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38767857</ArticleId><ArticleId IdType="pmc">PMC11187433</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocae109</ArticleId><ArticleId IdType="pii">7676584</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yang C, Kors JA, Ioannou S, et al. &#xa0;Trends in the conduct and reporting of clinical prediction model development and validation: a systematic review. J Am Med Inform Assoc. 2022;29(5):983-989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9006694</ArticleId><ArticleId IdType="pubmed">35045179</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani R. &#xa0;Regression shrinkage and selection via the LASSO. J R Stat Soc B. 1996;58(1):267-288.</Citation></Reference><Reference><Citation>Khalid S, Yang C, Blacketer C, et al. &#xa0;A standardized analytics pipeline for reliable and rapid development and validation of prediction models using observational health data. Comput Methods Programs Biomed. 2021;211:106394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420135</ArticleId><ArticleId IdType="pubmed">34560604</ArticleId></ArticleIdList></Reference><Reference><Citation>Siontis GCM, Tzoulaki I, Castaldi PJ, et al. &#xa0;External validation of new risk prediction models is infrequent and reveals worse prognostic discrimination. J Clin Epidemiol. 2015;68(1):25-34.</Citation><ArticleIdList><ArticleId IdType="pubmed">25441703</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, et al. &#xa0;Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul. 2013;23(1):1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou H, Hastie T. &#xa0;Regularization and variable selection via the elastic net. J R Stat Soc B. 2005;67(2):301-320.</Citation></Reference><Reference><Citation>Markus AF, Rijnbeek PR, Reps JM. Why predicting risk can&#x2019;t identify &#x2018;risk factors&#x2019;: empirical assessment of model stability in machine learning across observational health databases. In: Proceedings of the 7th Machine Learning for Healthcare Conference. PMLR;2022:828- 1514&#x2013;1521..</Citation></Reference><Reference><Citation>Su W, Bogdan M, Cand&#xe8;s E. &#xa0;False discoveries occur early on the LASSO path. Ann Stat. 2017;45(5):2133-2150.</Citation></Reference><Reference><Citation>Kumar A, Bhattacharyya S, Bouchard K. &#xa0;Numerical characterization of support recovery in sparse regression with correlated design. Commun Stat Simul Comput. 2024;53(3):1504-1518.</Citation></Reference><Reference><Citation>Hoerl AE, Kennard RW. &#xa0;Ridge regression: biased estimation for nonorthogonal problems. Technometrics. 1970;12(1):55-67.</Citation></Reference><Reference><Citation>Nogueira S, Sechidis K, Brown G. &#xa0;On the stability of feature selection algorithms. J Mach Learn Res. 2018;18(174):1-54.</Citation></Reference><Reference><Citation>Zou H. &#xa0;The adaptive LASSO and its oracle properties. J Am Stat Assoc. 2006;101(476):1418-1429.</Citation></Reference><Reference><Citation>Freijeiro-Gonz&#xe1;lez L, Febrero-Bande M, Gonz&#xe1;lez-Manteiga W. &#xa0;A critical review of LASSO and its derivatives for variable selection under dependence among covariates. Int Stat Rev. 2022;90(1):118-145.</Citation></Reference><Reference><Citation>Wahid A, Khan DM, Iqbal N, et al. &#xa0;A generalized stability estimator based on inter-intrastability of subsets for high-dimensional feature selection. Chemom Intell Lab Syst. 2022;220:104457.</Citation></Reference><Reference><Citation>Dai L, Chen K, Sun Z, et al. &#xa0;Broken adaptive ridge regression and its asymptotic properties. J Multivar Anal. 2018;168:334-351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6430210</ArticleId><ArticleId IdType="pubmed">30911202</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Peng X, Kawaguchi E, et al. &#xa0;A scalable surrogate L0 sparse regression method for generalized linear models with applications to large scale data. J Stat Plan Inference. 2021;213:262-281.</Citation></Reference><Reference><Citation>Blumensath T, Davies ME. &#xa0;Iterative hard thresholding for compressed sensing. Appl Comput Harmon Anal. 2009;27(3):265-274.</Citation></Reference><Reference><Citation>John LH, Kors JA, Reps JM, et al. &#xa0;Logistic regression models for patient-level prediction based on massive observational data: do we need all data? &#xa0;Int J Med Inform. 2022;163:104762.</Citation><ArticleIdList><ArticleId IdType="pubmed">35429722</ArticleId></ArticleIdList></Reference><Reference><Citation>John LH, Kors JA, Fridgeirsson EA, et al. &#xa0;External validation of existing dementia prediction models on observational health data. BMC Med Res Methodol. 2022;22(1):311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9720950</ArticleId><ArticleId IdType="pubmed">36471238</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, et al. &#xa0;Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc. 2018;25(8):969-975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Ryan P, Rijnbeek PR. &#xa0;Investigating the impact of development and internal validation design when training prognostic models using a retrospective cohort in big US observational healthcare data. BMJ Open. 2021;11(12):e050146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8710861</ArticleId><ArticleId IdType="pubmed">34952871</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons KGM, Altman DG, Reitsma JB, et al. &#xa0;Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1-W73.</Citation><ArticleIdList><ArticleId IdType="pubmed">25560730</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito T, Rehmsmeier M. &#xa0;The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets. PLoS One. 2015;10(3):e0118432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4349800</ArticleId><ArticleId IdType="pubmed">25738806</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC, Steyerberg EW. &#xa0;The integrated calibration index (ICI) and related metrics for quantifying the calibration of logistic regression models. Stat Med. 2019;38(21):4051-4065.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6771733</ArticleId><ArticleId IdType="pubmed">31270850</ArticleId></ArticleIdList></Reference><Reference><Citation>Demsar J. &#xa0;Statistical comparisons of classifiers over multiple data sets. J Mach Learn Res. 2006;7:1-30.</Citation></Reference><Reference><Citation>Hastie T, Tibshirani R, Tibshirani R. &#xa0;Best subset, forward stepwise or LASSO? Analysis and recommendations based on extensive comparisons. Stat Sci. 2020;35(4):579-592.</Citation></Reference><Reference><Citation>Cowley LE, Farewell DM, Maguire S, et al. &#xa0;Methodological standards for the development and evaluation of clinical prediction rules: a review of the literature. Diagn Progn Res. 2019;3:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6704664</ArticleId><ArticleId IdType="pubmed">31463368</ArticleId></ArticleIdList></Reference><Reference><Citation>Vickers AJ, Elkin EB. &#xa0;Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565-574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2577036</ArticleId><ArticleId IdType="pubmed">17099194</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan J, Li R. &#xa0;Variable selection via nonconcave penalized likelihood and its oracle properties. J Am Stat Assoc. 2001;96(456):1348-1360.</Citation></Reference><Reference><Citation>Bogdan M, van den Berg E, Sabatti C, et al. &#xa0;Slope&#x2014;adaptive variable selection via convex optimization. Ann Appl Stat. 2015;9(3):1103-1140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4689150</ArticleId><ArticleId IdType="pubmed">26709357</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells PS, Anderson DR, Rodger M, et al. &#xa0;Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med. 2001;135(2):98-107.</Citation><ArticleIdList><ArticleId IdType="pubmed">11453709</ArticleId></ArticleIdList></Reference><Reference><Citation>Lip GYH, Nieuwlaat R, Pisters R, et al. &#xa0;Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation. Chest. 2010;137(2):263-272.</Citation><ArticleIdList><ArticleId IdType="pubmed">19762550</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisters R, Lane DA, Nieuwlaat R, et al. &#xa0;A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093-1100.</Citation><ArticleIdList><ArticleId IdType="pubmed">20299623</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, et al. &#xa0;A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38773798</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1099-1557</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Pharmacoepidemiology and drug safety</Title><ISOAbbreviation>Pharmacoepidemiol Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Calculating daily dose in the Observational Medical Outcomes Partnership Common Data Model.</ArticleTitle><Pagination><StartPage>e5809</StartPage><MedlinePgn>e5809</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pds.5809</ELocationID><Abstract><AbstractText Label="PURPOSE">We aimed to develop a standardized method to calculate daily dose (i.e., the amount of drug a patient was exposed to per day) of any drug on a global scale using only drug information of typical observational data in the Observational Medical Outcomes Partnership Common Data Model (OMOP CDM) and a single reference table from Observational Health Data Sciences And Informatics (OHDSI).</AbstractText><AbstractText Label="MATERIALS AND METHODS">The OMOP DRUG_STRENGTH reference table contains information on the strength or concentration of drugs, whereas the OMOP DRUG_EXPOSURE table contains information on patients' drug prescriptions or dispensations/claims. Based on DRUG_EXPOSURE data from the primary care databases Clinical Practice Research Datalink GOLD (United Kingdom) and Integrated Primary Care Information (IPCI, The Netherlands) and healthcare claims from PharMetrics&#xae; Plus for Academics (USA), we developed four formulas to calculate daily dose given different DRUG_STRENGTH reference table information. We tested the dose formulas by comparing the calculated median daily dose to the World Health Organization (WHO) Defined Daily Dose (DDD) for six different ingredients in those three databases and additional four international databases representing a variety of healthcare settings: MAITT (Estonia, healthcare claims and discharge summaries), IQVIA Disease Analyzer Germany (outpatient data), IQVIA Longitudinal Patient Database Belgium (outpatient data), and IMASIS Parc Salut (Spain, hospital data). Finally, in each database, we assessed the proportion of drug records for which daily dose calculations were possible using the suggested formulas.</AbstractText><AbstractText Label="RESULTS">Applying the dose formulas, we obtained median daily doses that generally matched the WHO DDD definitions. Our dose formulas were applicable to &gt;85% of drug records in all but one of the assessed databases.</AbstractText><AbstractText Label="CONCLUSION">We have established and implemented a standardized daily dose calculation in OMOP CDM providing reliable and reproducible results.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. Pharmacoepidemiology and Drug Safety published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burkard</LastName><ForeName>Theresa</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1313-4473</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-G&#xfc;ell</LastName><ForeName>Kim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gorbachev</LastName><ForeName>Artem</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellas</LastName><ForeName>Luc&#xed;a</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Clinical Pharmacology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xf6;dicke</LastName><ForeName>Annika M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burn</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Ridder</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosseveld</LastName><ForeName>Mees</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gratton</LastName><ForeName>Jasmine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>IQVIA Ltd, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seager</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IQVIA Ltd, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vojinovic</LastName><ForeName>Dina</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>IQVIA Solutions B.V, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>Miguel Angel</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Management and Control Department, Hospital del Mar Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Program on Biomedical Informatics (GRIB). Hospital del Mar Research Institute (IMIM), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram&#xed;rez-Anguita</LastName><ForeName>Juan Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Research Program on Biomedical Informatics (GRIB). Hospital del Mar Research Institute (IMIM), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Pompeu Fabra, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mach&#xed;n</LastName><ForeName>Angela Leis</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Research Program on Biomedical Informatics (GRIB). Hospital del Mar Research Institute (IMIM), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oja</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolde</LastName><ForeName>Raivo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonadt</LastName><ForeName>Klaus</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>IQVIA Commercial GmbH &amp; Co. OHG, Frankfurt, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3950-6346</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Chistian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catal&#xe0;</LastName><ForeName>Mart&#xed;</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>EMA/2021/08/TDA</GrantID><Agency>Darwin EU</Agency><Country/></Grant><Grant><Agency>EHDEN</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacoepidemiol Drug Saf</MedlineTA><NlmUniqueID>9208369</NlmUniqueID><ISSNLinking>1053-8569</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054796" MajorTopicYN="N">Drug Dosage Calculations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017891" MajorTopicYN="N">Pharmacoepidemiology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014944" MajorTopicYN="N">World Health Organization</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">WHO DDD</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">dose</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>22</Day><Hour>1</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38773798</ArticleId><ArticleId IdType="doi">10.1002/pds.5809</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Reich C, Ostropolets A, Ryan P, et al. OHDSI standardized vocabularies&#x2014;a large&#x2010;scale centralized reference ontology for international data harmonization. J Am Med Inform Assoc. 2024;31:583&#x2010;590. doi:10.1093/jamia/ocad247</Citation></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22(3):553&#x2010;564. doi:10.1093/jamia/ocu023</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2010;578. http://www.ncbi.nlm.nih.gov/pubmed/26262116%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4815923</Citation></Reference><Reference><Citation>Darwin EU. coordination centre. DARWIN EU 2023. Accessed October 30. https://www.darwin-eu.org/</Citation></Reference><Reference><Citation>OHDSI. OMOP CDM Drug Strength Table. Accessed October 30. https://ohdsi.github.io/CommonDataModel/cdm54.html#DRUG_STRENGTH. 2023.</Citation></Reference><Reference><Citation>OHDSI. OMOP CDM Drug Exposure Table. Accessed October 30. https://ohdsi.github.io/CommonDataModel/cdm54.html#DRUG_EXPOSURE. 2023.</Citation></Reference><Reference><Citation>Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44(3):827&#x2010;836. doi:10.1093/ije/dyv098</Citation></Reference><Reference><Citation>De Ridder MAJ, De Wilde M, De Ben C, et al. Data resource profile: the integrated primary care information (IPCI) database The Netherlands. Int J Epidemiol. 2022;51(6):E314&#x2010;E323. doi:10.1093/ije/dyac026</Citation></Reference><Reference><Citation>IQVIA. IQVIA PharMetrics&#xae; Plus for Academics. 2022.</Citation></Reference><Reference><Citation>World Health Organisation. ATC/DDD Index. 2023 Accessed October 30 https://www.whocc.no/atc_ddd_index/</Citation></Reference><Reference><Citation>World Health Organization (WHO). Defined Daily Dose (DDD). Accessed April 5, https://www.who.int/tools/atc-ddd-toolkit/about-ddd 2024.</Citation></Reference><Reference><Citation>Oja M, Tamm S, Mooses K, et al. Transforming Estonian health data to the observational medical outcomes partnership (OMOP) common data model: lessons learned. JAMIA Open. 2023;6(4):1&#x2010;10. doi:10.1093/jamiaopen/ooad100</Citation></Reference><Reference><Citation>Rathmann W, Bongaerts B, Carius HJ, Kruppert S, Kostev K. Basic characteristics and representativeness of the German disease analyzer database. Int J Clin Pharmacol Ther. 2018;56(10):459&#x2010;466. doi:10.5414/CP203320</Citation></Reference><Reference><Citation>Mayer MA, Furlong LI, Torre P, et al. Reuse of EHRs to support clinical research in a hospital of reference. Stud. Health Technol. Inform. 2015;210. IOS Press:224&#x2010;226. doi:10.3233/978&#x2010;1&#x2010;61499&#x2010;512&#x2010;8&#x2010;224</Citation></Reference><Reference><Citation>Catala M, Mike D, Guo Y, Lopez&#x2010;Guell K. DrugUtilisation R Package. Accessed April 5 https://darwin-eu-dev.github.io/DrugUtilisation/index.html 2024.</Citation></Reference><Reference><Citation>Vignette addDailyDose() and addDrugUse(). Accessed April 5, https://darwin&#x2010;eu&#x2010;dev.github.io/DrugUtilisation/articles/a04_addDrugInfo.html. 2024.</Citation></Reference><Reference><Citation>Bodenreider O, Rodriguez LM. Analyzing U.S. prescription lists with RxNorm and the ATC/DDD index. AMIA Annu Symp Proc. 2014;297&#x2010;306.</Citation></Reference><Reference><Citation>Inberg G, Burn E, Guo Y, et al. DrugExposureDiagnostics. Accessed April 19, https://darwin-eu-dev.github.io/DrugExposureDiagnostics/ 2024.</Citation></Reference><Reference><Citation>OHDSI. OMOP CDM. Accessed April 12 https://ohdsi.github.io/CommonDataModel/index.html 2024.</Citation></Reference><Reference><Citation>Sadowski K, Blacketer C, Londhe A, et al. Data Quality Dashboard. Accessed April 12, https://ohdsi.github.io/DataQualityDashboard/ 2024.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38777085</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>155</Volume><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Converting OMOP CDM to phenopackets: A model alignment and patient data representation evaluation.</ArticleTitle><Pagination><StartPage>104659</StartPage><MedlinePgn>104659</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2024.104659</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(24)00077-7</ELocationID><Abstract><AbstractText Label="OBJECTIVE">This study aims to promote interoperability in precision medicine and translational research by aligning the Observational Medical Outcomes Partnership (OMOP) and Phenopackets data models. Phenopackets is an expert knowledge-driven schema designed to facilitate the storage and exchange of multimodal patient data, and support downstream analysis. The first goal of this paper is to explore model alignment by characterizing the common data models using a newly developed data transformation process and evaluation method. Second, using OMOP normalized clinical data, we evaluate the mapping of real-world patient data to Phenopackets. We evaluate the suitability of Phenopackets as a patient data representation for real-world clinical cases.</AbstractText><AbstractText Label="METHODS">We identified mappings between OMOP and Phenopackets and applied them to a real patient dataset to assess the transformation's success. We analyzed gaps between the models and identified key considerations for transforming data between them. Further, to improve ambiguous alignment, we incorporated Unified Medical Language System (UMLS) semantic type-based filtering to direct individual concepts to their most appropriate domain and conducted a domain-expert evaluation of the mapping's clinical utility.</AbstractText><AbstractText Label="RESULTS">The OMOP to Phenopacket transformation pipeline was executed for 1,000 Alzheimer's disease patients and successfully mapped all required entities. However, due to missing values in OMOP for required Phenopacket attributes, 10.2&#xa0;% of records were lost. The use of UMLS-semantic type filtering for ambiguous alignment of individual concepts resulted in 96&#xa0;% agreement with clinical thinking, increased from 68&#xa0;% when mapping exclusively by domain correspondence.</AbstractText><AbstractText Label="CONCLUSION">This study presents a pipeline to transform data from OMOP to Phenopackets. We identified considerations for the transformation to ensure data quality, handling restrictions for successful Phenopacket validation and discrepant data formats. We identified unmappable Phenopacket attributes that focus on specialty use cases, such as genomics or oncology, which OMOP does not currently support. We introduce UMLS semantic type filtering to resolve ambiguous alignment to Phenopacket entities to be most appropriate for real-world interpretation. We provide a systematic approach to align OMOP and Phenopackets schemas. Our work facilitates future use of Phenopackets in clinical applications by addressing key barriers to interoperability when deriving a Phenopacket from real-world patient data.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schiffer-Kane</LastName><ForeName>Kayla</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Cong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callahan</LastName><ForeName>Tiffany J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ta</LastName><ForeName>Casey</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nestor</LastName><ForeName>Jordan G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA. Electronic address: cw2384@cumc.columbia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T15 LM007079</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM009451</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG012655</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008680</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM012895</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG013031</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 TR003434</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017432" MajorTopicYN="Y">Unified Medical Language System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012660" MajorTopicYN="N">Semantics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057170" MajorTopicYN="N">Translational Research, Biomedical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="N">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data model</Keyword><Keyword MajorTopicYN="N">Health data standards</Keyword><Keyword MajorTopicYN="N">Interoperability</Keyword><Keyword MajorTopicYN="N">OMOP-CDM</Keyword><Keyword MajorTopicYN="N">Phenopackets schema</Keyword><Keyword MajorTopicYN="N">Phenotyping</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>16</Day><Hour>11</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>23</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>22</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38777085</ArticleId><ArticleId IdType="mid">NIHMS1996819</ArticleId><ArticleId IdType="pmc">PMC11181468</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2024.104659</ArticleId><ArticleId IdType="pii">S1532-0464(24)00077-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rajkomar A, Oren E, Chen K, Dai AM, Hajaj N, Hardt M, et al. Scalable and accurate deep learning with electronic health records. Npj Digit Med. 2018. May 8;1(1):18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6550175</ArticleId><ArticleId IdType="pubmed">31304302</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Hripcsak G, Swaminathan S, Weng C. Defining and measuring completeness of electronic health records for secondary use. J Biomed Inform. 2013. Oct 1;46(5):830&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3810243</ArticleId><ArticleId IdType="pubmed">23820016</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer RR, Rock MA, Vasilevsky N, Carmody L, Rando H, Anzalone AJ, et al. Characterizing Long COVID: Deep Phenotype of a Complex Condition. EBioMedicine. 2021. Nov 25;74:103722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Kline A, Wang H, Li Y, Dennis S, Hutch M, Xu Z, et al. Multimodal machine learning in precision health: A scoping review. Npj Digit Med. 2022. Nov 7;5(1):1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9640667</ArticleId><ArticleId IdType="pubmed">36344814</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson PN, Haendel MA. Ontologies, Knowledge Representation, and Machine Learning for Translational Research: Recent Contributions. Yearb Med Inform. 2020. Aug;29(01):159&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7442528</ArticleId><ArticleId IdType="pubmed">32823310</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel M, McMurry J, Relevo R, Mungall C, Robinson P, Chute C. A Census of Disease Ontologies. Annu Rev Biomed Data Sci. 2018. Jul 20;1.</Citation></Reference><Reference><Citation>Callahan TJ, Stefanski AL, Wyrwa JM, Zeng C, Ostropolets A, Banda JM, et al. Ontologizing health systems data at scale: making translational discovery a reality. Npj Digit Med. 2023. May 19;6(1):89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10196319</ArticleId><ArticleId IdType="pubmed">37208468</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel MA, Chute CG, Robinson PN. Classification, Ontology, and Precision Medicine. Phimister EG, editor. N Engl J Med. 2018. Oct 11;379(15):1452&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6503847</ArticleId><ArticleId IdType="pubmed">30304648</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi M, Starr R, Braunstein M, Duke J. OHDSI on FHIR Platform Development with OMOP CDM mapping to FHIR Resources.</Citation></Reference><Reference><Citation>Gruendner J, Schwachhofer T, Sippl P, Wolf N, Erpenbeck M, Gulden C, et al. KETOS: Clinical decision support and machine learning as a service &#x2013; A training and deployment platform based on Docker, OMOP-CDM, and FHIR Web Services. PLoS ONE. 2019. Oct 3;14(10):e0223010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6776354</ArticleId><ArticleId IdType="pubmed">31581246</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Shah NH, Hripcsak G. Deep phenotyping: Embracing complexity and temporality&#x2014;Towards scalability, portability, and interoperability. J Biomed Inform. 2020. May;105:103433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179504</ArticleId><ArticleId IdType="pubmed">32335224</ArticleId></ArticleIdList></Reference><Reference><Citation>Danis D, Jacobsen JOB, Wagner AH, Groza T, Beckwith MA, Rekerle L, et al. Phenopacket-tools: Building and validating GA4GH Phenopackets. PloS One. 2023;18(5):e0285433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10191354</ArticleId><ArticleId IdType="pubmed">37196000</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen JOB, Baudis M, Baynam GS, Beckmann JS, Beltran S, Buske OJ, et al. The GA4GH Phenopacket schema defines a computable representation of clinical data. Nat Biotechnol. 2022. Jun;40(6):817&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9363006</ArticleId><ArticleId IdType="pubmed">35705716</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinhaus R, Proft S, Seelow E, Schalau T, Robinson PN, Seelow D. Deep phenotyping: symptom annotation made simple with SAMS. Nucleic Acids Res. 2022. May 7;50(W1):W677&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9252818</ArticleId><ArticleId IdType="pubmed">35524573</ArticleId></ArticleIdList></Reference><Reference><Citation>Phenopackets v2.0 expands utility to provide a more complete medical picture [Internet]. [cited 2023 Dec 4]. Available from: https://www.ga4gh.org/news_item/phenopackets-v2-expands-utility-to-provide-a-more-complete-medical-picture/</Citation></Reference><Reference><Citation>Queralt-Rosinach N, Moreno PA, Callahan T, Delussu G, Fraboulet C, Jacobsen J, et al. 
Mapping OHDSI OMOP Common Data Model and GA4GH Phenopackets for COVID-19 disease epidemics and analytics [Internet]. BioHackrXiv; 2022. 
Nov [cited 2023 May 23]. Available from: https://osf.io/ep3xh</Citation></Reference><Reference><Citation>Bodenreider O The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res. 2004. Jan 1;32(90001):267D&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashyap V
The UMLS<sup>&#xae;</sup> Semantic Network and the Semantic Web. AMIA Annu Symp Proc. 2003;2003:351&#x2013;5.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1480032</ArticleId><ArticleId IdType="pubmed">14728193</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladewig MS, Jacobsen JOB, Wagner AH, Danis D, El Kassaby B, Gargano M, et al. GA4GH Phenopackets: A Practical Introduction. Adv Genet Hoboken NJ. 2023. Mar;4(1):2200016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10000265</ArticleId><ArticleId IdType="pubmed">36910590</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;hler S, Gargano M, Matentzoglu N, Carmody LC, Lewis-Smith D, Vasilevsky NA, et al. The Human Phenotype Ontology in 2021. Nucleic Acids Res. 2021. Jan 8;49(D1):D1207&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778952</ArticleId><ArticleId IdType="pubmed">33264411</ArticleId></ArticleIdList></Reference><Reference><Citation>Avram S, Bologa CG, Holmes J, Bocci G, Wilson TB, Nguyen DT, et al. DrugCentral 2021 supports drug discovery and repositioning. Nucleic Acids Res. 2021. Jan 8;49(D1):D1160&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7779058</ArticleId><ArticleId IdType="pubmed">33151287</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasilevsky NA, Matentzoglu NA, Toro S, Flack JE, Hegde H, Unni DR, et al. 
Mondo: Unifying diseases for the world, by the world [Internet]. Health Informatics; 2022. 
Apr [cited 2023 Dec 4]. Available from: http://medrxiv.org/lookup/doi/10.1101/2022.04.13.22273750</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.04.13.22273750</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson SJ, Zeng K, Kilbourne J, Powell T, Moore R. Normalized names for clinical drugs: RxNorm at 6 years. J Am Med Inform Assoc JAMIA. 2011;18(4):441&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128404</ArticleId><ArticleId IdType="pubmed">21515544</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald CJ, Huff SM, Suico JG, Hill G, Leavelle D, Aller R, et al. LOINC, a universal standard for identifying laboratory observations: a 5-year update. Clin Chem. 2003. Apr;49(4):624&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">12651816</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly K SNOMED-CT: The advanced terminology and coding system for eHealth. Stud Health Technol Inform. 2006;121:279&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">17095826</ArticleId></ArticleIdList></Reference><Reference><Citation>Informatics OHDS and. The Book of OHDSI [Internet]. [cited 2023 Sep 11]. Available from: https://ohdsi.github.io/TheBookOfOhdsi/</Citation></Reference><Reference><Citation>What is a Phenopacket? &#x2014; phenopacket-schema 2.0 documentation [Internet]. [cited 2023 Dec 4]. Available from: https://phenopacket-schema.readthedocs.io/en/latest/basics.html</Citation></Reference><Reference><Citation>National Libray of Medicine. UMLS release file: 2023AA. [Internet]. Available from: https://www.nlm.nih.gov/research/umls/licensedcontent/umlsarchives04.html</Citation></Reference><Reference><Citation>Yu Y, Zong N, Wen A, Liu S, Stone DJ, Knaack D, et al. Developing an ETL tool for converting the PCORnet CDM into the OMOP CDM to facilitate the COVID-19 data integration. J Biomed Inform. 2022. Mar;127:104002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8791245</ArticleId><ArticleId IdType="pubmed">35077901</ArticleId></ArticleIdList></Reference><Reference><Citation>Sioutos N, Coronado S de, Haber MW, Hartel FW, Shaiu WL, Wright LW. NCI Thesaurus: A semantic model integrating cancer-related clinical and molecular information. J Biomed Inform. 2007. Feb 1;40(1):30&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">16697710</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson Chris. Group Health Cooperative. Dementia. PheKB;  [Internet]. 2012; Available from: https://phekb.org/phenotype/10</Citation></Reference><Reference><Citation>PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability - PubMed [Internet]. [cited 2023 Dec 4]. Available from: https://pubmed-ncbi-nlm-nih-gov.ezproxy.cul.columbia.edu/27026615/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>Rueda M, Leist IC, Gut IG. Convert-Pheno: A software toolkit for the interconversion of standard data models for phenotypic data. J Biomed Inform. 2023. Nov 29;104558.</Citation><ArticleIdList><ArticleId IdType="pubmed">38035971</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisk R, Lin L, Sperrin M, Barrett JK, Tom B, Diaz-Ordaz K, et al. Informative presence and observation in routine health data: A review of methodology for clinical risk prediction. J Am Med Inform Assoc. 2021. Jan 15;28(1):155&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7810439</ArticleId><ArticleId IdType="pubmed">33164082</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38792452</PMID><DateRevised><Year>2025</Year><Month>01</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Symptoms and Conditions in Children and Adults up to 90 Days after SARS-CoV-2 Infection: A Retrospective Observational Study Utilizing the Common Data Model.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2911</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13102911</ELocationID><Abstract><AbstractText><b>Background/Objectives:</b> There have been widespread reports of persistent symptoms in both children and adults after SARS-CoV-2 infection, giving rise to debates on whether it should be regarded as a separate clinical entity from other postviral syndromes. This study aimed to characterize the clinical presentation of post-acute symptoms and conditions in the Korean pediatric and adult populations. <b>Methods</b>: A retrospective analysis was performed using a national, population-based database, which was encoded using the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). We compared individuals diagnosed with SARS-CoV-2 to those diagnosed with influenza, focusing on the risk of developing prespecified symptoms and conditions commonly associated with the post-acute sequelae of COVID-19. <b>Results</b>: Propensity score matching yielded 1,656 adult and 343 pediatric SARS-CoV-2 and influenza pairs. Ninety days after diagnosis, no symptoms were found to have elevated risk in either adults or children when compared with influenza controls. Conversely, at 1 day after diagnosis, adults with SARS-CoV-2 exhibited a significantly higher risk of developing abnormal liver function tests, cardiorespiratory symptoms, constipation, cough, thrombophlebitis/thromboembolism, and pneumonia. In contrast, children diagnosed with SARS-CoV-2 did not show an increased risk for any symptoms during either acute or post-acute phases. <b>Conclusions</b>: In the acute phase after infection, SARS-CoV-2 is associated with an elevated risk of certain symptoms in adults. The risk of developing post-acute COVID-19 sequelae is not significantly different from that of having postviral symptoms in children in both the acute and post-acute phases, and in adults in the post-acute phase. These observations warrant further validation through studies, including the severity of initial illness, vaccination status, and variant types.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Minjung</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9311-5370</Identifier><AffiliationInfo><Affiliation>Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chaum Life Center, CHA University School of Medicine, Seoul 06062, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Taehee</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-9224-6961</Identifier><AffiliationInfo><Affiliation>Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chun</LastName><ForeName>Hae-Ryoung</ForeName><Initials>HR</Initials><Identifier Source="ORCID">0000-0002-2567-2845</Identifier><AffiliationInfo><Affiliation>Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jo</LastName><ForeName>Suyoung</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7790-0160</Identifier><AffiliationInfo><Affiliation>Institute of Health and Environment, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jo</LastName><ForeName>Yeongchang</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-1913-2308</Identifier><AffiliationInfo><Affiliation>Department of Preventive Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Dong Han</ForeName><Initials>DH</Initials><Identifier Source="ORCID">0000-0003-0175-2012</Identifier><AffiliationInfo><Affiliation>Big Data Department, Health Insurance Review and Assessment Service, Wonju 26465, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Sooyoung</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8620-4925</Identifier><AffiliationInfo><Affiliation>Healthcare ICT Research Center, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Sung-Il</ForeName><Initials>SI</Initials><Identifier Source="ORCID">0000-0003-4085-1494</Identifier><AffiliationInfo><Affiliation>Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health and Environment, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">persistent symptoms of COVID-19</Keyword><Keyword MajorTopicYN="N">post-COVID condition</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of COVID-19</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>25</Day><Hour>10</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>25</Day><Hour>10</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>25</Day><Hour>1</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38792452</ArticleId><ArticleId IdType="pmc">PMC11122571</ArticleId><ArticleId IdType="doi">10.3390/jcm13102911</ArticleId><ArticleId IdType="pii">jcm13102911</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Siddiqui S., Alhamdi H.W.S., Alghamdi H.A. Recent Chronology of COVID-19 Pandemic. Front. Public Health. 2022;10:778037. doi: 10.3389/fpubh.2022.778037.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.778037</ArticleId><ArticleId IdType="pmc">PMC9114873</ArticleId><ArticleId IdType="pubmed">35602161</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  COVID-19 Dashboard.  [(accessed on 9 April 2024)]; Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Sorg A.-L., Becht S., Jank M., Armann J., von Both U., Hufnagel M., Lander F., Liese J.G., Niehues T., Verjans E. Association of SARS-CoV-2 seropositivity with myalgic encephalomyelitis and/or chronic fatigue syndrome among children and adolescents in Germany. JAMA Netw. Open. 2022;5:e2233454. doi: 10.1001/jamanetworkopen.2022.33454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.33454</ArticleId><ArticleId IdType="pmc">PMC9516317</ArticleId><ArticleId IdType="pubmed">36166227</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: A meta-analysis and systematic review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro F., Belati A., Tulone O., Diella L., Bavaro D.F., Bonica R., Genna V., Smith L., Trott M., Bruyere O., et al. Incidence of long COVID-19 in people with previous SARS-CoV-2 infection: A systematic review and meta-analysis of 120,970 patients. Intern. Emerg. Med. 2023;18:1573&#x2013;1581. doi: 10.1007/s11739-022-03164-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-03164-w</ArticleId><ArticleId IdType="pmc">PMC9709360</ArticleId><ArticleId IdType="pubmed">36449260</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J., Jansari V., Hornig M., Iwasaki A. Unexplained post-acute infection syndromes. Nat. Med. 2022;28:911&#x2013;923. doi: 10.1038/s41591-022-01810-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Su S., Zhao Y., Zeng N., Liu X., Zheng Y., Sun J., Zhong Y., Wu S., Ni S., Gong Y. Epidemiology, clinical presentation, pathophysiology, and management of long COVID: An update. Mol. Psychiatry. 2023;28:4056&#x2013;4069. doi: 10.1038/s41380-023-02171-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-02171-3</ArticleId><ArticleId IdType="pubmed">37491461</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrino R., Chiappini E., Licari A., Galli L., Marseglia G.L. Prevalence and clinical presentation of long COVID in children: A systematic review. Eur. J. Pediatr. 2022;181:3995&#x2013;4009. doi: 10.1007/s00431-022-04600-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04600-x</ArticleId><ArticleId IdType="pmc">PMC9476461</ArticleId><ArticleId IdType="pubmed">36107254</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Shafran R., Ladhani S.N. Long COVID in children and adolescents. Curr. Opin. Infect. Dis. 2022;35:461&#x2013;467. doi: 10.1097/qco.0000000000000854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/qco.0000000000000854</ArticleId><ArticleId IdType="pmc">PMC9553244</ArticleId><ArticleId IdType="pubmed">36098262</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo-Pujol J., Moron-Lopez S., Dalmau J., Gonzalez-Aumatell A., Carreras-Abad C., Mendez M., Rodrigo C., Martinez-Picado J. Post COVID-19 Condition in Children and Adolescents: An Emerging Problem. Front. Pediatr. 2022;10:894204. doi: 10.3389/fped.2022.894204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.894204</ArticleId><ArticleId IdType="pmc">PMC9130634</ArticleId><ArticleId IdType="pubmed">35633949</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazukhina E., Andreeva M., Spiridonova E., Bobkova P., Shikhaleva A., El-Taravi Y., Rumyantsev M., Gamirova A., Bairashevskaia A., Petrova P. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: A prospective, cohort study in Moscow (StopCOVID) BMC Med. 2022;20:244. doi: 10.1186/s12916-022-02448-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02448-4</ArticleId><ArticleId IdType="pmc">PMC9257572</ArticleId><ArticleId IdType="pubmed">35794549</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjenberg Z., Leng S., Tascini C., Garg M., Misso K., El Guerche Seblain C., Shaikh N. Risk of long COVID main symptoms after SARS-CoV-2 infection: A systematic review and meta-analysis. Sci. Rep. 2023;13:15332. doi: 10.1038/s41598-023-42321-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-42321-9</ArticleId><ArticleId IdType="pmc">PMC10504382</ArticleId><ArticleId IdType="pubmed">37714919</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Nemati H., Shahisavandi M., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Barzegar Z., Kabiri M., Zeraatpisheh Z., et al. Long COVID in children and adolescents. World J. Pediatr. 2021;17:495&#x2013;499. doi: 10.1007/s12519-021-00457-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-021-00457-6</ArticleId><ArticleId IdType="pmc">PMC8414448</ArticleId><ArticleId IdType="pubmed">34478045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C., Yu D.H., Baek H., Cho J., You S.C., Park R.W. Data Resource Profile: Health Insurance Review and Assessment Service COVID-19 Observational Medical Outcomes Partnership (HIRA COVID-19 OMOP) database in South Korea. Int. J. Epidemiol. 2024;53:dyae062. doi: 10.1093/ije/dyae062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyae062</ArticleId><ArticleId IdType="pubmed">38658170</ArticleId></ArticleIdList></Reference><Reference><Citation>Rho Y., Cho D.Y., Son Y., Lee Y.J., Kim J.W., Lee H.J., You S.C., Park R.W., Lee J.Y. COVID-19 International Collaborative Research by the Health Insurance Review and Assessment Service Using Its Nationwide Real-world Data: Database, Outcomes, and Implications. J. Prev. Med. Public Health. 2021;54:8&#x2013;16. doi: 10.3961/jpmph.20.616.</Citation><ArticleIdList><ArticleId IdType="doi">10.3961/jpmph.20.616</ArticleId><ArticleId IdType="pmc">PMC7939755</ArticleId><ArticleId IdType="pubmed">33618494</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi W., Kim B.H., Kim M., Kim J., Im M., Ryang S., Kim E.H., Jeon Y.K., Kim S.S., Kim I.J. Heart failure and stroke risks in users of liothyronine with or without levothyroxine compared with levothyroxine alone: A propensity score-matched analysis. Thyroid. 2022;32:764&#x2013;771. doi: 10.1089/thy.2021.0634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2021.0634</ArticleId><ArticleId IdType="pubmed">35570696</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E., You S.C., Sena A.G., Kostka K., Abedtash H., Abrah&#xe3;o M.T.F., Alberga A., Alghoul H., Alser O., Alshammari T.M., et al. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat. Commun. 2020;11:5009. doi: 10.1038/s41467-020-18849-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18849-z</ArticleId><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Jing N., Liu X., Lorman V., Maltenfort M., Schuchard J., Wu Q., Tong J., Razzaghi H., Mejias A., et al. Clinical Subphenotypes of Multisystem Inflammatory Syndrome in Children: An EHR-based cohort study from the RECOVER program. medRxiv. 2022 doi: 10.1101/2022.09.26.22280364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.09.26.22280364</ArticleId><ArticleId IdType="pmc">PMC10684592</ArticleId><ArticleId IdType="pubmed">38017007</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler M., Tesch F., Batram M., Jacob J., Loser F., Weidinger O., Wende D., Vivirito A., Toepfner N., Ehm F., et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 2022;19:e1004122. doi: 10.1371/journal.pmed.1004122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004122</ArticleId><ArticleId IdType="pmc">PMC9648706</ArticleId><ArticleId IdType="pubmed">36355754</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Lee G.M., Razzaghi H., Lorman V., Mejias A., Pajor N.M., Thacker D., Webb R., Dickinson K., Bailey L.C., et al. Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents. JAMA Pediatr. 2022;176:1000&#x2013;1009. doi: 10.1001/jamapediatrics.2022.2800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.2800</ArticleId><ArticleId IdType="pmc">PMC9396470</ArticleId><ArticleId IdType="pubmed">35994282</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D.Y., Kim C., Yu D.H., Park R.W. Safety outcomes of antipsychotics classes in drug-na&#xef;ve patients with first-episode schizophrenia: A nationwide cohort study in South Korea. Asian J. Psychiatry. 2024;91:103857. doi: 10.1016/j.ajp.2023.103857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2023.103857</ArticleId><ArticleId IdType="pubmed">38128353</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan You S., Krumholz H.M., Suchard M.A., Schuemie M.J., Hripcsak G., Chen R., Shea S., Duke J., Pratt N., Reich C.G. Comprehensive comparative effectiveness and safety of first-line &#x3b2;-blocker monotherapy in hypertensive patients: A large-scale multicenter observational study. Hypertension. 2021;77:1528&#x2013;1538. doi: 10.1161/HYPERTENSIONAHA.120.16402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.16402</ArticleId><ArticleId IdType="pmc">PMC8035236</ArticleId><ArticleId IdType="pubmed">33775125</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T.-H., Huang P.-Y., Wu J.-Y., Chuang M.-H., Hsu W.-H., Tsai Y.-W., Lai C.-C. Comparison of post-acute sequelae following hospitalization for COVID-19 and influenza. BMC Med. 2023;21:480. doi: 10.1186/s12916-023-03200-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-03200-2</ArticleId><ArticleId IdType="pmc">PMC10696681</ArticleId><ArticleId IdType="pubmed">38049876</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesch F., Ehm F., Loser F.L., Vivirito A., Wende D., Batram M., Bechmann L., Buschmann T., Menzer S., Ludwig M. Post-viral symptoms and conditions are more frequent in COVID-19 than influenza, but not more persistent. Res. Sq. 2024 doi: 10.21203/rs.3.rs-3870058/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-3870058/v1</ArticleId><ArticleId IdType="pmc">PMC11465902</ArticleId><ArticleId IdType="pubmed">39385128</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B., Sudry T., Flaks-Manov N., Yehezkelli Y., Kalkstein N., Akiva P., Ekka-Zohar A., Ben David S.S., Lerner U., Bivas-Benita M., et al. Long COVID outcomes at one year after mild SARS-CoV-2 infection: Nationwide cohort study. BMJ. 2023;380:e072529. doi: 10.1136/bmj-2022-072529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn K.L., Stukel T.A., Huang A., Abdel-Qadir H., Altaf A., Bell C.M., Cheung A.M., Detsky A.S., Goulding S., Herridge M. Comparison of Medical and Mental Health Sequelae Following Hospitalization for COVID-19, Influenza, and Sepsis. JAMA Intern. Med. 2023;183:806&#x2013;817. doi: 10.1001/jamainternmed.2023.2228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.2228</ArticleId><ArticleId IdType="pmc">PMC10282961</ArticleId><ArticleId IdType="pubmed">37338892</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzam A., Khaled H., Refaey N., Mohsen S., El-Emam O.A., Dawood N., Ahmed H.A., Soliman O.A., Mostafa S., Ramadan H. The burden of persistent symptoms after COVID-19 (long COVID): A meta-analysis of controlled studies in children and adults. Virol. J. 2024;21:16. doi: 10.1186/s12985-024-02284-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-024-02284-3</ArticleId><ArticleId IdType="pmc">PMC10785462</ArticleId><ArticleId IdType="pubmed">38212781</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi W.S. Comprehensive understanding and field application of COVID-19 vaccine. Korean J. Med. 2021;96:155&#x2013;159. doi: 10.3904/kjm.2021.96.3.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.3904/kjm.2021.96.3.155</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi M. Post-viral sequelae of COVID-19 and influenza. Lancet Infect. Dis. 2023;24:218&#x2013;219. doi: 10.1016/S1473-3099(23)00762-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00762-4</ArticleId><ArticleId IdType="pubmed">38104584</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha J.H., Lee J.Y., Choi S.Y., Park S.K. COVID-19 Waves and Their Characteristics in the Seoul Metropolitan Area (Jan 20, 2020&#x2013;Aug 31, 2022) Public Health Wkly. Rep. 2023;16:111&#x2013;136. doi: 10.56786/PHWR.2023.16.5.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.56786/PHWR.2023.16.5.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostka K., Roel E., Trinh N.T., Mercad&#xe9;-Besora N., Delmestri A., Mateu L., Paredes R., Duarte-Salles T., Prieto-Alhambra D., Catal&#xe0; M. The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis. Nat. Commun. 2023;14:7449. doi: 10.1038/s41467-023-42726-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-42726-0</ArticleId><ArticleId IdType="pmc">PMC10656441</ArticleId><ArticleId IdType="pubmed">37978296</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin M., Lee P., Jang W. An Exploratory Study on Deaths and Changes in Medical Use during the COVID-19 Pandemic. 2021.  [(accessed on 9 April 2024)].  Available online:  https://repository.hira.or.kr/handle/2019.oak/3057.</Citation></Reference><Reference><Citation>Behnood S.A., Shafran R., Bennett S., Zhang A.X., O&#x2019;Mahoney L.L., Stephenson T.J., Ladhani S., De Stavola B.L., Viner R., Swann O.V. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies. J. Infect. 2022;84:158&#x2013;170. doi: 10.1016/j.jinf.2021.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L., Li X., Nie J., Tang K., Bhutta Z.A. A systematic review of persistent clinical features after SARS-CoV-2 in the pediatric population. Pediatrics. 2023;152:e2022060351. doi: 10.1542/peds.2022-060351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2022-060351</ArticleId><ArticleId IdType="pmc">PMC10389775</ArticleId><ArticleId IdType="pubmed">37476923</ArticleId></ArticleIdList></Reference><Reference><Citation>Viner R.M., Ward J.L., Hudson L.D., Ashe M., Patel S.V., Hargreaves D., Whittaker E. Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents. Arch. Dis. Child. 2021;106:802&#x2013;807. doi: 10.1136/archdischild-2020-320972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2020-320972</ArticleId><ArticleId IdType="pubmed">33334728</ArticleId></ArticleIdList></Reference><Reference><Citation>Korea Law Translation Center  Korea Law Translation Center. Juvenile Act.  [(accessed on 9 April 2024)].  Available online:  https://elaw.klri.re.kr/eng_mobile/viewer.do?hseq=51556&amp;type=sogan&amp;key=9#:~:text=The%20term%20%22juveniles%22%20as%20used,presently%20supervising%20and%20protecting%20juveniles.</Citation></Reference><Reference><Citation>Buonsenso D., Pujol F.E., Munblit D., Pata D., McFarland S., Simpson F.K. Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: A survey of 510 children. Future Microbiol. 2022;17:577&#x2013;588. doi: 10.2217/fmb-2021-0285.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2021-0285</ArticleId><ArticleId IdType="pmc">PMC9248023</ArticleId><ArticleId IdType="pubmed">35360923</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Pereira S.M.P., Shafran R., De Stavola B.L., Rojas N., McOwat K., Simmons R., Zavala M., O&#x2019;mahoney L., Chalder T. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): A national matched cohort study. Lancet Child Adolesc. Health. 2022;6:230&#x2013;239. doi: 10.1016/S2352-4642(22)00022-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk A.L., Kuppermann N., Florin T.A., Tancredi D.J., Xie J., Kim K., Finkelstein Y., Neuman M.I., Salvadori M.I., Yock-Corrales A. Post&#x2013;COVID-19 conditions among children 90 days after SARS-CoV-2 infection. JAMA Netw. Open. 2022;5:e2223253. doi: 10.1001/jamanetworkopen.2022.23253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.23253</ArticleId><ArticleId IdType="pmc">PMC9308058</ArticleId><ArticleId IdType="pubmed">35867061</ArticleId></ArticleIdList></Reference><Reference><Citation>Roge I., Smane L., Kivite-Urtane A., Pucuka Z., Racko I., Klavina L., Pavare J. Comparison of persistent symptoms after COVID-19 and other non-SARS-CoV-2 infections in children. Front. Pediatr. 2021;9:752385. doi: 10.3389/fped.2021.752385.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.752385</ArticleId><ArticleId IdType="pmc">PMC8586002</ArticleId><ArticleId IdType="pubmed">34778143</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg S.K., Nielsen S.D., Nygaard U., Bundgaard H., Palm P., Rotvig C., Christensen A.V. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): A national, cross-sectional study. Lancet Child Adolesc. Health. 2022;6:240&#x2013;248. doi: 10.1016/S2352-4642(22)00004-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00004-9</ArticleId><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnachie E., Hapfelmeier A., Linde K., Tauscher M., Gerlach R., Greissel A., Schneider A. Incidence of post-COVID syndrome and associated symptoms in outpatient care in Bavaria, Germany: A retrospective cohort study using routinely collected claims data. BMJ Open. 2022;12:e064979. doi: 10.1136/bmjopen-2022-064979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-064979</ArticleId><ArticleId IdType="pmc">PMC9511014</ArticleId><ArticleId IdType="pubmed">36137635</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavala M., Ireland G., Amin-Chowdhury Z., Ramsay M.E., Ladhani S.N. Acute and persistent symptoms in children with polymerase chain reaction (PCR)&#x2013;confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection compared with test-negative children in England: Active, prospective, national surveillance. Clin. Infect. Dis. 2022;75:e191&#x2013;e200. doi: 10.1093/cid/ciab991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab991</ArticleId><ArticleId IdType="pmc">PMC8767867</ArticleId><ArticleId IdType="pubmed">34849658</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuitunen I. Long COVID-19 is rarely diagnosed in children: Nationwide register-based analysis. Arch. Dis. Child. 2023;108:151. doi: 10.1136/archdischild-2022-324998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2022-324998</ArticleId><ArticleId IdType="pubmed">36368772</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossley C.J., Kavaliunaite E., Harman K., Cook J., Ruiz G., Gupta A. Post-acute COVID-19 outcomes in children requiring hospitalisation. Sci. Rep. 2022;12:8208. doi: 10.1038/s41598-022-12415-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-12415-x</ArticleId><ArticleId IdType="pmc">PMC9113067</ArticleId><ArticleId IdType="pubmed">35581348</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L., Holm M., Knudsen M., Ellermann-Eriksen S., Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children-a nationwide cohort study. Eur. J. Pediatr. 2022;181:1597&#x2013;1607. doi: 10.1007/s00431-021-04345-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumont R., Richard V., Lorthe E., Loizeau A., Pennacchio F., Zaballa M.-E., Baysson H., Nehme M., Perrin A., L&#x2019;Huillier A.G. A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents. Nat. Commun. 2022;13:7086. doi: 10.1038/s41467-022-34616-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34616-8</ArticleId><ArticleId IdType="pmc">PMC9708639</ArticleId><ArticleId IdType="pubmed">36446760</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad A., Janda A., Renk H., Stich M., Frieh P., Kaier K., Lohrmann F., Nieters A., Willems A., Huzly D. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study. EBioMedicine. 2022;84:104245. doi: 10.1016/j.ebiom.2022.104245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104245</ArticleId><ArticleId IdType="pmc">PMC9495281</ArticleId><ArticleId IdType="pubmed">36155957</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov I.M., Spiridonova E., Bobkova P., Gamirova A., Shikhaleva A., Andreeva M., Blyuss O., El-Taravi Y., DunnGalvin A., Comberiati P. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. Eur. Respir. J. 2022;59:2101341. doi: 10.1183/13993003.01341-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P., Curtis N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch. Dis. Child. 2021;106:429&#x2013;439. doi: 10.1136/archdischild-2020-320338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2020-320338</ArticleId><ArticleId IdType="pubmed">33262177</ArticleId></ArticleIdList></Reference><Reference><Citation>Lingappan K., Karmouty-Quintana H., Davies J., Akkanti B., Harting M.T. Understanding the age divide in COVID-19: Why are children overwhelmingly spared? Am. J. Physiol.-Lung Cell. Mol. Physiol. 2020;319:L39&#x2013;L44. doi: 10.1152/ajplung.00183.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00183.2020</ArticleId><ArticleId IdType="pmc">PMC7324935</ArticleId><ArticleId IdType="pubmed">32491949</ArticleId></ArticleIdList></Reference><Reference><Citation>Cusenza F., Davino G., D&#x2019;Alvano T., Argentiero A., Fainardi V., Pisi G., Principi N., Esposito S. Silence of the lambs: The immunological and molecular mechanisms of COVID-19 in children in comparison with adults. Microorganisms. 2021;9:330. doi: 10.3390/microorganisms9020330.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9020330</ArticleId><ArticleId IdType="pmc">PMC7915740</ArticleId><ArticleId IdType="pubmed">33562210</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C., Chen W., Cai J., He Y. The mechanisms of milder clinical symptoms of COVID-19 in children compared to adults. Ital. J. Pediatr. 2024;50:28. doi: 10.1186/s13052-024-01587-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-024-01587-z</ArticleId><ArticleId IdType="pmc">PMC10865718</ArticleId><ArticleId IdType="pubmed">38355623</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38806105</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>155</Volume><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Data harmonization and federated learning for multi-cohort dementia research using the OMOP common data model: A Netherlands consortium of dementia cohorts case study.</ArticleTitle><Pagination><StartPage>104661</StartPage><MedlinePgn>104661</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2024.104661</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(24)00079-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">Establishing collaborations between cohort studies has been fundamental for progress in health research. However, such collaborations are hampered by heterogeneous data representations across cohorts and legal constraints to data sharing. The first arises from a lack of consensus in standards of data collection and representation across cohort studies and is usually tackled by applying data harmonization processes. The second is increasingly important due to raised awareness for privacy protection and stricter regulations, such as the GDPR. Federated learning has emerged as a privacy-preserving alternative to transferring data between institutions through analyzing data in a decentralized manner.</AbstractText><AbstractText Label="METHODS">In this study, we set up a federated learning infrastructure for a consortium of nine Dutch cohorts with appropriate data available to the etiology of dementia, including an extract, transform, and load (ETL) pipeline for data harmonization. Additionally, we assessed the challenges of transforming and standardizing cohort data using the Observational Medical Outcomes Partnership (OMOP) common data model (CDM) and evaluated our tool in one of the cohorts employing federated algorithms.</AbstractText><AbstractText Label="RESULTS">We successfully applied our ETL tool and observed a complete coverage of the cohorts' data by the OMOP CDM. The OMOP CDM facilitated the data representation and standardization, but we identified limitations for cohort-specific data fields and in the scope of the vocabularies available. Specific challenges arise in a multi-cohort federated collaboration due to technical constraints in local environments, data heterogeneity, and lack of direct access to the data.</AbstractText><AbstractText Label="CONCLUSION">In this article, we describe the solutions to these challenges and limitations encountered in our study. Our study shows the potential of federated learning as a privacy-preserving solution for multi-cohort studies that enhance reproducibility and reuse of both data and analyses.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mateus</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, Netherlands. Electronic address: pedro.mateus@maastro.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moonen</LastName><ForeName>Justine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, Netherlands; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beran</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht, Netherlands; Department of Epidemiology and Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaarsma</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Center for Nutrition, Prevention, and Health Services, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Epidemiology and Data Science, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Landen</LastName><ForeName>Sophie M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, Netherlands; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heuvelink</LastName><ForeName>Joost</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birhanu</LastName><ForeName>Mahlet</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Biomedical Imaging Group Rotterdam, Dept. Radiology &amp; Nuclear Medicine, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harms</LastName><ForeName>Alexander G J</ForeName><Initials>AGJ</Initials><AffiliationInfo><Affiliation>Biomedical Imaging Group Rotterdam, Dept. Radiology &amp; Nuclear Medicine, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bron</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Biomedical Imaging Group Rotterdam, Dept. Radiology &amp; Nuclear Medicine, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolters</LastName><ForeName>Frank J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Erasmus MC - University Medical Centre Rotterdam, Departments of Epidemiology and Radiology &amp; Nuclear Medicine, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cats</LastName><ForeName>Davy</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Sequencing Analysis Support Core, Department of Biomedical Data Sciences, Leiden University Medical Center, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mei</LastName><ForeName>Hailiang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Sequencing Analysis Support Core, Department of Biomedical Data Sciences, Leiden University Medical Center, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oomens</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jansen</LastName><ForeName>Willemijn</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schram</LastName><ForeName>Miranda T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands; Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, Netherlands; MHeNS School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands; Heart and Vascular Center, Maastricht University Medical Center+, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dekker</LastName><ForeName>Andre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bermejo</LastName><ForeName>Inigo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="N">Information Dissemination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CDM</Keyword><Keyword MajorTopicYN="N">Cohort studies</Keyword><Keyword MajorTopicYN="N">Data harmonization</Keyword><Keyword MajorTopicYN="N">ETL</Keyword><Keyword MajorTopicYN="N">Federated learning</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>16</Day><Hour>11</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>29</Day><Hour>0</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>28</Day><Hour>19</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38806105</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2024.104661</ArticleId><ArticleId IdType="pii">S1532-0464(24)00079-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38818114</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2574-2531</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>JAMIA open</Title><ISOAbbreviation>JAMIA Open</ISOAbbreviation></Journal><ArticleTitle>MENDS-on-FHIR: leveraging the OMOP common data model and FHIR standards for national chronic disease surveillance.</ArticleTitle><Pagination><StartPage>ooae045</StartPage><MedlinePgn>ooae045</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ooae045</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamiaopen/ooae045</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">The Multi-State EHR-Based Network for Disease Surveillance (MENDS) is a population-based chronic disease surveillance distributed data network that uses institution-specific extraction-transformation-load (ETL) routines. MENDS-on-FHIR examined using Health Language Seven's Fast Healthcare Interoperability Resources (HL7<sup>&#xae;</sup> FHIR<sup>&#xae;</sup>) and US Core Implementation Guide (US Core IG) compliant resources derived from the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) to create a standards-based ETL pipeline.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">The input data source was a research data warehouse containing clinical and administrative data in OMOP CDM Version 5.3 format. OMOP-to-FHIR transformations, using a unique JavaScript Object Notation (JSON)-to-JSON transformation language called Whistle, created FHIR R4 V4.0.1/US Core IG V4.0.0 conformant resources that were stored in a local FHIR server. A REST-based Bulk FHIR $export request extracted FHIR resources to populate a local MENDS database.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Eleven OMOP tables were used to create 10 FHIR/US Core compliant resource types. A total of 1.13 trillion resources were extracted and inserted into the MENDS repository. A very low rate of non-compliant resources was observed.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">OMOP-to-FHIR transformation results passed validation with less than a 1% non-compliance rate. These standards-compliant FHIR resources provided standardized data elements required by the MENDS surveillance use case. The Bulk FHIR application programming interface (API) enabled population-level data exchange using interoperable FHIR resources. The OMOP-to-FHIR transformation pipeline creates a FHIR interface for accessing OMOP data.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">MENDS-on-FHIR successfully replaced custom ETL with standards-based interoperable FHIR resources using Bulk FHIR. The OMOP-to-FHIR transformations provide an alternative mechanism for sharing OMOP data.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Essaid</LastName><ForeName>Shahim</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2338-2550</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Denver, CO 80045, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andre</LastName><ForeName>Jeff</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0007-2654-6764</Identifier><AffiliationInfo><Affiliation>Commonwealth Informatics Inc, Waltham, MA 02451, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brooks</LastName><ForeName>Ian M</ForeName><Initials>IM</Initials><Identifier Source="ORCID">0000-0003-2724-936X</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Denver, CO 80045, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Compass, University of Colorado Anschutz Medical Campus, Denver, CO 80045, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hohman</LastName><ForeName>Katherine H</ForeName><Initials>KH</Initials><Identifier Source="ORCID">0000-0003-1552-4010</Identifier><AffiliationInfo><Affiliation>National Association of Chronic Disease Directors (NACDD), Decatur, GA 30030, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hull</LastName><ForeName>Madelyne</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1387-5004</Identifier><AffiliationInfo><Affiliation>Health Data Compass, University of Colorado Anschutz Medical Campus, Denver, CO 80045, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Sandra L</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0003-4810-0572</Identifier><AffiliationInfo><Affiliation>National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, GA 30333, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0003-4786-6875</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Denver, CO 80045, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Compass, University of Colorado Anschutz Medical Campus, Denver, CO 80045, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraus</LastName><ForeName>Emily M</ForeName><Initials>EM</Initials><Identifier Source="ORCID">0000-0002-2966-6936</Identifier><AffiliationInfo><Affiliation>Kraushold Consulting, Denver, CO 80120, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Public Health Informatics Institute, Decatur, GA 30030, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandadi</LastName><ForeName>Neha</ForeName><Initials>N</Initials><Identifier Source="ORCID">0009-0008-8317-4327</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Denver, CO 80045, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Compass, University of Colorado Anschutz Medical Campus, Denver, CO 80045, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Amanda K</ForeName><Initials>AK</Initials><Identifier Source="ORCID">0000-0001-5549-7788</Identifier><AffiliationInfo><Affiliation>National Association of Chronic Disease Directors (NACDD), Decatur, GA 30030, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mui</LastName><ForeName>Joyce Y</ForeName><Initials>JY</Initials><Identifier Source="ORCID">0000-0002-4952-5735</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Denver, CO 80045, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Compass, University of Colorado Anschutz Medical Campus, Denver, CO 80045, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zambarano</LastName><ForeName>Bob</ForeName><Initials>B</Initials><Identifier Source="ORCID">0009-0003-5723-748X</Identifier><AffiliationInfo><Affiliation>Commonwealth Informatics Inc, Waltham, MA 02451, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soares</LastName><ForeName>Andrey</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4319-9411</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Colorado Anschutz Medical Campus, Denver, CO 80045, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMIA Open</MedlineTA><NlmUniqueID>101730643</NlmUniqueID><ISSNLinking>2574-2531</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2023 Nov 22:2023.08.09.23293900. doi: 10.1101/2023.08.09.23293900.</RefSource><PMID Version="1">38045364</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HL7 Fast Healthcare Interoperability Resources (FHIR)</Keyword><Keyword MajorTopicYN="N">Health Level Seven</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword><Keyword MajorTopicYN="N">health information interoperability</Keyword><Keyword MajorTopicYN="N">public health surveillance</Keyword></KeywordList><CoiStatement>B.Z. and J.A. are affiliated with an organization that has funding from the Massachusetts Department of Public Health for support and development of Electronic Medical Record Support for Public Health (ESP) and MDPHnet, which is the underlying technology of MENDS. All other authors declare no competing interests. No copyrighted materials were used in this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>31</Day><Hour>3</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38818114</ArticleId><ArticleId IdType="pmc">PMC11137321</ArticleId><ArticleId IdType="doi">10.1093/jamiaopen/ooae045</ArticleId><ArticleId IdType="pii">ooae045</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DeSalvo K, Hughes B, Bassett M, et al.Public health COVID-19 impact assessment: lessons learned and compelling needs. NAM Perspect. 2021:1-29. 10.31478/202104c.</Citation><ArticleIdList><ArticleId IdType="doi">10.31478/202104c</ArticleId><ArticleId IdType="pmc">PMC8406505</ArticleId><ArticleId IdType="pubmed">34532688</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadakia KT, Howell MD, DeSalvo KB.. Modernizing public health data systems: lessons from the Health Information Technology for Economic and Clinical Health (HITECH) act. JAMA. 2021;326(5):385-386. 10.1001/jama.2021.12000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.12000</ArticleId><ArticleId IdType="pubmed">34342612</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintana Y, Cullen TA, Holmes JH, et al.Global health informatics: the state of research and lessons learned. J Am Med Inform Assoc. 2023;30(4):627-633. 10.1093/jamia/ocad027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocad027</ArticleId><ArticleId IdType="pmc">PMC10018255</ArticleId><ArticleId IdType="pubmed">36924133</ArticleId></ArticleIdList></Reference><Reference><Citation>Acharya JC, Staes C, Allen KS, et al.Strengths, weaknesses, opportunities, and threats for the nation&#x2019;s public health information systems infrastructure: synthesis of discussions from the 2022 ACMI symposium. J Am Med Inform Assoc. 2023;30(6):1011-1021. 10.1093/jamia/ocad059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocad059</ArticleId><ArticleId IdType="pmc">PMC10198524</ArticleId><ArticleId IdType="pubmed">37146228</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee P, Abernethy A, Shaywitz D, et al.Digital Health COVID-19 impact assessment: lessons learned and compelling needs. In: Adams L, Ahmed M, Bailey A, et al., eds. Emerging Stronger COVID-19: Priorities Health System Transformation. National Academies Press; 2023: 177-234. 10.17226/26657.</Citation><ArticleIdList><ArticleId IdType="doi">10.17226/26657</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon BE, Staes C, Acharya J, et al.Enhancing the nation&#x2019;s public health information infrastructure: a report from the ACMI symposium. J Am Med Inform Assoc. 2023;30(5):1000-1005. 10.1093/jamia/ocad033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocad033</ArticleId><ArticleId IdType="pmc">PMC10114045</ArticleId><ArticleId IdType="pubmed">36917089</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross DA, Baker EL.. A brief history of public health informatics&#x2014;lessons for leaders and a look into the future. J Public Health Manag Pract. 2023;29(1):101-104. 10.1097/PHH.0000000000001672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHH.0000000000001672</ArticleId><ArticleId IdType="pubmed">36448762</ArticleId></ArticleIdList></Reference><Reference><Citation>Casey JA, Schwartz BS, Stewart WF, et al.Using electronic health records for population health research: a review of methods and applications. Annu Rev Public Health. 2016;37:61-81. 10.1146/annurev-publhealth-032315-021353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-publhealth-032315-021353</ArticleId><ArticleId IdType="pmc">PMC6724703</ArticleId><ArticleId IdType="pubmed">26667605</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, Resnic FS, Robbins SL, et al.Creating a common data model for comparative effectiveness with the observational medical outcomes partnership. Appl Clin Inform. 2015;6(3):536-547. 10.4338/ACI-2014-12-CR-0121.</Citation><ArticleIdList><ArticleId IdType="doi">10.4338/ACI-2014-12-CR-0121</ArticleId><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Gini R, Schuemie M, Brown J, et al.Data extraction and management in networks of observational health care databases for scientific research: a comparison among EU-ADR, OMOP, Mini-Sentinel, and MATRICE strategies. EGEMs Gener Evid Methods Improve Patient Outcomes. 2016;4(1):2. 10.13063/2327-9214.1189.</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1189</ArticleId><ArticleId IdType="pmc">PMC4780748</ArticleId><ArticleId IdType="pubmed">27014709</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong TC, Pradhananga R, Holve E, et al.A framework for classification of electronic health data extraction-transformation-loading challenges in data network participation. EGEMs Gener Evid Methods Improve Patient Outcomes. 2017;5:10. 10.13063/2327-9214.1295.</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1295</ArticleId><ArticleId IdType="pmc">PMC5994935</ArticleId><ArticleId IdType="pubmed">29930958</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook L, Espinoza J, Weiskopf NG, N3C Consortium, et al.Issues with variability in electronic health record data about race and ethnicity: descriptive analysis of the national COVID cohort collaborative data enclave. JMIR Med Inform. 2022;10(9):e39235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9490543</ArticleId><ArticleId IdType="pubmed">35917481</ArticleId></ArticleIdList></Reference><Reference><Citation>Leese P, Anand A, Girvin A, et al.Clinical encounter heterogeneity and methods for resolving in networked EHR data: a study from N3C and RECOVER programs. J Am Med Inform Assoc. 2023;30(6):1125-1136. 10.1093/jamia/ocad057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocad057</ArticleId><ArticleId IdType="pmc">PMC10198518</ArticleId><ArticleId IdType="pubmed">37087110</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Association of Chronic Disease Directors. Multi-State EHR-Based Network for Disease Surveillance (MENDS); 2023. Accessed June 29, 2023. https://chronicdisease.org/page/mendsinfo/</Citation></Reference><Reference><Citation>Lazarus R, Klompas M, Campion FX, et al.Electronic support for public health: validated case finding and reporting for notifiable diseases using electronic medical data. J Am Med Inform Assoc JAMIA. 2009;16(1):18-24. 10.1197/jamia.M2848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M2848</ArticleId><ArticleId IdType="pmc">PMC2605594</ArticleId><ArticleId IdType="pubmed">18952940</ArticleId></ArticleIdList></Reference><Reference><Citation>Klompas M, McVetta J, Lazarus R, et al.Integrating clinical practice and public health surveillance using electronic medical record systems. Am J Public Health. 2012;102(Suppl 3):S325-32. 10.2105/AJPH.2012.300811.</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2012.300811</ArticleId><ArticleId IdType="pmc">PMC3478075</ArticleId><ArticleId IdType="pubmed">22690967</ArticleId></ArticleIdList></Reference><Reference><Citation>Birkhead GS, Klompas M, Shah NR.. Uses of electronic health records for public health surveillance to advance public health. Annu Rev Public Health. 2015;36:345-359. 10.1146/annurev-publhealth-031914-122747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-publhealth-031914-122747</ArticleId><ArticleId IdType="pubmed">25581157</ArticleId></ArticleIdList></Reference><Reference><Citation>
ESPHealth. ESP: electronic medical record support for public health; n.d. Accessed May 3, 2023. https://www.esphealth.org/</Citation></Reference><Reference><Citation>Hohman KH, Martinez AK, Klompas M, et al.Leveraging electronic health record data for timely chronic disease surveillance: the Multi-State EHR-Based Network for Disease Surveillance. J Public Health Manag Pract. 2023;29(2):162-173. 10.1097/PHH.0000000000001693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHH.0000000000001693</ArticleId><ArticleId IdType="pmc">PMC9897452</ArticleId><ArticleId IdType="pubmed">36715594</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraus EM, Saintus L, Martinez AK, et al.Fostering governance and information partnerships for chronic disease surveillance: the Multi-State EHR-Based Network for Disease Surveillance. J Public Health Manag Pract. 2024;30(2):244-254. 10.1097/PHH.0000000000001810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHH.0000000000001810</ArticleId><ArticleId IdType="pmc">PMC10811406</ArticleId><ArticleId IdType="pubmed">38271106</ArticleId></ArticleIdList></Reference><Reference><Citation>
HL7. HL7 FHIR: Home; n.d. Accessed April 21, 2023. http://hl7.org/fhir/</Citation></Reference><Reference><Citation>
Posnack S, Barker W. The heat is on: US caught FHIR in 2019. Health IT Buzz; 2021. Accessed June 16, 2023. https://www.healthit.gov/buzz-blog/health-it/the-heat-is-on-us-caught-fhir-in-2019</Citation></Reference><Reference><Citation>Office of the National Coordinator. 2015 Edition Cures Update Overview.Office of the National Coordinator; 2015.</Citation></Reference><Reference><Citation>Actionable ways to meet the 2015 Edition Cures Update requirements. Health IT Buzz; 2022. Accessed June 18, 2023. https://www.healthit.gov/buzz-blog/healthit-certification/actionable-ways-to-meet-the-2015-edition-cures-update-requirements</Citation></Reference><Reference><Citation>
HL7. Profiling&#x2014;FHIR v4.0.1. HL7 FHIR Release 4; n.d. Accessed June 6, 2023. https://www.hl7.org/fhir/R4/profiling.html</Citation></Reference><Reference><Citation>
HL7. Implementation Guide&#x2014;FHIR v4.0.1. HL7 FHIR Release 4; n.d. Accessed June 6, 2023. https://www.hl7.org/fhir/R4/implementationguide.html</Citation></Reference><Reference><Citation>
HL7. HL7 FHIR: bulk data access IG; n.d. Accessed June 6, 2023. https://hl7.org/fhir/uv/bulkdata/</Citation></Reference><Reference><Citation>Mandl KD, Gottlieb D, Mandel JC, et al.Push button population health: the SMART/HL7 FHIR bulk data access application programming interface. NPJ Digit Med. 2020;3(1):151. 10.1038/s41746-020-00358-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-00358-4</ArticleId><ArticleId IdType="pmc">PMC7678833</ArticleId><ArticleId IdType="pubmed">33299056</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Health and Human Services. Health Information Technology: Standards, Implementation Specification, and Certification Criteria for Electronic Health Record Technology, 2014 Edition; Revisions to the Permanent Certification Program for Health Information Technology. Department of Health and Human Services; 2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">22946139</ArticleId></ArticleIdList></Reference><Reference><Citation> HL7 FHIR API criterion&#x2014;170.315(g)(10)&#x2014;ONC Health IT Certification Program API Resource Guide; n.d. Accessed November 15, 2023. https://onc-healthit.github.io/api-resource-guide/g10-criterion/</Citation></Reference><Reference><Citation>Jones J, Gottlieb D, Mandel JC, et al.A landscape survey of planned SMART/HL7 bulk FHIR data access API implementations and tools. J Am Med Inform Assoc. 2021;28(6):1284-1287. 10.1093/jamia/ocab028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocab028</ArticleId><ArticleId IdType="pmc">PMC8661398</ArticleId><ArticleId IdType="pubmed">33675659</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenert L, Jacobs J, Agnew J, et al.VACtrac: enhancing access immunization registry data for population outreach using the bulk Fast Healthcare Interoperable Resource (FHIR) protocol. J Am Med Inform Assoc JAMIA. 2022;30(3):551-558. 10.1093/jamia/ocac237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocac237</ArticleId><ArticleId IdType="pmc">PMC9933063</ArticleId><ArticleId IdType="pubmed">36474431</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones JR, Gottlieb D, McMurry AJ, et al.Real world performance of the 21st century cures act population level application programming interface. Health Informatics. 2023:1-18; 10.1101/2023.10.05.23296560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.10.05.23296560</ArticleId><ArticleId IdType="pmc">PMC11031206</ArticleId><ArticleId IdType="pubmed">38447593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Mui JY, Ames MJ, et al.Migrating a research data warehouse to a public cloud: challenges and opportunities. J Am Med Inform Assoc. 2022;29(4):592-600. 10.1093/jamia/ocab278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocab278</ArticleId><ArticleId IdType="pmc">PMC8922165</ArticleId><ArticleId IdType="pubmed">34919694</ArticleId></ArticleIdList></Reference><Reference><Citation> Google HCLS Data Harmonization. 2023. https://github.com/GoogleCloudPlatform/healthcare-data-harmonization</Citation></Reference><Reference><Citation> Using the FHIR Validator&#x2014;FHIR&#x2014;Confluence; n.d. Accessed April 21, 2023. https://confluence.hl7.org/display/FHIR/Using+the+FHIR+Validator</Citation></Reference><Reference><Citation>McClure RC, Macumber CL, Skapik JL, et al.Igniting harmonized digital clinical quality measurement through terminology, CQL, and FHIR. Appl Clin Inform. 2020;11(1):23-33. 10.1055/s-0039-3402755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-3402755</ArticleId><ArticleId IdType="pmc">PMC6949169</ArticleId><ArticleId IdType="pubmed">31914472</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin AM, Schwab A, Abolhassni R, et al.From authoring to evaluating an electronic health quality measure&#x2014;applying logic to FHIR&#xae; with CQL for calculating immunization coverage. In: Pfeifer B, Schreier G, Baumgartner M, et al., eds. Studies in Health Technology and Informatics. IOS Press; 2023:12-17. 10.3233/SHTI230004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI230004</ArticleId><ArticleId IdType="pubmed">37172145</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, Champion J, Bradford RL, et al.Fast healthcare interoperability resources (FHIR) as a meta model to integrate common data models: Development of a tool and quantitative validation study. JMIR Med Inform. 2019;7(4):e15199. 10.2196/15199.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/15199</ArticleId><ArticleId IdType="pmc">PMC6913576</ArticleId><ArticleId IdType="pubmed">31621639</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao G, Pfaff E, Prud'hommeaux E, et al.FHIR-Ontop-OMOP: building clinical knowledge graphs in FHIR RDF with the OMOP common data model. J Biomed Inform. 2022;134:104201. 10.1016/j.jbi.2022.104201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2022.104201</ArticleId><ArticleId IdType="pmc">PMC9561043</ArticleId><ArticleId IdType="pubmed">36089199</ArticleId></ArticleIdList></Reference><Reference><Citation>Marteau BL, Zhu Y, Giuste F, et al. Accelerating multi-site health informatics with streamlined data infrastructure using OMOP-on-FHIR. In: 2022 44th Annual International Conference on IEEE EMBC, Glasgow, Scotland, United Kingdom. IEEE; 2022: 4687-4690. 10.1109/EMBC48229.2022.9871865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/EMBC48229.2022.9871865</ArticleId><ArticleId IdType="pubmed">36085809</ArticleId></ArticleIdList></Reference><Reference><Citation>
OMOP on FHIR. GitHub; n.d. Accessed May 27, 2023. https://github.com/omoponfhir</Citation></Reference><Reference><Citation>Boussadi A, Zapletal E.. A fast healthcare interoperability resources (FHIR) layer implemented over i2b2. BMC Med Inform Decis Mak. 2017;17(1):120. 10.1186/s12911-017-0513-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-017-0513-6</ArticleId><ArticleId IdType="pmc">PMC5557515</ArticleId><ArticleId IdType="pubmed">28806953</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasthurirathne SN, Mamlin B, Kumara H, et al.Enabling better interoperability for healthcare: lessons in developing a standards based application programming interface for electronic medical record systems. J Med Syst. 2015;39(11):182.</Citation><ArticleIdList><ArticleId IdType="pubmed">26446013</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh WR, Weiner MG, Embi PJ, et al.Caveats for the use of operational electronic health record data in comparative effectiveness research. Med Care. 2013;51(8 Suppl 3):S30-S37. 10.1097/MLR.0b013e31829b1dbd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31829b1dbd</ArticleId><ArticleId IdType="pmc">PMC3748381</ArticleId><ArticleId IdType="pubmed">23774517</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A, Ryan P, Fife D, et al.Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug Saf. 2014;37(11):945-959. 10.1007/s40264-014-0214-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0214-3</ArticleId><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Levine ME, Shang N, et al.Effect of vocabulary mapping for conditions on phenotype cohorts. J Am Med Inform Assoc. 2018;25(12):1618-1625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289550</ArticleId><ArticleId IdType="pubmed">30395248</ArticleId></ArticleIdList></Reference><Reference><Citation>Papez V, Moinat M, Payralbe S, et al.Transforming and evaluating electronic health record disease phenotyping algorithms using the OMOP common data model: a case study in heart failure. JAMIA Open. 2021;4(3):ooab001. 10.1093/jamiaopen/ooab001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamiaopen/ooab001</ArticleId><ArticleId IdType="pmc">PMC8423424</ArticleId><ArticleId IdType="pubmed">34514354</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38818399</PMID><DateRevised><Year>2025</Year><Month>01</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>OHDSI-compliance: a set of document templates facilitating the implementation and operation of a software stack for real-world evidence generation.</ArticleTitle><Pagination><StartPage>1378866</StartPage><MedlinePgn>1378866</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1378866</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2024.1378866</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">The open-source software offered by the Observational Health Data Science and Informatics (OHDSI) collective, including the OMOP-CDM, serves as a major backbone for many real-world evidence networks and distributed health data analytics platforms. While container technology has significantly simplified deployments from a technical perspective, regulatory compliance can remain a major hurdle for the setup and operation of such platforms. In this paper, we present OHDSI-Compliance, a comprehensive set of document templates designed to streamline the data protection and information security-related documentation and coordination efforts required to establish OHDSI installations.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">To decide on a set of relevant document templates, we first analyzed the legal requirements and associated guidelines with a focus on the General Data Protection Regulation (GDPR). Moreover, we analyzed the software architecture of a typical OHDSI stack and related its components to the different general types of concepts and documentation identified. Then, we created those documents for a prototypical OHDSI installation, based on the so-called Broadsea package, following relevant guidelines from Germany. Finally, we generalized the documents by introducing placeholders and options at places where individual institution-specific content will be needed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We present four documents: (1) a record of processing activities, (2) an information security concept, (3) an authorization concept, as well as (4) an operational concept covering the technical details of maintaining the stack. The documents are publicly available under a permissive license.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">To the best of our knowledge, there are no other publicly available sets of documents designed to simplify the compliance process for OHDSI deployments. While our documents provide a comprehensive starting point, local specifics need to be added, and, due to the heterogeneity of legal requirements in different countries, further adoptions might be necessary.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Wirth, Abu Attieh and Prasser.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wirth</LastName><ForeName>Felix N</ForeName><Initials>FN</Initials><AffiliationInfo><Affiliation>Berlin Institute of Health at Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Center of Health Data Science, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu Attieh</LastName><ForeName>Hammam</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Berlin Institute of Health at Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Center of Health Data Science, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prasser</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Berlin Institute of Health at Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Center of Health Data Science, Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">data protection</Keyword><Keyword MajorTopicYN="N">health data analytics</Keyword><Keyword MajorTopicYN="N">observational health data science</Keyword><Keyword MajorTopicYN="N">real-world evidence</Keyword><Keyword MajorTopicYN="N">regulatory compliance</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>31</Day><Hour>4</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38818399</ArticleId><ArticleId IdType="pmc">PMC11137233</ArticleId><ArticleId IdType="doi">10.3389/fmed.2024.1378866</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, et al. . Real-world evidence - what is it and what can it tell us? N Engl J Med. (2016) 375:2293&#x2013;7. doi: 10.1056/NEJMsb1609216, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsb1609216</ArticleId><ArticleId IdType="pubmed">27959688</ArticleId></ArticleIdList></Reference><Reference><Citation>Coorevits P, Sundgren M, Klein GO, Bahr A, Claerhout B, Daniel C, et al. . Electronic health records: new opportunities for clinical research. J Intern Med. (2013) 274:547&#x2013;60. doi: 10.1111/joim.12119</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12119</ArticleId><ArticleId IdType="pubmed">23952476</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth FN, Meurers T, Johns M, Prasser F. Privacy-preserving data sharing infrastructures for medical research: systematization and comparison. BMC Med Inform Decis Mak. (2021) 21:242&#x2013;55. doi: 10.1186/s12911-021-01602-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-021-01602-x</ArticleId><ArticleId IdType="pmc">PMC8359765</ArticleId><ArticleId IdType="pubmed">34384406</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurry AJ, Murphy SN, MacFadden D, Weber G, Simons WW, Orechia J, et al. . SHRINE: enabling nationally scalable multi-site disease studies. PLoS One. (2013) 8:55811. doi: 10.1371/journal.pone.0055811</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0055811</ArticleId><ArticleId IdType="pmc">PMC3591385</ArticleId><ArticleId IdType="pubmed">23533569</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaye A, Marcon Y, Isaeva J, LaFlamme P, Turner A, Jones EM, et al. . DataSHIELD: taking the analysis to the data, not the data to the analysis. Int J Epidemiol. (2014) 43:1929&#x2013;44. doi: 10.1093/ije/dyu188, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyu188</ArticleId><ArticleId IdType="pmc">PMC4276062</ArticleId><ArticleId IdType="pubmed">25261970</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. . Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. (2015) 216:574&#x2013;8. doi: 10.3233/978-1-61499-564-7-574 PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/978-1-61499-564-7-574</ArticleId><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich C, Ostropolets A, Ryan P, Rijnbeek P, Schuemie M, Davydov A, et al. . OHDSI standardized vocabularies&#x2014;a large-scale centralized reference ontology for international data harmonization. J Am Med Inform Assoc. (2024) 31:583&#x2013;90. doi: 10.1093/jamia/ocad247</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocad247</ArticleId><ArticleId IdType="pmc">PMC10873827</ArticleId><ArticleId IdType="pubmed">38175665</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Blacketer C, van Sandijk S, Moinat M, Kallfelz M, van Speybroeck M, et al. . European Health Data &amp; Evidence Network-learnings from building out a standardized international health data network. J Am Med Inform Assoc JAMIA. (2023) 31:209&#x2013;19. doi: 10.1093/jamia/ocad214, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocad214</ArticleId><ArticleId IdType="pmc">PMC10746315</ArticleId><ArticleId IdType="pubmed">37952118</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabani M. Will the European health data space change data sharing rules? Science. (2022) 375:1357&#x2013;9. doi: 10.1126/science.abn4874, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abn4874</ArticleId><ArticleId IdType="pubmed">35324305</ArticleId></ArticleIdList></Reference><Reference><Citation>Welten S, Weber S, Holt A, Beyan O, Decker S. Will it run?-a proof of concept for smoke testing decentralized data analytics experiments. Front Med. (2023) 10:1305415. doi: 10.3389/fmed.2023.1305415</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1305415</ArticleId><ArticleId IdType="pmc">PMC10801058</ArticleId><ArticleId IdType="pubmed">38259836</ArticleId></ArticleIdList></Reference><Reference><Citation>Vis DJ, Lewin J, Liao RG, Mao M, Andre F, Ward RL, et al. . Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscape. Ann Oncol. (2017) 28:1145&#x2013;51. doi: 10.1093/annonc/mdx037, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/annonc/mdx037</ArticleId><ArticleId IdType="pmc">PMC5406763</ArticleId><ArticleId IdType="pubmed">28453708</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil R, Macdonald JC, Gustafson A, Aljuburi L, Bisordi F, Beakes-Read G. Walking the talk in digital transformation of regulatory review. Front Med. (2023) 10:1233142. doi: 10.3389/fmed.2023.1233142, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1233142</ArticleId><ArticleId IdType="pmc">PMC10411640</ArticleId><ArticleId IdType="pubmed">37564043</ArticleId></ArticleIdList></Reference><Reference><Citation>Act Accountability . Health insurance portability and accountability act of 1996. Public Law. (1996) 104:191.</Citation><ArticleIdList><ArticleId IdType="pubmed">16477734</ArticleId></ArticleIdList></Reference><Reference><Citation>Regulation Protection . Regulation (EU) 2016/679 of the European Parliament and of the council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing directive 95/46. Off J Eur Union OJ. (2016) 59:294.</Citation></Reference><Reference><Citation>UK GDPR . (2020). Available at: https://www.legislation.gov.uk/eur/2016/679/contents</Citation></Reference><Reference><Citation>Data Protection Act  (2018) Available at: https://www.legislation.gov.uk/ukpga/2018/12/contents</Citation></Reference><Reference><Citation>Privacy Act . (1988). Available at: https://www.legislation.gov.au/Details/C2022C00135</Citation></Reference><Reference><Citation>OneTrust DataGuidance . Comparing privacy laws: GDPR v. Thai Personal Data Protection Act [Internet]. (2024). Available at: https://www.dataguidance.com/sites/default/files/gdpr_v_thailand_updated.pdf</Citation></Reference><Reference><Citation>Azmi R, Tibben W, Win KT. Review of cybersecurity frameworks: context and shared concepts. J Cyber Policy. (2018) 3:258&#x2013;83. doi: 10.1080/23738871.2018.1520271</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23738871.2018.1520271</ArticleId></ArticleIdList></Reference><Reference><Citation>ISO/IEC . Information technology - security techniques - information security management systems - requirements (ISO/IEC 27001:2022). Geneva: International Organization for Standardization (ISO) and International Electrotechnical Commission (IEC) (2022).</Citation></Reference><Reference><Citation>Barrett MP. Framework for improving critical infrastructure cybersecurity. Gaithersburg: National Institute of Standards and Technology; (2018).</Citation></Reference><Reference><Citation>HITRUST Alliance . HITRUST common security framework (CSF version 9.0) [Internet]. Frisco: HITRUST Alliance; (2021).</Citation></Reference><Reference><Citation>Dierks C, Kircher P, Husemann C, Kleinschmidt J, Haase M. Data privacy in european medical research: A contemporary legal opinion. Berlin: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft; (2021).</Citation></Reference><Reference><Citation>International Association of Privacy Professional . Measuring privacy operations [Internet] (2019). Available at: https://iapp.org/media/pdf/resource_center/measuring_privacy_operations_2019.pdf</Citation></Reference><Reference><Citation>Becher SI, Benoliel U. Law in books and law in action: the readability of privacy policies and the GDPR In: Mathis K, Tor A, editors. Consumer law and economics. Berlin: Springer; (2021). 179&#x2013;204. doi: 10.1007/978-3-030-49028-7_9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-49028-7_9</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald AM, Cranor LF. The cost of reading privacy policies. J Law Policy Inf Soc. (2008) 4:543&#x2013;68.</Citation></Reference><Reference><Citation>Benoliel U, Becher S. The duty to read the unreadable. Boston Coll Law Rev. (2019) 60:2255&#x2013;96. doi: 10.2139/ssrn.3313837</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3313837</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc JAMIA. (2012) 19:54&#x2013;60. doi: 10.1136/amiajnl-2011-000376, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Obe RO, Hsu LS. PostgreSQL: Up and running: A practical guide to the advanced open source database. 3rd ed. Beijing, Boston, Farnham, Sebastopol, Tokyo: O&#x2019;Reilly; (2018). 294 p.</Citation></Reference><Reference><Citation>OHDSI . Software Tools (2024). Available at: https://www.ohdsi.org/software-tools/</Citation></Reference><Reference><Citation>Wirth FN, Abu Attieh H, Prasser F. OHDSI compliance. (2024) Available at: https://github.com/BIH-MI/ohdsi-compliance</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11137233</ArticleId><ArticleId IdType="pubmed">38818399</ArticleId></ArticleIdList></Reference><Reference><Citation>ISO/IEC . Information technology - security techniques - information security management systems - overview and vocabulary (ISO/IEC 27000:2020). Geneva: International Organization for Standardization (ISO) and international Electrotechnical commission (IEC) (2020).</Citation></Reference><Reference><Citation>Pommerening K, Drepper J, Helbing K, Ganslandt T. Leitfaden zum Datenschutz in medizinischen Forschungsprojekten: Generische L&#xf6;sungen der TMF 2.0. Berlin: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft; (2014).</Citation></Reference><Reference><Citation>National Institutes of Health . Protocol template for secondary research with biospecimens, data and/or medical records only [Internet]. Available at: https://ohsrp.nih.gov/confluence/download/attachments/67273200/Secondary%20Research%20Protocol%20Template.docx?api=v2</Citation></Reference><Reference><Citation>Center for Internet Security . NIST Cybersecurity Framework Policy Template Guide [Internet]. Available at: https://www.cisecurity.org/-/jssmedia/Project/cisecurity/cisecurity/data/media/files/uploads/2021/11/NIST-Cybersecurity-Framework-Policy-Template-Guide-v2111Online.pdf</Citation></Reference><Reference><Citation>Frielitz F, Storm N, Hiort O, Katalinic A, von Sengbusch S. Die Erstellung eines Datenschutzkonzeptes: eine Anleitung f&#xfc;r telemedizinische Versorgungsprojekte. Bundesgesundheitsblatt. (2019) 62:479: 485. doi: 10.1007/s00103-019-02918-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00103-019-02918-w</ArticleId><ArticleId IdType="pubmed">30874830</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace SE, Gaye A, Shoush O, Burton PR. Protecting personal data in epidemiological research: DataSHIELD and UK law. Public Health Genomics. (2014) 17:149&#x2013;57. doi: 10.1159/000360255, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000360255</ArticleId><ArticleId IdType="pubmed">24685519</ArticleId></ArticleIdList></Reference><Reference><Citation>Budin-Lj&#xf8;sne I, Burton P, Isaeva J, Gaye A, Turner A, Murtagh MJ, et al. . DataSHIELD: an ethically robust solution to multiple-site individual-level data analysis. Public Health Genomics. (2015) 18:87&#x2013;96. doi: 10.1159/000368959</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000368959</ArticleId><ArticleId IdType="pubmed">25532061</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes JH, Elliott TE, Brown JS, Raebel MA, Davidson A, Nelson AF, et al. . Clinical research data warehouse governance for distributed research networks in the USA: a systematic review of the literature. J Am Med Inform Assoc JAMIA. (2014) 21:730&#x2013;6. doi: 10.1136/amiajnl-2013-002370, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-002370</ArticleId><ArticleId IdType="pmc">PMC4078282</ArticleId><ArticleId IdType="pubmed">24682495</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlenko E, Strech D, Langhof H. Implementation of data access and use procedures in clinical data warehouses. A systematic review of literature and publicly available policies. BMC Med Inform Decis Mak. (2020) 20:157. doi: 10.1186/s12911-020-01177-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-020-01177-z</ArticleId><ArticleId IdType="pmc">PMC7353743</ArticleId><ArticleId IdType="pubmed">32652989</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Bonomi L, Dai W, Chen F, Cheung C, Bloss CS, et al. . Big data privacy in biomedical research. IEEE Trans Big Data. (2016) 6:296&#x2013;308. doi: 10.1109/TBDATA.2016.2608848, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TBDATA.2016.2608848</ArticleId><ArticleId IdType="pmc">PMC7258042</ArticleId><ArticleId IdType="pubmed">32478127</ArticleId></ArticleIdList></Reference><Reference><Citation>Arellano AM, Dai W, Wang S, Jiang X, Ohno-Machado L. Privacy policy and technology in biomedical data science. Annu Rev Biomed Data Sci. (2018) 1:115&#x2013;29. doi: 10.1146/annurev-biodatasci-080917-013416, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biodatasci-080917-013416</ArticleId><ArticleId IdType="pmc">PMC6497413</ArticleId><ArticleId IdType="pubmed">31058261</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamas E, Barh A, Brown D, Jaulent MC. Ethical, legal and social issues related to the health data-warehouses: re-using health data in the research and public health research. Stud Health Technol Inform. (2015) 210:719&#x2013;23. doi: 10.3233/978-1-61499-512-8-719 PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/978-1-61499-512-8-719</ArticleId><ArticleId IdType="pubmed">25991247</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkman S, Mostert M, Udo-Beauvisage N, van Delden JJ, van Thiel GJ. Responsible data sharing in a big data-driven translational research platform: lessons learned. BMC Med Inform Decis Mak. (2019) 19:283. doi: 10.1186/s12911-019-1001-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-019-1001-y</ArticleId><ArticleId IdType="pmc">PMC6936121</ArticleId><ArticleId IdType="pubmed">31888593</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlett P, Kj&#xe6;r J, Broich K, Cooke E. Real-world evidence in EU medicines regulation: enabling use and establishing value. Clin Pharmacol Ther. (2022) 111:21&#x2013;3. doi: 10.1002/cpt.2479, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.2479</ArticleId><ArticleId IdType="pmc">PMC9299492</ArticleId><ArticleId IdType="pubmed">34797920</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI . HL7 International and OHDSI announce collaboration to provide single common data model for sharing information in clinical care and observational research (2024). Available at: https://www.ohdsi.org/ohdsi-hl7-collaboration/</Citation></Reference><Reference><Citation>CNIL  The open source PIA software helps to carry out data protection impact assessment (2023). Available at: https://www.cnil.fr/en/open-source-pia-software-helps-carry-out-data-protection-impact-assessment</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38820647</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8243</ISSN><JournalIssue CitedMedium="Internet"><Volume>189</Volume><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>International journal of medical informatics</Title><ISOAbbreviation>Int J Med Inform</ISOAbbreviation></Journal><ArticleTitle>Using clinical text to refine unspecific condition codes in Dutch general practitioner EHR data.</ArticleTitle><Pagination><StartPage>105506</StartPage><MedlinePgn>105506</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijmedinf.2024.105506</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1386-5056(24)00169-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Observational studies using electronic health record (EHR) databases often face challenges due to unspecific clinical codes that can obscure detailed medical information, hindering precise data analysis. In this study, we aimed to assess the feasibility of refining these unspecific condition codes into more specific codes in a Dutch general practitioner (GP) EHR database by leveraging the available clinical free text.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We utilized three approaches for text classification-search queries, semi-supervised learning, and supervised learning-to improve the specificity of ten unspecific International Classification of Primary Care (ICPC-1) codes. Two text representations and three machine learning algorithms were evaluated for the (semi-)supervised models. Additionally, we measured the improvement achieved by the refinement process on all code occurrences in the database.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The classification models performed well for most codes. In general, no single classification approach consistently outperformed the others. However, there were variations in the relative performance of the classification approaches within each code and in the use of different text representations and machine learning algorithms. Class imbalance and limited training data affected the performance of the (semi-)supervised models, yet the simple search queries remained particularly effective. Ultimately, the developed models improved the specificity of over half of all the unspecific code occurrences in the database.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings show the feasibility of using information from clinical text to improve the specificity of unspecific condition codes in observational healthcare databases, even with a limited range of machine-learning techniques and modest annotated training sets. Future work could investigate transfer learning, integration of structured data, alternative semi-supervised methods, and validation of models across healthcare settings. The improved level of detail enriches the interpretation of medical information and can benefit observational research and patient care.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Seinen</LastName><ForeName>Tom M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: t.seinen@erasmusmc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kors</LastName><ForeName>Jan A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Mulligen</LastName><ForeName>Erik M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fridgeirsson</LastName><ForeName>Egill A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verhamme</LastName><ForeName>Katia Mc</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Int J Med Inform</MedlineTA><NlmUniqueID>9711057</NlmUniqueID><ISSNLinking>1386-5056</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058005" MajorTopicYN="Y">General Practitioners</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059019" MajorTopicYN="N">Clinical Coding</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="N">Natural Language Processing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Electronic Health Record</Keyword><Keyword MajorTopicYN="N">Machine Learning</Keyword><Keyword MajorTopicYN="N">Natural Language Processing</Keyword><Keyword MajorTopicYN="N">Primary Health Care</Keyword><Keyword MajorTopicYN="N">Text Mining</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>11</Day><Hour>4</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>1</Day><Hour>10</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>31</Day><Hour>18</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38820647</ArticleId><ArticleId IdType="doi">10.1016/j.ijmedinf.2024.105506</ArticleId><ArticleId IdType="pii">S1386-5056(24)00169-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38836701</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1477-4054</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>23</Day></PubDate></JournalIssue><Title>Briefings in bioinformatics</Title><ISOAbbreviation>Brief Bioinform</ISOAbbreviation></Journal><ArticleTitle>Sharing sensitive data in life sciences: an overview of centralized and federated approaches.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">bbae262</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/bib/bbae262</ELocationID><Abstract><AbstractText>Biomedical data are generated and collected from various sources, including medical imaging, laboratory tests and genome sequencing. Sharing these data for research can help address unmet health needs, contribute to scientific breakthroughs, accelerate the development of more effective treatments and inform public health policy. Due to the potential sensitivity of such data, however, privacy concerns have led to policies that restrict data sharing. In addition, sharing sensitive data requires a secure and robust infrastructure with appropriate storage solutions. Here, we examine and compare the centralized and federated data sharing models through the prism of five large-scale and real-world use cases of strategic significance within the European data sharing landscape: the French Health Data Hub, the BBMRI-ERIC Colorectal Cancer Cohort, the federated European Genome-phenome Archive, the Observational Medical Outcomes Partnership/OHDSI network and the EBRAINS Medical Informatics Platform. Our analysis indicates that centralized models facilitate data linkage, harmonization and interoperability, while federated models facilitate scaling up and legal compliance, as the data typically reside on the data generator's premises, allowing for better control of how data are shared. This comparative study thus offers guidance on the selection of the most appropriate sharing strategy for sensitive datasets and provides key insights for informed decision-making in data sharing efforts.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rujano</LastName><ForeName>Maria A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>European Clinical Research Infrastructure Network (ECRIN), Boulevard Saint Jacques 30, 75014, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boiten</LastName><ForeName>Jan-Willem</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Foundation Lygature, Jaarbeursplein 6, 3521 AL, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohmann</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>European Clinical Research Infrastructure Network (ECRIN), Boulevard Saint Jacques 30, 75014, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canham</LastName><ForeName>Steve</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>European Clinical Research Infrastructure Network (ECRIN), Boulevard Saint Jacques 30, 75014, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contrino</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>European Clinical Research Infrastructure Network (ECRIN), Boulevard Saint Jacques 30, 75014, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>David</LastName><ForeName>Romain</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>European Research Infrastructure on Highly Pathogenic Agents (ERINHA AISBL), rue du Tr&#xf4;ne 98/Bo&#xee;te 4B, 1050, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ewbank</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>European Research Infrastructure on Highly Pathogenic Agents (ERINHA AISBL), rue du Tr&#xf4;ne 98/Bo&#xee;te 4B, 1050, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filippone</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>European Research Infrastructure on Highly Pathogenic Agents (ERINHA AISBL), rue du Tr&#xf4;ne 98/Bo&#xee;te 4B, 1050, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Connellan</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>European Research Infrastructure on Highly Pathogenic Agents (ERINHA AISBL), rue du Tr&#xf4;ne 98/Bo&#xee;te 4B, 1050, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Custers</LastName><ForeName>Ilse</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Foundation Lygature, Jaarbeursplein 6, 3521 AL, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Nuland</LastName><ForeName>Rick</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Foundation Lygature, Jaarbeursplein 6, 3521 AL, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayrhofer</LastName><ForeName>Michaela Th</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-ERIC), Neue Stiftingtalstrasse 2/B/6, 8010, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holub</LastName><ForeName>Petr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-ERIC), Neue Stiftingtalstrasse 2/B/6, 8010, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1;lvarez</LastName><ForeName>Eva Garc&#xed;a</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-ERIC), Neue Stiftingtalstrasse 2/B/6, 8010, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bacry</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Health Data Hub (HDH), rue Georges Pitard 9, 75015, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Nigel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Antwerpseweg 15, 2340, Beerse, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freeberg</LastName><ForeName>Mallory A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute (EBI), Wellcome Genome Campus, CB10 1SD, Hinxton, Cambridgeshire, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaffhauser</LastName><ForeName>Birgit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois (CHUV), Rue du Bugnon 21, 1011, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagener</LastName><ForeName>Harald</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Digital Health, BIH@Charit&#xe9; University Medicine, Anna-Louisa-Karsch-Stra&#xdf;e 2, 10178, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Pla</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Genetics, Microbiology and Statistics, Universitat de Barcelona, Diagonal 643, 08028, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertolini</LastName><ForeName>Guido</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via GB Camozzi 3, 24020, Ranica (Bergamo), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panagiotopoulou</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4221-7254</Identifier><AffiliationInfo><Affiliation>European Clinical Research Infrastructure Network (ECRIN), Boulevard Saint Jacques 30, 75014, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>824087</GrantID><Agency>European Union's Horizon 2020 Framework Programme</Agency><Country/></Grant><Grant><GrantID>101057726</GrantID><Agency>European Union's Horizon Europe Framework Programme</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brief Bioinform</MedlineTA><NlmUniqueID>100912837</NlmUniqueID><ISSNLinking>1467-5463</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="Y">Information Dissemination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001690" MajorTopicYN="Y">Biological Science Disciplines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FAIR principles</Keyword><Keyword MajorTopicYN="N">GDPR</Keyword><Keyword MajorTopicYN="N">biomedical data</Keyword><Keyword MajorTopicYN="N">centralized model</Keyword><Keyword MajorTopicYN="N">data sharing</Keyword><Keyword MajorTopicYN="N">federated model</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>5</Day><Hour>13</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>5</Day><Hour>13</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>5</Day><Hour>9</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38836701</ArticleId><ArticleId IdType="pmc">PMC11151787</ArticleId><ArticleId IdType="doi">10.1093/bib/bbae262</ArticleId><ArticleId IdType="pii">7688102</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wilkinson &#xa0;MD, Dumontier &#xa0;M, Aalbersberg &#xa0;IJJ. et al. &#xa0;The FAIR guiding principles for scientific data management and stewardship. Sci Data &#xa0;2016;3:160018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4792175</ArticleId><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Holub &#xa0;P, Kohlmayer &#xa0;F, Prasser &#xa0;F. et al. &#xa0;Enhancing reuse of data and biological material in medical research: from FAIR to FAIR-Health. Biopreservation Biobanking &#xa0;2018;16:97&#x2013;105. 10.1089/bio.2017.0110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/bio.2017.0110</ArticleId><ArticleId IdType="pmc">PMC5906729</ArticleId><ArticleId IdType="pubmed">29359962</ArticleId></ArticleIdList></Reference><Reference><Citation>Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation) (text with EEA relevance). OJ L &#xa0;2016;119:1&#x2013;88.</Citation></Reference><Reference><Citation>Leistner &#xa0;M, Antoine &#xa0;L. IPR and the use of open data and data sharing initiatives by public and private actors. Study commissioned by the European Parliament's Policy Department for Citizens' and Constitutional Affairs at the request of the Committee on Legal Affairs 2022. 10.2139/ssrn.4125503.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.4125503</ArticleId></ArticleIdList></Reference><Reference><Citation>Directorate-General for Research and Innovation (European Commission) . Open science and intellectual property rights: How can they better interact?: state of the art and reflections&#xa0;: executive summary. LU: Publications Office of the European Union, 2022, See 10.2777/347305.</Citation><ArticleIdList><ArticleId IdType="doi">10.2777/347305</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins &#xa0;J, Cruz &#xa0;D, Vasconcelos &#xa0;V. The Nagoya Protocol and its implications on the EU Atlantic area countries. J Mar Sci Eng &#xa0;2020;8:92.</Citation></Reference><Reference><Citation>Greiber &#xa0;T. Implementation of the Nagoya Protocol in the European Union and in Germany. Phytomedicine Int J Phytother Phytopharm &#xa0;2019;53:313&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30392747</ArticleId></ArticleIdList></Reference><Reference><Citation>Drew &#xa0;TW, Mueller-Doblies &#xa0;UU. Dual use issues in research&#x2014;a subject of increasing concern? &#xa0;Vaccine &#xa0;2017;35:5990&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">28835345</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavouras &#xa0;P, Charitidis &#xa0;CA. 2019. &#xa0;Dual use in modern research. In: Handbook of Research Ethics and Scientific Integrity (ed R &#xa0;Iphofen), pp. 1&#x2013;21. Cham: Springer International Publishing. 10.1007/978-3-319-76040-7_7-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-76040-7_7-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzortzatou &#xa0;O, Slokenberga &#xa0;S, Reichel &#xa0;J. et al. &#xa0;Biobanking across Europe Post-GDPR: a deliberately fragmented landscape. In: Slokenberga &#xa0;S, Tzortzatou &#xa0;O, Reichel &#xa0;J (eds). GDPR and Biobanking: Individual Rights, Public Interest and Research Regulation across Europe. Cham: Springer International Publishing, 2021, 397&#x2013;419. 10.1007/978-3-030-49388-2_22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-49388-2_22</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke &#xa0;N, Vale &#xa0;G, Reeves &#xa0;EP. et al. &#xa0;GDPR: an impediment to research? &#xa0;Ir J Med Sci &#xa0;2019;188:1129&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">30734900</ArticleId></ArticleIdList></Reference><Reference><Citation>van Veen &#xa0;E-B. Observational health research in Europe: understanding the general data protection regulation and underlying debate. Eur J Cancer &#xa0;2018;104:70&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">30336359</ArticleId></ArticleIdList></Reference><Reference><Citation>Peloquin &#xa0;D, DiMaio &#xa0;M, Bierer &#xa0;B. et al. &#xa0;Disruptive and avoidable: GDPR challenges to secondary research uses of data. Eur J Hum Genet &#xa0;2020;28:697&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7411058</ArticleId><ArticleId IdType="pubmed">32123329</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoppers &#xa0;BM, Bernier &#xa0;A, Bowers &#xa0;S. et al. &#xa0;Open data in the era of the GDPR: lessons from the human cell atlas. Annu Rev Genomics Hum Genet &#xa0;2023;24:369&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">36791787</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernier &#xa0;A, Moln&#xe1;r-G&#xe1;bor &#xa0;F, Knoppers &#xa0;BM. The international data governance landscape. J Law Biosci &#xa0;2022;9:lsac005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8977111</ArticleId><ArticleId IdType="pubmed">35382430</ArticleId></ArticleIdList></Reference><Reference><Citation>Piasecki &#xa0;J, Cheah &#xa0;PY. Ownership of individual-level health data, data sharing, and data governance. BMC Med Ethics &#xa0;2022;23:104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9617739</ArticleId><ArticleId IdType="pubmed">36309719</ArticleId></ArticleIdList></Reference><Reference><Citation>Vayena &#xa0;E, Blasimme &#xa0;A. Biomedical big data: new models of control over access, use and governance. J Bioethical Inq &#xa0;2017;14:501&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5715037</ArticleId><ArticleId IdType="pubmed">28983835</ArticleId></ArticleIdList></Reference><Reference><Citation>David &#xa0;R, Ohmann &#xa0;C, Boiten &#xa0;JW. et al. &#xa0;An iterative and interdisciplinary categorisation process towards FAIRer digital resources for sensitive life-sciences data. Sci Rep &#xa0;2022;12:20989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9723099</ArticleId><ArticleId IdType="pubmed">36470968</ArticleId></ArticleIdList></Reference><Reference><Citation>Keerie &#xa0;C, Tuck &#xa0;C, Milne &#xa0;G. et al. &#xa0;Data sharing in clinical trials - practical guidance on anonymising trial datasets. Trials &#xa0;2018;19:25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5763739</ArticleId><ArticleId IdType="pubmed">29321053</ArticleId></ArticleIdList></Reference><Reference><Citation>Blatt &#xa0;M, Gusev &#xa0;A, Polyakov &#xa0;Y. et al. &#xa0;Secure large-scale genome-wide association studies using homomorphic encryption. Proc Natl Acad Sci U S A &#xa0;2020;117:11608&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7261120</ArticleId><ArticleId IdType="pubmed">32398369</ArticleId></ArticleIdList></Reference><Reference><Citation>Templ &#xa0;M, Sariyar &#xa0;M. A systematic overview on methods to protect sensitive data provided for various analyses. Int J Inf Secur &#xa0;2022;21:1233&#x2013;46.</Citation></Reference><Reference><Citation>Assante &#xa0;M, Candela &#xa0;L, Castelli &#xa0;D. et al. &#xa0;Are scientific data repositories coping with research data publishing? &#xa0;Data Sci J &#xa0;2016;15:6.</Citation></Reference><Reference><Citation>Lehne &#xa0;M, Sass &#xa0;J, Essenwanger &#xa0;A. et al. &#xa0;Why digital medicine depends on interoperability. NPJ Digit Med &#xa0;2019;2:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6702215</ArticleId><ArticleId IdType="pubmed">31453374</ArticleId></ArticleIdList></Reference><Reference><Citation>Canham &#xa0;S, Ohmann &#xa0;C, Boiten &#xa0;J-W &#xa0;et al. &#xa0;EOSC-life report on data standards for observational and interventional studies, and interoperability between healthcare and research data. Zenodo &#xa0;2021. 10.5281/zenodo.5810612.</Citation><ArticleIdList><ArticleId IdType="doi">10.5281/zenodo.5810612</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehsani-Moghaddam &#xa0;B, Martin &#xa0;K, Queenan &#xa0;JA. Data quality in healthcare: a report of practical experience with the Canadian Primary Care Sentinel Surveillance Network data. Health Inf Manag J &#xa0;2021;50:88&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">31805788</ArticleId></ArticleIdList></Reference><Reference><Citation>Botsis &#xa0;T, Hartvigsen &#xa0;G, Chen &#xa0;F. et al. &#xa0;Secondary use of EHR: data quality issues and informatics opportunities. Summit Transl Bioinform &#xa0;2010;2010:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041534</ArticleId><ArticleId IdType="pubmed">21347133</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgin &#xa0;J, Ahamed &#xa0;A, Cummins &#xa0;C. et al. &#xa0;The European Nucleotide Archive in 2022. Nucleic Acids Res &#xa0;2023;51:D121&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9825583</ArticleId><ArticleId IdType="pubmed">36399492</ArticleId></ArticleIdList></Reference><Reference><Citation>Athar &#xa0;A, F&#xfc;llgrabe &#xa0;A, George &#xa0;N. et al. &#xa0;ArrayExpress update - from bulk to single-cell expression data. Nucleic Acids Res &#xa0;2019;47:D711&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323929</ArticleId><ArticleId IdType="pubmed">30357387</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeberg &#xa0;MA, Fromont &#xa0;LA, D&#x2019;Altri &#xa0;T. et al. &#xa0;The European Genome-phenome Archive in 2021. Nucleic Acids Res &#xa0;2022;50:D980&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8728218</ArticleId><ArticleId IdType="pubmed">34791407</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee &#xa0;DM, O&#x2019;Neill &#xa0;TW, Pye &#xa0;SR. et al. &#xa0;The European male ageing study (EMAS): design, methods and recruitment. Int J Androl &#xa0;2009;32:11&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">18328041</ArticleId></ArticleIdList></Reference><Reference><Citation>Tikellis &#xa0;G, Dwyer &#xa0;T, Paltiel &#xa0;O. et al. &#xa0;The international childhood cancer cohort consortium (I4C): a research platform of prospective cohorts for studying the aetiology of childhood cancers. Paediatr Perinat Epidemiol &#xa0;2018;32:568&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11155068</ArticleId><ArticleId IdType="pubmed">30466188</ArticleId></ArticleIdList></Reference><Reference><Citation>Panagos &#xa0;P, Van Liedekerke &#xa0;M, Jones &#xa0;A. et al. &#xa0;European soil data Centre: response to European policy support and public data requirements. Land Use Policy &#xa0;2012;29:329&#x2013;38.</Citation></Reference><Reference><Citation>Neuhann &#xa0;JM, Stemler &#xa0;J, Carcas &#xa0;A. et al. &#xa0;A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults &#x2265;75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network. Trials &#xa0;2022;23:865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9547672</ArticleId><ArticleId IdType="pubmed">36209129</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieke &#xa0;N, Hancox &#xa0;J, Li &#xa0;W. et al. &#xa0;The future of digital health with federated learning. Npj Digit Med &#xa0;2020;3:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7490367</ArticleId><ArticleId IdType="pubmed">33015372</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyan &#xa0;O, Choudhury &#xa0;A, van Soest &#xa0;J. et al. &#xa0;Distributed analytics on sensitive medical data: the personal health train. Data Intell &#xa0;2020;2:96&#x2013;107.</Citation></Reference><Reference><Citation>

Keane &#xa0;T, Rambla &#xa0;J, Spalding &#xa0;D. et al.  &#xa0;EGA Federation: Structure and organisation, See https://ega-archive.org/assets/files/EGA-Federation-Structure-v1.1.pdf.</Citation></Reference><Reference><Citation>Manolio &#xa0;TA, Goodhand &#xa0;P, Ginsburg &#xa0;G. The international hundred thousand plus cohort consortium: integrating large-scale cohorts to address global scientific challenges. Lancet Digit Health &#xa0;2020;2:e567&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7572082</ArticleId><ArticleId IdType="pubmed">33103095</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards &#xa0;JL, Lane &#xa0;MA, Nielsen &#xa0;ES. Interoperability of biodiversity databases: biodiversity information on every desktop. Science &#xa0;2000;289:2312&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">11009409</ArticleId></ArticleIdList></Reference><Reference><Citation>
Article L1462-1 - Code de la sant&#xe9; publique - L&#xe9;gifrance. See https://www.legifrance.gouv.fr/codes/article_lc/LEGIARTI000038886833 (accessed on 30 October 2023).</Citation></Reference><Reference><Citation>
Arr&#xea;t&#xe9; du 29 novembre 2019 portant approbation d&#x2019;un avenant &#xe0; la convention constitutive du groupement d&#x2019;int&#xe9;r&#xea;t public &#xab;Institut national des donn&#xe9;es de sant&#xe9;&#xa0;&#xbb; portant cr&#xe9;ation du groupement d&#x2019;int&#xe9;r&#xea;t public &#xab;&#xa0;Plateforme des donn&#xe9;es de sant&#xe9;&#xa0;&#xbb; - L&#xe9;gifrance. See https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000039433105 (accessed on 30 October 2023).</Citation></Reference><Reference><Citation>
Arr&#xea;t&#xe9; du 22 mars 2017 relatif au r&#xe9;f&#xe9;rentiel de s&#xe9;curit&#xe9; applicable au Syst&#xe8;me national des donn&#xe9;es de sant&#xe9;. See https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000034265125 (accessed on 30 October 2023).</Citation></Reference><Reference><Citation>Holub &#xa0;P, Schl&#xfc;nuder &#xa0;I, Zatloukal &#xa0;K, T&#xf6;rnwall &#xa0;O, Adeniran &#xa0;A, Lavitrano &#xa0;M, Hummel &#xa0;M. 2023. &#xa0;BBMRI-ERIC Colorectal Cancer Cohort (CRC-Cohort): Data Protection Policy (1.5). Zenodo. 10.5281/zenodo.7930536.</Citation><ArticleIdList><ArticleId IdType="doi">10.5281/zenodo.7930536</ArticleId></ArticleIdList></Reference><Reference><Citation>
BBMRI-ERIC . BBMRI-ERIC Policy for Access to and Sharing of Biological Samples and Data, See https://www.bbmri-eric.eu/wp-content/uploads/AoM_10_8_Access-Policy_FINAL_EU.pdf (accessed on 14 December 2023).</Citation></Reference><Reference><Citation>Lappalainen &#xa0;I, Almeida-King &#xa0;J, Kumanduri &#xa0;V. et al. &#xa0;The European genome-phenome archive of human data consented for biomedical research. Nat Genet &#xa0;2015;47:692&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5426533</ArticleId><ArticleId IdType="pubmed">26111507</ArticleId></ArticleIdList></Reference><Reference><Citation>
Providing safe access to sensitive human data across borders: Federated EGA becomes a reality.
ELIXIR, 2022, See https://elixir-europe.org/news/federated_ega (accessed on 14 April 2023).</Citation></Reference><Reference><Citation>Fiume &#xa0;M, Cupak &#xa0;M, Keenan &#xa0;S. et al. &#xa0;Federated discovery and sharing of genomic data using beacons. Nat Biotechnol &#xa0;2019;37:220&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6728157</ArticleId><ArticleId IdType="pubmed">30833764</ArticleId></ArticleIdList></Reference><Reference><Citation>Rueda &#xa0;M, Ariosa &#xa0;R, Moldes &#xa0;M. et al. &#xa0;Beacon v2 reference implementation: a toolkit to enable federated sharing of genomic and phenotypic data. Bioinformatics &#xa0;2022;38:4656&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">35980167</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak &#xa0;G, Duke &#xa0;JD, Shah &#xa0;NH. et al. &#xa0;Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform &#xa0;2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang &#xa0;PE, Ryan &#xa0;PB, Racoosin &#xa0;JA. et al. &#xa0;Advancing the science for active surveillance: rationale and design for the observational medical outcomes partnership. Ann Intern Med &#xa0;2010;153:600&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>
OHDSI . OHDSI-Book2023-Our Journey, See https://www.ohdsi.org/wp-content/uploads/2023/10/OHDSI-Book2023.pdf.</Citation></Reference><Reference><Citation>Ahmadi &#xa0;N, Peng &#xa0;Y, Wolfien &#xa0;M. et al. &#xa0;OMOP CDM can facilitate data-driven studies for cancer prediction: a systematic review. Int J Mol Sci &#xa0;2022;23:11834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9569469</ArticleId><ArticleId IdType="pubmed">36233137</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu &#xa0;Y, Ruddy &#xa0;KJ, Hong &#xa0;N. et al. &#xa0;ADEpedia-on-OHDSI: a next generation pharmacovigilance signal detection platform using the OHDSI common data model. J Biomed Inform &#xa0;2019;91:103119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6432939</ArticleId><ArticleId IdType="pubmed">30738946</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss &#xa0;EA, Makadia &#xa0;R, Matcho &#xa0;A. et al. &#xa0;Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc &#xa0;2015;22:553&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza &#xa0;M, Del Fiol &#xa0;G, Tenenbaum &#xa0;J. et al. &#xa0;Evaluating common data models for use with a longitudinal community registry. J Biomed Inform &#xa0;2016;64:333&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak &#xa0;G, Schuemie &#xa0;MJ, Madigan &#xa0;D. et al. &#xa0;Drawing reproducible conclusions from observational clinical data with OHDSI. Yearb Med Inform &#xa0;2021;30:283&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8416226</ArticleId><ArticleId IdType="pubmed">33882595</ArticleId></ArticleIdList></Reference><Reference><Citation>
The Medical Informatics Platform (MIP) - Data Management Guideline, See https://github.com/HBPMedical/mip-docs/blob/master/MIP_Data_management_documentation.md (accessed on 6 November 2023).</Citation></Reference><Reference><Citation>
Medical Informatics Platform - Tools.
EBRAINS, See https://www.ebrains.eu/tools/medical-informatics-platform (accessed on 15 December 2023).</Citation></Reference><Reference><Citation>
EBRAINS Access Policy, 2022, See https://files.ebrains.eu/file/e4b05476-d2f0-49c2-8b45-41f9c317892e/EBRAINS_AISBL_Access_Policy_04_2022_85c8e61216.pdf (accessed on 15 December 2023).</Citation></Reference><Reference><Citation>Gradisek &#xa0;P, Carrara &#xa0;G, Antiga &#xa0;L. et al. &#xa0;Prognostic value of a combination of circulating biomarkers in critically ill patients with traumatic brain injury: results from the European Creactive study. J Neurotrauma &#xa0;2021;38:2667&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">34235978</ArticleId></ArticleIdList></Reference><Reference><Citation>
Medical Informatics Platform Architecture.
GitHub, See https://github.com/HBPMedical/mip-docs/blob/master/Architecture.md (accessed on 15 December 2023).</Citation></Reference><Reference><Citation>Powell &#xa0;K. The broken promise that undermines human genome research. Nature &#xa0;2021;590:198&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">33568833</ArticleId></ArticleIdList></Reference><Reference><Citation>Green &#xa0;ED, Watson &#xa0;JD, Collins &#xa0;FS. Human genome project: twenty-five years of big biology. Nature &#xa0;2015;526:29&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5101944</ArticleId><ArticleId IdType="pubmed">26432225</ArticleId></ArticleIdList></Reference><Reference><Citation>Hood &#xa0;L, Rowen &#xa0;L. The human genome project: big science transforms biology and medicine. Genome Med &#xa0;2013;5:79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4066586</ArticleId><ArticleId IdType="pubmed">24040834</ArticleId></ArticleIdList></Reference><Reference><Citation>
Bermuda Sequence Policies Archive, See https://web.ornl.gov/sci/techresources/Human_Genome/research/bermuda.shtml (accessed on 3 November 2023).</Citation></Reference><Reference><Citation>Cook-Deegan &#xa0;R, McGuire &#xa0;AL. Moving beyond Bermuda: sharing data to build a medical information commons. Genome Res &#xa0;2017;27:897&#x2013;901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5453323</ArticleId><ArticleId IdType="pubmed">28373484</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker &#xa0;M. 1,500 scientists lift the lid on reproducibility. Nature &#xa0;2016;533:452&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">27225100</ArticleId></ArticleIdList></Reference><Reference><Citation>Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the protection of individuals with regard to the processing of personal data and on the free movement of such data. OJ L &#xa0;1995;281:31&#x2013;50.</Citation></Reference><Reference><Citation>Proposal for a Regulation of the European Parliament and of the Council Laying Down Harmonised Rules on Artificial Intelligence (Artificial Intelligence Act) and Amending Certain Union Legislative Acts, European Commission 2021; COM/2021/206 final.</Citation></Reference><Reference><Citation>
Health Insurance Portability and Accountability Act of 1996 (HIPAA). Centers for Disease Control and Prevention (
CDC), 2022, See https://www.cdc.gov/phlp/publications/topic/hipaa.html (accessed on 7 November 2023).</Citation></Reference><Reference><Citation>World Medical Association . World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA &#xa0;2013;310:2191&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">24141714</ArticleId></ArticleIdList></Reference><Reference><Citation>
Oviedo Convention and its Protocols - Human Rights and Biomedicine. Council of Europe, See https://www.coe.int/en/web/bioethics/oviedo-convention (accessed on 7 November 2023).</Citation></Reference><Reference><Citation>Voss &#xa0;EA, Blacketer &#xa0;C, van Sandijk &#xa0;S. et al. &#xa0;European health data &amp; evidence network-learnings from building out a standardized international health data network. J Am Med Inform Assoc &#xa0;2023;31:209&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10746315</ArticleId><ArticleId IdType="pubmed">37952118</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorogood &#xa0;A, Rehm &#xa0;HL, Goodhand &#xa0;P. et al. &#xa0;International federation of genomic medicine databases using GA4GH standards. Cell Genomics &#xa0;2021;1:100032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8813094</ArticleId><ArticleId IdType="pubmed">35128509</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehm &#xa0;HL, Page &#xa0;AJH, Smith &#xa0;L. et al. &#xa0;GA4GH: international policies and standards for data sharing across genomic research and healthcare. Cell Genomics &#xa0;2021;1:100029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8774288</ArticleId><ArticleId IdType="pubmed">35072136</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Romero &#xa0;C, Mart&#xed;nez-Garc&#xed;a &#xa0;A, Bernabeu-Wittel &#xa0;M. et al. &#xa0;Health data hubs: an analysis of existing data governance features for research. Health Res Policy Syst &#xa0;2023;21:70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10332005</ArticleId><ArticleId IdType="pubmed">37430347</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundstr&#xf6;m &#xa0;J, Bj&#xf6;rkelund &#xa0;C, Giedraitis &#xa0;V. et al. &#xa0;Rationale for a Swedish cohort consortium. Ups J Med Sci &#xa0;2019;124:21&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6450580</ArticleId><ArticleId IdType="pubmed">30618330</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfson &#xa0;M, Wallace &#xa0;SE, Masca &#xa0;N. et al. &#xa0;DataSHIELD: resolving a conflict in contemporary bioscience--performing a pooled analysis of individual-level data without sharing the data. Int J Epidemiol &#xa0;2010;39:1372&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2972441</ArticleId><ArticleId IdType="pubmed">20630989</ArticleId></ArticleIdList></Reference><Reference><Citation>
Exareme2, 2023, See https://github.com/madgik/exareme2 (accessed on 15 December 2023).</Citation></Reference><Reference><Citation>
EOSC Multi-Annual Roadmap 2025 and 2026&#x2013;2027, See https://eosc.eu/wp-content/uploads/2023/08/MAR_2025-27_draft.pdf (accessed on 7 November 2023).</Citation></Reference><Reference><Citation>
EU Funding &amp; Tenders Portal, See https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-infra-2023-eosc-01-06 (accessed on 19 April 2024).</Citation></Reference><Reference><Citation>Proposal for a Decision of the European Parliament and of the Council establishing the 2030 Policy Programme &#x201c;Path to the Digital Decade&#x201d;, European Commission 2021;COM/2021/574 final</Citation></Reference><Reference><Citation>Decision (EU) 2022/2481 of the European Parliament and of the Council of 14 December 2022 establishing the Digital Decade Policy Programme 2030 (Text with EEA relevance). OJ L &#xa0;2022;323:4&#x2013;26.</Citation></Reference><Reference><Citation>Proposal for a Regulation of the European Parliament and of the Council on the European Health Data Space, European Commission 2022; COM/2022/197 final.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38854711</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2468-3574</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>International journal of surgery protocols</Title><ISOAbbreviation>Int J Surg Protoc</ISOAbbreviation></Journal><ArticleTitle>Research protocol for an observational health data analysis to assess the applicability of randomized controlled trials focusing on newly diagnosed metastatic prostate cancer using real-world data: PIONEER IMI's "big data for better outcomes" program.</ArticleTitle><Pagination><StartPage>64</StartPage><EndPage>72</EndPage><MedlinePgn>64-72</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SP9.0000000000000024</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Metastatic prostate cancer (PCa) constitutes ~5% of all new PCa diagnoses in Western countries. For most cases, primary consideration should be given to systemic therapies as the first-line approach based on evidence from randomized controlled trials (RCTs). Despite the importance of RCTs as the pinnacle of evidence in modern medicine, concerns have been raised about their applicability to real-life scenarios. These trials often feature participants who are younger with better performance statuses and prognoses compared to their real-world counterparts. The PIONEER project falls under the Innovative Medicine Initiative's (IMI) "Big Data for Better Outcomes" initiative, aimed at revolutionizing PCa care in Europe. The central focus lies in improving cancer-related outcomes, enhancing health system efficiency, and elevating the quality of health and social care. This study endeavours to evaluate the generalizability of RCT findings concerning newly diagnosed metastatic PCa.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A systematic review of the literature will be conducted to compile patient characteristics from RCTs addressing this subject within the past decade. To create a real-world benchmark, patients with recently diagnosed metastatic PCa from a network of population-based databases will serve as a comparison group. The objective is to assess the applicability of RCT results in two ways. First, a comparison will be made between the characteristics of patients with newly diagnosed metastatic PCa enroled in RCTs and those with the same condition included in our databases which might represent the real-world setting. Second, an evaluation will be undertaken to determine the proportion of real-world patients with newly diagnosed metastatic PCa who meet the criteria for RCT enrolment. This study will rely on extensive observational data, primarily sourced from population-based registries, electronic health records, and insurance claims data. The study cohort is established upon routinely gathered healthcare data, meticulously mapped to the Observational Medical Outcomes Partnership Common Data Model.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gandaglia</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Oncology/Unit of Urology, Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellegrino</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Oncology/Unit of Urology, Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Meulder</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Association EISBM, Vourles, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hijazy</LastName><ForeName>Ayman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Association EISBM, Vourles, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbott</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Astellas Pharma, Inc., Northbrook, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golozar</LastName><ForeName>Asieh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>OHDSI Center, Northeastern University, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicoletti</LastName><ForeName>Rossella</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Biomedical Science, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomez-Rivas</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Urology, Hospital Cl&#xed;nico San Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinbeisser</LastName><ForeName>Carl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Collaborate Project Management, Munich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans-Axelsson</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bayer AG, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briganti</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Oncology/Unit of Urology, Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N'Dow</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Academic Urology Unit, University of Aberdeen, Scotland, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Surg Protoc</MedlineTA><NlmUniqueID>101758186</NlmUniqueID><ISSNLinking>2468-3574</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Metastatic prostate cancer</Keyword><Keyword MajorTopicYN="N">prostatic cancer</Keyword><Keyword MajorTopicYN="N">randomized controlled trials</Keyword></KeywordList><CoiStatement>No.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>10</Day><Hour>5</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38854711</ArticleId><ArticleId IdType="pmc">PMC11161292</ArticleId><ArticleId IdType="doi">10.1097/SP9.0000000000000024</ArticleId><ArticleId IdType="pii">ISJP-D-23-00025</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rawla P. Epidemiology of prostate cancer. World J Oncol 2019;10:63&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6497009</ArticleId><ArticleId IdType="pubmed">31068988</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandaglia G, Leni R, Bray F, et al. . Epidemiology and prevention of prostate cancer. Eur Urol Oncol 2021;4:877&#x2013;892.</Citation><ArticleIdList><ArticleId IdType="pubmed">34716119</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasgupta P, Baade PD, Aitken JF, et al. . Geographical variations in prostate cancer outcomes: a systematic review of international evidence. Front Oncol 2019;9:238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6463763</ArticleId><ArticleId IdType="pubmed">31024842</ArticleId></ArticleIdList></Reference><Reference><Citation>Scher HI, Solo K, Valant J, et al. . Prevalence of prostate cancer clinical states and mortality in the United States: estimates using a dynamic progression model. PLoS One 2015;10:e0139440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4603789</ArticleId><ArticleId IdType="pubmed">26460686</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornford P, van den Bergh RCN, Briers E, et al. . EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II&#x2014;2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur Urol 2021;79:263&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pubmed">33039206</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowrance W, Dreicer R, Jarrard DF, et al. . Updates to Advanced Prostate Cancer: AUA/SUO Guideline (2023). J Urol 2023;209:1082&#x2013;1090.</Citation><ArticleIdList><ArticleId IdType="pubmed">37096583</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong AJ, Szmulewitz RZ, Petrylak DP, et al. . ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer. J Clin Oncol 2019;37:2974&#x2013;2986.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6839905</ArticleId><ArticleId IdType="pubmed">31329516</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney CJ, Chen Y-H, Carducci M, et al. . Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. N Engl J Med 2015;373:737&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4562797</ArticleId><ArticleId IdType="pubmed">26244877</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis ID, Martin AJ, Stockler MR, et al. . Enzalutamide with standard first-line therapy in metastatic prostate cancer. N Engl J Med 2019;381:121&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">31157964</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravis G, Fizazi K, Joly F, et al. . Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial. Lancet Oncol 2013;14:149&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pubmed">23306100</ArticleId></ArticleIdList></Reference><Reference><Citation>Boev&#xe9; LMS, Hulshof MCCM, Vis AN, et al. . Effect on survival of androgen deprivation therapy alone compared to androgen deprivation therapy combined with concurrent radiation therapy to the prostate in patients with primary bone metastatic prostate cancer in a prospective randomised clinical trial: data from the HORRAD Trial. Eur Urol 2019;75:410&#x2013;418.</Citation><ArticleIdList><ArticleId IdType="pubmed">30266309</ArticleId></ArticleIdList></Reference><Reference><Citation>Fizazi K, Tran N, Fein L, et al. . Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer. N Engl J Med 2017;377:352&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">28578607</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal N, Tangen CM, Hussain MHA, et al. . Orteronel for metastatic hormone-sensitive prostate cancer: a multicenter, randomized, open-label phase III Trial (SWOG-1216). J Clin Oncol 2022;40:3301&#x2013;3309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9553390</ArticleId><ArticleId IdType="pubmed">35446628</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaishampayan UN, Heilbrun LK, Monk P, et al. . Clinical efficacy of enzalutamide vs bicalutamide combined with androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: a randomized clinical trial. JAMA Netw Open 2021;4:e2034633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7838941</ArticleId><ArticleId IdType="pubmed">33496795</ArticleId></ArticleIdList></Reference><Reference><Citation>Fizazi K, Foulon S, Carles J, et al. . Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 &#xd7; 2 factorial design. Lancet 2022;399:1695&#x2013;1707.</Citation><ArticleIdList><ArticleId IdType="pubmed">35405085</ArticleId></ArticleIdList></Reference><Reference><Citation>James ND, de Bono JS, Spears MR, et al. . Abiraterone for prostate cancer not previously treated with hormone therapy. N Engl J Med 2017;377:338&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5533216</ArticleId><ArticleId IdType="pubmed">28578639</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi KN, Agarwal N, Bjartell A, et al. . Apalutamide for metastatic, castration-sensitive prostate cancer. N Engl J Med 2019;381:661.</Citation><ArticleIdList><ArticleId IdType="pubmed">31150574</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith MR, Hussain M, Saad F, et al. . Darolutamide and survival in metastatic, hormone-sensitive prostate cancer. N Engl J Med 2022;386:1132&#x2013;1142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9844551</ArticleId><ArticleId IdType="pubmed">35179323</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G, Oxman AD, Akl EA, et al. . GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011;64:383&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell PM. External validity of randomised controlled trials: &#x201c;to whom do the results of this trial apply? Lancet 2005;365:82&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">15639683</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy-Martin T, Curtis S, Faries D, et al. . A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials 2015;16:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4632358</ArticleId><ArticleId IdType="pubmed">26530985</ArticleId></ArticleIdList></Reference><Reference><Citation>Monti S, Grosso V, Todoerti M, et al. . Randomized controlled trials and real-world data: differences and similarities to untangle literature data. Rheumatology (Oxford) 2018;57:vii54&#x2013;vii58.</Citation><ArticleIdList><ArticleId IdType="pubmed">30289534</ArticleId></ArticleIdList></Reference><Reference><Citation>Omar MI, Roobol MJ, Ribal MJ, et al. . Introducing PIONEER: a project to harness big data in prostate cancer research. Nat Rev Urol 2020;17:6; 2020;17:351&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pubmed">32461687</ArticleId></ArticleIdList></Reference><Reference><Citation>Downes M, Gurrin LC, English DR, et al. . Multilevel regression and poststratification: a modeling approach to estimating population quantities from highly selected survey samples. Am J Epidemiol 2018;187:1780&#x2013;1790.</Citation><ArticleIdList><ArticleId IdType="pubmed">29635276</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency . Guidelines on good pharmacovigilance practices (GVP): Module VIII &#x2013; Post-authorisation safety studies. 2017. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-gvp-module-viii-post-authorisation-safety-studies-rev-3_en.pdf</Citation></Reference><Reference><Citation>Hallas J. Guidelines for good pharmacoepidemiology practice (GPP). Pharmacoepidemiol Drug Saf 2016;25:2&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">26537534</ArticleId></ArticleIdList></Reference><Reference><Citation>ICMJE . Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. 2019. https://www.icmje.org/icmje-recommendations.pdf</Citation><ArticleIdList><ArticleId IdType="pubmed">25558501</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38882578</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1179-1349</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Clinical epidemiology</Title><ISOAbbreviation>Clin Epidemiol</ISOAbbreviation></Journal><ArticleTitle>The Impact of the COVID-19 Pandemic on Incidence and Short-Term Survival for Common Solid Tumours in the United Kingdom: A Cohort Analysis.</ArticleTitle><Pagination><StartPage>417</StartPage><EndPage>429</EndPage><MedlinePgn>417-429</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/CLEP.S463160</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">The COVID-19 pandemic profoundly affected healthcare systems and patients. There is a need to comprehend the collateral effects of the pandemic on non-communicable diseases. We examined the impact of the pandemic on short-term survival for common solid tumours, including breast, colorectal, head and neck, liver, lung, oesophageal, pancreatic, prostate, and stomach cancer in the UK.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This was a population-based cohort study of electronic health records from the UK primary care Clinical Practice Research Datalink GOLD database. In sum, 12,259,744 eligible patients aged &#x2265;18 years with &#x2265;1 year's history identified from January 2000 to December 2022 were included. We estimated age-standardised incidence and short-term (one- and two-year) survival for several common cancers from 2000 to 2019 (in five-year strata) and compared these to 2020-2022 using the Kaplan-Meier method.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Incidence decreased for most cancers in 2020 and recovered to different extents in 2021-2022. Short-term survival improved for most cancers between 2000 and 2019, but then declined, albeit minimally, for those diagnosed in 2020-2022. This was most pronounced for colorectal cancer, with one-year survival falling from 78.8% (95% CI 78%-79.6%) in 2015-2019 to 77% (95% CI 75.6-78.3%) for those diagnosed in 2020-2022.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Short-term survival for many cancers was impacted, albeit minimally, by the pandemic in the UK, with reductions in survivorship from colorectal cancer equivalent to returning to the mortality seen in the first decade of the 2000s. While data on longer-term survival are needed to fully comprehend the impact of COVID-19 on cancer care, our findings illustrate the need for an urgent and substantial commitment from the UK National Health Service to address the existing backlog in cancer screening and diagnostic procedures to improve cancer care and mortality.</AbstractText><CopyrightInformation>&#xa9; 2024 Barclay et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barclay</LastName><ForeName>Nicola L</ForeName><Initials>NL</Initials><Identifier Source="ORCID">0000-0002-6500-9909</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burkard</LastName><ForeName>Theresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burn</LastName><ForeName>Edward</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9286-1128</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delmestri</LastName><ForeName>Antonella</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miquel Dominguez</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Otorrinolaringology department, Hospital Joan XXIII de Tarragona, Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golozar</LastName><ForeName>Asieh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guarner-Argente</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8180-1488</Identifier><AffiliationInfo><Affiliation>Gastroenterology Department, Hospital de la Santa Creu I Sant Pau, Universitat Aut&#xf2;noma de Barcelona, Sant Quint&#xed;, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avil&#xe9;s-Jurado</LastName><ForeName>Francesc Xavier</ForeName><Initials>FX</Initials><AffiliationInfo><Affiliation>Head Neck Tumors Unit, Hospital Cl&#xed;nic de Barcelona, Universitat de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Man</LastName><ForeName>Wai Yi</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosell&#xf3; Serrano</LastName><ForeName>&#xc0;lvar</ForeName><Initials>&#xc0;</Initials><Identifier Source="ORCID">0000-0002-8298-2890</Identifier><AffiliationInfo><Affiliation>Institut Catal&#xe0; d'Oncologia, Hospital Universitari Dr Josep Trueta, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosen</LastName><ForeName>Andreas Weinberger</ForeName><Initials>AW</Initials><Identifier Source="ORCID">0000-0001-9990-8155</Identifier><AffiliationInfo><Affiliation>Centre for Surgical Science, Department of Surgery, Zealand University Hospital, Koege, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Eng Hooi</ForeName><Initials>EH</Initials><Identifier Source="ORCID">0000-0003-4470-2736</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tietzova</LastName><ForeName>Ilona</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>First Department of Tuberculosis and Respiratory Diseases, First Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3950-6346</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Centre, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newby</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>OPTIMA Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Clin Epidemiol</MedlineTA><NlmUniqueID>101531700</NlmUniqueID><ISSNLinking>1179-1349</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">colorectal cancer</Keyword><Keyword MajorTopicYN="N">incidence</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword><Keyword MajorTopicYN="N">survival</Keyword></KeywordList><CoiStatement>NB reports personal fees from Sleep Universal, Roche and Theramex, outside the submitted work. DPA receives funding from the UK National Institute for Health and Care Research (NIHR) in the form of a senior research fellowship. DPA&#x2019;s group received partial support from the Oxford NIHR Biomedical Research Centre. DPA&#x2019;s department has received grant/s from Amgen, Chiesi-Taylor, Lilly, Janssen, Novartis, and UCB Biopharma. His research group has received consultancy fees from AstraZeneca and UCB Biopharma. Amgen, Astellas, Janssen, Synapse Management Partners, and UCB Biopharma have funded or supported training programmes organised by DPA&#x2019;s department. &#xc0;RS reports honoraria for presentations, lectures, speakers, support for attending meetings and travel from Janssen, Astellas, and Bayer and support for attending meetings and travel from Ipsen outside the submitted work. FX-A-J is funded by Fundaci&#xf3;n Cientifica AECC (LABAE18025AVIL) and Plan Estatal de I+D+I of the Instituto de Salud Carlos III (FIS PI15/02047 and FIS PI18/0844). DN reports grants from OPTIMA and EHDEN. All other authors declare no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>17</Day><Hour>5</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38882578</ArticleId><ArticleId IdType="pmc">PMC11179647</ArticleId><ArticleId IdType="doi">10.2147/CLEP.S463160</ArticleId><ArticleId IdType="pii">463160</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Machii R, Takahashi H. Japanese cancer screening programs during the COVID-19 pandemic: changes in participation between 2017-2020. Cancer Epidemiol. 2023;82:102313. doi:10.1016/j.canep.2022.102313</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canep.2022.102313</ArticleId><ArticleId IdType="pmc">PMC9726684</ArticleId><ArticleId IdType="pubmed">36508964</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkatout I, Biebl M, Momenimovahed Z, et al. Has COVID-19 affected cancer screening programs? A systematic review. Front Oncol. 2021;11:675038. doi:10.3389/fonc.2021.675038</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2021.675038</ArticleId><ArticleId IdType="pmc">PMC8165307</ArticleId><ArticleId IdType="pubmed">34079764</ArticleId></ArticleIdList></Reference><Reference><Citation>Barclay NL, Pineda-Moncus&#xed; M, J&#xf6;dicke AM, et al. The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study. MedRxiv. 2023. doi:10.1101/2023.07.21.23292937</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.07.21.23292937</ArticleId><ArticleId IdType="pmc">PMC11004443</ArticleId><ArticleId IdType="pubmed">38601756</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Research UK. Cancer mortality statistics. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/mortality#heading-Zero. Accessed September
28, 2023.</Citation></Reference><Reference><Citation>Rashid T, Bennett JE, Muller DC, et al. Mortality from leading cancers in districts of England from 2002 to 2019: a population-based, spatiotemporal study. Lancet Oncol. 2023;25:86&#x2013;98. doi:10.1016/S1470-2045(23)00530-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(23)00530-2</ArticleId><ArticleId IdType="pmc">PMC7615518</ArticleId><ArticleId IdType="pubmed">38096890</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold M, Rutherford MJ, Bardot A, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20(11):1493&#x2013;1505. doi:10.1016/S1470-2045(19)30456-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(19)30456-5</ArticleId><ArticleId IdType="pmc">PMC6838671</ArticleId><ArticleId IdType="pubmed">31521509</ArticleId></ArticleIdList></Reference><Reference><Citation>Alderwick H. Is the NHS overwhelmed? BMJ. 2022;376:051. doi:10.1136/bmj.o51</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o51</ArticleId><ArticleId IdType="pubmed">35017162</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr A, Smith JA, Camaradou J, Prieto-Alhambra D. Growing backlog of planned surgery due to covid-19. BMJ. 2021;2021:372.</Citation><ArticleIdList><ArticleId IdType="pubmed">33563590</ArticleId></ArticleIdList></Reference><Reference><Citation>McLellan A, Abbasi K. The NHS is not living with covid, it&#x2019;s dying from it. BMJ. 2022;2022:378.</Citation><ArticleIdList><ArticleId IdType="pubmed">35850953</ArticleId></ArticleIdList></Reference><Reference><Citation>Maringe C, Spicer J, Morris M, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020;21(8):1023&#x2013;1034. doi:10.1016/S1470-2045(20)30388-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(20)30388-0</ArticleId><ArticleId IdType="pmc">PMC7417808</ArticleId><ArticleId IdType="pubmed">32702310</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209&#x2013;249. doi:10.3322/caac.21660</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21660</ArticleId><ArticleId IdType="pubmed">33538338</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: clinical practice research Datalink (CPRD). Int J Epidemiol. 2015;44(3):827&#x2013;836. doi:10.1093/ije/dyv098</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyv098</ArticleId><ArticleId IdType="pmc">PMC4521131</ArticleId><ArticleId IdType="pubmed">26050254</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22(3):553&#x2013;564. doi:10.1093/jamia/ocu023</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocu023</ArticleId><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert J, Rao G, Schuemie M, Ryan P, Weaver J. CohortDiagnostics: diagnostics for OHDSI Cohorts. Available from: https://ohdsi.github.io/CohortDiagnostics. Accessed 2, August 2023.</Citation></Reference><Reference><Citation>Gallagher AM, Dedman D, Padmanabhan S, Leufkens HG, de Vries F. The accuracy of date of death recording in the clinical practice research Datalink GOLD database in England compared with the office for national statistics death registrations. Pharmacoepidemiol Drug Saf. 2019;28(5):563&#x2013;569. doi:10.1002/pds.4747</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4747</ArticleId><ArticleId IdType="pmc">PMC6593793</ArticleId><ArticleId IdType="pubmed">30908785</ArticleId></ArticleIdList></Reference><Reference><Citation>Eurostat Taskforce. Revision of the European Standard Population - Report of Eurostat&#x2019;s task force. Available from: https://ec.europa.eu/eurostat/web/products-manuals-and-guidelines/-/ks-ra-13-028. Accessed August
2, 2023.</Citation></Reference><Reference><Citation>Mazidimoradi A, Hadavandsiri F, Momenimovahed Z, Salehiniya H. Impact of the COVID-19 pandemic on colorectal cancer diagnosis and treatment: a systematic review. J Gastrointest Can. 2021;2021:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8628028</ArticleId><ArticleId IdType="pubmed">34843058</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Research UK. Cancer incidence for all cancers combined. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/all-cancers-combined. Accessed August
9, 2023.</Citation></Reference><Reference><Citation>Strongman H, Williams R, Bhaskaran K. What are the implications of using individual and combined sources of routinely collected data to identify and characterise incident site-specific cancers? A concordance and validation study using linked English electronic health records data. BMJ open. 2020;10(8):e037719. doi:10.1136/bmjopen-2020-037719</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-037719</ArticleId><ArticleId IdType="pmc">PMC7443310</ArticleId><ArticleId IdType="pubmed">32819994</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddams J, Utley M, Moller H. Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer. 2012;107(7):1195&#x2013;1202. doi:10.1038/bjc.2012.366</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjc.2012.366</ArticleId><ArticleId IdType="pmc">PMC3461160</ArticleId><ArticleId IdType="pubmed">22892390</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett R, Blanks R, Moss S. Evaluation of extension of breast screening to women aged 65&#x2013;70 in England using screening performance measures. Br J Cancer. 2009;100(7):1043&#x2013;1047. doi:10.1038/sj.bjc.6604981</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjc.6604981</ArticleId><ArticleId IdType="pmc">PMC2669999</ArticleId><ArticleId IdType="pubmed">19277039</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora N, Guiriguet C, Cantenys R, et al. Cancer diagnosis in primary care after second pandemic year in Catalonia: a time-series analysis of primary care electronic health records covering about 5 million people. Family Practice. 2023;40(1):183&#x2013;187. doi:10.1093/fampra/cmac083</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmac083</ArticleId><ArticleId IdType="pmc">PMC9384533</ArticleId><ArticleId IdType="pubmed">35861148</ArticleId></ArticleIdList></Reference><Reference><Citation>Skovlund CW, Friis S, Dehlendorff C, Nilbert MC, M&#xf8;rch LS. Hidden morbidities: drop in cancer diagnoses during the COVID-19 pandemic in Denmark. Acta oncologica. 2021;60(1):20&#x2013;23. doi:10.1080/0284186X.2020.1858235</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0284186X.2020.1858235</ArticleId><ArticleId IdType="pubmed">33287604</ArticleId></ArticleIdList></Reference><Reference><Citation>Nindenshuti PM, Caire-Juvera G. Changes in diet, physical activity, alcohol consumption, and tobacco use in adults during the COVID-19 pandemic: a systematic review. Inquiry. 2023;60:00469580231175780. doi:10.1177/00469580231175780</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00469580231175780</ArticleId><ArticleId IdType="pmc">PMC10208950</ArticleId><ArticleId IdType="pubmed">37219073</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey V, Mohan R, Kumar A, Gangadevi P, Kurien N. The impact of the COVID-19 outbreak on lifestyle-related behavior among the general population. Cureus. 2023;15(9):e45756. doi:10.7759/cureus.45756</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.45756</ArticleId><ArticleId IdType="pmc">PMC10590493</ArticleId><ArticleId IdType="pubmed">37872892</ArticleId></ArticleIdList></Reference><Reference><Citation>Concepcion J, Yeager M, Alfaro S, et al. Trends of cancer screenings, diagnoses, and mortalities during the COVID-19 pandemic: implications and future recommendations. Am Surg. 2022;14:31348221091948. doi:10.1177/00031348221091948</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00031348221091948</ArticleId><ArticleId IdType="pmc">PMC9014329</ArticleId><ArticleId IdType="pubmed">35420510</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38893186</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2072-6694</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>30</Day></PubDate></JournalIssue><Title>Cancers</Title><ISOAbbreviation>Cancers (Basel)</ISOAbbreviation></Journal><ArticleTitle>Transforming a Large-Scale Prostate Cancer Outcomes Dataset to the OMOP Common Data Model-Experiences from a Scientific Data Holder's Perspective.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2069</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cancers16112069</ELocationID><Abstract><AbstractText>To enhance international and joint research collaborations in prostate cancer research, data from different sources should use a common data model (CDM) that enables researchers to share their analysis scripts and merge results. The OMOP CDM maintained by OHDSI is such a data model developed for a federated data analysis with partners from different institutions that want to jointly investigate research questions using clinical care data. The German Cancer Society as the scientific lead of the Prostate Cancer Outcomes (PCO) study gathers data from prostate cancer care including routine oncological care data and survey data (incl. patient-reported outcomes) and uses a common data specification (called OncoBox Research Prostate) for this purpose. To further enhance research collaborations outside the PCO study, the purpose of this article is to describe the process of transferring the PCO study data to the internationally well-established OMOP CDM. This process was carried out together with an IT company that specialised in supporting research institutions to transfer their data to OMOP CDM. Of n = 49,692 prostate cancer cases with 318 data fields each, n = 392 had to be excluded during the OMOPing process, and n = 247 of the data fields could be mapped to OMOP CDM. The resulting PostgreSQL database with OMOPed PCO study data is now ready to use within larger research collaborations such as the EU-funded EHDEN and OPTIMA consortium.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sibert</LastName><ForeName>Nora Tabea</ForeName><Initials>NT</Initials><AffiliationInfo><Affiliation>Health Services Research Department, German Cancer Society, 14057 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soff</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0515-9013</Identifier><AffiliationInfo><Affiliation>Health Services Research Department, German Cancer Society, 14057 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Ferla</LastName><ForeName>Sebastiano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ITTM SA, Esch-sur-Alzette, 4354 Esch-sur-Alzette, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quaranta</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ITTM SA, Esch-sur-Alzette, 4354 Esch-sur-Alzette, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kremer</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1466-0600</Identifier><AffiliationInfo><Affiliation>ITTM SA, Esch-sur-Alzette, 4354 Esch-sur-Alzette, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowalski</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-7438-4321</Identifier><AffiliationInfo><Affiliation>Health Services Research Department, German Cancer Society, 14057 Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>806968</GrantID><Agency>This research was funded by an IMI EHDEN sub-grant for Data Partner call (EHDEN funding number: 806968).</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cancers (Basel)</MedlineTA><NlmUniqueID>101526829</NlmUniqueID><ISSNLinking>2072-6694</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">data harmonisation</Keyword><Keyword MajorTopicYN="N">observational dataset</Keyword><Keyword MajorTopicYN="N">prostate cancer</Keyword></KeywordList><CoiStatement>C.K., J.S. and N.T.S. are employees of the German Cancer Society. Apart from being employees/funders of ITTM, S.L.F, M.Q. and A.K. have no conflicts of interest to decare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>1</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38893186</ArticleId><ArticleId IdType="pmc">PMC11171220</ArticleId><ArticleId IdType="doi">10.3390/cancers16112069</ArticleId><ArticleId IdType="pii">cancers16112069</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rosenbloom S.T., Carroll R.J., Warner J.L., Matheny M.E., Denny J.C. Representing Knowledge Consistently Across Health Systems. Yearb. Med. Inform. 2017;26:139&#x2013;147. doi: 10.15265/IY-2017-018.</Citation><ArticleIdList><ArticleId IdType="doi">10.15265/IY-2017-018</ArticleId><ArticleId IdType="pmc">PMC6239235</ArticleId><ArticleId IdType="pubmed">29063555</ArticleId></ArticleIdList></Reference><Reference><Citation>Belenkaya R., Gurley M.J., Golozar A., Dymshyts D., Miller R.T., Williams A.E., Ratwani S., Siapos A., Korsik V., Warner J., et al. Extending the OMOP Common Data Model and Standardized Vocabularies to Support Observational Cancer Research. JCO Clin. Cancer Inform. 2021;5:12&#x2013;20. doi: 10.1200/CCI.20.00079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/CCI.20.00079</ArticleId><ArticleId IdType="pmc">PMC8140810</ArticleId><ArticleId IdType="pubmed">33411620</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlomer B.J., Copp H.L. Secondary Data Analysis of Large Data Sets in Urology: Successes and Errors to Avoid. J. Urol. 2014;191:587&#x2013;596. doi: 10.1016/j.juro.2013.09.091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.juro.2013.09.091</ArticleId><ArticleId IdType="pmc">PMC4299757</ArticleId><ArticleId IdType="pubmed">24140846</ArticleId></ArticleIdList></Reference><Reference><Citation>ICHOM International Consortium for Health Outcomes Measurement.  [(accessed on 19 November 2022)].  Available online:  https://www.ichom.org/</Citation></Reference><Reference><Citation>Kirkham J.J., Gorst S., Altman D.G., Blazeby J.M., Clarke M., Tunis S., Williamson P.R., COS-STAP Group Core Outcome Set-STAndardised Protocol Items: The COS-STAP Statement. Trials. 2019;20:116. doi: 10.1186/s13063-019-3230-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-019-3230-x</ArticleId><ArticleId IdType="pmc">PMC6371434</ArticleId><ArticleId IdType="pubmed">30744706</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkham J.J., Gorst S., Altman D.G., Blazeby J.M., Clarke M., Devane D., Gargon E., Moher D., Schmitt J., Tugwell P., et al. Core Outcome Set&#x2013;STAndards for Reporting: The COS-STAR Statement. PLOS Med. 2016;13:e1002148. doi: 10.1371/journal.pmed.1002148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002148</ArticleId><ArticleId IdType="pmc">PMC5068732</ArticleId><ArticleId IdType="pubmed">27755541</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLennan S., Williamson P.R. The Need for Core Outcome Sets in Urological Cancer Research. Transl. Androl. Urol. 2021;10:2832&#x2013;2835. doi: 10.21037/tau-20-1323.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/tau-20-1323</ArticleId><ArticleId IdType="pmc">PMC8261447</ArticleId><ArticleId IdType="pubmed">34295767</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsey I., Eckert M., Hutchinson A.D., Marker J., Corsini N. Core Outcome Sets in Cancer and Their Approaches to Identifying and Selecting Patient-Reported Outcome Measures: A Systematic Review. J. Patient Rep. Outcomes. 2020;4:77. doi: 10.1186/s41687-020-00244-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41687-020-00244-3</ArticleId><ArticleId IdType="pmc">PMC7492323</ArticleId><ArticleId IdType="pubmed">32930891</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang P.E., Ryan P.B., Racoosin J.A., Overhage J.M., Hartzema A.G., Reich C., Welebob E., Scarnecchia T., Woodcock J. Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership. Ann. Intern Med. 2010;153:600&#x2013;606. doi: 10.7326/0003-4819-153-9-201011020-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-153-9-201011020-00010</ArticleId><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics Informatics , editor. The Book of OHDSI. 2021.</Citation></Reference><Reference><Citation>Unberath P., Prokosch H.U., Gr&#xfc;ndner J., Erpenbeck M., Maier C., Christoph J. EHR-Independent Predictive Decision Support Architecture Based on OMOP. Appl. Clin. Inform. 2020;11:399&#x2013;404. doi: 10.1055/s-0040-1710393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1710393</ArticleId><ArticleId IdType="pmc">PMC7269719</ArticleId><ArticleId IdType="pubmed">32492716</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood W.A., Marks P., Plovnick R.M., Hewitt K., Neuberg D.S., Walters S., Dolan B.K., Tucker E.A., Abrams C.S., Thompson A.A., et al. ASH Research Collaborative: A Real-World Data Infrastructure to Support Real-World Evidence Development and Learning Healthcare Systems in Hematology. Blood Adv. 2021;5:5429&#x2013;5438. doi: 10.1182/bloodadvances.2021005902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2021005902</ArticleId><ArticleId IdType="pmc">PMC9153041</ArticleId><ArticleId IdType="pubmed">34673922</ArticleId></ArticleIdList></Reference><Reference><Citation>H J., Sc Y., Sy K., Si S., Jl W., R B., Rw P. Characterizing the Anticancer Treatment Trajectory and Pattern in Patients Receiving Chemotherapy for Cancer Using Harmonized Observational Databases: Retrospective Study. JMIR Med. Inform. 2021;9:e25035. doi: 10.2196/25035.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/25035</ArticleId><ArticleId IdType="pmc">PMC8058693</ArticleId><ArticleId IdType="pubmed">33720842</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss E.A., Blacketer C., van Sandijk S., Moinat M., Kallfelz M., van Speybroeck M., Prieto-Alhambra D., Schuemie M.J., Rijnbeek P.R. European Health Data &amp; Evidence Network-Learnings from Building out a Standardized International Health Data Network. J. Am. Med. Inform. Assoc. 2023;31:209&#x2013;219. doi: 10.1093/jamia/ocad214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocad214</ArticleId><ArticleId IdType="pmc">PMC10746315</ArticleId><ArticleId IdType="pubmed">37952118</ArticleId></ArticleIdList></Reference><Reference><Citation>Heads of Medicines Agency. European Medicines Agency . HMA-EMA Joint Big Data Taskforce Phase II Report: Evolving Data-Driven Regulation. European Medicines Agency; Amsterdam, The Netherlands: 2024.</Citation></Reference><Reference><Citation>Omar M.I., Roobol M.J., Ribal M.J., Abbott T., Agapow P.-M., Araujo S., Asiimwe A., Auffray C., Balaur I., Beyer K., et al. Introducing PIONEER: A Project to Harness Big Data in Prostate Cancer Research. Nat. Rev. Urol. 2020;17:351&#x2013;362. doi: 10.1038/s41585-020-0324-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41585-020-0324-x</ArticleId><ArticleId IdType="pubmed">32461687</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandaglia G., Pellegrino F., Golozar A., De Meulder B., Abbott T., Achtman A., Imran Omar M., Alshammari T., Areia C., Asiimwe A., et al. Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data. Eur. Urol. 2024;85:457&#x2013;465. doi: 10.1016/j.eururo.2023.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2023.06.012</ArticleId><ArticleId IdType="pubmed">37414703</ArticleId></ArticleIdList></Reference><Reference><Citation>Szymanski K.M., Wei J.T., Dunn R.L., Sanda M.G. Development and Validation of an Abbreviated Version of the Expanded Prostate Cancer Index Composite Instrument for Measuring Health-Related Quality of Life among Prostate Cancer Survivors. Urology. 2010;76:1245&#x2013;1250. doi: 10.1016/j.urology.2010.01.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urology.2010.01.027</ArticleId><ArticleId IdType="pmc">PMC3152317</ArticleId><ArticleId IdType="pubmed">20350762</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans S.M., Millar J.L., Moore C.M., Lewis J.D., Huland H., Sampurno F., Connor S.E., Villanti P., Litwin M.S. Cohort Profile: The TrueNTH Global Registry&#x2014;An International Registry to Monitor and Improve Localised Prostate Cancer Health Outcomes. BMJ Open. 2017;7:e017006. doi: 10.1136/bmjopen-2017-017006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-017006</ArticleId><ArticleId IdType="pmc">PMC5719323</ArticleId><ArticleId IdType="pubmed">29183925</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibert N.T., Pfaff H., Breidenbach C., Wesselmann S., Roth R., Feick G., Carl G., Dieng S., Gaber A.A., Blana A., et al. Variation across Operating Sites in Urinary and Sexual Outcomes after Radical Prostatectomy in Localized and Locally Advanced Prostate Cancer. World J. Urol. 2022;40:1437&#x2013;1446. doi: 10.1007/s00345-022-03985-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-022-03985-6</ArticleId><ArticleId IdType="pubmed">35347412</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalski C., Roth R., Carl G., Feick G., Oesterle A., Hinkel A., Steiner T., Brock M., Kaftan B., Borowitz R., et al. A Multicenter Paper-Based and Web-Based System for Collecting Patient-Reported Outcome Measures in Patients Undergoing Local Treatment for Prostate Cancer: First Experiences. J. Patient Rep. Outcomes. 2020;4:56. doi: 10.1186/s41687-020-00224-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41687-020-00224-7</ArticleId><ArticleId IdType="pmc">PMC7359206</ArticleId><ArticleId IdType="pubmed">32661594</ArticleId></ArticleIdList></Reference><Reference><Citation>ICHOM . International Consortium for Health Outcomes Measurement Localized Prostate Cancer Data Collection Reference Guide 2015. ICHOM; Boston, MA, USA: 2015.</Citation></Reference><Reference><Citation>Overhage J.M., Ryan P.B., Reich C.G., Hartzema A.G., Stang P.E. Validation of a Common Data Model for Active Safety Surveillance Research. J. Am. Med. Inform. Assoc. 2012;19:54&#x2013;60. doi: 10.1136/amiajnl-2011-000376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G., Duke J.D., Shah N.H., Reich C.G., Huser V., Schuemie M.J., Suchard M.A., Park R.W., Wong I.C.K., Rijnbeek P.R., et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud. Health Technol. Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) S3-Leitlinie Prostatakarzinom. Langversion 6.2. AWMF; Frankfurt, Germany: 2021. AWMF-Registernummer: 043/022OL, 2021.</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics (OHDSI) OHDSI/WhiteRabbit 2024. Columbia University; New York, NY, USA: 2024.</Citation></Reference><Reference><Citation>GitHub . OHDSI/Usagi 2024. GitHub; San Francisco, NY, USA: 2024.</Citation></Reference><Reference><Citation>GitHub . EHDEN/CdmInspection 2024. GitHub; San Francisco, NY, USA: 2024.</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics (OHDSI) OHDSI/Atlas 2024. Columbia University; New York, NY, USA: 2024.</Citation></Reference><Reference><Citation>GitHub . OHDSI/Hades 2024. GitHub; San Francisco, NY, USA: 2024.</Citation></Reference><Reference><Citation>Sibert N.T., Dieng S., Oesterle A., Feick G., Carl G., Steiner T., Minner J., Roghmann F., Kaftan B., Zengerling F., et al. Psychometric Validation of the German Version of the EPIC-26 Questionnaire for Patients with Localized and Locally Advanced Prostate Cancer. World J. Urol. 2021;39:11&#x2013;25. doi: 10.1007/s00345-019-02949-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-019-02949-7</ArticleId><ArticleId IdType="pubmed">31552467</ArticleId></ArticleIdList></Reference><Reference><Citation>Biedermann P., Ong R., Davydov A., Orlova A., Solovyev P., Sun H., Wetherill G., Brand M., Didden E.-M. Standardizing Registry Data to the OMOP Common Data Model: Experience from Three Pulmonary Hypertension Databases. BMC Med. Res. Methodol. 2021;21:238. doi: 10.1186/s12874-021-01434-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-021-01434-3</ArticleId><ArticleId IdType="pmc">PMC8565035</ArticleId><ArticleId IdType="pubmed">34727871</ArticleId></ArticleIdList></Reference><Reference><Citation>Carus J., N&#xfc;rnberg S., &#xdc;ckert F., Schl&#xfc;ter C., Bartels S. Mapping Cancer Registry Data to the Episode Domain of the Observational Medical Outcomes Partnership Model (OMOP) Appl. Sci. 2022;12:4010. doi: 10.3390/app12084010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app12084010</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H., Choi J., Jang I., Quach J., Ohno-Machado L. Feasibility of Representing Data from Published Nursing Research Using the OMOP Common Data Model. AMIA Annu. Symp. Proc. 2017;2016:715&#x2013;723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333244</ArticleId><ArticleId IdType="pubmed">28269868</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Maio M., Basch E., Denis F., Fallowfield L.J., Ganz P.A., Howell D., Kowalski C., Perrone F., Stover A.M., Sundaresan P., et al. The Role of Patient-Reported Outcome Measures in the Continuum of Cancer Clinical Care: ESMO Clinical Practice Guideline. Ann. Oncol. 2022;33:878&#x2013;892. doi: 10.1016/j.annonc.2022.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annonc.2022.04.007</ArticleId><ArticleId IdType="pubmed">35462007</ArticleId></ArticleIdList></Reference><Reference><Citation>Donovan J.L., Hamdy F.C., Lane J.A., Mason M., Metcalfe C., Walsh E., Blazeby J.M., Peters T.J., Holding P., Bonnington S., et al. Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N. Engl. J. Med. 2016;375:1425&#x2013;1437. doi: 10.1056/NEJMoa1606221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1606221</ArticleId><ArticleId IdType="pmc">PMC5134995</ArticleId><ArticleId IdType="pubmed">27626365</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Hussein Al Awamlh B., Wallis C.J.D., Penson D.F., Huang L.-C., Zhao Z., Conwill R., Talwar R., Morgans A.K., Goodman M., Hamilton A.S., et al. Functional Outcomes After Localized Prostate Cancer Treatment. JAMA. 2024;331:302. doi: 10.1001/jama.2023.26491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.26491</ArticleId><ArticleId IdType="pmc">PMC10807259</ArticleId><ArticleId IdType="pubmed">38261043</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajwa P., Borkowetz A., Abbott T., Alberti A., Bjartell A., Brash J.T., Campi R., Chilelli A., Conover M., Constantinovici N., et al. Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-Sensitive Prostate Cancer: Big Data Analytics Using the PIONEER Platform. Eur. Urol. Open Sci. 2024;63:81&#x2013;88. doi: 10.1016/j.euros.2024.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euros.2024.02.019</ArticleId><ArticleId IdType="pmc">PMC10987796</ArticleId><ArticleId IdType="pubmed">38572301</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroes J.A., Bansal A.T., Berret E., Christian N., Kremer A., Alloni A., Gabetta M., Marshall C., Wagers S., Djukanovic R., et al. Blueprint for Harmonising Unstandardised Disease Registries to Allow Federated Data Analysis: Prepare for the Future. ERJ Open Res. 2022;8:00168&#x2013;2022. doi: 10.1183/23120541.00168-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00168-2022</ArticleId><ArticleId IdType="pmc">PMC9530887</ArticleId><ArticleId IdType="pubmed">36199590</ArticleId></ArticleIdList></Reference><Reference><Citation>Raab R., K&#xfc;derle A., Zakreuskaya A., Stern A.D., Klucken J., Kaissis G., Rueckert D., Boll S., Eils R., Wagener H., et al. Federated Electronic Health Records for the European Health Data Space. Lancet Digit. Health. 2023;5:e840&#x2013;e847. doi: 10.1016/S2589-7500(23)00156-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(23)00156-5</ArticleId><ArticleId IdType="pubmed">37741765</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38903818</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Streamlining intersectoral provision of real-world health data: a service platform for improved clinical research and patient care.</ArticleTitle><Pagination><StartPage>1377209</StartPage><MedlinePgn>1377209</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1377209</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2024.1377209</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Obtaining real-world data from routine clinical care is of growing interest for scientific research and personalized medicine. Despite the abundance of medical data across various facilities - including hospitals, outpatient clinics, and physician practices - the intersectoral exchange of information remains largely hindered due to differences in data structure, content, and adherence to data protection regulations. In response to this challenge, the Medical Informatics Initiative (MII) was launched in Germany, focusing initially on university hospitals to foster the exchange and utilization of real-world data through the development of standardized methods and tools, including the creation of a common core dataset. Our aim, as part of the Medical Informatics Research Hub in Saxony (MiHUBx), is to extend the MII concepts to non-university healthcare providers in a more seamless manner to enable the exchange of real-world data among intersectoral medical sites.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We investigated what services are needed to facilitate the provision of harmonized real-world data for cross-site research. On this basis, we designed a Service Platform Prototype that hosts services for data harmonization, adhering to the globally recognized Health Level 7 (HL7) Fast Healthcare Interoperability Resources (FHIR) international standard communication format and the Observational Medical Outcomes Partnership (OMOP) common data model (CDM). Leveraging these standards, we implemented additional services facilitating data utilization, exchange and analysis. Throughout the development phase, we collaborated with an interdisciplinary team of experts from the fields of system administration, software engineering and technology acceptance to ensure that the solution is sustainable and reusable in the long term.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We have developed the pre-built packages "ResearchData-to-FHIR," "FHIR-to-OMOP," and "Addons," which provide the services for data harmonization and provision of project-related real-world data in both the FHIR MII Core dataset format (CDS) and the OMOP CDM format as well as utilization and a Service Platform Prototype to streamline data management and use.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our development shows a possible approach to extend the MII concepts to non-university healthcare providers to enable cross-site research on real-world data. Our Service Platform Prototype can thus pave the way for intersectoral data sharing, federated analysis, and provision of SMART-on-FHIR applications to support clinical decision making.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Hoffmann, Nesterow, Peng, Henke, Barnett, Klengel, Gruhl, Bartos, N&#xfc;&#xdf;ler, Gebler, Grummt, Seim, Bathelt, Reinecke, Wolfien, Weidner and Sedlmayr.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>Katja</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Carl Gustav Carus, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nesterow</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Carl Gustav Carus, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Carl Gustav Carus, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henke</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Carl Gustav Carus, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnett</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Data Integration Center, Center for Medical Informatics, University Hospital Carl Gustav Carus, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klengel</LastName><ForeName>Cigdem</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Carl Gustav Carus, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gruhl</LastName><ForeName>Mirko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Carl Gustav Carus, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartos</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Informatics, Klinikum Chemnitz gGmbH, Chemnitz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N&#xfc;&#xdf;ler</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Informatics, Klinikum Chemnitz gGmbH, Chemnitz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gebler</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Carl Gustav Carus, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grummt</LastName><ForeName>Sophia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Carl Gustav Carus, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seim</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Carl Gustav Carus, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bathelt</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Thiem-Research GmbH, Cottbus, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinecke</LastName><ForeName>Ines</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Data Integration Center, Center for Medical Informatics, University Hospital Carl Gustav Carus, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolfien</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Carl Gustav Carus, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Scalable Data Analytics and Artificial Intelligence, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weidner</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Carl Gustav Carus, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Carl Gustav Carus, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">data harmonization</Keyword><Keyword MajorTopicYN="N">health data space</Keyword><Keyword MajorTopicYN="N">interoperability</Keyword><Keyword MajorTopicYN="N">intersectoral data sharing</Keyword><Keyword MajorTopicYN="N">real-world data</Keyword><Keyword MajorTopicYN="N">research data infrastructure</Keyword><Keyword MajorTopicYN="N">secondary use of clinical data</Keyword><Keyword MajorTopicYN="N">service platform</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>4</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38903818</ArticleId><ArticleId IdType="pmc">PMC11188485</ArticleId><ArticleId IdType="doi">10.3389/fmed.2024.1377209</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bathelt F, Reinecke I, Peng Y, Henke E, Weidner J, Bartos M, et al. Opportunities of digital infrastructures for disease management&#x2013;exemplified on COVID-19-related change in diagnosis counts for diabetes-related eye diseases. Nutrients. (2022) 14:2016. 10.3390/nu14102016</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14102016</ArticleId><ArticleId IdType="pmc">PMC9147678</ArticleId><ArticleId IdType="pubmed">35631157</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Panagiotakos D. Real-world data: A brief review of the methods, applications, challenges and opportunities. BMC Med Res Methodol. (2022) 22:287. 10.1186/s12874-022-01768-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-022-01768-6</ArticleId><ArticleId IdType="pmc">PMC9636688</ArticleId><ArticleId IdType="pubmed">36335315</ArticleId></ArticleIdList></Reference><Reference><Citation>Orsini LS, Berger M, Crown W, Daniel G, Eichler HG, Goettsch W, et al. Improving transparency to build trust in real-world secondary data studies for hypothesis testing&#x2013;why, what, and how: Recommendations and a road map from the real-world evidence transparency initiative. Value Health. (2020) 23:1128&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">32940229</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra D. The importance of real-world data to precision medicine. Pers Med. (2019) 16:79&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">30724116</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfien M, Ahmadi N, Fitzer K, Grummt S, Heine KL, Jung IC, et al. Ten topics to get started in medical informatics research. J Med Internet Res. (2023) 25:e45948. 10.2196/45948</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/45948</ArticleId><ArticleId IdType="pmc">PMC10407648</ArticleId><ArticleId IdType="pubmed">37486754</ArticleId></ArticleIdList></Reference><Reference><Citation>Gehring S, Eulenfeld R. German medical informatics initiative: Unlocking data for research and health care. Methods Inf Med. (2018) 57:e46&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6178201</ArticleId><ArticleId IdType="pubmed">30016817</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler S, Wissing F, Heyder R. German medical informatics initiative: A national approach to integrating health data from patient care and medical research. Methods Inf Med. (2018) 57:e50&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6178199</ArticleId><ArticleId IdType="pubmed">30016818</ArticleId></ArticleIdList></Reference><Reference><Citation>Medical Informatics Initiative. The medical informatics initiative&#x2019;s core data set. Mainz: Medical Informatics Initiative; (2023).</Citation></Reference><Reference><Citation>HL7 FHIR. Health level seven international fast healthcare interoperability resources (HL7 FHIR). (2023). Available online at: http://hl7.org/fhir/
(accessed December 15, 2023).</Citation></Reference><Reference><Citation>Mandel JC, Kreda DA, Mandl KD, Kohane IS, Ramoni RB. SMART on FHIR: A standards-based, interoperable apps platform for electronic health records. Journal of the Am Med Inf Assoc. (2016) 23:899&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997036</ArticleId><ArticleId IdType="pubmed">26911829</ArticleId></ArticleIdList></Reference><Reference><Citation>HL7 International. (2024) Available online at: https://www.hl7.org
(accessed January 13, 2024).</Citation></Reference><Reference><Citation>OHDSI. (2024) Available online at: https://www.ohdsi.org
(accessed January 13, 2024).</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational health data sciences and informatics (OHDSI): Opportunities for observational researchers. Stud Health Technol Inform. (2015) 216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. HL7 international and OHDSI announce collaboration to provide single common data model for sharing information in clinical care and observational research. (2024). Available online at: https://www.ohdsi.org/ohdsi-hl7-collaboration/
(accessed January 13, 2024).</Citation></Reference><Reference><Citation>OHDSI. Standardized data: The OMOP common data model. (2024). Available online at: https://www.ohdsi.org/data-standardization/
(accessed December 15, 2023).</Citation></Reference><Reference><Citation>OHDSI. Software tools. (2024). Available online at: https://www.ohdsi.org/software-tools/
(accessed January 13, 2024).</Citation></Reference><Reference><Citation>Prokosch HU, Bahls T, Bialke M, Eils J, Fegeler C, Gruendner J, et al. editors. The COVID-19 data exchange platform of the German university medicine. In: S&#xe9;roussi B, Weber P, Dhombres F, Grouin C, Liebe JD, Pelayo S, et al. editors. Studies in health technology and informatics. Amsterdam: IOS Press; (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35612174</ArticleId></ArticleIdList></Reference><Reference><Citation>Prokosch HU, Gebhardt M, Gruendner J, Kleinert P, Buckow K, Rosenau L, et al. editors. Towards a national portal for medical research data (FDPG): Vision, status, and lessons learned. In: H&#xe4;gglund M, Blusi M, Bonacina S, Nilsson L, Cort Madsen I, Pelayo S, et al. editors. Studies in health technology and informatics. Amsterdam: IOS Press; (2023). 10.3233/SHTI230124</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI230124</ArticleId><ArticleId IdType="pubmed">37203668</ArticleId></ArticleIdList></Reference><Reference><Citation>Deutsche Zentrum f&#xfc;r Luft und Raumfahrt. MiHUBx: Ein digitales &#xf6;kosystem f&#xfc;r forschung, diagnostik und therapie. (2023). Available online at: https://www.gesundheitsforschung-bmbf.de/de/mihubx-ein-digitales-okosystem-fur-forschung-diagnostik-und-therapie-13054.php
(accessed December 15, 2023).</Citation></Reference><Reference><Citation>Medizininformatik-Initiative. Basismodule des kerndatensatzes der MII. (2023). Available online at: https://www.medizininformatik-initiative.de/de/basismodule-des-kerndatensatzes-der-mii
(accessed December 15, 2023).</Citation></Reference><Reference><Citation>Prokosch HU, Acker T, Bernarding J, Binder H, Boeker M, Boerries M, et al. MIRACUM: Medical informatics in research and care in university medicine: A large data sharing network to enhance translational research and medical care. Methods Inf Med. (2018) 57:e82&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6178200</ArticleId><ArticleId IdType="pubmed">30016814</ArticleId></ArticleIdList></Reference><Reference><Citation>Miracum. MIRACOLIX tools. (2024). Available online at: https://www.miracum.org/das-konsortium/datenintegrationszentren/miracolix-tools/
(accessed January 15, 2024).</Citation></Reference><Reference><Citation>Kiel A.
Blaze FHIR&#xae; server with internal, fast CQL engine. (2023). Available online at: https://samply.github.io/blaze/
(accessed December 15, 2023).</Citation></Reference><Reference><Citation>Sch&#xfc;ttler C, Prokosch HU, Hummel M, Lablans M, Kroll B, Engels C, et al. The journey to establishing an IT-infrastructure within the German biobank alliance. PLoS One. (2021) 16:e0257632. 10.1371/journal.pone.0257632</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257632</ArticleId><ArticleId IdType="pmc">PMC8457464</ArticleId><ArticleId IdType="pubmed">34551019</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruendner J, Deppenwiese N, Folz M, K&#xf6;hler T, Kroll B, Prokosch HU, et al. The architecture of a feasibility query portal for distributed COVID-19 fast healthcare interoperability resources (FHIR) patient data repositories: Design and implementation study. JMIR Med Inform. (2022) 10:e36709. 10.2196/36709</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/36709</ArticleId><ArticleId IdType="pmc">PMC9135115</ArticleId><ArticleId IdType="pubmed">35486893</ArticleId></ArticleIdList></Reference><Reference><Citation>GitHub. FHIR gateway. (2024). Available online at: https://github.com/miracum/fhir-gateway
(accessed January 15, 2024).</Citation></Reference><Reference><Citation>Gruhl M, Reinecke I, Sedlmayr M. Specification and distribution of vocabularies among consortial partners. Stud Health Technol Inform. (2020) 270:1393&#x2013;4. 10.3233/SHTI200458</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI200458</ArticleId><ArticleId IdType="pubmed">32570675</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y, Henke E, Reinecke I, Zoch M, Sedlmayr M, Bathelt F. An ETL-process design for data harmonization to participate in international research with German real-world data based on FHIR and OMOP CDM. Int J Med Inform. (2023) 169:104925. 10.1016/j.ijmedinf.2022.104925</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2022.104925</ArticleId><ArticleId IdType="pubmed">36395615</ArticleId></ArticleIdList></Reference><Reference><Citation>Henke E, Peng Y, Reinecke I, Zoch M, Sedlmayr M, Bathelt F. An ETL-process design for incremental loading German real-world data based on FHIR and OMOP CDM: Algorithm development and validation. JMIR Med Inform. (2023) 11:e47310. 10.2196/47310</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/47310</ArticleId><ArticleId IdType="pmc">PMC10466444</ArticleId><ArticleId IdType="pubmed">37621207</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;mmel M, Reinecke I, Gruhl M, Bathelt F, Sedlmayr M.
Transition database for a harmonized mapping of German patient data to the OMOP CDM &#x2013; The &#x2018;German TDB&#x2019;. (2020). Available online at: https://www.ohdsi.org/wp-content/uploads/2020/05/13_Poster.pdf
(accessed November 15, 2023).</Citation></Reference><Reference><Citation>PostgreSQL. PostgreSQL: The world&#x2019;s most advanced open source relational database. (2023). Available online at: https://www.postgresql.org
(accessed December 16, 2023).</Citation></Reference><Reference><Citation>HL7. FHIR core R4, administrative gender. (2023). Available online at: https://hl7.org/fhir/r4/valueset-administrative-gender.html
(accessed January 3, 2023).</Citation></Reference><Reference><Citation>Keycloak. Open source identity and access management. (2024). Available online at: https://www.keycloak.org
(accessed April 19, 2024).</Citation></Reference><Reference><Citation>OpenID. What is OpenID connect. San Ramon, CA: OpenID Foundation; (2023).</Citation></Reference><Reference><Citation>docker. Make better, secure software from the start. (2024). Available online at: https://www.docker.com
(accessed December 16, 2023).</Citation></Reference><Reference><Citation>docker. Docker compose. (2023). Available online at: https://docs.docker.com/compose/
(accessed January 19, 2023).</Citation></Reference><Reference><Citation>pgAdmin. Open source administration and development platform for PostgreSQL. (2023). Available online at: https://www.pgadmin.org
(accessed December 29, 2023).</Citation></Reference><Reference><Citation>Portainer.io. Container management software for kubernetes and docker. (2023). Available online at: https://www.portainer.io
(accessed December 29, 2023).</Citation></Reference><Reference><Citation>Geis T, Tesch G. Basiswissen usability und user experience: Aus&#x2013; und weiterbildung zum UXQB certified professional for usability and user experience (CPUX) &#x2013; foundation level (CPUX-F). 2., &#xfc;berarbeitete und aktualisierte Auflage. Heidelberg: dpunkt.verlag; (2023). 312 p.</Citation></Reference><Reference><Citation>Quarkus. A Kubernetes native java stack tailored for OpenJDK HotSpot and GraalVM, crafted from the best of breed Java libraries and standards. (2023). Available online at: https://quarkus.io
(accessed December 16, 2023).</Citation></Reference><Reference><Citation>Angular. The web development framework for building the future. (2023). Available online at: https://angular.io
(accessed December 16, 2023).</Citation></Reference><Reference><Citation>Bootstrap widgets. The angular way. (2024). Available online at: https://ng-bootstrap.github.io/
(accessed January 09, 2024).</Citation></Reference><Reference><Citation>gitHub. Java docker API client. (2024). Available online at: https://github.com/docker-java/docker-java
(accessed January 08, 2024).</Citation></Reference><Reference><Citation>RabbitMQ. Message broker. (2023). Available online at: https://www.rabbitmq.com
(accessed December 16, 2023).</Citation></Reference><Reference><Citation>Mihubx. ResearchData-TO-FHIR package. (2024). Available online at: https://gitlab.ukdd.de/pub/mihubx/fhir-to-omop-install-package
(accessed May 14, 2024)</Citation></Reference><Reference><Citation>Mihubx. FHIR-TO-OMOP package. (2024). Available online at: https://gitlab.ukdd.de/mihubx/fhir-to-omop-install-pkg
(accessed May 14, 2024)</Citation></Reference><Reference><Citation>Mihubx. Addons package. (2024). Available online at: https://gitlab.ukdd.de/pub/mihubx/addons-install-pkg
(accessed May 14, 2024)</Citation></Reference><Reference><Citation>Mihubx. MiHUBx service platform prototype. (2024). Available online at: https://gitlab.ukdd.de/pub/mihubx/mihubx-service-portal
(accessed May 14, 2024).</Citation></Reference><Reference><Citation>Das Deutsche Forschungsportal f&#xfc;r Gesundheit [FDPG]. (2024). Available online at: https://forschen-fuer-gesundheit.de
(accessed January 07, 2024).</Citation></Reference><Reference><Citation>Horgan D, Hajduch M, Vrana M, Soderberg J, Hughes N, Omar MI, et al. European health data space&#x2013;an opportunity now to grasp the future of data-driven healthcare. Healthcare. (2022) 10:1629. 10.3390/healthcare10091629</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10091629</ArticleId><ArticleId IdType="pmc">PMC9498352</ArticleId><ArticleId IdType="pubmed">36141241</ArticleId></ArticleIdList></Reference><Reference><Citation>gematik. ISiK &#x2013; Informationstechnische systeme in krankenh&#xe4;usern. (2024). Available online at: https://fachportal.gematik.de/informationen-fuer/isik
(accessed January 07, 2024).</Citation></Reference><Reference><Citation>KBV
MIO &#x2013; Medizinische Informationsobjekte. (2024). Available online at: https://mio.kbv.de/site/mio
(accessed April 19, 2024).</Citation></Reference><Reference><Citation>Hoffmann K, Nesterow I, Peng Y, Henke E, Barnett D, Klengel C, et al. Streamlining intersectoral provision of real-world health data: A service platform for improved clinical research and patient care. medRxiv [Preprint]. (2024): 10.1101/2024.01.29.24301922</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.01.29.24301922</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38909216</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2288</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>22</Day></PubDate></JournalIssue><Title>BMC medical research methodology</Title><ISOAbbreviation>BMC Med Res Methodol</ISOAbbreviation></Journal><ArticleTitle>Learning debiased graph representations from the OMOP common data model for synthetic data generation.</ArticleTitle><Pagination><StartPage>136</StartPage><MedlinePgn>136</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">136</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12874-024-02257-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Generating synthetic patient data is crucial for medical research, but common approaches build up on black-box models which do not allow for expert verification or intervention. We propose a highly available method which enables synthetic data generation from real patient records in a privacy preserving and compliant fashion, is interpretable and allows for expert intervention.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Our approach ties together two established tools in medical informatics, namely OMOP as a data standard for electronic health records and Synthea as a data synthetization method. For this study, data pipelines were built which extract data from OMOP, convert them into time series format, learn temporal rules by 2 statistical algorithms (Markov chain, TARM) and 3 algorithms of causal discovery (DYNOTEARS, J-PCMCI+, LiNGAM) and map the outputs into Synthea graphs. The graphs are evaluated quantitatively by their individual and relative complexity and qualitatively by medical experts.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The algorithms were found to learn qualitatively and quantitatively different graph representations. Whereas the Markov chain results in extremely large graphs, TARM, DYNOTEARS, and J-PCMCI+ were found to reduce the data dimension during learning. The MultiGroupDirect LiNGAM algorithm was found to not be applicable to the problem statement at hand.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Only TARM and DYNOTEARS are practical algorithms for real-world data in this use case. As causal discovery is a method to debias purely statistical relationships, the gradient-based causal discovery algorithm DYNOTEARS was found to be most suitable.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schulz</LastName><ForeName>Nicolas Alexander</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Institute for Applied Medical Informatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. n.schulz@uke.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carus</LastName><ForeName>Jasmin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiederhold</LastName><ForeName>Alexander Johannes</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Institute for Applied Medical Informatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johanns</LastName><ForeName>Ole</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Cancer Registry Hamburg, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>Frederik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cancer Registry Hamburg, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rath</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Saarland Cancer Registry, Saarbr&#xfc;cken, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rausch</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Saarland Cancer Registry, Saarbr&#xfc;cken, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holleczek</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Saarland Cancer Registry, Saarbr&#xfc;cken, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katalinic</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cancer Registry Schleswig-Holstein, L&#xfc;beck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>AI-CARE Working Group</CollectiveName></Author><Author ValidYN="Y"><LastName>Gundler</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Applied Medical Informatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. c.gundler@uke.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Res Methodol</MedlineTA><NlmUniqueID>100968545</NlmUniqueID><ISSNLinking>1471-2288</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008390" MajorTopicYN="N">Markov Chains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Causal Discovery</Keyword><Keyword MajorTopicYN="N">Constraint-based Causal Discovery</Keyword><Keyword MajorTopicYN="N">DYNOTEARS</Keyword><Keyword MajorTopicYN="N">Discrete Time Series</Keyword><Keyword MajorTopicYN="N">Gradient-Based Causal Discovery</Keyword><Keyword MajorTopicYN="N">Graphical Models</Keyword><Keyword MajorTopicYN="N">Standardized Electronic Health Records</Keyword><Keyword MajorTopicYN="N">Structural Equation Models</Keyword><Keyword MajorTopicYN="N">Synthetic Data Generation</Keyword><Keyword MajorTopicYN="N">Temporal Association Rule Mining (TARM)</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Nennecke</LastName><ForeName>Alice</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kusche</LastName><ForeName>Henrik</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heinrichs</LastName><ForeName>Vera</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eberle</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luttmann</LastName><ForeName>Sabine</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abnaof</LastName><ForeName>Khalid</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kim-Wanner</LastName><ForeName>Soo-Zin</ForeName><Initials>SZ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Handels</LastName><ForeName>Heinz</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Germer</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Halber</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richter</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinnau</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reiner</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schaaf</LastName><ForeName>Jannik</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Storf</LastName><ForeName>Holger</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hartz</LastName><ForeName>Tobias</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goeken</LastName><ForeName>Nils</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>B&#xf6;sche</LastName><ForeName>Janina</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stein</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weitmann</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Labohm</LastName><ForeName>Louisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rudolph</LastName><ForeName>Christiane</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gundler</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>&#xdc;ckert</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>23</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>23</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>22</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38909216</ArticleId><ArticleId IdType="pmc">PMC11193245</ArticleId><ArticleId IdType="doi">10.1186/s12874-024-02257-8</ArticleId><ArticleId IdType="pii">10.1186/s12874-024-02257-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ellahham S, Ellahham N, Simsekler MCE. Application of Artificial Intelligence in the Health Care Safety Context Opportunities and Challenges. Am J Med Qual. 2020;35(4):341&#x2013;8. doi: 10.1177/1062860619878515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1062860619878515</ArticleId><ArticleId IdType="pubmed">31581790</ArticleId></ArticleIdList></Reference><Reference><Citation>Abouelmehdi K, Beni-Hssane A, Khaloufi H, Saadi M. Big data security and privacy in healthcare: A Review. Procedia Comput Sci. 2017;113:73&#x2013;80. doi: 10.1016/j.procs.2017.08.292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.procs.2017.08.292</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrows RC, Clayton PD. Privacy, Confidentiality, and Electronic Medical Records. J Am Med Inform Assoc. 1996;3(2):139&#x2013;48. doi: 10.1136/jamia.1996.96236282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.1996.96236282</ArticleId><ArticleId IdType="pmc">PMC116296</ArticleId><ArticleId IdType="pubmed">8653450</ArticleId></ArticleIdList></Reference><Reference><Citation>Graumann S, Bertschek I, Weber T, Ebert M, Ohnemus J. Monitoring-Report Wirtschaft DIGITAL 2017-Kompakt [Internet]. 2017. Available from: https://ftp.zew.de/pub/zew-docs/gutachten/ZEW_MonitoringWirtschaftDigital2017Langfassung.pdf</Citation></Reference><Reference><Citation>OHDSI. The Book of OHDSI [Internet]. 2021. Available from: https://ohdsi.github.io/TheBookOfOhdsi/</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. Athena. Available from: https://athena.ohdsi.org/search-terms/start</Citation></Reference><Reference><Citation>Hernandez M, Epelde G, Alberdi A, Cilla R, Rankin D. Synthetic data generation for tabular health records: A systematic review. Neurocomputing. 2022;493:28&#x2013;45. doi: 10.1016/j.neucom.2022.04.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucom.2022.04.053</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashidian S, Wang F, Moffitt R, Garcia V, Dutt A, Chang W, et al. SMOOTH-GAN: Towards Sharp and Smooth Synthetic EHR Data Generation. In: Michalowski M, Moskovitch R, editors. Artificial Intelligence in Medicine. Cham: Springer International Publishing; 2020 [cited 2024 Apr 25]. p. 37&#x2013;48. (Lecture Notes in Computer Science; vol. 12299). Available from: https://link.springer.com/10.1007/978-3-030-59137-3_4</Citation></Reference><Reference><Citation>Chin-Cheong K, Sutter T, Vogt JE. Generation of Heterogeneous Synthetic Electronic Health Records using GANs. 2019 Dec 13 [cited 2024 Apr 25]; Available from: http://hdl.handle.net/20.500.11850/392473</Citation></Reference><Reference><Citation>Walonoski J, Kramer M, Nichols J, Quina A, Moesel C, Hall D, et al. Synthea: An approach, method, and software mechanism for generating synthetic patients and the synthetic electronic health care record. J Am Med Inform Assoc. 2018;25(3):230&#x2013;8. doi: 10.1093/jamia/ocx079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx079</ArticleId><ArticleId IdType="pmc">PMC7651916</ArticleId><ArticleId IdType="pubmed">29025144</ArticleId></ArticleIdList></Reference><Reference><Citation>MITRE. Synthea Github Modules. [cited 2023 May 10]. Available from: https://github.com/synthetichealth/synthea/blob/master/src/main/resources/modules/lung_cancer/lung_cancer_probabilities.json</Citation></Reference><Reference><Citation>Katalinic M, Schenk M, Franke S, Katalinic A, Neumuth T, Dietz A, et al. Generation of a Realistic Synthetic Laryngeal Cancer Cohort for AI Applications. Cancers. 2024;16(3):639. doi: 10.3390/cancers16030639.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers16030639</ArticleId><ArticleId IdType="pmc">PMC10854797</ArticleId><ArticleId IdType="pubmed">38339389</ArticleId></ArticleIdList></Reference><Reference><Citation>Glymour C, Zhang K, Spirtes P. Review of Causal Discovery Methods Based on Graphical Models. Front Genet. 2019;10:524. doi: 10.3389/fgene.2019.00524.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2019.00524</ArticleId><ArticleId IdType="pmc">PMC6558187</ArticleId><ArticleId IdType="pubmed">31214249</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi N, Peng Y, Wolfien M, Zoch M, Sedlmayr M. OMOP CDM Can Facilitate Data-Driven Studies for Cancer Prediction: A Systematic Review. Int J Mol Sci. 2022;23(19):11834. doi: 10.3390/ijms231911834.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231911834</ArticleId><ArticleId IdType="pmc">PMC9569469</ArticleId><ArticleId IdType="pubmed">36233137</ArticleId></ArticleIdList></Reference><Reference><Citation>Data Standardization &#x2013; OHDSI. [cited 2023 Mar 21]. Available from: https://www.ohdsi.org/data-standardization/</Citation></Reference><Reference><Citation>MITRE. Synthea Wiki. [cited 2023 Mar 9]. Available from: https://github.com/synthetichealth/synthea/wiki/</Citation></Reference><Reference><Citation>Fournier-Viger P, Faghihi U, Nkambou R, Nguifo EM. CMRules: Mining sequential rules common to several sequences. Knowl-Based Syst. 2012;25(1):63&#x2013;76. doi: 10.1016/j.knosys.2011.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.knosys.2011.07.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearl J, Glymour M, Jewell NP. Causal inference in statistics: a primer. Chichester, West Sussex, UK: John Wiley &amp; Sons Ltd; 2016. p. 1.</Citation></Reference><Reference><Citation>Pamfil R, Sriwattanaworachai N, Desai N, Pilgerstorfer P, Beaumont P, Georgatzis K, et al. DYNOTEARS: Structure Learning from Time-Series Data. 2020 Apr 27; Available from: https://arxiv.org/pdf/2002.00498.pdf</Citation></Reference><Reference><Citation>Hasan U, Hossain E, Gani MO. A Survey on Causal Discovery Methods for I.I.D. and Time Series Data. 2023 [cited 2024 Feb 23]; Available from: https://arxiv.org/abs/2303.15027</Citation></Reference><Reference><Citation>Zheng X, Aragam B, Ravikumar P, Xing EP. DAGs with NO TEARS: Continuous Optimization for Structure Learning. 2018; Available from: https://proceedings.neurips.cc/paper_files/paper/2018/file/e347c51419ffb23ca3fd5050202f9c3d-Paper.pdf</Citation></Reference><Reference><Citation>Runge J, Nowack P, Kretschmer M, Flaxman S, Sejdinovic D. Detecting and quantifying causal associations in large nonlinear time series datasets. Sci Adv. 2019;5(11):eaau4996. doi: 10.1126/sciadv.aau4996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aau4996</ArticleId><ArticleId IdType="pmc">PMC6881151</ArticleId><ArticleId IdType="pubmed">31807692</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nther W, Ninad U, Runge J. Causal discovery for time series from multiple datasets with latent contexts. 2023 [cited 2024 Feb 29]; Available from: https://arxiv.org/abs/2306.12896</Citation></Reference><Reference><Citation>Shimizu S. Joint estimation of linear non-Gaussian acyclic models. Neurocomputing. 2012;81:104&#x2013;7. doi: 10.1016/j.neucom.2011.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucom.2011.11.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu S, Hoyer, Patrik O., Hyv&#xe4;rinen A, Kerminen A. A linear non-gaussian acyclic model for causal discovery. J Mach Learn Res. 2006;7(10):2003&#x2013;30.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38923168</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1360-0443</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Addiction (Abingdon, England)</Title><ISOAbbreviation>Addiction</ISOAbbreviation></Journal><ArticleTitle>Predictability of buprenorphine-naloxone treatment retention: A multi-site analysis combining electronic health records and machine learning.</ArticleTitle><Pagination><StartPage>1792</StartPage><EndPage>1802</EndPage><MedlinePgn>1792-1802</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/add.16587</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Opioid use disorder (OUD) and opioid dependence lead to significant morbidity and mortality, yet treatment retention, crucial for the effectiveness of medications like buprenorphine-naloxone, remains unpredictable. Our objective was to determine the predictability of 6-month retention in buprenorphine-naloxone treatment using electronic health record (EHR) data from diverse clinical settings and to identify key predictors.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">This retrospective observational study developed and validated machine learning-based clinical risk prediction models using EHR data.</AbstractText><AbstractText Label="SETTING AND CASES" NlmCategory="METHODS">Data were sourced from Stanford University's healthcare system and Holmusk's NeuroBlu database, reflecting a wide range of healthcare settings. The study analyzed 1800 Stanford and 7957 NeuroBlu treatment encounters from 2008 to 2023 and from 2003 to 2023, respectively.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">Predict continuous prescription of buprenorphine-naloxone for at least 6&#xa0;months, without a gap of more than 30&#x2009;days. The performance of machine learning prediction models was assessed by area under receiver operating characteristic (ROC-AUC) analysis as well as precision, recall and calibration. To further validate our approach's clinical applicability, we conducted two secondary analyses: a time-to-event analysis on a single site to estimate the duration of buprenorphine-naloxone treatment continuity evaluated by the C-index and a comparative evaluation against predictions made by three human clinical experts.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">Attrition rates at 6&#xa0;months were 58% (NeuroBlu) and 61% (Stanford). Prediction models trained and internally validated on NeuroBlu data achieved ROC-AUCs up to 75.8 (95% confidence interval [CI]&#x2009;=&#x2009;73.6-78.0). Addiction medicine specialists' predictions show a ROC-AUC of 67.8 (95% CI&#x2009;=&#x2009;50.4-85.2). Time-to-event analysis on Stanford data indicated a median treatment retention time of 65&#x2009;days, with random survival forest model achieving an average C-index of 65.9. The top predictor of treatment retention identified included the diagnosis of opioid dependence.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">US patients with opioid use disorder or opioid dependence treated with buprenorphine-naloxone prescriptions appear to have a high (&#x223c;60%) treatment attrition by 6&#xa0;months. Machine learning models trained on diverse electronic health record datasets appear to be able to predict treatment continuity with accuracy comparable to that of clinical experts.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Addiction published by John Wiley &amp; Sons Ltd on behalf of Society for the Study of Addiction.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nateghi Haredasht</LastName><ForeName>Fateme</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-8874-8835</Identifier><AffiliationInfo><Affiliation>Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hospital Medicine, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Excellence Research Center, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fouladvand</LastName><ForeName>Sajjad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hospital Medicine, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Excellence Research Center, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tate</LastName><ForeName>Steven</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9544-594X</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Min Min</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Holmusk Technologies, Inc., Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Holmusk Technologies, Inc., New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeow</LastName><ForeName>Joannas Jie Lin</ForeName><Initials>JJL</Initials><AffiliationInfo><Affiliation>Holmusk Technologies, Inc., Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Holmusk Technologies, Inc., New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griffiths</LastName><ForeName>Kira</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Holmusk Technologies, Inc., Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Holmusk Technologies, Inc., New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hospital Medicine, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Excellence Research Center, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertz</LastName><ForeName>Jeremiah W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Center for the Clinical Trials Network, National Institute on Drug Abuse, North Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miner</LastName><ForeName>Adam S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez-Boussard</LastName><ForeName>Tina</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hospital Medicine, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Excellence Research Center, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chwen-Yuen Angie</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Division of Primary Care and Population Health, Department of Medicine Stanford University School of Medicine, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Huiqiong</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-9822-2856</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humphreys</LastName><ForeName>Keith</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-0694-5761</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lembke</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vance</LastName><ForeName>L Alexander</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Holmusk Technologies, Inc., Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Holmusk Technologies, Inc., New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jonathan H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hospital Medicine, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Excellence Research Center, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UG1 DA015815</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>12409</GrantID><Agency>Gordon and Betty Moore Foundation</Agency><Country/></Grant><Grant><GrantID>UG1DA015815-CTN-0136</GrantID><Agency>National Institutes of Health (NIH)/National Institute on Drug Abuse Clinical Trials Network</Agency><Country/></Grant><Grant><Agency>Stanford Artificial Intelligence in Medicine and Imaging-Human-Centered Artificial Intelligence (AIMI-HAI) Partnership Grant</Agency><Country/></Grant><Grant><GrantID>1R01AI17812101</GrantID><Agency>NIH/National Institute of Allergy and Infectious Diseases</Agency><Country/></Grant><Grant><Agency>American Heart Association-Strategically Focused Research Network on Diversity in Clinical Trials</Agency><Country/></Grant><Grant><GrantID>UG1DA015815 - CTN-0136</GrantID><Agency>NIH/National Institute on Drug Abuse Clinical Trials Network</Agency><Country/></Grant><Grant><GrantID>UL1 TR003142</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1TR003142</GrantID><Agency>NIH-NCATS-CTSA</Agency><Country/></Grant><Grant><Agency>Google;</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Addiction</MedlineTA><NlmUniqueID>9304118</NlmUniqueID><ISSNLinking>0965-2140</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000069479">Buprenorphine, Naloxone Drug Combination</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009292">Narcotic Antagonists</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009293" MajorTopicYN="Y">Opioid-Related Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069479" MajorTopicYN="Y">Buprenorphine, Naloxone Drug Combination</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009292" MajorTopicYN="N">Narcotic Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058850" MajorTopicYN="N">Opiate Substitution Treatment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OMOP common data model</Keyword><Keyword MajorTopicYN="N">buprenorphine</Keyword><Keyword MajorTopicYN="N">electronic health records (EHR)</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">opioid use disorder (OUD)</Keyword><Keyword MajorTopicYN="N">time&#x2010;to&#x2010;event prediction</Keyword></KeywordList><CoiStatement>Conflict of Interest Disclosures. MMC, JY, KG, and LAV report employment with and equity ownership in Holmusk Technologies, Inc. during the conduct of this study. MMC, JY, KG, and LAV are employees of and hold equity in Holmusk Technologies, Inc. JHC reports being co-founder of Reaction Explorer LLC that develops and licenses organic chemistry education software and has been paid consulting fees from Sutton Pierce, Younker Hyde MacFarlane, and Sykes McAllister as a medical expert witness. <b>Declaration of interests:</b> MMC, JY, KG, and LAV report employment with and equity ownership in Holmusk Technologies, Inc. during the conduct of this study. MMC, JY, KG, and LAV are employees of and hold equity in Holmusk Technologies, Inc. JHC reports being co-founder of Reaction Explorer LLC that develops and licenses organic chemistry education software and has been paid consulting fees from Sutton Pierce, Younker Hyde MacFarlane, and Sykes McAllister as a medical expert witness.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>7</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>26</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>26</Day><Hour>12</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38923168</ArticleId><ArticleId IdType="mid">NIHMS2055832</ArticleId><ArticleId IdType="pmc">PMC11891486</ArticleId><ArticleId IdType="doi">10.1111/add.16587</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Spencer MR, Mini&#xf1;o A, and Warner M, &#x201c;Drug overdose deaths in the United States, 2001&#x2013;2021,&#x201d; NCHS Data Brief no 457, 2022, doi: 10.15620/cdc:122556.</Citation><ArticleIdList><ArticleId IdType="doi">10.15620/cdc:122556</ArticleId><ArticleId IdType="pubmed">36598401</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphreys K et al., &#x201c;Responding to the opioid crisis in North America and beyond: Recommendations of the Stanford&#x2013;Lancet Commission,&#x201d; The Lancet, vol. 399, no. 10324, pp. 555&#x2013;604, 2022, doi: 10.1016/S0140-6736(21)02252-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02252-2</ArticleId><ArticleId IdType="pmc">PMC9261968</ArticleId><ArticleId IdType="pubmed">35122753</ArticleId></ArticleIdList></Reference><Reference><Citation>Hser Y-I et al., &#x201c;Long-term Outcomes after Randomization to Buprenorphine/Naloxone versus Methadone in A Multi-site Trial,&#x201d; Addiction (Abingdon, England), vol. 111, no. 4, pp. 695&#x2013;705, 2016, doi: 10.1111/add.13238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/add.13238</ArticleId><ArticleId IdType="pmc">PMC4801718</ArticleId><ArticleId IdType="pubmed">26599131</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakeman SE et al., &#x201c;Comparative effectiveness of different treatment pathways for opioid use disorder,&#x201d; JAMA Netw Open, vol. 3, no. 2, pp. e1920622&#x2013;e1920622, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11143463</ArticleId><ArticleId IdType="pubmed">32022884</ArticleId></ArticleIdList></Reference><Reference><Citation>Sordo L et al., &#x201c;Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies,&#x201d; BMJ, vol. 357, p. j1550, 2017, doi: 10.1136/bmj.j1550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j1550</ArticleId><ArticleId IdType="pmc">PMC5421454</ArticleId><ArticleId IdType="pubmed">28446428</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauro PM, Gutkind S, Annunziato EM, and Samples H, &#x201c;Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019,&#x201d; JAMA Netw Open, vol. 5, no. 3, p. e223821, 2022, doi: 10.1001/jamanetworkopen.2022.3821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.3821</ArticleId><ArticleId IdType="pmc">PMC8943638</ArticleId><ArticleId IdType="pubmed">35319762</ArticleId></ArticleIdList></Reference><Reference><Citation>Samples H, Williams AR, Olfson M, and Crystal S, &#x201c;Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees,&#x201d; J Subst Abuse Treat, vol. 95, pp. 9&#x2013;17, 2018, doi: 10.1016/j.jsat.2018.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsat.2018.09.001</ArticleId><ArticleId IdType="pmc">PMC6354252</ArticleId><ArticleId IdType="pubmed">30352671</ArticleId></ArticleIdList></Reference><Reference><Citation>Brorson HH, Ajo Arnevik E, Rand-Hendriksen K, and Duckert F, &#x201c;Drop-out from addiction treatment: A systematic review of risk factors,&#x201d; Clin Psychol Rev, vol. 33, no. 8, pp. 1010&#x2013;1024, Dec. 2013, doi: 10.1016/j.cpr.2013.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpr.2013.07.007</ArticleId><ArticleId IdType="pubmed">24029221</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy AJ et al., &#x201c;Factors Associated with Long-Term Retention in Buprenorphine-Based Addiction Treatment Programs: a Systematic Review,&#x201d; J Gen Intern Med, vol. 37, no. 2, pp. 332&#x2013;340, Feb. 2022, doi: 10.1007/S11606-020-06448-Z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11606-020-06448-Z</ArticleId><ArticleId IdType="pmc">PMC8810983</ArticleId><ArticleId IdType="pubmed">33469778</ArticleId></ArticleIdList></Reference><Reference><Citation>Fouladvand S et al., &#x201c;A Comparative Effectiveness Study on Opioid Use Disorder Prediction Using Artificial Intelligence and Existing Risk Models,&#x201d; IEEE J Biomed Health Inform, vol. 27, no. 7, pp. 3589&#x2013;3598, 2023, doi: 10.1109/JBHI.2023.3265920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/JBHI.2023.3265920</ArticleId><ArticleId IdType="pubmed">37037255</ArticleId></ArticleIdList></Reference><Reference><Citation>V Karhade A et al., &#x201c;Predicting prolonged opioid prescriptions in opioid-naive lumbar spine surgery patients,&#x201d; The Spine Journal, vol. 20, no. 6, pp. 888&#x2013;895, 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">31901553</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo-Ciganic W-H et al., &#x201c;Developing and validating a machine-learning algorithm to predict opioid overdose in Medicaid beneficiaries in two US states: a prognostic modelling study,&#x201d; Lancet Digit Health, vol. 4, no. 6, pp. e455&#x2013;e465, 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9236281</ArticleId><ArticleId IdType="pubmed">35623798</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan MM et al., &#x201c;A machine learning based two-stage clinical decision support system for predicting patients&#x2019; discontinuation from opioid use disorder treatment: retrospective observational study,&#x201d; BMC Med Inform Decis Mak, vol. 21, pp. 1&#x2013;21, 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8620531</ArticleId><ArticleId IdType="pubmed">34836524</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb A, Yatsco A, Bakos-Block C, Langabeer JR, and Champagne-Langabeer T, &#x201c;Machine learning for predicting risk of early dropout in a recovery program for opioid use disorder,&#x201d; in Healthcare, 2022, p. 223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8871589</ArticleId><ArticleId IdType="pubmed">35206838</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis B et al., &#x201c;AI-based analysis of social media language predicts addiction treatment dropout at 90 days,&#x201d; Neuropsychopharmacology 2023 48:11, vol. 48, no. 11, pp. 1579&#x2013;1585, Apr. 2023, doi: 10.1038/s41386-023-01585-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-023-01585-5</ArticleId><ArticleId IdType="pmc">PMC10517013</ArticleId><ArticleId IdType="pubmed">37095253</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrell DS et al., &#x201c;Using natural language processing to identify problem usage of prescription opioids,&#x201d; Int J Med Inform, vol. 84, no. 12, pp. 1057&#x2013;1064, 2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">26456569</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x201c;STARR OMOP | Observational Medical Outcomes Partnership | Stanford Medicine.&#x201d; Accessed: Jan. 18, 2024.
[Online]. Available: https://med.stanford.edu/starr-omop.html</Citation></Reference><Reference><Citation>&#x201c;NeuroBlu | Behavioral Health Real-World Data and Analytics.&#x201d; Accessed: Jan. 18, 2024.
[Online]. Available: https://www.neuroblu.ai/</Citation></Reference><Reference><Citation>Jones CM et al., &#x201c;Receipt of telehealth services, receipt and retention of medications for opioid use disorder, and medically treated overdose among Medicare beneficiaries before and during the COVID-19 pandemic,&#x201d; JAMA Psychiatry, vol. 79, no. 10, pp. 981&#x2013;992, 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9434479</ArticleId><ArticleId IdType="pubmed">36044198</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x201c;Pharmacotherapy for Opioid Use Disorder - NCQA.&#x201d; Accessed: Jan. 18, 2024.
[Online]. Available: https://www.ncqa.org/hedis/measures/pharmacotherapy-for-opioid-use-disorder/</Citation></Reference><Reference><Citation>Williams AR, V Nunes E, Bisaga A, Levin FR, and Olfson M, &#x201c;Development of a Cascade of Care for responding to the opioid epidemic,&#x201d; Am J Drug Alcohol Abuse, vol. 45, no. 1, pp. 1&#x2013;10, 2019, doi: 10.1080/00952990.2018.1546862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00952990.2018.1546862</ArticleId><ArticleId IdType="pmc">PMC6404749</ArticleId><ArticleId IdType="pubmed">30675818</ArticleId></ArticleIdList></Reference><Reference><Citation>Breiman L, &#x201c;Random forests,&#x201d; Mach Learn, vol. 45, no. 1, pp. 5&#x2013;32, Oct. 2001, doi: 10.1023/A:1010933404324/METRICS.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1010933404324/METRICS</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie T, Tibshirani R, Friedman JH, and Friedman JH, The elements of statistical learning: data mining, inference, and prediction, vol. 2. Springer, 2009.</Citation></Reference><Reference><Citation>Chen T and Guestrin C, &#x201c;Xgboost: A scalable tree boosting system,&#x201d; in Proceedings of the 22nd acm sigkdd international conference on knowledge discovery and data mining, 2016, pp. 785&#x2013;794.</Citation></Reference><Reference><Citation>Warren D et al., &#x201c;Using machine learning to study the effect of medication adherence in Opioid Use Disorder,&#x201d; PLoS One, vol. 17, no. 12, p. e0278988, 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9754174</ArticleId><ArticleId IdType="pubmed">36520864</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishwaran H, Kogalur UB, Blackstone EH, and Lauer MS, &#x201c;Random survival forests,&#x201d; Annals of Applied Statistics, vol. 2, no. 3, pp. 841&#x2013;860, 2008.</Citation></Reference><Reference><Citation>Harrell FE Jr and Harrell FE, &#x201c;Cox proportional hazards regression model,&#x201d; Regression modeling strategies: With applications to linear models, logistic and ordinal regression, and survival analysis, pp. 475&#x2013;519, 2015.</Citation></Reference><Reference><Citation>Harrell FE, Califf RM, Pryor DB, Lee KL, and Rosati RA, &#x201c;Evaluating the yield of medical tests,&#x201d; JAMA, vol. 247, no. 18, pp. 2543&#x2013;2546, 1982.</Citation><ArticleIdList><ArticleId IdType="pubmed">7069920</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg SM and Lee S-I, &#x201c;A unified approach to interpreting model predictions,&#x201d; in Advances in Neural Information Processing Systems, 2017, pp. 4765&#x2013;4774.</Citation></Reference><Reference><Citation>P&#xf6;lsterl S, &#x201c;scikit-survival: A Library for Time-to-Event Analysis Built on Top of scikit-learn,&#x201d; The Journal of Machine Learning Research, vol. 21, no. 1, pp. 8747&#x2013;8752, 2020.</Citation></Reference><Reference><Citation>Lip GYH et al., &#x201c;Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation,&#x201d; Chest, vol. 137, no. 2, pp. 263&#x2013;272, Feb. 2010, doi: 10.1378/chest.09-1584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.09-1584</ArticleId><ArticleId IdType="pubmed">19762550</ArticleId></ArticleIdList></Reference><Reference><Citation>Rana JS et al., &#x201c;Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population,&#x201d; J Am Coll Cardiol, vol. 67, no. 18, pp. 2118&#x2013;2130, May 2016, doi: 10.1016/j.jacc.2016.02.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.02.055</ArticleId><ArticleId IdType="pmc">PMC5097466</ArticleId><ArticleId IdType="pubmed">27151343</ArticleId></ArticleIdList></Reference><Reference><Citation>Ker S et al., &#x201c;Factors that affect patient attrition in buprenorphine treatment for opioid use disorder: a retrospective real-world study using electronic health records,&#x201d; Neuropsychiatr Dis Treat, pp. 3229&#x2013;3244, 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8560173</ArticleId><ArticleId IdType="pubmed">34737569</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherrer JF, Sullivan MD, LaRochelle MR, and Grucza R, &#x201c;Validating opioid use disorder diagnoses in administrative data: a commentary on existing evidence and future directions,&#x201d; Addiction Science &amp; Clinical Practice, vol. 18, no. 1, p. 49, 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10433556</ArticleId><ArticleId IdType="pubmed">37592369</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor AM, Cousins G, Durand L, Barry J, and Boland F, &#x201c;Retention of patients in opioid substitution treatment: a systematic review,&#x201d; PLoS One, vol. 15, no. 5, p. e0232086, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7224511</ArticleId><ArticleId IdType="pubmed">32407321</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38934643</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Annotation-preserving machine translation of English corpora to validate Dutch clinical concept extraction tools.</ArticleTitle><Pagination><StartPage>1725</StartPage><EndPage>1734</EndPage><MedlinePgn>1725-1734</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocae159</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To explore the feasibility of validating Dutch concept extraction tools using annotated corpora translated from English, focusing on preserving annotations during translation and addressing the scarcity of non-English annotated clinical corpora.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Three annotated corpora were standardized and translated from English to Dutch using 2 machine translation services, Google Translate and OpenAI GPT-4, with annotations preserved through a proposed method of embedding annotations in the text before translation. The performance of 2 concept extraction tools, MedSpaCy and MedCAT, was assessed across the corpora in both Dutch and English.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The translation process effectively generated Dutch annotated corpora and the concept extraction tools performed similarly in both English and Dutch. Although there were some differences in how annotations were preserved across translations, these did not affect extraction accuracy. Supervised MedCAT models consistently outperformed unsupervised models, whereas MedSpaCy demonstrated high recall but lower precision.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Our validation of Dutch concept extraction tools on corpora translated from English was successful, highlighting the efficacy of our annotation preservation method and the potential for efficiently creating multilingual corpora. Further improvements and comparisons of annotation preservation techniques and strategies for corpus synthesis could lead to more efficient development of multilingual corpora and accurate non-English concept extraction tools.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study has demonstrated that translated English corpora can be used to validate non-English concept extraction tools. The annotation preservation method used during translation proved effective, and future research can apply this corpus translation method to additional languages and clinical settings.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Seinen</LastName><ForeName>Tom M</ForeName><Initials>TM</Initials><Identifier Source="ORCID">0000-0001-5369-8260</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kors</LastName><ForeName>Jan A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Mulligen</LastName><ForeName>Erik M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>European Health Data &amp; Evidence Network</Agency><Country/></Grant><Grant><Agency>European Union's Horizon 2020</Agency><Country/></Grant><Grant><GrantID>806968</GrantID><Agency>Innovative Medicines Initiative 2 Joint Undertaking</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D014175" MajorTopicYN="Y">Translating</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="N">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007802" MajorTopicYN="N">Language</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical concept extraction</Keyword><Keyword MajorTopicYN="N">corpus annotation</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">named entity recognition</Keyword><Keyword MajorTopicYN="N">natural language processing</Keyword><Keyword MajorTopicYN="N">text mining</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>9</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38934643</ArticleId><ArticleId IdType="pmc">PMC11258409</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocae159</ArticleId><ArticleId IdType="pii">7697361</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB, Rijnbeek PR. &#xa0;Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc. 2018;25(8):969-975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Knevel R, Liao KP. &#xa0;From real-world electronic health record data to real-world results using artificial intelligence. Ann Rheum Dis. 2023;82(3):306-311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9933153</ArticleId><ArticleId IdType="pubmed">36150748</ArticleId></ArticleIdList></Reference><Reference><Citation>Percha B. &#xa0;Modern clinical text mining: a guide and review. Annu Rev Biomed Data Sci. 2021;4:165-187.</Citation><ArticleIdList><ArticleId IdType="pubmed">34465177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford E, Carroll JA, Smith HE, Scott D, Cassell JA. &#xa0;Extracting information from the text of electronic medical records to improve case detection: a systematic review. J Am Med Inform Assoc. 2016;23(5):1007-1015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997034</ArticleId><ArticleId IdType="pubmed">26911811</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenreider O. &#xa0;The unified medical language system (UMLS): integrating biomedical terminology. Nucleic Acids Res Spec Publ. 2004;32(suppl_1):D267-D270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>Seinen TM, Kors JA, van Mulligen EM, et al. &#xa0;The added value of text from Dutch general practitioner notes in predictive modeling. J Am Med Inform Assoc. 2023;30(12):1973-1984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10654855</ArticleId><ArticleId IdType="pubmed">37587084</ArticleId></ArticleIdList></Reference><Reference><Citation>Seinen TM, Fridgeirsson EA, Ioannou S, et al. &#xa0;Use of unstructured text in prognostic clinical prediction models: a systematic review. J Am Med Inform Assoc. 2022;29(7):1292-1302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9196702</ArticleId><ArticleId IdType="pubmed">35475536</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreimeyer K, Foster M, Pandey A, &#xa0;et al. &#xa0;Natural language processing systems for capturing and standardizing unstructured clinical information: a systematic review. J Biomed Inform. 2017;73:14-29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6864736</ArticleId><ArticleId IdType="pubmed">28729030</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraile Navarro D, Ijaz K, Rezazadegan D, &#xa0;et al. &#xa0;Clinical named entity recognition and relation extraction using natural language processing of medical free text: A systematic review. Int J Med Inform. 2023;177:105122.</Citation><ArticleIdList><ArticleId IdType="pubmed">37295138</ArticleId></ArticleIdList></Reference><Reference><Citation>
AlShuweihi M, Salloum SA, Shaalan K. &#xa0;Biomedical corpora and natural language processing on clinical text in languages other than English: a systematic review. In: Al-Emran M, Shaalan K, Hassanien AE, eds. <i>Recent Advances in Intelligent Systems and Smart Applications</i>. Cham: Springer International Publishing;&#xa0;2021:491-509. 10.1007/978-3-030-47411-9_27</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-47411-9_27</ArticleId></ArticleIdList></Reference><Reference><Citation>Savova GK, Masanz JJ, Ogren PV, et al. &#xa0;Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications. J Am Med Inform Assoc. 2010;17(5):507-513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995668</ArticleId><ArticleId IdType="pubmed">20819853</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson AR. &#xa0;Effective mapping of biomedical text to the UMLS Metathesaurus: the MetaMap program. Proc AMIA Symp. 2001:17-21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2243666</ArticleId><ArticleId IdType="pubmed">11825149</ArticleId></ArticleIdList></Reference><Reference><Citation>Soldaini L, Goharian N. &#xa0;QuickUMLS: a fast, unsupervised approach for medical concept extraction. MedIR Workshop, SIGIR &#xa0;2016.</Citation></Reference><Reference><Citation>Kraljevic Z, Searle T, Shek A, &#xa0;et al. &#xa0;Multi-domain clinical natural language processing with MedCAT: The Medical Concept Annotation Toolkit. Artif Intell Med. 2021;117:102083.</Citation><ArticleIdList><ArticleId IdType="pubmed">34127232</ArticleId></ArticleIdList></Reference><Reference><Citation>
Bai L, Mulvenna MD, Wang Z, et al.  Clinical entity extraction: comparison between MetaMap, cTAKES, CLAMP and Amazon Comprehend Medical. In: <i>2021 32nd Irish Signals and Systems Conference</i> (ISSC). IEEE; 2021:1-6. 10.1109/ISSC52156.2021.9467856</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/ISSC52156.2021.9467856</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Ameer I, Zuo X, et al. Zero-shot clinical entity recognition using ChatGPT. arXiv. 2023. arXiv:2303.16416.</Citation></Reference><Reference><Citation>Arlett P, Kjaer J, Broich K, et al. &#xa0;Real&#x2010;world evidence in EU medicines regulation: enabling use and establishing value. Clin Pharmacol Ther. 2022;111(1):21-23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9299492</ArticleId><ArticleId IdType="pubmed">34797920</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovestone S, Consortium E; EMIF Consortium. The European Medical Information Framework: a novel ecosystem for sharing healthcare data across Europe. Learn Health Syst. 2020;4(2):e10214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7156868</ArticleId><ArticleId IdType="pubmed">32313838</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauffin O, Brand JS, Vidlin SH, et al. &#xa0;Supporting pharmacovigilance signal validation and prioritization with analyses of routinely collected health data: lessons learned from an EHDEN Network Study. Drug Saf. 2023;46(12):1335-1352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10684396</ArticleId><ArticleId IdType="pubmed">37804398</ArticleId></ArticleIdList></Reference><Reference><Citation>
European Medicines Agency. <i>Data Analysis and Real World Interrogation Network</i>. DARWIN EU. Accessed June 17, 2024. https://www.darwin-eu.org/</Citation></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, et al. &#xa0;Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54-60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich C, Ostropolets A, Ryan P, et al. &#xa0;OHDSI Standardized Vocabularies&#x2014;a large-scale centralized reference ontology for international data harmonization. J Am Med Inform Assoc. 2024;31(3):583-590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10873827</ArticleId><ArticleId IdType="pubmed">38175665</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es B, Reteig LC, Tan SC, et al. &#xa0;Negation detection in Dutch clinical texts: an evaluation of rule-based and machine learning methods. BMC Bioinformatics. 2023;24(1):10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9830789</ArticleId><ArticleId IdType="pubmed">36624385</ArticleId></ArticleIdList></Reference><Reference><Citation>Kersloot MG, van Putten FJ, Abu-Hanna A, et al. &#xa0;Natural language processing algorithms for mapping clinical text fragments onto ontology concepts: a systematic review and recommendations for future studies. J Biomed Semant. 2020;11(1):1-21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7670625</ArticleId><ArticleId IdType="pubmed">33198814</ArticleId></ArticleIdList></Reference><Reference><Citation>Uzuner &#xd6;, South BR, Shen S, et al. &#xa0;2010 i2b2/VA challenge on concepts, assertions, and relations in clinical text. J Am Med Inform Assoc. 2011;18(5):552-556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3168320</ArticleId><ArticleId IdType="pubmed">21685143</ArticleId></ArticleIdList></Reference><Reference><Citation>
Mowery DL, Velupillai S, South BR, et al.  Task 2: ShARe/CLEF eHealth evaluation lab 2014. In: <i>Proceedings of CLEF 2014</i>. 2014:31-42. ISSN 1613-0073.</Citation></Reference><Reference><Citation>Mohan S, Li D. MedMentions: a large biomedical corpus annotated with UMLS concepts. arXiv. 2019. arXiv:1902.09476.</Citation></Reference><Reference><Citation>
De Vries W, Wieling M, Nissim M. DUMB: a benchmark for smart evaluation of Dutch models. In: <i>Proceedings of the 2023 Conference on Empirical Methods in Natural Language Processing.</i> Association for Computational Linguistics;&#xa0;2023:7221-7241.</Citation></Reference><Reference><Citation>Kors JA, Clematide S, Akhondi SA, et al. &#xa0;A multilingual gold-standard corpus for biomedical concept recognition: the Mantra GSC. J Am Med Inform Assoc. 2015;22(5):948-956.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986661</ArticleId><ArticleId IdType="pubmed">25948699</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xe9;v&#xe9;ol A, Dalianis H, Velupillai S, et al. &#xa0;Clinical natural language processing in languages other than English: opportunities and challenges. J Biomed Semant. 2018;9(1):1-13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5877394</ArticleId><ArticleId IdType="pubmed">29602312</ArticleId></ArticleIdList></Reference><Reference><Citation>
Patel P, Davey D, Panchal V, et al.  Annotation of a large clinical entity corpus. In: Riloff E, Chiang D, Hockenmaier J, Tsujii J, eds. <i>Proceedings of the 2018 Conference on Empirical Methods in Natural Language Processing</i>. Association for Computational Linguistics; 2018:2033-2041. 10.18653/v1/D18-1228</Citation><ArticleIdList><ArticleId IdType="doi">10.18653/v1/D18-1228</ArticleId></ArticleIdList></Reference><Reference><Citation>
Anaby-Tavor A, Carmeli B, Goldbraich E, et al.  Do not have enough data? Deep learning to the rescue! In: Wooldridge M, Dy J, Natarajan S, eds. <i>Proceedings of the AAAI Conference on Artificial Intelligence</i>. Association for the Advancement of Artificial Intelligence; 2020:7383-7390. 10.1609/aaai.v34i05.6233</Citation><ArticleIdList><ArticleId IdType="doi">10.1609/aaai.v34i05.6233</ArticleId></ArticleIdList></Reference><Reference><Citation>
Schick T, Sch&#xfc;tze H. Generating datasets with pretrained language models. In: Moens M, Huang X, Specia L, Yih S, eds. <i>Proceedings of the 2021 Conference on Empirical Methods in Natural Language Processing.</i> Association for Computational Linguistics; 2021:6943-6951. 10.18653/v1/2021.emnlp-main.555</Citation><ArticleIdList><ArticleId IdType="doi">10.18653/v1/2021.emnlp-main.555</ArticleId></ArticleIdList></Reference><Reference><Citation>
Whitehouse C, Choudhury M, Aji AF. LLM-powered data augmentation for enhanced crosslingual performance. In: <i>Proceedings of the 2023 Conference on Empirical Methods in Natural Language Processing.</i> Association for Computational Linguistics; 2023:671-686.</Citation></Reference><Reference><Citation>Frei J, Kramer F. &#xa0;Annotated dataset creation through large language models for non-english medical NLP. J Biomed Inform. 2023;145:104478.</Citation><ArticleIdList><ArticleId IdType="pubmed">37625508</ArticleId></ArticleIdList></Reference><Reference><Citation>Frei J, Kramer F. &#xa0;GERNERMED: An open German medical NER model. Software Impacts. 2022;11:100212.</Citation></Reference><Reference><Citation>Wang H, Wu HUA, He Z, Huang L, Church KW. &#xa0;Progress in machine translation. Engineering. 2022;18:143-153.</Citation></Reference><Reference><Citation>
Gaschi F, Fontaine X, Rastin P, et al.  Multilingual clinical NER: translation or cross-lingual transfer? In: Naumann T, Abacha AB, Bethard S, Roberts K, Rumshisky A, eds. <i>Proceedings of the 5th Clinical Natural Language Processing Workshop</i>. Association for Computational Linguistics; 2023:289-311. 10.18653/v1/2023.clinicalnlp-1.34</Citation><ArticleIdList><ArticleId IdType="doi">10.18653/v1/2023.clinicalnlp-1.34</ArticleId></ArticleIdList></Reference><Reference><Citation>Frei J, Frei-Stuber L, Kramer F. &#xa0;GERNERMED++: Semantic annotation in German medical NLP through transfer-learning, translation and word alignment. J Biomed Inform. 2023;147:104513.</Citation><ArticleIdList><ArticleId IdType="pubmed">37838290</ArticleId></ArticleIdList></Reference><Reference><Citation>Achiam J, Adler S, Agarwal S, et al. GPT-4 technical report. arXiv. 2023. arXiv:2303.08774</Citation></Reference><Reference><Citation>
Papineni K, Roukos S, Ward T, et al.  BLEU: a method for automatic evaluation of machine translation. In: Isabelle P, Charniak E, Lin D, eds. <i>Proceedings of the 40th annual meeting of the Association for Computational Linguistics</i>. Association for Computational Linguistics; 2002:311-318. 10.3115/1073083.1073135</Citation><ArticleIdList><ArticleId IdType="doi">10.3115/1073083.1073135</ArticleId></ArticleIdList></Reference><Reference><Citation>
Popovi&#x107; M. chrF: character n-gram F-score for automatic MT evaluation. In: Bojar O, Chatterjee R, Federmann C, Haddow B, Hokamp C, Huck M, Logacheva V, Pecina P, eds. <i>Proceedings of the Tenth Workshop on Statistical Machine Translation</i>. Association for Computational Linguistics; 2015:392-395. 10.18653/v1/W15-3049</Citation><ArticleIdList><ArticleId IdType="doi">10.18653/v1/W15-3049</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson AE, Pollard TJ, Shen L, et al. &#xa0;MIMIC-III, a freely accessible critical care database. Sci Data. 2016;3(1):160035-160039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4878278</ArticleId><ArticleId IdType="pubmed">27219127</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiken M. &#xa0;An updated evaluation of Google translate accuracy. Stud Linguist Literature. 2019;3(3):253-260.</Citation></Reference><Reference><Citation>Jiao W, Wang W, Huang J-T, et al. Is ChatGPT a good translator? Yes with GPT-4 as the engine. arXiv. 2023. arXiv:2301.08745.</Citation></Reference><Reference><Citation>Son J, Kim B. &#xa0;Translation performance from the user&#x2019;s perspective of large language models and neural machine translation systems. Inform. 2023;14(10):574.</Citation></Reference><Reference><Citation>Remy F, Demuynck K, Demeester T. &#xa0;BioLORD-2023: semantic textual representations fusing large language models and clinical knowledge graph insights. J Am Med Inform Assoc. 2024. 10.1093/jamia/ocae029</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocae029</ArticleId><ArticleId IdType="pmc">PMC11339519</ArticleId><ArticleId IdType="pubmed">38412333</ArticleId></ArticleIdList></Reference><Reference><Citation>
Liu F, Vuli&#x107; I, Korhonen A, et al.  Learning domain-specialised representations for cross-lingual biomedical entity linking. In: Zong C, Xia F, Li W, Navigli R, eds. <i>Proceedings of the 59th Annual Meeting of the Association for Computational Linguistics and the 11th International Joint Conference on Natural Language Processing (Short Papers)</i>. Association for Computational Linguistics; 2021:565-574.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38944260</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>156</Volume><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Enhancing healthcare process analysis through object-centric process mining: Transforming OMOP common data models into object-centric event logs.</ArticleTitle><Pagination><StartPage>104682</StartPage><MedlinePgn>104682</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2024.104682</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(24)00100-X</ELocationID><Abstract><AbstractText Label="OBJECTIVES">This study aims to enhance the analysis of healthcare processes by introducing Object-Centric Process Mining (OCPM). By offering a holistic perspective that accounts for the interactions among various objects, OCPM transcends the constraints of conventional patient-centric process mining approaches, ensuring a more detailed and inclusive understanding of healthcare dynamics.</AbstractText><AbstractText Label="METHODS">We develop a novel method to transform the Observational Medical Outcomes Partnership Common Data Models (OMOP CDM) into Object-Centric Event Logs (OCELs). First, an OMOP CDM4PM is created from the standard OMOP CDM, focusing on data relevant to generating OCEL and addressing healthcare data's heterogeneity and standardization challenges. Second, this subset is transformed into OCEL based on specified healthcare criteria, including identifying various object types, clinical activities, and their relationships. The methodology is tested on the MIMIC-IV database to evaluate its effectiveness and utility.</AbstractText><AbstractText Label="RESULTS">Our proposed method effectively produces OCELs when applied to the MIMIC-IV dataset, allowing for the implementation of OCPM in the healthcare industry. We rigorously evaluate the comprehensiveness and level of abstraction to validate our approach's effectiveness. Additionally, we create diverse object-centric process models intricately designed to navigate the complexities inherent in healthcare processes.</AbstractText><AbstractText Label="CONCLUSION">Our approach introduces a novel perspective by integrating multiple viewpoints simultaneously. To the best of our knowledge, this is the inaugural application of OCPM within the healthcare sector, marking a significant advancement in the field.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Gyunam</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Process and Data Science Group (PADS), RWTH Aachen University, Ahornstra&#xdf;e 55, Aachen, 52074, North Rhine-Westphalia, Germany. Electronic address: gnpark@pads.rwth-aachen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yaejin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Information Convergence, Kwangwoon University, Kwangwoon-ro 20, Seoul, 01897, South Korea. Electronic address: 19lyaejin@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Minsu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Information Convergence, Kwangwoon University, Kwangwoon-ro 20, Seoul, 01897, South Korea. Electronic address: mcho@kw.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="Y">Data Mining</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017064" MajorTopicYN="N">Process Assessment, Health Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Health informatics</Keyword><Keyword MajorTopicYN="N">Healthcare process</Keyword><Keyword MajorTopicYN="N">OMOP common data model</Keyword><Keyword MajorTopicYN="N">Object-centric event log</Keyword><Keyword MajorTopicYN="N">Object-centric process mining</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>30</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>29</Day><Hour>19</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38944260</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2024.104682</ArticleId><ArticleId IdType="pii">S1532-0464(24)00100-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38964369</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>KG-LIME: predicting individualized risk of adverse drug events for multiple sclerosis disease-modifying therapy.</ArticleTitle><Pagination><StartPage>1693</StartPage><EndPage>1703</EndPage><MedlinePgn>1693-1703</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocae155</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this project was to create time-aware, individual-level risk score models for adverse drug events related to multiple sclerosis disease-modifying therapy and to provide interpretable explanations for model prediction behavior.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We used temporal sequences of observational medical outcomes partnership common data model (OMOP CDM) concepts derived from an electronic health record as model features. Each concept was assigned an embedding representation that was learned from a graph convolution network trained on a knowledge graph (KG) of OMOP concept relationships. Concept embeddings were fed into long short-term memory networks for 1-year adverse event prediction following drug exposure. Finally, we implemented a novel extension of the local interpretable model agnostic explanation (LIME) method, knowledge graph LIME (KG-LIME) to leverage the KG and explain individual predictions of each model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">For a set of 4859 patients, we found that our model was effective at predicting 32 out of 56 adverse event types (P&#x2009;&lt;&#x2009;.05) when compared to demographics and past diagnosis as variables. We also assessed discrimination in the form of area under the curve (AUC&#x2009;=&#x2009;0.77&#x2009;&#xb1;&#x2009;0.15) and area under the precision-recall curve (AUC-PR&#x2009;=&#x2009;0.31&#x2009;&#xb1;&#x2009;0.27) and assessed calibration in the form of Brier score (BS&#x2009;=&#x2009;0.04&#x2009;&#xb1;&#x2009;0.04). Additionally, KG-LIME generated interpretable literature-validated lists of relevant medical concepts used for prediction.</AbstractText><AbstractText Label="DISCUSSION AND CONCLUSION" NlmCategory="CONCLUSIONS">Many of our risk models demonstrated high calibration and discrimination for adverse event prediction. Furthermore, our novel KG-LIME method was able to utilize the knowledge graph to highlight concepts that were important to prediction. Future work will be required to further explore the temporal window of adverse event occurrence beyond the generic 1-year window used here, particularly for short-term inpatient adverse events and long-term severe adverse events.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patterson</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY 10032, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatonetti</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY 10032, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computational Biomedicine, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, CA 90048, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 GM131905</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35GM131905</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="Y">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="Y">Drug-Related Side Effects and Adverse Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OMOP; EHR</Keyword><Keyword MajorTopicYN="N">adverse drug events</Keyword><Keyword MajorTopicYN="N">explainable AI</Keyword><Keyword MajorTopicYN="N">graph neural network</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>5</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>4</Day><Hour>19</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38964369</ArticleId><ArticleId IdType="pmc">PMC11535856</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocae155</ArticleId><ArticleId IdType="pii">7706266</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Walton C, King R, Rechtman L, et al. &#xa0;Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler. 2020;26:1816-1821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7720355</ArticleId><ArticleId IdType="pubmed">33174475</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard J, Trevick S, Younger DS. &#xa0;Epidemiology of multiple sclerosis. Neurol Clin. 2016;34(4):919-939.</Citation><ArticleIdList><ArticleId IdType="pubmed">27720001</ArticleId></ArticleIdList></Reference><Reference><Citation>
<i>Multiple Sclerosis&#x2014;Symptoms and Causes</i>. Mayo Clinic. Accessed March 7, 2023. https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/symptoms-causes/syc-20350269</Citation></Reference><Reference><Citation>Klineova S, Lublin FD. &#xa0;Clinical course of multiple sclerosis. Cold Spring Harb Perspect Med. 2018;8(9):a028928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6120692</ArticleId><ArticleId IdType="pubmed">29358317</ArticleId></ArticleIdList></Reference><Reference><Citation>Doshi A, Chataway J. &#xa0;Multiple sclerosis, a treatable disease. Clin Med. 2016;16(Suppl 6):s53-s59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6329568</ArticleId><ArticleId IdType="pubmed">27956442</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Multiple Sclerosis Society. Medications. Accessed March 24, 2023. https://www.nationalmssociety.org/Treating-MS/Medications</Citation></Reference><Reference><Citation>Ziemssen T, Derfuss T, de Stefano N, et al. &#xa0;Optimizing treatment success in multiple sclerosis. J Neurol. 2016;263(6):1053-1065.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4893374</ArticleId><ArticleId IdType="pubmed">26705122</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldito NG, Shirani A, Salter A, Stuve O. &#xa0;Adverse event profile differences between rituximab and ocrelizumab: findings from the FDA Adverse Event Reporting Database. Mult Scler. &#xa0;2021;27:1066-1076.</Citation><ArticleIdList><ArticleId IdType="pubmed">32820687</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammer H, Kamber N, Pistor M, et al. &#xa0;Ocrelizumab-related neutropenia: effects of age, sex and bodyweight using the FDA Adverse Event Reporting System (FAERS). Mult Scler Relat Disord. 2022;65:104015.</Citation><ArticleIdList><ArticleId IdType="pubmed">35810719</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonsen CS, Flemmen H, Broch L, et al. &#xa0;Early high efficacy treatment in multiple sclerosis is the best predictor of future disease activity over 1 and 2 years in a Norwegian population-based registry. Front Neurol. 2021;12:693017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8248666</ArticleId><ArticleId IdType="pubmed">34220694</ArticleId></ArticleIdList></Reference><Reference><Citation>He A, Merkel B, Brown JWL, et al. &#xa0;Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study. Lancet Neurol. 2020;19(4):307-316.</Citation><ArticleIdList><ArticleId IdType="pubmed">32199096</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson R, Craner M, Waddingham E, et al. &#xa0;OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis. BMJ Open. 2021;11(11):e050176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8627413</ArticleId><ArticleId IdType="pubmed">34824113</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A. The newly available FAERS public dashboard: implications for health care professionals. <i>Hosp Pharm</i>. 2019;54(2):75-77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6431724</ArticleId><ArticleId IdType="pubmed">30923396</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang A. &#xa0;Real-world evidence: a primer. Pharm Med. 2023;37(1):25-36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9815890</ArticleId><ArticleId IdType="pubmed">36604368</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeng D, Boscarino J, Stewart W, Yan X, Steigerwalt N. &#xa0;PS1-11: a comparison of electronic medical records vs claims data for rheumatoid arthritis patients in a large healthcare system: an exploratory analysis. Clin Med Res. 2014;12(1-2):108.</Citation></Reference><Reference><Citation>Deimazar G, Sheikhtaheri A. &#xa0;Machine learning models to detect and predict patient safety events using electronic health records: a systematic review. Int J Med Inform. 2023;180:105246.</Citation><ArticleIdList><ArticleId IdType="pubmed">37837710</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasrebi-de Kom IAR, Dongelmans DA, de Keizer NF, et al. &#xa0;Electronic health record-based prediction models for in-hospital adverse drug event diagnosis or prognosis: a systematic review. J Am Med Inform Assoc. 2023;30(5):978-988.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10114128</ArticleId><ArticleId IdType="pubmed">36805926</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagattini F, Karlsson I, Rebane J, Papapetrou P. &#xa0;A classification framework for exploiting sparse multi-variate temporal features with application to adverse drug event detection in medical records. BMC Med Inform Decis Making. 2019;19(1):7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6327495</ArticleId><ArticleId IdType="pubmed">30630486</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinze G, Wallisch C, Dunkler D. &#xa0;Variable selection&#x2014;a review and recommendations for the practicing statistician. Biom J. 2018;60(3):431-449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5969114</ArticleId><ArticleId IdType="pubmed">29292533</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang C, Jiang X, Kalluri KS, et al. Nov. 2021. CEHR-BERT: incorporating temporal information from structured EHR data to improve prediction tasks, arXiv, arXiv:2111.08585 [cs], preprint: not peer reviewed.</Citation></Reference><Reference><Citation>Monnin P, R&#xe4;&#x131;ssi C, Napoli A, Coulet A. Oct. 2021. Discovering alignment relations with graph convolutional networks: a biomedical case study, arXiv, arXiv:2011.06023 [cs], preprint: not peer reviewed.</Citation></Reference><Reference><Citation>Tanaka Y, Chen HY, Belloni P, et al. OnSIDES (ON-label SIDE effectS resource) database: extracting adverse drug events from drug labels using natural language processing models, medRxiv 2024.03.22.24304724. 10.1101/2024.03.22.24304724, 2024, preprint: not peer reviewed.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.03.22.24304724</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursu O, Holmes J, Knockel J, et al. DrugCentral: online drug compendium. <i>Nucleic Acids Res.</i> 2017;45(D1):D932-D939.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5210665</ArticleId><ArticleId IdType="pubmed">27789690</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XA, Yates A, Vasilevsky N, et al. &#xa0;Semantic integration of clinical laboratory tests from electronic health records for deep phenotyping and biomarker discovery. NPJ Digital Med. &#xa0;2019;2:32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6527418</ArticleId><ArticleId IdType="pubmed">31119199</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, et al. &#xa0;Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22(3):553-564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlichtkrull M, Kipf TN, Bloem P, Titov I, van den Berg R, Welling M. Oct. 2017. Modeling relational data with graph convolutional networks, arXiv, arXiv:1703.06103 [cs, stat], preprint: not peer reviewed.</Citation></Reference><Reference><Citation>Zhang Z, Cai J, Zhang Y, Wang J. Apr. 2022. Learning hierarchy-aware knowledge graph embeddings for link prediction, arXiv, arXiv:1911.09419 [cs, stat], preprint: not peer reviewed.</Citation></Reference><Reference><Citation>Pedregosa F, Varoquaux G, Gramfort A, et al. &#xa0;Scikit-learn: machine learning in Python. J Mach Learn Res. 2011;12:2825-2830.</Citation></Reference><Reference><Citation>Fard MM, Mangylov O, Bakst W, et al. TensorFlow lattice, Version 2.0.6 [Software]. 2020. https://github.com/tensorflow/lattice</Citation></Reference><Reference><Citation>Ribeiro MT, Singh S, Guestrin C. Aug. 2016. &#x201c;Why should I trust you?&#x201d;: explaining the predictions of any classifier, arXiv, arXiv:1602.04938 [cs, stat], preprint: not peer reviewed.</Citation></Reference><Reference><Citation>Sun Z, Deng Z-H, Nie J-Y, Tang J. Feb. 2019. Rotate: knowledge graph embedding by relational rotation in complex space. arXiv, arXiv:1902.10197, preprint: not peer reviewed.</Citation></Reference><Reference><Citation>Shepshelovich D, Edel Y, Goldvaser H, Dujovny T, Wolach O, Raanani P. &#xa0;Pharmacodynamics of cytarabine induced leucopenia: a retrospective cohort study. Br J Clin Pharmacol. 2015;79(4):685-691.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4386953</ArticleId><ArticleId IdType="pubmed">25303309</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayo Clinic. Busulfan (intravenous route) precautions&#x2014;Mayo Clinic. Accessed February 2, 2023. https://www.mayoclinic.org/drugs-supplements/busulfan-intravenous-route/precautions/drg-20067303</Citation></Reference><Reference><Citation>Suga J, Saijo N, Shinkai T, et al. &#xa0;Phase II study of mitoxantrone in patients with non-small cell lung cancer. Jpn J Clin Oncol. June 1986;16(2):147-151.</Citation><ArticleIdList><ArticleId IdType="pubmed">3735704</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith A, Couvillion R, Zhang R, et al. &#xa0;Incidence and management of leukopenia/neutropenia in 233 kidney transplant patients following single dose alemtuzumab induction. Transpl Proc. 2014;46(10):3400-3404.</Citation><ArticleIdList><ArticleId IdType="pubmed">25498059</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudick RA, Panzara MA. &#xa0;Natalizumab for the treatment of relapsing multiple sclerosis. Biologics . 2008;2(2):189-199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2721353</ArticleId><ArticleId IdType="pubmed">19707353</ArticleId></ArticleIdList></Reference><Reference><Citation>Salihu SA, Ghafari H, Ahmadimanesh M, Gortany NK, Shafaroodi H, Ghazi-Khansari M. &#xa0;Glatiramer acetate attenuates depressive/anxiety-like behaviors and cognitive deficits induced by post-weaning social isolation in male mice. Psychopharmacology (Berl). 2021;238(8):2121-2132.</Citation><ArticleIdList><ArticleId IdType="pubmed">33797571</ArticleId></ArticleIdList></Reference><Reference><Citation>Uca AU, Odaba&#x15f; F&#xd6;, Alta&#x15f; M, Uguz F, Tokg&#xf6;z OS. Depression and anxiety in patients with multiple sclerosis: a retrospective study on the impact of glatiramer acetate. <i>IAMR</i>. 2021;13(1):1-10.</Citation></Reference><Reference><Citation>Clerico M, Artusi CA, Liberto AD, et al. &#xa0;Natalizumab in multiple sclerosis: long-term management. Int J Mol Sci. 2017;18(5):E940.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5454853</ArticleId><ArticleId IdType="pubmed">28468254</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38968598</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1438-8871</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><PubDate><Year>2024</Year><Month>Jul</Month><Day>05</Day></PubDate></JournalIssue><Title>Journal of medical Internet research</Title><ISOAbbreviation>J Med Internet Res</ISOAbbreviation></Journal><ArticleTitle>Electronic Health Record-Oriented Knowledge Graph System for Collaborative Clinical Decision Support Using Multicenter Fragmented Medical Data: Design and Application Study.</ArticleTitle><Pagination><StartPage>e54263</StartPage><MedlinePgn>e54263</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e54263</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/54263</ELocationID><Abstract><AbstractText Label="BACKGROUND">The medical knowledge graph provides explainable decision support, helping clinicians with prompt diagnosis and treatment suggestions. However, in real-world clinical practice, patients visit different hospitals seeking various medical services, resulting in fragmented patient data across hospitals. With data security issues, data fragmentation limits the application of knowledge graphs because single-hospital data cannot provide complete evidence for generating precise decision support and comprehensive explanations. It is important to study new methods for knowledge graph systems to integrate into multicenter, information-sensitive medical environments, using fragmented patient records for decision support while maintaining data privacy and security.</AbstractText><AbstractText Label="OBJECTIVE">This study aims to propose an electronic health record (EHR)-oriented knowledge graph system for collaborative reasoning with multicenter fragmented patient medical data, all the while preserving data privacy.</AbstractText><AbstractText Label="METHODS">The study introduced an EHR knowledge graph framework and a novel collaborative reasoning process for utilizing multicenter fragmented information. The system was deployed in each hospital and used a unified semantic structure and Observational Medical Outcomes Partnership (OMOP) vocabulary to standardize the local EHR data set. The system transforms local EHR data into semantic formats and performs semantic reasoning to generate intermediate reasoning findings. The generated intermediate findings used hypernym concepts to isolate original medical data. The intermediate findings and hash-encrypted patient identities were synchronized through a blockchain network. The multicenter intermediate findings were collaborated for final reasoning and clinical decision support without gathering original EHR data.</AbstractText><AbstractText Label="RESULTS">The system underwent evaluation through an application study involving the utilization of multicenter fragmented EHR data to alert non-nephrology clinicians about overlooked patients with chronic kidney disease (CKD). The study covered 1185 patients in nonnephrology departments from 3 hospitals. The patients visited at least two of the hospitals. Of these, 124 patients were identified as meeting CKD diagnosis criteria through collaborative reasoning using multicenter EHR data, whereas the data from individual hospitals alone could not facilitate the identification of CKD in these patients. The assessment by clinicians indicated that 78/91 (86%) patients were CKD positive.</AbstractText><AbstractText Label="CONCLUSIONS">The proposed system was able to effectively utilize multicenter fragmented EHR data for clinical application. The application study showed the clinical benefits of the system with prompt and comprehensive decision support.</AbstractText><CopyrightInformation>&#xa9;Yong Shang, Yu Tian, Kewei Lyu, Tianshu Zhou, Ping Zhang, Jianghua Chen, Jingsong Li. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 05.07.2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Shang</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-8648-790X</Identifier><AffiliationInfo><Affiliation>Research Center for Data Hub and Security, Zhejiang Laboratory, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tian</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-6791-8217</Identifier><AffiliationInfo><Affiliation>Engineering Research Center of EMR and Intelligent Expert System, Ministry of Education, College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Biomedical Engineering of Ministry of Education, College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lyu</LastName><ForeName>Kewei</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8013-8146</Identifier><AffiliationInfo><Affiliation>Engineering Research Center of EMR and Intelligent Expert System, Ministry of Education, College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Biomedical Engineering of Ministry of Education, College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Tianshu</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-5858-6353</Identifier><AffiliationInfo><Affiliation>Research Center for Data Hub and Security, Zhejiang Laboratory, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ping</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9538-8743</Identifier><AffiliationInfo><Affiliation>Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jianghua</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3282-3998</Identifier><AffiliationInfo><Affiliation>Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jingsong</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1064-637X</Identifier><AffiliationInfo><Affiliation>Research Center for Data Hub and Security, Zhejiang Laboratory, Hangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Med Internet Res</MedlineTA><NlmUniqueID>100959882</NlmUniqueID><ISSNLinking>1438-8871</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="Y">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CKD</Keyword><Keyword MajorTopicYN="N">EHR</Keyword><Keyword MajorTopicYN="N">blockchain</Keyword><Keyword MajorTopicYN="N">collaboration</Keyword><Keyword MajorTopicYN="N">collaborative</Keyword><Keyword MajorTopicYN="N">data fragmentation</Keyword><Keyword MajorTopicYN="N">data privacy</Keyword><Keyword MajorTopicYN="N">data science</Keyword><Keyword MajorTopicYN="N">decision support</Keyword><Keyword MajorTopicYN="N">electronic health record</Keyword><Keyword MajorTopicYN="N">encrypt</Keyword><Keyword MajorTopicYN="N">encrypted</Keyword><Keyword MajorTopicYN="N">encryption</Keyword><Keyword MajorTopicYN="N">health record</Keyword><Keyword MajorTopicYN="N">hypernym</Keyword><Keyword MajorTopicYN="N">kidney</Keyword><Keyword MajorTopicYN="N">knowledge graph</Keyword><Keyword MajorTopicYN="N">knowledge graphs</Keyword><Keyword MajorTopicYN="N">nephrology</Keyword><Keyword MajorTopicYN="N">ontologies</Keyword><Keyword MajorTopicYN="N">ontology</Keyword><Keyword MajorTopicYN="N">privacy</Keyword><Keyword MajorTopicYN="N">security</Keyword><Keyword MajorTopicYN="N">semantic</Keyword><Keyword MajorTopicYN="N">visualization</Keyword><Keyword MajorTopicYN="N">vocabulary</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>5</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>5</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>5</Day><Hour>16</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38968598</ArticleId><ArticleId IdType="pmc">PMC11259764</ArticleId><ArticleId IdType="doi">10.2196/54263</ArticleId><ArticleId IdType="pii">v26i1e54263</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kern LM, Grinspan Z, Shapiro JS, Kaushal R. Patients' use of multiple hospitals in a major US city: implications for population management. Popul Health Manag. 2017 Apr;20(2):99&#x2013;102. doi: 10.1089/pop.2016.0021. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/pop.2016.0021</ArticleId><ArticleId IdType="pmc">PMC5749602</ArticleId><ArticleId IdType="pubmed">27268133</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgeois FC, Olson KL, Mandl KD. Patients treated at multiple acute health care facilities: quantifying information fragmentation. Arch Intern Med. 2010 Dec 13;170(22):1989&#x2013;95. doi: 10.1001/archinternmed.2010.439.170/22/1989</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2010.439</ArticleId><ArticleId IdType="pubmed">21149756</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnell JT, Overhage JM, Grannis S. All health care is not local: an evaluation of the distribution of emergency department care delivered in Indiana. AMIA Annu Symp Proc. 2011;2011:409&#x2013;16. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243262</ArticleId><ArticleId IdType="pubmed">22195094</ArticleId></ArticleIdList></Reference><Reference><Citation>Kho A, Yu J, Bryan M, Gladfelter C, Gordon H, Grannis S. Privacy-preserving record linkage to identify fragmented electronic medical records in the all of us research program. In: Cellier P, Driessens K, editors. Machine Learning and Knowledge Discovery in Databases. ECML PKDD 2019. Communications in Computer and Information Science (vol 1168) Cham, Switzerland: Springer; 2020. Mar 28, pp. 77&#x2013;87.</Citation></Reference><Reference><Citation>Cwinn MA, Forster AJ, Cwinn AA, Hebert G, Calder L, Stiell IG. Prevalence of information gaps for seniors transferred from nursing homes to the emergency department. CJEM. 2009 Sep;11(5):462&#x2013;71. doi: 10.1017/s1481803500011660.1584</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1481803500011660</ArticleId><ArticleId IdType="pubmed">19788791</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansler JP, Havn EC, Schmidt K. Infrastructure for Healthcare: Global Heathcare: Proceedings of the 3rd International Workshop 2011. Copenhagen, Denmark: IT-Universitetet i K&#xf8;benhavn; 2011. A study of the fragmentation of the medical record; pp. 94&#x2013;97.</Citation></Reference><Reference><Citation>Kish LJ, Topol EJ. Unpatients-why patients should own their medical data. Nat Biotechnol. 2015 Sep;33(9):921&#x2013;4. doi: 10.1038/nbt.3340.nbt.3340</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3340</ArticleId><ArticleId IdType="pubmed">26348958</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Talaei-Khoei A, Zowghi D, Daniel J. Data completeness in healthcare: a literature survey. PAJAIS. 2017;9(2):75&#x2013;100. doi: 10.17705/1pais.09204. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.17705/1pais.09204</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith PC, Araya-Guerra R, Bublitz C, Parnes B, Dickinson LM, Van Vorst Rebecca, Westfall JM, Pace WD. Missing clinical information during primary care visits. JAMA. 2005 Feb 02;293(5):565&#x2013;71. doi: 10.1001/jama.293.5.565.293/5/565</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.293.5.565</ArticleId><ArticleId IdType="pubmed">15687311</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson Price II W. Riskresilience in health data infrastructure. SSRN. 2017.  [2024-05-04].  
 https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2928997
.</Citation></Reference><Reference><Citation>Chen X, Jia S, Xiang Y. A review: knowledge reasoning over knowledge graph. Expert Systems with Applications. 2020 Mar;141:112948. doi: 10.1016/j.eswa.2019.112948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eswa.2019.112948</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Wang P, Yan J, Wang Y, Li S, Jiang J, Sun Z, Tang B, Chang T, Wang S, Liu Y. Real-world data medical knowledge graph: construction and applications. Artif Intell Med. 2020 Mar;103:101817. doi: 10.1016/j.artmed.2020.101817.S0933-3657(19)30954-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artmed.2020.101817</ArticleId><ArticleId IdType="pubmed">32143785</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong C, Rush E, Liu M, Zhou D, Sun J, Sonabend A, Castro VM, Schubert P, Panickan VA, Cai T, Costa L, He Z, Link N, Hauser R, Gaziano JM, Murphy SN, Ostrouchov G, Ho Y, Begoli E, Lu J, Cho K, Liao KP, Cai T, VA Million Veteran Program Clinical knowledge extraction via sparse embedding regression (KESER) with multi-center large scale electronic health record data. NPJ Digit Med. 2021 Oct 27;4(1):151. doi: 10.1038/s41746-021-00519-z. doi: 10.1038/s41746-021-00519-z.10.1038/s41746-021-00519-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-021-00519-z</ArticleId><ArticleId IdType="doi">10.1038/s41746-021-00519-z</ArticleId><ArticleId IdType="pmc">PMC8551205</ArticleId><ArticleId IdType="pubmed">34707226</ArticleId></ArticleIdList></Reference><Reference><Citation>Thukral A, Dhiman S, Meher R, Bedi P. Knowledge graph enrichment from clinical narratives using NLP, NER, and biomedical ontologies for healthcare applications. Int J Inf Technol. 2023 Jan 03;15(1):53&#x2013;65. doi: 10.1007/s41870-022-01145-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41870-022-01145-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao G, Pfaff E, Prud'hommeaux E, Booth D, Sharma DK, Huo N, Yu Y, Zong N, Ruddy KJ, Chute CG, Jiang G. FHIR-Ontop-OMOP: building clinical knowledge graphs in FHIR RDF with the OMOP common data model. J Biomed Inform. 2022 Oct;134:104201. doi: 10.1016/j.jbi.2022.104201. 
 
S1532-0464(22)00206-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2022.104201</ArticleId><ArticleId IdType="pmc">PMC9561043</ArticleId><ArticleId IdType="pubmed">36089199</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho RMS, Oliveira D, Pesquita C. Knowledge graph embeddings for ICU readmission prediction. BMC Med Inform Decis Mak. 2023 Jan 19;23(1):12. doi: 10.1186/s12911-022-02070-7. 
 
10.1186/s12911-022-02070-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-022-02070-7</ArticleId><ArticleId IdType="doi">10.1186/s12911-022-02070-7</ArticleId><ArticleId IdType="pmc">PMC9850812</ArticleId><ArticleId IdType="pubmed">36658526</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Li X, Peng H, He L, Philip S. Heterogeneous similarity graph neural network on electronic health records. 2020 IEEE International Conference on Big Data (Big Data); December 10-13, 2020; Atlanta, GA. New York, NY: IEEE; 2020. pp. 1196&#x2013;1205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/BigData50022.2020.9377795</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang Y, Tian Y, Zhou M, Zhou T, Lyu K, Wang Z, Xin R, Liang T, Zhu S, Li J. EHR-oriented knowledge graph system: toward efficient utilization of non-used information buried in routine clinical practice. IEEE J Biomed Health Inform. 2021 Jul;25(7):2463&#x2013;2475. doi: 10.1109/JBHI.2021.3085003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/JBHI.2021.3085003</ArticleId><ArticleId IdType="pubmed">34057901</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Leibson CL, Ransom JE, Kho AN, Caraballo PJ, Chai HS, Yawn BP, Pacheco JA, Chute CG. Impact of data fragmentation across healthcare centers on the accuracy of a high-throughput clinical phenotyping algorithm for specifying subjects with type 2 diabetes mellitus. J Am Med Inform Assoc. 2012;19(2):219&#x2013;24. doi: 10.1136/amiajnl-2011-000597. 
 
amiajnl-2011-000597</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000597</ArticleId><ArticleId IdType="pmc">PMC3277630</ArticleId><ArticleId IdType="pubmed">22249968</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal R, Prabakaran S. Big data in digital healthcare: lessons learnt and recommendations for general practice. Heredity (Edinb) 2020 Apr;124(4):525&#x2013;534. doi: 10.1038/s41437-020-0303-2. 
 
10.1038/s41437-020-0303-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41437-020-0303-2</ArticleId><ArticleId IdType="pmc">PMC7080757</ArticleId><ArticleId IdType="pubmed">32139886</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Jia Y, Li A, Jiang R, Song Y. Multi-source knowledge fusion: a survey. World Wide Web. 2020 Apr 08;23(4):2567&#x2013;2592. doi: 10.1007/s11280-020-00811-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11280-020-00811-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L, Kou Z, Zhang Y, Chen J, Wang D. A privacy-aware distributed knowledge graph approach to QoIS-driven COVID-19 misinformation detection. 2022 IEEE/ACM 30th International Symposium on Quality of Service (IWQoS); June 10-12, 2022; Oslo, Norway. New York, NY: IEEE; 2022. pp. 1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/iwqos54832.2022.9812879</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Yuan N, Lian D, Xie X. Collaborative knowledge base embedding for recommender systems. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining; The 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining; Augest 13-17, 2016; San Francisco, CA. New York, NY: Association for Computing Machinery; 2016. Aug 13, pp. 353&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2939672.2939673</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Beltr&#xe1;n Alejandra, Tagger B, Finkelstein A. Federated ontology-based queries over cancer data. BMC Bioinformatics. 2012 Jan 25;13 Suppl 1(Suppl 1):S9. doi: 10.1186/1471-2105-13-S1-S9. 
 
1471-2105-13-S1-S9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-13-S1-S9</ArticleId><ArticleId IdType="doi">10.1186/1471-2105-13-S1-S9</ArticleId><ArticleId IdType="pmc">PMC3471355</ArticleId><ArticleId IdType="pubmed">22373043</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Zhang W, Yuan Z, Jia Y, Chen H. Fede: embedding knowledge graphs in federated setting. The 10th International Joint Conference on Knowledge Graphs; December 6-8, 2021; Virtual Event, Thailand. 2022. Jan 24, pp. 80&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/3502223.3502233</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng H, Li H, Song Y, Zheng V, Li J. Differentially private federated knowledge graphs embedding. CIKM '21: Proceedings of the 30th ACM International Conference on Information &amp; Knowledge Management; CIKM '21: The 30th ACM International Conference on Information and Knowledge Management; November 1-5, 2021; Virtual Event, Queensland, Australia. New York, NY: Association for Computing Machinery; 2021. Oct 30, pp. 1416&#x2013;1425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/3459637.3482252</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheller MJ, Edwards B, Reina GA, Martin J, Pati S, Kotrotsou A, Milchenko M, Xu W, Marcus D, Colen RR, Bakas S. Federated learning in medicine: facilitating multi-institutional collaborations without sharing patient data. Sci Rep. 2020 Jul 28;10(1):12598. doi: 10.1038/s41598-020-69250-1. doi: 10.1038/s41598-020-69250-1.10.1038/s41598-020-69250-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-69250-1</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-69250-1</ArticleId><ArticleId IdType="pmc">PMC7387485</ArticleId><ArticleId IdType="pubmed">32724046</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR, van der Lei Johan, Pratt N, Nor&#xe9;n G Niklas, Li Y, Stang PE, Madigan D, Ryan PB. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Axfors C, Schmitt AM, Janiaud P, Van't Hooft J, Abd-Elsalam S, Abdo EF, Abella BS, Akram J, Amaravadi RK, Angus DC, Arabi YM, Azhar S, Baden LR, Baker AW, Belkhir L, Benfield T, Berrevoets MAH, Chen C, Chen T, Cheng S, Cheng C, Chung W, Cohen YZ, Cowan LN, Dalgard O, de Almeida E Val FF, de Lacerda MVG, de Melo GC, Derde L, Dubee V, Elfakir A, Gordon AC, Hernandez-Cardenas CM, Hills T, Hoepelman AIM, Huang Y, Igau B, Jin R, Jurado-Camacho F, Khan KS, Kremsner PG, Kreuels B, Kuo C, Le T, Lin Y, Lin W, Lin T, Lyngbakken MN, McArthur C, McVerry BJ, Meza-Meneses P, Monteiro WM, Morpeth SC, Mourad A, Mulligan MJ, Murthy S, Naggie S, Narayanasamy S, Nichol A, Novack LA, O'Brien SM, Okeke NL, Perez L, Perez-Padilla R, Perrin L, Remigio-Luna A, Rivera-Martinez NE, Rockhold FW, Rodriguez-Llamazares S, Rolfe R, Rosa R, R&#xf8;sj&#xf8; Helge, Sampaio VS, Seto TB, Shahzad M, Soliman S, Stout JE, Thirion-Romero I, Troxel AB, Tseng T, Turner NA, Ulrich RJ, Walsh SR, Webb SA, Weehuizen JM, Velinova M, Wong H, Wrenn R, Zampieri FG, Zhong W, Moher D, Goodman SN, Ioannidis JPA, Hemkens LG. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nat Commun. 2021 Apr 15;12(1):2349. doi: 10.1038/s41467-021-22446-z. doi: 10.1038/s41467-021-22446-z.10.1038/s41467-021-22446-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22446-z</ArticleId><ArticleId IdType="doi">10.1038/s41467-021-22446-z</ArticleId><ArticleId IdType="pmc">PMC8050319</ArticleId><ArticleId IdType="pubmed">33859192</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuffield Department of Population Health Renal Studies Group. SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials. Lancet. 2022 Nov 19;400(10365):1788&#x2013;1801. doi: 10.1016/S0140-6736(22)02074-8.S0140-6736(22)02074-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)02074-8</ArticleId><ArticleId IdType="pmc">PMC7613836</ArticleId><ArticleId IdType="pubmed">36351458</ArticleId></ArticleIdList></Reference><Reference><Citation>Noman AA, Rahaman M, Pranto TH, Rahman RM. Blockchain for medical collaboration: a federated learning-based approach for multi-class respiratory disease classification. Healthcare Analytics. 2023 Nov;3:100135. doi: 10.1016/j.health.2023.100135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.health.2023.100135</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Shang Y, Tong D, Chi S, Li J, Kong X, Ding K, Li J. POPCORN: A web service for individual PrognOsis prediction based on multi-center clinical data CollabORatioN without patient-level data sharing. J Biomed Inform. 2018 Oct;86:1&#x2013;14. doi: 10.1016/j.jbi.2018.08.008. 
 
S1532-0464(18)30163-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2018.08.008</ArticleId><ArticleId IdType="pubmed">30103028</ArticleId></ArticleIdList></Reference><Reference><Citation>The Book of OHDSI. OHDSI.  [2022-12-15].  
 https://ohdsi.github.io/TheBookOfOhdsi/
</Citation></Reference><Reference><Citation>Chen Y, Ding S, Xu Z, Zheng H, Yang S. Blockchain-based medical records secure storage and medical service framework. J Med Syst. 2018 Nov 22;43(1):5. doi: 10.1007/s10916-018-1121-4.10.1007/s10916-018-1121-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10916-018-1121-4</ArticleId><ArticleId IdType="pubmed">30467604</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Zhang J, Wang H, Liu P, Liu S, Huo T, Duan Y, Dong Z, Lu L, Ye Z. Applications of blockchain in the medical field: narrative review. J Med Internet Res. 2021 Oct 28;23(10):e28613. doi: 10.2196/28613. 
 
v23i10e28613</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/28613</ArticleId><ArticleId IdType="pmc">PMC8555946</ArticleId><ArticleId IdType="pubmed">34533470</ArticleId></ArticleIdList></Reference><Reference><Citation>Golang. Go.  [2024-05-04].  
 https://go.dev/
</Citation></Reference><Reference><Citation>libp2p: a modular, P2P, networking library. libp2p.  [2024-05-04].  
 https://libp2p.io/
</Citation></Reference><Reference><Citation>Yao A. How to generate and exchange secrets. 27th Annual Symposium on Foundations of Computer Science (sfcs 1986); October 27-29, 1986; Toronto, ON, Canada. New York, NY: IEEE; 1986. pp. 162&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/sfcs.1986.25</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017 Mar 25;389(10075):1238&#x2013;1252. doi: 10.1016/S0140-6736(16)32064-5.S0140-6736(16)32064-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)32064-5</ArticleId><ArticleId IdType="pubmed">27887750</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, Chen N, Zhang J, Hu Z, Liu F, Hong D, Ma L, Liu H, Zhou X, Chen J, Pan L, Chen W, Wang W, Li X, Wang H. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012 Mar 03;379(9818):815&#x2013;22. doi: 10.1016/S0140-6736(12)60033-6.S0140-6736(12)60033-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)60033-6</ArticleId><ArticleId IdType="pubmed">22386035</ArticleId></ArticleIdList></Reference><Reference><Citation>Israni RK, Shea JA, Joffe MM, Feldman HI. Physician characteristics and knowledge of CKD management. Am J Kidney Dis. 2009 Aug;54(2):238&#x2013;47. doi: 10.1053/j.ajkd.2009.01.258.S0272-6386(09)00428-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2009.01.258</ArticleId><ArticleId IdType="pubmed">19359079</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox CH, Brooks A, Zayas LE, McClellan W, Murray B. Primary care physicians' knowledge and practice patterns in the treatment of chronic kidney disease: an Upstate New York Practice-based Research Network (UNYNET) study. J Am Board Fam Med. 2006;19(1):54&#x2013;61. doi: 10.3122/jabfm.19.1.54. 
 
19/1/54</Citation><ArticleIdList><ArticleId IdType="doi">10.3122/jabfm.19.1.54</ArticleId><ArticleId IdType="pubmed">16492006</ArticleId></ArticleIdList></Reference><Reference><Citation>Drawz PE, Archdeacon P, McDonald CJ, Powe NR, Smith KA, Norton J, Williams DE, Patel UD, Narva A. CKD as a model for improving chronic disease care through electronic health records. Clin J Am Soc Nephrol. 2015 Aug 07;10(8):1488&#x2013;99. doi: 10.2215/CJN.00940115. 
 
CJN.00940115</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.00940115</ArticleId><ArticleId IdType="pmc">PMC4527017</ArticleId><ArticleId IdType="pubmed">26111857</ArticleId></ArticleIdList></Reference><Reference><Citation>NA  Erratum: Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). . 2017;7:1-59. Kidney Int Suppl (2011) 2017 Dec;7(3):1&#x2013;150. doi: 10.1016/j.kisu.2017.10.001. 
 
S2157-1716(17)30058-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kisu.2017.10.001</ArticleId><ArticleId IdType="pmc">PMC6340919</ArticleId><ArticleId IdType="pubmed">30675420</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Lameire N, KDIGO AKI Guideline Work Group  Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1) Crit Care. 2013 Feb 04;17(1):204. doi: 10.1186/cc11454. 
 
cc11454</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11454</ArticleId><ArticleId IdType="doi">10.1186/cc11454</ArticleId><ArticleId IdType="pmc">PMC4057151</ArticleId><ArticleId IdType="pubmed">23394211</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassalotti JA, Centor R, Turner BJ, Greer RC, Choi M, Sequist TD, National Kidney Foundation Kidney Disease Outcomes Quality Initiative  Practical approach to detection and management of chronic kidney disease for the primary care clinician. Am J Med. 2016 Feb;129(2):153&#x2013;162.e7. doi: 10.1016/j.amjmed.2015.08.025. 
 
S0002-9343(15)00855-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2015.08.025</ArticleId><ArticleId IdType="pubmed">26391748</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson DW, Atai E, Chan M, Phoon RK, Scott C, Toussaint ND, Turner GL, Usherwood T, Wiggins KJ, KHA-CARI KHA-CARI guideline: early chronic kidney disease: detection, prevention and management. Nephrology (Carlton) 2013 May;18(5):340&#x2013;50. doi: 10.1111/nep.12052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.12052</ArticleId><ArticleId IdType="pubmed">23506545</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh WR, Totten AM, Eden KB, Devine B, Gorman P, Kassakian SZ, Woods SS, Daeges M, Pappas M, McDonagh MS. Outcomes from health information exchange: systematic review and future research needs. JMIR Med Inform. 2015 Dec 15;3(4):e39. doi: 10.2196/medinform.5215. 
 
v3i4e39</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/medinform.5215</ArticleId><ArticleId IdType="pmc">PMC4704923</ArticleId><ArticleId IdType="pubmed">26678413</ArticleId></ArticleIdList></Reference><Reference><Citation>Westphal E, Seitz H. Digital and decentralized management of patient data in healthcare using blockchain implementations. Front Blockchain. 2021 Aug 26;4:732112. doi: 10.3389/fbloc.2021.732112.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbloc.2021.732112</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu H, Qiu M, Liu M, Memmi G. Secure health data sharing for medical cyber-physical systems for the healthcare 4.0. IEEE J Biomed Health Inform. 2020 Sep;24(9):2499&#x2013;2505. doi: 10.1109/JBHI.2020.2973467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/JBHI.2020.2973467</ArticleId><ArticleId IdType="pubmed">32071015</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelladurai U, Pandian S. A novel blockchain based electronic health record automation system for healthcare. J Ambient Intell Human Comput. 2021 Mar 23;13(1):693&#x2013;703. doi: 10.1007/s12652-021-03163-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12652-021-03163-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo K, Chen T, Ren S, Li N, Hu M, Kang J. Federated learning empowered real-time medical data processing method for smart healthcare. IEEE/ACM Trans Comput Biol Bioinform. 2022 Jun 23;:e1. doi: 10.1109/TCBB.2022.3185395. (forthcoming)</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TCBB.2022.3185395</ArticleId><ArticleId IdType="pubmed">35737631</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38985896</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1536-0210</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Investigative radiology</Title><ISOAbbreviation>Invest Radiol</ISOAbbreviation></Journal><ArticleTitle>Advancing Medical Imaging Research Through Standardization: The Path to Rapid Development, Rigorous Validation, and Robust Reproducibility.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>10</EndPage><MedlinePgn>1-10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/RLI.0000000000001106</ELocationID><Abstract><AbstractText>Artificial intelligence (AI) has made significant advances in radiology. Nonetheless, challenges in AI development, validation, and reproducibility persist, primarily due to the lack of high-quality, large-scale, standardized data across the world. Addressing these challenges requires comprehensive standardization of medical imaging data and seamless integration with structured medical data.Developed by the Observational Health Data Sciences and Informatics community, the OMOP Common Data Model enables large-scale international collaborations with structured medical data. It ensures syntactic and semantic interoperability, while supporting the privacy-protected distribution of research across borders. The recently proposed Medical Imaging Common Data Model is designed to encompass all DICOM-formatted medical imaging data and integrate imaging-derived features with clinical data, ensuring their provenance.The harmonization of medical imaging data and its seamless integration with structured clinical data at a global scale will pave the way for advanced AI research in radiology. This standardization will enable federated learning, ensuring privacy-preserving collaboration across institutions and promoting equitable AI through the inclusion of diverse patient populations. Moreover, it will facilitate the development of foundation models trained on large-scale, multimodal datasets, serving as powerful starting points for specialized AI applications. Objective and transparent algorithm validation on a standardized data infrastructure will enhance reproducibility and interoperability of AI systems, driving innovation and reliability in clinical applications.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Kyulee</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Department of Biomedical Systems Informatics, Yonsei University, Seoul, South Korea (K.J., S.C.Y.); Institution for Innovation in Digital Healthcare, Yonsei University, Seoul, South Korea (K.J., S.C.Y.); Biomedical Informatics and Data Science, Johns Hopkins University, Baltimore, MD (W.Y.P., P.N.); Department of Radiology, University of Pennsylvania, Philadelphia, PA (C.E.K.); and Department of Radiology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea (S.H.Y.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Woo Yeon</ForeName><Initials>WY</Initials></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Charles E</ForeName><Initials>CE</Initials><Suffix>Jr</Suffix></Author><Author ValidYN="Y"><LastName>Nagy</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Soon Ho</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0002-3700-0165</Identifier></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Invest Radiol</MedlineTA><NlmUniqueID>0045377</NlmUniqueID><ISSNLinking>0020-9996</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003952" MajorTopicYN="Y">Diagnostic Imaging</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011873" MajorTopicYN="N">Radiology Information Systems</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of interest and sources of funding: S.C.Y. reports being a chief technology officer of PHI Digital Healthcare. S.H.Y. has stocks and stock options outside this work. This study was supported by the NAVER Digital Bio Innovation Research Fund, funded by NAVER Corporation (grant no. 3720230020).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>10</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>10</Day><Hour>14</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38985896</ArticleId><ArticleId IdType="doi">10.1097/RLI.0000000000001106</ArticleId><ArticleId IdType="pii">00004424-990000000-00232</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>West E, Mutasa S, Zhu Z, et al. Global trend in artificial intelligence&#x2013;based publications in radiology from 2000 to 2018. AJR Am J Roentgenol . 2019;213:1204&#x2013;1206.</Citation></Reference><Reference><Citation>Kocak B, Baessler B, Cuocolo R, et al. Trends and statistics of artificial intelligence and radiomics research in radiology, nuclear medicine, and medical imaging: bibliometric analysis. Eur Radiol . 2023;33:7542&#x2013;7555.</Citation></Reference><Reference><Citation>Krizhevsky A, Sutskever I, Hinton GE. ImageNet Classification with Deep Convolutional Neural Networks. Advances in Neural Information Processing Systems, 2012 . Curran Associates, Inc.; 2012.</Citation></Reference><Reference><Citation>Esteva A, Chou K, Yeung S, et al. Deep learning&#x2013;enabled medical computer vision. NPJ Digit Med . 2021;4:5.</Citation></Reference><Reference><Citation>Ronneberger O, Fischer P, Brox T. U-Net: Convolutional Networks for Biomedical Image Segmentation. arXiv . 2015.</Citation></Reference><Reference><Citation>Redmon J, Divvala S, Girshick R, et al. You Only Look Once: Unified, Real-Time Object Detection. 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR). 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), 2016/06// . Las Vegas, NV: IEEE; 2016:779&#x2013;788.</Citation></Reference><Reference><Citation>Deng J, Dong W, Socher R, et al. ImageNet: A Large-Scale Hierarchical Image Database. 2009 IEEE Conference on Computer Vision and Pattern Recognition. 2009 IEEE Conference on Computer Vision and Pattern Recognition, 2009/06// . 2009:248&#x2013;255.</Citation></Reference><Reference><Citation>Aiello M, Esposito G, Pagliari G, et al. How does DICOM support big data management? Investigating its use in medical imaging community. Insights Imaging . 2021;12:164.</Citation></Reference><Reference><Citation>About DICOM&#x2013;Overview. DICOM .</Citation></Reference><Reference><Citation>Herrmann MD, Clunie DA, Fedorov A, et al. Implementing the DICOM standard for digital pathology. J Pathol Inform . 2018;9:37.</Citation></Reference><Reference><Citation>Hilbel T, Brown BD, de Bie J, et al. Innovation and Advantage of the DICOM ECG Standard for Viewing, Interchange and Permanent Archiving of the Diagnostic Electrocardiogram. 2007 Computers in Cardiology. 2007 Computers in Cardiology, 2007/09// . 2007:633&#x2013;636.</Citation></Reference><Reference><Citation>Maskell G. Why does demand for medical imaging keep rising? BMJ . 2022;379:o2614.</Citation></Reference><Reference><Citation>Smith-Bindman R, Kwan ML, Marlow EC, et al. Trends in use of medical imaging in US health care systems and in Ontario, Canada, 2000&#x2013;2016. JAMA . 2019;322:843&#x2013;856.</Citation></Reference><Reference><Citation>McDonald RJ, Schwartz KM, Eckel LJ, et al. The effects of changes in utilization and technological advancements of cross-sectional imaging on radiologist workload. Acad Radiol . 2015;22:1191&#x2013;1198.</Citation></Reference><Reference><Citation>Ohno Y, Ozawa Y, Nagata H, et al. Lung magnetic resonance imaging: technical advancements and clinical applications. Invest Radiol . 2024;59:38&#x2013;52.</Citation></Reference><Reference><Citation>van Leeuwen KG, Schalekamp S, Rutten MJCM, et al. Artificial intelligence in radiology: 100 commercially available products and their scientific evidence. Eur Radiol . 2021;31:3797&#x2013;3804.</Citation></Reference><Reference><Citation>Institute ACoRDS. Available at: https://aicentral.acrdsi.org/ .</Citation></Reference><Reference><Citation>Koch LM, Baumgartner CF, Berens P. Distribution shift detection for the postmarket surveillance of medical AI algorithms: a retrospective simulation study. NPJ Digit Med . 2024;7:120.</Citation></Reference><Reference><Citation>Bhowmik A, Monga N, Belen K, et al. Automated triage of screening breast MRI examinations in high-risk women using an ensemble deep learning model. Invest Radiol . 2023;58:710&#x2013;719.</Citation></Reference><Reference><Citation>Willemink MJ, Koszek WA, Hardell C, et al. Preparing medical imaging data for machine learning. Radiology . 2020;295:4&#x2013;15.</Citation></Reference><Reference><Citation>Moutakanni T, Bojanowski P, Chassagnon G, et al. Advancing human-centric AI for robust x-ray analysis through holistic self-supervised learning. arXiv . 2024.</Citation></Reference><Reference><Citation>Hoppe BF, Rueckel J, Dikhtyar Y, et al. Implementing artificial intelligence for emergency radiology impacts physicians' knowledge and perception: a prospective pre- and post-analysis. Invest Radiol . 2024;59:404&#x2013;412.</Citation></Reference><Reference><Citation>Kohli MD, Summers RM, Geis JR. Medical image data and datasets in the era of machine learning&#x2014;whitepaper from the 2016 C-MIMI meeting dataset session. J Digit Imaging . 2017;30:392&#x2013;399.</Citation></Reference><Reference><Citation>Halevy A, Norvig P, Pereira F. The unreasonable effectiveness of data. IEEE Intelligent Systems . 2009;24:8&#x2013;12.</Citation></Reference><Reference><Citation>Sun C, Shrivastava A, Singh S, et al. Revisiting unreasonable effectiveness of data in deep learning era. arXiv . 2017.</Citation></Reference><Reference><Citation>Karargyris A, Umeton R, Sheller MJ, et al. Federated benchmarking of medical artificial intelligence with MedPerf. Nat Mach Intell . 2023;5:799&#x2013;810.</Citation></Reference><Reference><Citation>Langlotz CP, Allen B, Erickson BJ, et al. A roadmap for foundational research on artificial intelligence in medical imaging: from the 2018 NIH/RSNA/ACR/The Academy Workshop. Radiology . 2019;291:781&#x2013;791.</Citation></Reference><Reference><Citation>Wennmann M, Neher P, Stanczyk N, et al. Deep learning for automatic bone marrow apparent diffusion coefficient measurements from whole-body magnetic resonance imaging in patients with multiple myeloma: a retrospective multicenter study. Invest Radiol . 2023;58:273&#x2013;282.</Citation></Reference><Reference><Citation>Haubold J, Baldini G, Parmar V, et al. BOA: a CT-based body and organ analysis for radiologists at the point of care. Invest Radiol . 2024;59:433&#x2013;441.</Citation></Reference><Reference><Citation>Lin DJ, Walter SS, Fritz J. Artificial intelligence&#x2013;driven ultra-fast superresolution MRI: 10-fold accelerated musculoskeletal turbo spin echo MRI within reach. Invest Radiol . 2023;58:28&#x2013;42.</Citation></Reference><Reference><Citation>Hagiwara A, Fujita S, Ohno Y, et al. Variability and standardization of quantitative imaging: monoparametric to multiparametric quantification, radiomics, and artificial intelligence. Invest Radiol . 2020;55:601&#x2013;616.</Citation></Reference><Reference><Citation>Basu A, Warzel D, Eftekhari A, et al. Call for data standardization: lessons learned and recommendations in an imaging study. JCO Clin Cancer Inform . 2019;3:1&#x2013;11.</Citation></Reference><Reference><Citation>Wright BD, Vo N, Nolan J, et al. An analysis of key indicators of reproducibility in radiology. Insights Imaging . 2020;11:65.</Citation></Reference><Reference><Citation>You SC, Lee S, Choi B, et al. Establishment of an international evidence sharing network through common data model for cardiovascular research. Korean Circ J . 2022;52:853&#x2013;864.</Citation></Reference><Reference><Citation>Reich C, Ostropolets A, Ryan P, et al. OHDSI standardized vocabularies&#x2014;a large-scale centralized reference ontology for international data harmonization. J Am Med Inform Assoc . 2024;31:583&#x2013;590.</Citation></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, et al. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform . 2016;64:333&#x2013;341.</Citation></Reference><Reference><Citation>Seong Y, You SC, Ostropolets A, et al. Incorporation of Korean electronic data interchange vocabulary into observational medical outcomes partnership vocabulary. Healthc Inform Res . 2021;27:29&#x2013;38.</Citation></Reference><Reference><Citation>Kim J-W, Kim C, Kim K-H, et al. Scalable infrastructure supporting reproducible nationwide healthcare data analysis toward FAIR stewardship. Sci Data . 2023;10:674.</Citation></Reference><Reference><Citation>Ostropolets A, Albogami Y, Conover M, et al. Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational study. J Am Med Inform Assoc . 2023;30:859&#x2013;868.</Citation></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Pratt N, et al. Principles of large-scale evidence generation and evaluation across a network of databases (LEGEND). J Am Med Inform Assoc . 2020;27:1331&#x2013;1337.</Citation></Reference><Reference><Citation>Hallinan CM, Ward R, Hart GK, et al. Seamless EMR data access: integrated governance, digital health and the OMOP-CDM. BMJ Health Care Inform . 2024;31:e100953.</Citation></Reference><Reference><Citation>Puttmann D, De Keizer N, Cornet R, et al. FAIRifying a quality registry using OMOP CDM: challenges and solutions. Stud Health Technol Inform . 2022;294:367&#x2013;371.</Citation></Reference><Reference><Citation>Puttmann D, de Groot R, de Keizer N, et al. Assessing the FAIRness of databases on the EHDEN portal: a case study on two Dutch ICU databases. Int J Med Inform . 2023;176:105104.</Citation></Reference><Reference><Citation>Wolfien M, Ahmadi N, Fitzer K, et al. Ten topics to get started in medical informatics research. J Med Internet Res . 2023;25:e45948.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform . 2015;216:574&#x2013;578.</Citation></Reference><Reference><Citation>OHDSI News and Updates&#x2013;OHDSI.</Citation></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. The Lancet . 2019;394:1816&#x2013;1826.</Citation></Reference><Reference><Citation>You SC, Seo SI, Falconer T, et al. Ranitidine use and incident cancer in a multinational cohort. JAMA Netw Open . 2023;6:e2333495.</Citation></Reference><Reference><Citation>Keloth VK, Banda JM, Gurley M, et al. Representing and utilizing clinical textual data for real world studies: an OHDSI approach. J Biomed Inform . 2023;142:104343.</Citation></Reference><Reference><Citation>Park J, You SC, Jeong E, et al. A framework (SOCRATex) for hierarchical annotation of unstructured electronic health records and integration into a standardized medical database: development and usability study. JMIR Med Inform . 2021;9:e23983.</Citation></Reference><Reference><Citation>Shin SJ, You SC, Park YR, et al. Genomic common data model for seamless interoperation of biomedical data in clinical practice: retrospective study. J Med Internet Res . 2019;21:e13249.</Citation></Reference><Reference><Citation>Belenkaya R, Gurley MJ, Golozar A, et al. Extending the OMOP common data model and standardized vocabularies to support observational cancer research. JCO Clin Cancer Inform . 2021;5:12&#x2013;20.</Citation></Reference><Reference><Citation>Park C, You SC, Jeon H, et al. Development and validation of the radiology common data model (R-CDM) for the international standardization of medical imaging data. Yonsei Med J . 2022;63(Suppl):S74&#x2013;S83.</Citation></Reference><Reference><Citation>Vreeman DJ, Abhyankar S, Wang KC, et al. The LOINC RSNA radiology playbook&#x2014;a unified terminology for radiology procedures. J Am Med Inform Assoc . 2018;25:885&#x2013;893.</Citation></Reference><Reference><Citation>Park WY, Jeon K, Schmidt TS, et al. Development of medical imaging data standardization for imaging-based observational research: OMOP common data model extension. J Imaging Inform Med . 2024;37:899&#x2013;908.</Citation></Reference><Reference><Citation>Varma DR. Managing DICOM images: tips and tricks for the radiologist. Indian J Radiol Imaging . 2012;22:4&#x2013;13.</Citation></Reference><Reference><Citation>Dance A. Sharper signals: how machine learning is cleaning up microscopy images. Nature . 2021;589:318&#x2013;319.</Citation></Reference><Reference><Citation>Westbrook C. Handbook of MRI Technique . Chapter 3 ed. New York, NY: John Wiley &amp; Sons; 2021.</Citation></Reference><Reference><Citation>Sosna J. Fewer reproducible radiomic features mean better reproducibility within the same patient. Radiology . 2019;293:592&#x2013;593.</Citation></Reference><Reference><Citation>Yang Y, Xia L, Liu P, et al. A prospective multicenter clinical research study validating the effectiveness and safety of a chest x-ray&#x2013;based pulmonary tuberculosis screening software JF CXR-1 built on a convolutional neural network algorithm. Front Med . 2023;10:1195451.</Citation></Reference><Reference><Citation>Fedorov A, Longabaugh WJR, Pot D, et al. NCI imaging data commons. Cancer Res . 2021;81:4188&#x2013;4193.</Citation></Reference><Reference><Citation>Bonmat&#xed; LM, Miguel A, Su&#xe1;rez A, et al. CHAIMELEON project: creation of a Pan-European repository of health imaging data for the development of AI-powered cancer management tools. Front Oncol . 2022;12.</Citation></Reference><Reference><Citation>Gorgolewski KJ, Auer T, Calhoun VD, et al. The brain imaging data structure, a format for organizing and describing outputs of neuroimaging experiments. Sci Data . 2016;3:160044.</Citation></Reference><Reference><Citation>Saenz A, Chen E, Marklund H, et al. The MAIDA initiative: establishing a framework for global medical-imaging data sharing. Lancet Digit Health . 2024;6:e6&#x2013;e8.</Citation></Reference><Reference><Citation>Halford JJ, Clunie DA, Brinkmann BH, et al. Standardization of neurophysiology signal data into the DICOM&#xae; standard. Clin Neurophysiol . 2021;132:993&#x2013;997.</Citation></Reference><Reference><Citation>Baxter R, Nind T, Sutherland J, et al. The Scottish Medical Imaging Archive: 57.3 million radiology studies linked to their medical records. Radiol Artif Intell . 2023;6:e220266.</Citation></Reference><Reference><Citation>Ueda D, Kakinuma T, Fujita S, et al. Fairness of artificial intelligence in healthcare: review and recommendations. Jpn J Radiol . 2024;42:3&#x2013;15.</Citation></Reference><Reference><Citation>Sheller MJ, Edwards B, Reina GA, et al. Federated learning in medicine: facilitating multi-institutional collaborations without sharing patient data. Sci Rep . 2020;10:12598.</Citation></Reference><Reference><Citation>McMahan HB, Moore E, Ramage D, et al. Communication-efficient learning of deep networks from decentralized data. arXiv . 2023.</Citation></Reference><Reference><Citation>Mahon P, Chatzitheofilou I, Dekker A, et al. A federated learning system for precision oncology in Europe: DigiONE. Nat Med . 2024;30:334&#x2013;337.</Citation></Reference><Reference><Citation>Lee GH, Park J, Kim J, et al. Feasibility study of federated learning on the distributed research network of OMOP common data model. Healthc Inform Res . 2023;29:168&#x2013;173.</Citation></Reference><Reference><Citation>Huang SC, Pareek A, Seyyedi S, et al. Fusion of medical imaging and electronic health records using deep learning: a systematic review and implementation guidelines. NPJ Digit Med . 2020;3:136.</Citation></Reference><Reference><Citation>Oren O, Gersh BJ, Bhatt DL. Artificial intelligence in medical imaging: switching from radiographic pathological data to clinically meaningful endpoints. Lancet Digit Health . 2020;2:e486&#x2013;e488.</Citation></Reference><Reference><Citation>Cui C, Yang H, Wang Y, et al. Deep multimodal fusion of image and non-image data in disease diagnosis and prognosis: a review. Prog Biomed Eng (Bristol) . 2023;5:022001.</Citation></Reference><Reference><Citation>Fritz B, Yi PH, Kijowski R, et al. Radiomics and deep learning for disease detection in musculoskeletal radiology: an overview of novel MRI- and CT-based approaches. Invest Radiol . 2023;58:3&#x2013;13.</Citation></Reference><Reference><Citation>Ma J, He Y, Li F, et al. Segment anything in medical images. Nat Commun . 2024;15:654.</Citation></Reference><Reference><Citation>Alsentzer E, Rasmussen MJ, Fontoura R, et al. Zero-shot interpretable phenotyping of postpartum hemorrhage using large language models. NPJ Digit Med . 2023;6:212.</Citation></Reference><Reference><Citation>Shyr C, Hu Y, Harris PA, et al. Identifying and extracting rare disease phenotypes with large language models. J Healthc Informatics Res . 2024;8:438&#x2013;461.</Citation></Reference><Reference><Citation>Topol EJ. AI-enabled opportunistic medical scan interpretation. Lancet . 2024;403:1842.</Citation></Reference><Reference><Citation>Vogt N. Reproducibility in MRI. Nat Methods . 2023;20:34.</Citation></Reference><Reference><Citation>Wennmann M, Ming W, Bauer F, et al. Prediction of bone marrow biopsy results from MRI in multiple myeloma patients using deep learning and radiomics. Invest Radiol . 2023;58:754&#x2013;765.</Citation></Reference><Reference><Citation>Roberts M, Driggs D, Thorpe M, et al. Common pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scans. Nat Mach Intell . 2021;3:199&#x2013;217.</Citation></Reference><Reference><Citation>Sohn E. The reproducibility issues that haunt health-care AI. Nature . 2023;613:402&#x2013;403.</Citation></Reference><Reference><Citation>Wilson JR, Prevedello LM, Witiw CD, et al. Data liberation and crowdsourcing in medical research: the intersection of collective and artificial intelligence. Radiol Artif Intell . 2024;6:e230006.</Citation></Reference><Reference><Citation>Bell LC, Shimron E. Sharing data is essential for the future of AI in medical imaging. Radiol Artif Intell . 2024;6:e230337.</Citation></Reference><Reference><Citation>Perkel JM. How to fix your scientific coding errors. Nature . 2022;602:172&#x2013;173.</Citation></Reference><Reference><Citation>McKiernan EC, Barba L, Bourne PE, et al. Policy recommendations to ensure that research software is openly accessible and reusable. PLoS Biol . 2023;21:e3002204.</Citation></Reference><Reference><Citation>Hosny A, Parmar C, Quackenbush J, et al. Artificial intelligence in radiology. Nat Rev Cancer . 2018;18:500&#x2013;510.</Citation></Reference><Reference><Citation>Shah NH, Halamka JD, Saria S, et al. A Nationwide network of health AI assurance laboratories. JAMA . 2024;331:245&#x2013;249.</Citation></Reference><Reference><Citation>Thrall JH, Li X, Li Q, et al. Artificial intelligence and machine learning in radiology: opportunities, challenges, pitfalls, and criteria for success. J Am Coll Radiol . 2018;15(3, Part B):504&#x2013;508.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>